<?xml version="1.0" standalone="yes"?>
<REMINDER_EXCHANGE_FILE_ENTRY>
<PACKAGE_VERSION>2.0P65</PACKAGE_VERSION>
<INDEX_AT>43843</INDEX_AT>
<SOURCE>
<NAME>UPDATE_2_0_483A VA-ONCOLOGY BREAST CA CLINICAL PATHWAYS UPDAT</NAME>
<USER>PACKER,REMINDER</USER>
<SITE>FOIA</SITE>
<ENV>NATREM^NATREM^oitausdhctlexb.r02.domain.ext^NATREM:LEXR0TSVR</ENV>
<DATE_PACKED>06/09/2026@08:52:36</DATE_PACKED>
</SOURCE>
<DESCRIPTION><![CDATA[
The following Clinical Reminder items were selected for packing:
REMINDER DIALOG
  VA-ONCOLOGY BRCA STAGE I-III PATHWAY
  VA-GP ONC BREAST CA IV ANY ER/PR/HER2+
 
REMINDER TERM
  VA-REMINDER UPDATE_2_0_483A
]]></DESCRIPTION>
<KEYWORDS>
</KEYWORDS>
<PACKING ATTRIBUTES><![CDATA[
<ATTRIBUTE>GROUPING DIALOG COMPONENTS</ATTRIBUTE>
]]></PACKING ATTRIBUTES>
<M_ROUTINE>
<ROUTINE_NAME>PXRMPDEM</ROUTINE_NAME>
<CHECKSUM>380043725</CHECKSUM>
<CODE>
<![CDATA[
PXRMPDEM ;SLC/PKR - Computed findings for patient demographics. ;02/28/2022
 ;;2.0;CLINICAL REMINDERS;**5,4,11,12,17,18,24,47,42,78**;Feb 04, 2005
 ;
 ;DBIA   USED
 ;10061  DEM^VADPT
 ;10035  $P(^DPT(DFN,0),U,3)
 ;10060  ^VA(200)
 ;1372   ^DGPT
 ;1378   ^DGPM
 ;======================================================
AGE(DFN,TEST,DATE,VALUE,TEXT) ;Computed finding for returning a patient's
 ;age
 S DATE=$$NOW^PXRMDATE,TEST=1
 I $D(PXRMPDEM) D  Q
 . S VALUE=PXRMPDEM("AGE")
 . I +PXRMPDEM("DOD")=0 S VALUE("DECEASED")=0 Q
 . I +PXRMPDEM("DOD")>0 S VALUE("DECEASED")=1,TEXT="Patient is deceased"
 I '$D(PXRMPDEM) D
 . N DOB,DOD
 .;DBIA #10035
 . S DOB=$P(^DPT(DFN,0),U,3)
 . S DOD=$P($G(^DPT(DFN,.35)),U,1)
 . S VALUE=$$AGE^PXRMAGE(DOB,DOD,$$NOW^PXRMDATE)
 . I +DOD=0 S VALUE("DECEASED")=0 Q
 . I +DOD>0 S VALUE("DECEASED")=1,TEXT="Patient is deceased"
 Q
 ;
 ;======================================================
DFA(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;This computed finding
 ;returns the date the patient turns a specified age. Based on
 ;work by AJM: 9/16/08.
 ;DBIA #10035 DATE OF BIRTH is a required field.
 I TEST="" S NFOUND=0,DATE(1)=$$NOW^PXRMDATE,TEST(1)=0 Q
 S TEST=$P(TEST,".",1)
 N BDAY,DOB,YEAR,YOB
 S NFOUND=1
 S DOB=$S($D(PXRMDOB):PXRMDOB,1:$P(^DPT(DFN,0),U,3))
 S YOB=$E(DOB,1,3)
 S BDAY=$E(DOB,4,7)
 S YEAR=YOB+TEST
 I BDAY="0229",'$$ISLEAP^PXRMDATE(YEAR) S BDAY="0228"
 S (DATE(1),VALUE(1,"VALUE"))=YEAR_BDAY
 S TEST(1)=1
 S TEXT(1)="Patient "_$S(DATE(1)>$$NOW^PXRMDATE:"will be ",1:"was ")_+TEST_" years old on "_$$FMTE^XLFDT(DATE(1),"5Z")
 Q
 ;
 ;======================================================
DOB(DFN,TEST,DATE,VALUE,TEXT) ;Computed finding for a patient's
 ;date of birth.
 I $D(PXRMPDEM) S VALUE=PXRMPDEM("DOB")
 ;DBIA #10035 DATE OF BIRTH is a required field.
 I '$D(PXRMPDEM) S VALUE=$P(^DPT(DFN,0),U,3)
 S TEST=$S(VALUE<$$NOW^PXRMDATE:1,1:0)
 I TEST S DATE=VALUE,TEXT=$$EDATE^PXRMDATE(VALUE)
 Q
 ;
 ;======================================================
DOD(DFN,TEST,DATE,VALUE,TEXT)   ;Computed finding for a patient's
 ;date of death.
 I $D(PXRMPDEM) S VALUE=+PXRMPDEM("DOD")
 ;DBIA #10035
 I '$D(PXRMPDEM) S VALUE=+$P($G(^DPT(DFN,.35)),U,1)
 S TEST=$S(VALUE=0:0,VALUE>$$NOW^PXRMDATE:0,1:1)
 I TEST S DATE=VALUE,TEXT=$$EDATE^PXRMDATE(VALUE)
 Q
 ;
 ;======================================================
EMPLOYE(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;This computed finding
 ;will return true if the patient is an employee.
 ;DBIA #10035, #10060
 N EDATE,IEN,PAID,SSN,TDATE
 S NFOUND=0,DATE(1)=$$NOW^PXRMDATE,TEST(1)=0
 S SSN=$P($G(^DPT(DFN,0)),U,9)
 I SSN="" Q
 ;Use SSN to make the link to file #200.
 S IEN=+$O(^VA(200,"SSN",SSN,""))
 I IEN=0 Q
 S PAID=+$P($G(^VA(200,IEN,450)),U,1)
 I PAID=0 Q
 ;Get the entered date.
 S EDATE=+$P(^VA(200,IEN,1),U,7)
 S VALUE(1,"DATE ENTERED")=EDATE
 I (EDATE=0)!(EDATE>EDT) Q
 ;Check for a termination date.
 S TDATE=+$P(^VA(200,IEN,0),U,11)
 S VALUE(1,"TERMINATION DATE")=TDATE
 I (TDATE>0),(TDATE<BDT) Q
 S NFOUND=1,TEST(1)=1,TEXT(1)="Patient is an employee."
 Q
 ;
 ;======================================================
ETHNY(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;Computed finding for
 ;a patient's ethnicity.
 N CNT,CNT1,VADM
 D DEM^VADPT
 I $D(VADM(11))'=11 S NFOUND=0 D KVA^VADPT Q
 S NGET=$S(NGET<0:-NGET,1:NGET)
 S (CNT,CNT1)=0
 F  S CNT=$O(VADM(11,CNT)) Q:(CNT="")!(CNT1=NGET)  D
 . S CNT1=CNT1+1,TEST(CNT1)=1,DATE(CNT1)=$$NOW^PXRMDATE
 . S TEXT(CNT1)="",VALUE(CNT1,"VALUE")=$P($G(VADM(11,CNT)),U,2)
 S NFOUND=CNT1
 D KVA^VADPT
 Q
 ;
 ;======================================================
HDISCH(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,DATA,TEXT) ;Computed finding for
 ;a list of a patient's discharge dates from PTF.
 ;References to ^DGPT covered by DBIA #1372.
 N DAS,DDATE,DDATEL,DONE,FEEBASIS,IEN,IND,INCEN,INFEE,NF,SDIR,TEMP,TYPE
 S TEMP=$$UP^XLFSTR(TEST)
 S TEMP=$P(TEMP,"IN:",2)
 S INFEE=$S(TEMP["FEE":1,1:0)
 S INCEN=$S(TEMP["CEN":1,1:0)
 S IEN="",NFOUND=0
 F  S IEN=$O(^DGPT("B",DFN,IEN)) Q:IEN=""  D
 . S DDATE=+$P($G(^DGPT(IEN,70)),U,1)
 . I DDATE>0,DDATE'<BDT,DDATE'>EDT S NFOUND=NFOUND+1,DDATEL(DDATE,NFOUND)=^DGPT(IEN,0)
 I NFOUND=0 Q
 S SDIR=$S(NGET<0:1,1:-1)
 S NGET=$S(NGET<0:-NGET,1:NGET)
 S (DONE,NF)=0
 S DDATE=""
 F IND=1:1:NFOUND Q:DONE  D
 . S DDATE=$O(DDATEL(DDATE),SDIR)
 . I DDATE="" S DONE=1 Q
 . S IEN=0
 . F  S IEN=$O(DDATEL(DDATE,IEN)) Q:(IEN="")!(DONE)  D
 .. S FEEBASIS=$P(DDATEL(DDATE,IEN),U,4)
 .. I FEEBASIS=1,'INFEE Q
 ..;Type 1 is PTF, Type 2 is Census
 .. S TYPE=$P(DDATEL(DDATE,IEN),U,11)
 .. I TYPE=2,'INCEN Q
 .. S NF=NF+1
 .. S TEST(NF)=1,(DATE(NF),VALUE(NF))=DDATE
 .. I FEEBASIS=1 S TEXT(NF)="Fee basis"
 .. I TYPE=2 S TEXT(NF)="Census"
 .. I NF=NGET S DONE=1
 S NFOUND=NF
 Q
 ;
 ;======================================================
INP(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;Computed finding for
 ;determining if a patient is an inpatient on the evaluation date.
 N VAIN,VAINDT
 S NFOUND=1
 S (DATE(1),VAINDT)=$$NOW^PXRMDATE
 D INP^VADPT
 I VAIN(1)="" S TEST(1)=0 D KVAR^VADPT Q
 S TEST(1)=1
 S VALUE(1,"PRIMARY PROVIDER")=$P(VAIN(2),U,2)
 S VALUE(1,"TREATING SPECIALTY")=$P(VAIN(3),U,2)
 S VALUE(1,"WARD LOCATION")=$P(VAIN(4),U,2)
 S VALUE(1,"ADMISSION DATE/TIME")=$P(VAIN(7),U,1)
 S VALUE(1,"ADMISSION TYPE")=$P(VAIN(8),U,2)
 S VALUE(1,"ATTENDING PHYSICIAN")=$P(VAIN(11),U,2)
 S TEXT(1)="Patient is an inpatient; admission date/time: "_$$FMTE^XLFDT(VALUE(1,"ADMISSION DATE/TIME"),"5Z")
 D KVAR^VADPT
 Q
 ;
 ;======================================================
NEWRACE(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;Computed finding
 ;for returning a patient's multi-valued race.
 N IND,VADM
 D DEM^VADPT
 S NFOUND=VADM(12)
 I NFOUND=0 D KVA^VADPT Q
 S NGET=$S(NGET<0:-NGET,1:NGET)
 I NFOUND>NGET S NFOUND=NGET
 F IND=1:1:NFOUND D
 . S TEST(IND)=1,DATE(IND)=$$NOW^PXRMDATE,TEXT(IND)=""
 . S (VALUE(IND,"VALUE"),VALUE(IND,"RACE"))=$P(VADM(12,IND),U,2)
 D KVA^VADPT
 Q
 ;
 ;======================================================
PATTYPE(DFN,TEST,DATE,VALUE,TEXT) ;Computed finding to return the patient
 ;type
 N VAEL
 S VALUE=""
 S DATE=$$NOW^PXRMDATE
 D ELIG^VADPT
 S TEST=$S($G(VAEL(6))'="":1,1:0)
 S VALUE=$P(VAEL(6),U,2)
 D KVAR^VADPT
 Q
 ;
 ;======================================================
RACE(DFN,TEST,DATE,VALUE,TEXT) ;Computed finding for checking a patient's race.
 N RACE
 S DATE=$$NOW^PXRMDATE
 ;DBIA #10035
 S RACE=$P($G(^DPT(DFN,0)),U,6)
 I RACE="" S TEST=0,VALUE="" Q
 Q
 ;
 ;======================================================
SEX(DFN,TEST,DATE,VALUE,TEXT) ;Computed finding for returning a patient's
 ;sex.
 S DATE=$$NOW^PXRMDATE,TEST=1
 I $D(PXRMPDEM) S VALUE=PXRMPDEM("SEX") Q
 ;DBIA #10035 SEX is a required field.
 I '$D(PXRMPDEM) S VALUE=$P(^DPT(DFN,0),U,2)
 Q
 ;
SEXOR(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;
 N ARRAY,IDX,CNT,SDIR,SOSTATUS,SO,SOTYPE,TMPDATE,VADM
 D DEM^VADPT
 S SOSTATUS=$G(TEST),NFOUND=0
 ;collect data from file 2
 S IDX=0 F  S IDX=$O(VADM(14,1,IDX)) Q:IDX'>0  D
 .I SOSTATUS'="",SOSTATUS'=$P(VADM(14,1,IDX,1),U) Q
 .S SO=$P(VADM(14,1,IDX),U),SOTYPE=$P(VADM(14,1,IDX),U,2)
 .S TMPDATE=$S(+$P(VADM(14,1,IDX,3),U,2)>0:$P(VADM(14,1,IDX,3),U,2),1:$P(VADM(14,1,IDX,2),U,2))
 .I TMPDATE<BDT Q
 .I TMPDATE>EDT Q
 .S ARRAY(TMPDATE)=""
 .S ARRAY(TMPDATE,IDX,"SEXUAL ORIENTATION")=SO
 .S ARRAY(TMPDATE,IDX,"SEXUAL ORIENTATION TYPE CODE")=SOTYPE
 .S ARRAY(TMPDATE,IDX,"SO STATUS")=$P(VADM(14,1,IDX,1),U)
 ;handle return based off positive or negative NGET value 
 S SDIR=$S(NGET<0:+1,1:-1)
 S TMPDATE=""
 F  S TMPDATE=$O(ARRAY(TMPDATE),SDIR) Q:TMPDATE=""  D
 .S NFOUND=NFOUND+1 I NFOUND>NGET Q
 .S DATE(NFOUND)=TMPDATE,TEST(NFOUND)=1
 .S VALUE(NFOUND,"SEXUAL ORIENTATION DAS")=DFN
 .S TEXT(NFOUND)="List of sexual orientation:"
 .S IDX=0,CNT=0 F  S IDX=$O(ARRAY(TMPDATE,IDX)) Q:IDX'>0  D
 ..S VALUE(NFOUND,"SEXUAL ORIENTATION",IDX)=ARRAY(TMPDATE,IDX,"SEXUAL ORIENTATION")
 ..S VALUE(NFOUND,"SEXUAL ORIENTATION TYPE CODE",IDX)=ARRAY(TMPDATE,IDX,"SEXUAL ORIENTATION TYPE CODE")
 ..S CNT=CNT+1,TEXT(NFOUND,CNT)="            "_VALUE(NFOUND,"SEXUAL ORIENTATION",IDX)
 ..I VALUE(NFOUND,"SEXUAL ORIENTATION",IDX)="Another Option, please describe",$G(VADM(14,2))'="" D
 ...S VALUE(NFOUND,"OTHER DESCRIPTION")=VADM(14,2)
 ...S CNT=CNT+1,TEXT(NFOUND,CNT)="              Description: "_VALUE(NFOUND,"OTHER DESCRIPTION")
 ..S VALUE(NFOUND,"SO STATUS",IDX)=ARRAY(TMPDATE,IDX,"SO STATUS")
 ..S VALUE(NFOUND,"DIALOG")=1,VALUE(NFOUND,"PACKAGE")="REGISTRATION",VALUE(NFOUND,"PACKAGE PREFIX")="DG"
 Q
 ;
 ;======================================================
WASINP(DFN,NGET,BDT,EDT,NFOUND,TEST,DATE,VALUE,TEXT) ;Computed finding for
 ;determining if a patient was an inpatient in the period defined
 ;by BDT and EDT.
 ;Access to DGPM covered by DBIA #1378
 N ADATE,ADM,ADML,AWARD,DDATE,DWARD,IEN,INDT,FDATE,LOS,NOCC,SDIR,TEMP
 S FDATE=$S(TEST="DISCH":"DISCH",1:"ADM")
 S SDIR=$S(NGET<0:1,1:-1)
 S NOCC=$S(NGET<0:-NGET,1:NGET)
 S NFOUND=0
 ;Use the "ATID3" index to build a list of past admissions and
 ;discharges.
 S INDT=""
 F  S INDT=$O(^DGPM("ATID3",DFN,INDT)) Q:INDT=""  D
 . S IEN=$O(^DGPM("ATID3",DFN,INDT,""))
 . S TEMP=^DGPM(IEN,0)
 . S DDATE=$P(TEMP,U,1)
 . S ADM=$P(TEMP,U,14)
 . S ADATE=$P(^DGPM(ADM,0),U,1)
 . I $$OVERLAP^PXRMINDX(ADATE,DDATE,BDT,EDT)'="O" Q
 . S AWARD=$$GET1^DIQ(405,ADM,.06),DWARD=$$GET1^DIQ(405,IEN,200)
 . S ADML(ADATE)=DDATE_U_AWARD_U_DWARD
 ;Check for the last admission and add it if it is not on the list.
 S INDT=$O(^DGPM("ATID1",DFN,""))
 I INDT'="" D
 . S IEN=$O(^DGPM("ATID1",DFN,INDT,""))
 . S TEMP=^DGPM(IEN,0)
 . S ADATE=$P(TEMP,U,1),AWARD=$$GET1^DIQ(405,IEN,.06)
 . I $D(ADML(ADATE)) Q
 . S IEN=$P(TEMP,U,17)
 .;Since this is the last admission there may not be a discharge.
 . S DDATE=$S(IEN="":$$NOW^PXRMDATE,1:$P(^DGPM(IEN,0),U,1))
 . I $$OVERLAP^PXRMINDX(ADATE,DDATE,BDT,EDT)="O" D
 .. S DWARD=$S(IEN="":"",1:$$GET1^DIQ(405,IEN,200))
 .. S ADML(ADATE)=DDATE_U_AWARD_U_DWARD
 ;Sort the list.
 S ADATE=""
 F  S ADATE=$O(ADML(ADATE),SDIR) Q:(NFOUND=NOCC)!(ADATE="")  D
 . S NFOUND=NFOUND+1,TEST(NFOUND)=1
 . S DDATE=$P(ADML(ADATE),U,1),AWARD=$P(ADML(ADATE),U,2),DWARD=$P(ADML(ADATE),U,3)
 . I DDATE="" S DDATE=PXRMDATE
 . S DATE(NFOUND)=$S(FDATE="DISCH":DDATE,1:ADATE)
 . S LOS=$$FMDIFF^XLFDT(DDATE,ADATE)+1
 . S TEMP="Inpatient from: "_$$FMTE^XLFDT(ADATE,"5Z")_" to "
 . S TEMP=TEMP_$S(DDATE=PXRMDATE:"now",1:$$FMTE^XLFDT(DDATE,"5Z"))
 . S TEMP=TEMP_"; Length of stay "_LOS_" days"
 . S TEMP=TEMP_"; Admission ward: "_AWARD
 . I DWARD'="" S TEMP=TEMP_"; Discharge ward: "_DWARD
 . S TEXT(NFOUND)=TEMP
 . S VALUE(NFOUND,"ADMISSION DATE")=ADATE
 . S VALUE(NFOUND,"ADMISSION WARD")=AWARD
 . S VALUE(NFOUND,"DISCHARGE DATE")=DDATE
 . S VALUE(NFOUND,"DISCHARGE WARD")=DWARD
 . S VALUE(NFOUND,"LENGTH OF STAY")=LOS
 Q
 ;
]]>
</CODE>
</M_ROUTINE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER GENERAL FINDINGS</FILE_NAME>
<FILE_NUMBER>801.46</FILE_NUMBER>
<POINT_01>VIEW PROGRESS NOTE TEXT</POINT_01>
<INTERNAL_ENTRY_NUMBER>454</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1980651110</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.46;+454,;.01~VIEW PROGRESS NOTE TEXT
801.46;+454,;2~CLINICAL REMINDERS^PXRM
801.46;+454,;3~801.41
801.46;+454,;10~GF_VIEW
801.46;+454,;11~VIEW PROGRESS NOTE TEXT
801.46;+454,;20~SINGLE VALUE
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC OFF REASON TXT</POINT_01>
<INTERNAL_ENTRY_NUMBER>7551</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3060976492</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+7551,;.01~VA-ONC OFF REASON TXT
8927.1;+7551,;.02~Text
8927.1;+7551,;.03~NO
8927.1;+7551,;.04~0
8927.1;+7551,;.07~0
8927.1;+7551,;.08~NO
8927.1;+7551,;.09~NO
8927.1;+7551,;.1~0
8927.1;+7551,;.11~0
8927.1;+7551,;.12~0
8927.1;+7551,;.13~0
8927.1;+7551,;.14~0
8927.1;+7551,;.15~0
8927.1;+7551,;10~WP-start~1
REASON OFF PATHWAY:
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC TREATMENT REASON</POINT_01>
<INTERNAL_ENTRY_NUMBER>7550</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1969443347</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+7550,;.01~VA-ONC TREATMENT REASON
8927.1;+7550,;.02~Text
8927.1;+7550,;.03~NO
8927.1;+7550,;.04~0
8927.1;+7550,;.07~0
8927.1;+7550,;.08~NO
8927.1;+7550,;.09~YES
8927.1;+7550,;.1~0
8927.1;+7550,;.11~0
8927.1;+7550,;.12~0
8927.1;+7550,;.13~0
8927.1;+7550,;.14~0
8927.1;+7550,;.15~0
8927.1;+7550,;10~WP-start~1
(specify treatment Veteran will receive)
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC CLINICAL TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>20438</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1857125923</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+20438,;.01~VA-ONC CLINICAL TRIAL
8927.1;+20438,;.02~Text
8927.1;+20438,;.03~NO
8927.1;+20438,;.04~0
8927.1;+20438,;.07~0
8927.1;+20438,;.08~NO
8927.1;+20438,;.09~YES
8927.1;+20438,;.1~0
8927.1;+20438,;.11~0
8927.1;+20438,;.12~0
8927.1;+20438,;.13~0
8927.1;+20438,;.14~0
8927.1;+20438,;.15~0
8927.1;+20438,;10~WP-start~1
Clinical trial (specify name of study and NCT number):
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC NEITHER ON/OFF</POINT_01>
<INTERNAL_ENTRY_NUMBER>11983</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3160039956</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+11983,;.01~VA-ONC NEITHER ON/OFF
8927.1;+11983,;.02~Text
8927.1;+11983,;.03~NO
8927.1;+11983,;.04~0
8927.1;+11983,;.07~0
8927.1;+11983,;.08~NO
8927.1;+11983,;.09~YES
8927.1;+11983,;.1~0
8927.1;+11983,;.11~0
8927.1;+11983,;.12~0
8927.1;+11983,;.13~0
8927.1;+11983,;.14~0
8927.1;+11983,;.15~0
8927.1;+11983,;10~WP-start~1
(neither on or off pathway)
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC PRESUMPTIVE CONDITIONS</POINT_01>
<INTERNAL_ENTRY_NUMBER>11598</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2232043786</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+11598,;.01~VA-ONC PRESUMPTIVE CONDITIONS
8927.1;+11598,;.02~Hyperlink
8927.1;+11598,;.03~NO
8927.1;+11598,;.04~0
8927.1;+11598,;.05~Presumptive Disability Benefits
8927.1;+11598,;.07~0
8927.1;+11598,;.08~NO
8927.1;+11598,;.09~YES
8927.1;+11598,;.1~0
8927.1;+11598,;.11~2
8927.1;+11598,;.12~0
8927.1;+11598,;.13~0
8927.1;+11598,;.14~0
8927.1;+11598,;.15~0
8927.1;+11598,;3~https://www.benefits.domain.ext/BENEFITS/factsheets/serviceconnected/presumption.pdf
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC PATHWAYS SHAREPOINT</POINT_01>
<INTERNAL_ENTRY_NUMBER>18139</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1384808292</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+18139,;.01~VA-ONC PATHWAYS SHAREPOINT
8927.1;+18139,;.02~Hyperlink
8927.1;+18139,;.03~NO
8927.1;+18139,;.04~0
8927.1;+18139,;.05~Clinical Pathways SharePoint
8927.1;+18139,;.07~0
8927.1;+18139,;.08~NO
8927.1;+18139,;.09~YES
8927.1;+18139,;.1~0
8927.1;+18139,;.11~2
8927.1;+18139,;.12~0
8927.1;+18139,;.13~0
8927.1;+18139,;.14~0
8927.1;+18139,;.15~0
8927.1;+18139,;3~https://dvagov.sharepoint.com/sites/VHACP
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU TEMPLATE FIELD</FILE_NAME>
<FILE_NUMBER>8927.1</FILE_NUMBER>
<POINT_01>VA-ONC CT RN NAV</POINT_01>
<INTERNAL_ENTRY_NUMBER>17561</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3884540967</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8927.1;+17561,;.01~VA-ONC CT RN NAV
8927.1;+17561,;.02~Hyperlink
8927.1;+17561,;.03~NO
8927.1;+17561,;.04~0
8927.1;+17561,;.05~VA Cancer Clinical Trial Nurse Navigator
8927.1;+17561,;.07~0
8927.1;+17561,;.08~NO
8927.1;+17561,;.09~YES
8927.1;+17561,;.1~0
8927.1;+17561,;.11~0
8927.1;+17561,;.12~0
8927.1;+17561,;.13~0
8927.1;+17561,;.14~0
8927.1;+17561,;.15~0
8927.1;+17561,;3~mailto:CancerClinicalTrialsNavigation@domain.ext
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-REMINDER UPDATES [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>8722</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>981639263</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+8722,;.01~VA-REMINDER UPDATES [C]
9999999.64;+8722,;.1~CATEGORY
9999999.64;+8722,;100~LOCAL
9999999.64;+8722,;200~Reminder Updates
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-UPDATE_2_0_483A</POINT_01>
<INTERNAL_ENTRY_NUMBER>46543</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3720093763</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46543,;.01~VA-UPDATE_2_0_483A
9999999.64;+46543,;.03~VA-REMINDER UPDATES [C]
9999999.64;+46543,;.08~YES
9999999.64;+46543,;.1~FACTOR
9999999.64;+46543,;100~NATIONAL
9999999.64;+46543,;200~Update_2_0_483A
9999999.64;+46543,;201~WP-start~1
VA-UPDATE_2_0_483A
9999999.65;+46544,+46543,;.01~MAY 15, 2026@07:47:42
9999999.65;+46544,+46543,;2~WP-start~1
Copied from VA-UPDATE_2_0_483
9999999.65;+46545,+46543,;.01~MAY 15, 2026@07:47:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46544^1
46545^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33208</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1356335848</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33208,;.01~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33208,;.08~YES
9999999.64;+33208,;.1~CATEGORY
9999999.64;+33208,;100~NATIONAL
9999999.64;+33208,;101~VHA ONCOLOGY
9999999.64;+33208,;200~Breast Cancer-Stage Any IV ER/PR/HER2+ Clinical Pathway
9999999.64;+33208,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage IV Any ER/PR/HER2+
Clinical Pathway
9999999.65;+33209,+33208,;.01~MAR 11, 2024@12:35:45
9999999.65;+33209,+33208,;2~WP-start~1
Copied from VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY
9999999.65;+33210,+33208,;.01~MAR 11, 2024@12:38:50
9999999.65;+33211,+33208,;.01~MAR 21, 2024@10:56:27
9999999.65;+33212,+33208,;.01~DEC 03, 2024@13:57:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33209^1
33210^2
33211^3
33212^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33236</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3535892675</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33236,;.01~VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH RSN
9999999.64;+33236,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33236,;.08~YES
9999999.64;+33236,;.1~FACTOR
9999999.64;+33236,;100~NATIONAL
9999999.64;+33236,;101~VHA ONCOLOGY
9999999.64;+33236,;200~BRCA Stage IV Any ER not chemo cand after tras off path rsn
9999999.64;+33236,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; not a chemotherapy candidate after
adjuvant trastuzumab, off pathway reason
9999999.65;+33237,+33236,;.01~MAR 12, 2024@08:24:25
9999999.65;+33237,+33236,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH TX
9999999.65;+33238,+33236,;.01~MAR 12, 2024@08:25:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33237^1
33238^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33235</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3284840352</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33235,;.01~VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH TX
9999999.64;+33235,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33235,;.08~YES
9999999.64;+33235,;.1~FACTOR
9999999.64;+33235,;100~NATIONAL
9999999.64;+33235,;101~VHA ONCOLOGY
9999999.64;+33235,;200~BRCA Stage IV Any ER not chemo cand after tras off path tx
9999999.64;+33235,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; not a chemotherapy candidate after
adjuvant trastuzumab, off pathway treatment
9999999.65;+33236,+33235,;.01~MAR 12, 2024@08:22:11
9999999.65;+33236,+33235,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NOT CHEMO CLIN TRIAL
9999999.65;+33237,+33235,;.01~MAR 12, 2024@08:23:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33236^1
33237^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NOT CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33232</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1809794776</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33232,;.01~VA-ONC BRCA IV ANY ER NOT CHEMO CLIN TRIAL
9999999.64;+33232,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33232,;.08~YES
9999999.64;+33232,;.1~FACTOR
9999999.64;+33232,;100~NATIONAL
9999999.64;+33232,;101~VHA ONCOLOGY
9999999.64;+33232,;200~BRCA Stage IV Any ER not chemo cand after tras clin trial
9999999.64;+33232,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; not a chemotherapy candidate after
adjuvant trastuzumab, on pathway clinical trial
9999999.65;+33233,+33232,;.01~MAR 12, 2024@08:09:36
9999999.65;+33233,+33232,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
9999999.65;+33234,+33232,;.01~MAR 12, 2024@08:11:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33233^1
33234^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NOT CHEMO ABE+TRAS+FUL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33234</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3769264475</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33234,;.01~VA-ONC BRCA IV ANY ER NOT CHEMO ABE+TRAS+FUL
9999999.64;+33234,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33234,;.08~YES
9999999.64;+33234,;.1~FACTOR
9999999.64;+33234,;100~NATIONAL
9999999.64;+33234,;101~VHA ONCOLOGY
9999999.64;+33234,;200~BRCA Stage IV Any ER not chemo cand after tras abemaciclib+tras
9999999.64;+33234,;201~WP-start~3
Breast Cancer-Stage IV Any ER/PR/HER2+; not a chemotherapy candidate after
adjuvant trastuzumab, on pathway abemaciclib and trastuzumab plus 
fulvestrant if HR positive
9999999.65;+33235,+33234,;.01~MAR 12, 2024@08:16:49
9999999.65;+33235,+33234,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NOT CHEMO TRAS+LAP
9999999.65;+33236,+33234,;.01~MAR 12, 2024@08:20:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33235^1
33236^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NOT CHEMO TRAS+LAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33233</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3589146365</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33233,;.01~VA-ONC BRCA IV ANY ER NOT CHEMO TRAS+LAP
9999999.64;+33233,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33233,;.08~YES
9999999.64;+33233,;.1~FACTOR
9999999.64;+33233,;100~NATIONAL
9999999.64;+33233,;101~VHA ONCOLOGY
9999999.64;+33233,;200~BRCA Stage IV Any ER not chemo cand after tras trastuzumab+lap
9999999.64;+33233,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; not a chemotherapy candidate after
adjuvant trastuzumab, on pathway trastuzumab and lapatinib
9999999.65;+33234,+33233,;.01~MAR 12, 2024@08:12:46
9999999.65;+33234,+33233,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NOT CHEMO CLIN TRIAL
9999999.65;+33235,+33233,;.01~MAR 12, 2024@08:14:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33234^1
33235^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO NERA+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33226</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1628328080</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33226,;.01~VA-ONC BRCA IV ANY ER CHEMO NERA+CAP
9999999.64;+33226,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33226,;.08~YES
9999999.64;+33226,;.1~FACTOR
9999999.64;+33226,;100~NATIONAL
9999999.64;+33226,;101~VHA ONCOLOGY
9999999.64;+33226,;200~BRCA Stage IV Any ER chemo cand after tras neratinib+cap
9999999.64;+33226,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, on pathway neratinib and capecitabine
9999999.65;+33227,+33226,;.01~MAR 12, 2024@07:42:35
9999999.65;+33227,+33226,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
9999999.65;+33228,+33226,;.01~MAR 12, 2024@07:45:07
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33227^1
33228^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO TRAS+OTHER CHEMO</POINT_01>
<INTERNAL_ENTRY_NUMBER>33231</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2132527104</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33231,;.01~VA-ONC BRCA IV ANY ER CHEMO TRAS+OTHER CHEMO
9999999.64;+33231,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33231,;.08~YES
9999999.64;+33231,;.1~FACTOR
9999999.64;+33231,;100~NATIONAL
9999999.64;+33231,;101~VHA ONCOLOGY
9999999.64;+33231,;200~BRCA Stage IV Any ER chemo cand after tras trastuzumab+chemo
9999999.64;+33231,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, on pathway trastuzumab and chemotherapy
9999999.65;+33232,+33231,;.01~MAR 12, 2024@07:57:10
9999999.65;+33232,+33231,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO TRAS+VINO
9999999.65;+33233,+33231,;.01~MAR 12, 2024@08:06:28
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33232^1
33233^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33225</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3025710897</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33225,;.01~VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
9999999.64;+33225,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33225,;.08~YES
9999999.64;+33225,;.1~FACTOR
9999999.64;+33225,;100~NATIONAL
9999999.64;+33225,;101~VHA ONCOLOGY
9999999.64;+33225,;200~BRCA Stage IV Any ER chemo cand after tras clin trial
9999999.64;+33225,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, on pathway clinical trial
9999999.65;+33226,+33225,;.01~MAR 12, 2024@07:37
9999999.65;+33226,+33225,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER METS CLIN TRIAL
9999999.65;+33227,+33225,;.01~MAR 12, 2024@07:39:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33226^1
33227^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33229</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3371916754</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33229,;.01~VA-ONC BRCA IV ANY ER CHEMO OFF PATH RSN
9999999.64;+33229,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33229,;.08~YES
9999999.64;+33229,;.1~FACTOR
9999999.64;+33229,;100~NATIONAL
9999999.64;+33229,;101~VHA ONCOLOGY
9999999.64;+33229,;200~BRCA Stage IV Any ER chemo cand after tras off path reason
9999999.64;+33229,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, off pathway reason
9999999.65;+33230,+33229,;.01~MAR 12, 2024@07:51:41
9999999.65;+33230,+33229,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX
9999999.65;+33231,+33229,;.01~MAR 12, 2024@07:52:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33230^1
33231^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33228</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3765840427</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33228,;.01~VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX
9999999.64;+33228,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33228,;.08~YES
9999999.64;+33228,;.1~FACTOR
9999999.64;+33228,;100~NATIONAL
9999999.64;+33228,;101~VHA ONCOLOGY
9999999.64;+33228,;200~BRCA Stage IV Any ER chemo cand after tras off path treatment
9999999.64;+33228,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, off pathway treatment
9999999.65;+33229,+33228,;.01~MAR 12, 2024@07:48:34
9999999.65;+33229,+33228,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
9999999.65;+33230,+33228,;.01~MAR 12, 2024@07:51:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33229^1
33230^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO LAP+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33230</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4079971203</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33230,;.01~VA-ONC BRCA IV ANY ER CHEMO LAP+CAP
9999999.64;+33230,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33230,;.08~YES
9999999.64;+33230,;.1~FACTOR
9999999.64;+33230,;100~NATIONAL
9999999.64;+33230,;101~VHA ONCOLOGY
9999999.64;+33230,;200~BRCA Stage IV Any ER chemo cand after tras lapatinib+cap
9999999.64;+33230,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, on pathway lapatinib and capecitabine
9999999.65;+33231,+33230,;.01~MAR 12, 2024@07:53:55
9999999.65;+33231,+33230,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO NERA+CAP
9999999.65;+33232,+33230,;.01~MAR 12, 2024@07:55:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33231^1
33232^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS TUC/PERT/DOCE+</POINT_01>
<INTERNAL_ENTRY_NUMBER>46120</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2276891537</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46120,;.01~VA-ONC BRCA IV ANY ER NO METS TUC/PERT/DOCE+
9999999.64;+46120,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+46120,;.08~YES
9999999.64;+46120,;.1~FACTOR
9999999.64;+46120,;100~NATIONAL
9999999.64;+46120,;101~VHA ONCOLOGY
9999999.64;+46120,;200~BRCA Stage IV Any ER No Brain Mets s/p Fam-tras Tuc/Pert/Doce+
9999999.64;+46120,;201~WP-start~4
Breast Cancer-Stage IV Any ER/PR/HER2+; no brain metastases after 
fam-trastuzumab deruxtecan, on pathway trastuzumab, pertuzumab, and 
docetaxel (4-6 months max response), followed by, tucatinib, trastuzumab, 
and capecitabine, and then, ado-trastuzumab emtansine
9999999.65;+46121,+46120,;.01~APR 06, 2026@09:15:35
9999999.65;+46121,+46120,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NO METS ADO-TRAS+TUC+TRAS+CAP
9999999.65;+46122,+46120,;.01~APR 06, 2026@09:16:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46121^1
46122^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33224</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1715553955</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33224,;.01~VA-ONC BRCA IV ANY ER NO METS OFF PATH RSN
9999999.64;+33224,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33224,;.08~YES
9999999.64;+33224,;.1~FACTOR
9999999.64;+33224,;100~NATIONAL
9999999.64;+33224,;101~VHA ONCOLOGY
9999999.64;+33224,;200~BRCA Stage IV Any ER No Brain Mets after fam-tras off path rsn
9999999.64;+33224,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; no brain metastases after 
fam-trastuzumab deruxtecan, off pathway reason
9999999.65;+33225,+33224,;.01~MAR 12, 2024@07:22:09
9999999.65;+33225,+33224,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NO METS OFF PATH TX
9999999.65;+33226,+33224,;.01~MAR 12, 2024@07:22:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33225^1
33226^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33223</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3198986450</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33223,;.01~VA-ONC BRCA IV ANY ER NO METS OFF PATH TX
9999999.64;+33223,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33223,;.08~YES
9999999.64;+33223,;.1~FACTOR
9999999.64;+33223,;100~NATIONAL
9999999.64;+33223,;101~VHA ONCOLOGY
9999999.64;+33223,;200~BRCA Stage IV Any ER No Brain Mets after fam-tras off path tx
9999999.64;+33223,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; no brain metastases after 
fam-trastuzumab deruxtecan, off pathway treatment
9999999.65;+33224,+33223,;.01~MAR 12, 2024@07:20:50
9999999.65;+33224,+33223,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL
9999999.65;+33225,+33223,;.01~MAR 12, 2024@07:21:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33224^1
33225^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33221</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2361862065</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33221,;.01~VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL
9999999.64;+33221,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33221,;.08~YES
9999999.64;+33221,;.1~FACTOR
9999999.64;+33221,;100~NATIONAL
9999999.64;+33221,;101~VHA ONCOLOGY
9999999.64;+33221,;200~BRCA Stage IV Any ER No Brain Mets after fam-tras clin trial
9999999.64;+33221,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; no brain metastases after 
fam-trastuzumab deruxtecan, on pathway clinical trial
9999999.65;+33222,+33221,;.01~MAR 12, 2024@07:10:13
9999999.65;+33222,+33221,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER METS CLIN TRIAL
9999999.65;+33223,+33221,;.01~MAR 12, 2024@07:13:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33222^1
33223^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS TUC/TRAS/CAP+</POINT_01>
<INTERNAL_ENTRY_NUMBER>46119</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1295656522</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46119,;.01~VA-ONC BRCA IV ANY ER METS TUC/TRAS/CAP+
9999999.64;+46119,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+46119,;.08~YES
9999999.64;+46119,;.1~FACTOR
9999999.64;+46119,;100~NATIONAL
9999999.64;+46119,;101~VHA ONCOLOGY
9999999.64;+46119,;200~BRCA Stage IV Any ER Brain Mets s/p Fam-tras Tuc/tras/cap+
9999999.64;+46119,;201~WP-start~4
Breast Cancer-Stage IV Any ER/PR/HER2+; brain metastases after 
fam-trastuzumab deruxtecan, on pathway tucatinib, trastuzumab and 
capecitabine followed by: ado-trastuzumab followed by tucatinib, 
trastuzumab, and capecitabine
9999999.65;+46120,+46119,;.01~APR 06, 2026@09:08:41
9999999.65;+46120,+46119,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NO METS ADO-TRAS+TUC+TRAS+CAP
9999999.65;+46121,+46119,;.01~APR 06, 2026@09:11:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46120^1
46121^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33217</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4241843480</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33217,;.01~VA-ONC BRCA IV ANY ER METS CLIN TRIAL
9999999.64;+33217,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33217,;.08~YES
9999999.64;+33217,;.1~FACTOR
9999999.64;+33217,;100~NATIONAL
9999999.64;+33217,;101~VHA ONCOLOGY
9999999.64;+33217,;200~BRCA Stage IV Any ER Brain Mets after fam-tras clin trial
9999999.64;+33217,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; Brain metastases after 
fam-trastuzumab deruxtecan, on pathway clinical trial
9999999.65;+33218,+33217,;.01~MAR 12, 2024@06:33:47
9999999.65;+33218,+33217,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER > 12M TAX CLIN TRIAL
9999999.65;+33219,+33217,;.01~MAR 12, 2024@06:38:25
9999999.65;+33220,+33217,;.01~MAR 12, 2024@06:45:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33218^1
33219^2
33220^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33220</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2029448382</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33220,;.01~VA-ONC BRCA IV ANY ER METS OFF PATH RSN
9999999.64;+33220,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33220,;.08~YES
9999999.64;+33220,;.1~FACTOR
9999999.64;+33220,;100~NATIONAL
9999999.64;+33220,;101~VHA ONCOLOGY
9999999.64;+33220,;200~BRCA Stage IV Any ER Brain Mets after fam-tras off path reason
9999999.64;+33220,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; Brain metastases after 
fam-trastuzumab deruxtecan, off pathway reason
9999999.65;+33221,+33220,;.01~MAR 12, 2024@06:47:05
9999999.65;+33221,+33220,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER METS OFF PATH TX
9999999.65;+33222,+33220,;.01~MAR 12, 2024@06:47:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33221^1
33222^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33219</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2299803254</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33219,;.01~VA-ONC BRCA IV ANY ER METS OFF PATH TX
9999999.64;+33219,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33219,;.08~YES
9999999.64;+33219,;.1~FACTOR
9999999.64;+33219,;100~NATIONAL
9999999.64;+33219,;101~VHA ONCOLOGY
9999999.64;+33219,;200~BRCA Stage IV Any ER Brain Mets after fam-tras off path tx
9999999.64;+33219,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; Brain metastases after 
fam-trastuzumab deruxtecan, off pathway treatment
9999999.65;+33220,+33219,;.01~MAR 12, 2024@06:42:56
9999999.65;+33220,+33219,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER METS CLIN TRIAL
9999999.65;+33221,+33219,;.01~MAR 12, 2024@06:44:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33220^1
33221^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46118</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>55173957</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46118,;.01~VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH RSN
9999999.64;+46118,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+46118,;.08~YES
9999999.64;+46118,;.1~FACTOR
9999999.64;+46118,;100~NATIONAL
9999999.64;+46118,;101~VHA ONCOLOGY
9999999.64;+46118,;200~BRCA Stage IV Any ER Initial Rx Off Path RSN
9999999.64;+46118,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+, initial treatment; off pathway 
reason
9999999.65;+46119,+46118,;.01~APR 06, 2026@09:03:58
9999999.65;+46119,+46118,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH TX
9999999.65;+46120,+46118,;.01~APR 06, 2026@09:04:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46119^1
46120^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46117</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4070215337</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46117,;.01~VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH TX
9999999.64;+46117,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+46117,;.08~YES
9999999.64;+46117,;.1~FACTOR
9999999.64;+46117,;100~NATIONAL
9999999.64;+46117,;101~VHA ONCOLOGY
9999999.64;+46117,;200~BRCA Stage IV Any ER Initial Rx Off Path TX
9999999.64;+46117,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+, initial treatment; off pathway 
treatment
9999999.65;+46118,+46117,;.01~APR 06, 2026@09:02:53
9999999.65;+46118,+46117,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER INITIAL RX CLIN TRIAL
9999999.65;+46119,+46117,;.01~APR 06, 2026@09:03:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46118^1
46119^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER INITIAL RX FAM-T-DXD+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>46116</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1665017538</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46116,;.01~VA-ONC BRCA IV ANY ER INITIAL RX FAM-T-DXD+PERT
9999999.64;+46116,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+46116,;.08~YES
9999999.64;+46116,;.1~FACTOR
9999999.64;+46116,;100~NATIONAL
9999999.64;+46116,;101~VHA ONCOLOGY
9999999.64;+46116,;200~BRCA Stage IV Any ER Initial Rx Fam-T-Dxd+ Pertuzumab
9999999.64;+46116,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+, initial treatment; on pathway 
Fam-trastuzumab deruxtecan and pertuzumab
9999999.65;+46117,+46116,;.01~APR 06, 2026@09:01:24
9999999.65;+46117,+46116,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER INITIAL RX CLIN TRIAL
9999999.65;+46118,+46116,;.01~APR 06, 2026@09:02:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46117^1
46118^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER INITIAL RX CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46115</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>48296451</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46115,;.01~VA-ONC BRCA IV ANY ER INITIAL RX CLIN TRIAL
9999999.64;+46115,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+46115,;.08~YES
9999999.64;+46115,;.1~FACTOR
9999999.64;+46115,;100~NATIONAL
9999999.64;+46115,;101~VHA ONCOLOGY
9999999.64;+46115,;200~BRCA Stage IV Any ER Initial Rx Clinical Trial
9999999.64;+46115,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+, initial treatment; on pathway 
clinical trial
9999999.65;+46116,+46115,;.01~APR 06, 2026@08:59:56
9999999.65;+46116,+46115,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER < 12M TAX CLIN TRIAL
9999999.65;+46117,+46115,;.01~APR 06, 2026@09:00:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46116^1
46117^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONCOLOGY PATHWAYS [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>23018</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1432377665</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+23018,;.01~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+23018,;.08~YES
9999999.64;+23018,;.1~CATEGORY
9999999.64;+23018,;100~NATIONAL
9999999.64;+23018,;101~VHA ONCOLOGY
9999999.64;+23018,;200~Oncology Pathways
9999999.64;+23018,;201~WP-start~2
For all pathways; the health factor that designates that the template was 
opened.
9999999.65;+23019,+23018,;.01~AUG 24, 2021@09:05:11
9999999.65;+23019,+23018,;2~WP-start~1
 Creation.
9999999.65;+23020,+23018,;.01~SEP 03, 2024@07:46:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
23019^1
23020^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STG IV ANY ER/PR/HER2+ CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33207</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3551745698</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33207,;.01~VA-ONC BRCA STG IV ANY ER/PR/HER2+ CLINICAL PATHWAY
9999999.64;+33207,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+33207,;.08~YES
9999999.64;+33207,;.1~FACTOR
9999999.64;+33207,;100~NATIONAL
9999999.64;+33207,;101~VHA ONCOLOGY
9999999.64;+33207,;200~Breast Cancer-Stage IV Any ER/PR/HER2+ Clinical Pathway
9999999.64;+33207,;201~WP-start~2
Designates that the Category for all health factors in Breast 
Cancer-Stage IV Any ER/PR/HER2+ Clinical Pathway was opened.
9999999.65;+33208,+33207,;.01~MAR 11, 2024@12:32:15
9999999.65;+33208,+33207,;2~WP-start~1
Copied from VA-ONC BRCA STG IV ER+ OR PR+/HER2- CLINICAL PATHWAY
9999999.65;+33209,+33207,;.01~MAR 11, 2024@12:33:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33208^1
33209^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA GERMLINE TESTING PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>36443</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>409274120</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36443,;.01~VA-ONC BRCA GERMLINE TESTING PATHWAY [C]
9999999.64;+36443,;.08~YES
9999999.64;+36443,;.1~CATEGORY
9999999.64;+36443,;100~NATIONAL
9999999.64;+36443,;101~VHA ONCOLOGY
9999999.64;+36443,;200~Breast Cancer Germline Genetic Testing Pathway
9999999.64;+36443,;201~WP-start~1
Category for Breast Cancer Germline Genetic Testing Pathway health factors
9999999.65;+36444,+36443,;.01~JUL 11, 2024@07:25:52
9999999.65;+36444,+36443,;2~WP-start~1
Copied from VA-ONC PRCA MOLECULAR TESTING PATHWAY [C]
9999999.65;+36445,+36443,;.01~JUL 11, 2024@07:29:29
9999999.65;+36446,+36443,;.01~AUG 14, 2024@13:47:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36444^1
36445^2
36446^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA GERMLINE TEST NOT ORDERED OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36450</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>982874700</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36450,;.01~VA-ONC BRCA GERMLINE TEST NOT ORDERED OFF PATH RSN
9999999.64;+36450,;.03~VA-ONC BRCA GERMLINE TESTING PATHWAY [C]
9999999.64;+36450,;.08~YES
9999999.64;+36450,;.1~FACTOR
9999999.64;+36450,;100~NATIONAL
9999999.64;+36450,;101~VHA ONCOLOGY
9999999.64;+36450,;200~Breast CA Germline Testing Not Ordered Reason
9999999.64;+36450,;201~WP-start~2
Breast Cancer Molecular Testing germline genetic testing; off pathway
testing not performed reason
9999999.65;+36451,+36450,;.01~JUL 11, 2024@08:28:41
9999999.65;+36451,+36450,;2~WP-start~1
Copied from VA-ONC PRCA GERM CGP ORDER: OFF PATH
9999999.65;+36452,+36450,;.01~JUL 11, 2024@08:30:07
9999999.65;+36453,+36450,;.01~AUG 15, 2024@09:48:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36451^1
36452^2
36453^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-CCGS CLINICAL CANCER GENETICS SERVICE [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>28031</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3018026634</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+28031,;.01~VA-CCGS CLINICAL CANCER GENETICS SERVICE [C]
9999999.64;+28031,;.08~YES
9999999.64;+28031,;.1~CATEGORY
9999999.64;+28031,;100~NATIONAL
9999999.64;+28031,;101~VHA ONCOLOGY
9999999.64;+28031,;200~Clinical Cancer Genetics Service (CCGS)
9999999.64;+28031,;201~WP-start~2
Category for Clinical Cancer Genetics Service (CCGS) germline ordering 
template health factors
9999999.65;+28032,+28031,;.01~MAR 28, 2023@06:31:43
9999999.65;+28032,+28031,;2~WP-start~1
 Creation.
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
28032^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-CCGS GERMLINE TESTING DECLINED</POINT_01>
<INTERNAL_ENTRY_NUMBER>28037</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4185025365</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+28037,;.01~VA-CCGS GERMLINE TESTING DECLINED
9999999.64;+28037,;.03~VA-CCGS CLINICAL CANCER GENETICS SERVICE [C]
9999999.64;+28037,;.08~YES
9999999.64;+28037,;.1~FACTOR
9999999.64;+28037,;100~NATIONAL
9999999.64;+28037,;101~VHA ONCOLOGY
9999999.64;+28037,;200~CCGS Germline Testing Declined
9999999.64;+28037,;201~WP-start~1
Clinical Cancer Genetics Service (CCGS) germline testing declined
9999999.65;+28038,+28037,;.01~MAR 28, 2023@06:36:24
9999999.65;+28038,+28037,;2~WP-start~1
 Creation.
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
28038^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA GERMLINE TEST DECLINED</POINT_01>
<INTERNAL_ENTRY_NUMBER>36451</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3449263109</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36451,;.01~VA-ONC BRCA GERMLINE TEST DECLINED
9999999.64;+36451,;.03~VA-ONC BRCA GERMLINE TESTING PATHWAY [C]
9999999.64;+36451,;.08~YES
9999999.64;+36451,;.1~FACTOR
9999999.64;+36451,;100~NATIONAL
9999999.64;+36451,;101~VHA ONCOLOGY
9999999.64;+36451,;200~Breast CA Germline Testing Declined
9999999.64;+36451,;201~WP-start~2
Breast Cancer Molecular Testing germline genetic testing; on pathway
patient declined testing
9999999.65;+36452,+36451,;.01~JUL 11, 2024@08:31:01
9999999.65;+36452,+36451,;2~WP-start~1
Copied from VA-ONC PRCA GERM CGP PT DECLINE: ON PATH
9999999.65;+36453,+36451,;.01~JUL 11, 2024@08:33:41
9999999.65;+36454,+36451,;.01~AUG 15, 2024@09:44:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36452^1
36453^2
36454^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA GERMLINE TEST CONSENT DISCUSSION IN FUTURE</POINT_01>
<INTERNAL_ENTRY_NUMBER>36449</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4213204638</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36449,;.01~VA-ONC BRCA GERMLINE TEST CONSENT DISCUSSION IN FUTURE
9999999.64;+36449,;.03~VA-ONC BRCA GERMLINE TESTING PATHWAY [C]
9999999.64;+36449,;.08~YES
9999999.64;+36449,;.1~FACTOR
9999999.64;+36449,;100~NATIONAL
9999999.64;+36449,;101~VHA ONCOLOGY
9999999.64;+36449,;200~Breast CA Germline Testing Consent Discussion in Future
9999999.64;+36449,;201~WP-start~2
Breast Cancer Molecular Testing germline genetic testing; consent 
discussion in the future neither on or off pathway
9999999.65;+36450,+36449,;.01~JUL 11, 2024@08:25:19
9999999.65;+36450,+36449,;2~WP-start~1
Copied from VA-ONC PRCA GERMLINE TEST CONSENT DISCUSSION IN FUTURE
9999999.65;+36451,+36449,;.01~JUL 11, 2024@08:27:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36450^1
36451^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA GERMLINE TEST ORDERED</POINT_01>
<INTERNAL_ENTRY_NUMBER>36452</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1352919523</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36452,;.01~VA-ONC BRCA GERMLINE TEST ORDERED
9999999.64;+36452,;.03~VA-ONC BRCA GERMLINE TESTING PATHWAY [C]
9999999.64;+36452,;.08~YES
9999999.64;+36452,;.1~FACTOR
9999999.64;+36452,;100~NATIONAL
9999999.64;+36452,;101~VHA ONCOLOGY
9999999.64;+36452,;200~Breast CA Germline Testing Ordered
9999999.64;+36452,;201~WP-start~2
Breast Cancer Molecular Testing germline genetic testing on pathway
testing ordered
9999999.65;+36453,+36452,;.01~JUL 11, 2024@08:42:21
9999999.65;+36453,+36452,;2~WP-start~1
Copied from VA-ONC PRCA GERM CGP ORDER: ON PATH
9999999.65;+36454,+36452,;.01~JUL 11, 2024@08:45:59
9999999.65;+36455,+36452,;.01~AUG 15, 2024@09:43:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36453^1
36454^2
36455^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA GERMLINE TESTING</POINT_01>
<INTERNAL_ENTRY_NUMBER>36444</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1527535868</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36444,;.01~VA-ONC BRCA GERMLINE TESTING
9999999.64;+36444,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+36444,;.08~YES
9999999.64;+36444,;.1~FACTOR
9999999.64;+36444,;100~NATIONAL
9999999.64;+36444,;101~VHA ONCOLOGY
9999999.64;+36444,;200~Breast Cancer Germline Genetic Testing Pathway
9999999.64;+36444,;201~WP-start~2
Designates that the Breast Cancer Germline Genetic Testing Pathway was
opened
9999999.65;+36445,+36444,;.01~JUL 11, 2024@07:44:36
9999999.65;+36445,+36444,;2~WP-start~1
Copied from VA-ONC PRCA MOLECULAR TESTING
9999999.65;+36446,+36444,;.01~JUL 11, 2024@07:45:31
9999999.65;+36447,+36444,;.01~AUG 14, 2024@13:44:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36445^1
36446^2
36447^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>46131</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3161236547</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46131,;.01~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46131,;.08~YES
9999999.64;+46131,;.1~CATEGORY
9999999.64;+46131,;100~NATIONAL
9999999.64;+46131,;101~VHA ONCOLOGY
9999999.64;+46131,;200~Breast CA-Adj Hormone Therapy ER+ or PR+/HER2- Clinical Pathway
9999999.64;+46131,;201~WP-start~2
Category for all health factors in Breast Cancer- Adjuvant Hormone 
Therapy for ER+ or PR+/HER2- Clinical Pathway.
9999999.65;+46132,+46131,;.01~APR 06, 2026@10:01:43
9999999.65;+46132,+46131,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.65;+46133,+46131,;.01~APR 06, 2026@10:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46132^1
46133^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46210</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1521095566</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46210,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH RSN
9999999.64;+46210,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46210,;.08~YES
9999999.64;+46210,;.1~FACTOR
9999999.64;+46210,;100~NATIONAL
9999999.64;+46210,;101~VHA ONCOLOGY
9999999.64;+46210,;200~BRCA Adj Hormone Tx HER2- Low Risk Pst-Men/M- Y1-5 Off Path RSN
9999999.64;+46210,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
post-menopausal or not male, years 1-5; off pathway reason
9999999.65;+46211,+46210,;.01~APR 07, 2026@08:28:29
9999999.65;+46211,+46210,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH TX
9999999.65;+46212,+46210,;.01~APR 07, 2026@08:28:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46211^1
46212^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46209</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1202337684</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46209,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH TX
9999999.64;+46209,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46209,;.08~YES
9999999.64;+46209,;.1~FACTOR
9999999.64;+46209,;100~NATIONAL
9999999.64;+46209,;101~VHA ONCOLOGY
9999999.64;+46209,;200~BRCA Adj Hormone Tx HER2- Low Risk Pst-Men/M- Y1-5 Off Path TX
9999999.64;+46209,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
post-menopausal or not male, years 1-5; off pathway treatment
9999999.65;+46210,+46209,;.01~APR 07, 2026@08:27:35
9999999.65;+46210,+46209,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 TAM+SURV
9999999.65;+46211,+46209,;.01~APR 07, 2026@08:28:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46210^1
46211^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46206</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3403851294</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46206,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 CLIN TRIAL
9999999.64;+46206,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46206,;.08~YES
9999999.64;+46206,;.1~FACTOR
9999999.64;+46206,;100~NATIONAL
9999999.64;+46206,;101~VHA ONCOLOGY
9999999.64;+46206,;200~BRCA Adj Hormone Tx HER2- Low Risk Pst-Men/M- Y1-5 Clin Trial
9999999.64;+46206,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
post-menopausal or not male, years 1-5; on pathway clinical trial
9999999.65;+46207,+46206,;.01~APR 07, 2026@08:20:17
9999999.65;+46207,+46206,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 CLIN TRIAL
9999999.65;+46208,+46206,;.01~APR 07, 2026@08:21:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46207^1
46208^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 TAM+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46208</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3511937534</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46208,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 TAM+SURV
9999999.64;+46208,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46208,;.08~YES
9999999.64;+46208,;.1~FACTOR
9999999.64;+46208,;100~NATIONAL
9999999.64;+46208,;101~VHA ONCOLOGY
9999999.64;+46208,;200~BRCA Adj Hormone Tx HER2- Low Risk Pst-Men/M- Y1-5 Tam+Surv
9999999.64;+46208,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
post-menopausal or not male, years 1-5; on pathway tamoxifen followed by 
surveillance
9999999.65;+46209,+46208,;.01~APR 07, 2026@08:23:47
9999999.65;+46209,+46208,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 CLIN TRIAL
9999999.65;+46210,+46208,;.01~APR 07, 2026@08:24:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46209^1
46210^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 ANA+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46207</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1247442203</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46207,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 ANA+SURV
9999999.64;+46207,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46207,;.08~YES
9999999.64;+46207,;.1~FACTOR
9999999.64;+46207,;100~NATIONAL
9999999.64;+46207,;101~VHA ONCOLOGY
9999999.64;+46207,;200~BRCA Adj Hormone Tx HER2- Low Risk Pst-Men/M- Y1-5 Ana+Surv
9999999.64;+46207,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
post-menopausal or not male, years 1-5; on pathway anastrozole followed 
by surveillance
9999999.65;+46208,+46207,;.01~APR 07, 2026@08:22:23
9999999.65;+46208,+46207,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 CLIN TRIAL
9999999.65;+46209,+46207,;.01~APR 07, 2026@08:23:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46208^1
46209^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46205</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2187763686</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46205,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH RSN
9999999.64;+46205,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46205,;.08~YES
9999999.64;+46205,;.1~FACTOR
9999999.64;+46205,;100~NATIONAL
9999999.64;+46205,;101~VHA ONCOLOGY
9999999.64;+46205,;200~BRCA Adj Hormone Tx HER2- Low Risk Pre-Men/M+ Y1-5 Off Path RSN
9999999.64;+46205,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
pre-menopausal or male, years 1-5; off pathway reason
9999999.65;+46206,+46205,;.01~APR 07, 2026@08:16:41
9999999.65;+46206,+46205,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH TX
9999999.65;+46207,+46205,;.01~APR 07, 2026@08:17:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46206^1
46207^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46204</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>921761463</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46204,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH TX
9999999.64;+46204,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46204,;.08~YES
9999999.64;+46204,;.1~FACTOR
9999999.64;+46204,;100~NATIONAL
9999999.64;+46204,;101~VHA ONCOLOGY
9999999.64;+46204,;200~BRCA Adj Hormone Tx HER2- Low Risk Pre-Men/M+ Y1-5 Off Path TX
9999999.64;+46204,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
pre-menopausal or male, years 1-5; off pathway treatment
9999999.65;+46205,+46204,;.01~APR 07, 2026@08:13:44
9999999.65;+46205,+46204,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 TAM
9999999.65;+46206,+46204,;.01~APR 07, 2026@08:16:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46205^1
46206^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46200</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2029585173</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46200,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 CLIN TRIAL
9999999.64;+46200,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46200,;.08~YES
9999999.64;+46200,;.1~FACTOR
9999999.64;+46200,;100~NATIONAL
9999999.64;+46200,;101~VHA ONCOLOGY
9999999.64;+46200,;200~BRCA Adj Hormone Tx HER2- Low Risk Pre-Men/M+ Y1-5 Clin Trial
9999999.64;+46200,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
pre-menopausal or male, years 1-5; on pathway clinical trial
9999999.65;+46201,+46200,;.01~APR 07, 2026@08:03:03
9999999.65;+46201,+46200,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 CLIN TRIAL
9999999.65;+46202,+46200,;.01~APR 07, 2026@08:04:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46201^1
46202^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 ADT+ANA/SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46203</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1054674551</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46203,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 ADT+ANA/SURV
9999999.64;+46203,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46203,;.08~YES
9999999.64;+46203,;.1~FACTOR
9999999.64;+46203,;100~NATIONAL
9999999.64;+46203,;101~VHA ONCOLOGY
9999999.64;+46203,;200~BRCA Adj Hormone Tx HER2- Low Risk Pre-Men/M+ Y1-5 ADT+Ana/Surv
9999999.64;+46203,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
pre-menopausal or male, years 1-5; on pathway ADT+anastrozole followed by 
surveillance
9999999.65;+46204,+46203,;.01~APR 07, 2026@08:12:25
9999999.65;+46204,+46203,;2~WP-start~1
Copied from VA-MOVE SESSION FINE TUNE GOAL3-PRT MET
9999999.65;+46205,+46203,;.01~APR 07, 2026@08:13:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46204^1
46205^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OS+ANA/SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46202</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1594745611</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46202,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OS+ANA/SURV
9999999.64;+46202,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46202,;.08~YES
9999999.64;+46202,;.1~FACTOR
9999999.64;+46202,;100~NATIONAL
9999999.64;+46202,;101~VHA ONCOLOGY
9999999.64;+46202,;200~BRCA Adj Hormone Tx HER2- Low Risk Pre-Men/M+ Y1-5 OS+Ana/Surv
9999999.64;+46202,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
pre-menopausal or male, years 1-5; on pathway OS+anastrozole followed by 
surveillance
9999999.65;+46203,+46202,;.01~APR 07, 2026@08:06:11
9999999.65;+46203,+46202,;2~WP-start~1
Copied from VA-MOVE SESSION FINE TUNE GOAL3-PRT MET
9999999.65;+46204,+46202,;.01~APR 07, 2026@08:07:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46203^1
46204^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46201</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3367190403</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46201,;.01~VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 TAM
9999999.64;+46201,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46201,;.08~YES
9999999.64;+46201,;.1~FACTOR
9999999.64;+46201,;100~NATIONAL
9999999.64;+46201,;101~VHA ONCOLOGY
9999999.64;+46201,;200~BRCA Adj Hormone Tx HER2- Low Risk Pre-Men/M+ Y1-5 Tam
9999999.64;+46201,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, low risk, 
pre-menopausal or male, years 1-5; on pathway tamoxifen
9999999.65;+46202,+46201,;.01~APR 07, 2026@08:05:27
9999999.65;+46202,+46201,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 CLIN TRIAL
9999999.65;+46203,+46201,;.01~APR 07, 2026@08:05:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46202^1
46203^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46199</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2463443069</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46199,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH RSN
9999999.64;+46199,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46199,;.08~YES
9999999.64;+46199,;.1~FACTOR
9999999.64;+46199,;100~NATIONAL
9999999.64;+46199,;101~VHA ONCOLOGY
9999999.64;+46199,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y6-8 Off Path RSN
9999999.64;+46199,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 6-8; off pathway 
reason
9999999.65;+46200,+46199,;.01~APR 07, 2026@07:59:21
9999999.65;+46200,+46199,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH TX
9999999.65;+46201,+46199,;.01~APR 07, 2026@08:00:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46200^1
46201^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46198</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>93005633</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46198,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH TX
9999999.64;+46198,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46198,;.08~YES
9999999.64;+46198,;.1~FACTOR
9999999.64;+46198,;100~NATIONAL
9999999.64;+46198,;101~VHA ONCOLOGY
9999999.64;+46198,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y6-8 Off Path TX
9999999.64;+46198,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 6-8; off pathway 
treatment
9999999.65;+46199,+46198,;.01~APR 07, 2026@07:58:19
9999999.65;+46199,+46198,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 CLIN TRIAL
9999999.65;+46200,+46198,;.01~APR 07, 2026@07:59:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46199^1
46200^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46195</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>816388993</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46195,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 CLIN TRIAL
9999999.64;+46195,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46195,;.08~YES
9999999.64;+46195,;.1~FACTOR
9999999.64;+46195,;100~NATIONAL
9999999.64;+46195,;101~VHA ONCOLOGY
9999999.64;+46195,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y6-8 Clin Trial
9999999.64;+46195,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 6-8; on pathway
clinical trial
9999999.65;+46196,+46195,;.01~APR 07, 2026@07:12:13
9999999.65;+46196,+46195,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 CLIN TRIAL
9999999.65;+46197,+46195,;.01~APR 07, 2026@07:13:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46196^1
46197^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 TAM+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46196</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>178589066</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46196,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 TAM+SURV
9999999.64;+46196,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46196,;.08~YES
9999999.64;+46196,;.1~FACTOR
9999999.64;+46196,;100~NATIONAL
9999999.64;+46196,;101~VHA ONCOLOGY
9999999.64;+46196,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y6-8 Tam+Surv
9999999.64;+46196,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 6-8; on pathway 
tamoxifen followed by surveillance
9999999.65;+46197,+46196,;.01~APR 07, 2026@07:55:50
9999999.65;+46197,+46196,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 CLIN TRIAL
9999999.65;+46198,+46196,;.01~APR 07, 2026@07:56:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46197^1
46198^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 ANA+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46197</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>431324560</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46197,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 ANA+SURV
9999999.64;+46197,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46197,;.08~YES
9999999.64;+46197,;.1~FACTOR
9999999.64;+46197,;100~NATIONAL
9999999.64;+46197,;101~VHA ONCOLOGY
9999999.64;+46197,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y6-8 Ana+Surv
9999999.64;+46197,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 6-8; on pathway 
anastrozole followed by surveillance
9999999.65;+46198,+46197,;.01~APR 07, 2026@07:57:13
9999999.65;+46198,+46197,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 TAM+SURV
9999999.65;+46199,+46197,;.01~APR 07, 2026@07:57:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46198^1
46199^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46194</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3061807666</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46194,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH RSN
9999999.64;+46194,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46194,;.08~YES
9999999.64;+46194,;.1~FACTOR
9999999.64;+46194,;100~NATIONAL
9999999.64;+46194,;101~VHA ONCOLOGY
9999999.64;+46194,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y4-5 Off Path RSN
9999999.64;+46194,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 4-5; off pathway 
reason
9999999.65;+46195,+46194,;.01~APR 07, 2026@07:10:58
9999999.65;+46195,+46194,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH TX
9999999.65;+46196,+46194,;.01~APR 07, 2026@07:11:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46195^1
46196^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46193</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1698579919</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46193,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH TX
9999999.64;+46193,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46193,;.08~YES
9999999.64;+46193,;.1~FACTOR
9999999.64;+46193,;100~NATIONAL
9999999.64;+46193,;101~VHA ONCOLOGY
9999999.64;+46193,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y4-5 Off Path TX
9999999.64;+46193,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 4-5; off pathway 
treatment
9999999.65;+46194,+46193,;.01~APR 07, 2026@07:10
9999999.65;+46194,+46193,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 TAM
9999999.65;+46195,+46193,;.01~APR 07, 2026@07:10:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46194^1
46195^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46190</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2857754954</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46190,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 CLIN TRIAL
9999999.64;+46190,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46190,;.08~YES
9999999.64;+46190,;.1~FACTOR
9999999.64;+46190,;100~NATIONAL
9999999.64;+46190,;101~VHA ONCOLOGY
9999999.64;+46190,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y4-5 Clin Trial
9999999.64;+46190,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 4-5; on pathway
clinical trial
9999999.65;+46191,+46190,;.01~APR 07, 2026@06:56:14
9999999.65;+46191,+46190,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 CLIN TRIAL
9999999.65;+46192,+46190,;.01~APR 07, 2026@07:01:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46191^1
46192^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46192</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>931429577</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46192,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 TAM
9999999.64;+46192,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46192,;.08~YES
9999999.64;+46192,;.1~FACTOR
9999999.64;+46192,;100~NATIONAL
9999999.64;+46192,;101~VHA ONCOLOGY
9999999.64;+46192,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y4-5 Tam
9999999.64;+46192,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 4-5; on pathway 
tamoxifen
9999999.65;+46193,+46192,;.01~APR 07, 2026@07:09:16
9999999.65;+46193,+46192,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 ANA
9999999.65;+46194,+46192,;.01~APR 07, 2026@07:09:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46193^1
46194^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>46191</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2814503760</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46191,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 ANA
9999999.64;+46191,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46191,;.08~YES
9999999.64;+46191,;.1~FACTOR
9999999.64;+46191,;100~NATIONAL
9999999.64;+46191,;101~VHA ONCOLOGY
9999999.64;+46191,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y4-5 Ana
9999999.64;+46191,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 4-5; on pathway 
anastrozole
9999999.65;+46192,+46191,;.01~APR 07, 2026@07:07:21
9999999.65;+46192,+46191,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 CLIN TRIAL
9999999.65;+46193,+46191,;.01~APR 07, 2026@07:07:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46192^1
46193^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46189</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1086276266</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46189,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH RSN
9999999.64;+46189,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46189,;.08~YES
9999999.64;+46189,;.1~FACTOR
9999999.64;+46189,;100~NATIONAL
9999999.64;+46189,;101~VHA ONCOLOGY
9999999.64;+46189,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y1-3 Off Path RSN
9999999.64;+46189,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 1-3; off pathway
reason
9999999.65;+46190,+46189,;.01~APR 07, 2026@06:46:40
9999999.65;+46190,+46189,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH TX
9999999.65;+46191,+46189,;.01~APR 07, 2026@06:55:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46190^1
46191^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46188</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1223603092</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46188,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH TX
9999999.64;+46188,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46188,;.08~YES
9999999.64;+46188,;.1~FACTOR
9999999.64;+46188,;100~NATIONAL
9999999.64;+46188,;101~VHA ONCOLOGY
9999999.64;+46188,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y1-3 Off Path TX
9999999.64;+46188,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 1-3; off pathway
treatment
9999999.65;+46189,+46188,;.01~APR 07, 2026@06:45:39
9999999.65;+46189,+46188,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 ANA/RIB
9999999.65;+46190,+46188,;.01~APR 07, 2026@06:46:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46189^1
46190^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46185</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1606904237</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46185,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 CLIN TRIAL
9999999.64;+46185,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46185,;.08~YES
9999999.64;+46185,;.1~FACTOR
9999999.64;+46185,;100~NATIONAL
9999999.64;+46185,;101~VHA ONCOLOGY
9999999.64;+46185,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y1-3 Clin Trial
9999999.64;+46185,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 1-3; on pathway
clinical trial
9999999.65;+46186,+46185,;.01~APR 07, 2026@06:26:54
9999999.65;+46186,+46185,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 CLIN TRIAL
9999999.65;+46187,+46185,;.01~APR 07, 2026@06:34:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46186^1
46187^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 TAM/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>46187</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1975875911</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46187,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 TAM/RIB
9999999.64;+46187,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46187,;.08~YES
9999999.64;+46187,;.1~FACTOR
9999999.64;+46187,;100~NATIONAL
9999999.64;+46187,;101~VHA ONCOLOGY
9999999.64;+46187,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y1-3 Tam/Rib
9999999.64;+46187,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 1-3; on pathway
tamoxifen with ribociclib
9999999.65;+46188,+46187,;.01~APR 07, 2026@06:44:41
9999999.65;+46188,+46187,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 ANA/RIB
9999999.65;+46189,+46187,;.01~APR 07, 2026@06:45:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46188^1
46189^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 ANA/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>46186</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2432768563</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46186,;.01~VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 ANA/RIB
9999999.64;+46186,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46186,;.08~YES
9999999.64;+46186,;.1~FACTOR
9999999.64;+46186,;100~NATIONAL
9999999.64;+46186,;101~VHA ONCOLOGY
9999999.64;+46186,;200~BRCA Adj Hormone Tx HER2- Int Risk Pst-Men/M- Y1-3 Ana/Rib
9999999.64;+46186,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, post-menopausal or not male, years 1-3; on pathway
anastrozole with ribociclib
9999999.65;+46187,+46186,;.01~APR 07, 2026@06:35:39
9999999.65;+46187,+46186,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 CLIN TRIAL
9999999.65;+46188,+46186,;.01~APR 07, 2026@06:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46187^1
46188^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46184</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1456208747</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46184,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH RSN
9999999.64;+46184,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46184,;.08~YES
9999999.64;+46184,;.1~FACTOR
9999999.64;+46184,;100~NATIONAL
9999999.64;+46184,;101~VHA ONCOLOGY
9999999.64;+46184,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y6-8 Pth RSN
9999999.64;+46184,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 6-8; off pathway reason
9999999.65;+46185,+46184,;.01~APR 07, 2026@06:25:44
9999999.65;+46185,+46184,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH TX
9999999.65;+46186,+46184,;.01~APR 07, 2026@06:26:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46185^1
46186^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46183</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2952205665</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46183,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH TX
9999999.64;+46183,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46183,;.08~YES
9999999.64;+46183,;.1~FACTOR
9999999.64;+46183,;100~NATIONAL
9999999.64;+46183,;101~VHA ONCOLOGY
9999999.64;+46183,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y6-8 Pth TX
9999999.64;+46183,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 6-8; off pathway 
treatment
9999999.65;+46184,+46183,;.01~APR 07, 2026@06:22:59
9999999.65;+46184,+46183,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 TAM+SURV
9999999.65;+46185,+46183,;.01~APR 07, 2026@06:24:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46184^1
46185^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46180</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2623194687</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46180,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 CLIN TRIAL
9999999.64;+46180,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46180,;.08~YES
9999999.64;+46180,;.1~FACTOR
9999999.64;+46180,;100~NATIONAL
9999999.64;+46180,;101~VHA ONCOLOGY
9999999.64;+46180,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y6-8 Clin Trial
9999999.64;+46180,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 6-8; on pathway clinical 
trial
9999999.65;+46181,+46180,;.01~APR 07, 2026@06:11:50
9999999.65;+46181,+46180,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 CLIN TRIAL
9999999.65;+46182,+46180,;.01~APR 07, 2026@06:12:28
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46181^1
46182^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 TAM+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46181</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3103624845</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46181,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 TAM+SURV
9999999.64;+46181,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46181,;.08~YES
9999999.64;+46181,;.1~FACTOR
9999999.64;+46181,;100~NATIONAL
9999999.64;+46181,;101~VHA ONCOLOGY
9999999.64;+46181,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y6-8 Tam+Surv
9999999.64;+46181,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 6-8; on pathway 
tamoxifen followed by surveillance
9999999.65;+46182,+46181,;.01~APR 07, 2026@06:15:25
9999999.65;+46182,+46181,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 CLIN TRIAL
9999999.65;+46183,+46181,;.01~APR 07, 2026@06:20:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46182^1
46183^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 ANA+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46182</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>781024788</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46182,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 ANA+SURV
9999999.64;+46182,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46182,;.08~YES
9999999.64;+46182,;.1~FACTOR
9999999.64;+46182,;100~NATIONAL
9999999.64;+46182,;101~VHA ONCOLOGY
9999999.64;+46182,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y6-8 Ana+Surv
9999999.64;+46182,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 6-8; on pathway 
anastrozole followed by surveillance
9999999.65;+46183,+46182,;.01~APR 07, 2026@06:20:56
9999999.65;+46183,+46182,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 TAM+SURV
9999999.65;+46184,+46182,;.01~APR 07, 2026@06:21:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46183^1
46184^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46179</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1134005059</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46179,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH RSN
9999999.64;+46179,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46179,;.08~YES
9999999.64;+46179,;.1~FACTOR
9999999.64;+46179,;100~NATIONAL
9999999.64;+46179,;101~VHA ONCOLOGY
9999999.64;+46179,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 Pth RSN
9999999.64;+46179,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; off pathway reason
9999999.65;+46180,+46179,;.01~APR 07, 2026@05:55:44
9999999.65;+46180,+46179,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH TX
9999999.65;+46181,+46179,;.01~APR 07, 2026@05:56:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46180^1
46181^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46178</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1673139945</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46178,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH TX
9999999.64;+46178,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46178,;.08~YES
9999999.64;+46178,;.1~FACTOR
9999999.64;+46178,;100~NATIONAL
9999999.64;+46178,;101~VHA ONCOLOGY
9999999.64;+46178,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 Pth TX
9999999.64;+46178,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; off pathway 
treatment
9999999.65;+46179,+46178,;.01~APR 07, 2026@05:54:12
9999999.65;+46179,+46178,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+TAM
9999999.65;+46180,+46178,;.01~APR 07, 2026@05:55:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46179^1
46180^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46173</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3095530175</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46173,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 CLIN TRIAL
9999999.64;+46173,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46173,;.08~YES
9999999.64;+46173,;.1~FACTOR
9999999.64;+46173,;100~NATIONAL
9999999.64;+46173,;101~VHA ONCOLOGY
9999999.64;+46173,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 Clin Trial
9999999.64;+46173,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; on pathway clinical 
trial
9999999.65;+46174,+46173,;.01~APR 07, 2026@05:37:22
9999999.65;+46174,+46173,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 CLIN TRIAL
9999999.65;+46175,+46173,;.01~APR 07, 2026@05:38:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46174^1
46175^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 ADT+TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46177</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1039575736</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46177,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 ADT+TAM
9999999.64;+46177,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46177,;.08~YES
9999999.64;+46177,;.1~FACTOR
9999999.64;+46177,;100~NATIONAL
9999999.64;+46177,;101~VHA ONCOLOGY
9999999.64;+46177,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 ADT+Tam
9999999.64;+46177,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; on pathway 
ADT+tamoxifen
9999999.65;+46178,+46177,;.01~APR 07, 2026@05:53:13
9999999.65;+46178,+46177,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+TAM
9999999.65;+46179,+46177,;.01~APR 07, 2026@05:53:41
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46178^1
46179^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46176</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2713060267</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46176,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+TAM
9999999.64;+46176,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46176,;.08~YES
9999999.64;+46176,;.1~FACTOR
9999999.64;+46176,;100~NATIONAL
9999999.64;+46176,;101~VHA ONCOLOGY
9999999.64;+46176,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 OS+Tam
9999999.64;+46176,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; on pathway 
OS+tamoxifen
9999999.65;+46177,+46176,;.01~APR 07, 2026@05:52:11
9999999.65;+46177,+46176,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+ANA
9999999.65;+46178,+46176,;.01~APR 07, 2026@05:52:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46177^1
46178^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 ADT+ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>46175</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1848130995</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46175,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 ADT+ANA
9999999.64;+46175,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46175,;.08~YES
9999999.64;+46175,;.1~FACTOR
9999999.64;+46175,;100~NATIONAL
9999999.64;+46175,;101~VHA ONCOLOGY
9999999.64;+46175,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 ADT+Ana
9999999.64;+46175,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; on pathway 
ADT+anastrozole
9999999.65;+46176,+46175,;.01~APR 07, 2026@05:50:51
9999999.65;+46176,+46175,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+ANA
9999999.65;+46177,+46175,;.01~APR 07, 2026@05:51:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46176^1
46177^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>46174</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>906524752</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46174,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+ANA
9999999.64;+46174,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46174,;.08~YES
9999999.64;+46174,;.1~FACTOR
9999999.64;+46174,;100~NATIONAL
9999999.64;+46174,;101~VHA ONCOLOGY
9999999.64;+46174,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y4-5 OS+Ana
9999999.64;+46174,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 4-5; on pathway 
OS+anastrozole
9999999.65;+46175,+46174,;.01~APR 07, 2026@05:44:12
9999999.65;+46175,+46174,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 CLIN TRIAL
9999999.65;+46176,+46174,;.01~APR 07, 2026@05:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46175^1
46176^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46172</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>506572258</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46172,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH RSN
9999999.64;+46172,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46172,;.08~YES
9999999.64;+46172,;.1~FACTOR
9999999.64;+46172,;100~NATIONAL
9999999.64;+46172,;101~VHA ONCOLOGY
9999999.64;+46172,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 Off Path RSN
9999999.64;+46172,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; off pathway reason
9999999.65;+46173,+46172,;.01~APR 06, 2026@13:28:19
9999999.65;+46173,+46172,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH TX
9999999.65;+46174,+46172,;.01~APR 06, 2026@13:28:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46173^1
46174^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46171</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>177241397</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46171,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH TX
9999999.64;+46171,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46171,;.08~YES
9999999.64;+46171,;.1~FACTOR
9999999.64;+46171,;100~NATIONAL
9999999.64;+46171,;101~VHA ONCOLOGY
9999999.64;+46171,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 Off Path TX
9999999.64;+46171,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; off pathway 
treatment
9999999.65;+46172,+46171,;.01~APR 06, 2026@13:27:27
9999999.65;+46172,+46171,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 CLIN TRIAL
9999999.65;+46173,+46171,;.01~APR 06, 2026@13:28:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46172^1
46173^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46166</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1124537573</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46166,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 CLIN TRIAL
9999999.64;+46166,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46166,;.08~YES
9999999.64;+46166,;.1~FACTOR
9999999.64;+46166,;100~NATIONAL
9999999.64;+46166,;101~VHA ONCOLOGY
9999999.64;+46166,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 Clin Trial
9999999.64;+46166,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; on pathway clinical 
trial
9999999.65;+46167,+46166,;.01~APR 06, 2026@13:18:02
9999999.65;+46167,+46166,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 CLIN TRIAL
9999999.65;+46168,+46166,;.01~APR 06, 2026@13:20:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46167^1
46168^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 ADT+ANA/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>46168</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2332126911</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46168,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 ADT+ANA/RIB
9999999.64;+46168,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46168,;.08~YES
9999999.64;+46168,;.1~FACTOR
9999999.64;+46168,;100~NATIONAL
9999999.64;+46168,;101~VHA ONCOLOGY
9999999.64;+46168,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 ADT+Ana/Rib
9999999.64;+46168,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; on pathway 
ADT+anastrozole and ribociclib
9999999.65;+46169,+46168,;.01~APR 06, 2026@13:24:26
9999999.65;+46169,+46168,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+ANA/RIB
9999999.65;+46170,+46168,;.01~APR 06, 2026@13:24:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46169^1
46170^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+TAM/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>46169</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1164724141</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46169,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+TAM/RIB
9999999.64;+46169,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46169,;.08~YES
9999999.64;+46169,;.1~FACTOR
9999999.64;+46169,;100~NATIONAL
9999999.64;+46169,;101~VHA ONCOLOGY
9999999.64;+46169,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 OS+Tam/Rib
9999999.64;+46169,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; on pathway 
OS+tamoxifen and ribociclib
9999999.65;+46170,+46169,;.01~APR 06, 2026@13:25:43
9999999.65;+46170,+46169,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+ANA/RIB
9999999.65;+46171,+46169,;.01~APR 06, 2026@13:26:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46170^1
46171^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 ADT+TAM/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>46170</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4067013352</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46170,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 ADT+TAM/RIB
9999999.64;+46170,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46170,;.08~YES
9999999.64;+46170,;.1~FACTOR
9999999.64;+46170,;100~NATIONAL
9999999.64;+46170,;101~VHA ONCOLOGY
9999999.64;+46170,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 ADT+Tam/Rib
9999999.64;+46170,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; on pathway 
ADT+tamoxifen and ribociclib
9999999.65;+46171,+46170,;.01~APR 06, 2026@13:26:41
9999999.65;+46171,+46170,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+TAM/RIB
9999999.65;+46172,+46170,;.01~APR 06, 2026@13:27:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46171^1
46172^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+ANA/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>46167</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1325107596</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46167,;.01~VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+ANA/RIB
9999999.64;+46167,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46167,;.08~YES
9999999.64;+46167,;.1~FACTOR
9999999.64;+46167,;100~NATIONAL
9999999.64;+46167,;101~VHA ONCOLOGY
9999999.64;+46167,;200~BRCA Adj Hormone Tx HER2- Int Risk Pre-Men/M+ Y1-3 OS+Ana/Rib
9999999.64;+46167,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, 
intermediate risk, pre-menopausal or male, years 1-3; on pathway 
OS+anastrozole and ribociclib
9999999.65;+46168,+46167,;.01~APR 06, 2026@13:22:55
9999999.65;+46168,+46167,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 CLIN TRIAL
9999999.65;+46169,+46167,;.01~APR 06, 2026@13:23:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46168^1
46169^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46165</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3084367532</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46165,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH RSN
9999999.64;+46165,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46165,;.08~YES
9999999.64;+46165,;.1~FACTOR
9999999.64;+46165,;100~NATIONAL
9999999.64;+46165,;101~VHA ONCOLOGY
9999999.64;+46165,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y6-8 Off Path RSN
9999999.64;+46165,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 6-8; off pathway reason
9999999.65;+46166,+46165,;.01~APR 06, 2026@13:08:58
9999999.65;+46166,+46165,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH TX
9999999.65;+46167,+46165,;.01~APR 06, 2026@13:09:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46166^1
46167^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46164</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>883578217</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46164,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH TX
9999999.64;+46164,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46164,;.08~YES
9999999.64;+46164,;.1~FACTOR
9999999.64;+46164,;100~NATIONAL
9999999.64;+46164,;101~VHA ONCOLOGY
9999999.64;+46164,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y6-8 Off Path TX
9999999.64;+46164,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 6-8; off pathway treatment
9999999.65;+46165,+46164,;.01~APR 06, 2026@13:08:10
9999999.65;+46165,+46164,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 TAM+SURV
9999999.65;+46166,+46164,;.01~APR 06, 2026@13:08:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46165^1
46166^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46162</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1897780378</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46162,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 CLIN TRIAL
9999999.64;+46162,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46162,;.08~YES
9999999.64;+46162,;.1~FACTOR
9999999.64;+46162,;100~NATIONAL
9999999.64;+46162,;101~VHA ONCOLOGY
9999999.64;+46162,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y6-8 Clin Trial
9999999.64;+46162,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 6-8; on pathway clinical trial
9999999.65;+46163,+46162,;.01~APR 06, 2026@12:41:58
9999999.65;+46163,+46162,;2~WP-start~1
Copied from VA-SCI/D PQD-SCID
9999999.65;+46164,+46162,;.01~APR 06, 2026@12:42:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46163^1
46164^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OS+ANA/SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46163</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2546462462</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46163,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OS+ANA/SURV
9999999.64;+46163,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46163,;.08~YES
9999999.64;+46163,;.1~FACTOR
9999999.64;+46163,;100~NATIONAL
9999999.64;+46163,;101~VHA ONCOLOGY
9999999.64;+46163,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y6-8 OS+Ana/Surv
9999999.64;+46163,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 6-8; on pathway OS+anastrozole 
followed by surveillance
9999999.65;+46164,+46163,;.01~APR 06, 2026@12:59:21
9999999.65;+46164,+46163,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 TAM+SURV
9999999.65;+46165,+46163,;.01~APR 06, 2026@13:03:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46164^1
46165^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 TAM+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46113</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4072572384</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46113,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 TAM+SURV
9999999.64;+46113,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46113,;.08~YES
9999999.64;+46113,;.1~FACTOR
9999999.64;+46113,;100~NATIONAL
9999999.64;+46113,;101~VHA ONCOLOGY
9999999.64;+46113,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y6-8 Tam+Surv
9999999.64;+46113,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 6-8; on pathway tamoxifen followed by 
surveillance
9999999.65;+46114,+46113,;.01~APR 06, 2026@12:55:16
9999999.65;+46114,+46113,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL
9999999.65;+46115,+46113,;.01~APR 06, 2026@12:56:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46114^1
46115^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46161</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3717913291</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46161,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH RSN
9999999.64;+46161,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46161,;.08~YES
9999999.64;+46161,;.1~FACTOR
9999999.64;+46161,;100~NATIONAL
9999999.64;+46161,;101~VHA ONCOLOGY
9999999.64;+46161,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y3-5 Off Path RSN
9999999.64;+46161,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 3-5; off pathway reason
9999999.65;+46162,+46161,;.01~APR 06, 2026@12:39:38
9999999.65;+46162,+46161,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH TX
9999999.65;+46163,+46161,;.01~APR 06, 2026@12:40:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46162^1
46163^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46160</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1633451973</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46160,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH TX
9999999.64;+46160,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46160,;.08~YES
9999999.64;+46160,;.1~FACTOR
9999999.64;+46160,;100~NATIONAL
9999999.64;+46160,;101~VHA ONCOLOGY
9999999.64;+46160,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y3-5 Off Path TX
9999999.64;+46160,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 3-5; off pathway treatment
9999999.65;+46161,+46160,;.01~APR 06, 2026@12:29:53
9999999.65;+46161,+46160,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 TAM
9999999.65;+46162,+46160,;.01~APR 06, 2026@12:30:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46161^1
46162^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46157</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1389731572</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46157,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 CLIN TRIAL
9999999.64;+46157,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46157,;.08~YES
9999999.64;+46157,;.1~FACTOR
9999999.64;+46157,;100~NATIONAL
9999999.64;+46157,;101~VHA ONCOLOGY
9999999.64;+46157,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y3-5 Clin Trial
9999999.64;+46157,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 3-5; on pathway clinical trial
9999999.65;+46158,+46157,;.01~APR 06, 2026@12:16
9999999.65;+46158,+46157,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 CLIN TRIAL
9999999.65;+46159,+46157,;.01~APR 06, 2026@12:16:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46158^1
46159^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46159</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>875622593</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46159,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 TAM
9999999.64;+46159,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46159,;.08~YES
9999999.64;+46159,;.1~FACTOR
9999999.64;+46159,;100~NATIONAL
9999999.64;+46159,;101~VHA ONCOLOGY
9999999.64;+46159,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y3-5 Tam
9999999.64;+46159,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 3-5; on pathway tamoxifen
9999999.65;+46160,+46159,;.01~APR 06, 2026@12:25:16
9999999.65;+46160,+46159,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 ANA
9999999.65;+46161,+46159,;.01~APR 06, 2026@12:25:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46160^1
46161^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>46158</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2080680547</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46158,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 ANA
9999999.64;+46158,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46158,;.08~YES
9999999.64;+46158,;.1~FACTOR
9999999.64;+46158,;100~NATIONAL
9999999.64;+46158,;101~VHA ONCOLOGY
9999999.64;+46158,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y3-5 Ana
9999999.64;+46158,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 3-5; on pathway anastrozole
9999999.65;+46159,+46158,;.01~APR 06, 2026@12:21:01
9999999.65;+46159,+46158,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 CLIN TRIAL
9999999.65;+46160,+46158,;.01~APR 06, 2026@12:21:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46159^1
46160^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46156</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3268839877</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46156,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH RSN
9999999.64;+46156,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46156,;.08~YES
9999999.64;+46156,;.1~FACTOR
9999999.64;+46156,;100~NATIONAL
9999999.64;+46156,;101~VHA ONCOLOGY
9999999.64;+46156,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y1-2 Off Path RSN
9999999.64;+46156,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 1-2; off pathway reason
9999999.65;+46157,+46156,;.01~APR 06, 2026@11:57:06
9999999.65;+46157,+46156,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH TX
9999999.65;+46158,+46156,;.01~APR 06, 2026@12:09:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46157^1
46158^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46155</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3224718712</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46155,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH TX
9999999.64;+46155,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46155,;.08~YES
9999999.64;+46155,;.1~FACTOR
9999999.64;+46155,;100~NATIONAL
9999999.64;+46155,;101~VHA ONCOLOGY
9999999.64;+46155,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y1-2 Off Path TX
9999999.64;+46155,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 1-2; off pathway treatment
9999999.65;+46156,+46155,;.01~APR 06, 2026@11:42:57
9999999.65;+46156,+46155,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 TAM/ABE
9999999.65;+46157,+46155,;.01~APR 06, 2026@11:48:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46156^1
46157^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46152</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1192763436</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46152,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 CLIN TRIAL
9999999.64;+46152,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46152,;.08~YES
9999999.64;+46152,;.1~FACTOR
9999999.64;+46152,;100~NATIONAL
9999999.64;+46152,;101~VHA ONCOLOGY
9999999.64;+46152,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y1-2 Clin Trial
9999999.64;+46152,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 1-2; on pathway clinical trial
9999999.65;+46153,+46152,;.01~APR 06, 2026@11:26:47
9999999.65;+46153,+46152,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 CLIN TRIAL
9999999.65;+46154,+46152,;.01~APR 06, 2026@11:27:24
9999999.65;+46155,+46152,;.01~APR 06, 2026@11:41:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46153^1
46154^2
46155^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 TAM/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>46154</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2564592684</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46154,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 TAM/ABE
9999999.64;+46154,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46154,;.08~YES
9999999.64;+46154,;.1~FACTOR
9999999.64;+46154,;100~NATIONAL
9999999.64;+46154,;101~VHA ONCOLOGY
9999999.64;+46154,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y1-2 Tam/Abe
9999999.64;+46154,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 1-2; on pathway tamoxifen and
abemaciclib
9999999.65;+46155,+46154,;.01~APR 06, 2026@11:41:46
9999999.65;+46155,+46154,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 ANA/ABE
9999999.65;+46156,+46154,;.01~APR 06, 2026@11:42:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46155^1
46156^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 ANA/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>46153</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1640260154</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46153,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 ANA/ABE
9999999.64;+46153,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46153,;.08~YES
9999999.64;+46153,;.1~FACTOR
9999999.64;+46153,;100~NATIONAL
9999999.64;+46153,;101~VHA ONCOLOGY
9999999.64;+46153,;200~BRCA Adj Hormone Tx HER2- High Risk Pst-Men/M- Y1-2 Ana/Abe
9999999.64;+46153,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
post-menopausal or not male, years 1-2; on pathway anastrozole and 
abemaciclib
9999999.65;+46154,+46153,;.01~APR 06, 2026@11:27:49
9999999.65;+46154,+46153,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 CLIN TRIAL
9999999.65;+46155,+46153,;.01~APR 06, 2026@11:36:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46154^1
46155^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46151</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>596080946</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46151,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH RSN
9999999.64;+46151,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46151,;.08~YES
9999999.64;+46151,;.1~FACTOR
9999999.64;+46151,;100~NATIONAL
9999999.64;+46151,;101~VHA ONCOLOGY
9999999.64;+46151,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y6-8 Off Path RSN
9999999.64;+46151,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 6-8; off pathway reason
9999999.65;+46152,+46151,;.01~APR 06, 2026@11:25:23
9999999.65;+46152,+46151,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH TX
9999999.65;+46153,+46151,;.01~APR 06, 2026@11:25:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46152^1
46153^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46150</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1686765052</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46150,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH TX
9999999.64;+46150,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46150,;.08~YES
9999999.64;+46150,;.1~FACTOR
9999999.64;+46150,;100~NATIONAL
9999999.64;+46150,;101~VHA ONCOLOGY
9999999.64;+46150,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y6-8 Off Path TX
9999999.64;+46150,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 6-8; off pathway treatment
9999999.65;+46151,+46150,;.01~APR 06, 2026@11:24:07
9999999.65;+46151,+46150,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 CLIN TRIAL
9999999.65;+46152,+46150,;.01~APR 06, 2026@11:24:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46151^1
46152^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46146</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>347257093</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46146,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 CLIN TRIAL
9999999.64;+46146,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46146,;.08~YES
9999999.64;+46146,;.1~FACTOR
9999999.64;+46146,;100~NATIONAL
9999999.64;+46146,;101~VHA ONCOLOGY
9999999.64;+46146,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y6-8 Clin Trial
9999999.64;+46146,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 6-8; on pathway clinical trial
9999999.65;+46147,+46146,;.01~APR 06, 2026@11:08:35
9999999.65;+46147,+46146,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+ANA
9999999.65;+46148,+46146,;.01~APR 06, 2026@11:09:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46147^1
46148^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OS+ANA/SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46149</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3824034547</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46149,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OS+ANA/SURV
9999999.64;+46149,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46149,;.08~YES
9999999.64;+46149,;.1~FACTOR
9999999.64;+46149,;100~NATIONAL
9999999.64;+46149,;101~VHA ONCOLOGY
9999999.64;+46149,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y6-8 OS+ANA+Surv
9999999.64;+46149,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 6-8; on pathway OS+anastrozole followed by
surveillance
9999999.65;+46150,+46149,;.01~APR 06, 2026@11:20:42
9999999.65;+46150,+46149,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 ADT+ANA/SURV
9999999.65;+46151,+46149,;.01~APR 06, 2026@11:21:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46150^1
46151^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 ADT+ANA/SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46148</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2617345606</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46148,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 ADT+ANA/SURV
9999999.64;+46148,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46148,;.08~YES
9999999.64;+46148,;.1~FACTOR
9999999.64;+46148,;100~NATIONAL
9999999.64;+46148,;101~VHA ONCOLOGY
9999999.64;+46148,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y6-8 ADT+ANA+Surv
9999999.64;+46148,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 6-8; on pathway ADT+anastrozole followed by 
surveillance
9999999.65;+46149,+46148,;.01~APR 06, 2026@11:15:31
9999999.65;+46149,+46148,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 TAM+SURV
9999999.65;+46150,+46148,;.01~APR 06, 2026@11:16:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46149^1
46150^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 TAM+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>46147</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1045905249</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46147,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 TAM+SURV
9999999.64;+46147,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46147,;.08~YES
9999999.64;+46147,;.1~FACTOR
9999999.64;+46147,;100~NATIONAL
9999999.64;+46147,;101~VHA ONCOLOGY
9999999.64;+46147,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y6-8 Tam+Surv
9999999.64;+46147,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 6-8; on pathway tamoxifen followed by 
surveillance
9999999.65;+46148,+46147,;.01~APR 06, 2026@11:11:06
9999999.65;+46148,+46147,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 CLIN TRIAL
9999999.65;+46149,+46147,;.01~APR 06, 2026@11:11:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46148^1
46149^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46139</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>309976464</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46139,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 CLIN TRIAL
9999999.64;+46139,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46139,;.08~YES
9999999.64;+46139,;.1~FACTOR
9999999.64;+46139,;100~NATIONAL
9999999.64;+46139,;101~VHA ONCOLOGY
9999999.64;+46139,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 Clin Trial
9999999.64;+46139,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; on pathway clinical trial
9999999.65;+46140,+46139,;.01~APR 06, 2026@10:54:34
9999999.65;+46140,+46139,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 CLIN TRIAL
9999999.65;+46141,+46139,;.01~APR 06, 2026@10:56:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46140^1
46141^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46145</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3983701898</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46145,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH RSN
9999999.64;+46145,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46145,;.08~YES
9999999.64;+46145,;.1~FACTOR
9999999.64;+46145,;100~NATIONAL
9999999.64;+46145,;101~VHA ONCOLOGY
9999999.64;+46145,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 Off Path RSN
9999999.64;+46145,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; off pathway reason
9999999.65;+46146,+46145,;.01~APR 06, 2026@11:05:09
9999999.65;+46146,+46145,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH TX
9999999.65;+46147,+46145,;.01~APR 06, 2026@11:05:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46146^1
46147^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46144</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1526641873</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46144,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH TX
9999999.64;+46144,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46144,;.08~YES
9999999.64;+46144,;.1~FACTOR
9999999.64;+46144,;100~NATIONAL
9999999.64;+46144,;101~VHA ONCOLOGY
9999999.64;+46144,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 Off Path TX
9999999.64;+46144,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; off pathway treatment
9999999.65;+46145,+46144,;.01~APR 06, 2026@11:02:37
9999999.65;+46145,+46144,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+TAM
9999999.65;+46146,+46144,;.01~APR 06, 2026@11:03:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46145^1
46146^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 ADT+TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46143</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>933728596</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46143,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 ADT+TAM
9999999.64;+46143,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46143,;.08~YES
9999999.64;+46143,;.1~FACTOR
9999999.64;+46143,;100~NATIONAL
9999999.64;+46143,;101~VHA ONCOLOGY
9999999.64;+46143,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 ADT+Tam
9999999.64;+46143,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; on pathway ADT+tamoxifen
9999999.65;+46144,+46143,;.01~APR 06, 2026@11:01:44
9999999.65;+46144,+46143,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+TAM
9999999.65;+46145,+46143,;.01~APR 06, 2026@11:02:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46144^1
46145^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>46142</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3715093098</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46142,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+TAM
9999999.64;+46142,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46142,;.08~YES
9999999.64;+46142,;.1~FACTOR
9999999.64;+46142,;100~NATIONAL
9999999.64;+46142,;101~VHA ONCOLOGY
9999999.64;+46142,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 OS+Tam
9999999.64;+46142,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; on pathway OS+tamoxifen
9999999.65;+46143,+46142,;.01~APR 06, 2026@11:00:51
9999999.65;+46143,+46142,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+ANA
9999999.65;+46144,+46142,;.01~APR 06, 2026@11:01:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46143^1
46144^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 ADT+ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>46141</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4116421433</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46141,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 ADT+ANA
9999999.64;+46141,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46141,;.08~YES
9999999.64;+46141,;.1~FACTOR
9999999.64;+46141,;100~NATIONAL
9999999.64;+46141,;101~VHA ONCOLOGY
9999999.64;+46141,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 ADT+Ana
9999999.64;+46141,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; on pathway ADT+anastrozole
9999999.65;+46142,+46141,;.01~APR 06, 2026@10:58:33
9999999.65;+46142,+46141,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+ANA
9999999.65;+46143,+46141,;.01~APR 06, 2026@10:59:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46142^1
46143^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>46140</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3341681387</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46140,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+ANA
9999999.64;+46140,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46140,;.08~YES
9999999.64;+46140,;.1~FACTOR
9999999.64;+46140,;100~NATIONAL
9999999.64;+46140,;101~VHA ONCOLOGY
9999999.64;+46140,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y3-5 OS+Ana
9999999.64;+46140,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 3-5; on pathway OS+anastrozole
9999999.65;+46141,+46140,;.01~APR 06, 2026@10:57:13
9999999.65;+46141,+46140,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 CLIN TRIAL
9999999.65;+46142,+46140,;.01~APR 06, 2026@10:58:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46141^1
46142^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>46132</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>667676646</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46132,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 CLIN TRIAL
9999999.64;+46132,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46132,;.08~YES
9999999.64;+46132,;.1~FACTOR
9999999.64;+46132,;100~NATIONAL
9999999.64;+46132,;101~VHA ONCOLOGY
9999999.64;+46132,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 Clin Trial
9999999.64;+46132,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; on pathway clinical trial
9999999.65;+46133,+46132,;.01~APR 06, 2026@10:43:18
9999999.65;+46133,+46132,;2~WP-start~1
 Creation.
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46133^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>46138</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>72337868</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46138,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH RSN
9999999.64;+46138,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46138,;.08~YES
9999999.64;+46138,;.1~FACTOR
9999999.64;+46138,;100~NATIONAL
9999999.64;+46138,;101~VHA ONCOLOGY
9999999.64;+46138,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 Off Path RSN
9999999.64;+46138,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; off pathway reason
9999999.65;+46139,+46138,;.01~APR 06, 2026@10:53:07
9999999.65;+46139,+46138,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH TX
9999999.65;+46140,+46138,;.01~APR 06, 2026@10:53:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46139^1
46140^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>46137</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4047875915</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46137,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH TX
9999999.64;+46137,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46137,;.08~YES
9999999.64;+46137,;.1~FACTOR
9999999.64;+46137,;100~NATIONAL
9999999.64;+46137,;101~VHA ONCOLOGY
9999999.64;+46137,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 Off Path TX
9999999.64;+46137,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; off pathway treatment
9999999.65;+46138,+46137,;.01~APR 06, 2026@10:51:30
9999999.65;+46138,+46137,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 CLIN TRIAL
9999999.65;+46139,+46137,;.01~APR 06, 2026@10:52:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46138^1
46139^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 ADT+TAM/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>46136</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3975278618</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46136,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 ADT+TAM/ABE
9999999.64;+46136,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46136,;.08~YES
9999999.64;+46136,;.1~FACTOR
9999999.64;+46136,;100~NATIONAL
9999999.64;+46136,;101~VHA ONCOLOGY
9999999.64;+46136,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 ADT+Tam/Abe
9999999.64;+46136,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; on pathway ADT+tamoxifen and
abemaciclib
9999999.65;+46137,+46136,;.01~APR 06, 2026@10:50:33
9999999.65;+46137,+46136,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+TAM/ABE
9999999.65;+46138,+46136,;.01~APR 06, 2026@10:51:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46137^1
46138^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+TAM/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>46135</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1604748701</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46135,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+TAM/ABE
9999999.64;+46135,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46135,;.08~YES
9999999.64;+46135,;.1~FACTOR
9999999.64;+46135,;100~NATIONAL
9999999.64;+46135,;101~VHA ONCOLOGY
9999999.64;+46135,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 OS+Tam/Abe
9999999.64;+46135,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; on pathway OS+tamoxifen and abemaciclib
9999999.65;+46136,+46135,;.01~APR 06, 2026@10:49:26
9999999.65;+46136,+46135,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+ANA/ABE
9999999.65;+46137,+46135,;.01~APR 06, 2026@10:50:09
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46136^1
46137^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 ADT+ANA/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>46134</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4256000665</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46134,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 ADT+ANA/ABE
9999999.64;+46134,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46134,;.08~YES
9999999.64;+46134,;.1~FACTOR
9999999.64;+46134,;100~NATIONAL
9999999.64;+46134,;101~VHA ONCOLOGY
9999999.64;+46134,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 ADT+Ana/Abe
9999999.64;+46134,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; on pathway ADT+anastrozole and 
abemaciclib
9999999.65;+46135,+46134,;.01~APR 06, 2026@10:47:17
9999999.65;+46135,+46134,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+ANA/ABE
9999999.65;+46136,+46134,;.01~APR 06, 2026@10:48:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46135^1
46136^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+ANA/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>46133</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>980529745</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+46133,;.01~VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+ANA/ABE
9999999.64;+46133,;.03~VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
9999999.64;+46133,;.08~YES
9999999.64;+46133,;.1~FACTOR
9999999.64;+46133,;100~NATIONAL
9999999.64;+46133,;101~VHA ONCOLOGY
9999999.64;+46133,;200~BRCA Adj Hormone Tx HER2- High Risk Pre-Men/M+ Y1-2 OS+Ana/Abe
9999999.64;+46133,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy for ER+ or PR+/HER2-, high risk, 
pre-menopausal or male, years 1-2; on pathway OS+anastrozole and 
abemaciclib
9999999.65;+46134,+46133,;.01~APR 06, 2026@10:44:19
9999999.65;+46134,+46133,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 CLIN TRIAL
9999999.65;+46135,+46133,;.01~APR 06, 2026@10:45:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46134^1
46135^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33310</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2371913491</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33310,;.01~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33310,;.08~YES
9999999.64;+33310,;.1~CATEGORY
9999999.64;+33310,;100~NATIONAL
9999999.64;+33310,;101~VHA ONCOLOGY
9999999.64;+33310,;200~Breast Cancer-Adjuvant Hormone Therapy Clinical Pathway
9999999.64;+33310,;201~WP-start~2
Category for all health factors in Breast Cancer- Adjuvant Hormone Therapy
Treatment Clinical Pathway.
9999999.65;+33311,+33310,;.01~MAR 18, 2024@12:29:28
9999999.65;+33311,+33310,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY
9999999.65;+33312,+33310,;.01~MAR 18, 2024@12:34:21
9999999.65;+33313,+33310,;.01~DEC 04, 2024@05:29:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33311^1
33312^2
33313^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33326</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>498084841</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33326,;.01~VA-ONC BRCA ADJ HT MALE NODE- OFF PATH RSN
9999999.64;+33326,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33326,;.08~YES
9999999.64;+33326,;.1~FACTOR
9999999.64;+33326,;100~NATIONAL
9999999.64;+33326,;101~VHA ONCOLOGY
9999999.64;+33326,;200~BRCA Adj Hormone Tx male Node- off path reason
9999999.64;+33326,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; off pathway
reason
9999999.65;+33327,+33326,;.01~MAR 19, 2024@07:45:09
9999999.65;+33327,+33326,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE- OFF PATH TX
9999999.65;+33328,+33326,;.01~MAR 19, 2024@07:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33327^1
33328^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33325</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2400126247</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33325,;.01~VA-ONC BRCA ADJ HT MALE NODE- OFF PATH TX
9999999.64;+33325,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33325,;.08~YES
9999999.64;+33325,;.1~FACTOR
9999999.64;+33325,;100~NATIONAL
9999999.64;+33325,;101~VHA ONCOLOGY
9999999.64;+33325,;200~BRCA Adj Hormone Tx male Node- off path treatment
9999999.64;+33325,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; off pathway
treatment
9999999.65;+33326,+33325,;.01~MAR 19, 2024@07:37:03
9999999.65;+33326,+33325,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE- CLIN TRIAL
9999999.65;+33327,+33325,;.01~MAR 19, 2024@07:40:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33326^1
33327^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33323</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2301198893</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33323,;.01~VA-ONC BRCA ADJ HT MALE NODE- CLIN TRIAL
9999999.64;+33323,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33323,;.08~YES
9999999.64;+33323,;.1~FACTOR
9999999.64;+33323,;100~NATIONAL
9999999.64;+33323,;101~VHA ONCOLOGY
9999999.64;+33323,;200~BRCA Adj Hormone Tx male Node- clinical trial
9999999.64;+33323,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; on
pathway clinical trial
9999999.65;+33324,+33323,;.01~MAR 19, 2024@07:23:11
9999999.65;+33324,+33323,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 CLIN TRIAL
9999999.65;+33325,+33323,;.01~MAR 19, 2024@07:30:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33324^1
33325^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE- TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33324</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3917111111</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33324,;.01~VA-ONC BRCA ADJ HT MALE NODE- TAMOX
9999999.64;+33324,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33324,;.08~YES
9999999.64;+33324,;.1~FACTOR
9999999.64;+33324,;100~NATIONAL
9999999.64;+33324,;101~VHA ONCOLOGY
9999999.64;+33324,;200~BRCA Adj Hormone Tx male Node- tamoxifen 5 years
9999999.64;+33324,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; on pathway
tamoxifen for 5 years
9999999.65;+33325,+33324,;.01~MAR 19, 2024@07:32:34
9999999.65;+33325,+33324,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE- CLIN TRIAL
9999999.65;+33326,+33324,;.01~MAR 19, 2024@07:35:16
9999999.65;+33327,+33324,;.01~MAR 19, 2024@07:43:09
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33325^1
33326^2
33327^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33334</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1378571205</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33334,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH RSN
9999999.64;+33334,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33334,;.08~YES
9999999.64;+33334,;.1~FACTOR
9999999.64;+33334,;100~NATIONAL
9999999.64;+33334,;101~VHA ONCOLOGY
9999999.64;+33334,;200~BRCA Adj Hormone Tx female Node- post-menopause off path rsn
9999999.64;+33334,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopause; off pathway reason
9999999.65;+33335,+33334,;.01~MAR 19, 2024@08:50
9999999.65;+33335,+33334,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH TX
9999999.65;+33336,+33334,;.01~MAR 19, 2024@08:51:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33335^1
33336^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33333</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>358963569</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33333,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH TX
9999999.64;+33333,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33333,;.08~YES
9999999.64;+33333,;.1~FACTOR
9999999.64;+33333,;100~NATIONAL
9999999.64;+33333,;101~VHA ONCOLOGY
9999999.64;+33333,;200~BRCA Adj Hormone Tx female Node- post-menopause off path tx
9999999.64;+33333,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopause; off pathway treatment
9999999.65;+33334,+33333,;.01~MAR 19, 2024@08:46:31
9999999.65;+33334,+33333,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP CLIN TRIAL
9999999.65;+33335,+33333,;.01~MAR 19, 2024@08:49:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33334^1
33335^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33331</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3455227309</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33331,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP CLIN TRIAL
9999999.64;+33331,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33331,;.08~YES
9999999.64;+33331,;.1~FACTOR
9999999.64;+33331,;100~NATIONAL
9999999.64;+33331,;101~VHA ONCOLOGY
9999999.64;+33331,;200~BRCA Adj Hormone Tx female Node- post-menopause clin trial
9999999.64;+33331,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopause; on pathway clinical trial
9999999.65;+33332,+33331,;.01~MAR 19, 2024@08:38:06
9999999.65;+33332,+33331,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP CLIN TRIAL
9999999.65;+33333,+33331,;.01~MAR 19, 2024@08:40:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33332^1
33333^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP ANAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33332</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2140682188</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33332,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP ANAS
9999999.64;+33332,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33332,;.08~YES
9999999.64;+33332,;.1~FACTOR
9999999.64;+33332,;100~NATIONAL
9999999.64;+33332,;101~VHA ONCOLOGY
9999999.64;+33332,;200~BRCA Adj Hormone Tx female Node- post-menopause anas
9999999.64;+33332,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopause; on pathway anastrozole for 5 years
9999999.65;+33333,+33332,;.01~MAR 19, 2024@08:41:39
9999999.65;+33333,+33332,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP CLIN TRIAL
9999999.65;+33334,+33332,;.01~MAR 19, 2024@08:43:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33333^1
33334^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33330</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>739182768</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33330,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH RSN
9999999.64;+33330,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33330,;.08~YES
9999999.64;+33330,;.1~FACTOR
9999999.64;+33330,;100~NATIONAL
9999999.64;+33330,;101~VHA ONCOLOGY
9999999.64;+33330,;200~BRCA Adj Hormone Tx female Node- pre-menopause off path rsn
9999999.64;+33330,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopause; off pathway reason
9999999.65;+33331,+33330,;.01~MAR 19, 2024@08:34:34
9999999.65;+33331,+33330,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH TX
9999999.65;+33332,+33330,;.01~MAR 19, 2024@08:36:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33331^1
33332^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33329</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2434600175</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33329,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH TX
9999999.64;+33329,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33329,;.08~YES
9999999.64;+33329,;.1~FACTOR
9999999.64;+33329,;100~NATIONAL
9999999.64;+33329,;101~VHA ONCOLOGY
9999999.64;+33329,;200~BRCA Adj Hormone Tx female Node- pre-menopause off path tx
9999999.64;+33329,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopause; off pathway treatment
9999999.65;+33330,+33329,;.01~MAR 19, 2024@08:29:33
9999999.65;+33330,+33329,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP CLIN TRIAL
9999999.65;+33331,+33329,;.01~MAR 19, 2024@08:31:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33330^1
33331^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33327</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>233032306</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33327,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP CLIN TRIAL
9999999.64;+33327,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33327,;.08~YES
9999999.64;+33327,;.1~FACTOR
9999999.64;+33327,;100~NATIONAL
9999999.64;+33327,;101~VHA ONCOLOGY
9999999.64;+33327,;200~BRCA Adj Hormone Tx female Node- pre-menopause clin trial
9999999.64;+33327,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopause; on pathway clinical trial
9999999.65;+33328,+33327,;.01~MAR 19, 2024@08:17:27
9999999.65;+33328,+33327,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE- CLIN TRIAL
9999999.65;+33329,+33327,;.01~MAR 19, 2024@08:23:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33328^1
33329^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33328</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1971582377</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33328,;.01~VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP TAMOX
9999999.64;+33328,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33328,;.08~YES
9999999.64;+33328,;.1~FACTOR
9999999.64;+33328,;100~NATIONAL
9999999.64;+33328,;101~VHA ONCOLOGY
9999999.64;+33328,;200~BRCA Adj Hormone Tx female Node- pre-menopause tamoxifen
9999999.64;+33328,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Not Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopause; on pathway tamoxifen for 5 years
9999999.65;+33329,+33328,;.01~MAR 19, 2024@08:25:08
9999999.65;+33329,+33328,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP CLIN TRIAL
9999999.65;+33330,+33328,;.01~MAR 19, 2024@08:27:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33329^1
33330^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ TUMOR&lt;5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33322</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1349201073</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33322,;.01~VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 OFF PATH RSN
9999999.64;+33322,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33322,;.08~YES
9999999.64;+33322,;.1~FACTOR
9999999.64;+33322,;100~NATIONAL
9999999.64;+33322,;101~VHA ONCOLOGY
9999999.64;+33322,;200~BRCA Adj Hormone Tx Node+ Tumor <5cm/hist grade 3 off path rsn
9999999.64;+33322,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor less 
than 5cm or histologic grade 3, off pathway reason
9999999.65;+33323,+33322,;.01~MAR 19, 2024@06:58:24
9999999.65;+33323,+33322,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 OFF PATH TX
9999999.65;+33324,+33322,;.01~MAR 19, 2024@07:01:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33323^1
33324^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ TUMOR&lt;5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33321</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>383590836</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33321,;.01~VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 OFF PATH TX
9999999.64;+33321,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33321,;.08~YES
9999999.64;+33321,;.1~FACTOR
9999999.64;+33321,;100~NATIONAL
9999999.64;+33321,;101~VHA ONCOLOGY
9999999.64;+33321,;200~BRCA Adj Hormone Tx Node+ Tumor <5cm/hist grade 3 off path tx
9999999.64;+33321,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor less 
than 5cm or histologic grade 3, off pathway treatment
9999999.65;+33322,+33321,;.01~MAR 19, 2024@06:54:18
9999999.65;+33322,+33321,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 CLIN TRIAL
9999999.65;+33323,+33321,;.01~MAR 19, 2024@06:56:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33322^1
33323^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ TUMOR&lt;5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33319</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3425860517</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33319,;.01~VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 CLIN TRIAL
9999999.64;+33319,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33319,;.08~YES
9999999.64;+33319,;.1~FACTOR
9999999.64;+33319,;100~NATIONAL
9999999.64;+33319,;101~VHA ONCOLOGY
9999999.64;+33319,;200~BRCA Adj Hormone Tx Node+ Tumor <5cm/hist grade 3 clin trial
9999999.64;+33319,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor less 
than 5cm or histologic grade 3, on pathway clinical trial
9999999.65;+33320,+33319,;.01~MAR 19, 2024@06:31:01
9999999.65;+33320,+33319,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2- CLIN TRIAL
9999999.65;+33321,+33319,;.01~MAR 19, 2024@06:41:09
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33320^1
33321^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ TUMOR&lt;5 TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33320</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3102126837</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33320,;.01~VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 TAMOX
9999999.64;+33320,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33320,;.08~YES
9999999.64;+33320,;.1~FACTOR
9999999.64;+33320,;100~NATIONAL
9999999.64;+33320,;101~VHA ONCOLOGY
9999999.64;+33320,;200~BRCA Adj Hormone Tx Node+ Tumor <5cm/hist grade 3 tamoxifen
9999999.64;+33320,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor less 
than 5cm or histologic grade 3, on pathway tamoxifen for 7-8 years total
9999999.65;+33321,+33320,;.01~MAR 19, 2024@06:46:32
9999999.65;+33321,+33320,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 CLIN TRIAL
9999999.65;+33322,+33320,;.01~MAR 19, 2024@06:48:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33321^1
33322^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33318</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1591690212</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33318,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH RSN
9999999.64;+33318,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33318,;.08~YES
9999999.64;+33318,;.1~FACTOR
9999999.64;+33318,;100~NATIONAL
9999999.64;+33318,;101~VHA ONCOLOGY
9999999.64;+33318,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2 neg off path reason
9999999.64;+33318,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor 5cm or 
more or histologic grade 3, HER2-, off pathway reason
9999999.65;+33319,+33318,;.01~MAR 19, 2024@06:04:06
9999999.65;+33319,+33318,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH TX
9999999.65;+33320,+33318,;.01~MAR 19, 2024@06:04:57
9999999.65;+33321,+33318,;.01~MAR 19, 2024@06:42:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33319^1
33320^2
33321^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33317</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>766665002</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33317,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH TX
9999999.64;+33317,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33317,;.08~YES
9999999.64;+33317,;.1~FACTOR
9999999.64;+33317,;100~NATIONAL
9999999.64;+33317,;101~VHA ONCOLOGY
9999999.64;+33317,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2 neg off path treatment
9999999.64;+33317,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor 5cm or 
more or histologic grade 3, HER2-, off pathway treatment
9999999.65;+33318,+33317,;.01~MAR 19, 2024@06:02:50
9999999.65;+33318,+33317,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2- CLIN TRIAL
9999999.65;+33319,+33317,;.01~MAR 19, 2024@06:03:47
9999999.65;+33320,+33317,;.01~MAR 19, 2024@06:42:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33318^1
33319^2
33320^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33315</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1260124825</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33315,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2- CLIN TRIAL
9999999.64;+33315,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33315,;.08~YES
9999999.64;+33315,;.1~FACTOR
9999999.64;+33315,;100~NATIONAL
9999999.64;+33315,;101~VHA ONCOLOGY
9999999.64;+33315,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2 neg clin trial
9999999.64;+33315,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor 5cm or 
more or histologic grade 3, HER2-, on pathway clinical trial
9999999.65;+33316,+33315,;.01~MAR 18, 2024@13:29:39
9999999.65;+33316,+33315,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL
9999999.65;+33317,+33315,;.01~MAR 18, 2024@13:47:02
9999999.65;+33318,+33315,;.01~MAR 19, 2024@06:42:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33316^1
33317^2
33318^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2- ADT+ANAS+ABE+</POINT_01>
<INTERNAL_ENTRY_NUMBER>33316</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2251164021</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33316,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2- ADT+ANAS+ABE+
9999999.64;+33316,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33316,;.08~YES
9999999.64;+33316,;.1~FACTOR
9999999.64;+33316,;100~NATIONAL
9999999.64;+33316,;101~VHA ONCOLOGY
9999999.64;+33316,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2 neg ADT+ANAS++ABE+TAMO
9999999.64;+33316,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Male; tumor 5cm or 
more or histologic grade 3, HER2-, on pathway ADT, anastrozole, and 
abermaciclib in years 1-2; then tamoxifen in years 3-8.
9999999.65;+33317,+33316,;.01~MAR 18, 2024@13:49:21
9999999.65;+33317,+33316,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2- CLIN TRIAL
9999999.65;+33318,+33316,;.01~MAR 18, 2024@13:59:34
9999999.65;+33319,+33316,;.01~MAR 19, 2024@06:41:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33317^1
33318^2
33319^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33314</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>581410786</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33314,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH RSN
9999999.64;+33314,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33314,;.08~YES
9999999.64;+33314,;.1~FACTOR
9999999.64;+33314,;100~NATIONAL
9999999.64;+33314,;101~VHA ONCOLOGY
9999999.64;+33314,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2+ off path reason
9999999.64;+33314,;201~WP-start~2
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, off pathway reason
9999999.65;+33315,+33314,;.01~MAR 18, 2024@13:22:15
9999999.65;+33315,+33314,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH TX
9999999.65;+33316,+33314,;.01~MAR 18, 2024@13:22:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33315^1
33316^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33313</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>875072636</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33313,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH TX
9999999.64;+33313,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33313,;.08~YES
9999999.64;+33313,;.1~FACTOR
9999999.64;+33313,;100~NATIONAL
9999999.64;+33313,;101~VHA ONCOLOGY
9999999.64;+33313,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2+ off path treatment
9999999.64;+33313,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, off pathway 
treatment
9999999.65;+33314,+33313,;.01~MAR 18, 2024@13:19:52
9999999.65;+33314,+33313,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL
9999999.65;+33315,+33313,;.01~MAR 18, 2024@13:21:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33314^1
33315^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33311</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1162673102</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33311,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL
9999999.64;+33311,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33311,;.08~YES
9999999.64;+33311,;.1~FACTOR
9999999.64;+33311,;100~NATIONAL
9999999.64;+33311,;101~VHA ONCOLOGY
9999999.64;+33311,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2+ clin trial
9999999.64;+33311,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, on pathway clinical
trial
9999999.65;+33312,+33311,;.01~MAR 18, 2024@12:51:38
9999999.65;+33312,+33311,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+33313,+33311,;.01~MAR 18, 2024@12:55:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33312^1
33313^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE NODE+ HER2+ TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33312</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>394079807</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33312,;.01~VA-ONC BRCA ADJ HT MALE NODE+ HER2+ TAMOX
9999999.64;+33312,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33312,;.08~YES
9999999.64;+33312,;.1~FACTOR
9999999.64;+33312,;100~NATIONAL
9999999.64;+33312,;101~VHA ONCOLOGY
9999999.64;+33312,;200~BRCA Adj Hormone Tx Node+ Tumor >=5 HER2+ Tamoxifen
9999999.64;+33312,;201~WP-start~2
Breast Cancer-Stage DCIS; breast conservation candidate, on pathway
tamoxifen for 7-8 years total
9999999.65;+33313,+33312,;.01~MAR 18, 2024@13:16
9999999.65;+33313,+33312,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE CLIN TRIAL
9999999.65;+33314,+33312,;.01~MAR 18, 2024@13:18:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33313^1
33314^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR&lt;5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33360</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3505167603</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33360,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 OFF PATH RSN
9999999.64;+33360,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33360,;.08~YES
9999999.64;+33360,;.1~FACTOR
9999999.64;+33360,;100~NATIONAL
9999999.64;+33360,;101~VHA ONCOLOGY
9999999.64;+33360,;200~BRCA Adj Hormone Tx female Node+ post men Tumor<5 off path rsn
9999999.64;+33360,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; off pathway
reason
9999999.65;+33361,+33360,;.01~MAR 20, 2024@07:24:24
9999999.65;+33361,+33360,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 OFF PATH TX
9999999.65;+33362,+33360,;.01~MAR 20, 2024@07:25:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33361^1
33362^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR&lt;5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33359</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>560211885</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33359,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 OFF PATH TX
9999999.64;+33359,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33359,;.08~YES
9999999.64;+33359,;.1~FACTOR
9999999.64;+33359,;100~NATIONAL
9999999.64;+33359,;101~VHA ONCOLOGY
9999999.64;+33359,;200~BRCA Adj Hormone Tx female Node+ post men Tumor<5 off path tx
9999999.64;+33359,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; off pathway
treatment
9999999.65;+33360,+33359,;.01~MAR 20, 2024@07:19:41
9999999.65;+33360,+33359,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 CLIN TRIAL
9999999.65;+33361,+33359,;.01~MAR 20, 2024@07:24:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33360^1
33361^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR&lt;5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33357</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2243582062</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33357,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 CLIN TRIAL
9999999.64;+33357,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33357,;.08~YES
9999999.64;+33357,;.1~FACTOR
9999999.64;+33357,;100~NATIONAL
9999999.64;+33357,;101~VHA ONCOLOGY
9999999.64;+33357,;200~BRCA Adj Hormone Tx female Node+ post men Tumor<5 clin trial
9999999.64;+33357,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3;
on pathway clinical trial
9999999.65;+33358,+33357,;.01~MAR 20, 2024@07:13:15
9999999.65;+33358,+33357,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 CLIN TRIAL
9999999.65;+33359,+33357,;.01~MAR 20, 2024@07:15:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33358^1
33359^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP &lt;5 PREFER SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>33368</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1806346517</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33368,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER SURV
9999999.64;+33368,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33368,;.08~YES
9999999.64;+33368,;.1~FACTOR
9999999.64;+33368,;100~NATIONAL
9999999.64;+33368,;101~VHA ONCOLOGY
9999999.64;+33368,;200~BRCA Adj Hormone Tx female Node+ post men+anas 5y surveillance
9999999.64;+33368,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; after 
anastrozole for 5 years, on pathway surveillance
9999999.65;+33369,+33368,;.01~MAR 20, 2024@09:46:42
9999999.65;+33369,+33368,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER CLIN TRIAL
9999999.65;+33370,+33368,;.01~MAR 20, 2024@09:48:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33369^1
33370^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP &lt;5 PREFER TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33367</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1049195919</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33367,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER TAMOX
9999999.64;+33367,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33367,;.08~YES
9999999.64;+33367,;.1~FACTOR
9999999.64;+33367,;100~NATIONAL
9999999.64;+33367,;101~VHA ONCOLOGY
9999999.64;+33367,;200~BRCA Adj Hormone Tx female Node+ post men+anas 5y prefer tamox
9999999.64;+33367,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; after 
anastrozole for 5 years, on pathway tamoxifen (7-8 years total)
9999999.65;+33368,+33367,;.01~MAR 20, 2024@09:42:26
9999999.65;+33368,+33367,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER ANAS
9999999.65;+33369,+33367,;.01~MAR 20, 2024@09:45:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33368^1
33369^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP &lt;5 PREFER ANAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33366</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2024867930</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33366,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER ANAS
9999999.64;+33366,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33366,;.08~YES
9999999.64;+33366,;.1~FACTOR
9999999.64;+33366,;100~NATIONAL
9999999.64;+33366,;101~VHA ONCOLOGY
9999999.64;+33366,;200~BRCA Adj Hormone Tx female Node+ post men+anas 5y prefer anas
9999999.64;+33366,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; after 
anastrozole for 5 years, on pathway anastrozole (7-8 years total)
9999999.65;+33367,+33366,;.01~MAR 20, 2024@09:36:39
9999999.65;+33367,+33366,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER CLIN TRIAL
9999999.65;+33368,+33366,;.01~MAR 20, 2024@09:40:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33367^1
33368^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR&lt;5 ANAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>33358</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1866304528</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33358,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 ANAST
9999999.64;+33358,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33358,;.08~YES
9999999.64;+33358,;.1~FACTOR
9999999.64;+33358,;100~NATIONAL
9999999.64;+33358,;101~VHA ONCOLOGY
9999999.64;+33358,;200~BRCA Adj Hormone Tx female Node+ post men Tumor<5 anastrozole 5y
9999999.64;+33358,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3;
on pathway anastrozole for 5 years
9999999.65;+33359,+33358,;.01~MAR 20, 2024@07:17:03
9999999.65;+33359,+33358,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 CLIN TRIAL
9999999.65;+33360,+33358,;.01~MAR 20, 2024@07:18:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33359^1
33360^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33364</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>560965208</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33364,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH RSN
9999999.64;+33364,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33364,;.08~YES
9999999.64;+33364,;.1~FACTOR
9999999.64;+33364,;100~NATIONAL
9999999.64;+33364,;101~VHA ONCOLOGY
9999999.64;+33364,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2- off path rsn
9999999.64;+33364,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3, not HER2+; off
pathway reason
9999999.65;+33365,+33364,;.01~MAR 20, 2024@08:45:26
9999999.65;+33365,+33364,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH TX
9999999.65;+33366,+33364,;.01~MAR 20, 2024@08:45:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33365^1
33366^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33363</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3888566295</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33363,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH TX
9999999.64;+33363,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33363,;.08~YES
9999999.64;+33363,;.1~FACTOR
9999999.64;+33363,;100~NATIONAL
9999999.64;+33363,;101~VHA ONCOLOGY
9999999.64;+33363,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2- off path tx
9999999.64;+33363,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3, not HER2+; off
pathway treatment
9999999.65;+33364,+33363,;.01~MAR 20, 2024@08:43:04
9999999.65;+33364,+33363,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- CLIN TRIAL
9999999.65;+33365,+33363,;.01~MAR 20, 2024@08:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33364^1
33365^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33361</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>439410751</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33361,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- CLIN TRIAL
9999999.64;+33361,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33361,;.08~YES
9999999.64;+33361,;.1~FACTOR
9999999.64;+33361,;100~NATIONAL
9999999.64;+33361,;101~VHA ONCOLOGY
9999999.64;+33361,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2- clin trial
9999999.64;+33361,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3, not HER2+; on
pathway clinical trial
9999999.65;+33362,+33361,;.01~MAR 20, 2024@07:42:08
9999999.65;+33362,+33361,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ CLIN TRIAL
9999999.65;+33363,+33361,;.01~MAR 20, 2024@07:48:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33362^1
33363^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- ANAS+ABE+ANAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33362</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2161340147</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33362,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- ANAS+ABE+ANAS
9999999.64;+33362,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33362,;.08~YES
9999999.64;+33362,;.1~FACTOR
9999999.64;+33362,;100~NATIONAL
9999999.64;+33362,;101~VHA ONCOLOGY
9999999.64;+33362,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2- ANAS+ABE+ANAS
9999999.64;+33362,;201~WP-start~5
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3, not HER2+; on
pathway anastrozole and abemaciclib (years 1-2) and then anastrozole 
(years 3-5)
9999999.65;+33363,+33362,;.01~MAR 20, 2024@08:31:49
9999999.65;+33363,+33362,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- CLIN TRIAL
9999999.65;+33364,+33362,;.01~MAR 20, 2024@08:38:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33363^1
33364^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33350</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2134003103</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33350,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH RSN
9999999.64;+33350,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33350,;.08~YES
9999999.64;+33350,;.1~FACTOR
9999999.64;+33350,;100~NATIONAL
9999999.64;+33350,;101~VHA ONCOLOGY
9999999.64;+33350,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2+ off path rsn
9999999.64;+33350,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, HER2+; off pathway reason
9999999.65;+33351,+33350,;.01~MAR 19, 2024@13:44:06
9999999.65;+33351,+33350,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH TX
9999999.65;+33352,+33350,;.01~MAR 19, 2024@13:44:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33351^1
33352^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33349</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1197335784</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33349,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH TX
9999999.64;+33349,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33349,;.08~YES
9999999.64;+33349,;.1~FACTOR
9999999.64;+33349,;100~NATIONAL
9999999.64;+33349,;101~VHA ONCOLOGY
9999999.64;+33349,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2+ off path tx
9999999.64;+33349,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, HER2+; off pathway treatment
9999999.65;+33350,+33349,;.01~MAR 19, 2024@13:40:53
9999999.65;+33350,+33349,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ CLIN TRIAL
9999999.65;+33351,+33349,;.01~MAR 19, 2024@13:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33350^1
33351^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33347</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2322145702</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33347,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ CLIN TRIAL
9999999.64;+33347,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33347,;.08~YES
9999999.64;+33347,;.1~FACTOR
9999999.64;+33347,;100~NATIONAL
9999999.64;+33347,;101~VHA ONCOLOGY
9999999.64;+33347,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2+ clin trial
9999999.64;+33347,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, HER2+; on pathway clinical trial
9999999.65;+33348,+33347,;.01~MAR 19, 2024@13:31:23
9999999.65;+33348,+33347,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
9999999.65;+33349,+33347,;.01~MAR 19, 2024@13:35:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33348^1
33349^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>33354</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1459924518</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33354,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER SURV
9999999.64;+33354,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33354,;.08~YES
9999999.64;+33354,;.1~FACTOR
9999999.64;+33354,;100~NATIONAL
9999999.64;+33354,;101~VHA ONCOLOGY
9999999.64;+33354,;200~BRCA Adj Hormone Tx Node+ post-men >=5 HER2+ prefer surveillance
9999999.64;+33354,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3 HER2+; after 
initial anastrozole for 5 years, on pathway surveillance
9999999.65;+33355,+33354,;.01~MAR 20, 2024@06:30:16
9999999.65;+33355,+33354,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER ANAS 7-8Y
9999999.65;+33356,+33354,;.01~MAR 20, 2024@06:31:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33355^1
33356^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER ANAS 7-8Y</POINT_01>
<INTERNAL_ENTRY_NUMBER>33351</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3372518860</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33351,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER ANAS 7-8Y
9999999.64;+33351,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33351,;.08~YES
9999999.64;+33351,;.1~FACTOR
9999999.64;+33351,;100~NATIONAL
9999999.64;+33351,;101~VHA ONCOLOGY
9999999.64;+33351,;200~BRCA Adj Hormone Tx Node+ post-men >=5 HER2+ prefer ana 7-8years
9999999.64;+33351,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3 HER2+; after 
initial anastrozole for 5 years, on pathway anastrozole for 7-8 years
9999999.65;+33352,+33351,;.01~MAR 19, 2024@13:56:29
9999999.65;+33352,+33351,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ ANAS 5Y
9999999.65;+33353,+33351,;.01~MAR 19, 2024@13:58:11
9999999.65;+33354,+33351,;.01~MAR 20, 2024@06:21:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33352^1
33353^2
33354^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER TAMO 7-8Y</POINT_01>
<INTERNAL_ENTRY_NUMBER>33371</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2795548696</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33371,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER TAMO 7-8Y
9999999.64;+33371,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33371,;.08~YES
9999999.64;+33371,;.1~FACTOR
9999999.64;+33371,;100~NATIONAL
9999999.64;+33371,;101~VHA ONCOLOGY
9999999.64;+33371,;200~BRCA Adj Hormone Tx Node+ post-men >=5 HER2+ prefer tamo 7-8year
9999999.64;+33371,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3 HER2+; after 
initial anastrozole for 5 years, on pathway tamoxifen for 7-8 years
9999999.65;+33372,+33371,;.01~MAR 20, 2024@10:02:47
9999999.65;+33372,+33371,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER ANAS 7-8Y
9999999.65;+33373,+33371,;.01~MAR 20, 2024@10:06:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33372^1
33373^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ ANAS 5Y</POINT_01>
<INTERNAL_ENTRY_NUMBER>33348</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2429563238</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33348,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ ANAS 5Y
9999999.64;+33348,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33348,;.08~YES
9999999.64;+33348,;.1~FACTOR
9999999.64;+33348,;100~NATIONAL
9999999.64;+33348,;101~VHA ONCOLOGY
9999999.64;+33348,;200~BRCA Adj Hormone Tx Node+ post men Tumor >=5 HER2+ anastrozole 
9999999.64;+33348,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, HER2+; on pathway anastrozole for 5 years
9999999.65;+33349,+33348,;.01~MAR 19, 2024@13:37:42
9999999.65;+33349,+33348,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ CLIN TRIAL
9999999.65;+33350,+33348,;.01~MAR 19, 2024@13:39:29
9999999.65;+33351,+33348,;.01~MAR 19, 2024@13:59:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33349^1
33350^2
33351^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR&lt;5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33346</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>8980959</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33346,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OFF PATH RSN
9999999.64;+33346,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33346,;.08~YES
9999999.64;+33346,;.1~FACTOR
9999999.64;+33346,;100~NATIONAL
9999999.64;+33346,;101~VHA ONCOLOGY
9999999.64;+33346,;200~BRCA Adj Hormone Tx female Node+ pre men Tumor<5 off path rsn
9999999.64;+33346,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not tumor 5 cm or more or histologic grade 3; off pathway
reason
9999999.65;+33347,+33346,;.01~MAR 19, 2024@12:32:04
9999999.65;+33347,+33346,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OFF PATH TX
9999999.65;+33348,+33346,;.01~MAR 19, 2024@12:34:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33347^1
33348^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR&lt;5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33345</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4140237042</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33345,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OFF PATH TX
9999999.64;+33345,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33345,;.08~YES
9999999.64;+33345,;.1~FACTOR
9999999.64;+33345,;100~NATIONAL
9999999.64;+33345,;101~VHA ONCOLOGY
9999999.64;+33345,;200~BRCA Adj Hormone Tx female Node+ pre men Tumor<5 off path tx
9999999.64;+33345,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not tumor 5 cm or more or histologic grade 3; off pathway
treatment
9999999.65;+33346,+33345,;.01~MAR 19, 2024@12:28:07
9999999.65;+33346,+33345,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 CLIN TRIAL
9999999.65;+33347,+33345,;.01~MAR 19, 2024@12:31:06
9999999.65;+33348,+33345,;.01~MAR 19, 2024@12:40:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33346^1
33347^2
33348^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR&lt;5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33343</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>456312877</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33343,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 CLIN TRIAL
9999999.64;+33343,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33343,;.08~YES
9999999.64;+33343,;.1~FACTOR
9999999.64;+33343,;100~NATIONAL
9999999.64;+33343,;101~VHA ONCOLOGY
9999999.64;+33343,;200~BRCA Adj Hormone Tx female Node+ pre men Tumor<5 clin trial
9999999.64;+33343,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not tumor 5 cm or more or histologic grade 3;
on pathway clinical trial
9999999.65;+33344,+33343,;.01~MAR 19, 2024@11:41:45
9999999.65;+33344,+33343,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
9999999.65;+33345,+33343,;.01~MAR 19, 2024@11:48:35
9999999.65;+33346,+33343,;.01~MAR 19, 2024@12:36:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33344^1
33345^2
33346^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR&lt;5 OS+ANA+</POINT_01>
<INTERNAL_ENTRY_NUMBER>33344</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1834511666</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33344,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OS+ANA+
9999999.64;+33344,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33344,;.08~YES
9999999.64;+33344,;.1~FACTOR
9999999.64;+33344,;100~NATIONAL
9999999.64;+33344,;101~VHA ONCOLOGY
9999999.64;+33344,;200~BRCA Adj Hormone Tx female Node+ pre men Tumor<5 OS+ANAS+TAMOX
9999999.64;+33344,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not tumor 5 cm or more or histologic grade 3; on pathway
OS and anastrozole (yeasr 1-5) then tamoxifen (years 6-8)
9999999.65;+33345,+33344,;.01~MAR 19, 2024@11:51:23
9999999.65;+33345,+33344,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 CLIN TRIAL
9999999.65;+33346,+33344,;.01~MAR 19, 2024@11:57:21
9999999.65;+33347,+33344,;.01~MAR 19, 2024@12:42:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33345^1
33346^2
33347^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33342</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1831567160</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33342,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH RSN
9999999.64;+33342,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33342,;.08~YES
9999999.64;+33342,;.1~FACTOR
9999999.64;+33342,;100~NATIONAL
9999999.64;+33342,;101~VHA ONCOLOGY
9999999.64;+33342,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2- off path rsn
9999999.64;+33342,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not HER2+; off pathway reason
9999999.65;+33343,+33342,;.01~MAR 19, 2024@11:30:54
9999999.65;+33343,+33342,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH TX
9999999.65;+33344,+33342,;.01~MAR 19, 2024@11:32:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33343^1
33344^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33341</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3549398802</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33341,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH TX
9999999.64;+33341,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33341,;.08~YES
9999999.64;+33341,;.1~FACTOR
9999999.64;+33341,;100~NATIONAL
9999999.64;+33341,;101~VHA ONCOLOGY
9999999.64;+33341,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2- off path tx
9999999.64;+33341,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not HER2+; off pathway treatment
9999999.65;+33342,+33341,;.01~MAR 19, 2024@11:27:54
9999999.65;+33342,+33341,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- CLIN TRIAL
9999999.65;+33343,+33341,;.01~MAR 19, 2024@11:29:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33342^1
33343^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33339</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1644483138</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33339,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- CLIN TRIAL
9999999.64;+33339,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33339,;.08~YES
9999999.64;+33339,;.1~FACTOR
9999999.64;+33339,;100~NATIONAL
9999999.64;+33339,;101~VHA ONCOLOGY
9999999.64;+33339,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2- clin trial
9999999.64;+33339,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not HER2+; on pathway clinical trial
9999999.65;+33340,+33339,;.01~MAR 19, 2024@11:14:55
9999999.65;+33340,+33339,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
9999999.65;+33341,+33339,;.01~MAR 19, 2024@11:18:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33340^1
33341^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OS+ANA+ABE+</POINT_01>
<INTERNAL_ENTRY_NUMBER>33340</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1296004199</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33340,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OS+ANA+ABE+
9999999.64;+33340,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33340,;.08~YES
9999999.64;+33340,;.1~FACTOR
9999999.64;+33340,;100~NATIONAL
9999999.64;+33340,;101~VHA ONCOLOGY
9999999.64;+33340,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2- OS+ANA+ABE+
9999999.64;+33340,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, not HER2+; on pathway OS, anastrazole and abemaciclib 
(years 1-2), OS and anastrozole (years 3-5), and tamoxifen (years 6-8)
9999999.65;+33341,+33340,;.01~MAR 19, 2024@11:18:51
9999999.65;+33341,+33340,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- CLIN TRIAL
9999999.65;+33342,+33340,;.01~MAR 19, 2024@11:21:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33341^1
33342^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33338</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1418746410</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33338,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH RSN
9999999.64;+33338,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33338,;.08~YES
9999999.64;+33338,;.1~FACTOR
9999999.64;+33338,;100~NATIONAL
9999999.64;+33338,;101~VHA ONCOLOGY
9999999.64;+33338,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2+ off path rsn
9999999.64;+33338,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, HER2+; off pathway reason
9999999.65;+33339,+33338,;.01~MAR 19, 2024@11:11:14
9999999.65;+33339,+33338,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH TX
9999999.65;+33340,+33338,;.01~MAR 19, 2024@11:12:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33339^1
33340^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33337</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2347885821</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33337,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH TX
9999999.64;+33337,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33337,;.08~YES
9999999.64;+33337,;.1~FACTOR
9999999.64;+33337,;100~NATIONAL
9999999.64;+33337,;101~VHA ONCOLOGY
9999999.64;+33337,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2+ off path tx
9999999.64;+33337,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, HER2+; off pathway treatment
9999999.65;+33338,+33337,;.01~MAR 19, 2024@11:06:21
9999999.65;+33338,+33337,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
9999999.65;+33339,+33337,;.01~MAR 19, 2024@11:07:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33338^1
33339^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33335</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>363459643</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33335,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
9999999.64;+33335,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33335,;.08~YES
9999999.64;+33335,;.1~FACTOR
9999999.64;+33335,;100~NATIONAL
9999999.64;+33335,;101~VHA ONCOLOGY
9999999.64;+33335,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2+ clin trial
9999999.64;+33335,;201~WP-start~3
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, HER2+; on pathway clinical trial
9999999.65;+33336,+33335,;.01~MAR 19, 2024@10:53:11
9999999.65;+33336,+33335,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL
9999999.65;+33337,+33335,;.01~MAR 19, 2024@10:56:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33336^1
33337^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OS+ANA+TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>33336</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3583543551</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33336,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OS+ANA+TAM
9999999.64;+33336,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33336,;.08~YES
9999999.64;+33336,;.1~FACTOR
9999999.64;+33336,;100~NATIONAL
9999999.64;+33336,;101~VHA ONCOLOGY
9999999.64;+33336,;200~BRCA Adj Hormone Tx Node+ pre men Tumor >=5 HER2+ OS+ANA+TAMOX
9999999.64;+33336,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
pre-menopausal, HER2+; on pathway OS, anastrozole (years 1-5) then 
tamoxifen (years 6-8)
9999999.65;+33337,+33336,;.01~MAR 19, 2024@10:59:52
9999999.65;+33337,+33336,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
9999999.65;+33338,+33336,;.01~MAR 19, 2024@11:05:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33337^1
33338^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HORMONE TX CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33309</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2592615458</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33309,;.01~VA-ONC BRCA ADJ HORMONE TX CLINICAL PATHWAY
9999999.64;+33309,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+33309,;.08~YES
9999999.64;+33309,;.1~FACTOR
9999999.64;+33309,;100~NATIONAL
9999999.64;+33309,;101~VHA ONCOLOGY
9999999.64;+33309,;200~Breast CA-Adjuvant Hormone Therapy Clinical Pathway
9999999.64;+33309,;201~WP-start~2
Designates that the Category for all health factors in Breast Cancer 
Adjuvant Hormone Therapy Treatment Clinical Pathway was opened.
9999999.65;+33310,+33309,;.01~MAR 18, 2024@12:22:21
9999999.65;+33310,+33309,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NEOADJ TX CLINICAL PATHWAY
9999999.65;+33311,+33309,;.01~MAR 18, 2024@12:26:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33310^1
33311^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>32791</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>265847306</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32791,;.01~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32791,;.08~YES
9999999.64;+32791,;.1~CATEGORY
9999999.64;+32791,;100~NATIONAL
9999999.64;+32791,;101~VHA ONCOLOGY
9999999.64;+32791,;200~Breast Cancer-Local/Regional Mgmt After Tx Clinical Pathway
9999999.64;+32791,;201~WP-start~2
Category for all health factors in Breast Cancer-Local/Regional 
Management After Neoadjuvant Clinical Pathway.
9999999.65;+32792,+32791,;.01~FEB 23, 2024@08:31:54
9999999.65;+32792,+32791,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY
9999999.65;+32793,+32791,;.01~FEB 23, 2024@08:32:52
9999999.65;+32794,+32791,;.01~MAR 18, 2024@12:38:50
9999999.65;+32795,+32791,;.01~DEC 04, 2024@05:34:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32792^1
32793^2
32794^3
32795^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32837</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3213231986</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32837,;.01~VA-ONC BRCA LRM AFTER NOT BC NEG MARG CLIN TRIAL
9999999.64;+32837,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32837,;.08~YES
9999999.64;+32837,;.1~FACTOR
9999999.64;+32837,;100~NATIONAL
9999999.64;+32837,;101~VHA ONCOLOGY
9999999.64;+32837,;200~ BRCA LRM AFTER not BC neg margin s/p mast clinical trial
9999999.64;+32837,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
not a breast conservation candidate; after adjuvant therapy, negative
margins, on pathway clinical trial
9999999.65;+32838,+32837,;.01~FEB 27, 2024@08:49:16
9999999.65;+32838,+32837,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL
9999999.65;+32839,+32837,;.01~FEB 27, 2024@08:51:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32838^1
32839^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32841</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>336979421</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32841,;.01~VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH RSN
9999999.64;+32841,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32841,;.08~YES
9999999.64;+32841,;.1~FACTOR
9999999.64;+32841,;100~NATIONAL
9999999.64;+32841,;101~VHA ONCOLOGY
9999999.64;+32841,;200~ BRCA LRM AFTER not BC neg margin s/p mast off path reason
9999999.64;+32841,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
not a breast conservation candidate; after adjuvant therapy, negative
margins, off pathway reason
9999999.65;+32842,+32841,;.01~FEB 27, 2024@09:05:55
9999999.65;+32842,+32841,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH TX
9999999.65;+32843,+32841,;.01~FEB 27, 2024@09:06:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32842^1
32843^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32840</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3661846371</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32840,;.01~VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH TX
9999999.64;+32840,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32840,;.08~YES
9999999.64;+32840,;.1~FACTOR
9999999.64;+32840,;100~NATIONAL
9999999.64;+32840,;101~VHA ONCOLOGY
9999999.64;+32840,;200~ BRCA LRM AFTER not BC neg margin s/p mast off path treatment
9999999.64;+32840,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
not a breast conservation candidate; after adjuvant therapy, negative
margins, off pathway treatment
9999999.65;+32841,+32840,;.01~FEB 27, 2024@09:02
9999999.65;+32841,+32840,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC NEG MARG CLIN TRIAL
9999999.65;+32842,+32840,;.01~FEB 27, 2024@09:04:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32841^1
32842^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC NEG MARG RAD+I-III PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32838</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1073970224</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32838,;.01~VA-ONC BRCA LRM AFTER NOT BC NEG MARG RAD+I-III PTHWY
9999999.64;+32838,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32838,;.08~YES
9999999.64;+32838,;.1~FACTOR
9999999.64;+32838,;100~NATIONAL
9999999.64;+32838,;101~VHA ONCOLOGY
9999999.64;+32838,;200~ BRCA LRM AFTER Not BC Neg Margin s/p Mast Rad+I-III Pathway
9999999.64;+32838,;201~WP-start~4
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
not a breast conservation candidate; after adjuvant therapy, negative
margins, on pathway radiation and then follow appropriate Stage I-III 
Pathway
9999999.65;+32839,+32838,;.01~FEB 27, 2024@08:53:20
9999999.65;+32839,+32838,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC NEG MARG CLIN TRIAL
9999999.65;+32840,+32838,;.01~FEB 27, 2024@08:54:06
9999999.65;+32841,+32838,;.01~FEB 27, 2024@09:00:33
9999999.65;+32842,+32838,;.01~APR 16, 2024@09:42:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32839^1
32840^2
32841^3
32842^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>32753</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2259733839</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32753,;.01~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32753,;.08~YES
9999999.64;+32753,;.1~CATEGORY
9999999.64;+32753,;100~NATIONAL
9999999.64;+32753,;101~VHA ONCOLOGY
9999999.64;+32753,;200~Breast Cancer-Local/Regional Mgmt Prior Tx Clinical Pathway
9999999.64;+32753,;201~WP-start~2
Category for all health factors in Breast Cancer-Local/Regional Mgmt Tx 
Clinical Pathway.
9999999.65;+32754,+32753,;.01~FEB 21, 2024@13:55:48
9999999.65;+32754,+32753,;2~WP-start~1
Copied from VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY
9999999.65;+32755,+32753,;.01~FEB 21, 2024@13:57:24
9999999.65;+32756,+32753,;.01~FEB 23, 2024@08:38:11
9999999.65;+32757,+32753,;.01~DEC 04, 2024@05:38:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32754^1
32755^2
32756^3
32757^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC S/P MAST NO NEG MARGIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32847</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4135432109</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32847,;.01~VA-ONC BRCA LRM AFTER NOT BC S/P MAST NO NEG MARGIN
9999999.64;+32847,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32847,;.08~YES
9999999.64;+32847,;.1~FACTOR
9999999.64;+32847,;100~NATIONAL
9999999.64;+32847,;101~VHA ONCOLOGY
9999999.64;+32847,;200~BRCA LRM AFTER not breast conserve s/p mast no neg margins
9999999.64;+32847,;201~WP-start~3
Breast Cancer-Local/Regional Management After Adjuvant Treatment; breast 
conservation candidate, no negative margins, after adjuvant therapy, not 
on or off pathway negative margins
9999999.65;+32848,+32847,;.01~FEB 27, 2024@10:29:24
9999999.65;+32848,+32847,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NO NEG MARGIN 
9999999.65;+32849,+32847,;.01~FEB 27, 2024@10:30:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32848^1
32849^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC S/P MAST NEG MARGIN </POINT_01>
<INTERNAL_ENTRY_NUMBER>32846</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3987796165</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32846,;.01~VA-ONC BRCA LRM AFTER NOT BC S/P MAST NEG MARGIN 
9999999.64;+32846,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32846,;.08~YES
9999999.64;+32846,;.1~FACTOR
9999999.64;+32846,;100~NATIONAL
9999999.64;+32846,;101~VHA ONCOLOGY
9999999.64;+32846,;200~BRCA LRM AFTER not breast conserve s/p mast neg margins
9999999.64;+32846,;201~WP-start~3
Breast Cancer-Local/Regional Management After Adjuvant Treatment; 
breast conservation candidate, negative margins, after adjuvant therapy, 
not on or off pathway negative margins
9999999.65;+32847,+32846,;.01~FEB 27, 2024@10:26:52
9999999.65;+32847,+32846,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NEG MARGIN
9999999.65;+32848,+32846,;.01~FEB 27, 2024@10:28:07
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32847^1
32848^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32819</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4238889939</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32819,;.01~VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH RSN
9999999.64;+32819,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32819,;.08~YES
9999999.64;+32819,;.1~FACTOR
9999999.64;+32819,;100~NATIONAL
9999999.64;+32819,;101~VHA ONCOLOGY
9999999.64;+32819,;200~BRCA LRM AFTER not breast conserve N1 off path reason
9999999.64;+32819,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; not a breast conservation candidate, off pathway reason
9999999.65;+32820,+32819,;.01~FEB 26, 2024@08:28:08
9999999.65;+32820,+32819,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH RSN
9999999.65;+32821,+32819,;.01~FEB 26, 2024@08:29:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32820^1
32821^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32818</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3700821578</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32818,;.01~VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH TX
9999999.64;+32818,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32818,;.08~YES
9999999.64;+32818,;.1~FACTOR
9999999.64;+32818,;100~NATIONAL
9999999.64;+32818,;101~VHA ONCOLOGY
9999999.64;+32818,;200~BRCA LRM AFTER not breast conserve N1 off path treatment
9999999.64;+32818,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; not a breast conservation candidate, off pathway treatment
9999999.65;+32819,+32818,;.01~FEB 26, 2024@08:22:44
9999999.65;+32819,+32818,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH TX
9999999.65;+32820,+32818,;.01~FEB 26, 2024@08:27:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32819^1
32820^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32816</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2797071883</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32816,;.01~VA-ONC BRCA LRM AFTER NOT BC N1 CLIN TRIAL
9999999.64;+32816,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32816,;.08~YES
9999999.64;+32816,;.1~FACTOR
9999999.64;+32816,;100~NATIONAL
9999999.64;+32816,;101~VHA ONCOLOGY
9999999.64;+32816,;200~BRCA LRM AFTER not breast conserve N1 clinical trial
9999999.64;+32816,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; not a breast conservation candidate, on pathway clinical trial
9999999.65;+32817,+32816,;.01~FEB 26, 2024@08:05:58
9999999.65;+32817,+32816,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL
9999999.65;+32818,+32816,;.01~FEB 26, 2024@08:07:30
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32817^1
32818^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N1 MRM</POINT_01>
<INTERNAL_ENTRY_NUMBER>32817</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2302917836</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32817,;.01~VA-ONC BRCA LRM AFTER NOT BC N1 MRM
9999999.64;+32817,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32817,;.08~YES
9999999.64;+32817,;.1~FACTOR
9999999.64;+32817,;100~NATIONAL
9999999.64;+32817,;101~VHA ONCOLOGY
9999999.64;+32817,;200~BRCA LRM AFTER not breast conserve N1 mod radical mastectomy
9999999.64;+32817,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; not a breast conservation candidate, on pathway modified radical
mastectomy
9999999.65;+32818,+32817,;.01~FEB 26, 2024@08:14:33
9999999.65;+32818,+32817,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 MAST+NODE BX
9999999.65;+32819,+32817,;.01~FEB 26, 2024@08:17:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32818^1
32819^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32802</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2787843744</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32802,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH RSN
9999999.64;+32802,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32802,;.08~YES
9999999.64;+32802,;.1~FACTOR
9999999.64;+32802,;100~NATIONAL
9999999.64;+32802,;101~VHA ONCOLOGY
9999999.64;+32802,;200~BRCA LRM AFTER not breast conserve N0 off path reason
9999999.64;+32802,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, off pathway reason
9999999.65;+32803,+32802,;.01~FEB 23, 2024@13:37:03
9999999.65;+32803,+32802,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH TX
9999999.65;+32804,+32802,;.01~FEB 23, 2024@13:37:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32803^1
32804^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32801</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3334814183</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32801,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH TX
9999999.64;+32801,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32801,;.08~YES
9999999.64;+32801,;.1~FACTOR
9999999.64;+32801,;100~NATIONAL
9999999.64;+32801,;101~VHA ONCOLOGY
9999999.64;+32801,;200~BRCA LRM AFTER not breast conserve N0 off path treatment
9999999.64;+32801,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, off pathway treatment
9999999.65;+32802,+32801,;.01~FEB 23, 2024@13:32:17
9999999.65;+32802,+32801,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL
9999999.65;+32803,+32801,;.01~FEB 23, 2024@13:36
9999999.65;+32804,+32801,;.01~FEB 23, 2024@13:37:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32802^1
32803^2
32804^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32799</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2228302737</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32799,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL
9999999.64;+32799,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32799,;.08~YES
9999999.64;+32799,;.1~FACTOR
9999999.64;+32799,;100~NATIONAL
9999999.64;+32799,;101~VHA ONCOLOGY
9999999.64;+32799,;200~BRCA LRM AFTER not breast conserve N0 clinical trial
9999999.64;+32799,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, on pathway clinical trial
9999999.65;+32800,+32799,;.01~FEB 23, 2024@12:54:46
9999999.65;+32800,+32799,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 CLIN TRIAL
9999999.65;+32801,+32799,;.01~FEB 23, 2024@12:57:45
9999999.65;+32802,+32799,;.01~FEB 26, 2024@08:08:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32800^1
32801^2
32802^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 &gt; NODE+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32827</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2896284644</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32827,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ OFF PATH RSN
9999999.64;+32827,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32827,;.08~YES
9999999.64;+32827,;.1~FACTOR
9999999.64;+32827,;100~NATIONAL
9999999.64;+32827,;101~VHA ONCOLOGY
9999999.64;+32827,;200~BRCA LRM AFTER not breast conserve N0 >1 Node+ off path reason
9999999.64;+32827,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, >1 Node+ after mastectomy 
with sentinel node biopsy, off pathway reason
9999999.65;+32828,+32827,;.01~FEB 26, 2024@10:17:36
9999999.65;+32828,+32827,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ OFF PATH TX
9999999.65;+32829,+32827,;.01~FEB 26, 2024@10:19:43
9999999.65;+32830,+32827,;.01~FEB 27, 2024@07:53:26
9999999.65;+32831,+32827,;.01~FEB 27, 2024@08:07:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32828^1
32829^2
32830^3
32831^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 &gt; NODE+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32826</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3834345882</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32826,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ OFF PATH TX
9999999.64;+32826,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32826,;.08~YES
9999999.64;+32826,;.1~FACTOR
9999999.64;+32826,;100~NATIONAL
9999999.64;+32826,;101~VHA ONCOLOGY
9999999.64;+32826,;200~BRCA LRM AFTER not breast conserve N0 >1 Node+ off path tx
9999999.64;+32826,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, >1 Node+ after mastectomy 
with sentinel node biopsy, off pathway treatment
9999999.65;+32827,+32826,;.01~FEB 26, 2024@10:15:04
9999999.65;+32827,+32826,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ CLIN TRIAL
9999999.65;+32828,+32826,;.01~FEB 26, 2024@10:17:01
9999999.65;+32829,+32826,;.01~FEB 27, 2024@08:08:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32827^1
32828^2
32829^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 &gt; NODE+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32824</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3962193164</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32824,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ CLIN TRIAL
9999999.64;+32824,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32824,;.08~YES
9999999.64;+32824,;.1~FACTOR
9999999.64;+32824,;100~NATIONAL
9999999.64;+32824,;101~VHA ONCOLOGY
9999999.64;+32824,;200~BRCA LRM AFTER not breast conserve N0 >1 Node+ clinical trial
9999999.64;+32824,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, >1 Node+ after mastectomy 
with sentinel node biopsy, on pathway clinical trial
9999999.65;+32825,+32824,;.01~FEB 26, 2024@09:57:03
9999999.65;+32825,+32824,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 > NODE+ CLIN TRIAL
9999999.65;+32826,+32824,;.01~FEB 26, 2024@10:01:56
9999999.65;+32827,+32824,;.01~FEB 27, 2024@07:50:43
9999999.65;+32828,+32824,;.01~FEB 27, 2024@08:05:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32825^1
32826^2
32827^3
32828^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 &gt; NODE+ AX DISSECT</POINT_01>
<INTERNAL_ENTRY_NUMBER>32825</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1877545724</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32825,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ AX DISSECT
9999999.64;+32825,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32825,;.08~YES
9999999.64;+32825,;.1~FACTOR
9999999.64;+32825,;100~NATIONAL
9999999.64;+32825,;101~VHA ONCOLOGY
9999999.64;+32825,;200~BRCA LRM AFTER not breast conserve N0 >1 Node+ axill dissection
9999999.64;+32825,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, >1 Node+ after mastectomy 
with sentinel node biopsy, on pathway axillary dissection
9999999.65;+32826,+32825,;.01~FEB 26, 2024@10:05:36
9999999.65;+32826,+32825,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ CLIN TRIAL
9999999.65;+32827,+32825,;.01~FEB 26, 2024@10:09:39
9999999.65;+32828,+32825,;.01~FEB 26, 2024@11:18:18
9999999.65;+32829,+32825,;.01~FEB 27, 2024@07:48:56
9999999.65;+32830,+32825,;.01~FEB 27, 2024@08:06:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32826^1
32827^2
32828^3
32829^4
32830^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NOT BC N0 MAST+NODE BX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32800</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2409559081</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32800,;.01~VA-ONC BRCA LRM AFTER NOT BC N0 MAST+NODE BX
9999999.64;+32800,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32800,;.08~YES
9999999.64;+32800,;.1~FACTOR
9999999.64;+32800,;100~NATIONAL
9999999.64;+32800,;101~VHA ONCOLOGY
9999999.64;+32800,;200~BRCA LRM AFTER not breast conserve N0 mastectomy+biopsy
9999999.64;+32800,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; not a breast conservation candidate, on pathway mastectomy 
with sentinel node biopsy
9999999.65;+32801,+32800,;.01~FEB 23, 2024@13:29:31
9999999.65;+32801,+32800,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL
9999999.65;+32802,+32800,;.01~FEB 23, 2024@13:31:30
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32801^1
32802^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32832</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2830829163</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32832,;.01~VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH RSN
9999999.64;+32832,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32832,;.08~YES
9999999.64;+32832,;.1~FACTOR
9999999.64;+32832,;100~NATIONAL
9999999.64;+32832,;101~VHA ONCOLOGY
9999999.64;+32832,;200~ BRCA LRM AFTER BC neg margin s/p lump off path reason
9999999.64;+32832,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, negative margins,
off pathway reason
9999999.65;+32833,+32832,;.01~FEB 26, 2024@13:40:30
9999999.65;+32833,+32832,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH TX
9999999.65;+32834,+32832,;.01~FEB 26, 2024@13:41:12
9999999.65;+32835,+32832,;.01~FEB 27, 2024@08:21:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32833^1
32834^2
32835^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32831</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2827146918</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32831,;.01~VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH TX
9999999.64;+32831,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32831,;.08~YES
9999999.64;+32831,;.1~FACTOR
9999999.64;+32831,;100~NATIONAL
9999999.64;+32831,;101~VHA ONCOLOGY
9999999.64;+32831,;200~ BRCA LRM AFTER BC neg margin s/p lump off path treatment
9999999.64;+32831,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, negative margins,
off pathway treatment
9999999.65;+32832,+32831,;.01~FEB 26, 2024@13:37:24
9999999.65;+32832,+32831,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL
9999999.65;+32833,+32831,;.01~FEB 26, 2024@13:38:25
9999999.65;+32834,+32831,;.01~FEB 27, 2024@08:21:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32832^1
32833^2
32834^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32828</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1354882688</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32828,;.01~VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL
9999999.64;+32828,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32828,;.08~YES
9999999.64;+32828,;.1~FACTOR
9999999.64;+32828,;100~NATIONAL
9999999.64;+32828,;101~VHA ONCOLOGY
9999999.64;+32828,;200~ BRCA LRM AFTER BC neg margin s/p lump clinical trial
9999999.64;+32828,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, negative margins,
on pathway clinical trial
9999999.65;+32829,+32828,;.01~FEB 26, 2024@12:44:02
9999999.65;+32829,+32828,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 CLIN TRIAL
9999999.65;+32830,+32828,;.01~FEB 26, 2024@13:02:20
9999999.65;+32831,+32828,;.01~FEB 26, 2024@13:32:34
9999999.65;+32832,+32828,;.01~FEB 27, 2024@08:17:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32829^1
32830^2
32831^3
32832^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NEG MARG RAD+I-III PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32829</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2535168394</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32829,;.01~VA-ONC BRCA LRM AFTER BC NEG MARG RAD+I-III PTHWY
9999999.64;+32829,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32829,;.08~YES
9999999.64;+32829,;.1~FACTOR
9999999.64;+32829,;100~NATIONAL
9999999.64;+32829,;101~VHA ONCOLOGY
9999999.64;+32829,;200~ BRCA LRM AFTER BC Neg Margin s/p Lump Radiation+I-III Pathway
9999999.64;+32829,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, negative margins,
on pathway radiation then follow the appropriate Stage I-III pathway
9999999.65;+32830,+32829,;.01~FEB 26, 2024@13:15:20
9999999.65;+32830,+32829,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL
9999999.65;+32831,+32829,;.01~FEB 26, 2024@13:21:32
9999999.65;+32832,+32829,;.01~FEB 26, 2024@13:33:40
9999999.65;+32833,+32829,;.01~FEB 27, 2024@08:19:41
9999999.65;+32834,+32829,;.01~APR 16, 2024@08:01:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32830^1
32831^2
32832^3
32833^4
32834^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32836</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3359806603</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32836,;.01~VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH RSN
9999999.64;+32836,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32836,;.08~YES
9999999.64;+32836,;.1~FACTOR
9999999.64;+32836,;100~NATIONAL
9999999.64;+32836,;101~VHA ONCOLOGY
9999999.64;+32836,;200~ BRCA LRM AFTER BC no neg margin s/p lump off path reason
9999999.64;+32836,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, no negative 
margins, off pathway reason
9999999.65;+32837,+32836,;.01~FEB 27, 2024@07:27:26
9999999.65;+32837,+32836,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH TX
9999999.65;+32838,+32836,;.01~FEB 27, 2024@07:28:52
9999999.65;+32839,+32836,;.01~FEB 27, 2024@08:31:09
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32837^1
32838^2
32839^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32835</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1712718133</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32835,;.01~VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH TX
9999999.64;+32835,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32835,;.08~YES
9999999.64;+32835,;.1~FACTOR
9999999.64;+32835,;100~NATIONAL
9999999.64;+32835,;101~VHA ONCOLOGY
9999999.64;+32835,;200~ BRCA LRM AFTER BC no neg margin s/p lump off path treatment
9999999.64;+32835,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, no negative 
margins, off pathway treatment
9999999.65;+32836,+32835,;.01~FEB 27, 2024@07:21:36
9999999.65;+32836,+32835,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NO NEG MARG CLIN TRIAL
9999999.65;+32837,+32835,;.01~FEB 27, 2024@07:26:06
9999999.65;+32838,+32835,;.01~FEB 27, 2024@08:31:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32836^1
32837^2
32838^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NO NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32833</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3609848858</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32833,;.01~VA-ONC BRCA LRM AFTER BC NO NEG MARG CLIN TRIAL
9999999.64;+32833,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32833,;.08~YES
9999999.64;+32833,;.1~FACTOR
9999999.64;+32833,;100~NATIONAL
9999999.64;+32833,;101~VHA ONCOLOGY
9999999.64;+32833,;200~ BRCA LRM AFTER BC no neg margin s/p lump clinical trial
9999999.64;+32833,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, no negative 
margins, on pathway clinical trial
9999999.65;+32834,+32833,;.01~FEB 26, 2024@13:57:04
9999999.65;+32834,+32833,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL
9999999.65;+32835,+32833,;.01~FEB 26, 2024@14:00:43
9999999.65;+32836,+32833,;.01~FEB 27, 2024@08:29:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32834^1
32835^2
32836^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC NO NEG MARG CLEAR+RAD+I-III PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32834</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1123422294</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32834,;.01~VA-ONC BRCA LRM AFTER BC NO NEG MARG CLEAR+RAD+I-III PTHWY
9999999.64;+32834,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32834,;.08~YES
9999999.64;+32834,;.1~FACTOR
9999999.64;+32834,;100~NATIONAL
9999999.64;+32834,;101~VHA ONCOLOGY
9999999.64;+32834,;200~ BRCA LRM AFTER BC No Neg Margin s/p Lump Margin Clear+Rad+Pthwy
9999999.64;+32834,;201~WP-start~4
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
breast conservation candidate; after adjuvant therapy, no negative 
margins, on pathway margin clearance followed by radiation then follow
appropriate Stage I-III Pathway
9999999.65;+32835,+32834,;.01~FEB 27, 2024@07:18:24
9999999.65;+32835,+32834,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC NO NEG MARG CLIN TRIAL
9999999.65;+32836,+32834,;.01~FEB 27, 2024@07:21:18
9999999.65;+32837,+32834,;.01~FEB 27, 2024@08:26:28
9999999.65;+32838,+32834,;.01~APR 16, 2024@10:43:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32835^1
32836^2
32837^3
32838^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32798</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1851690428</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32798,;.01~VA-ONC BRCA LRM AFTER BC N1 OFF PATH RSN
9999999.64;+32798,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32798,;.08~YES
9999999.64;+32798,;.1~FACTOR
9999999.64;+32798,;100~NATIONAL
9999999.64;+32798,;101~VHA ONCOLOGY
9999999.64;+32798,;200~BRCA LRM AFTER breast conserve N1 off path reason
9999999.64;+32798,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; breast conservation candidate, off pathway reason
9999999.65;+32799,+32798,;.01~FEB 23, 2024@12:41:08
9999999.65;+32799,+32798,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N1 OFF PATH TX
9999999.65;+32800,+32798,;.01~FEB 23, 2024@12:42:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32799^1
32800^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32797</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1368215493</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32797,;.01~VA-ONC BRCA LRM AFTER BC N1 OFF PATH TX
9999999.64;+32797,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32797,;.08~YES
9999999.64;+32797,;.1~FACTOR
9999999.64;+32797,;100~NATIONAL
9999999.64;+32797,;101~VHA ONCOLOGY
9999999.64;+32797,;200~BRCA LRM AFTER breast conserve N1 off path treatment
9999999.64;+32797,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; breast conservation candidate, off pathway treatment
9999999.65;+32798,+32797,;.01~FEB 23, 2024@12:39:48
9999999.65;+32798,+32797,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 OFF PATH TX
9999999.65;+32799,+32797,;.01~FEB 23, 2024@12:40:30
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32798^1
32799^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32795</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1525755777</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32795,;.01~VA-ONC BRCA LRM AFTER BC N1 CLIN TRIAL
9999999.64;+32795,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32795,;.08~YES
9999999.64;+32795,;.1~FACTOR
9999999.64;+32795,;100~NATIONAL
9999999.64;+32795,;101~VHA ONCOLOGY
9999999.64;+32795,;200~BRCA LRM AFTER breast conservation N1 clinical trial
9999999.64;+32795,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; breast conservation candidate, on pathway clinical trial
9999999.65;+32796,+32795,;.01~FEB 23, 2024@12:26:13
9999999.65;+32796,+32795,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 CLIN TRIAL
9999999.65;+32797,+32795,;.01~FEB 23, 2024@12:27:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32796^1
32797^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N1 LUMP+AX NODE DS</POINT_01>
<INTERNAL_ENTRY_NUMBER>32796</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>647833284</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32796,;.01~VA-ONC BRCA LRM AFTER BC N1 LUMP+AX NODE DS
9999999.64;+32796,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32796,;.08~YES
9999999.64;+32796,;.1~FACTOR
9999999.64;+32796,;100~NATIONAL
9999999.64;+32796,;101~VHA ONCOLOGY
9999999.64;+32796,;200~BRCA LRM AFTER breast conserve N1 LUMP+AX Node Dissect
9999999.64;+32796,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N1; breast conservation candidate, on pathway lumpectomy, and 
axillary node dissection
9999999.65;+32797,+32796,;.01~FEB 23, 2024@12:33:14
9999999.65;+32797,+32796,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 LUMP+NODE BX+REMOVAL
9999999.65;+32798,+32796,;.01~FEB 23, 2024@12:34:42
9999999.65;+32799,+32796,;.01~MAR 22, 2024@13:26:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32797^1
32798^2
32799^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32793</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1789483940</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32793,;.01~VA-ONC BRCA LRM AFTER BC N0 OFF PATH RSN
9999999.64;+32793,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32793,;.08~YES
9999999.64;+32793,;.1~FACTOR
9999999.64;+32793,;100~NATIONAL
9999999.64;+32793,;101~VHA ONCOLOGY
9999999.64;+32793,;200~BRCA LRM AFTER breast conserve N0 off path reason
9999999.64;+32793,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, off pathway reason
9999999.65;+32794,+32793,;.01~FEB 23, 2024@09:54:25
9999999.65;+32794,+32793,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN
9999999.65;+32795,+32793,;.01~FEB 23, 2024@09:55:30
9999999.65;+32796,+32793,;.01~FEB 23, 2024@12:46:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32794^1
32795^2
32796^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32794</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2028789072</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32794,;.01~VA-ONC BRCA LRM AFTER BC N0 OFF PATH TX
9999999.64;+32794,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32794,;.08~YES
9999999.64;+32794,;.1~FACTOR
9999999.64;+32794,;100~NATIONAL
9999999.64;+32794,;101~VHA ONCOLOGY
9999999.64;+32794,;200~BRCA LRM AFTER breast conserve N0 off path treatment
9999999.64;+32794,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, off pathway treatment
9999999.65;+32795,+32794,;.01~FEB 23, 2024@09:57:59
9999999.65;+32795,+32794,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
9999999.65;+32796,+32794,;.01~FEB 23, 2024@09:58:54
9999999.65;+32797,+32794,;.01~FEB 23, 2024@12:47:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32795^1
32796^2
32797^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32792</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>466254365</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32792,;.01~VA-ONC BRCA LRM AFTER BC N0 CLIN TRIAL
9999999.64;+32792,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32792,;.08~YES
9999999.64;+32792,;.1~FACTOR
9999999.64;+32792,;100~NATIONAL
9999999.64;+32792,;101~VHA ONCOLOGY
9999999.64;+32792,;200~BRCA LRM AFTER breast conservation N0 clinical trial
9999999.64;+32792,;201~WP-start~2
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, on pathway clinical trial
9999999.65;+32793,+32792,;.01~FEB 23, 2024@08:54:36
9999999.65;+32793,+32792,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+32794,+32792,;.01~FEB 23, 2024@08:57:25
9999999.65;+32795,+32792,;.01~FEB 23, 2024@09:45:50
9999999.65;+32796,+32792,;.01~FEB 23, 2024@12:46:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32793^1
32794^2
32795^3
32796^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 &gt; NODE+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32823</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>776620324</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32823,;.01~VA-ONC BRCA LRM AFTER BC N0 > NODE+ OFF PATH RSN
9999999.64;+32823,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32823,;.08~YES
9999999.64;+32823,;.1~FACTOR
9999999.64;+32823,;100~NATIONAL
9999999.64;+32823,;101~VHA ONCOLOGY
9999999.64;+32823,;200~BRCA LRM AFTER breast conserve N0 >1 Node+ off path reason
9999999.64;+32823,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, >1 Node+ after lumpectomy, 
sentinel node biopsy and removal of clipped node, off pathway reason
9999999.65;+32824,+32823,;.01~FEB 26, 2024@09:41:49
9999999.65;+32824,+32823,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 > NODE+ OFF PATH TX
9999999.65;+32825,+32823,;.01~FEB 26, 2024@09:42:34
9999999.65;+32826,+32823,;.01~FEB 27, 2024@07:58:09
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32824^1
32825^2
32826^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 &gt; NODE+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32822</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1255001936</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32822,;.01~VA-ONC BRCA LRM AFTER BC N0 > NODE+ OFF PATH TX
9999999.64;+32822,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32822,;.08~YES
9999999.64;+32822,;.1~FACTOR
9999999.64;+32822,;100~NATIONAL
9999999.64;+32822,;101~VHA ONCOLOGY
9999999.64;+32822,;200~BRCA LRM AFTER breast conserve N0 >1 Node+ off path treatment
9999999.64;+32822,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, >1 Node+ after lumpectomy, 
sentinel node biopsy and removal of clipped node, off pathway treatment
9999999.65;+32823,+32822,;.01~FEB 26, 2024@09:35:45
9999999.65;+32823,+32822,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 > NODE+ CLIN TRIAL
9999999.65;+32824,+32822,;.01~FEB 26, 2024@09:39:30
9999999.65;+32825,+32822,;.01~FEB 27, 2024@07:58:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32823^1
32824^2
32825^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 &gt; NODE+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32820</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1269099529</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32820,;.01~VA-ONC BRCA LRM AFTER BC N0 > NODE+ CLIN TRIAL
9999999.64;+32820,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32820,;.08~YES
9999999.64;+32820,;.1~FACTOR
9999999.64;+32820,;100~NATIONAL
9999999.64;+32820,;101~VHA ONCOLOGY
9999999.64;+32820,;200~BRCA LRM AFTER breast conserve N0 >1 Node+ clinical trial
9999999.64;+32820,;201~WP-start~4
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, >1 Node+ after lumpectomy, 
sentinel node biopsy and removal of clipped node, on pathway clinical
trial
9999999.65;+32821,+32820,;.01~FEB 26, 2024@08:51:16
9999999.65;+32821,+32820,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL
9999999.65;+32822,+32820,;.01~FEB 26, 2024@08:58:55
9999999.65;+32823,+32820,;.01~FEB 26, 2024@09:31:06
9999999.65;+32824,+32820,;.01~FEB 27, 2024@07:59:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32821^1
32822^2
32823^3
32824^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 LUMP+NODE BX+REMOVAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32789</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2594030932</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32789,;.01~VA-ONC BRCA LRM AFTER BC N0 LUMP+NODE BX+REMOVAL
9999999.64;+32789,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32789,;.08~YES
9999999.64;+32789,;.1~FACTOR
9999999.64;+32789,;100~NATIONAL
9999999.64;+32789,;101~VHA ONCOLOGY
9999999.64;+32789,;200~BRCA LRM AFTER breast conserve N0 LUMP+Node bx+removal
9999999.64;+32789,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, on pathway lumpectomy, sentinel 
node biopsy, and removal of clipped node
9999999.65;+32790,+32789,;.01~FEB 23, 2024@09:08:10
9999999.65;+32790,+32789,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 LUMP+BX+AX
9999999.65;+32791,+32789,;.01~FEB 23, 2024@09:11:48
9999999.65;+32792,+32789,;.01~FEB 23, 2024@09:15:55
9999999.65;+32793,+32789,;.01~FEB 23, 2024@09:46:45
9999999.65;+32794,+32789,;.01~FEB 23, 2024@12:46:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32790^1
32791^2
32792^3
32793^4
32794^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NEOADJ TX CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32790</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3577393911</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32790,;.01~VA-ONC BRCA LRM AFTER NEOADJ TX CLINICAL PATHWAY
9999999.64;+32790,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+32790,;.08~YES
9999999.64;+32790,;.1~FACTOR
9999999.64;+32790,;100~NATIONAL
9999999.64;+32790,;101~VHA ONCOLOGY
9999999.64;+32790,;200~Breast CA-LRM After Neoadj Treatment Clinical Pathway
9999999.64;+32790,;201~WP-start~3
Designates that the Category for all health factors in Breast Cancer 
Local/Regional Management After Neoadjuvant Treatment Clinical Pathway
was opened.
9999999.65;+32791,+32790,;.01~FEB 23, 2024@08:28:01
9999999.65;+32791,+32790,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR ADJ TX CLINICAL PATHWAY
9999999.65;+32792,+32790,;.01~FEB 23, 2024@08:30:17
9999999.65;+32793,+32790,;.01~FEB 23, 2024@09:50:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32791^1
32792^2
32793^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC &gt;T3,N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32787</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3080677529</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32787,;.01~VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 OFF PATH RSN
9999999.64;+32787,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32787,;.08~YES
9999999.64;+32787,;.1~FACTOR
9999999.64;+32787,;100~NATIONAL
9999999.64;+32787,;101~VHA ONCOLOGY
9999999.64;+32787,;200~BRCA LRM PRIOR not BC s/p mast >T3N1 off path reason
9999999.64;+32787,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
not a breast conservation candidate, after mastectomy and node 
dissection, >3TN1, off pathway reason
9999999.65;+32788,+32787,;.01~FEB 22, 2024@10:30:56
9999999.65;+32788,+32787,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 OFF PATH TX
9999999.65;+32789,+32787,;.01~FEB 22, 2024@10:31:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32788^1
32789^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC &gt;T3,N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32786</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2674211837</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32786,;.01~VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 OFF PATH TX
9999999.64;+32786,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32786,;.08~YES
9999999.64;+32786,;.1~FACTOR
9999999.64;+32786,;100~NATIONAL
9999999.64;+32786,;101~VHA ONCOLOGY
9999999.64;+32786,;200~BRCA LRM PRIOR not BC s/p mast >T3N1 off path treatment
9999999.64;+32786,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
not a breast conservation candidate, after mastectomy and node 
dissection, >3TN1, off pathway treatment
9999999.65;+32787,+32786,;.01~FEB 22, 2024@10:28:28
9999999.65;+32787,+32786,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 CLIN TRIAL
9999999.65;+32788,+32786,;.01~FEB 22, 2024@10:30:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32787^1
32788^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC &gt;T3,N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32783</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1196915501</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32783,;.01~VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 CLIN TRIAL
9999999.64;+32783,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32783,;.08~YES
9999999.64;+32783,;.1~FACTOR
9999999.64;+32783,;100~NATIONAL
9999999.64;+32783,;101~VHA ONCOLOGY
9999999.64;+32783,;200~BRCA LRM PRIOR not BC s/p mast >T3N1 clinical trial
9999999.64;+32783,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
not a breast conservation candidate, after mastectomy and node 
dissection, >3TN1, on pathway clinical trial
9999999.65;+32784,+32783,;.01~FEB 22, 2024@10:14:29
9999999.65;+32784,+32783,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
9999999.65;+32785,+32783,;.01~FEB 22, 2024@10:20:02
9999999.65;+32786,+32783,;.01~FEB 22, 2024@10:24:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32784^1
32785^2
32786^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC &gt;T3,N1 I-III PTHWY+RAD</POINT_01>
<INTERNAL_ENTRY_NUMBER>32785</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3770200286</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32785,;.01~VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 I-III PTHWY+RAD
9999999.64;+32785,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32785,;.08~YES
9999999.64;+32785,;.1~FACTOR
9999999.64;+32785,;100~NATIONAL
9999999.64;+32785,;101~VHA ONCOLOGY
9999999.64;+32785,;200~BRCA LRM PRIOR not BC s/p mast >T3N1 follow I-III pathway+rad
9999999.64;+32785,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
not a breast conservation candidate, after mastectomy and node 
dissection, >3TN1, on pathway follow stage I-III pathway then radiation
9999999.65;+32786,+32785,;.01~FEB 22, 2024@10:25:36
9999999.65;+32786,+32785,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 RADIATION
9999999.65;+32787,+32785,;.01~FEB 22, 2024@10:27:24
9999999.65;+32788,+32785,;.01~MAR 21, 2024@07:47:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32786^1
32787^2
32788^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NO NEG MARGIN </POINT_01>
<INTERNAL_ENTRY_NUMBER>32782</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>372640634</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32782,;.01~VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NO NEG MARGIN 
9999999.64;+32782,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32782,;.08~YES
9999999.64;+32782,;.1~FACTOR
9999999.64;+32782,;100~NATIONAL
9999999.64;+32782,;101~VHA ONCOLOGY
9999999.64;+32782,;200~BRCA LRM PRIOR not breast conserve s/p mast no neg margins
9999999.64;+32782,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment; 
breast conservation candidate, no negative margins, after lumpectomy and 
node dissection, not on or off pathway negative margins
9999999.65;+32783,+32782,;.01~FEB 22, 2024@10:08:29
9999999.65;+32783,+32782,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NEG MARGIN
9999999.65;+32784,+32782,;.01~FEB 22, 2024@10:09:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32783^1
32784^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NEG MARGIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32781</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>806896030</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32781,;.01~VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NEG MARGIN
9999999.64;+32781,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32781,;.08~YES
9999999.64;+32781,;.1~FACTOR
9999999.64;+32781,;100~NATIONAL
9999999.64;+32781,;101~VHA ONCOLOGY
9999999.64;+32781,;200~BRCA LRM PRIOR not breast conserve s/p mast neg margins
9999999.64;+32781,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment; 
breast conservation candidate, no negative margins, after lumpectomy and 
node dissection, not on or off pathway no negative margins
9999999.65;+32782,+32781,;.01~FEB 22, 2024@10:04:57
9999999.65;+32782,+32781,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL
9999999.65;+32783,+32781,;.01~FEB 22, 2024@10:08
9999999.65;+32784,+32781,;.01~FEB 22, 2024@10:10:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32782^1
32783^2
32784^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32763</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1945709559</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32763,;.01~VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH RSN
9999999.64;+32763,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32763,;.08~YES
9999999.64;+32763,;.1~FACTOR
9999999.64;+32763,;100~NATIONAL
9999999.64;+32763,;101~VHA ONCOLOGY
9999999.64;+32763,;200~BRCA LRM PRIOR not breast conserve cand N0 off path reason
9999999.64;+32763,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; not a breast conservation candidate, off pathway reason
9999999.65;+32764,+32763,;.01~FEB 22, 2024@07:45:18
9999999.65;+32764,+32763,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH TX
9999999.65;+32765,+32763,;.01~FEB 22, 2024@07:45:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32764^1
32765^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32762</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1998239659</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32762,;.01~VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH TX
9999999.64;+32762,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32762,;.08~YES
9999999.64;+32762,;.1~FACTOR
9999999.64;+32762,;100~NATIONAL
9999999.64;+32762,;101~VHA ONCOLOGY
9999999.64;+32762,;200~BRCA LRM PRIOR not breast conserve cand N0 off path treatment
9999999.64;+32762,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; not a breast conservation candidate, off pathway treatment
9999999.65;+32763,+32762,;.01~FEB 22, 2024@07:37:31
9999999.65;+32763,+32762,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL
9999999.65;+32764,+32762,;.01~FEB 22, 2024@07:44:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32763^1
32764^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32760</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3239452964</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32760,;.01~VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL
9999999.64;+32760,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32760,;.08~YES
9999999.64;+32760,;.1~FACTOR
9999999.64;+32760,;100~NATIONAL
9999999.64;+32760,;101~VHA ONCOLOGY
9999999.64;+32760,;200~BRCA LRM PRIOR not breast conserve cand N0 clinical trial
9999999.64;+32760,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; not a breast conservation candidate, on pathway clinical trial
9999999.65;+32761,+32760,;.01~FEB 22, 2024@07:27:58
9999999.65;+32761,+32760,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+32762,+32760,;.01~FEB 22, 2024@07:29:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32761^1
32762^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N0 MAST+AX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32761</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2313516479</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32761,;.01~VA-ONC BRCA LRM PRIOR NOT BC N0 MAST+AX
9999999.64;+32761,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32761,;.08~YES
9999999.64;+32761,;.1~FACTOR
9999999.64;+32761,;100~NATIONAL
9999999.64;+32761,;101~VHA ONCOLOGY
9999999.64;+32761,;200~BRCA LRM PRIOR not breast conserve cand N0 mast+ax dissect
9999999.64;+32761,;201~WP-start~4
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; not a breast conservation candidate, on pathway mastectomy with 
sentinel node biopsy followed by axillary dissection if 3 or greater 
nodes positive
9999999.65;+32762,+32761,;.01~FEB 22, 2024@07:31:25
9999999.65;+32762,+32761,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL
9999999.65;+32763,+32761,;.01~FEB 22, 2024@07:36:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32762^1
32763^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32780</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1408600651</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32780,;.01~VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH RSN
9999999.64;+32780,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32780,;.08~YES
9999999.64;+32780,;.1~FACTOR
9999999.64;+32780,;100~NATIONAL
9999999.64;+32780,;101~VHA ONCOLOGY
9999999.64;+32780,;200~BRCA LRM PRIOR BC no neg margin s/p lump off path reason
9999999.64;+32780,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, no negative margins, after lumpectomy and
node dissection, off pathway reason
9999999.65;+32781,+32780,;.01~FEB 22, 2024@09:44:16
9999999.65;+32781,+32780,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH TX
9999999.65;+32782,+32780,;.01~FEB 22, 2024@09:44:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32781^1
32782^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32779</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4020006426</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32779,;.01~VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH TX
9999999.64;+32779,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32779,;.08~YES
9999999.64;+32779,;.1~FACTOR
9999999.64;+32779,;100~NATIONAL
9999999.64;+32779,;101~VHA ONCOLOGY
9999999.64;+32779,;200~BRCA LRM PRIOR BC no neg margin s/p lump off path treatment
9999999.64;+32779,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, no negative margins, after lumpectomy and
node dissection, off pathway treatment
9999999.65;+32780,+32779,;.01~FEB 22, 2024@09:39:15
9999999.65;+32780,+32779,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLIN TRIAL
9999999.65;+32781,+32779,;.01~FEB 22, 2024@09:43:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32780^1
32781^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32777</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>246767824</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32777,;.01~VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLIN TRIAL
9999999.64;+32777,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32777,;.08~YES
9999999.64;+32777,;.1~FACTOR
9999999.64;+32777,;100~NATIONAL
9999999.64;+32777,;101~VHA ONCOLOGY
9999999.64;+32777,;200~BRCA LRM PRIOR BC no neg margin s/p lump clinical trial
9999999.64;+32777,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, no negative margins, after lumpectomy and
node dissection, on pathway clinical trial
9999999.65;+32778,+32777,;.01~FEB 22, 2024@09:15:27
9999999.65;+32778,+32777,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
9999999.65;+32779,+32777,;.01~FEB 22, 2024@09:16:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32778^1
32779^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLEARANCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>32778</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1350031705</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32778,;.01~VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLEARANCE
9999999.64;+32778,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32778,;.08~YES
9999999.64;+32778,;.1~FACTOR
9999999.64;+32778,;100~NATIONAL
9999999.64;+32778,;101~VHA ONCOLOGY
9999999.64;+32778,;200~BRCA LRM PRIOR BC no neg margin s/p lump margin clearance
9999999.64;+32778,;201~WP-start~4
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, no negative margins, after lumpectomy and
node dissection, on pathway margin clearance then follow appropriate 
stage I-III pathway
9999999.65;+32779,+32778,;.01~FEB 22, 2024@09:17:40
9999999.65;+32779,+32778,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLIN TRIAL
9999999.65;+32780,+32778,;.01~FEB 22, 2024@09:20:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32779^1
32780^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG I-III PTHWY+RAD</POINT_01>
<INTERNAL_ENTRY_NUMBER>32774</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2420882749</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32774,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG I-III PTHWY+RAD
9999999.64;+32774,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32774,;.08~YES
9999999.64;+32774,;.1~FACTOR
9999999.64;+32774,;100~NATIONAL
9999999.64;+32774,;101~VHA ONCOLOGY
9999999.64;+32774,;200~BRCA LRM PRIOR BC neg margin s/p lump follow I-III pathway+rad
9999999.64;+32774,;201~WP-start~4
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, negative margins, after lumpectomy and node
dissection, on pathway follow appropriate stage I-III pathway then 
radiation
9999999.65;+32775,+32774,;.01~FEB 22, 2024@09:02:02
9999999.65;+32775,+32774,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NEG MARG RADIATON
9999999.65;+32776,+32774,;.01~FEB 22, 2024@09:02:57
9999999.65;+32777,+32774,;.01~MAR 21, 2024@07:43:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32775^1
32776^2
32777^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32776</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2230027652</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32776,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH RSN
9999999.64;+32776,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32776,;.08~YES
9999999.64;+32776,;.1~FACTOR
9999999.64;+32776,;100~NATIONAL
9999999.64;+32776,;101~VHA ONCOLOGY
9999999.64;+32776,;200~BRCA LRM PRIOR BC neg margin s/p lump off path reason
9999999.64;+32776,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, negative margins, after lumpectomy and node
dissection, off pathway reason
9999999.65;+32777,+32776,;.01~FEB 22, 2024@09:05:02
9999999.65;+32777,+32776,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX
9999999.65;+32778,+32776,;.01~FEB 22, 2024@09:05:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32777^1
32778^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32775</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3568423770</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32775,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX
9999999.64;+32775,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32775,;.08~YES
9999999.64;+32775,;.1~FACTOR
9999999.64;+32775,;100~NATIONAL
9999999.64;+32775,;101~VHA ONCOLOGY
9999999.64;+32775,;200~BRCA LRM PRIOR BC neg margin s/p lump off path treatment
9999999.64;+32775,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, negative margins, after lumpectomy and node
dissection, off pathway treatment
9999999.65;+32776,+32775,;.01~FEB 22, 2024@09:03:25
9999999.65;+32776,+32775,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
9999999.65;+32777,+32775,;.01~FEB 22, 2024@09:04:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32776^1
32777^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32772</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2995759323</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32772,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
9999999.64;+32772,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32772,;.08~YES
9999999.64;+32772,;.1~FACTOR
9999999.64;+32772,;100~NATIONAL
9999999.64;+32772,;101~VHA ONCOLOGY
9999999.64;+32772,;200~BRCA LRM PRIOR BC neg margin s/p lump clinical trial
9999999.64;+32772,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment;
breast conservation candidate, negative margins, after lumpectomy and node
dissection, on pathway clinical trial
9999999.65;+32773,+32772,;.01~FEB 22, 2024@08:39:32
9999999.65;+32773,+32772,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+32774,+32772,;.01~FEB 22, 2024@08:43:07
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32773^1
32774^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32767</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3668911356</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32767,;.01~VA-ONC BRCA LRM PRIOR BC N1 OFF PATH RSN
9999999.64;+32767,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32767,;.08~YES
9999999.64;+32767,;.1~FACTOR
9999999.64;+32767,;100~NATIONAL
9999999.64;+32767,;101~VHA ONCOLOGY
9999999.64;+32767,;200~BRCA LRM PRIOR breast conserve N1 off path reason
9999999.64;+32767,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; breast conservation candidate, off pathway reason
9999999.65;+32768,+32767,;.01~FEB 22, 2024@08:02:50
9999999.65;+32768,+32767,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN
9999999.65;+32769,+32767,;.01~FEB 22, 2024@08:03:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32768^1
32769^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32766</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3192680001</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32766,;.01~VA-ONC BRCA LRM PRIOR BC N1 OFF PATH TX
9999999.64;+32766,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32766,;.08~YES
9999999.64;+32766,;.1~FACTOR
9999999.64;+32766,;100~NATIONAL
9999999.64;+32766,;101~VHA ONCOLOGY
9999999.64;+32766,;200~BRCA LRM PRIOR breast conserve N1 off path treatment
9999999.64;+32766,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; breast conservation candidate, off pathway treatment
9999999.65;+32767,+32766,;.01~FEB 22, 2024@08:01:22
9999999.65;+32767,+32766,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
9999999.65;+32768,+32766,;.01~FEB 22, 2024@08:01:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32767^1
32768^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32764</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1581609881</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32764,;.01~VA-ONC BRCA LRM PRIOR BC N1 CLIN TRIAL
9999999.64;+32764,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32764,;.08~YES
9999999.64;+32764,;.1~FACTOR
9999999.64;+32764,;100~NATIONAL
9999999.64;+32764,;101~VHA ONCOLOGY
9999999.64;+32764,;200~BRCA LRM PRIOR breast conservation N1 clinical trial
9999999.64;+32764,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; breast conservation candidate, on pathway clinical trial
9999999.65;+32765,+32764,;.01~FEB 22, 2024@07:54:27
9999999.65;+32765,+32764,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+32766,+32764,;.01~FEB 22, 2024@07:56:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32765^1
32766^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 LUMP+AX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32765</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>717011119</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32765,;.01~VA-ONC BRCA LRM PRIOR BC N1 LUMP+AX
9999999.64;+32765,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32765,;.08~YES
9999999.64;+32765,;.1~FACTOR
9999999.64;+32765,;100~NATIONAL
9999999.64;+32765,;101~VHA ONCOLOGY
9999999.64;+32765,;200~BRCA LRM PRIOR breast conservation N1 LUMP+AX
9999999.64;+32765,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; breast conservation candidate, on pathway lumpectomy and
axillary node dissection
9999999.65;+32766,+32765,;.01~FEB 22, 2024@07:57:20
9999999.65;+32766,+32765,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 LUMP+BX+AX
9999999.65;+32767,+32765,;.01~FEB 22, 2024@07:59:46
9999999.65;+32768,+32765,;.01~FEB 22, 2024@08:06:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32766^1
32767^2
32768^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32759</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>543470313</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32759,;.01~VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN
9999999.64;+32759,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32759,;.08~YES
9999999.64;+32759,;.1~FACTOR
9999999.64;+32759,;100~NATIONAL
9999999.64;+32759,;101~VHA ONCOLOGY
9999999.64;+32759,;200~BRCA LRM PRIOR breast conserve N0 off path reason
9999999.64;+32759,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; breast conservation candidate, off pathway reason
9999999.65;+32760,+32759,;.01~FEB 22, 2024@07:21:50
9999999.65;+32760,+32759,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
9999999.65;+32761,+32759,;.01~FEB 22, 2024@07:22:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32760^1
32761^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32758</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1803718232</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32758,;.01~VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
9999999.64;+32758,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32758,;.08~YES
9999999.64;+32758,;.1~FACTOR
9999999.64;+32758,;100~NATIONAL
9999999.64;+32758,;101~VHA ONCOLOGY
9999999.64;+32758,;200~BRCA LRM PRIOR breast conserve N0 off path treatment
9999999.64;+32758,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; breast conservation candidate, off pathway treatment
9999999.65;+32759,+32758,;.01~FEB 22, 2024@07:16:33
9999999.65;+32759,+32758,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+32760,+32758,;.01~FEB 22, 2024@07:20:28
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32759^1
32760^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32756</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1585956633</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32756,;.01~VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.64;+32756,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32756,;.08~YES
9999999.64;+32756,;.1~FACTOR
9999999.64;+32756,;100~NATIONAL
9999999.64;+32756,;101~VHA ONCOLOGY
9999999.64;+32756,;200~BRCA LRM PRIOR breast conservation N0 clinical trial
9999999.64;+32756,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; breast conservation candidate, on pathway clinical trial
9999999.65;+32757,+32756,;.01~FEB 22, 2024@06:49:49
9999999.65;+32757,+32756,;2~WP-start~1
 Creation.
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32757^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 LUMP+BX+AX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32757</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>816154270</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32757,;.01~VA-ONC BRCA LRM PRIOR BC N0 LUMP+BX+AX
9999999.64;+32757,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32757,;.08~YES
9999999.64;+32757,;.1~FACTOR
9999999.64;+32757,;100~NATIONAL
9999999.64;+32757,;101~VHA ONCOLOGY
9999999.64;+32757,;200~BRCA LRM PRIOR breast conservation N0 LUMP+BX+AX
9999999.64;+32757,;201~WP-start~4
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N0; breast conservation candidate, on pathway lumpectomy and 
sentinel node biopsy followed by axillary dissection if 3 or greater 
nodes positive
9999999.65;+32758,+32757,;.01~FEB 22, 2024@07:12:14
9999999.65;+32758,+32757,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
9999999.65;+32759,+32757,;.01~FEB 22, 2024@07:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32758^1
32759^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR ADJ TX CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32755</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2389860559</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32755,;.01~VA-ONC BRCA LRM PRIOR ADJ TX CLINICAL PATHWAY
9999999.64;+32755,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+32755,;.08~YES
9999999.64;+32755,;.1~FACTOR
9999999.64;+32755,;100~NATIONAL
9999999.64;+32755,;101~VHA ONCOLOGY
9999999.64;+32755,;200~Breast CA-LRM Prior Adj Treatment Clinical Pathway
9999999.64;+32755,;201~WP-start~3
Designates that the Category for all health factors in Breast Cancer 
Local/Regional Management Prior Adjuvant Treatment Clinical Pathway was
opened.
9999999.65;+32756,+32755,;.01~FEB 22, 2024@06:38:09
9999999.65;+32756,+32755,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CLINICAL PATHWAY
9999999.65;+32757,+32755,;.01~FEB 22, 2024@06:42:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32756^1
32757^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33020</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4074679513</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33020,;.01~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33020,;.08~YES
9999999.64;+33020,;.1~CATEGORY
9999999.64;+33020,;100~NATIONAL
9999999.64;+33020,;101~VHA ONCOLOGY
9999999.64;+33020,;200~Breast Cancer-Stage I-III ER-/PR-/HER2- Clinical Pathway
9999999.64;+33020,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage ER-/PR-/HER2-
Clinical Pathway
9999999.65;+33021,+33020,;.01~MAR 01, 2024@10:10:13
9999999.65;+33021,+33020,;2~WP-start~1
Copied from VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY
9999999.65;+33022,+33020,;.01~MAR 01, 2024@10:11:44
9999999.65;+33023,+33020,;.01~DEC 03, 2024@13:57:28
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33021^1
33022^2
33023^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33085</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3669944634</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33085,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH RSN
9999999.64;+33085,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33085,;.08~YES
9999999.64;+33085,;.1~FACTOR
9999999.64;+33085,;100~NATIONAL
9999999.64;+33085,;101~VHA ONCOLOGY
9999999.64;+33085,;200~BRCA Stage I-III ER- T2N+ not imm resid germline- off path rsn
9999999.64;+33085,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV negative, off
pathway reason
9999999.65;+33086,+33085,;.01~MAR 04, 2024@11:51:35
9999999.65;+33086,+33085,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH TX
9999999.65;+33087,+33085,;.01~MAR 04, 2024@11:52:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33086^1
33087^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33084</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3403740568</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33084,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH TX
9999999.64;+33084,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33084,;.08~YES
9999999.64;+33084,;.1~FACTOR
9999999.64;+33084,;100~NATIONAL
9999999.64;+33084,;101~VHA ONCOLOGY
9999999.64;+33084,;200~BRCA Stage I-III ER- T2N+ not imm resid dz germline- off path tx
9999999.64;+33084,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV negative, off
pathway treatment
9999999.65;+33085,+33084,;.01~MAR 04, 2024@11:47:44
9999999.65;+33085,+33084,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CLIN TRIAL
9999999.65;+33086,+33084,;.01~MAR 04, 2024@11:50:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33085^1
33086^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33082</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3418754191</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33082,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CLIN TRIAL
9999999.64;+33082,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33082,;.08~YES
9999999.64;+33082,;.1~FACTOR
9999999.64;+33082,;100~NATIONAL
9999999.64;+33082,;101~VHA ONCOLOGY
9999999.64;+33082,;200~BRCA Stage I-III ER- T2N+ not imm resid dz germline- clin trial
9999999.64;+33082,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV negative, on
pathway clinical trial
9999999.65;+33083,+33082,;.01~MAR 04, 2024@11:39:03
9999999.65;+33083,+33082,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ CLIN TRIAL
9999999.65;+33084,+33082,;.01~MAR 04, 2024@11:44:28
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33083^1
33084^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33083</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1455664437</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33083,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CAP
9999999.64;+33083,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33083,;.08~YES
9999999.64;+33083,;.1~FACTOR
9999999.64;+33083,;100~NATIONAL
9999999.64;+33083,;101~VHA ONCOLOGY
9999999.64;+33083,;200~BRCA Stage I-III ER- T2N+ not imm resid dz germline- capecitabin
9999999.64;+33083,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV negative, on
pathway capecitabine
9999999.65;+33084,+33083,;.01~MAR 04, 2024@11:45:29
9999999.65;+33084,+33083,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CLIN TRIAL
9999999.65;+33085,+33083,;.01~MAR 04, 2024@11:47:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33084^1
33085^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33081</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2943335269</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33081,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH RSN
9999999.64;+33081,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33081,;.08~YES
9999999.64;+33081,;.1~FACTOR
9999999.64;+33081,;100~NATIONAL
9999999.64;+33081,;101~VHA ONCOLOGY
9999999.64;+33081,;200~BRCA Stage I-III ER- T2N+ not imm resid germline+ off path rsn
9999999.64;+33081,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV positive, off 
pathway reason
9999999.65;+33082,+33081,;.01~MAR 04, 2024@11:31:14
9999999.65;+33082,+33081,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH TX
9999999.65;+33083,+33081,;.01~MAR 04, 2024@11:34:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33082^1
33083^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33080</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1946965239</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33080,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH TX
9999999.64;+33080,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33080,;.08~YES
9999999.64;+33080,;.1~FACTOR
9999999.64;+33080,;100~NATIONAL
9999999.64;+33080,;101~VHA ONCOLOGY
9999999.64;+33080,;200~BRCA Stage I-III ER- T2N+ not imm resid dz germline+ treatment
9999999.64;+33080,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV positive, off 
pathway treatment
9999999.65;+33081,+33080,;.01~MAR 04, 2024@11:28:53
9999999.65;+33081,+33080,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ CLIN TRIAL
9999999.65;+33082,+33080,;.01~MAR 04, 2024@11:29:40
9999999.65;+33083,+33080,;.01~MAR 04, 2024@11:36:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33081^1
33082^2
33083^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33078</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3618499285</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33078,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ CLIN TRIAL
9999999.64;+33078,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33078,;.08~YES
9999999.64;+33078,;.1~FACTOR
9999999.64;+33078,;100~NATIONAL
9999999.64;+33078,;101~VHA ONCOLOGY
9999999.64;+33078,;200~BRCA Stage I-III ER- T2N+ not imm resid dz germline+ clin trial
9999999.64;+33078,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV positive, on
pathway clinical trial
9999999.65;+33079,+33078,;.01~MAR 04, 2024@11:20:23
9999999.65;+33079,+33078,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID CLIN TRIAL
9999999.65;+33080,+33078,;.01~MAR 04, 2024@11:23:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33079^1
33080^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33079</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2038042416</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33079,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OLAP
9999999.64;+33079,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33079,;.08~YES
9999999.64;+33079,;.1~FACTOR
9999999.64;+33079,;100~NATIONAL
9999999.64;+33079,;101~VHA ONCOLOGY
9999999.64;+33079,;200~BRCA Stage I-III ER- T2N+ not imm resid dz germline+ olparib
9999999.64;+33079,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, residual disease after, germline BRCA1/2 PV positive, on
pathway olparib
9999999.65;+33080,+33079,;.01~MAR 04, 2024@11:27:53
9999999.65;+33080,+33079,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ CLIN TRIAL
9999999.65;+33081,+33079,;.01~MAR 04, 2024@11:28:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33080^1
33081^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33077</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>638478145</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33077,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH RSN
9999999.64;+33077,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33077,;.08~YES
9999999.64;+33077,;.1~FACTOR
9999999.64;+33077,;100~NATIONAL
9999999.64;+33077,;101~VHA ONCOLOGY
9999999.64;+33077,;200~BRCA Stage I-III ER- T2N+ not immun cand no resid off path rsn
9999999.64;+33077,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, no residual disease after, off pathway reason
9999999.65;+33078,+33077,;.01~MAR 04, 2024@11:13:19
9999999.65;+33078,+33077,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH TX
9999999.65;+33079,+33077,;.01~MAR 04, 2024@11:15:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33078^1
33079^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33076</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>633202252</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33076,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH TX
9999999.64;+33076,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33076,;.08~YES
9999999.64;+33076,;.1~FACTOR
9999999.64;+33076,;100~NATIONAL
9999999.64;+33076,;101~VHA ONCOLOGY
9999999.64;+33076,;200~BRCA Stage I-III ER- T2N+ not immun cand no resid dz off path tx
9999999.64;+33076,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, no residual disease after, off pathway treatment
9999999.65;+33077,+33076,;.01~MAR 04, 2024@11:10:47
9999999.65;+33077,+33076,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID CLIN TRIAL
9999999.65;+33078,+33076,;.01~MAR 04, 2024@11:13:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33077^1
33078^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33074</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3302529147</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33074,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID CLIN TRIAL
9999999.64;+33074,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33074,;.08~YES
9999999.64;+33074,;.1~FACTOR
9999999.64;+33074,;100~NATIONAL
9999999.64;+33074,;101~VHA ONCOLOGY
9999999.64;+33074,;200~BRCA Stage I-III ER- T2N+ not immun cand no resid dz clin trial
9999999.64;+33074,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, no residual disease after, on pathway clinical trial
9999999.65;+33075,+33074,;.01~MAR 04, 2024@10:38:22
9999999.65;+33075,+33074,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL
9999999.65;+33076,+33074,;.01~MAR 04, 2024@10:43:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33075^1
33076^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>33075</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3772549030</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33075,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID SURV
9999999.64;+33075,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33075,;.08~YES
9999999.64;+33075,;.1~FACTOR
9999999.64;+33075,;100~NATIONAL
9999999.64;+33075,;101~VHA ONCOLOGY
9999999.64;+33075,;200~BRCA Stage I-III ER- T2N+ not immun cand no resid dz clin trial
9999999.64;+33075,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, no residual disease after, on pathway surveillance
9999999.65;+33076,+33075,;.01~MAR 04, 2024@11:08:21
9999999.65;+33076,+33075,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID CLIN TRIAL
9999999.65;+33077,+33075,;.01~MAR 04, 2024@11:10:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33076^1
33077^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33073</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3347278984</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33073,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH RSN
9999999.64;+33073,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33073,;.08~YES
9999999.64;+33073,;.1~FACTOR
9999999.64;+33073,;100~NATIONAL
9999999.64;+33073,;101~VHA ONCOLOGY
9999999.64;+33073,;200~BRCA Stage I-III ER- T2N+ not immuno cand off path reason
9999999.64;+33073,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, off pathway reason
9999999.65;+33074,+33073,;.01~MAR 04, 2024@10:31:21
9999999.65;+33074,+33073,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH TX
9999999.65;+33075,+33073,;.01~MAR 04, 2024@10:32:33
9999999.65;+33076,+33073,;.01~MAR 04, 2024@13:59:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33074^1
33075^2
33076^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33072</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1413603775</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33072,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH TX
9999999.64;+33072,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33072,;.08~YES
9999999.64;+33072,;.1~FACTOR
9999999.64;+33072,;100~NATIONAL
9999999.64;+33072,;101~VHA ONCOLOGY
9999999.64;+33072,;200~BRCA Stage I-III ER- T2N+ not immuno cand off path treatment
9999999.64;+33072,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, off pathway treatment
9999999.65;+33073,+33072,;.01~MAR 04, 2024@10:24:08
9999999.65;+33073,+33072,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND CLIN TRIAL
9999999.65;+33074,+33072,;.01~MAR 04, 2024@10:27:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33073^1
33074^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33070</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3111108451</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33070,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND CLIN TRIAL
9999999.64;+33070,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33070,;.08~YES
9999999.64;+33070,;.1~FACTOR
9999999.64;+33070,;100~NATIONAL
9999999.64;+33070,;101~VHA ONCOLOGY
9999999.64;+33070,;200~BRCA Stage I-III ER- T2N+ not immuno cand clinical trial
9999999.64;+33070,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, on pathway clinical trial
9999999.65;+33071,+33070,;.01~MAR 04, 2024@09:55:23
9999999.65;+33071,+33070,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL
9999999.65;+33072,+33070,;.01~MAR 04, 2024@10:11:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33071^1
33072^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND ddAC-T+LRM AFTER</POINT_01>
<INTERNAL_ENTRY_NUMBER>33071</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1900424135</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33071,;.01~VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND ddAC-T+LRM AFTER
9999999.64;+33071,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33071,;.08~YES
9999999.64;+33071,;.1~FACTOR
9999999.64;+33071,;100~NATIONAL
9999999.64;+33071,;101~VHA ONCOLOGY
9999999.64;+33071,;200~BRCA Stage I-III ER- T2N+ not immuno cand ddAC-T+LRM After Pthwy
9999999.64;+33071,;201~WP-start~4
Breast Cancer-Stage I-III ER- T2 or greater or N+; not a immunotherapy 
candidate, on pathway Dose-dense AC-T doxorubicin and cyclophosphamide 
(dd-ACT) then follow Local/Regional Management After Neoadjuvant 
Treatment Pathway
9999999.65;+33072,+33071,;.01~MAR 04, 2024@10:14:59
9999999.65;+33072,+33071,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND CLIN TRIAL
9999999.65;+33073,+33071,;.01~MAR 04, 2024@10:22:51
9999999.65;+33074,+33071,;.01~MAR 04, 2024@10:27:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33072^1
33073^2
33074^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33069</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>636285521</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33069,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH RSN
9999999.64;+33069,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33069,;.08~YES
9999999.64;+33069,;.1~FACTOR
9999999.64;+33069,;100~NATIONAL
9999999.64;+33069,;101~VHA ONCOLOGY
9999999.64;+33069,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline- off path rsn
9999999.64;+33069,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, residual disease after, germline BRCA1/2 negative, off pathway 
reason
9999999.65;+33070,+33069,;.01~MAR 04, 2024@09:38:05
9999999.65;+33070,+33069,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH TX
9999999.65;+33071,+33069,;.01~MAR 04, 2024@09:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33070^1
33071^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33068</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3954550208</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33068,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH TX
9999999.64;+33068,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33068,;.08~YES
9999999.64;+33068,;.1~FACTOR
9999999.64;+33068,;100~NATIONAL
9999999.64;+33068,;101~VHA ONCOLOGY
9999999.64;+33068,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline- off path tx
9999999.64;+33068,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, residual disease after, germline BRCA1/2 negative, off pathway 
treatment
9999999.65;+33069,+33068,;.01~MAR 04, 2024@09:36:18
9999999.65;+33069,+33068,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- CLIN TRIAL
9999999.65;+33070,+33068,;.01~MAR 04, 2024@09:37:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33069^1
33070^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33065</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2502893386</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33065,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- CLIN TRIAL
9999999.64;+33065,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33065,;.08~YES
9999999.64;+33065,;.1~FACTOR
9999999.64;+33065,;100~NATIONAL
9999999.64;+33065,;101~VHA ONCOLOGY
9999999.64;+33065,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline- clin trial
9999999.64;+33065,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, residual disease after, germline BRCA1/2 negative, on pathway 
clinical trial
9999999.65;+33066,+33065,;.01~MAR 04, 2024@09:22:06
9999999.65;+33066,+33065,;2~WP-start~1
Copied from VA-ONC HN ORAL CAV T1-2, N0, M0 ADFE/+ MARG NO RE-RESECT RAD/CFL
9999999.65;+33067,+33065,;.01~MAR 04, 2024@09:25:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33066^1
33067^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33067</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3970810064</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33067,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB
9999999.64;+33067,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33067,;.08~YES
9999999.64;+33067,;.1~FACTOR
9999999.64;+33067,;100~NATIONAL
9999999.64;+33067,;101~VHA ONCOLOGY
9999999.64;+33067,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline- pembro
9999999.64;+33067,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, residual disease after, germline BRCA1/2 negative, on pathway 
pembrolizumab
9999999.65;+33068,+33067,;.01~MAR 04, 2024@09:28:15
9999999.65;+33068,+33067,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB+CAP
9999999.65;+33069,+33067,;.01~MAR 04, 2024@09:28:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33068^1
33069^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33066</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3738114639</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33066,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB+CAP
9999999.64;+33066,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33066,;.08~YES
9999999.64;+33066,;.1~FACTOR
9999999.64;+33066,;100~NATIONAL
9999999.64;+33066,;101~VHA ONCOLOGY
9999999.64;+33066,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline- pembro+cap
9999999.64;+33066,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, residual disease after, germline BRCA1/2 negative, on pathway 
pembrolizumab and capecitabine
9999999.65;+33067,+33066,;.01~MAR 04, 2024@09:26:50
9999999.65;+33067,+33066,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- CLIN TRIAL
9999999.65;+33068,+33066,;.01~MAR 04, 2024@09:27:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33067^1
33068^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33064</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1523101754</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33064,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ OFF PATH RSN
9999999.64;+33064,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33064,;.08~YES
9999999.64;+33064,;.1~FACTOR
9999999.64;+33064,;100~NATIONAL
9999999.64;+33064,;101~VHA ONCOLOGY
9999999.64;+33064,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline+ off path rsn
9999999.64;+33064,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy candidate, residual disease after, germline BRCA1/2 positive,
off pathway reason
9999999.65;+33065,+33064,;.01~MAR 04, 2024@08:49:59
9999999.65;+33065,+33064,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID OFF PATH TX
9999999.65;+33066,+33064,;.01~MAR 04, 2024@08:50:35
9999999.65;+33067,+33064,;.01~MAR 04, 2024@08:56:38
9999999.65;+33068,+33064,;.01~MAR 04, 2024@09:01:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33065^1
33066^2
33067^3
33068^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33063</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4282301230</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33063,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ OFF PATH TX
9999999.64;+33063,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33063,;.08~YES
9999999.64;+33063,;.1~FACTOR
9999999.64;+33063,;100~NATIONAL
9999999.64;+33063,;101~VHA ONCOLOGY
9999999.64;+33063,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline+ off path tx
9999999.64;+33063,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy candidate, residual disease after, germline BRCA1/2 positive,
off pathway treatment
9999999.65;+33064,+33063,;.01~MAR 04, 2024@08:48:02
9999999.65;+33064,+33063,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ CLIN TRIAL
9999999.65;+33065,+33063,;.01~MAR 04, 2024@08:49:40
9999999.65;+33066,+33063,;.01~MAR 04, 2024@08:57:35
9999999.65;+33067,+33063,;.01~MAR 04, 2024@08:58:12
9999999.65;+33068,+33063,;.01~MAR 04, 2024@09:01:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33064^1
33065^2
33066^3
33067^4
33068^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33060</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4172993919</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33060,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ CLIN TRIAL
9999999.64;+33060,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33060,;.08~YES
9999999.64;+33060,;.1~FACTOR
9999999.64;+33060,;100~NATIONAL
9999999.64;+33060,;101~VHA ONCOLOGY
9999999.64;+33060,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline+ clin trial
9999999.64;+33060,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy candidate, residual disease after, germline BRCA1/2 positive,
on pathway clinical trial
9999999.65;+33061,+33060,;.01~MAR 04, 2024@08:35:43
9999999.65;+33061,+33060,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL
9999999.65;+33062,+33060,;.01~MAR 04, 2024@08:40:16
9999999.65;+33063,+33060,;.01~MAR 04, 2024@09:00:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33061^1
33062^2
33063^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33062</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>911148990</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33062,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB
9999999.64;+33062,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33062,;.08~YES
9999999.64;+33062,;.1~FACTOR
9999999.64;+33062,;100~NATIONAL
9999999.64;+33062,;101~VHA ONCOLOGY
9999999.64;+33062,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline+ pembro
9999999.64;+33062,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy candidate, residual disease after, germline BRCA1/2 positive,
on pathway pembrolizumab
9999999.65;+33063,+33062,;.01~MAR 04, 2024@08:46:45
9999999.65;+33063,+33062,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB+OLAP
9999999.65;+33064,+33062,;.01~MAR 04, 2024@08:47:27
9999999.65;+33065,+33062,;.01~MAR 04, 2024@08:59:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33063^1
33064^2
33065^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB+OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33061</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>663912219</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33061,;.01~VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB+OLAP
9999999.64;+33061,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33061,;.08~YES
9999999.64;+33061,;.1~FACTOR
9999999.64;+33061,;100~NATIONAL
9999999.64;+33061,;101~VHA ONCOLOGY
9999999.64;+33061,;200~BRCA Stage I-III ER- T2N+ immun resid dz germline+ pembro+olap
9999999.64;+33061,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy candidate, residual disease after, germline BRCA1/2 positive,
on pathway pembrolizumab and olaparib for 1 year
9999999.65;+33062,+33061,;.01~MAR 04, 2024@08:41:56
9999999.65;+33062,+33061,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ CLIN TRIAL
9999999.65;+33063,+33061,;.01~MAR 04, 2024@08:45:48
9999999.65;+33064,+33061,;.01~MAR 04, 2024@09:00:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33062^1
33063^2
33064^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33059</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3211504296</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33059,;.01~VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH RSN
9999999.64;+33059,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33059,;.08~YES
9999999.64;+33059,;.1~FACTOR
9999999.64;+33059,;100~NATIONAL
9999999.64;+33059,;101~VHA ONCOLOGY
9999999.64;+33059,;200~BRCA Stage I-III ER- T2N+ immun cand no residual dz off path rsn
9999999.64;+33059,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, no residual disease after, off pathway reason
9999999.65;+33060,+33059,;.01~MAR 04, 2024@08:25:49
9999999.65;+33060,+33059,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH TX
9999999.65;+33061,+33059,;.01~MAR 04, 2024@08:26:32
9999999.65;+33062,+33059,;.01~MAR 04, 2024@09:19:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33060^1
33061^2
33062^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33058</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1515946652</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33058,;.01~VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH TX
9999999.64;+33058,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33058,;.08~YES
9999999.64;+33058,;.1~FACTOR
9999999.64;+33058,;100~NATIONAL
9999999.64;+33058,;101~VHA ONCOLOGY
9999999.64;+33058,;200~BRCA Stage I-III ER- T2N+ immun cand no residual dz off path tx
9999999.64;+33058,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, no residual disease after, off pathway treatment
9999999.65;+33059,+33058,;.01~MAR 04, 2024@08:16:29
9999999.65;+33059,+33058,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL
9999999.65;+33060,+33058,;.01~MAR 04, 2024@08:21:57
9999999.65;+33061,+33058,;.01~MAR 04, 2024@09:20:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33059^1
33060^2
33061^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33056</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2565961346</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33056,;.01~VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL
9999999.64;+33056,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33056,;.08~YES
9999999.64;+33056,;.1~FACTOR
9999999.64;+33056,;100~NATIONAL
9999999.64;+33056,;101~VHA ONCOLOGY
9999999.64;+33056,;200~BRCA Stage I-III ER- T2N+ immun cand no residual dz clin trial
9999999.64;+33056,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, no residual disease after, on pathway clinical trial
9999999.65;+33057,+33056,;.01~MAR 04, 2024@08:07:28
9999999.65;+33057,+33056,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL
9999999.65;+33058,+33056,;.01~MAR 04, 2024@08:10:38
9999999.65;+33059,+33056,;.01~MAR 04, 2024@10:45:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33057^1
33058^2
33059^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM NO RESID ADJ PEMB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33057</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>345571951</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33057,;.01~VA-ONC BRCA I-III ER- T2N+ IMM NO RESID ADJ PEMB
9999999.64;+33057,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33057,;.08~YES
9999999.64;+33057,;.1~FACTOR
9999999.64;+33057,;100~NATIONAL
9999999.64;+33057,;101~VHA ONCOLOGY
9999999.64;+33057,;200~BRCA Stage I-III ER- T2N+ immun cand no residual dz adj pembro
9999999.64;+33057,;201~WP-start~3
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, no residual disease after, on pathway adjuvant permbrolizumab 
(9 cycles, 27 weeks)
9999999.65;+33058,+33057,;.01~MAR 04, 2024@08:11:53
9999999.65;+33058,+33057,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL
9999999.65;+33059,+33057,;.01~MAR 04, 2024@08:14:58
9999999.65;+33060,+33057,;.01~MAR 04, 2024@09:16:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33058^1
33059^2
33060^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33055</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3152200124</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33055,;.01~VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH RSN
9999999.64;+33055,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33055,;.08~YES
9999999.64;+33055,;.1~FACTOR
9999999.64;+33055,;100~NATIONAL
9999999.64;+33055,;101~VHA ONCOLOGY
9999999.64;+33055,;200~BRCA Stage I-III ER- T2N+ immuno cand off path reason
9999999.64;+33055,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, off pathway reason
9999999.65;+33056,+33055,;.01~MAR 04, 2024@06:44:02
9999999.65;+33056,+33055,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH TX
9999999.65;+33057,+33055,;.01~MAR 04, 2024@06:45:22
9999999.65;+33058,+33055,;.01~MAR 04, 2024@09:14:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33056^1
33057^2
33058^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33054</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3709393594</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33054,;.01~VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH TX
9999999.64;+33054,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33054,;.08~YES
9999999.64;+33054,;.1~FACTOR
9999999.64;+33054,;100~NATIONAL
9999999.64;+33054,;101~VHA ONCOLOGY
9999999.64;+33054,;200~BRCA Stage I-III ER- T2N+ immuno cand off path treatment
9999999.64;+33054,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, off pathway treatment
9999999.65;+33055,+33054,;.01~MAR 04, 2024@06:41:03
9999999.65;+33055,+33054,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL
9999999.65;+33056,+33054,;.01~MAR 04, 2024@06:43:43
9999999.65;+33057,+33054,;.01~MAR 04, 2024@09:11:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33055^1
33056^2
33057^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33052</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3548361494</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33052,;.01~VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL
9999999.64;+33052,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33052,;.08~YES
9999999.64;+33052,;.1~FACTOR
9999999.64;+33052,;100~NATIONAL
9999999.64;+33052,;101~VHA ONCOLOGY
9999999.64;+33052,;200~BRCA Stage I-III ER- T2N+ immuno cand clinical trial
9999999.64;+33052,;201~WP-start~2
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, on pathway clinical trial
9999999.65;+33053,+33052,;.01~MAR 04, 2024@06:21:37
9999999.65;+33053,+33052,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT UPSTG ANTH CLIN TRIAL
9999999.65;+33054,+33052,;.01~MAR 04, 2024@06:25:27
9999999.65;+33055,+33052,;.01~MAR 04, 2024@09:10:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33053^1
33054^2
33055^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T2N+ IMM CAND PEMB+CARB/PAC</POINT_01>
<INTERNAL_ENTRY_NUMBER>33053</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2730347720</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33053,;.01~VA-ONC BRCA I-III ER- T2N+ IMM CAND PEMB+CARB/PAC
9999999.64;+33053,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33053,;.08~YES
9999999.64;+33053,;.1~FACTOR
9999999.64;+33053,;100~NATIONAL
9999999.64;+33053,;101~VHA ONCOLOGY
9999999.64;+33053,;200~BRCA Stage I-III ER- T2N+ immuno cand Pemb+Carb or Pac
9999999.64;+33053,;201~WP-start~4
Breast Cancer-Stage I-III ER- T2 or greater or N+; immunotherapy 
candidate, on pathway Pembrolizumab and Carboplatin/Paclitaxel (4 cycles, 
12 weeks); then Pembrolizumab and AC (4 Cycles, 12 weeks); then Follow
Local/Regional Management After Neoadjuvant Treatment Pathway.
9999999.65;+33054,+33053,;.01~MAR 04, 2024@06:33:08
9999999.65;+33054,+33053,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL
9999999.65;+33055,+33053,;.01~MAR 04, 2024@06:40:31
9999999.65;+33056,+33053,;.01~MAR 04, 2024@09:09:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33054^1
33055^2
33056^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33025</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>407864902</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33025,;.01~VA-ONC BRCA I-III ER- T1B OFF PATH RSN
9999999.64;+33025,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33025,;.08~YES
9999999.64;+33025,;.1~FACTOR
9999999.64;+33025,;100~NATIONAL
9999999.64;+33025,;101~VHA ONCOLOGY
9999999.64;+33025,;200~BRCA Stage I-III ER- T1b/c,N0 off pathway reason
9999999.64;+33025,;201~WP-start~1
Breast Cancer-Stage I-III ER- T1b/c,N0; off pathway reason
9999999.65;+33026,+33025,;.01~MAR 01, 2024@11:12:34
9999999.65;+33026,+33025,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 OFF PATH TX
9999999.65;+33027,+33025,;.01~MAR 01, 2024@11:13:15
9999999.65;+33028,+33025,;.01~AUG 05, 2024@11:12:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33026^1
33027^2
33028^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33024</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>386510306</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33024,;.01~VA-ONC BRCA I-III ER- T1B OFF PATH TX
9999999.64;+33024,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33024,;.08~YES
9999999.64;+33024,;.1~FACTOR
9999999.64;+33024,;100~NATIONAL
9999999.64;+33024,;101~VHA ONCOLOGY
9999999.64;+33024,;200~BRCA Stage I-III ER- T1b/c,N0 off pathway treatment
9999999.64;+33024,;201~WP-start~1
Breast Cancer-Stage I-III ER- T1b/c,N0; off pathway treatment
9999999.65;+33025,+33024,;.01~MAR 01, 2024@11:10:17
9999999.65;+33025,+33024,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 CLIN TRIAL
9999999.65;+33026,+33024,;.01~MAR 01, 2024@11:11:45
9999999.65;+33027,+33024,;.01~AUG 05, 2024@11:12:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33025^1
33026^2
33027^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B TC+LRM PRIOR+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>36599</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4213742628</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36599,;.01~VA-ONC BRCA I-III ER- T1B TC+LRM PRIOR+SURV
9999999.64;+36599,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+36599,;.08~YES
9999999.64;+36599,;.1~FACTOR
9999999.64;+36599,;100~NATIONAL
9999999.64;+36599,;101~VHA ONCOLOGY
9999999.64;+36599,;200~BRCA Stage I-III ER- T1b/c,N0 TC+ Follow LRM Prior+Surv
9999999.64;+36599,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; on pathway TC, follow LRM Prior to
Adjuvant Treatment Pathway then surveillance
9999999.65;+36600,+36599,;.01~AUG 05, 2024@11:34:22
9999999.65;+36600,+36599,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1B FOLLOW LRM PRIOR ADJ PTHWY
9999999.65;+36601,+36599,;.01~AUG 05, 2024@11:37:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36600^1
36601^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B NOT UPSTG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33040</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3091166331</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33040,;.01~VA-ONC BRCA I-III ER- T1B NOT UPSTG OFF PATH TX
9999999.64;+33040,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33040,;.08~YES
9999999.64;+33040,;.1~FACTOR
9999999.64;+33040,;100~NATIONAL
9999999.64;+33040,;101~VHA ONCOLOGY
9999999.64;+33040,;200~BRCA Stage I-III ER- T1b/c,N0 Not Upstage Off Path TX
9999999.64;+33040,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; not surgically upstage, off
pathway treatment
9999999.65;+33041,+33040,;.01~MAR 01, 2024@13:09:24
9999999.65;+33041,+33040,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT UPSTG ANTH CLIN TRIAL
9999999.65;+33042,+33040,;.01~MAR 01, 2024@13:11:04
9999999.65;+33043,+33040,;.01~AUG 05, 2024@10:36:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33041^1
33042^2
33043^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B NOT UPSTG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33050</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1009920591</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33050,;.01~VA-ONC BRCA I-III ER- T1B NOT UPSTG OFF PATH RSN
9999999.64;+33050,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33050,;.08~YES
9999999.64;+33050,;.1~FACTOR
9999999.64;+33050,;100~NATIONAL
9999999.64;+33050,;101~VHA ONCOLOGY
9999999.64;+33050,;200~BRCA Stage I-III ER- T1b/c,N0 Not Upstg Off Path RSN
9999999.64;+33050,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; not surgically upstage, off
pathway reason
9999999.65;+33051,+33050,;.01~MAR 01, 2024@13:34:28
9999999.65;+33051,+33050,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT ANTH CAND OFF PATH TX
9999999.65;+33052,+33050,;.01~MAR 01, 2024@13:36:08
9999999.65;+33053,+33050,;.01~AUG 05, 2024@10:43:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33051^1
33052^2
33053^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B NOT UPSTG TC+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>33039</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>597225245</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33039,;.01~VA-ONC BRCA I-III ER- T1B NOT UPSTG TC+SURV
9999999.64;+33039,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33039,;.08~YES
9999999.64;+33039,;.1~FACTOR
9999999.64;+33039,;100~NATIONAL
9999999.64;+33039,;101~VHA ONCOLOGY
9999999.64;+33039,;200~BRCA Stage I-III ER- T1b/c,N0 Not Upstage TC+Surv
9999999.64;+33039,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; not surgically upstage, on
pathway Docetaxel and Cyclophosphamide (TC) then surveillance
9999999.65;+33040,+33039,;.01~MAR 01, 2024@13:04:34
9999999.65;+33040,+33039,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT UPSTG ANTH CLIN TRIAL
9999999.65;+33041,+33039,;.01~MAR 01, 2024@13:06:34
9999999.65;+33042,+33039,;.01~AUG 05, 2024@10:29:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33040^1
33041^2
33042^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B NOT UPSTG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33045</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3326456025</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33045,;.01~VA-ONC BRCA I-III ER- T1B NOT UPSTG CLIN TRIAL
9999999.64;+33045,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33045,;.08~YES
9999999.64;+33045,;.1~FACTOR
9999999.64;+33045,;100~NATIONAL
9999999.64;+33045,;101~VHA ONCOLOGY
9999999.64;+33045,;200~BRCA Stage I-III ER- T1b/c,N0 Not Upstg Clin Trial
9999999.64;+33045,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; not surgically upstage, on pathway
clinical trial
9999999.65;+33046,+33045,;.01~MAR 01, 2024@13:20
9999999.65;+33046,+33045,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT UPSTG ANTH CLIN TRIAL
9999999.65;+33047,+33045,;.01~MAR 01, 2024@13:22:11
9999999.65;+33048,+33045,;.01~MAR 01, 2024@13:29:12
9999999.65;+33049,+33045,;.01~MAR 01, 2024@13:37:51
9999999.65;+33050,+33045,;.01~AUG 05, 2024@10:40:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33046^1
33047^2
33048^3
33049^4
33050^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33037</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1900477997</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33037,;.01~VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM OFF PATH RSN
9999999.64;+33037,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33037,;.08~YES
9999999.64;+33037,;.1~FACTOR
9999999.64;+33037,;100~NATIONAL
9999999.64;+33037,;101~VHA ONCOLOGY
9999999.64;+33037,;200~BRCA Stage I-III ER- T1b/c,N0 upstg not germline+ off path rsn
9999999.64;+33037,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, not Germline
BRCA1/2 PV and T2 or greater or N+, off pathway reason
9999999.65;+33038,+33037,;.01~MAR 01, 2024@12:31:38
9999999.65;+33038,+33037,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG NOT GERM OFF PATH TX
9999999.65;+33039,+33037,;.01~MAR 01, 2024@12:32:12
9999999.65;+33040,+33037,;.01~AUG 05, 2024@11:16:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33038^1
33039^2
33040^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33036</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3857807208</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33036,;.01~VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM OFF PATH TX
9999999.64;+33036,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33036,;.08~YES
9999999.64;+33036,;.1~FACTOR
9999999.64;+33036,;100~NATIONAL
9999999.64;+33036,;101~VHA ONCOLOGY
9999999.64;+33036,;200~BRCA Stage I-III ER- T1b/c,N0 upstg not germline+ off path tx
9999999.64;+33036,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, not Germline
BRCA1/2 PV and T2 or greater or N+, off pathway treatment
9999999.65;+33037,+33036,;.01~MAR 01, 2024@12:30:29
9999999.65;+33037,+33036,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG NOT GERM CLIN TRIAL
9999999.65;+33038,+33036,;.01~MAR 01, 2024@12:31:18
9999999.65;+33039,+33036,;.01~AUG 05, 2024@11:16:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33037^1
33038^2
33039^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33034</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2779294206</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33034,;.01~VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM CLIN TRIAL
9999999.64;+33034,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33034,;.08~YES
9999999.64;+33034,;.1~FACTOR
9999999.64;+33034,;100~NATIONAL
9999999.64;+33034,;101~VHA ONCOLOGY
9999999.64;+33034,;200~BRCA Stage I-III ER- T1b/c,N0 upstg not germline+ clin trial
9999999.64;+33034,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, not Germline
BRCA1/2 PV and T2 or greater or N+, on pathway clinical trial
9999999.65;+33035,+33034,;.01~MAR 01, 2024@12:22:44
9999999.65;+33035,+33034,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG GERM CLIN TRIAL
9999999.65;+33036,+33034,;.01~MAR 01, 2024@12:24:14
9999999.65;+33037,+33034,;.01~AUG 05, 2024@11:15:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33035^1
33036^2
33037^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>33035</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1003532504</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33035,;.01~VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM SURV
9999999.64;+33035,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33035,;.08~YES
9999999.64;+33035,;.1~FACTOR
9999999.64;+33035,;100~NATIONAL
9999999.64;+33035,;101~VHA ONCOLOGY
9999999.64;+33035,;200~BRCA Stage I-III ER- T1b/c,N0 upstg not germline+ surveillance
9999999.64;+33035,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, not Germline
BRCA1/2 PV and T2 or greater or N+, on pathway surveillance
9999999.65;+33036,+33035,;.01~MAR 01, 2024@12:24:47
9999999.65;+33036,+33035,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG NOT GERM CLIN TRIAL
9999999.65;+33037,+33035,;.01~MAR 01, 2024@12:25:58
9999999.65;+33038,+33035,;.01~AUG 05, 2024@11:16:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33036^1
33037^2
33038^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG GERM OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33033</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2150275050</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33033,;.01~VA-ONC BRCA I-III ER- T1B UPSTG GERM OFF PATH RSN
9999999.64;+33033,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33033,;.08~YES
9999999.64;+33033,;.1~FACTOR
9999999.64;+33033,;100~NATIONAL
9999999.64;+33033,;101~VHA ONCOLOGY
9999999.64;+33033,;200~BRCA Stage I-III ER- T1b/c,N0 surg upstge germline+ off path rsn
9999999.64;+33033,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, Germline BRCA1/2
PV and T2 or greater or N+, off pathway reason
9999999.65;+33034,+33033,;.01~MAR 01, 2024@12:16:37
9999999.65;+33034,+33033,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG GERM OFF PATH TX
9999999.65;+33035,+33033,;.01~MAR 01, 2024@12:18:34
9999999.65;+33036,+33033,;.01~AUG 05, 2024@11:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33034^1
33035^2
33036^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG GERM OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33032</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3304083945</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33032,;.01~VA-ONC BRCA I-III ER- T1B UPSTG GERM OFF PATH TX
9999999.64;+33032,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33032,;.08~YES
9999999.64;+33032,;.1~FACTOR
9999999.64;+33032,;100~NATIONAL
9999999.64;+33032,;101~VHA ONCOLOGY
9999999.64;+33032,;200~BRCA Stage I-III ER- T1b/c,N0 surg upstage germline+ off path tx
9999999.64;+33032,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, Germline BRCA1/2
PV and T2 or greater or N+, off pathway treatment
9999999.65;+33033,+33032,;.01~MAR 01, 2024@12:14:07
9999999.65;+33033,+33032,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG GERM CLIN TRIAL
9999999.65;+33034,+33032,;.01~MAR 01, 2024@12:16:06
9999999.65;+33035,+33032,;.01~AUG 05, 2024@11:15:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33033^1
33034^2
33035^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG GERM CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33030</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2225356232</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33030,;.01~VA-ONC BRCA I-III ER- T1B UPSTG GERM CLIN TRIAL
9999999.64;+33030,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33030,;.08~YES
9999999.64;+33030,;.1~FACTOR
9999999.64;+33030,;100~NATIONAL
9999999.64;+33030,;101~VHA ONCOLOGY
9999999.64;+33030,;200~BRCA Stage I-III ER- T1b/c,N0 surg upstage germline+ clin trial
9999999.64;+33030,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, Germline BRCA1/2
PV and T2 or greater or N+, on pathway clinical trial
9999999.65;+33031,+33030,;.01~MAR 01, 2024@12:02:32
9999999.65;+33031,+33030,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTAGE CLIN TRIAL
9999999.65;+33032,+33030,;.01~MAR 01, 2024@12:04:40
9999999.65;+33033,+33030,;.01~AUG 05, 2024@11:14:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33031^1
33032^2
33033^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTG GERM OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33031</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>232028049</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33031,;.01~VA-ONC BRCA I-III ER- T1B UPSTG GERM OLAP
9999999.64;+33031,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33031,;.08~YES
9999999.64;+33031,;.1~FACTOR
9999999.64;+33031,;100~NATIONAL
9999999.64;+33031,;101~VHA ONCOLOGY
9999999.64;+33031,;200~ BRCA Stage I-III ER- T1b/c,N0 surg upstage germline+ Olaparib
9999999.64;+33031,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, Germline 
BRCA1/2 PV and T2 or greater or N+, on pathway Olaparib for 1 year
9999999.65;+33032,+33031,;.01~MAR 01, 2024@12:06:57
9999999.65;+33032,+33031,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 > NODE+ AX DISSECT
9999999.65;+33033,+33031,;.01~MAR 01, 2024@12:09:26
9999999.65;+33034,+33031,;.01~AUG 05, 2024@11:15:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33032^1
33033^2
33034^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B UPSTAGE DDAC-T</POINT_01>
<INTERNAL_ENTRY_NUMBER>33026</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3388211815</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33026,;.01~VA-ONC BRCA I-III ER- T1B UPSTAGE DDAC-T
9999999.64;+33026,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33026,;.08~YES
9999999.64;+33026,;.1~FACTOR
9999999.64;+33026,;100~NATIONAL
9999999.64;+33026,;101~VHA ONCOLOGY
9999999.64;+33026,;200~BRCA Stage I-III ER- T1b/c,N0 surgical upstage ddAC-T
9999999.64;+33026,;201~WP-start~3
Breast Cancer-Stage I-III ER- T1b/c,N0; surgical upstage, on pathway 
treatment escalation to Dose-dense AC-T doxorubicin and cyclophosphamide
(ddAC-T)
9999999.65;+33027,+33026,;.01~MAR 01, 2024@11:24:15
9999999.65;+33027,+33026,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 CLIN TRIAL
9999999.65;+33028,+33026,;.01~MAR 01, 2024@11:28:36
9999999.65;+33029,+33026,;.01~AUG 05, 2024@11:14:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33027^1
33028^2
33029^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B FOLLOW LRM PRIOR ADJ PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33023</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3065708892</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33023,;.01~VA-ONC BRCA I-III ER- T1B FOLLOW LRM PRIOR ADJ PTHWY
9999999.64;+33023,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33023,;.08~YES
9999999.64;+33023,;.1~FACTOR
9999999.64;+33023,;100~NATIONAL
9999999.64;+33023,;101~VHA ONCOLOGY
9999999.64;+33023,;200~BRCA Stage I-III ER- T1b/c,N0 follow LRM prior adj tx pathway
9999999.64;+33023,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1b/c,N0; on pathway follow LRM Prior to 
Adjuvant Treatment Pathway
9999999.65;+33024,+33023,;.01~MAR 01, 2024@11:07:31
9999999.65;+33024,+33023,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 CLIN TRIAL
9999999.65;+33025,+33023,;.01~MAR 01, 2024@11:09:37
9999999.65;+33026,+33023,;.01~MAR 01, 2024@11:13:59
9999999.65;+33027,+33023,;.01~AUG 05, 2024@11:12:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33024^1
33025^2
33026^3
33027^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1B CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33022</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>981021417</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33022,;.01~VA-ONC BRCA I-III ER- T1B CLIN TRIAL
9999999.64;+33022,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33022,;.08~YES
9999999.64;+33022,;.1~FACTOR
9999999.64;+33022,;100~NATIONAL
9999999.64;+33022,;101~VHA ONCOLOGY
9999999.64;+33022,;200~BRCA Stage I-III ER- T1b/c,N0 clinical trial
9999999.64;+33022,;201~WP-start~1
Breast Cancer-Stage I-III ER- T1b/c,N0; on pathway clinical trial
9999999.65;+33023,+33022,;.01~MAR 01, 2024@10:52:01
9999999.65;+33023,+33022,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
9999999.65;+33024,+33022,;.01~MAR 01, 2024@10:54:56
9999999.65;+33025,+33022,;.01~AUG 05, 2024@11:11:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33023^1
33024^2
33025^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1A OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33041</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1552167890</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33041,;.01~VA-ONC BRCA I-III ER- T1A OFF PATH RSN
9999999.64;+33041,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33041,;.08~YES
9999999.64;+33041,;.1~FACTOR
9999999.64;+33041,;100~NATIONAL
9999999.64;+33041,;101~VHA ONCOLOGY
9999999.64;+33041,;200~BRCA Stage I-III ER- T1a,N0 Off Path RSN
9999999.64;+33041,;201~WP-start~1
Breast Cancer-Stage I-III ER- T1a,N0; off pathway reason
9999999.65;+33042,+33041,;.01~MAR 01, 2024@13:11:36
9999999.65;+33042,+33041,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT UPSTG ANTH OFF PATH TX
9999999.65;+33043,+33041,;.01~MAR 01, 2024@13:13:10
9999999.65;+33044,+33041,;.01~AUG 05, 2024@09:36:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33042^1
33043^2
33044^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1A OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33049</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3507936441</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33049,;.01~VA-ONC BRCA I-III ER- T1A OFF PATH TX
9999999.64;+33049,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33049,;.08~YES
9999999.64;+33049,;.1~FACTOR
9999999.64;+33049,;100~NATIONAL
9999999.64;+33049,;101~VHA ONCOLOGY
9999999.64;+33049,;200~BRCA Stage I-III ER- T1a,N0 Off Path TX
9999999.64;+33049,;201~WP-start~1
Breast Cancer-Stage I-III ER- T1a,N0; off pathway treatment
9999999.65;+33050,+33049,;.01~MAR 01, 2024@13:29:38
9999999.65;+33050,+33049,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 FOLLOW LRM PRIOR ADJ PTHWY
9999999.65;+33051,+33049,;.01~MAR 01, 2024@13:33:41
9999999.65;+33052,+33049,;.01~AUG 05, 2024@09:37:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33050^1
33051^2
33052^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1A LRM PRIOR+SURVEILLANCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33048</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1395805347</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33048,;.01~VA-ONC BRCA I-III ER- T1A LRM PRIOR+SURVEILLANCE
9999999.64;+33048,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33048,;.08~YES
9999999.64;+33048,;.1~FACTOR
9999999.64;+33048,;100~NATIONAL
9999999.64;+33048,;101~VHA ONCOLOGY
9999999.64;+33048,;200~BRCA Stage I-III ER- T1a,N0 Follow LRM Prior Pathway+Surv
9999999.64;+33048,;201~WP-start~2
Breast Cancer-Stage I-III ER- T1a,N0; on pathway Follow LRM Prior to 
Adjuvant Treatment Pathway then surveillance
9999999.65;+33049,+33048,;.01~MAR 01, 2024@13:24:29
9999999.65;+33049,+33048,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 NOT ANTH CLIN TRIAL
9999999.65;+33050,+33048,;.01~MAR 01, 2024@13:28:25
9999999.65;+33051,+33048,;.01~AUG 05, 2024@09:33:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33049^1
33050^2
33051^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER- T1A CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33038</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2489538048</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33038,;.01~VA-ONC BRCA I-III ER- T1A CLIN TRIAL
9999999.64;+33038,;.03~VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
9999999.64;+33038,;.08~YES
9999999.64;+33038,;.1~FACTOR
9999999.64;+33038,;100~NATIONAL
9999999.64;+33038,;101~VHA ONCOLOGY
9999999.64;+33038,;200~BRCA Stage I-III ER- T1a, N0 Clin Trial
9999999.64;+33038,;201~WP-start~1
Breast Cancer-Stage I-III ER- T1a,N0; on pathway clinical trial
9999999.65;+33039,+33038,;.01~MAR 01, 2024@12:59:34
9999999.65;+33039,+33038,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER- T1N0 UPSTG GERM CLIN TRIAL
9999999.65;+33040,+33038,;.01~MAR 01, 2024@13:02:25
9999999.65;+33041,+33038,;.01~AUG 05, 2024@09:28:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33039^1
33040^2
33041^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STG I-III ER-/PR-/HER2- CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33019</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2981495824</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33019,;.01~VA-ONC BRCA STG I-III ER-/PR-/HER2- CLINICAL PATHWAY
9999999.64;+33019,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+33019,;.08~YES
9999999.64;+33019,;.1~FACTOR
9999999.64;+33019,;100~NATIONAL
9999999.64;+33019,;101~VHA ONCOLOGY
9999999.64;+33019,;200~Breast Cancer-Stage I-III ER-/PR-/HER2- Clinical Pathway
9999999.64;+33019,;201~WP-start~2
Designates that the Category for all health factors in Breast 
Cancer-Stage I-III ER-/PR-/HER2- Clinical Pathway was opened.
9999999.65;+33020,+33019,;.01~MAR 01, 2024@10:05:15
9999999.65;+33020,+33019,;2~WP-start~1
Copied from VA-ONC BRCA STG I-III ER+ OR PR+/HER2- CLINICAL PATHWAY
9999999.65;+33021,+33019,;.01~MAR 01, 2024@10:07:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33020^1
33021^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>32933</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4119757149</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32933,;.01~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32933,;.08~YES
9999999.64;+32933,;.1~CATEGORY
9999999.64;+32933,;100~NATIONAL
9999999.64;+32933,;101~VHA ONCOLOGY
9999999.64;+32933,;200~Breast Cancer-Stage I-III Any ER or PR/HER2+ Clinical Pathway
9999999.64;+32933,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage I-III Any ER or
PR/HER2+ Clinical Pathway
9999999.65;+32934,+32933,;.01~FEB 29, 2024@09:14:46
9999999.65;+32934,+32933,;2~WP-start~1
Copied from VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY
9999999.65;+32935,+32933,;.01~FEB 29, 2024@09:19:06
9999999.65;+32936,+32933,;.01~DEC 03, 2024@13:56:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32934^1
32935^2
32936^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33002</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2248490263</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33002,;.01~VA-ONC BRCA I-III ANY ER N+ OFF PATH RSN
9999999.64;+33002,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33002,;.08~YES
9999999.64;+33002,;.1~FACTOR
9999999.64;+33002,;100~NATIONAL
9999999.64;+33002,;101~VHA ONCOLOGY
9999999.64;+33002,;200~BRCA Stage I-III Any ER N+ off pathway reason
9999999.64;+33002,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; off 
pathway reason
9999999.65;+33003,+33002,;.01~MAR 01, 2024@06:48:45
9999999.65;+33003,+33002,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ OFF PATH TX
9999999.65;+33004,+33002,;.01~MAR 01, 2024@06:49:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33003^1
33004^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33001</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>630935245</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33001,;.01~VA-ONC BRCA I-III ANY ER N+ OFF PATH TX
9999999.64;+33001,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33001,;.08~YES
9999999.64;+33001,;.1~FACTOR
9999999.64;+33001,;100~NATIONAL
9999999.64;+33001,;101~VHA ONCOLOGY
9999999.64;+33001,;200~BRCA Stage I-III Any ER N+ off pathway treatment
9999999.64;+33001,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; off 
pathway treatment
9999999.65;+33002,+33001,;.01~MAR 01, 2024@06:46:52
9999999.65;+33002,+33001,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
9999999.65;+33003,+33001,;.01~MAR 01, 2024@06:48:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33002^1
33003^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32999</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3210157529</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32999,;.01~VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
9999999.64;+32999,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32999,;.08~YES
9999999.64;+32999,;.1~FACTOR
9999999.64;+32999,;100~NATIONAL
9999999.64;+32999,;101~VHA ONCOLOGY
9999999.64;+32999,;200~BRCA Stage I-III Any ER N+ clinical trial
9999999.64;+32999,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; on
pathway clinical trial
9999999.65;+33000,+32999,;.01~MAR 01, 2024@06:32:58
9999999.65;+33000,+32999,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 INCOMP CLIN TRIAL
9999999.65;+33001,+32999,;.01~MAR 01, 2024@06:40:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33000^1
33001^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33018</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2133043382</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33018,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH RSN
9999999.64;+33018,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33018,;.08~YES
9999999.64;+33018,;.1~FACTOR
9999999.64;+33018,;100~NATIONAL
9999999.64;+33018,;101~VHA ONCOLOGY
9999999.64;+33018,;200~BRCA Stage I-III Any ER N+ ER/PR negative off pathway reason
9999999.64;+33018,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status negative after adjuvant therapy, off pathway reason
9999999.65;+33019,+33018,;.01~MAR 01, 2024@09:17:48
9999999.65;+33019,+33018,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH TX
9999999.65;+33020,+33018,;.01~MAR 01, 2024@09:18:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33019^1
33020^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33017</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>383303860</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33017,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH TX
9999999.64;+33017,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33017,;.08~YES
9999999.64;+33017,;.1~FACTOR
9999999.64;+33017,;100~NATIONAL
9999999.64;+33017,;101~VHA ONCOLOGY
9999999.64;+33017,;200~BRCA Stage I-III Any ER N+ ER/PR negative off pathway treatment
9999999.64;+33017,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status negative after adjuvant therapy, off pathway treatment
9999999.65;+33018,+33017,;.01~MAR 01, 2024@09:16:47
9999999.65;+33018,+33017,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR NEG CLIN TRIAL
9999999.65;+33019,+33017,;.01~MAR 01, 2024@09:17:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33018^1
33019^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33015</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3429596437</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33015,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR NEG CLIN TRIAL
9999999.64;+33015,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33015,;.08~YES
9999999.64;+33015,;.1~FACTOR
9999999.64;+33015,;100~NATIONAL
9999999.64;+33015,;101~VHA ONCOLOGY
9999999.64;+33015,;200~BRCA Stage I-III Any ER N+ ER/PR negative clinical trial
9999999.64;+33015,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status negative after adjuvant therapy, on pathway clinical trial
9999999.65;+33016,+33015,;.01~MAR 01, 2024@09:11:04
9999999.65;+33016,+33015,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL
9999999.65;+33017,+33015,;.01~MAR 01, 2024@09:12:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33016^1
33017^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR NEG HER2 TX+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>33016</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>79432315</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33016,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR NEG HER2 TX+SURV
9999999.64;+33016,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33016,;.08~YES
9999999.64;+33016,;.1~FACTOR
9999999.64;+33016,;100~NATIONAL
9999999.64;+33016,;101~VHA ONCOLOGY
9999999.64;+33016,;200~BRCA Stage I-III Any ER N+ ER/PR negative HER2 therapy+surv
9999999.64;+33016,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status negative after adjuvant therapy, on pathway complete HER2 directed 
therapy followed by surveillance
9999999.65;+33017,+33016,;.01~MAR 01, 2024@09:13:03
9999999.65;+33017,+33016,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR NEG CLIN TRIAL
9999999.65;+33018,+33016,;.01~MAR 01, 2024@09:16:30
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33017^1
33018^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33014</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2548675007</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33014,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH RSN
9999999.64;+33014,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33014,;.08~YES
9999999.64;+33014,;.1~FACTOR
9999999.64;+33014,;100~NATIONAL
9999999.64;+33014,;101~VHA ONCOLOGY
9999999.64;+33014,;200~BRCA Stage I-III Any ER N+ ER/PR positive off path reason
9999999.64;+33014,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status after adjuvant therapy, off pathway reason
9999999.65;+33015,+33014,;.01~MAR 01, 2024@08:50:49
9999999.65;+33015,+33014,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX
9999999.65;+33016,+33014,;.01~MAR 01, 2024@08:51:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33015^1
33016^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33013</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2176927869</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33013,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX
9999999.64;+33013,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33013,;.08~YES
9999999.64;+33013,;.1~FACTOR
9999999.64;+33013,;100~NATIONAL
9999999.64;+33013,;101~VHA ONCOLOGY
9999999.64;+33013,;200~BRCA Stage I-III Any ER N+ ER/PR positive off path treatment
9999999.64;+33013,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status after adjuvant therapy, off pathway treatment
9999999.65;+33014,+33013,;.01~MAR 01, 2024@08:49:08
9999999.65;+33014,+33013,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL
9999999.65;+33015,+33013,;.01~MAR 01, 2024@08:50:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33014^1
33015^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33011</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1732497365</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33011,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL
9999999.64;+33011,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33011,;.08~YES
9999999.64;+33011,;.1~FACTOR
9999999.64;+33011,;100~NATIONAL
9999999.64;+33011,;101~VHA ONCOLOGY
9999999.64;+33011,;200~BRCA Stage I-III Any ER N+ ER/PR positive clinical trial
9999999.64;+33011,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status after adjuvant therapy, on pathway clinical trial
9999999.65;+33012,+33011,;.01~MAR 01, 2024@08:41:09
9999999.65;+33012,+33011,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
9999999.65;+33013,+33011,;.01~MAR 01, 2024@08:43:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33012^1
33013^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS ADJ HT</POINT_01>
<INTERNAL_ENTRY_NUMBER>33012</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2754086938</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33012,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS ADJ HT
9999999.64;+33012,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33012,;.08~YES
9999999.64;+33012,;.1~FACTOR
9999999.64;+33012,;100~NATIONAL
9999999.64;+33012,;101~VHA ONCOLOGY
9999999.64;+33012,;200~BRCA Stage I-III Any ER N+ ER/PR positive adj hormone therapy
9999999.64;+33012,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; ER/PR 
status after adjuvant therapy, on pathway adjuvnat hormone therapy for 
ER/PR/HER2 Positive
9999999.65;+33013,+33012,;.01~MAR 01, 2024@08:47:10
9999999.65;+33013,+33012,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL
9999999.65;+33014,+33012,;.01~MAR 01, 2024@08:48:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33013^1
33014^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33010</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>86276060</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33010,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH RSN
9999999.64;+33010,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33010,;.08~YES
9999999.64;+33010,;.1~FACTOR
9999999.64;+33010,;100~NATIONAL
9999999.64;+33010,;101~VHA ONCOLOGY
9999999.64;+33010,;200~BRCA Stage I-III Any ER N+ TCHP incomplete response off path rsn
9999999.64;+33010,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; 
incomplete response after TCHP, off pathway reason
9999999.65;+33011,+33010,;.01~MAR 01, 2024@08:31:37
9999999.65;+33011,+33010,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH TX
9999999.65;+33012,+33010,;.01~MAR 01, 2024@08:32:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33011^1
33012^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33009</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>196791759</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33009,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH TX
9999999.64;+33009,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33009,;.08~YES
9999999.64;+33009,;.1~FACTOR
9999999.64;+33009,;100~NATIONAL
9999999.64;+33009,;101~VHA ONCOLOGY
9999999.64;+33009,;200~BRCA Stage I-III Any ER N+ TCHP incomplete response off path tx
9999999.64;+33009,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; 
incomplete response after TCHP, off pathway treatment
9999999.65;+33010,+33009,;.01~MAR 01, 2024@08:29:03
9999999.65;+33010,+33009,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR CLIN TRIAL
9999999.65;+33011,+33009,;.01~MAR 01, 2024@08:30:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33010^1
33011^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33007</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1261986415</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33007,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR CLIN TRIAL
9999999.64;+33007,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33007,;.08~YES
9999999.64;+33007,;.1~FACTOR
9999999.64;+33007,;100~NATIONAL
9999999.64;+33007,;101~VHA ONCOLOGY
9999999.64;+33007,;200~BRCA Stage I-III Any ER N+ TCHP incomplete response clin trial
9999999.64;+33007,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; 
incomplete response after TCHP, on pathway clinical trial
9999999.65;+33008,+33007,;.01~MAR 01, 2024@08:21:45
9999999.65;+33008,+33007,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR CLIN TRIAL
9999999.65;+33009,+33007,;.01~MAR 01, 2024@08:23:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33008^1
33009^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR ADO-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33008</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2639539594</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33008,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR ADO-TRAS
9999999.64;+33008,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33008,;.08~YES
9999999.64;+33008,;.1~FACTOR
9999999.64;+33008,;100~NATIONAL
9999999.64;+33008,;101~VHA ONCOLOGY
9999999.64;+33008,;200~BRCA Stage I-III Any ER N+ TCHP incomplete response Ado-tras
9999999.64;+33008,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; 
incomplete response after TCHP, on pathway Ado-trastuzumab emtansine
9999999.65;+33009,+33008,;.01~MAR 01, 2024@08:26:38
9999999.65;+33009,+33008,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR CLIN TRIAL
9999999.65;+33010,+33008,;.01~MAR 01, 2024@08:28:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33009^1
33010^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33006</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1610321931</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33006,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH RSN
9999999.64;+33006,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33006,;.08~YES
9999999.64;+33006,;.1~FACTOR
9999999.64;+33006,;100~NATIONAL
9999999.64;+33006,;101~VHA ONCOLOGY
9999999.64;+33006,;200~BRCA Stage I-III Any ER N+ TCHP complete response off path rsn
9999999.64;+33006,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; complete 
response after TCHP, off pathway reason
9999999.65;+33007,+33006,;.01~MAR 01, 2024@08:15:53
9999999.65;+33007,+33006,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH TX
9999999.65;+33008,+33006,;.01~MAR 01, 2024@08:16:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33007^1
33008^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33005</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1714171755</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33005,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH TX
9999999.64;+33005,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33005,;.08~YES
9999999.64;+33005,;.1~FACTOR
9999999.64;+33005,;100~NATIONAL
9999999.64;+33005,;101~VHA ONCOLOGY
9999999.64;+33005,;200~BRCA Stage I-III Any ER N+ TCHP complete response off path tx
9999999.64;+33005,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; complete 
response after TCHP, off pathway treatment
9999999.65;+33006,+33005,;.01~MAR 01, 2024@08:12:31
9999999.65;+33006,+33005,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR CLIN TRIAL
9999999.65;+33007,+33005,;.01~MAR 01, 2024@08:15:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33006^1
33007^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33003</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4020808553</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33003,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR CLIN TRIAL
9999999.64;+33003,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33003,;.08~YES
9999999.64;+33003,;.1~FACTOR
9999999.64;+33003,;100~NATIONAL
9999999.64;+33003,;101~VHA ONCOLOGY
9999999.64;+33003,;200~BRCA Stage I-III Any ER N+ TCHP complete response clinical trial
9999999.64;+33003,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; complete 
response after TCHP, on pathway clinical trial
9999999.65;+33004,+33003,;.01~MAR 01, 2024@08:05
9999999.65;+33004,+33003,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
9999999.65;+33005,+33003,;.01~MAR 01, 2024@08:08:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33004^1
33005^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR TRAS+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>33004</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>470381367</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33004,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR TRAS+PERT
9999999.64;+33004,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33004,;.08~YES
9999999.64;+33004,;.1~FACTOR
9999999.64;+33004,;100~NATIONAL
9999999.64;+33004,;101~VHA ONCOLOGY
9999999.64;+33004,;200~BRCA Stage I-III Any ER N+ TCHP complete response trast+pert
9999999.64;+33004,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; complete 
response after TCHP, on pathway trastuzumab and pertuzumab for 1 year
9999999.65;+33005,+33004,;.01~MAR 01, 2024@08:08:56
9999999.65;+33005,+33004,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR CLIN TRIAL
9999999.65;+33006,+33004,;.01~MAR 01, 2024@08:10:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33005^1
33006^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ TCHP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33000</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1213232225</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33000,;.01~VA-ONC BRCA I-III ANY ER N+ TCHP
9999999.64;+33000,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+33000,;.08~YES
9999999.64;+33000,;.1~FACTOR
9999999.64;+33000,;100~NATIONAL
9999999.64;+33000,;101~VHA ONCOLOGY
9999999.64;+33000,;200~BRCA Stage I-III Any ER N+ TCHP
9999999.64;+33000,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N+; on
pathway Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP)
9999999.65;+33001,+33000,;.01~MAR 01, 2024@06:42:33
9999999.65;+33001,+33000,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
9999999.65;+33002,+33000,;.01~MAR 01, 2024@06:45:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33001^1
33002^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NO NEOADJ TAX+TRAS-PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>36575</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2666068141</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36575,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ TAX+TRAS-PERT
9999999.64;+36575,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36575,;.08~YES
9999999.64;+36575,;.1~FACTOR
9999999.64;+36575,;100~NATIONAL
9999999.64;+36575,;101~VHA ONCOLOGY
9999999.64;+36575,;200~BRCA Stage I-III Any ER N0 Tumor >T1B No Neoadj Tax+Tras-Pert
9999999.64;+36575,;201~WP-start~4
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; not a candidate for neoadjuvant therapy, follow 
LRM Prior Neoadjuvant Therapy Pathway, on pathway taxane and trastuzumab
containing regimen with or without pertuzumab
9999999.65;+36576,+36575,;.01~AUG 03, 2024@11:27:13
9999999.65;+36576,+36575,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ TAX+TRAS+PERT
9999999.65;+36577,+36575,;.01~AUG 03, 2024@11:27:36
9999999.65;+36578,+36575,;.01~AUG 03, 2024@11:40:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36576^1
36577^2
36578^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NO NEOADJ TAX+TRAS+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>36574</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3613251752</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36574,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ TAX+TRAS+PERT
9999999.64;+36574,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36574,;.08~YES
9999999.64;+36574,;.1~FACTOR
9999999.64;+36574,;100~NATIONAL
9999999.64;+36574,;101~VHA ONCOLOGY
9999999.64;+36574,;200~BRCA Stage I-III Any ER N0 Tumor >T1B No Neoadj Tax+Tras+Pert
9999999.64;+36574,;201~WP-start~4
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; not a candidate for neoadjuvant therapy, follow 
LRM Prior Neoadjuvant Therapy Pathway, on pathway taxane and trastuzumab
containing regimen with or without pertuzumab
9999999.65;+36575,+36574,;.01~AUG 03, 2024@11:22:18
9999999.65;+36575,+36574,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ CLIN TRIAL
9999999.65;+36576,+36574,;.01~AUG 03, 2024@11:26:42
9999999.65;+36577,+36574,;.01~AUG 03, 2024@11:38:48
9999999.65;+36578,+36574,;.01~AUG 03, 2024@11:41:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36575^1
36576^2
36577^3
36578^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NO NEOADJ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36573</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3816021569</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36573,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ CLIN TRIAL
9999999.64;+36573,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36573,;.08~YES
9999999.64;+36573,;.1~FACTOR
9999999.64;+36573,;100~NATIONAL
9999999.64;+36573,;101~VHA ONCOLOGY
9999999.64;+36573,;200~BRCA Stage I-III Any ER N0 Tumor >T1B No Neoadj Clin Trial
9999999.64;+36573,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; not a candidate for neoadjuvant therapy, follow LRM Prior 
Neoadjuvant Therapy Pathway, on pathway clinical trial
9999999.65;+36574,+36573,;.01~AUG 03, 2024@11:19:58
9999999.65;+36574,+36573,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ CLIN TRIA
9999999.65;+36575,+36573,;.01~AUG 03, 2024@11:21:26
9999999.65;+36576,+36573,;.01~AUG 03, 2024@11:29:59
9999999.65;+36577,+36573,;.01~AUG 03, 2024@11:42:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36574^1
36575^2
36576^3
36577^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NO NEOADJ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36577</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1744402569</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36577,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ OFF PATH RSN
9999999.64;+36577,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36577,;.08~YES
9999999.64;+36577,;.1~FACTOR
9999999.64;+36577,;100~NATIONAL
9999999.64;+36577,;101~VHA ONCOLOGY
9999999.64;+36577,;200~BRCA Stage I-III Any ER N0 Tumor >T1B No Neoadj Off Path RSN
9999999.64;+36577,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; not a candidate for neoadjuvant therapy, follow LRM Prior 
Neoadjuvant Therapy Pathway, off pathway reason
9999999.65;+36578,+36577,;.01~AUG 03, 2024@11:35:13
9999999.65;+36578,+36577,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ OFF PATH TX
9999999.65;+36579,+36577,;.01~AUG 03, 2024@11:35:41
9999999.65;+36580,+36577,;.01~AUG 03, 2024@11:44:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36578^1
36579^2
36580^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NO NEOADJ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36576</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3154168078</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36576,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ OFF PATH TX
9999999.64;+36576,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36576,;.08~YES
9999999.64;+36576,;.1~FACTOR
9999999.64;+36576,;100~NATIONAL
9999999.64;+36576,;101~VHA ONCOLOGY
9999999.64;+36576,;200~BRCA Stage I-III Any ER N0 Tumor >T1B No Neoadj Off Path TX
9999999.64;+36576,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; not a candidate for neoadjuvant therapy, follow LRM Prior 
Neoadjuvant Therapy Pathway, off pathway treatment
9999999.65;+36577,+36576,;.01~AUG 03, 2024@11:30:21
9999999.65;+36577,+36576,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ CLIN TRIAL
9999999.65;+36578,+36576,;.01~AUG 03, 2024@11:34:48
9999999.65;+36579,+36576,;.01~AUG 03, 2024@11:44:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36577^1
36578^2
36579^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B INCOMP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32995</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1265129100</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32995,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP OFF PATH RSN
9999999.64;+32995,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32995,;.08~YES
9999999.64;+32995,;.1~FACTOR
9999999.64;+32995,;100~NATIONAL
9999999.64;+32995,;101~VHA ONCOLOGY
9999999.64;+32995,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Incomplete Off Path RSN
9999999.64;+32995,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, incomplete 
pathological response; off pathway reason
9999999.65;+32996,+32995,;.01~FEB 29, 2024@13:03:16
9999999.65;+32996,+32995,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 INCOMP OFF PATH TX
9999999.65;+32997,+32995,;.01~FEB 29, 2024@13:05:21
9999999.65;+32998,+32995,;.01~FEB 29, 2024@13:16:24
9999999.65;+32999,+32995,;.01~AUG 02, 2024@11:15:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32996^1
32997^2
32998^3
32999^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B INCOMP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32994</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2150602227</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32994,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP OFF PATH TX
9999999.64;+32994,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32994,;.08~YES
9999999.64;+32994,;.1~FACTOR
9999999.64;+32994,;100~NATIONAL
9999999.64;+32994,;101~VHA ONCOLOGY
9999999.64;+32994,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Incomplete Off Path TX
9999999.64;+32994,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, incomplete 
pathological response; off pathway treatment
9999999.65;+32995,+32994,;.01~FEB 29, 2024@12:58:01
9999999.65;+32995,+32994,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 INCOMP CLIN TRIAL
9999999.65;+32996,+32994,;.01~FEB 29, 2024@12:58:58
9999999.65;+32997,+32994,;.01~AUG 02, 2024@11:18:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32995^1
32996^2
32997^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B INCOMP CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32992</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2286735128</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32992,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP CLIN TRIAL
9999999.64;+32992,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32992,;.08~YES
9999999.64;+32992,;.1~FACTOR
9999999.64;+32992,;100~NATIONAL
9999999.64;+32992,;101~VHA ONCOLOGY
9999999.64;+32992,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Incomplete Clin Trial
9999999.64;+32992,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, incomplete 
pathological response; on pathway clinical trial
9999999.65;+32993,+32992,;.01~FEB 29, 2024@12:52:51
9999999.65;+32993,+32992,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 CLIN TRIAL
9999999.65;+32994,+32992,;.01~FEB 29, 2024@12:55:51
9999999.65;+32995,+32992,;.01~AUG 02, 2024@11:13:07
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32993^1
32994^2
32995^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B INCOMP ADO-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>32993</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2276301599</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32993,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP ADO-TRAS
9999999.64;+32993,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32993,;.08~YES
9999999.64;+32993,;.1~FACTOR
9999999.64;+32993,;100~NATIONAL
9999999.64;+32993,;101~VHA ONCOLOGY
9999999.64;+32993,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Incomplete Ado-Trastuzumab
9999999.64;+32993,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, incomplete 
pathological response; on pathway Ado-tratuzumab emtansine
9999999.65;+32994,+32993,;.01~FEB 29, 2024@12:56:36
9999999.65;+32994,+32993,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 INCOMP CLIN TRIAL
9999999.65;+32995,+32993,;.01~FEB 29, 2024@12:57:28
9999999.65;+32996,+32993,;.01~AUG 02, 2024@11:04:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32994^1
32995^2
32996^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36585</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>63463280</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36585,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH RSN
9999999.64;+36585,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36585,;.08~YES
9999999.64;+36585,;.1~FACTOR
9999999.64;+36585,;100~NATIONAL
9999999.64;+36585,;101~VHA ONCOLOGY
9999999.64;+36585,;200~BRCA Stage I-III Any ER N0 ER/PR Negative Off Path RSN
9999999.64;+36585,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
negative after adjuvant therapy, off pathway reason
9999999.65;+36586,+36585,;.01~AUG 03, 2024@12:25
9999999.65;+36586,+36585,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX
9999999.65;+36587,+36585,;.01~AUG 03, 2024@12:26:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36586^1
36587^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36584</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>518506976</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36584,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX
9999999.64;+36584,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36584,;.08~YES
9999999.64;+36584,;.1~FACTOR
9999999.64;+36584,;100~NATIONAL
9999999.64;+36584,;101~VHA ONCOLOGY
9999999.64;+36584,;200~BRCA Stage I-III Any ER N0 ER/PR Negative Off Path TX
9999999.64;+36584,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
negative after adjuvant therapy, off pathway treatment
9999999.65;+36585,+36584,;.01~AUG 03, 2024@12:22:29
9999999.65;+36585,+36584,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR NEG CLIN TRIAL
9999999.65;+36586,+36584,;.01~AUG 03, 2024@12:23:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36585^1
36586^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR NEG HER2 TX+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>36583</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2958319860</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36583,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG HER2 TX+SURV
9999999.64;+36583,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36583,;.08~YES
9999999.64;+36583,;.1~FACTOR
9999999.64;+36583,;100~NATIONAL
9999999.64;+36583,;101~VHA ONCOLOGY
9999999.64;+36583,;200~BRCA Stage I-III Any ER N0 ER/PR Negative HER2 Therapy+Surv
9999999.64;+36583,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
negative after adjuvant therapy, on pathway complete HER2 therapy 
followed by surveillance
9999999.65;+36584,+36583,;.01~AUG 03, 2024@12:19:50
9999999.65;+36584,+36583,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR NEG CLIN TRIAL
9999999.65;+36585,+36583,;.01~AUG 03, 2024@12:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36584^1
36585^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36582</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2024926862</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36582,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG CLIN TRIAL
9999999.64;+36582,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36582,;.08~YES
9999999.64;+36582,;.1~FACTOR
9999999.64;+36582,;100~NATIONAL
9999999.64;+36582,;101~VHA ONCOLOGY
9999999.64;+36582,;200~BRCA Stage I-III Any ER N0 ER/PR Negative Clin Trial
9999999.64;+36582,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
negative after adjuvant therapy, on pathway clinical trial
9999999.65;+36583,+36582,;.01~AUG 03, 2024@12:18:01
9999999.65;+36583,+36582,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR POS CLIN TRIAL
9999999.65;+36584,+36582,;.01~AUG 03, 2024@12:18:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36583^1
36584^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32991</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3381765688</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32991,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ OFF PATH RSN
9999999.64;+32991,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32991,;.08~YES
9999999.64;+32991,;.1~FACTOR
9999999.64;+32991,;100~NATIONAL
9999999.64;+32991,;101~VHA ONCOLOGY
9999999.64;+32991,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N+ Off Path RSN
9999999.64;+32991,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete pathological
response, nodal status N+; off pathway reason
9999999.65;+32992,+32991,;.01~FEB 29, 2024@12:16:10
9999999.65;+32992,+32991,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N+ OFF PATH TX
9999999.65;+32993,+32991,;.01~FEB 29, 2024@12:18:31
9999999.65;+32994,+32991,;.01~AUG 02, 2024@10:47:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32992^1
32993^2
32994^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32990</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>774008682</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32990,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ OFF PATH TX
9999999.64;+32990,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32990,;.08~YES
9999999.64;+32990,;.1~FACTOR
9999999.64;+32990,;100~NATIONAL
9999999.64;+32990,;101~VHA ONCOLOGY
9999999.64;+32990,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N+ Off Path TX
9999999.64;+32990,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete
pathological response, nodal status N+; off pathway treatment
9999999.65;+32991,+32990,;.01~FEB 29, 2024@12:14:09
9999999.65;+32991,+32990,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 OFF PATH TX
9999999.65;+32992,+32990,;.01~FEB 29, 2024@12:15:23
9999999.65;+32993,+32990,;.01~AUG 02, 2024@10:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32991^1
32992^2
32993^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32988</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2577426638</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32988,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ CLIN TRIAL
9999999.64;+32988,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32988,;.08~YES
9999999.64;+32988,;.1~FACTOR
9999999.64;+32988,;100~NATIONAL
9999999.64;+32988,;101~VHA ONCOLOGY
9999999.64;+32988,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N+ Clin Trial
9999999.64;+32988,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
size 0.5cm or more; candidate for neoadjuvant therapy, complete 
pathological response, nodal status N+; on pathway clinical trial
9999999.65;+32989,+32988,;.01~FEB 29, 2024@11:59:11
9999999.65;+32989,+32988,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 CLIN TRIAL
9999999.65;+32990,+32988,;.01~FEB 29, 2024@12:02:17
9999999.65;+32991,+32988,;.01~AUG 02, 2024@10:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32989^1
32990^2
32991^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N+ TRAS+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>32989</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1487185418</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32989,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ TRAS+PERT
9999999.64;+32989,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32989,;.08~YES
9999999.64;+32989,;.1~FACTOR
9999999.64;+32989,;100~NATIONAL
9999999.64;+32989,;101~VHA ONCOLOGY
9999999.64;+32989,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N+ TRAS+PERT
9999999.64;+32989,;201~WP-start~4
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete 
pathological response, nodal status N+; on pathway trastuzumab and 
pertuzumab for 1 year
9999999.65;+32990,+32989,;.01~FEB 29, 2024@12:04:07
9999999.65;+32990,+32989,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 TRAS
9999999.65;+32991,+32989,;.01~FEB 29, 2024@12:11:14
9999999.65;+32992,+32989,;.01~AUG 02, 2024@10:50:21
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32990^1
32991^2
32992^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32987</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>126561938</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32987,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N0 OFF PATH RSN
9999999.64;+32987,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32987,;.08~YES
9999999.64;+32987,;.1~FACTOR
9999999.64;+32987,;100~NATIONAL
9999999.64;+32987,;101~VHA ONCOLOGY
9999999.64;+32987,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N0 Off Path RSN
9999999.64;+32987,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete 
pathological response, nodal status N0; off pathway reason
9999999.65;+32988,+32987,;.01~FEB 29, 2024@11:44:14
9999999.65;+32988,+32987,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 OFF PATH TX
9999999.65;+32989,+32987,;.01~FEB 29, 2024@11:44:49
9999999.65;+32990,+32987,;.01~AUG 02, 2024@10:59:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32988^1
32989^2
32990^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; TIB COMP N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32986</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3061366669</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32986,;.01~VA-ONC BRCA I-III ANY ER N0 > TIB COMP N0 OFF PATH TX
9999999.64;+32986,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32986,;.08~YES
9999999.64;+32986,;.1~FACTOR
9999999.64;+32986,;100~NATIONAL
9999999.64;+32986,;101~VHA ONCOLOGY
9999999.64;+32986,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N0 Off Path TX
9999999.64;+32986,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete 
pathological response, nodal status N0; off pathway treatment
9999999.65;+32987,+32986,;.01~FEB 29, 2024@11:42:05
9999999.65;+32987,+32986,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 TRAS
9999999.65;+32988,+32986,;.01~FEB 29, 2024@11:44:01
9999999.65;+32989,+32986,;.01~AUG 02, 2024@11:00:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32987^1
32988^2
32989^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32983</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3901648041</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32983,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N0 CLIN TRIAL
9999999.64;+32983,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32983,;.08~YES
9999999.64;+32983,;.1~FACTOR
9999999.64;+32983,;100~NATIONAL
9999999.64;+32983,;101~VHA ONCOLOGY
9999999.64;+32983,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N0 Clin Trial
9999999.64;+32983,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete 
pathological response, nodal status N0; on pathway clinical trial
9999999.65;+32984,+32983,;.01~FEB 29, 2024@11:32:49
9999999.65;+32984,+32983,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 NEOADJ CLIN TRIA
9999999.65;+32985,+32983,;.01~FEB 29, 2024@11:36:47
9999999.65;+32986,+32983,;.01~AUG 02, 2024@10:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32984^1
32985^2
32986^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B COMP N0 TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>32985</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>495649892</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32985,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B COMP N0 TRAS
9999999.64;+32985,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32985,;.08~YES
9999999.64;+32985,;.1~FACTOR
9999999.64;+32985,;100~NATIONAL
9999999.64;+32985,;101~VHA ONCOLOGY
9999999.64;+32985,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Complete N0 Trastuzumab
9999999.64;+32985,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, complete 
pathological response, nodal status N0; on pathway trastuzumab
9999999.65;+32986,+32985,;.01~FEB 29, 2024@11:38:14
9999999.65;+32986,+32985,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 COMP N0 CLIN TRIAL
9999999.65;+32987,+32985,;.01~FEB 29, 2024@11:40:02
9999999.65;+32988,+32985,;.01~AUG 02, 2024@11:02:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32986^1
32987^2
32988^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NEOADJ TAX+TRAS W/O PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>36572</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2941855121</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36572,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ TAX+TRAS W/O PERT
9999999.64;+36572,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36572,;.08~YES
9999999.64;+36572,;.1~FACTOR
9999999.64;+36572,;100~NATIONAL
9999999.64;+36572,;101~VHA ONCOLOGY
9999999.64;+36572,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Neoadj Tax+Tras w/o Pert
9999999.64;+36572,;201~WP-start~4
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, on pathway taxane and
trastuzumab containing regimen with or without pertuzumab then follow 
LRM After Neoadjuvant Therapy Pathway
9999999.65;+36573,+36572,;.01~AUG 02, 2024@11:28:49
9999999.65;+36573,+36572,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ TAX+TRAS W/PERT
9999999.65;+36574,+36572,;.01~AUG 02, 2024@11:29:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36573^1
36574^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NEOADJ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32945</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>176872026</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32945,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ OFF PATH RSN
9999999.64;+32945,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32945,;.08~YES
9999999.64;+32945,;.1~FACTOR
9999999.64;+32945,;100~NATIONAL
9999999.64;+32945,;101~VHA ONCOLOGY
9999999.64;+32945,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Neoadj Off Path RSN
9999999.64;+32945,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, off pathway reason
9999999.65;+32946,+32945,;.01~FEB 29, 2024@09:46:25
9999999.65;+32946,+32945,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 NEOADJ OFF PATH TX
9999999.65;+32947,+32945,;.01~FEB 29, 2024@09:47:16
9999999.65;+32948,+32945,;.01~AUG 02, 2024@11:21:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32946^1
32947^2
32948^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NEOADJ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32942</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1740173051</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32942,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ OFF PATH TX
9999999.64;+32942,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32942,;.08~YES
9999999.64;+32942,;.1~FACTOR
9999999.64;+32942,;100~NATIONAL
9999999.64;+32942,;101~VHA ONCOLOGY
9999999.64;+32942,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Neoadj Off Path TX
9999999.64;+32942,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, off pathway treatment
9999999.65;+32943,+32942,;.01~FEB 29, 2024@09:43:09
9999999.65;+32943,+32942,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 NEOADJ CLIN TRIA
9999999.65;+32944,+32942,;.01~FEB 29, 2024@09:46:11
9999999.65;+32945,+32942,;.01~AUG 02, 2024@11:23:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32943^1
32944^2
32945^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NEOADJ CLIN TRIA</POINT_01>
<INTERNAL_ENTRY_NUMBER>32932</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4135242355</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32932,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ CLIN TRIA
9999999.64;+32932,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32932,;.08~YES
9999999.64;+32932,;.1~FACTOR
9999999.64;+32932,;100~NATIONAL
9999999.64;+32932,;101~VHA ONCOLOGY
9999999.64;+32932,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Neoadj Cand Clin Trial
9999999.64;+32932,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, on pathway clinical
trial
9999999.65;+32933,+32932,;.01~FEB 29, 2024@09:07:47
9999999.65;+32933,+32932,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+32934,+32932,;.01~FEB 29, 2024@09:12:35
9999999.65;+32935,+32932,;.01~FEB 29, 2024@09:25:44
9999999.65;+32936,+32932,;.01~AUG 02, 2024@11:20:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32933^1
32934^2
32935^3
32936^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 &gt; T1B NEOADJ TAX+TRAS W/PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>32936</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3309656983</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32936,;.01~VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ TAX+TRAS W/PERT
9999999.64;+32936,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+32936,;.08~YES
9999999.64;+32936,;.1~FACTOR
9999999.64;+32936,;100~NATIONAL
9999999.64;+32936,;101~VHA ONCOLOGY
9999999.64;+32936,;200~BRCA Stage I-III Any ER N0 Tumor >T1B Neoadj Tax+Tras w/Pert
9999999.64;+32936,;201~WP-start~4
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0, Tumor 
T1B or more; candidate for neoadjuvant therapy, on pathway taxane and
trastuzumab containing regimen with or without pertuzumab then follow 
LRM After Neoadjuvant Therapy Pathway
9999999.65;+32937,+32936,;.01~FEB 29, 2024@09:37:37
9999999.65;+32937,+32936,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 > 0.5 NEOADJ CLIN TRIA
9999999.65;+32938,+32936,;.01~FEB 29, 2024@09:41:32
9999999.65;+32939,+32936,;.01~AUG 02, 2024@11:27:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32937^1
32938^2
32939^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STG I-III ANY ER OR PR/HER2+ CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32934</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>376839715</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32934,;.01~VA-ONC BRCA STG I-III ANY ER OR PR/HER2+ CLINICAL PATHWAY
9999999.64;+32934,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+32934,;.08~YES
9999999.64;+32934,;.1~FACTOR
9999999.64;+32934,;100~NATIONAL
9999999.64;+32934,;101~VHA ONCOLOGY
9999999.64;+32934,;200~Breast Cancer-Stage I-III Any ER or PR/HER2+ Clinical Pathway
9999999.64;+32934,;201~WP-start~2
Designates that the Category for all health factors in Breast 
Cancer-Stage I-III Any ER or PR/HER2+ Clinical Pathway was opened.
9999999.65;+32935,+32934,;.01~FEB 29, 2024@09:22:43
9999999.65;+32935,+32934,;2~WP-start~1
Copied from VA-ONC BRCA STG I-III ER+ OR PR+/HER2- CLINICAL PATHWAY
9999999.65;+32936,+32934,;.01~FEB 29, 2024@09:24:35
9999999.65;+32937,+32934,;.01~MAR 01, 2024@09:29:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32935^1
32936^2
32937^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>32850</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2458658077</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32850,;.01~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32850,;.08~YES
9999999.64;+32850,;.1~CATEGORY
9999999.64;+32850,;100~NATIONAL
9999999.64;+32850,;101~VHA ONCOLOGY
9999999.64;+32850,;200~Breast Cancer-Stage I-III ER+ or PR+/HER2- Clinical Pathway
9999999.64;+32850,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage I-III ER+ or
PR+/HER2- Clinical Pathway
9999999.65;+32851,+32850,;.01~FEB 28, 2024@06:41:01
9999999.65;+32851,+32850,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY
9999999.65;+32852,+32850,;.01~FEB 28, 2024@06:42:40
9999999.65;+32853,+32850,;.01~FEB 29, 2024@09:20:48
9999999.65;+32854,+32850,;.01~DEC 03, 2024@13:57:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32851^1
32852^2
32853^3
32854^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A LRM PRIOR+MED ONC</POINT_01>
<INTERNAL_ENTRY_NUMBER>36557</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3313093144</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36557,;.01~VA-ONC BRCA I-III ER+ T1A LRM PRIOR+MED ONC
9999999.64;+36557,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36557,;.08~YES
9999999.64;+36557,;.1~FACTOR
9999999.64;+36557,;100~NATIONAL
9999999.64;+36557,;101~VHA ONCOLOGY
9999999.64;+36557,;200~BRCA Stage I-III ER+ T1a Follow LRM Prior+Refer Med Onc
9999999.64;+36557,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1a, on pathway follow
LRM Prior to Adjuvant Treatment pathway then refer to Medical Oncology for
risk reduction discussion
9999999.65;+36558,+36557,;.01~JUL 31, 2024@13:22:43
9999999.65;+36558,+36557,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
9999999.65;+36559,+36557,;.01~JUL 31, 2024@13:26:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36558^1
36559^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36556</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3361738974</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36556,;.01~VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
9999999.64;+36556,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36556,;.08~YES
9999999.64;+36556,;.1~FACTOR
9999999.64;+36556,;100~NATIONAL
9999999.64;+36556,;101~VHA ONCOLOGY
9999999.64;+36556,;200~BRCA Stage I-III ER+ T1a Clinical Trial
9999999.64;+36556,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1a, on pathway clinical
trial
9999999.65;+36557,+36556,;.01~JUL 31, 2024@13:17:04
9999999.65;+36557,+36556,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+36558,+36556,;.01~JUL 31, 2024@13:20:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36557^1
36558^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36558</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3229941752</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36558,;.01~VA-ONC BRCA I-III ER+ T1A OFF PATH TX
9999999.64;+36558,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36558,;.08~YES
9999999.64;+36558,;.1~FACTOR
9999999.64;+36558,;100~NATIONAL
9999999.64;+36558,;101~VHA ONCOLOGY
9999999.64;+36558,;200~BRCA Stage I-III ER+ T1a Off Path Treatment
9999999.64;+36558,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1a, off pathway 
treatment
9999999.65;+36559,+36558,;.01~JUL 31, 2024@13:27:11
9999999.65;+36559,+36558,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
9999999.65;+36560,+36558,;.01~JUL 31, 2024@13:29:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36559^1
36560^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36559</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>913343281</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36559,;.01~VA-ONC BRCA I-III ER+ T1A OFF PATH RSN
9999999.64;+36559,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36559,;.08~YES
9999999.64;+36559,;.1~FACTOR
9999999.64;+36559,;100~NATIONAL
9999999.64;+36559,;101~VHA ONCOLOGY
9999999.64;+36559,;200~BRCA Stage I-III ER+ T1a Off Path Reason
9999999.64;+36559,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1a, off pathway 
reason
9999999.65;+36560,+36559,;.01~JUL 31, 2024@13:30:55
9999999.65;+36560,+36559,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1A OFF PATH TX
9999999.65;+36561,+36559,;.01~JUL 31, 2024@13:31:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36560^1
36561^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&lt;3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36610</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1368178346</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36610,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS<3 OFF PATH RSN
9999999.64;+36610,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36610,;.08~YES
9999999.64;+36610,;.1~FACTOR
9999999.64;+36610,;100~NATIONAL
9999999.64;+36610,;101~VHA ONCOLOGY
9999999.64;+36610,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG<3 Off Path RSN
9999999.64;+36610,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV positive,
CPS+EG Score less that 3; off pathway reason
9999999.65;+36611,+36610,;.01~AUG 06, 2024@08:09:56
9999999.65;+36611,+36610,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ GERMLINE CPS<3 OFF PATH TX
9999999.65;+36612,+36610,;.01~AUG 06, 2024@08:11:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36611^1
36612^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&lt;3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36609</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1793681758</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36609,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS<3 OFF PATH TX
9999999.64;+36609,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36609,;.08~YES
9999999.64;+36609,;.1~FACTOR
9999999.64;+36609,;100~NATIONAL
9999999.64;+36609,;101~VHA ONCOLOGY
9999999.64;+36609,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG<3 Off Path TX
9999999.64;+36609,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV positive,
CPS+EG Score less that 3; off pathway treatment
9999999.65;+36610,+36609,;.01~AUG 06, 2024@08:07:29
9999999.65;+36610,+36609,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ GERMLINE CPS<3 CLIN TRIAL
9999999.65;+36611,+36609,;.01~AUG 06, 2024@08:09:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36610^1
36611^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&lt;3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36607</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3161714014</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36607,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS<3 CLIN TRIAL
9999999.64;+36607,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36607,;.08~YES
9999999.64;+36607,;.1~FACTOR
9999999.64;+36607,;100~NATIONAL
9999999.64;+36607,;101~VHA ONCOLOGY
9999999.64;+36607,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG<3 Clin Trial
9999999.64;+36607,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV positive,
CPS+EG Score less that 3; on pathway clinical trial
9999999.65;+36608,+36607,;.01~AUG 06, 2024@07:57:13
9999999.65;+36608,+36607,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ GERMLINE CPS>3 CLIN TRIAL
9999999.65;+36609,+36607,;.01~AUG 06, 2024@07:59:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36608^1
36609^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&lt;3 ADJ HT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>36608</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>985485912</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36608,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS<3 ADJ HT PTHWY
9999999.64;+36608,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36608,;.08~YES
9999999.64;+36608,;.1~FACTOR
9999999.64;+36608,;100~NATIONAL
9999999.64;+36608,;101~VHA ONCOLOGY
9999999.64;+36608,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG<3 Follow Adj HT Pthwy
9999999.64;+36608,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV positive,
CPS+EG Score less that 3; on pathway follow Adjuvant Hormone Therapy for 
ER+ or PR+/HER2 any pathway
9999999.65;+36609,+36608,;.01~AUG 06, 2024@08:02:08
9999999.65;+36609,+36608,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ GERMLINE CPS<3 CLIN TRIAL
9999999.65;+36610,+36608,;.01~AUG 06, 2024@08:06:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36609^1
36610^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&gt;3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32883</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2895745762</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32883,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS>3 OFF PATH RSN
9999999.64;+32883,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32883,;.08~YES
9999999.64;+32883,;.1~FACTOR
9999999.64;+32883,;100~NATIONAL
9999999.64;+32883,;101~VHA ONCOLOGY
9999999.64;+32883,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG>3 off path rsn
9999999.64;+32883,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV 
positive, CPS+EG Score 3 or more; off pathway reason
9999999.65;+32884,+32883,;.01~FEB 28, 2024@10:54:46
9999999.65;+32884,+32883,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ GL+ CPS>3 OFF PATH TX
9999999.65;+32885,+32883,;.01~FEB 28, 2024@10:55:55
9999999.65;+32886,+32883,;.01~FEB 28, 2024@13:57:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32884^1
32885^2
32886^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&gt;3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32880</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1838179844</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32880,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS>3 OFF PATH TX
9999999.64;+32880,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32880,;.08~YES
9999999.64;+32880,;.1~FACTOR
9999999.64;+32880,;100~NATIONAL
9999999.64;+32880,;101~VHA ONCOLOGY
9999999.64;+32880,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG>3 off path tx
9999999.64;+32880,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV 
positive, CPS+EG Score 3 or more; off pathway treatment
9999999.65;+32881,+32880,;.01~FEB 28, 2024@10:52:21
9999999.65;+32881,+32880,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ GL+ CPS>3 CLIN TRIAL
9999999.65;+32882,+32880,;.01~FEB 28, 2024@10:53:59
9999999.65;+32883,+32880,;.01~FEB 28, 2024@14:05:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32881^1
32882^2
32883^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&gt;3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32873</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1839720880</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32873,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS>3 CLIN TRIAL
9999999.64;+32873,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32873,;.08~YES
9999999.64;+32873,;.1~FACTOR
9999999.64;+32873,;100~NATIONAL
9999999.64;+32873,;101~VHA ONCOLOGY
9999999.64;+32873,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG>3 clinical trial
9999999.64;+32873,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV positive,
CPS+EG Score 3 or more; on pathway clinical trial
9999999.65;+32874,+32873,;.01~FEB 28, 2024@10:42:59
9999999.65;+32874,+32873,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+32875,+32873,;.01~FEB 28, 2024@10:45:58
9999999.65;+32876,+32873,;.01~FEB 28, 2024@10:51:23
9999999.65;+32877,+32873,;.01~FEB 28, 2024@13:52:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32874^1
32875^2
32876^3
32877^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ GERMLINE CPS&gt;3 OLAP+ADJ HT</POINT_01>
<INTERNAL_ENTRY_NUMBER>32878</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2383837063</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32878,;.01~VA-ONC BRCA I-III ER+ GERMLINE CPS>3 OLAP+ADJ HT
9999999.64;+32878,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32878,;.08~YES
9999999.64;+32878,;.1~FACTOR
9999999.64;+32878,;100~NATIONAL
9999999.64;+32878,;101~VHA ONCOLOGY
9999999.64;+32878,;200~BRCA Stage I-III ER+ Germline Pos CPS+EG>3 Olap+adj HT
9999999.64;+32878,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; germline BRCA 1/2 PV 
positive, CPS+EG Score 3 or more; on pathway Olaparib for 1 year follow 
by Adjuvant Hormone Therapy for ER+ or PR+/HER2 any pathway
9999999.65;+32879,+32878,;.01~FEB 28, 2024@10:47:46
9999999.65;+32879,+32878,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+  GL+ CPS>3 CLIN TRIAL
9999999.65;+32880,+32878,;.01~FEB 28, 2024@10:50:51
9999999.65;+32881,+32878,;.01~FEB 28, 2024@13:59:41
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32879^1
32880^2
32881^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ ANY T &gt; N2</POINT_01>
<INTERNAL_ENTRY_NUMBER>32930</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2052500237</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32930,;.01~VA-ONC BRCA I-III ER+ ANY T > N2
9999999.64;+32930,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32930,;.08~YES
9999999.64;+32930,;.1~FACTOR
9999999.64;+32930,;100~NATIONAL
9999999.64;+32930,;101~VHA ONCOLOGY
9999999.64;+32930,;200~BRCA Stage I-III ER+ ANY T>N2 CPS+EG >3 Treatment
9999999.64;+32930,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T>N2, ddAC-T follow by LRM
After Neoadjuvant Treatment, incomplete pathological response; positive
germline, not on or off pathway CPS+EG Score
9999999.65;+32931,+32930,;.01~FEB 29, 2024@08:23:54
9999999.65;+32931,+32930,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS 16-25 NODE N+
9999999.65;+32932,+32930,;.01~FEB 29, 2024@08:41:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32931^1
32932^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 NOT ANTH OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32923</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2587342031</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32923,;.01~VA-ONC BRCA I-III ER+ T>N2 NOT ANTH OFF PATH RSN
9999999.64;+32923,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32923,;.08~YES
9999999.64;+32923,;.1~FACTOR
9999999.64;+32923,;100~NATIONAL
9999999.64;+32923,;101~VHA ONCOLOGY
9999999.64;+32923,;200~BRCA Stage I-III ER+ T>N2 Not Anth Cand off path reason
9999999.64;+32923,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, not a candidate for anthracycline, off pathway reason
9999999.65;+32924,+32923,;.01~FEB 28, 2024@13:33:21
9999999.65;+32924,+32923,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 NOT ANTH OFF PATH TX
9999999.65;+32925,+32923,;.01~FEB 28, 2024@13:33:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32924^1
32925^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 NOT ANTH OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32922</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1482900415</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32922,;.01~VA-ONC BRCA I-III ER+ T>N2 NOT ANTH OFF PATH TX
9999999.64;+32922,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32922,;.08~YES
9999999.64;+32922,;.1~FACTOR
9999999.64;+32922,;100~NATIONAL
9999999.64;+32922,;101~VHA ONCOLOGY
9999999.64;+32922,;200~BRCA Stage I-III ER+ T>N2 Not Anth Cand off path treatment
9999999.64;+32922,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, not a candidate for anthracycline, off pathway treatment
9999999.65;+32923,+32922,;.01~FEB 28, 2024@13:31:20
9999999.65;+32923,+32922,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 NOT ANTH CLIN TRIAL
9999999.65;+32924,+32922,;.01~FEB 28, 2024@13:32:59
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32923^1
32924^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 NOT ANTH CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32916</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1806779708</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32916,;.01~VA-ONC BRCA I-III ER+ T>N2 NOT ANTH CLIN TRIAL
9999999.64;+32916,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32916,;.08~YES
9999999.64;+32916,;.1~FACTOR
9999999.64;+32916,;100~NATIONAL
9999999.64;+32916,;101~VHA ONCOLOGY
9999999.64;+32916,;200~BRCA Stage I-III ER+ T>N2 Not Anth Cand clinical trial
9999999.64;+32916,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, not a candidate for anthracycline, on pathway clinical trial
9999999.65;+32917,+32916,;.01~FEB 28, 2024@13:26:05
9999999.65;+32917,+32916,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 ANTH CAND CLIN TRIAL
9999999.65;+32918,+32916,;.01~FEB 28, 2024@13:27:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32917^1
32918^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 NOT ANTH TC+LRM AFTER PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32920</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2714661819</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32920,;.01~VA-ONC BRCA I-III ER+ T>N2 NOT ANTH TC+LRM AFTER PTHWY
9999999.64;+32920,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32920,;.08~YES
9999999.64;+32920,;.1~FACTOR
9999999.64;+32920,;100~NATIONAL
9999999.64;+32920,;101~VHA ONCOLOGY
9999999.64;+32920,;200~BRCA Stage I-III ER+ T>N2 Not Anth Cand TC+LRM after pathway
9999999.64;+32920,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, not a candidate for anthracycline, on pathway TC then follow LRM 
After Neoadjuvant Treatment Pathway
9999999.65;+32921,+32920,;.01~FEB 28, 2024@13:28:05
9999999.65;+32921,+32920,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 NOT ANTH CLIN TRIAL
9999999.65;+32922,+32920,;.01~FEB 28, 2024@13:31:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32921^1
32922^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 ANTH CAND OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32914</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3271348845</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32914,;.01~VA-ONC BRCA I-III ER+ T>N2 ANTH CAND OFF PATH RSN
9999999.64;+32914,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32914,;.08~YES
9999999.64;+32914,;.1~FACTOR
9999999.64;+32914,;100~NATIONAL
9999999.64;+32914,;101~VHA ONCOLOGY
9999999.64;+32914,;200~BRCA Stage I-III ER+ T>N2 Anth Cand off path reason
9999999.64;+32914,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, candidate for anthracycline, off pathway reason
9999999.65;+32915,+32914,;.01~FEB 28, 2024@13:17:49
9999999.65;+32915,+32914,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 ANTH CAND OFF PATH TX
9999999.65;+32916,+32914,;.01~FEB 28, 2024@13:18:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32915^1
32916^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 ANTH CAND OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32913</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2995329218</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32913,;.01~VA-ONC BRCA I-III ER+ T>N2 ANTH CAND OFF PATH TX
9999999.64;+32913,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32913,;.08~YES
9999999.64;+32913,;.1~FACTOR
9999999.64;+32913,;100~NATIONAL
9999999.64;+32913,;101~VHA ONCOLOGY
9999999.64;+32913,;200~BRCA Stage I-III ER+ T>N2 Anth Cand off path treatment
9999999.64;+32913,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, candidate for anthracycline, off pathway treatment
9999999.65;+32914,+32913,;.01~FEB 28, 2024@13:15:01
9999999.65;+32914,+32913,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 ANTH CAND CLIN TRIAL
9999999.65;+32915,+32913,;.01~FEB 28, 2024@13:16:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32914^1
32915^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 ANTH CAND CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32905</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1820365983</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32905,;.01~VA-ONC BRCA I-III ER+ T>N2 ANTH CAND CLIN TRIAL
9999999.64;+32905,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32905,;.08~YES
9999999.64;+32905,;.1~FACTOR
9999999.64;+32905,;100~NATIONAL
9999999.64;+32905,;101~VHA ONCOLOGY
9999999.64;+32905,;200~BRCA Stage I-III ER+ T>N2 Anth Cand clinical trial
9999999.64;+32905,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, candidate for anthracycline, on pathway clinical trial
9999999.65;+32906,+32905,;.01~FEB 28, 2024@13:02:52
9999999.65;+32906,+32905,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS > 25 CLIN TRIAL
9999999.65;+32907,+32905,;.01~FEB 28, 2024@13:09:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32906^1
32907^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 ANTH CAND ddAC-T+LRM AFT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32911</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3601954691</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32911,;.01~VA-ONC BRCA I-III ER+ T>N2 ANTH CAND ddAC-T+LRM AFT PTHWY
9999999.64;+32911,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32911,;.08~YES
9999999.64;+32911,;.1~FACTOR
9999999.64;+32911,;100~NATIONAL
9999999.64;+32911,;101~VHA ONCOLOGY
9999999.64;+32911,;200~BRCA Stage I-III ER+ T>N2 Anth Cand ddAC-T+LRM after pthwy
9999999.64;+32911,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Any T greater that on equal 
to N2, candidate for anthracycline, on pathway ddAC-T+LRM after 
neoadjuvant pathway
9999999.65;+32912,+32911,;.01~FEB 28, 2024@13:11:50
9999999.65;+32912,+32911,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T>N2 ANTH CAND CLIN TRIAL
9999999.65;+32913,+32911,;.01~FEB 28, 2024@13:14:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32912^1
32913^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36563</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2814084853</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36563,;.01~VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH RSN
9999999.64;+36563,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36563,;.08~YES
9999999.64;+36563,;.1~FACTOR
9999999.64;+36563,;100~NATIONAL
9999999.64;+36563,;101~VHA ONCOLOGY
9999999.64;+36563,;200~BRCA Stage I-III ER+ T1b Not Chemo Cand Off Path RSN
9999999.64;+36563,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1b, not candidate 
for chemotherapy, off pathway reason
9999999.65;+36564,+36563,;.01~JUL 31, 2024@13:47:26
9999999.65;+36564,+36563,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH TX
9999999.65;+36565,+36563,;.01~JUL 31, 2024@13:48:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36564^1
36565^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36562</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3607994729</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36562,;.01~VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH TX
9999999.64;+36562,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36562,;.08~YES
9999999.64;+36562,;.1~FACTOR
9999999.64;+36562,;100~NATIONAL
9999999.64;+36562,;101~VHA ONCOLOGY
9999999.64;+36562,;200~BRCA Stage I-III ER+ T1b Not Chemo Cand Off Path TX
9999999.64;+36562,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1b, not candidate 
for chemotherapy, off pathway treatment
9999999.65;+36563,+36562,;.01~JUL 31, 2024@13:46:07
9999999.65;+36563,+36562,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1B NO CHEMO CLIN TRIAL
9999999.65;+36564,+36562,;.01~JUL 31, 2024@13:47:09
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36563^1
36564^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B NO CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36560</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>195397853</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36560,;.01~VA-ONC BRCA I-III ER+ T1B NO CHEMO CLIN TRIAL
9999999.64;+36560,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36560,;.08~YES
9999999.64;+36560,;.1~FACTOR
9999999.64;+36560,;100~NATIONAL
9999999.64;+36560,;101~VHA ONCOLOGY
9999999.64;+36560,;200~BRCA Stage I-III ER+ T1b Not Chemo Cand Clin Trial
9999999.64;+36560,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1b, not candidate 
for chemotherapy, on pathway clinical trial
9999999.65;+36561,+36560,;.01~JUL 31, 2024@13:38:20
9999999.65;+36561,+36560,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
9999999.65;+36562,+36560,;.01~JUL 31, 2024@13:40:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36561^1
36562^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B NO CHEMO ADJ HT PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>36561</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2973113893</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36561,;.01~VA-ONC BRCA I-III ER+ T1B NO CHEMO ADJ HT PATHWAY
9999999.64;+36561,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36561,;.08~YES
9999999.64;+36561,;.1~FACTOR
9999999.64;+36561,;100~NATIONAL
9999999.64;+36561,;101~VHA ONCOLOGY
9999999.64;+36561,;200~BRCA Stage I-III ER+ T1b Not Chemo Cand Adj HT Pthwy
9999999.64;+36561,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Stage T1b, not candidate 
for chemotherapy, on pathway follow adjuvant hormone therapy for ER+ or 
PR+/HER2 Any Pathway
9999999.65;+36562,+36561,;.01~JUL 31, 2024@13:41:19
9999999.65;+36562,+36561,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ T1B NO CHEMO CLIN TRIAL
9999999.65;+36563,+36561,;.01~JUL 31, 2024@13:45:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36562^1
36563^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B RS &gt; 25</POINT_01>
<INTERNAL_ENTRY_NUMBER>32929</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1259301022</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32929,;.01~VA-ONC BRCA I-III ER+ T1B RS > 25
9999999.64;+32929,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32929,;.08~YES
9999999.64;+32929,;.1~FACTOR
9999999.64;+32929,;100~NATIONAL
9999999.64;+32929,;101~VHA ONCOLOGY
9999999.64;+32929,;200~BRCA Stage I-III ER+ T1b Risk Score > 25 CPS+EG >3 Treatment
9999999.64;+32929,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Risk Score > 25, ddAC-T
follow by LRM After Neoadjuvant Treatment, incomplete pathological
response; positive germline, not on or off pathway CPS+EG Score
9999999.65;+32930,+32929,;.01~FEB 29, 2024@07:59:28
9999999.65;+32930,+32929,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS 16-25 NODE N+
9999999.65;+32931,+32929,;.01~FEB 29, 2024@08:02:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32930^1
32931^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &gt; 25 ddAC-T+LRM AFTER PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32891</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>743622618</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32891,;.01~VA-ONC BRCA I-III ER+ RS > 25 ddAC-T+LRM AFTER PTHWY
9999999.64;+32891,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32891,;.08~YES
9999999.64;+32891,;.1~FACTOR
9999999.64;+32891,;100~NATIONAL
9999999.64;+32891,;101~VHA ONCOLOGY
9999999.64;+32891,;200~BRCA Stage I-III ER+ Risk Score >25 ddAC-T+LRM After pthwy
9999999.64;+32891,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; candidate for chemotherapy,
Risk Score > 25, on pathway ddAC-T then follow LRM After Neoadjuvant 
Treatment pathway
9999999.65;+32892,+32891,;.01~FEB 28, 2024@12:14:35
9999999.65;+32892,+32891,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS > 25 CLIN TRIAL
9999999.65;+32893,+32891,;.01~FEB 28, 2024@12:18:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32892^1
32893^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &gt; 25 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32893</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2048516424</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32893,;.01~VA-ONC BRCA I-III ER+ RS > 25 OFF PATH RSN
9999999.64;+32893,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32893,;.08~YES
9999999.64;+32893,;.1~FACTOR
9999999.64;+32893,;100~NATIONAL
9999999.64;+32893,;101~VHA ONCOLOGY
9999999.64;+32893,;200~BRCA Stage I-III ER+ Risk Score > 25 off path reason
9999999.64;+32893,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; candidate for chemotherapy,
Risk Score > 25, on pathway reason
9999999.65;+32894,+32893,;.01~FEB 28, 2024@12:21:01
9999999.65;+32894,+32893,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS > 25 OFF PATH TX
9999999.65;+32895,+32893,;.01~FEB 28, 2024@12:23:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32894^1
32895^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &gt; 25 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32892</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>249180155</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32892,;.01~VA-ONC BRCA I-III ER+ RS > 25 OFF PATH TX
9999999.64;+32892,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32892,;.08~YES
9999999.64;+32892,;.1~FACTOR
9999999.64;+32892,;100~NATIONAL
9999999.64;+32892,;101~VHA ONCOLOGY
9999999.64;+32892,;200~BRCA Stage I-III ER+ Risk Score > 25 off path treatment
9999999.64;+32892,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; candidate for chemotherapy,
Risk Score > 25, on pathway treatment
9999999.65;+32893,+32892,;.01~FEB 28, 2024@12:19:48
9999999.65;+32893,+32892,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS > 25 CLIN TRIAL
9999999.65;+32894,+32892,;.01~FEB 28, 2024@12:20:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32893^1
32894^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &gt; 25 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32888</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1972567633</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32888,;.01~VA-ONC BRCA I-III ER+ RS > 25 CLIN TRIAL
9999999.64;+32888,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32888,;.08~YES
9999999.64;+32888,;.1~FACTOR
9999999.64;+32888,;100~NATIONAL
9999999.64;+32888,;101~VHA ONCOLOGY
9999999.64;+32888,;200~BRCA Stage I-III ER+ Risk Score > 25 clinical trial
9999999.64;+32888,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; candidate for chemotherapy,
Risk Score > 25, on pathway clinical trial
9999999.65;+32889,+32888,;.01~FEB 28, 2024@12:08:16
9999999.65;+32889,+32888,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+32890,+32888,;.01~FEB 28, 2024@12:12:04
9999999.65;+32891,+32888,;.01~FEB 28, 2024@12:19:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32889^1
32890^2
32891^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 POST OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36571</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2949222504</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36571,;.01~VA-ONC BRCA I-III ER+ RS < 25 POST OFF PATH RSN
9999999.64;+36571,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36571,;.08~YES
9999999.64;+36571,;.1~FACTOR
9999999.64;+36571,;100~NATIONAL
9999999.64;+36571,;101~VHA ONCOLOGY
9999999.64;+36571,;200~BRCA Stage I-III ER+ Risk Score <25 Post-Men Off Path RSN
9999999.64;+36571,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; post-menopause, Risk Score <
25, off pathway reason
9999999.65;+36572,+36571,;.01~AUG 02, 2024@10:15:06
9999999.65;+36572,+36571,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 POST OFF PATH TX
9999999.65;+36573,+36571,;.01~AUG 02, 2024@10:16:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36572^1
36573^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 POST OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36570</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2685521538</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36570,;.01~VA-ONC BRCA I-III ER+ RS < 25 POST OFF PATH TX
9999999.64;+36570,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36570,;.08~YES
9999999.64;+36570,;.1~FACTOR
9999999.64;+36570,;100~NATIONAL
9999999.64;+36570,;101~VHA ONCOLOGY
9999999.64;+36570,;200~BRCA Stage I-III ER+ Risk Score <25 Post-Men Off Path TX
9999999.64;+36570,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; post-menopause, Risk Score <
25, off pathway treatment
9999999.65;+36571,+36570,;.01~AUG 02, 2024@10:13:03
9999999.65;+36571,+36570,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 POST CLIN TRIAL
9999999.65;+36572,+36570,;.01~AUG 02, 2024@10:14:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36571^1
36572^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 POST CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36569</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3505867932</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36569,;.01~VA-ONC BRCA I-III ER+ RS < 25 POST CLIN TRIAL
9999999.64;+36569,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36569,;.08~YES
9999999.64;+36569,;.1~FACTOR
9999999.64;+36569,;100~NATIONAL
9999999.64;+36569,;101~VHA ONCOLOGY
9999999.64;+36569,;200~BRCA Stage I-III ER+ Risk Score <25 Post-Men Clin Trial
9999999.64;+36569,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; post-menopause, Risk Score <
25, on pathway clinical trial
9999999.65;+36570,+36569,;.01~AUG 02, 2024@10:10:41
9999999.65;+36570,+36569,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 POST ADJ HT PTHWY
9999999.65;+36571,+36569,;.01~AUG 02, 2024@10:11:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36570^1
36571^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 POST ADJ HT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>36568</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>46220694</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36568,;.01~VA-ONC BRCA I-III ER+ RS < 25 POST ADJ HT PTHWY
9999999.64;+36568,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+36568,;.08~YES
9999999.64;+36568,;.1~FACTOR
9999999.64;+36568,;100~NATIONAL
9999999.64;+36568,;101~VHA ONCOLOGY
9999999.64;+36568,;200~BRCA Stage I-III ER+ Risk Score <25 Post-Men Follow Adj HT Pthwy
9999999.64;+36568,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; post-menopause, Risk Score <
25, on pathway follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any
pathway
9999999.65;+36569,+36568,;.01~AUG 02, 2024@10:00:28
9999999.65;+36569,+36568,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS <= 15 ADJ HT PTHWY
9999999.65;+36570,+36568,;.01~AUG 02, 2024@10:09:26
9999999.65;+36571,+36568,;.01~AUG 02, 2024@10:18:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36569^1
36570^2
36571^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS 16-25 NODE N+</POINT_01>
<INTERNAL_ENTRY_NUMBER>32928</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3350562055</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32928,;.01~VA-ONC BRCA I-III ER+ RS 16-25 NODE N+
9999999.64;+32928,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32928,;.08~YES
9999999.64;+32928,;.1~FACTOR
9999999.64;+32928,;100~NATIONAL
9999999.64;+32928,;101~VHA ONCOLOGY
9999999.64;+32928,;200~BRCA Stage I-III ER+ Risk Score < 25 N+ CPS+EG >3 Treatment
9999999.64;+32928,;201~WP-start~4
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N+, ddAC-T follow by LRM After Neoadjuvant Treatment, 
incomplete pathological response; positive germline, not on or off 
pathway CPS+EG Score
9999999.65;+32929,+32928,;.01~FEB 29, 2024@07:48:14
9999999.65;+32929,+32928,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+32930,+32928,;.01~FEB 29, 2024@07:53:49
9999999.65;+32931,+32928,;.01~FEB 29, 2024@08:50:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32929^1
32930^2
32931^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N+ ddAC-T+LRM AFTER PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32862</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3054238102</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32862,;.01~VA-ONC BRCA I-III ER+ RS < 25 N+ ddAC-T+LRM AFTER PTHWY
9999999.64;+32862,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32862,;.08~YES
9999999.64;+32862,;.1~FACTOR
9999999.64;+32862,;100~NATIONAL
9999999.64;+32862,;101~VHA ONCOLOGY
9999999.64;+32862,;200~BRCA Stage I-III ER+ Risk Score < 25 N+ddAC-T then LRM After 
9999999.64;+32862,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N+, on pathway ddAC-T then follow LRM After Neoadjuvant
Treatment Pathway
9999999.65;+32863,+32862,;.01~FEB 28, 2024@09:48:37
9999999.65;+32863,+32862,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+32864,+32862,;.01~FEB 28, 2024@10:00:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32863^1
32864^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32865</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1414356354</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32865,;.01~VA-ONC BRCA I-III ER+ RS < 25 N+ OFF PATH RSN
9999999.64;+32865,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32865,;.08~YES
9999999.64;+32865,;.1~FACTOR
9999999.64;+32865,;100~NATIONAL
9999999.64;+32865,;101~VHA ONCOLOGY
9999999.64;+32865,;200~BRCA Stage I-III ER+ Risk Score < 25 N+ off path reason
9999999.64;+32865,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N+, off pathway reason
9999999.65;+32866,+32865,;.01~FEB 28, 2024@10:16:29
9999999.65;+32866,+32865,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ OFF PATH TX
9999999.65;+32867,+32865,;.01~FEB 28, 2024@10:18:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32866^1
32867^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32864</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3131595608</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32864,;.01~VA-ONC BRCA I-III ER+ RS < 25 N+ OFF PATH TX
9999999.64;+32864,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32864,;.08~YES
9999999.64;+32864,;.1~FACTOR
9999999.64;+32864,;100~NATIONAL
9999999.64;+32864,;101~VHA ONCOLOGY
9999999.64;+32864,;200~BRCA Stage I-III ER+ Risk Score < 25 N+ off path treatment
9999999.64;+32864,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N+, off pathway treatment
9999999.65;+32865,+32864,;.01~FEB 28, 2024@10:02:53
9999999.65;+32865,+32864,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.65;+32866,+32864,;.01~FEB 28, 2024@10:03:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32865^1
32866^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32860</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2790489941</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32860,;.01~VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
9999999.64;+32860,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32860,;.08~YES
9999999.64;+32860,;.1~FACTOR
9999999.64;+32860,;100~NATIONAL
9999999.64;+32860,;101~VHA ONCOLOGY
9999999.64;+32860,;200~BRCA Stage I-III ER+ Risk Score < 25 N+ clinical trial
9999999.64;+32860,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N+, on pathway clinical trial
9999999.65;+32861,+32860,;.01~FEB 28, 2024@09:44:49
9999999.65;+32861,+32860,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.65;+32862,+32860,;.01~FEB 28, 2024@09:46:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32861^1
32862^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32855</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4109289533</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32855,;.01~VA-ONC BRCA I-III ER+ RS < 25 N0 OFF PATH RSN
9999999.64;+32855,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32855,;.08~YES
9999999.64;+32855,;.1~FACTOR
9999999.64;+32855,;100~NATIONAL
9999999.64;+32855,;101~VHA ONCOLOGY
9999999.64;+32855,;200~BRCA Stage I-III ER+ Risk Score < 25 N0 off path reason
9999999.64;+32855,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N0, off pathway reason
9999999.65;+32856,+32855,;.01~FEB 28, 2024@09:04:50
9999999.65;+32856,+32855,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 OFF PATH TX
9999999.65;+32857,+32855,;.01~FEB 28, 2024@09:05:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32856^1
32857^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32854</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2906366223</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32854,;.01~VA-ONC BRCA I-III ER+ RS < 25 N0 OFF PATH TX
9999999.64;+32854,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32854,;.08~YES
9999999.64;+32854,;.1~FACTOR
9999999.64;+32854,;100~NATIONAL
9999999.64;+32854,;101~VHA ONCOLOGY
9999999.64;+32854,;200~BRCA Stage I-III ER+ Risk Score < 25 N0 off path treatment
9999999.64;+32854,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N0, off pathway treatment
9999999.65;+32855,+32854,;.01~FEB 28, 2024@09:02:47
9999999.65;+32855,+32854,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.65;+32856,+32854,;.01~FEB 28, 2024@09:04:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32855^1
32856^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32852</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3184300435</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32852,;.01~VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.64;+32852,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32852,;.08~YES
9999999.64;+32852,;.1~FACTOR
9999999.64;+32852,;100~NATIONAL
9999999.64;+32852,;101~VHA ONCOLOGY
9999999.64;+32852,;200~BRCA Stage I-III ER+ Risk Score < 25 N0 clinical trial
9999999.64;+32852,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 25
nodal status N0, on pathway clinical trial
9999999.65;+32853,+32852,;.01~FEB 28, 2024@07:34:11
9999999.65;+32853,+32852,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG < 2 CLIN TRIAL
9999999.65;+32854,+32852,;.01~FEB 28, 2024@07:38:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32853^1
32854^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N0 ADJ HT PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32856</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2617580880</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32856,;.01~VA-ONC BRCA I-III ER+ RS < 25 N0 ADJ HT PATHWAY
9999999.64;+32856,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32856,;.08~YES
9999999.64;+32856,;.1~FACTOR
9999999.64;+32856,;100~NATIONAL
9999999.64;+32856,;101~VHA ONCOLOGY
9999999.64;+32856,;200~BRCA Stage I-III ER+ Risk Score < 25 N0 follow Adj HT pathway
9999999.64;+32856,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 
25 nodal status N0, on pathway follow Adjuvant Hormone Therapy for ER+ or
PR+/HER2 any pathway
9999999.65;+32857,+32856,;.01~FEB 28, 2024@09:16:29
9999999.65;+32857,+32856,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 TC+ADJ HT PTHWY
9999999.65;+32858,+32856,;.01~FEB 28, 2024@09:18:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32857^1
32858^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt; 25 N0 TC+ADJ HT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32853</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3840546314</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32853,;.01~VA-ONC BRCA I-III ER+ RS < 25 N0 TC+ADJ HT PTHWY
9999999.64;+32853,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+32853,;.08~YES
9999999.64;+32853,;.1~FACTOR
9999999.64;+32853,;100~NATIONAL
9999999.64;+32853,;101~VHA ONCOLOGY
9999999.64;+32853,;200~BRCA Stage I-III ER+ Risk Score < 25 N0 TC then Adj HT pathway
9999999.64;+32853,;201~WP-start~3
Breast Cancer-Stage I-III ER+ or PR+/HER2-; pre-menopause, Risk Score < 
25 nodal status N0, on pathway TC then follow Adjuvant Hormone Therapy 
for ER+ or PR+/HER2 any pathway
9999999.65;+32854,+32853,;.01~FEB 28, 2024@08:49:43
9999999.65;+32854,+32853,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.65;+32855,+32853,;.01~FEB 28, 2024@09:02:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32854^1
32855^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt;= 15 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33588</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2881484083</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33588,;.01~VA-ONC BRCA I-III ER+ RS <= 15 OFF PATH RSN
9999999.64;+33588,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+33588,;.08~YES
9999999.64;+33588,;.1~FACTOR
9999999.64;+33588,;100~NATIONAL
9999999.64;+33588,;101~VHA ONCOLOGY
9999999.64;+33588,;200~BRCA Stage I-III ER+ Risk Score <=15 Off Path RSN
9999999.64;+33588,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Risk Score <= 15, off pathway
reason
9999999.65;+33589,+33588,;.01~AUG 02, 2024@09:38:18
9999999.65;+33589,+33588,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS <= 15 OFF PATH TX
9999999.65;+33590,+33588,;.01~AUG 02, 2024@09:38:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33589^1
33590^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt;= 15 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33587</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1196035387</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33587,;.01~VA-ONC BRCA I-III ER+ RS <= 15 OFF PATH TX
9999999.64;+33587,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+33587,;.08~YES
9999999.64;+33587,;.1~FACTOR
9999999.64;+33587,;100~NATIONAL
9999999.64;+33587,;101~VHA ONCOLOGY
9999999.64;+33587,;200~BRCA Stage I-III ER+ Risk Score <=15 Off Path TX
9999999.64;+33587,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Risk Score <= 15, off pathway
treatment
9999999.65;+33588,+33587,;.01~AUG 02, 2024@09:35:59
9999999.65;+33588,+33587,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS <= 15 CLIN TRIAL
9999999.65;+33589,+33587,;.01~AUG 02, 2024@09:37:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33588^1
33589^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt;= 15 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33584</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>759255747</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33584,;.01~VA-ONC BRCA I-III ER+ RS <= 15 CLIN TRIAL
9999999.64;+33584,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+33584,;.08~YES
9999999.64;+33584,;.1~FACTOR
9999999.64;+33584,;100~NATIONAL
9999999.64;+33584,;101~VHA ONCOLOGY
9999999.64;+33584,;200~BRCA Stage I-III ER+ Risk Score <=15 Clin Trial
9999999.64;+33584,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Risk Score <= 15, on pathway
clinical trial
9999999.65;+33585,+33584,;.01~AUG 02, 2024@09:27:44
9999999.65;+33585,+33584,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.65;+33586,+33584,;.01~AUG 02, 2024@09:30:03
9999999.65;+33587,+33584,;.01~AUG 02, 2024@09:31:05
9999999.65;+33588,+33584,;.01~AUG 02, 2024@09:46:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33585^1
33586^2
33587^3
33588^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS &lt;= 15 ADJ HT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33585</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>177367479</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33585,;.01~VA-ONC BRCA I-III ER+ RS <= 15 ADJ HT PTHWY
9999999.64;+33585,;.03~VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
9999999.64;+33585,;.08~YES
9999999.64;+33585,;.1~FACTOR
9999999.64;+33585,;100~NATIONAL
9999999.64;+33585,;101~VHA ONCOLOGY
9999999.64;+33585,;200~BRCA Stage I-III ER+ Risk Score <=15 Follow Adj HT Pthwy
9999999.64;+33585,;201~WP-start~2
Breast Cancer-Stage I-III ER+ or PR+/HER2-; Risk Score <= 15, on pathway
follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any pathway
9999999.65;+33586,+33585,;.01~AUG 02, 2024@09:32:10
9999999.65;+33586,+33585,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS <= 15 CLIN TRIAL
9999999.65;+33587,+33585,;.01~AUG 02, 2024@09:33:32
9999999.65;+33588,+33585,;.01~AUG 02, 2024@09:47:03
9999999.65;+33589,+33585,;.01~AUG 02, 2024@09:53:50
9999999.65;+33590,+33585,;.01~AUG 02, 2024@10:19:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33586^1
33587^2
33588^3
33589^4
33590^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STG I-III ER+ OR PR+/HER2- CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>32851</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1625930716</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32851,;.01~VA-ONC BRCA STG I-III ER+ OR PR+/HER2- CLINICAL PATHWAY
9999999.64;+32851,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+32851,;.08~YES
9999999.64;+32851,;.1~FACTOR
9999999.64;+32851,;100~NATIONAL
9999999.64;+32851,;101~VHA ONCOLOGY
9999999.64;+32851,;200~Breast Cancer-Stage I-III ER+ or PR+/HER2- Clinical Pathway
9999999.64;+32851,;201~WP-start~2
Designates that the Category for all health factors in Breast 
Cancer-Stage I-III ER+ or PR+/HER2- Clinical Pathway was opened.
9999999.65;+32852,+32851,;.01~FEB 28, 2024@06:53:29
9999999.65;+32852,+32851,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER NEOADJ TX CLINICAL PATHWAY
9999999.65;+32853,+32851,;.01~FEB 28, 2024@06:55:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32852^1
32853^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE I-III CLINICAL PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33372</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>168383191</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33372,;.01~VA-ONC BRCA STAGE I-III CLINICAL PATHWAY
9999999.64;+33372,;.03~VA-ONCOLOGY PATHWAYS [C]
9999999.64;+33372,;.08~YES
9999999.64;+33372,;.1~FACTOR
9999999.64;+33372,;100~NATIONAL
9999999.64;+33372,;101~VHA ONCOLOGY
9999999.64;+33372,;200~Breast Cancer-Stage I-III Clinical Pathway
9999999.64;+33372,;201~WP-start~2
Designates that the reminder dialog for Breast Cancer-Stages I-III
Clinical Pathway was opened.
9999999.65;+33373,+33372,;.01~MAR 21, 2024@09:01:30
9999999.65;+33373,+33372,;2~WP-start~1
Copied from VA-ONC BRCA STG I-III ER+ OR PR+/HER2- CLINICAL PATHWAY
9999999.65;+33374,+33372,;.01~MAR 21, 2024@09:04:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33373^1
33374^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BREAST TUMOR GENOMIC TESTING [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33305</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2721653747</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33305,;.01~VA-ONC BREAST TUMOR GENOMIC TESTING [C]
9999999.64;+33305,;.08~YES
9999999.64;+33305,;.1~CATEGORY
9999999.64;+33305,;100~NATIONAL
9999999.64;+33305,;101~VHA ONCOLOGY
9999999.64;+33305,;200~Breast Cancer Tumor Genomic Testing Pathway
9999999.64;+33305,;201~WP-start~2
Category for all health factors in Breast Cancer Tumor Genomic Testing 
Pathway
9999999.65;+33306,+33305,;.01~MAR 18, 2024@11:25:37
9999999.65;+33306,+33305,;2~WP-start~1
Copied from VA-ONC ESOPH CA MOLECULAR TESTING [C]
9999999.65;+33307,+33305,;.01~MAR 18, 2024@11:31:07
9999999.65;+33308,+33305,;.01~DEC 03, 2024@13:58:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33306^1
33307^2
33308^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BREAST TUMOR GENOMIC TEST PREVIOUS ORDERED</POINT_01>
<INTERNAL_ENTRY_NUMBER>36845</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2101765353</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36845,;.01~VA-ONC BREAST TUMOR GENOMIC TEST PREVIOUS ORDERED
9999999.64;+36845,;.03~VA-ONC BREAST TUMOR GENOMIC TESTING [C]
9999999.64;+36845,;.08~YES
9999999.64;+36845,;.1~FACTOR
9999999.64;+36845,;100~NATIONAL
9999999.64;+36845,;101~VHA ONCOLOGY
9999999.64;+36845,;200~Breast Cancer Tumor Genomic Testing Previously Ordered
9999999.64;+36845,;201~WP-start~2
Breast Cancer CGP Testing: on pathway tumor genomic test previously
ordered
9999999.65;+36846,+36845,;.01~AUG 12, 2024@13:51:01
9999999.65;+36846,+36845,;2~WP-start~1
Copied from VA-ONC BREAST TUMOR GENETIC TEST ORDERED
9999999.65;+36847,+36845,;.01~AUG 12, 2024@13:53:30
9999999.65;+36848,+36845,;.01~AUG 13, 2024@07:35:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36846^1
36847^2
36848^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BREAST TUMOR GENOMIC TEST NOT ORDERED OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33308</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4076545720</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33308,;.01~VA-ONC BREAST TUMOR GENOMIC TEST NOT ORDERED OFF PATH RSN
9999999.64;+33308,;.03~VA-ONC BREAST TUMOR GENOMIC TESTING [C]
9999999.64;+33308,;.08~YES
9999999.64;+33308,;.1~FACTOR
9999999.64;+33308,;100~NATIONAL
9999999.64;+33308,;101~VHA ONCOLOGY
9999999.64;+33308,;200~Breast Cancer Tumor Genomic Testing Not Ordered Off Path RSN
9999999.64;+33308,;201~WP-start~2
Breast Cancer CGP Testing: Tumor genomic test not ordered, off pathway 
reason
9999999.65;+33309,+33308,;.01~MAR 18, 2024@11:46:53
9999999.65;+33309,+33308,;2~WP-start~1
Copied from VA-ONC BREAST TUMOR GENETIC TEST ORDERED
9999999.65;+33310,+33308,;.01~MAR 18, 2024@11:49:39
9999999.65;+33311,+33308,;.01~AUG 13, 2024@07:31:08
9999999.65;+33312,+33308,;.01~AUG 13, 2024@07:37:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33309^1
33310^2
33311^3
33312^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BREAST TUMOR GENOMIC TEST FUTURE ORDER</POINT_01>
<INTERNAL_ENTRY_NUMBER>33307</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>47246157</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33307,;.01~VA-ONC BREAST TUMOR GENOMIC TEST FUTURE ORDER
9999999.64;+33307,;.03~VA-ONC BREAST TUMOR GENOMIC TESTING [C]
9999999.64;+33307,;.08~YES
9999999.64;+33307,;.1~FACTOR
9999999.64;+33307,;100~NATIONAL
9999999.64;+33307,;101~VHA ONCOLOGY
9999999.64;+33307,;200~Breast Cancer Tumor Genomic Testing Order in Future
9999999.64;+33307,;201~WP-start~2
Breast Cancer CGP Testing: tumor genomic test will be ordered at a future 
date. This is neither on or off pathway.
9999999.65;+33308,+33307,;.01~MAR 18, 2024@11:42:07
9999999.65;+33308,+33307,;2~WP-start~1
Copied from VA-ONC BREAST TUMOR GENETIC TEST ORDERED
9999999.65;+33309,+33307,;.01~MAR 18, 2024@11:45:04
9999999.65;+33310,+33307,;.01~AUG 13, 2024@07:34:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33308^1
33309^2
33310^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BREAST TUMOR GENOMIC TEST ORDERED</POINT_01>
<INTERNAL_ENTRY_NUMBER>33306</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3281411820</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33306,;.01~VA-ONC BREAST TUMOR GENOMIC TEST ORDERED
9999999.64;+33306,;.03~VA-ONC BREAST TUMOR GENOMIC TESTING [C]
9999999.64;+33306,;.08~YES
9999999.64;+33306,;.1~FACTOR
9999999.64;+33306,;100~NATIONAL
9999999.64;+33306,;101~VHA ONCOLOGY
9999999.64;+33306,;200~Breast Cancer Tumor Genomic Testing Ordered
9999999.64;+33306,;201~WP-start~1
Breast Cancer CGP Testing: on pathway tumor genomic test ordered
9999999.65;+33307,+33306,;.01~MAR 18, 2024@11:32:47
9999999.65;+33307,+33306,;2~WP-start~1
Copied from VA-ONC ESOPH CA MSI/MMR TEST ORDERED
9999999.65;+33308,+33306,;.01~MAR 18, 2024@11:38:55
9999999.65;+33309,+33306,;.01~AUG 13, 2024@07:32:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33307^1
33308^2
33309^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33239</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>256157098</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33239,;.01~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33239,;.08~YES
9999999.64;+33239,;.1~CATEGORY
9999999.64;+33239,;100~NATIONAL
9999999.64;+33239,;101~VHA ONCOLOGY
9999999.64;+33239,;200~Breast Cancer-Stage IV ER-/PR-/HER2- Clinical Pathway
9999999.64;+33239,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage IV 
ER-/PR-/HER2- Clinical Pathway 
9999999.65;+33240,+33239,;.01~MAR 12, 2024@11:58:06
9999999.65;+33240,+33239,;2~WP-start~1
Copied from VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY
9999999.65;+33241,+33239,;.01~MAR 12, 2024@12:01:32
9999999.65;+33242,+33239,;.01~MAR 21, 2024@10:59:54
9999999.65;+33243,+33239,;.01~DEC 03, 2024@13:59:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33240^1
33241^2
33242^3
33243^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33282</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3653303443</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33282,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO OFF PATH RSN
9999999.64;+33282,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33282,;.08~YES
9999999.64;+33282,;.1~FACTOR
9999999.64;+33282,;100~NATIONAL
9999999.64;+33282,;101~VHA ONCOLOGY
9999999.64;+33282,;200~BRCA Stage IV ER- <2 prior chemo received off path reason
9999999.64;+33282,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, off pathway reason
9999999.65;+33283,+33282,;.01~MAR 13, 2024@11:29:11
9999999.65;+33283,+33282,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO OFF PATH TX
9999999.65;+33284,+33282,;.01~MAR 13, 2024@11:29:42
9999999.65;+33285,+33282,;.01~APR 04, 2024@13:36:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33283^1
33284^2
33285^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33281</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3790534188</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33281,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO OFF PATH TX
9999999.64;+33281,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33281,;.08~YES
9999999.64;+33281,;.1~FACTOR
9999999.64;+33281,;100~NATIONAL
9999999.64;+33281,;101~VHA ONCOLOGY
9999999.64;+33281,;200~BRCA Stage IV ER- <2 prior chemo received off path treatment
9999999.64;+33281,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, off pathway treatment
9999999.65;+33282,+33281,;.01~MAR 13, 2024@11:27:56
9999999.65;+33282,+33281,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO CLIN TRIAL
9999999.65;+33283,+33281,;.01~MAR 13, 2024@11:28:53
9999999.65;+33284,+33281,;.01~APR 04, 2024@13:38:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33282^1
33283^2
33284^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: PEMBROLIZUMAB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33280</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>149784953</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33280,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PEMBROLIZUMAB
9999999.64;+33280,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33280,;.08~YES
9999999.64;+33280,;.1~FACTOR
9999999.64;+33280,;100~NATIONAL
9999999.64;+33280,;101~VHA ONCOLOGY
9999999.64;+33280,;200~BRCA Stage IV ER- <2 prior chemo received pembrolizumab
9999999.64;+33280,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway pembrolizumab
9999999.65;+33281,+33280,;.01~MAR 13, 2024@11:20:51
9999999.65;+33281,+33280,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: VINORELBINE
9999999.65;+33282,+33280,;.01~MAR 13, 2024@11:21:36
9999999.65;+33283,+33280,;.01~APR 04, 2024@13:41:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33281^1
33282^2
33283^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: VINORELBINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33279</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2337058579</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33279,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: VINORELBINE
9999999.64;+33279,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33279,;.08~YES
9999999.64;+33279,;.1~FACTOR
9999999.64;+33279,;100~NATIONAL
9999999.64;+33279,;101~VHA ONCOLOGY
9999999.64;+33279,;200~BRCA Stage IV ER- <2 prior chemo received vinorelbine
9999999.64;+33279,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of chemotherapy
received, on pathway vinorelbine
9999999.65;+33280,+33279,;.01~MAR 13, 2024@11:19:46
9999999.65;+33280,+33279,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.65;+33281,+33279,;.01~MAR 13, 2024@11:20:37
9999999.65;+33282,+33279,;.01~APR 04, 2024@13:42:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33280^1
33281^2
33282^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: LIPO DOXORUBICIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33278</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>233011505</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33278,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: LIPO DOXORUBICIN
9999999.64;+33278,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33278,;.08~YES
9999999.64;+33278,;.1~FACTOR
9999999.64;+33278,;100~NATIONAL
9999999.64;+33278,;101~VHA ONCOLOGY
9999999.64;+33278,;200~BRCA Stage IV ER- <2 prior chemo received lipo doxorubicin
9999999.64;+33278,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway liposomal doxorubicin
9999999.65;+33279,+33278,;.01~MAR 13, 2024@11:17:13
9999999.65;+33279,+33278,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.65;+33280,+33278,;.01~MAR 13, 2024@11:18:54
9999999.65;+33281,+33278,;.01~APR 04, 2024@13:40:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33279^1
33280^2
33281^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: GEMCITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33277</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2650929014</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33277,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: GEMCITABINE
9999999.64;+33277,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33277,;.08~YES
9999999.64;+33277,;.1~FACTOR
9999999.64;+33277,;100~NATIONAL
9999999.64;+33277,;101~VHA ONCOLOGY
9999999.64;+33277,;200~BRCA Stage IV ER- <2 prior chemo received gemcitabine
9999999.64;+33277,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway gemcitabine
9999999.65;+33278,+33277,;.01~MAR 13, 2024@11:14:18
9999999.65;+33278,+33277,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.65;+33279,+33277,;.01~MAR 13, 2024@11:15:22
9999999.65;+33280,+33277,;.01~APR 04, 2024@13:40:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33278^1
33279^2
33280^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: ERIBULIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33276</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1263221163</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33276,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: ERIBULIN
9999999.64;+33276,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33276,;.08~YES
9999999.64;+33276,;.1~FACTOR
9999999.64;+33276,;100~NATIONAL
9999999.64;+33276,;101~VHA ONCOLOGY
9999999.64;+33276,;200~BRCA Stage IV ER- <2 prior chemo received eribulin
9999999.64;+33276,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway eribulin
9999999.65;+33277,+33276,;.01~MAR 13, 2024@11:11:13
9999999.65;+33277,+33276,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.65;+33278,+33276,;.01~MAR 13, 2024@11:12:19
9999999.65;+33279,+33276,;.01~APR 04, 2024@13:39:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33277^1
33278^2
33279^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: CARBOPLATIN </POINT_01>
<INTERNAL_ENTRY_NUMBER>33275</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2262026052</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33275,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: CARBOPLATIN 
9999999.64;+33275,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33275,;.08~YES
9999999.64;+33275,;.1~FACTOR
9999999.64;+33275,;100~NATIONAL
9999999.64;+33275,;101~VHA ONCOLOGY
9999999.64;+33275,;200~BRCA Stage IV ER- <2 prior chemo received carboplatin
9999999.64;+33275,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway carboplatin
9999999.65;+33276,+33275,;.01~MAR 13, 2024@11:07:51
9999999.65;+33276,+33275,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.65;+33277,+33275,;.01~MAR 13, 2024@11:09
9999999.65;+33278,+33275,;.01~APR 04, 2024@13:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33276^1
33277^2
33278^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: CAPECITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33274</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1656190552</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33274,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: CAPECITABINE
9999999.64;+33274,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33274,;.08~YES
9999999.64;+33274,;.1~FACTOR
9999999.64;+33274,;100~NATIONAL
9999999.64;+33274,;101~VHA ONCOLOGY
9999999.64;+33274,;200~BRCA Stage IV ER- <2 prior chemo received capecitabine
9999999.64;+33274,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway capecitabine
9999999.65;+33275,+33274,;.01~MAR 13, 2024@11:04:45
9999999.65;+33275,+33274,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.65;+33276,+33274,;.01~MAR 13, 2024@11:07:32
9999999.65;+33277,+33274,;.01~APR 04, 2024@13:38:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33275^1
33276^2
33277^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO: PACLITAXEL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33273</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2275960547</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33273,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO: PACLITAXEL
9999999.64;+33273,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33273,;.08~YES
9999999.64;+33273,;.1~FACTOR
9999999.64;+33273,;100~NATIONAL
9999999.64;+33273,;101~VHA ONCOLOGY
9999999.64;+33273,;200~BRCA Stage IV ER- <2 prior chemo received paclitaxel
9999999.64;+33273,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway paclitaxel
9999999.65;+33274,+33273,;.01~MAR 13, 2024@10:57:01
9999999.65;+33274,+33273,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- <2 PRIOR CHEMO CLIN TRIAL
9999999.65;+33275,+33273,;.01~MAR 13, 2024@11:00:11
9999999.65;+33276,+33273,;.01~MAR 13, 2024@11:02:03
9999999.65;+33277,+33273,;.01~APR 04, 2024@13:41:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33274^1
33275^2
33276^3
33277^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &lt;2 PRIOR CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33272</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>357162021</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33272,;.01~VA-ONC BRCA IV ER- <2 PRIOR CHEMO CLIN TRIAL
9999999.64;+33272,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33272,;.08~YES
9999999.64;+33272,;.1~FACTOR
9999999.64;+33272,;100~NATIONAL
9999999.64;+33272,;101~VHA ONCOLOGY
9999999.64;+33272,;200~BRCA Stage IV ER- <2 prior chemo received clinical trial
9999999.64;+33272,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; less than 2 lines of
chemotherapy received, on pathway clinical trial
9999999.65;+33273,+33272,;.01~MAR 13, 2024@10:54:04
9999999.65;+33273,+33272,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: CARBOPLATIN
9999999.65;+33274,+33272,;.01~MAR 13, 2024@10:56:09
9999999.65;+33275,+33272,;.01~MAR 13, 2024@11:01:30
9999999.65;+33276,+33272,;.01~APR 04, 2024@13:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33273^1
33274^2
33275^3
33276^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: PEMBROLIZUMAB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33271</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>883238705</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33271,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: PEMBROLIZUMAB
9999999.64;+33271,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33271,;.08~YES
9999999.64;+33271,;.1~FACTOR
9999999.64;+33271,;100~NATIONAL
9999999.64;+33271,;101~VHA ONCOLOGY
9999999.64;+33271,;200~BRCA Stage IV ER->= 2 prior chemo rec sacituzumab+pembrolizumab
9999999.64;+33271,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then pembrolizumab
9999999.65;+33272,+33271,;.01~MAR 13, 2024@10:48:34
9999999.65;+33272,+33271,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: VINORELBINE
9999999.65;+33273,+33271,;.01~MAR 13, 2024@10:51:29
9999999.65;+33274,+33271,;.01~APR 04, 2024@13:33:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33272^1
33273^2
33274^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: VINORELBINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33270</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3016425026</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33270,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: VINORELBINE
9999999.64;+33270,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33270,;.08~YES
9999999.64;+33270,;.1~FACTOR
9999999.64;+33270,;100~NATIONAL
9999999.64;+33270,;101~VHA ONCOLOGY
9999999.64;+33270,;200~BRCA Stage IV ER->= 2 prior chemo rec sacituzumab+vinorelbine
9999999.64;+33270,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then vinorelbine
9999999.65;+33271,+33270,;.01~MAR 13, 2024@10:46:58
9999999.65;+33271,+33270,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL
9999999.65;+33272,+33270,;.01~MAR 13, 2024@10:48:19
9999999.65;+33273,+33270,;.01~APR 04, 2024@13:34:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33271^1
33272^2
33273^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: LIPO DOXORUBICIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33269</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>756680867</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33269,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: LIPO DOXORUBICIN
9999999.64;+33269,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33269,;.08~YES
9999999.64;+33269,;.1~FACTOR
9999999.64;+33269,;100~NATIONAL
9999999.64;+33269,;101~VHA ONCOLOGY
9999999.64;+33269,;200~BRCA Stage IV ER->= 2 prior chemo rec sacituzumab+lip doxo
9999999.64;+33269,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then liposomal doxorubicin
9999999.65;+33270,+33269,;.01~MAR 13, 2024@10:41:11
9999999.65;+33270,+33269,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL
9999999.65;+33271,+33269,;.01~MAR 13, 2024@10:45:13
9999999.65;+33272,+33269,;.01~APR 04, 2024@13:32:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33270^1
33271^2
33272^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: GEMCITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33268</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3381234216</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33268,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: GEMCITABINE
9999999.64;+33268,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33268,;.08~YES
9999999.64;+33268,;.1~FACTOR
9999999.64;+33268,;100~NATIONAL
9999999.64;+33268,;101~VHA ONCOLOGY
9999999.64;+33268,;200~BRCA Stage IV ER->= 2 prior chemo rec sacituzumab+gemcitabine
9999999.64;+33268,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then gemcitabine
9999999.65;+33269,+33268,;.01~MAR 13, 2024@10:38:34
9999999.65;+33269,+33268,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL
9999999.65;+33270,+33268,;.01~MAR 13, 2024@10:39:34
9999999.65;+33271,+33268,;.01~APR 04, 2024@13:31:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33269^1
33270^2
33271^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: ERIBULIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33267</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2989881589</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33267,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: ERIBULIN
9999999.64;+33267,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33267,;.08~YES
9999999.64;+33267,;.1~FACTOR
9999999.64;+33267,;100~NATIONAL
9999999.64;+33267,;101~VHA ONCOLOGY
9999999.64;+33267,;200~BRCA Stage IV ER->= 2 prior chemo rec sacituzumab+eribulin
9999999.64;+33267,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then eribulin
9999999.65;+33268,+33267,;.01~MAR 13, 2024@10:37:17
9999999.65;+33268,+33267,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL
9999999.65;+33269,+33267,;.01~MAR 13, 2024@10:38:05
9999999.65;+33270,+33267,;.01~APR 04, 2024@13:31:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33268^1
33269^2
33270^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: CARBOPLATIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33266</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4289480806</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33266,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: CARBOPLATIN
9999999.64;+33266,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33266,;.08~YES
9999999.64;+33266,;.1~FACTOR
9999999.64;+33266,;100~NATIONAL
9999999.64;+33266,;101~VHA ONCOLOGY
9999999.64;+33266,;200~BRCA Stage IV ER- >= 2 prior chemo rec sacituzumab+carboplatin
9999999.64;+33266,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then carboplatin
9999999.65;+33267,+33266,;.01~MAR 13, 2024@09:57:32
9999999.65;+33267,+33266,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: CAPECITABINE
9999999.65;+33268,+33266,;.01~MAR 13, 2024@09:58:59
9999999.65;+33269,+33266,;.01~APR 04, 2024@13:30:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33267^1
33268^2
33269^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: CAPECITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33265</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>460286234</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33265,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: CAPECITABINE
9999999.64;+33265,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33265,;.08~YES
9999999.64;+33265,;.1~FACTOR
9999999.64;+33265,;100~NATIONAL
9999999.64;+33265,;101~VHA ONCOLOGY
9999999.64;+33265,;200~BRCA Stage IV ER- >= 2 prior chemo rec sacituzumab+capecitabine
9999999.64;+33265,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then capecitabine
9999999.65;+33266,+33265,;.01~MAR 13, 2024@09:54:28
9999999.65;+33266,+33265,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL
9999999.65;+33267,+33265,;.01~MAR 13, 2024@09:56:18
9999999.65;+33268,+33265,;.01~APR 04, 2024@13:29:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33266^1
33267^2
33268^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33264</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2287545651</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33264,;.01~VA-ONC BRCA IV ER- PRIOR CHEMO: PACLITAXEL
9999999.64;+33264,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33264,;.08~YES
9999999.64;+33264,;.1~FACTOR
9999999.64;+33264,;100~NATIONAL
9999999.64;+33264,;101~VHA ONCOLOGY
9999999.64;+33264,;200~BRCA Stage IV ER->= 2 prior chemo rec sacituzumab+paclitaxel
9999999.64;+33264,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab then paclitaxel
9999999.65;+33265,+33264,;.01~MAR 13, 2024@09:43:15
9999999.65;+33265,+33264,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- >=2 PRIOR CHEMO SACITUZUMAB
9999999.65;+33266,+33264,;.01~MAR 13, 2024@09:46:27
9999999.65;+33267,+33264,;.01~APR 04, 2024@13:33:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33265^1
33266^2
33267^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &gt;=2 PRIOR CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33263</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3496082564</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33263,;.01~VA-ONC BRCA IV ER- >=2 PRIOR CHEMO OFF PATH RSN
9999999.64;+33263,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33263,;.08~YES
9999999.64;+33263,;.1~FACTOR
9999999.64;+33263,;100~NATIONAL
9999999.64;+33263,;101~VHA ONCOLOGY
9999999.64;+33263,;200~BRCA Stage IV ER- >= 2 prior chemo received off path reason
9999999.64;+33263,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, off pathway reason
9999999.65;+33264,+33263,;.01~MAR 13, 2024@09:37
9999999.65;+33264,+33263,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- >=2 PRIOR CHEMO OFF PATH TX
9999999.65;+33265,+33263,;.01~MAR 13, 2024@09:37:51
9999999.65;+33266,+33263,;.01~APR 04, 2024@13:27:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33264^1
33265^2
33266^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &gt;=2 PRIOR CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33262</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3957649507</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33262,;.01~VA-ONC BRCA IV ER- >=2 PRIOR CHEMO OFF PATH TX
9999999.64;+33262,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33262,;.08~YES
9999999.64;+33262,;.1~FACTOR
9999999.64;+33262,;100~NATIONAL
9999999.64;+33262,;101~VHA ONCOLOGY
9999999.64;+33262,;200~BRCA Stage IV ER- >= 2 prior chemo received off path treatment
9999999.64;+33262,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, off pathway treatment
9999999.65;+33263,+33262,;.01~MAR 13, 2024@09:34:47
9999999.65;+33263,+33262,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- >=2 PRIOR CHEMO CLIN TRIAL
9999999.65;+33264,+33262,;.01~MAR 13, 2024@09:36:18
9999999.65;+33265,+33262,;.01~APR 04, 2024@13:27:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33263^1
33264^2
33265^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &gt;=2 PRIOR CHEMO SACITUZUMAB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33261</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1186422513</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33261,;.01~VA-ONC BRCA IV ER- >=2 PRIOR CHEMO SACITUZUMAB
9999999.64;+33261,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33261,;.08~YES
9999999.64;+33261,;.1~FACTOR
9999999.64;+33261,;100~NATIONAL
9999999.64;+33261,;101~VHA ONCOLOGY
9999999.64;+33261,;200~BRCA Stage IV ER- >= 2 prior chemo received sacituzumab
9999999.64;+33261,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway sacituzumab
9999999.65;+33262,+33261,;.01~MAR 13, 2024@09:32:31
9999999.65;+33262,+33261,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- >=2 PRIOR CHEMO CLIN TRIAL
9999999.65;+33263,+33261,;.01~MAR 13, 2024@09:33:59
9999999.65;+33264,+33261,;.01~APR 04, 2024@13:28:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33262^1
33263^2
33264^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- &gt;=2 PRIOR CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33260</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>982001367</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33260,;.01~VA-ONC BRCA IV ER- >=2 PRIOR CHEMO CLIN TRIAL
9999999.64;+33260,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33260,;.08~YES
9999999.64;+33260,;.1~FACTOR
9999999.64;+33260,;100~NATIONAL
9999999.64;+33260,;101~VHA ONCOLOGY
9999999.64;+33260,;200~BRCA Stage IV ER- >= 2 prior chemo received clinical trial
9999999.64;+33260,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; 2 or more prior lines of
chemotherapy received, on pathway clinical trial
9999999.65;+33261,+33260,;.01~MAR 13, 2024@09:25:35
9999999.65;+33261,+33260,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- CHEMO HER2 LOW CLIN TRIAL
9999999.65;+33262,+33260,;.01~MAR 13, 2024@09:31:22
9999999.65;+33263,+33260,;.01~APR 04, 2024@13:26:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33261^1
33262^2
33263^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- CHEMO HER2 LOW OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33259</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3361291031</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33259,;.01~VA-ONC BRCA IV ER- CHEMO HER2 LOW OFF PATH RSN
9999999.64;+33259,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33259,;.08~YES
9999999.64;+33259,;.1~FACTOR
9999999.64;+33259,;100~NATIONAL
9999999.64;+33259,;101~VHA ONCOLOGY
9999999.64;+33259,;200~BRCA Stage IV ER- HER2 low yes off path reason
9999999.64;+33259,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; HER2 low (IHC 1+ or 2+) and
received one or more prior line of chemotherapy, off pathway reason
9999999.65;+33260,+33259,;.01~MAR 13, 2024@09:18:51
9999999.65;+33260,+33259,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- CHEMO HER2 LOW OFF PATH TX
9999999.65;+33261,+33259,;.01~MAR 13, 2024@09:19:51
9999999.65;+33262,+33259,;.01~APR 04, 2024@13:23:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33260^1
33261^2
33262^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- CHEMO HER2 LOW OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33258</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1455371996</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33258,;.01~VA-ONC BRCA IV ER- CHEMO HER2 LOW OFF PATH TX
9999999.64;+33258,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33258,;.08~YES
9999999.64;+33258,;.1~FACTOR
9999999.64;+33258,;100~NATIONAL
9999999.64;+33258,;101~VHA ONCOLOGY
9999999.64;+33258,;200~BRCA Stage IV ER- HER2 low yes off path treatment
9999999.64;+33258,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; HER2 low (IHC 1+ or 2+) and
received one or more prior line of chemotherapy, off pathway treatment
9999999.65;+33259,+33258,;.01~MAR 13, 2024@09:12:17
9999999.65;+33259,+33258,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- CHEMO HER2 LOW CLIN TRIAL
9999999.65;+33260,+33258,;.01~MAR 13, 2024@09:16:06
9999999.65;+33261,+33258,;.01~APR 04, 2024@13:23:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33259^1
33260^2
33261^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- CHEMO HER2 LOW FAM-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33257</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>147535076</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33257,;.01~VA-ONC BRCA IV ER- CHEMO HER2 LOW FAM-TRAS
9999999.64;+33257,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33257,;.08~YES
9999999.64;+33257,;.1~FACTOR
9999999.64;+33257,;100~NATIONAL
9999999.64;+33257,;101~VHA ONCOLOGY
9999999.64;+33257,;200~BRCA Stage IV ER- HER2 low yes fam-trastuzumab deruxtecan
9999999.64;+33257,;201~WP-start~3
Breast Cancer-Stage IV ER-/PR-/HER2-; HER2 low (IHC 1+ or 2+) and 
received one or more prior line of chemotherapy, on pathway 
fam-trastuzumab deruxtecan
9999999.65;+33258,+33257,;.01~MAR 13, 2024@09:06:03
9999999.65;+33258,+33257,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- CHEMO HER2 LOW CLIN TRIAL
9999999.65;+33259,+33257,;.01~MAR 13, 2024@09:08:40
9999999.65;+33260,+33257,;.01~APR 04, 2024@13:23:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33258^1
33259^2
33260^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- CHEMO HER2 LOW CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33256</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3533725485</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33256,;.01~VA-ONC BRCA IV ER- CHEMO HER2 LOW CLIN TRIAL
9999999.64;+33256,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33256,;.08~YES
9999999.64;+33256,;.1~FACTOR
9999999.64;+33256,;100~NATIONAL
9999999.64;+33256,;101~VHA ONCOLOGY
9999999.64;+33256,;200~BRCA Stage IV ER- HER2 low yes clinical trial
9999999.64;+33256,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; HER2 low (IHC 1+ or 2+) and
received one or more prior line of chemotherapy, on pathway clinical trial
9999999.65;+33257,+33256,;.01~MAR 13, 2024@08:58:58
9999999.65;+33257,+33256,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GERMLINE NO CLIN TRIAL
9999999.65;+33258,+33256,;.01~MAR 13, 2024@09:03:58
9999999.65;+33259,+33256,;.01~MAR 13, 2024@09:11:36
9999999.65;+33260,+33256,;.01~APR 04, 2024@13:22:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33257^1
33258^2
33259^3
33260^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33255</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2532607149</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33255,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO OFF PATH RSN
9999999.64;+33255,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33255,;.08~YES
9999999.64;+33255,;.1~FACTOR
9999999.64;+33255,;100~NATIONAL
9999999.64;+33255,;101~VHA ONCOLOGY
9999999.64;+33255,;200~BRCA Stage IV ER- germline yes prior chemo rec no off path rsn
9999999.64;+33255,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, no prior chemotherapy received, off pathway reason
9999999.65;+33256,+33255,;.01~MAR 13, 2024@08:10:13
9999999.65;+33256,+33255,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO OFF PATH TX
9999999.65;+33257,+33255,;.01~MAR 13, 2024@08:11:10
9999999.65;+33258,+33255,;.01~APR 04, 2024@12:47:22
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33256^1
33257^2
33258^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33254</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2632111039</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33254,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO OFF PATH TX
9999999.64;+33254,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33254,;.08~YES
9999999.64;+33254,;.1~FACTOR
9999999.64;+33254,;100~NATIONAL
9999999.64;+33254,;101~VHA ONCOLOGY
9999999.64;+33254,;200~BRCA Stage IV ER- germline yes prior chemo rec no off path tx
9999999.64;+33254,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, no prior chemotherapy received, off pathway treatment
9999999.65;+33255,+33254,;.01~MAR 13, 2024@08:06:58
9999999.65;+33255,+33254,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO CLIN TRIAL
9999999.65;+33256,+33254,;.01~MAR 13, 2024@08:08:48
9999999.65;+33257,+33254,;.01~APR 04, 2024@12:48:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33255^1
33256^2
33257^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO CARB+GEM+OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33253</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1172549541</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33253,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO CARB+GEM+OLAP
9999999.64;+33253,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33253,;.08~YES
9999999.64;+33253,;.1~FACTOR
9999999.64;+33253,;100~NATIONAL
9999999.64;+33253,;101~VHA ONCOLOGY
9999999.64;+33253,;200~BRCA Stage IV ER- germline yes prior chemo rec no carb+gem+olap
9999999.64;+33253,;201~WP-start~3
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, no prior chemotherapy received, on pathway carboplatin and 
gemcitabine then olaparib
9999999.65;+33254,+33253,;.01~MAR 13, 2024@08:02:05
9999999.65;+33254,+33253,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO CLIN TRIAL
9999999.65;+33255,+33253,;.01~MAR 13, 2024@08:06:17
9999999.65;+33256,+33253,;.01~APR 04, 2024@12:46:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33254^1
33255^2
33256^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33252</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>557297876</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33252,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO NO CLIN TRIAL
9999999.64;+33252,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33252,;.08~YES
9999999.64;+33252,;.1~FACTOR
9999999.64;+33252,;100~NATIONAL
9999999.64;+33252,;101~VHA ONCOLOGY
9999999.64;+33252,;200~BRCA Stage IV ER- germline yes prior chemo rec no clin trial
9999999.64;+33252,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, no prior chemotherapy received, on pathway clinical trial
9999999.65;+33253,+33252,;.01~MAR 13, 2024@07:59:13
9999999.65;+33253,+33252,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO CLIN TRIAL
9999999.65;+33254,+33252,;.01~MAR 13, 2024@08:00:51
9999999.65;+33255,+33252,;.01~APR 04, 2024@12:46:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33253^1
33254^2
33255^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33251</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4173645836</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33251,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OFF PATH RSN
9999999.64;+33251,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33251,;.08~YES
9999999.64;+33251,;.1~FACTOR
9999999.64;+33251,;100~NATIONAL
9999999.64;+33251,;101~VHA ONCOLOGY
9999999.64;+33251,;200~BRCA Stage IV ER- germline yes prior chemo rec off path rsn
9999999.64;+33251,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, prior chemotherapy received, off pathway reason
9999999.65;+33252,+33251,;.01~MAR 13, 2024@07:51:36
9999999.65;+33252,+33251,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OFF PATH TX
9999999.65;+33253,+33251,;.01~MAR 13, 2024@07:53:07
9999999.65;+33254,+33251,;.01~APR 04, 2024@12:49:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33252^1
33253^2
33254^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33250</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>673503095</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33250,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OFF PATH TX
9999999.64;+33250,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33250,;.08~YES
9999999.64;+33250,;.1~FACTOR
9999999.64;+33250,;100~NATIONAL
9999999.64;+33250,;101~VHA ONCOLOGY
9999999.64;+33250,;200~BRCA Stage IV ER- germline yes prior chemo rec off path tx
9999999.64;+33250,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, prior chemotherapy received, off pathway treatment
9999999.65;+33251,+33250,;.01~MAR 13, 2024@07:49:29
9999999.65;+33251,+33250,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OLAP
9999999.65;+33252,+33250,;.01~MAR 13, 2024@07:50:36
9999999.65;+33253,+33250,;.01~APR 04, 2024@12:49:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33251^1
33252^2
33253^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33249</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1214290571</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33249,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO OLAP
9999999.64;+33249,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33249,;.08~YES
9999999.64;+33249,;.1~FACTOR
9999999.64;+33249,;100~NATIONAL
9999999.64;+33249,;101~VHA ONCOLOGY
9999999.64;+33249,;200~BRCA Stage IV ER- germline yes prior chemo rec Olaparib
9999999.64;+33249,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, prior chemotherapy received, on pathway olaparib
9999999.65;+33250,+33249,;.01~MAR 13, 2024@07:47:04
9999999.65;+33250,+33249,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GL YES PRIOR CHEMO CLIN TRIAL
9999999.65;+33251,+33249,;.01~MAR 13, 2024@07:48:30
9999999.65;+33252,+33249,;.01~APR 04, 2024@12:50:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33250^1
33251^2
33252^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GERMLINE NO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33248</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1361127532</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33248,;.01~VA-ONC BRCA IV ER- GERMLINE NO OFF PATH RSN
9999999.64;+33248,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33248,;.08~YES
9999999.64;+33248,;.1~FACTOR
9999999.64;+33248,;100~NATIONAL
9999999.64;+33248,;101~VHA ONCOLOGY
9999999.64;+33248,;200~BRCA Stage IV ER- germline no off path reason
9999999.64;+33248,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic BRCA1/2,
or germline PV in PALB2 no, off pathway reason
9999999.65;+33249,+33248,;.01~MAR 13, 2024@07:37:35
9999999.65;+33249,+33248,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GERMLINE NO OFF PATH TX
9999999.65;+33250,+33248,;.01~MAR 13, 2024@07:39:19
9999999.65;+33251,+33248,;.01~APR 04, 2024@12:52:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33249^1
33250^2
33251^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GERMLINE NO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33247</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>345036291</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33247,;.01~VA-ONC BRCA IV ER- GERMLINE NO OFF PATH TX
9999999.64;+33247,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33247,;.08~YES
9999999.64;+33247,;.1~FACTOR
9999999.64;+33247,;100~NATIONAL
9999999.64;+33247,;101~VHA ONCOLOGY
9999999.64;+33247,;200~BRCA Stage IV ER- germline no off path treatment
9999999.64;+33247,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic BRCA1/2,
or germline PV in PALB2 no, off pathway treatment
9999999.65;+33248,+33247,;.01~MAR 13, 2024@07:35:41
9999999.65;+33248,+33247,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GERMLINE NO CLIN TRIAL
9999999.65;+33249,+33247,;.01~MAR 13, 2024@07:36:50
9999999.65;+33250,+33247,;.01~APR 04, 2024@12:52:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33248^1
33249^2
33250^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GERMLINE NO PACLITAXEL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33246</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2376020322</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33246,;.01~VA-ONC BRCA IV ER- GERMLINE NO PACLITAXEL
9999999.64;+33246,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33246,;.08~YES
9999999.64;+33246,;.1~FACTOR
9999999.64;+33246,;100~NATIONAL
9999999.64;+33246,;101~VHA ONCOLOGY
9999999.64;+33246,;200~BRCA Stage IV ER- germline no Paclitaxel
9999999.64;+33246,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic BRCA1/2,
or germline PV in PALB2 no, on pathway paclitaxel
9999999.65;+33247,+33246,;.01~MAR 13, 2024@07:33:15
9999999.65;+33247,+33246,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- GERMLINE NO CLIN TRIAL
9999999.65;+33248,+33246,;.01~MAR 13, 2024@07:35:01
9999999.65;+33249,+33246,;.01~APR 04, 2024@12:53:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33247^1
33248^2
33249^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GERMLINE NO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33245</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2256966877</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33245,;.01~VA-ONC BRCA IV ER- GERMLINE NO CLIN TRIAL
9999999.64;+33245,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33245,;.08~YES
9999999.64;+33245,;.1~FACTOR
9999999.64;+33245,;100~NATIONAL
9999999.64;+33245,;101~VHA ONCOLOGY
9999999.64;+33245,;200~BRCA Stage IV ER- germline no clinical trial
9999999.64;+33245,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic BRCA1/2,
or germline PV in PALB2 no, on pathway clinical trial
9999999.65;+33246,+33245,;.01~MAR 12, 2024@13:40:48
9999999.65;+33246,+33245,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PDL1 >= 10 YES
9999999.65;+33247,+33245,;.01~MAR 12, 2024@13:43:06
9999999.65;+33248,+33245,;.01~MAR 12, 2024@14:03:11
9999999.65;+33249,+33245,;.01~MAR 13, 2024@07:32:30
9999999.65;+33250,+33245,;.01~APR 04, 2024@12:51:40
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33246^1
33247^2
33248^3
33249^4
33250^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- GL YES PRIOR CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33244</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4269415138</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33244,;.01~VA-ONC BRCA IV ER- GL YES PRIOR CHEMO CLIN TRIAL
9999999.64;+33244,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33244,;.08~YES
9999999.64;+33244,;.1~FACTOR
9999999.64;+33244,;100~NATIONAL
9999999.64;+33244,;101~VHA ONCOLOGY
9999999.64;+33244,;200~BRCA Stage IV ER- germline yes prior chemo rec clin trial
9999999.64;+33244,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; germline BRCA1/2 PV, somatic 
BRCA1/2 yes, prior chemotherapy received, on pathway clinical trial
9999999.65;+33245,+33244,;.01~MAR 12, 2024@13:36:52
9999999.65;+33245,+33244,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PDL1 >= 10 CLIN TRIAL
9999999.65;+33246,+33244,;.01~MAR 12, 2024@13:39:08
9999999.65;+33247,+33244,;.01~MAR 12, 2024@13:45:09
9999999.65;+33248,+33244,;.01~MAR 13, 2024@07:29:31
9999999.65;+33249,+33244,;.01~APR 04, 2024@12:45:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33245^1
33246^2
33247^3
33248^4
33249^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PDL1 &gt;= 10 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33243</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4077789219</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33243,;.01~VA-ONC BRCA IV ER- PDL1 >= 10 OFF PATH RSN
9999999.64;+33243,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33243,;.08~YES
9999999.64;+33243,;.1~FACTOR
9999999.64;+33243,;100~NATIONAL
9999999.64;+33243,;101~VHA ONCOLOGY
9999999.64;+33243,;200~BRCA Stage IV ER- PDL1 by CPS >= 10 off path reason
9999999.64;+33243,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; PD-L1 CPS >= 10, off pathway 
reason
9999999.65;+33244,+33243,;.01~MAR 12, 2024@13:28:47
9999999.65;+33244,+33243,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PDL1 >= 10 OFF PATH TX
9999999.65;+33245,+33243,;.01~MAR 12, 2024@13:29:47
9999999.65;+33246,+33243,;.01~APR 04, 2024@12:41:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33244^1
33245^2
33246^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PDL1 &gt;= 10 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33242</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>222776324</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33242,;.01~VA-ONC BRCA IV ER- PDL1 >= 10 OFF PATH TX
9999999.64;+33242,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33242,;.08~YES
9999999.64;+33242,;.1~FACTOR
9999999.64;+33242,;100~NATIONAL
9999999.64;+33242,;101~VHA ONCOLOGY
9999999.64;+33242,;200~BRCA Stage IV ER- PDL1 by CPS >= 10 off path treatment
9999999.64;+33242,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; PD-L1 CPS >= 10, off pathway 
treatment
9999999.65;+33243,+33242,;.01~MAR 12, 2024@13:27:07
9999999.65;+33243,+33242,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PDL1 >= 10 CLIN TRIAL
9999999.65;+33244,+33242,;.01~MAR 12, 2024@13:28:27
9999999.65;+33245,+33242,;.01~MAR 12, 2024@13:30:56
9999999.65;+33246,+33242,;.01~APR 04, 2024@12:42:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33243^1
33244^2
33245^3
33246^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PDL1 &gt;= 10 PEMB+CARB+GEM</POINT_01>
<INTERNAL_ENTRY_NUMBER>33241</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2279070900</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33241,;.01~VA-ONC BRCA IV ER- PDL1 >= 10 PEMB+CARB+GEM
9999999.64;+33241,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33241,;.08~YES
9999999.64;+33241,;.1~FACTOR
9999999.64;+33241,;100~NATIONAL
9999999.64;+33241,;101~VHA ONCOLOGY
9999999.64;+33241,;200~BRCA Stage IV ER- PDL1 by CPS >= 10 pembrolizumab+carb+gem
9999999.64;+33241,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; PD-L1 CPS >= 10, on pathway
pembrolizumab, carboplatin, and gemcitabine
9999999.65;+33242,+33241,;.01~MAR 12, 2024@13:18:28
9999999.65;+33242,+33241,;2~WP-start~1
Copied from VA-ONC BRCA IV ER- PDL1 >= 10 CLINC TRIAL
9999999.65;+33243,+33241,;.01~MAR 12, 2024@13:20:30
9999999.65;+33244,+33241,;.01~MAR 12, 2024@13:31:19
9999999.65;+33245,+33241,;.01~APR 04, 2024@12:42:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33242^1
33243^2
33244^3
33245^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER- PDL1 &gt;= 10 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33240</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3276560705</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33240,;.01~VA-ONC BRCA IV ER- PDL1 >= 10 CLIN TRIAL
9999999.64;+33240,;.03~VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
9999999.64;+33240,;.08~YES
9999999.64;+33240,;.1~FACTOR
9999999.64;+33240,;100~NATIONAL
9999999.64;+33240,;101~VHA ONCOLOGY
9999999.64;+33240,;200~BRCA Stage IV ER- PDL1 by CPS >= 10 clin trial
9999999.64;+33240,;201~WP-start~2
Breast Cancer-Stage IV ER-/PR-/HER2-; PD-L1 CPS >= 10, on pathway
clinical trial
9999999.65;+33241,+33240,;.01~MAR 12, 2024@12:25:56
9999999.65;+33241,+33240,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
9999999.65;+33242,+33240,;.01~MAR 12, 2024@12:30:40
9999999.65;+33243,+33240,;.01~MAR 12, 2024@13:22:31
9999999.65;+33244,+33240,;.01~MAR 12, 2024@13:30:28
9999999.65;+33245,+33240,;.01~APR 04, 2024@12:39:50
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33241^1
33242^2
33243^3
33244^4
33245^5
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO TRAS+VINO</POINT_01>
<INTERNAL_ENTRY_NUMBER>33227</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>512849730</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33227,;.01~VA-ONC BRCA IV ANY ER CHEMO TRAS+VINO
9999999.64;+33227,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33227,;.08~YES
9999999.64;+33227,;.1~FACTOR
9999999.64;+33227,;100~NATIONAL
9999999.64;+33227,;101~VHA ONCOLOGY
9999999.64;+33227,;200~BRCA Stage IV Any ER chemo cand after tras trastuzumab+vino
9999999.64;+33227,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; chemotherapy candidate after 
adjuvant trastuzumab, on pathway trastuzumab and vinorelbine
9999999.65;+33228,+33227,;.01~MAR 12, 2024@07:46:01
9999999.65;+33228,+33227,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
9999999.65;+33229,+33227,;.01~MAR 12, 2024@07:48:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33228^1
33229^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS ADO-TRAS+TUC+TRAS+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33222</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>831061792</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33222,;.01~VA-ONC BRCA IV ANY ER NO METS ADO-TRAS+TUC+TRAS+CAP
9999999.64;+33222,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33222,;.08~YES
9999999.64;+33222,;.1~FACTOR
9999999.64;+33222,;100~NATIONAL
9999999.64;+33222,;101~VHA ONCOLOGY
9999999.64;+33222,;200~BRCA Stage IV Any ER No Brain Mets s/p fam-tras ado+tuc+tras+cap
9999999.64;+33222,;201~WP-start~3
Breast Cancer-Stage IV Any ER/PR/HER2+; no brain metastases after 
fam-trastuzumab deruxtecan, on pathway ado-trastuzumab followed by 
tucatinib, trastuzumab, and capecitabine
9999999.65;+33223,+33222,;.01~MAR 12, 2024@07:15:05
9999999.65;+33223,+33222,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL
9999999.65;+33224,+33222,;.01~MAR 12, 2024@07:17:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33223^1
33224^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS TUC+TRAS+CAP+ADO</POINT_01>
<INTERNAL_ENTRY_NUMBER>33218</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3882621636</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33218,;.01~VA-ONC BRCA IV ANY ER METS TUC+TRAS+CAP+ADO
9999999.64;+33218,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33218,;.08~YES
9999999.64;+33218,;.1~FACTOR
9999999.64;+33218,;100~NATIONAL
9999999.64;+33218,;101~VHA ONCOLOGY
9999999.64;+33218,;200~BRCA Stage IV Any ER Brain Mets after fam-tras tuc+trast+cap+ado
9999999.64;+33218,;201~WP-start~3
Breast Cancer-Stage IV Any ER/PR/HER2+; Brain metastases after 
fam-trastuzumab deruxtecan, on pathway tucatinib, trastuzumab, and 
capecitabine followed by ado-trastuzumab emtansine
9999999.65;+33219,+33218,;.01~MAR 12, 2024@06:39:50
9999999.65;+33219,+33218,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER METS CLIN TRIAL
9999999.65;+33220,+33218,;.01~MAR 12, 2024@06:42:16
9999999.65;+33221,+33218,;.01~MAR 12, 2024@06:46:41
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33219^1
33220^2
33221^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &gt; 12M TAX OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33216</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1541777387</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33216,;.01~VA-ONC BRCA IV ANY ER > 12M TAX OFF PATH RSN
9999999.64;+33216,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33216,;.08~YES
9999999.64;+33216,;.1~FACTOR
9999999.64;+33216,;100~NATIONAL
9999999.64;+33216,;101~VHA ONCOLOGY
9999999.64;+33216,;200~BRCA Stage IV Any ER >12Mos adj taxane received off path rsn
9999999.64;+33216,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; more than 12 months since adjuvant
taxane HER2 directed therapy received, off pathway reason
9999999.65;+33217,+33216,;.01~MAR 11, 2024@13:39:25
9999999.65;+33217,+33216,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER > 12M TAX OFF PATH TX
9999999.65;+33218,+33216,;.01~MAR 11, 2024@13:40:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33217^1
33218^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &gt; 12M TAX OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33215</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1688231979</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33215,;.01~VA-ONC BRCA IV ANY ER > 12M TAX OFF PATH TX
9999999.64;+33215,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33215,;.08~YES
9999999.64;+33215,;.1~FACTOR
9999999.64;+33215,;100~NATIONAL
9999999.64;+33215,;101~VHA ONCOLOGY
9999999.64;+33215,;200~BRCA Stage IV Any ER >12Mos adj taxane received off path tx
9999999.64;+33215,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; more than 12 months since adjuvant
taxane HER2 directed therapy received, off pathway treatment
9999999.65;+33216,+33215,;.01~MAR 11, 2024@13:38:06
9999999.65;+33216,+33215,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER > 12M TAX CLIN TRIAL
9999999.65;+33217,+33215,;.01~MAR 11, 2024@13:39:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33216^1
33217^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &gt; 12M TAX TRAS+PERT+DOCE+</POINT_01>
<INTERNAL_ENTRY_NUMBER>33214</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>146707301</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33214,;.01~VA-ONC BRCA IV ANY ER > 12M TAX TRAS+PERT+DOCE+
9999999.64;+33214,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33214,;.08~YES
9999999.64;+33214,;.1~FACTOR
9999999.64;+33214,;100~NATIONAL
9999999.64;+33214,;101~VHA ONCOLOGY
9999999.64;+33214,;200~BRCA Stage IV Any ER >12Mos adj taxane rec TRAS+PERT+DOCE+
9999999.64;+33214,;201~WP-start~4
Breast Cancer-Stage IV Any ER/PR/HER2+; more than 12 months since adjuvant
taxane HER2 directed therapy received, on pathway trastuzumab, pertuzumab,
and docetaxel (4-6 month max response) followed by maintenance trastuzumab
and pertuzumab then treatment with fam-trastuzumab deruxtecan.
9999999.65;+33215,+33214,;.01~MAR 11, 2024@13:30:17
9999999.65;+33215,+33214,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER > 12M TAX CLIN TRIAL
9999999.65;+33216,+33214,;.01~MAR 11, 2024@13:37:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33215^1
33216^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &gt; 12M TAX CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33213</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>308249832</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33213,;.01~VA-ONC BRCA IV ANY ER > 12M TAX CLIN TRIAL
9999999.64;+33213,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33213,;.08~YES
9999999.64;+33213,;.1~FACTOR
9999999.64;+33213,;100~NATIONAL
9999999.64;+33213,;101~VHA ONCOLOGY
9999999.64;+33213,;200~BRCA Stage IV Any ER >12Mos adj taxane received clinical trial
9999999.64;+33213,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; more than 12 months since adjuvant
taxane HER2 directed therapy received, on pathway clinical trial
9999999.65;+33214,+33213,;.01~MAR 11, 2024@13:24:21
9999999.65;+33214,+33213,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER < 12M TAX CLIN TRIAL
9999999.65;+33215,+33213,;.01~MAR 11, 2024@13:26:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33214^1
33215^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &lt; 12M TAX OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33212</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4275167422</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33212,;.01~VA-ONC BRCA IV ANY ER < 12M TAX OFF PATH RSN
9999999.64;+33212,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33212,;.08~YES
9999999.64;+33212,;.1~FACTOR
9999999.64;+33212,;100~NATIONAL
9999999.64;+33212,;101~VHA ONCOLOGY
9999999.64;+33212,;200~BRCA Stage IV Any ER <12Mos adj taxane received off path reason
9999999.64;+33212,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; 12 or less months since adjuvant
taxane HER2 directed therapy received, off pathway reason
9999999.65;+33213,+33212,;.01~MAR 11, 2024@12:58:28
9999999.65;+33213,+33212,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER < 12M TAX OFF PATH TX
9999999.65;+33214,+33212,;.01~MAR 11, 2024@13:01:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33213^1
33214^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &lt; 12M TAX OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33211</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2178213492</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33211,;.01~VA-ONC BRCA IV ANY ER < 12M TAX OFF PATH TX
9999999.64;+33211,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33211,;.08~YES
9999999.64;+33211,;.1~FACTOR
9999999.64;+33211,;100~NATIONAL
9999999.64;+33211,;101~VHA ONCOLOGY
9999999.64;+33211,;200~BRCA Stage IV Any ER <12Mos adj taxane received off path tx
9999999.64;+33211,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; 12 or less months since adjuvant
taxane HER2 directed therapy received, off pathway treatment
9999999.65;+33212,+33211,;.01~MAR 11, 2024@12:55:47
9999999.65;+33212,+33211,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER < 12M TAX CLIN TRIAL
9999999.65;+33213,+33211,;.01~MAR 11, 2024@12:57:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33212^1
33213^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &lt; 12M TAX FAM-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33210</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1901067375</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33210,;.01~VA-ONC BRCA IV ANY ER < 12M TAX FAM-TRAS
9999999.64;+33210,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33210,;.08~YES
9999999.64;+33210,;.1~FACTOR
9999999.64;+33210,;100~NATIONAL
9999999.64;+33210,;101~VHA ONCOLOGY
9999999.64;+33210,;200~BRCA Stage IV Any ER <12Mos adj taxane received FAM-TRAS DER
9999999.64;+33210,;201~WP-start~3
Breast Cancer-Stage IV Any ER/PR/HER2+; 12 or less months since adjuvant
taxane HER2 directed therapy received, on pathway fam-trastuzumab 
deruxtecan
9999999.65;+33211,+33210,;.01~MAR 11, 2024@12:49:36
9999999.65;+33211,+33210,;2~WP-start~1
Copied from VA-ONC BRCA IV ANY ER < 12M TAX CLIN TRIAL
9999999.65;+33212,+33210,;.01~MAR 11, 2024@12:52:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33211^1
33212^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER &lt; 12M TAX CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33209</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1604963387</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33209,;.01~VA-ONC BRCA IV ANY ER < 12M TAX CLIN TRIAL
9999999.64;+33209,;.03~VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
9999999.64;+33209,;.08~YES
9999999.64;+33209,;.1~FACTOR
9999999.64;+33209,;100~NATIONAL
9999999.64;+33209,;101~VHA ONCOLOGY
9999999.64;+33209,;200~BRCA Stage IV Any ER <12Mos adj taxane received clinical trial
9999999.64;+33209,;201~WP-start~2
Breast Cancer-Stage IV Any ER/PR/HER2+; 12 or less months since adjuvant
taxane HER2 directed therapy received, on pathway clinical trial
9999999.65;+33210,+33209,;.01~MAR 11, 2024@12:42:41
9999999.65;+33210,+33209,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR CLIN TRIAL
9999999.65;+33211,+33209,;.01~MAR 11, 2024@12:46:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33210^1
33211^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33107</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>623880368</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33107,;.01~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33107,;.08~YES
9999999.64;+33107,;.1~CATEGORY
9999999.64;+33107,;100~NATIONAL
9999999.64;+33107,;101~VHA ONCOLOGY
9999999.64;+33107,;200~Breast Cancer-Stage IV ER+ or PR+/HER2- Clinical Pathway
9999999.64;+33107,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage IV ER+ or PR+/HER2-
Clinical Pathway
9999999.65;+33108,+33107,;.01~MAR 05, 2024@12:51:32
9999999.65;+33108,+33107,;2~WP-start~1
Copied from VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY
9999999.65;+33109,+33107,;.01~MAR 05, 2024@12:53:28
9999999.65;+33110,+33107,;.01~DEC 03, 2024@13:59:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33108^1
33109^2
33110^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR ANAS+RIBO+OS/ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>38665</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2717411284</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+38665,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+OS/ADT
9999999.64;+38665,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+38665,;.08~YES
9999999.64;+38665,;.1~FACTOR
9999999.64;+38665,;100~NATIONAL
9999999.64;+38665,;101~VHA ONCOLOGY
9999999.64;+38665,;200~BRCA Stage IV ER+ >12Mos prior/new dx anast+ribo+OS/ADT
9999999.64;+38665,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, pre-menopausal; on pathway
anastrozole and ribociclib with OS and ADT
9999999.65;+38666,+38665,;.01~OCT 31, 2024@09:54:08
9999999.65;+38666,+38665,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+OS
9999999.65;+38667,+38665,;.01~OCT 31, 2024@09:55:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
38666^1
38667^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA MALE FUL+ALP+ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>36625</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1185361618</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36625,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA MALE FUL+ALP+ADT
9999999.64;+36625,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+36625,;.08~YES
9999999.64;+36625,;.1~FACTOR
9999999.64;+36625,;100~NATIONAL
9999999.64;+36625,;101~VHA ONCOLOGY
9999999.64;+36625,;200~BRCA Stage IV ER+ molecular target ID PIK3ca Male FUL+ALP+ADT
9999999.64;+36625,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, PIK3CA, male; on pathway fulvestrant, alpelisib
and ADT
9999999.65;+36626,+36625,;.01~AUG 08, 2024@12:52:23
9999999.65;+36626,+36625,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+ADT
9999999.65;+36627,+36625,;.01~AUG 08, 2024@12:53:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36626^1
36627^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP</POINT_01>
<INTERNAL_ENTRY_NUMBER>36624</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3950055540</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36624,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP
9999999.64;+36624,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+36624,;.08~YES
9999999.64;+36624,;.1~FACTOR
9999999.64;+36624,;100~NATIONAL
9999999.64;+36624,;101~VHA ONCOLOGY
9999999.64;+36624,;200~BRCA Stage IV ER+ molecular target ID PIK3ca FUL+ALP
9999999.64;+36624,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, post-menopausal; on pathway fulvestrant, alpelisib
9999999.65;+36625,+36624,;.01~AUG 08, 2024@12:48:20
9999999.65;+36625,+36624,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+ADT
9999999.65;+36626,+36624,;.01~AUG 08, 2024@12:50:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36625^1
36626^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR MALE ANAS+RIBO+ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>36618</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3395912881</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36618,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR MALE ANAS+RIBO+ADT
9999999.64;+36618,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+36618,;.08~YES
9999999.64;+36618,;.1~FACTOR
9999999.64;+36618,;100~NATIONAL
9999999.64;+36618,;101~VHA ONCOLOGY
9999999.64;+36618,;200~BRCA Stage IV ER+ >12Mos Male prior/new dx anast+ribo+ADT
9999999.64;+36618,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, male; on pathway anastrozole and
ribociclib and ADT
9999999.65;+36619,+36618,;.01~AUG 08, 2024@12:17:08
9999999.65;+36619,+36618,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+ADT
9999999.65;+36620,+36618,;.01~AUG 08, 2024@12:17:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36619^1
36620^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR ANAS+RIBO</POINT_01>
<INTERNAL_ENTRY_NUMBER>36616</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2915471518</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36616,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO
9999999.64;+36616,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+36616,;.08~YES
9999999.64;+36616,;.1~FACTOR
9999999.64;+36616,;100~NATIONAL
9999999.64;+36616,;101~VHA ONCOLOGY
9999999.64;+36616,;200~BRCA Stage IV ER+ >12Mos prior/new dx anast+ribo+ADT
9999999.64;+36616,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, post-menopausal; on pathway 
anastrozole and ribociclib
9999999.65;+36617,+36616,;.01~AUG 08, 2024@12:14:02
9999999.65;+36617,+36616,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+ADT
9999999.65;+36618,+36616,;.01~AUG 08, 2024@12:15:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36617^1
36618^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: PEMBROLIZUMAB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33199</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>216541525</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33199,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: PEMBROLIZUMAB
9999999.64;+33199,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33199,;.08~YES
9999999.64;+33199,;.1~FACTOR
9999999.64;+33199,;100~NATIONAL
9999999.64;+33199,;101~VHA ONCOLOGY
9999999.64;+33199,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: pembrolizumab
9999999.64;+33199,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: pembrolizumab
9999999.65;+33200,+33199,;.01~MAR 07, 2024@11:07:59
9999999.65;+33200,+33199,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: IXABEPILONE
9999999.65;+33201,+33199,;.01~MAR 07, 2024@11:09:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33200^1
33201^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: VINORELBINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33198</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3510662383</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33198,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: VINORELBINE
9999999.64;+33198,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33198,;.08~YES
9999999.64;+33198,;.1~FACTOR
9999999.64;+33198,;100~NATIONAL
9999999.64;+33198,;101~VHA ONCOLOGY
9999999.64;+33198,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: vinorelbine
9999999.64;+33198,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: vinorelbine
9999999.65;+33199,+33198,;.01~MAR 07, 2024@11:05:19
9999999.65;+33199,+33198,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: IXABEPILONE
9999999.65;+33200,+33198,;.01~MAR 07, 2024@11:06:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33199^1
33200^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: IXABEPILONE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33197</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2639965046</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33197,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: IXABEPILONE
9999999.64;+33197,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33197,;.08~YES
9999999.64;+33197,;.1~FACTOR
9999999.64;+33197,;100~NATIONAL
9999999.64;+33197,;101~VHA ONCOLOGY
9999999.64;+33197,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: ixabepilone
9999999.64;+33197,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: ixabepilone
9999999.65;+33198,+33197,;.01~MAR 07, 2024@11:02:11
9999999.65;+33198,+33197,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: ERIBULIN
9999999.65;+33199,+33197,;.01~MAR 07, 2024@11:05:05
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33198^1
33199^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: LIPO DOXORUBICIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33196</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3505609106</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33196,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: LIPO DOXORUBICIN
9999999.64;+33196,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33196,;.08~YES
9999999.64;+33196,;.1~FACTOR
9999999.64;+33196,;100~NATIONAL
9999999.64;+33196,;101~VHA ONCOLOGY
9999999.64;+33196,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: lip doxorubicin
9999999.64;+33196,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: liposomal doxorubicin
9999999.65;+33197,+33196,;.01~MAR 07, 2024@10:59:37
9999999.65;+33197,+33196,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: GEMCITABINE
9999999.65;+33198,+33196,;.01~MAR 07, 2024@11:01:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33197^1
33198^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: GEMCITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33195</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1456187866</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33195,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: GEMCITABINE
9999999.64;+33195,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33195,;.08~YES
9999999.64;+33195,;.1~FACTOR
9999999.64;+33195,;100~NATIONAL
9999999.64;+33195,;101~VHA ONCOLOGY
9999999.64;+33195,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: gemcitabine
9999999.64;+33195,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: gemcitabine
9999999.65;+33196,+33195,;.01~MAR 07, 2024@10:58:03
9999999.65;+33196,+33195,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: ERIBULIN
9999999.65;+33197,+33195,;.01~MAR 07, 2024@10:59:19
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33196^1
33197^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: ERIBULIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33194</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2493558653</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33194,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: ERIBULIN
9999999.64;+33194,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33194,;.08~YES
9999999.64;+33194,;.1~FACTOR
9999999.64;+33194,;100~NATIONAL
9999999.64;+33194,;101~VHA ONCOLOGY
9999999.64;+33194,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: eribulin
9999999.64;+33194,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: eribulin
9999999.65;+33195,+33194,;.01~MAR 07, 2024@10:56:04
9999999.65;+33195,+33194,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: PACLITAXEL
9999999.65;+33196,+33194,;.01~MAR 07, 2024@10:57:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33195^1
33196^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: CARBOPLATIN </POINT_01>
<INTERNAL_ENTRY_NUMBER>33193</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>306573358</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33193,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: CARBOPLATIN 
9999999.64;+33193,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33193,;.08~YES
9999999.64;+33193,;.1~FACTOR
9999999.64;+33193,;100~NATIONAL
9999999.64;+33193,;101~VHA ONCOLOGY
9999999.64;+33193,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: carboplatin
9999999.64;+33193,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: carboplatin
9999999.65;+33194,+33193,;.01~MAR 07, 2024@10:49:53
9999999.65;+33194,+33193,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: PACLITAXEL
9999999.65;+33195,+33193,;.01~MAR 07, 2024@10:54:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33194^1
33195^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: CAPECITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33192</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1956072963</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33192,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: CAPECITABINE
9999999.64;+33192,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33192,;.08~YES
9999999.64;+33192,;.1~FACTOR
9999999.64;+33192,;100~NATIONAL
9999999.64;+33192,;101~VHA ONCOLOGY
9999999.64;+33192,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: capecitabine
9999999.64;+33192,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: capecitabine
9999999.65;+33193,+33192,;.01~MAR 07, 2024@10:47:12
9999999.65;+33193,+33192,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO: PACLITAXEL
9999999.65;+33194,+33192,;.01~MAR 07, 2024@10:47:33
9999999.65;+33195,+33192,;.01~MAR 07, 2024@10:55:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33193^1
33194^2
33195^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO: PACLITAXEL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33191</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1697728448</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33191,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO: PACLITAXEL
9999999.64;+33191,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33191,;.08~YES
9999999.64;+33191,;.1~FACTOR
9999999.64;+33191,;100~NATIONAL
9999999.64;+33191,;101~VHA ONCOLOGY
9999999.64;+33191,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec: paclitaxel
9999999.64;+33191,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway: paclitaxel
9999999.65;+33192,+33191,;.01~MAR 07, 2024@10:17:51
9999999.65;+33192,+33191,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: CAPECITABINE
9999999.65;+33193,+33191,;.01~MAR 07, 2024@10:19:42
9999999.65;+33194,+33191,;.01~MAR 07, 2024@10:49:36
9999999.65;+33195,+33191,;.01~MAR 07, 2024@10:57:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33192^1
33193^2
33194^3
33195^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33190</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2744498494</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33190,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO OFF PATH RSN
9999999.64;+33190,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33190,;.08~YES
9999999.64;+33190,;.1~FACTOR
9999999.64;+33190,;100~NATIONAL
9999999.64;+33190,;101~VHA ONCOLOGY
9999999.64;+33190,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec off path reason
9999999.64;+33190,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, off pathway reason
9999999.65;+33191,+33190,;.01~MAR 07, 2024@10:14:54
9999999.65;+33191,+33190,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO OFF PATH TX
9999999.65;+33192,+33190,;.01~MAR 07, 2024@10:16:53
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33191^1
33192^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33189</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1248989038</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33189,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO OFF PATH TX
9999999.64;+33189,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33189,;.08~YES
9999999.64;+33189,;.1~FACTOR
9999999.64;+33189,;100~NATIONAL
9999999.64;+33189,;101~VHA ONCOLOGY
9999999.64;+33189,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec off path tx
9999999.64;+33189,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, off pathway treatment
9999999.65;+33190,+33189,;.01~MAR 07, 2024@10:13:29
9999999.65;+33190,+33189,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < PRIOR CHEMO CLIN TRIAL
9999999.65;+33191,+33189,;.01~MAR 07, 2024@10:14:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33190^1
33191^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; PRIOR CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33188</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1309609437</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33188,;.01~VA-ONC BRCA IV ER+ < PRIOR CHEMO CLIN TRIAL
9999999.64;+33188,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33188,;.08~YES
9999999.64;+33188,;.1~FACTOR
9999999.64;+33188,;100~NATIONAL
9999999.64;+33188,;101~VHA ONCOLOGY
9999999.64;+33188,;200~BRCA Stage IV ER+ <2 prior lines of chemo rec clinical trial
9999999.64;+33188,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy not received, on pathway clinical trial
9999999.65;+33189,+33188,;.01~MAR 07, 2024@10:04:09
9999999.65;+33189,+33188,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > PRIOR CHEMO CLIN TRIAL
9999999.65;+33190,+33188,;.01~MAR 07, 2024@10:07:33
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33189^1
33190^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; PRIOR CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33187</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2443970594</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33187,;.01~VA-ONC BRCA IV ER+ > PRIOR CHEMO OFF PATH RSN
9999999.64;+33187,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33187,;.08~YES
9999999.64;+33187,;.1~FACTOR
9999999.64;+33187,;100~NATIONAL
9999999.64;+33187,;101~VHA ONCOLOGY
9999999.64;+33187,;200~BRCA Stage IV ER+ >2 prior lines of chemo rec off path reason
9999999.64;+33187,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, off pathway reason
9999999.65;+33188,+33187,;.01~MAR 07, 2024@09:34:28
9999999.65;+33188,+33187,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > PRIOR CHEMO OFF PATH TX
9999999.65;+33189,+33187,;.01~MAR 07, 2024@09:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33188^1
33189^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; PRIOR CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33186</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1442254470</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33186,;.01~VA-ONC BRCA IV ER+ > PRIOR CHEMO OFF PATH TX
9999999.64;+33186,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33186,;.08~YES
9999999.64;+33186,;.1~FACTOR
9999999.64;+33186,;100~NATIONAL
9999999.64;+33186,;101~VHA ONCOLOGY
9999999.64;+33186,;200~BRCA Stage IV ER+ >2 prior lines of chemo rec off path treatment
9999999.64;+33186,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, off pathway treatment
9999999.65;+33187,+33186,;.01~MAR 07, 2024@09:32:51
9999999.65;+33187,+33186,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > PRIOR CHEMO CLIN TRIAL
9999999.65;+33188,+33186,;.01~MAR 07, 2024@09:33:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33187^1
33188^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; PRIOR CHEMO SACITUZUMAB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33185</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>923137708</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33185,;.01~VA-ONC BRCA IV ER+ > PRIOR CHEMO SACITUZUMAB
9999999.64;+33185,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33185,;.08~YES
9999999.64;+33185,;.1~FACTOR
9999999.64;+33185,;100~NATIONAL
9999999.64;+33185,;101~VHA ONCOLOGY
9999999.64;+33185,;200~BRCA Stage IV ER+ >2 prior lines of chemo rec sac govitecan
9999999.64;+33185,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway sacituzumab govitecan
9999999.65;+33186,+33185,;.01~MAR 07, 2024@09:24:42
9999999.65;+33186,+33185,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > PRIOR CHEMO CLIN TRIAL
9999999.65;+33187,+33185,;.01~MAR 07, 2024@09:26:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33186^1
33187^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: PEMBROLIZUMAB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33184</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>166423070</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33184,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: PEMBROLIZUMAB
9999999.64;+33184,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33184,;.08~YES
9999999.64;+33184,;.1~FACTOR
9999999.64;+33184,;100~NATIONAL
9999999.64;+33184,;101~VHA ONCOLOGY
9999999.64;+33184,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: pembrolizumab
9999999.64;+33184,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway: pembrolizumab
9999999.65;+33185,+33184,;.01~MAR 07, 2024@08:54:19
9999999.65;+33185,+33184,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: IXABEPILONE
9999999.65;+33186,+33184,;.01~MAR 07, 2024@08:55:21
9999999.65;+33187,+33184,;.01~MAR 07, 2024@12:06:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33185^1
33186^2
33187^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: VINORELBINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33183</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1804092458</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33183,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: VINORELBINE
9999999.64;+33183,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33183,;.08~YES
9999999.64;+33183,;.1~FACTOR
9999999.64;+33183,;100~NATIONAL
9999999.64;+33183,;101~VHA ONCOLOGY
9999999.64;+33183,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: vinorelbine
9999999.64;+33183,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway: vinorelbine
9999999.65;+33184,+33183,;.01~MAR 07, 2024@08:52:27
9999999.65;+33184,+33183,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: IXABEPILONE
9999999.65;+33185,+33183,;.01~MAR 07, 2024@08:53:10
9999999.65;+33186,+33183,;.01~MAR 07, 2024@12:06:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33184^1
33185^2
33186^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: IXABEPILONE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33182</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4207940488</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33182,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: IXABEPILONE
9999999.64;+33182,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33182,;.08~YES
9999999.64;+33182,;.1~FACTOR
9999999.64;+33182,;100~NATIONAL
9999999.64;+33182,;101~VHA ONCOLOGY
9999999.64;+33182,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: ixabepilone
9999999.64;+33182,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway: ixabepilone
9999999.65;+33183,+33182,;.01~MAR 07, 2024@08:48:11
9999999.65;+33183,+33182,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL
9999999.65;+33184,+33182,;.01~MAR 07, 2024@08:49:24
9999999.65;+33185,+33182,;.01~MAR 07, 2024@12:02:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33183^1
33184^2
33185^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: LIPO DOXORUBICIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33181</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3745048235</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33181,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: LIPO DOXORUBICIN
9999999.64;+33181,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33181,;.08~YES
9999999.64;+33181,;.1~FACTOR
9999999.64;+33181,;100~NATIONAL
9999999.64;+33181,;101~VHA ONCOLOGY
9999999.64;+33181,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: lip doxorubin
9999999.64;+33181,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway: liposomal doxorubin
9999999.65;+33182,+33181,;.01~MAR 07, 2024@08:42:22
9999999.65;+33182,+33181,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL
9999999.65;+33183,+33181,;.01~MAR 07, 2024@08:45:17
9999999.65;+33184,+33181,;.01~MAR 07, 2024@12:03:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33182^1
33183^2
33184^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: GEMCITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33180</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>506825925</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33180,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: GEMCITABINE
9999999.64;+33180,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33180,;.08~YES
9999999.64;+33180,;.1~FACTOR
9999999.64;+33180,;100~NATIONAL
9999999.64;+33180,;101~VHA ONCOLOGY
9999999.64;+33180,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: gemcitabine
9999999.64;+33180,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received on pathway: gemcitabine
9999999.65;+33181,+33180,;.01~MAR 07, 2024@08:40:21
9999999.65;+33181,+33180,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL
9999999.65;+33182,+33180,;.01~MAR 07, 2024@08:41:06
9999999.65;+33183,+33180,;.01~MAR 07, 2024@12:00:11
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33181^1
33182^2
33183^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: ERIBULIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33179</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>889900577</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33179,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: ERIBULIN
9999999.64;+33179,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33179,;.08~YES
9999999.64;+33179,;.1~FACTOR
9999999.64;+33179,;100~NATIONAL
9999999.64;+33179,;101~VHA ONCOLOGY
9999999.64;+33179,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: eribulin
9999999.64;+33179,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received on pathway: eribulin
9999999.65;+33180,+33179,;.01~MAR 07, 2024@08:17:20
9999999.65;+33180,+33179,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: CAPECITABINE
9999999.65;+33181,+33179,;.01~MAR 07, 2024@08:30:34
9999999.65;+33182,+33179,;.01~MAR 07, 2024@11:59:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33180^1
33181^2
33182^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: CARBOPLATIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33178</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1975890140</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33178,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: CARBOPLATIN
9999999.64;+33178,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33178,;.08~YES
9999999.64;+33178,;.1~FACTOR
9999999.64;+33178,;100~NATIONAL
9999999.64;+33178,;101~VHA ONCOLOGY
9999999.64;+33178,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: carboplatin
9999999.64;+33178,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway: carboplatin
9999999.65;+33179,+33178,;.01~MAR 07, 2024@08:08:17
9999999.65;+33179,+33178,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL
9999999.65;+33180,+33178,;.01~MAR 07, 2024@08:09:20
9999999.65;+33181,+33178,;.01~MAR 07, 2024@11:58:18
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33179^1
33180^2
33181^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: CAPECITABINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33177</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1099796019</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33177,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: CAPECITABINE
9999999.64;+33177,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33177,;.08~YES
9999999.64;+33177,;.1~FACTOR
9999999.64;+33177,;100~NATIONAL
9999999.64;+33177,;101~VHA ONCOLOGY
9999999.64;+33177,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: capecitabine
9999999.64;+33177,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received on pathway: capecitabine
9999999.65;+33178,+33177,;.01~MAR 07, 2024@08:05:04
9999999.65;+33178,+33177,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL
9999999.65;+33179,+33177,;.01~MAR 07, 2024@08:07:08
9999999.65;+33180,+33177,;.01~MAR 07, 2024@11:57:46
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33178^1
33179^2
33180^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33175</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2698547497</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33175,;.01~VA-ONC BRCA IV ER+ PRIOR CHEMO: PACLITAXEL
9999999.64;+33175,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33175,;.08~YES
9999999.64;+33175,;.1~FACTOR
9999999.64;+33175,;100~NATIONAL
9999999.64;+33175,;101~VHA ONCOLOGY
9999999.64;+33175,;200~BRCA Stage IV ER+ prior lines of chemotherapy rec: paclitaxel
9999999.64;+33175,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway: paclitaxel
9999999.65;+33176,+33175,;.01~MAR 07, 2024@07:46:08
9999999.65;+33176,+33175,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > PRIOR CHEMO CLIN TRIAL
9999999.65;+33177,+33175,;.01~MAR 07, 2024@07:52:24
9999999.65;+33178,+33175,;.01~MAR 07, 2024@12:05:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33176^1
33177^2
33178^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; PRIOR CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33174</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3517887894</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33174,;.01~VA-ONC BRCA IV ER+ > PRIOR CHEMO CLIN TRIAL
9999999.64;+33174,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33174,;.08~YES
9999999.64;+33174,;.1~FACTOR
9999999.64;+33174,;100~NATIONAL
9999999.64;+33174,;101~VHA ONCOLOGY
9999999.64;+33174,;200~BRCA Stage IV ER+ >2 prior lines of chemo rec clinical trial
9999999.64;+33174,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 2 or more prior lines of 
chemotherapy received, on pathway clinical trial
9999999.65;+33175,+33174,;.01~MAR 07, 2024@07:22:30
9999999.65;+33175,+33174,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < 12M PRIOR CLIN TRIAL
9999999.65;+33176,+33174,;.01~MAR 07, 2024@07:26:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33175^1
33176^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NOT CHEMO CAND OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33172</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>96913273</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33172,;.01~VA-ONC BRCA IV ER+ NOT CHEMO CAND OFF PATH RSN
9999999.64;+33172,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33172,;.08~YES
9999999.64;+33172,;.1~FACTOR
9999999.64;+33172,;100~NATIONAL
9999999.64;+33172,;101~VHA ONCOLOGY
9999999.64;+33172,;200~BRCA Stage IV ER+ not chemo candidate off path reason
9999999.64;+33172,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, not a chemotherapy candidate, off pathway reason
9999999.65;+33173,+33172,;.01~MAR 06, 2024@13:38:50
9999999.65;+33173,+33172,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NOT CHEMO CAND OFF PATH TX
9999999.65;+33174,+33172,;.01~MAR 06, 2024@13:39:20
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33173^1
33174^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NOT CHEMO CAND OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33171</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2177347508</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33171,;.01~VA-ONC BRCA IV ER+ NOT CHEMO CAND OFF PATH TX
9999999.64;+33171,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33171,;.08~YES
9999999.64;+33171,;.1~FACTOR
9999999.64;+33171,;100~NATIONAL
9999999.64;+33171,;101~VHA ONCOLOGY
9999999.64;+33171,;200~BRCA Stage IV ER+ not chemo candidate off path treatment
9999999.64;+33171,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, not a chemotherapy candidate, off pathway treatment
9999999.65;+33172,+33171,;.01~MAR 06, 2024@13:32:50
9999999.65;+33172,+33171,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NOT CHEMO CAND CLIN TRIAL
9999999.65;+33173,+33171,;.01~MAR 06, 2024@13:35:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33172^1
33173^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NOT CHEMO CAND HORMONE TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33170</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>391476707</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33170,;.01~VA-ONC BRCA IV ER+ NOT CHEMO CAND HORMONE TX
9999999.64;+33170,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33170,;.08~YES
9999999.64;+33170,;.1~FACTOR
9999999.64;+33170,;100~NATIONAL
9999999.64;+33170,;101~VHA ONCOLOGY
9999999.64;+33170,;200~BRCA Stage IV ER+ not chemo candidate hormonal-base therapy
9999999.64;+33170,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, not a chemotherapy candidate, on pathway hormonal-base therapy
9999999.65;+33171,+33170,;.01~MAR 06, 2024@13:29:41
9999999.65;+33171,+33170,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NOT CHEMO CAND CLIN TRIAL
9999999.65;+33172,+33170,;.01~MAR 06, 2024@13:31:49
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33171^1
33172^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NOT CHEMO CAND CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33169</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1268485945</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33169,;.01~VA-ONC BRCA IV ER+ NOT CHEMO CAND CLIN TRIAL
9999999.64;+33169,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33169,;.08~YES
9999999.64;+33169,;.1~FACTOR
9999999.64;+33169,;100~NATIONAL
9999999.64;+33169,;101~VHA ONCOLOGY
9999999.64;+33169,;200~BRCA Stage IV ER+ not chemo candidate clinical trial
9999999.64;+33169,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, not a chemotherapy candidate, on pathway clinical trial
9999999.65;+33170,+33169,;.01~MAR 06, 2024@13:25:11
9999999.65;+33170,+33169,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ CHEMO HER2 LOW CLIN TRIAL
9999999.65;+33171,+33169,;.01~MAR 06, 2024@13:27:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33170^1
33171^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ CHEMO HER2 LOW OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33168</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2616639843</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33168,;.01~VA-ONC BRCA IV ER+ CHEMO HER2 LOW OFF PATH RSN
9999999.64;+33168,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33168,;.08~YES
9999999.64;+33168,;.1~FACTOR
9999999.64;+33168,;100~NATIONAL
9999999.64;+33168,;101~VHA ONCOLOGY
9999999.64;+33168,;200~BRCA Stage IV ER+ chemo cand HER2 low off path reason
9999999.64;+33168,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, chemotherapy candidate, HER2 Low (IHC 1+ or 2+) and received 1 or
more line of prior chemotherapy, off pathway reason
9999999.65;+33169,+33168,;.01~MAR 06, 2024@13:19:20
9999999.65;+33169,+33168,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ CHEMO HER2 LOW OFF PATH TX
9999999.65;+33170,+33168,;.01~MAR 06, 2024@13:20:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33169^1
33170^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ CHEMO HER2 LOW OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33167</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2460457502</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33167,;.01~VA-ONC BRCA IV ER+ CHEMO HER2 LOW OFF PATH TX
9999999.64;+33167,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33167,;.08~YES
9999999.64;+33167,;.1~FACTOR
9999999.64;+33167,;100~NATIONAL
9999999.64;+33167,;101~VHA ONCOLOGY
9999999.64;+33167,;200~BRCA Stage IV ER+ chemo cand HER2 low off path treatment
9999999.64;+33167,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, chemotherapy candidate, HER2 Low (IHC 1+ or 2+) and received 1 or
more line of prior chemotherapy, off pathway treatment
9999999.65;+33168,+33167,;.01~MAR 06, 2024@13:13:52
9999999.65;+33168,+33167,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ CHEMO HER2 LOW CLIN TRIAL
9999999.65;+33169,+33167,;.01~MAR 06, 2024@13:16:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33168^1
33169^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ CHEMO HER2 LOW TRAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>33166</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4067713480</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33166,;.01~VA-ONC BRCA IV ER+ CHEMO HER2 LOW TRAST
9999999.64;+33166,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33166,;.08~YES
9999999.64;+33166,;.1~FACTOR
9999999.64;+33166,;100~NATIONAL
9999999.64;+33166,;101~VHA ONCOLOGY
9999999.64;+33166,;200~BRCA Stage IV ER+ chemo cand HER2 low trastuzumab deruxtecan
9999999.64;+33166,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, chemotherapy candidate, HER2 Low (IHC 1+ or 2+) and received 1 or
more line of prior chemotherapy, on pathway trastuzumab deruxtecan
9999999.65;+33167,+33166,;.01~MAR 06, 2024@13:10:17
9999999.65;+33167,+33166,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ CHEMO HER2 LOW CLIN TRIAL
9999999.65;+33168,+33166,;.01~MAR 06, 2024@13:13:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33167^1
33168^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ CHEMO HER2 LOW CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33165</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3829559906</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33165,;.01~VA-ONC BRCA IV ER+ CHEMO HER2 LOW CLIN TRIAL
9999999.64;+33165,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33165,;.08~YES
9999999.64;+33165,;.1~FACTOR
9999999.64;+33165,;100~NATIONAL
9999999.64;+33165,;101~VHA ONCOLOGY
9999999.64;+33165,;200~BRCA Stage IV ER+ chemo cand HER2 low clinical trial
9999999.64;+33165,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; yes or no ESR1 after adjuvant
therapy, chemotherapy candidate, HER2 Low (IHC 1+ or 2+) and received 1 or
more line of prior chemotherapy, on pathway clinical trial
9999999.65;+33166,+33165,;.01~MAR 06, 2024@12:58:48
9999999.65;+33166,+33165,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NO ESR1 AFTER ADJ THERAPY
9999999.65;+33167,+33165,;.01~MAR 06, 2024@13:08:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33166^1
33167^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NO ESR1 AFTER ADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>33164</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2396417393</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33164,;.01~VA-ONC BRCA IV ER+ NO ESR1 AFTER ADJ THERAPY
9999999.64;+33164,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33164,;.08~YES
9999999.64;+33164,;.1~FACTOR
9999999.64;+33164,;100~NATIONAL
9999999.64;+33164,;101~VHA ONCOLOGY
9999999.64;+33164,;200~BRCA Stage IV ER+ no ESR1 after adjuvant therapy
9999999.64;+33164,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; no ESR1 after adjuvant therapy,
neither on or off pathway
9999999.65;+33165,+33164,;.01~MAR 06, 2024@12:48:43
9999999.65;+33165,+33164,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ ESR1 CLIN TRIAL
9999999.65;+33166,+33164,;.01~MAR 06, 2024@12:51:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33165^1
33166^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ ESR1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33163</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2385638904</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33163,;.01~VA-ONC BRCA IV ER+ ESR1 OFF PATH RSN
9999999.64;+33163,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33163,;.08~YES
9999999.64;+33163,;.1~FACTOR
9999999.64;+33163,;100~NATIONAL
9999999.64;+33163,;101~VHA ONCOLOGY
9999999.64;+33163,;200~BRCA Stage IV ER+ ESR1 off pathway reason
9999999.64;+33163,;201~WP-start~1
Breast Cancer-Stage IV ER+ or PR+/HER2-; ESR1, off pathway reason
9999999.65;+33164,+33163,;.01~MAR 06, 2024@12:44:03
9999999.65;+33164,+33163,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ ESR1 OFF PATH TX
9999999.65;+33165,+33163,;.01~MAR 06, 2024@12:44:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33164^1
33165^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ ESR1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33162</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>215896386</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33162,;.01~VA-ONC BRCA IV ER+ ESR1 OFF PATH TX
9999999.64;+33162,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33162,;.08~YES
9999999.64;+33162,;.1~FACTOR
9999999.64;+33162,;100~NATIONAL
9999999.64;+33162,;101~VHA ONCOLOGY
9999999.64;+33162,;200~BRCA Stage IV ER+ ESR1 off pathway treatment
9999999.64;+33162,;201~WP-start~1
Breast Cancer-Stage IV ER+ or PR+/HER2-; ESR1, off pathway treatment
9999999.65;+33163,+33162,;.01~MAR 06, 2024@12:41:54
9999999.65;+33163,+33162,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ ESR1 CLIN TRIAL
9999999.65;+33164,+33162,;.01~MAR 06, 2024@12:42:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33163^1
33164^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ ESR1 ELACESTRANT</POINT_01>
<INTERNAL_ENTRY_NUMBER>33161</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>390665947</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33161,;.01~VA-ONC BRCA IV ER+ ESR1 ELACESTRANT
9999999.64;+33161,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33161,;.08~YES
9999999.64;+33161,;.1~FACTOR
9999999.64;+33161,;100~NATIONAL
9999999.64;+33161,;101~VHA ONCOLOGY
9999999.64;+33161,;200~BRCA Stage IV ER+ ESR1 elacestrant
9999999.64;+33161,;201~WP-start~1
Breast Cancer-Stage IV ER+ or PR+/HER2-; ESR1, on pathway elacestrant
9999999.65;+33162,+33161,;.01~MAR 06, 2024@12:38:31
9999999.65;+33162,+33161,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ ESR1 CLIN TRIAL
9999999.65;+33163,+33161,;.01~MAR 06, 2024@12:39:30
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33162^1
33163^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ ESR1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33160</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>93391063</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33160,;.01~VA-ONC BRCA IV ER+ ESR1 CLIN TRIAL
9999999.64;+33160,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33160,;.08~YES
9999999.64;+33160,;.1~FACTOR
9999999.64;+33160,;100~NATIONAL
9999999.64;+33160,;101~VHA ONCOLOGY
9999999.64;+33160,;200~BRCA Stage IV ER+ ESR1 clinical trial
9999999.64;+33160,;201~WP-start~1
Breast Cancer-Stage IV ER+ or PR+/HER2-; ESR1, on pathway clinical trial
9999999.65;+33161,+33160,;.01~MAR 06, 2024@12:29:12
9999999.65;+33161,+33160,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR FUL CLIN TRIAL
9999999.65;+33162,+33160,;.01~MAR 06, 2024@12:30:54
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33161^1
33162^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NO PRIOR FUL OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33159</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2493308648</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33159,;.01~VA-ONC BRCA IV ER+ NO PRIOR FUL OFF PATH RSN
9999999.64;+33159,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33159,;.08~YES
9999999.64;+33159,;.1~FACTOR
9999999.64;+33159,;.11~INACTIVE
9999999.64;+33159,;100~NATIONAL
9999999.64;+33159,;101~VHA ONCOLOGY
9999999.64;+33159,;200~BRCA Stage IV ER+ no prior fulvestrant off path reason
9999999.64;+33159,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; either molecular target not
identified or after adjuvant therapy, no prior fulvestrant, off pathway 
reason
9999999.65;+33160,+33159,;.01~MAR 06, 2024@11:39:02
9999999.65;+33160,+33159,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NO PRIOR FUL OFF PATH TX
9999999.65;+33161,+33159,;.01~MAR 06, 2024@11:39:49
9999999.65;+33162,+33159,;.01~FEB 25, 2025@13:38:38
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33160^1
33161^2
33162^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NO PRIOR FUL OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33158</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1003999429</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33158,;.01~VA-ONC BRCA IV ER+ NO PRIOR FUL OFF PATH TX
9999999.64;+33158,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33158,;.08~YES
9999999.64;+33158,;.1~FACTOR
9999999.64;+33158,;.11~INACTIVE
9999999.64;+33158,;100~NATIONAL
9999999.64;+33158,;101~VHA ONCOLOGY
9999999.64;+33158,;200~BRCA Stage IV ER+ no prior fulvestrant off path treatment
9999999.64;+33158,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; either molecular target not
identified or after adjuvant therapy, no prior fulvestrant, off pathway
treatment
9999999.65;+33159,+33158,;.01~MAR 06, 2024@11:37:59
9999999.65;+33159,+33158,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NO PRIOR FUL CLIN TRIAL
9999999.65;+33160,+33158,;.01~MAR 06, 2024@11:38:47
9999999.65;+33161,+33158,;.01~FEB 25, 2025@13:38:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33159^1
33160^2
33161^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NO PRIOR FUL EVE+FUL+ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>33157</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2451802955</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33157,;.01~VA-ONC BRCA IV ER+ NO PRIOR FUL EVE+FUL+ADT
9999999.64;+33157,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33157,;.08~YES
9999999.64;+33157,;.1~FACTOR
9999999.64;+33157,;.11~INACTIVE
9999999.64;+33157,;100~NATIONAL
9999999.64;+33157,;101~VHA ONCOLOGY
9999999.64;+33157,;200~BRCA Stage IV ER+ no prior fulvestrant EVE+FUL+ADT
9999999.64;+33157,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; either molecular target not
identified or after adjuvant therapy, no prior fulvestrant, on pathway
everolimus, fulvestrant and ADT
9999999.65;+33158,+33157,;.01~MAR 06, 2024@11:24:09
9999999.65;+33158,+33157,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NO PRIOR FUL EVE+FUL+OS
9999999.65;+33159,+33157,;.01~MAR 06, 2024@11:35:09
9999999.65;+33160,+33157,;.01~FEB 25, 2025@13:38:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33158^1
33159^2
33160^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NO PRIOR FUL EVE+FUL+OS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33156</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2568612053</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33156,;.01~VA-ONC BRCA IV ER+ NO PRIOR FUL EVE+FUL+OS
9999999.64;+33156,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33156,;.08~YES
9999999.64;+33156,;.1~FACTOR
9999999.64;+33156,;.11~INACTIVE
9999999.64;+33156,;100~NATIONAL
9999999.64;+33156,;101~VHA ONCOLOGY
9999999.64;+33156,;200~BRCA Stage IV ER+ no prior fulvestrant EVE+FUL+OS
9999999.64;+33156,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; either molecular target not
identified or after adjuvant therapy, no prior fulvestrant, on pathway
everolimus, fulvestrant and OS
9999999.65;+33157,+33156,;.01~MAR 06, 2024@11:05:38
9999999.65;+33157,+33156,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ NO PRIOR FUL CLIN TRIAL
9999999.65;+33158,+33156,;.01~MAR 06, 2024@11:16:59
9999999.65;+33159,+33156,;.01~FEB 25, 2025@13:38:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33157^1
33158^2
33159^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ NO PRIOR FUL CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33155</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3289385844</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33155,;.01~VA-ONC BRCA IV ER+ NO PRIOR FUL CLIN TRIAL
9999999.64;+33155,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33155,;.08~YES
9999999.64;+33155,;.1~FACTOR
9999999.64;+33155,;.11~INACTIVE
9999999.64;+33155,;100~NATIONAL
9999999.64;+33155,;101~VHA ONCOLOGY
9999999.64;+33155,;200~BRCA Stage IV ER+ no prior fulvestrant clinical trial
9999999.64;+33155,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; either molecular target not
identified or after adjuvant therapy, no prior fulvestrant, on pathway
clinical trial
9999999.65;+33156,+33155,;.01~MAR 06, 2024@11:02:04
9999999.65;+33156,+33155,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ PRIOR FUL CLIN TRIAL
9999999.65;+33157,+33155,;.01~MAR 06, 2024@11:04:04
9999999.65;+33158,+33155,;.01~FEB 25, 2025@13:37:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33156^1
33157^2
33158^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE TARGET NOT ID</POINT_01>
<INTERNAL_ENTRY_NUMBER>33149</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2787383226</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33149,;.01~VA-ONC BRCA IV ER+ MOLE TARGET NOT ID
9999999.64;+33149,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33149,;.08~YES
9999999.64;+33149,;.1~FACTOR
9999999.64;+33149,;100~NATIONAL
9999999.64;+33149,;101~VHA ONCOLOGY
9999999.64;+33149,;200~BRCA Stage IV ER+ molecular target not identified
9999999.64;+33149,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target not identified, 
neither on or off pathway
9999999.65;+33150,+33149,;.01~MAR 06, 2024@10:16:45
9999999.65;+33150,+33149,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID GERMLINE CLIN TRIAL
9999999.65;+33151,+33149,;.01~MAR 06, 2024@10:19:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33150^1
33151^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID GERMLINE OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33148</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>938226016</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33148,;.01~VA-ONC BRCA IV ER+ MOLE ID GERMLINE OFF PATH RSN
9999999.64;+33148,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33148,;.08~YES
9999999.64;+33148,;.1~FACTOR
9999999.64;+33148,;100~NATIONAL
9999999.64;+33148,;101~VHA ONCOLOGY
9999999.64;+33148,;200~BRCA Stage IV ER+ molecular ID germline off path reason
9999999.64;+33148,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, Germline BRCA 1/2 PV, somatic BRCA 1/2 PV, or 
germline PV in PALB2, off pathway reason
9999999.65;+33149,+33148,;.01~MAR 06, 2024@09:18:10
9999999.65;+33149,+33148,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID GERMLINE OFF PATH TX
9999999.65;+33150,+33148,;.01~MAR 06, 2024@09:18:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33149^1
33150^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID GERMLINE OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33147</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3285222587</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33147,;.01~VA-ONC BRCA IV ER+ MOLE ID GERMLINE OFF PATH TX
9999999.64;+33147,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33147,;.08~YES
9999999.64;+33147,;.1~FACTOR
9999999.64;+33147,;100~NATIONAL
9999999.64;+33147,;101~VHA ONCOLOGY
9999999.64;+33147,;200~BRCA Stage IV ER+ molecular ID germline off path treatment
9999999.64;+33147,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, Germline BRCA 1/2 PV, somatic BRCA 1/2 PV, or 
germline PV in PALB2, off pathway treatment
9999999.65;+33148,+33147,;.01~MAR 06, 2024@09:12:43
9999999.65;+33148,+33147,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID GERMLINE CLIN TRIAL
9999999.65;+33149,+33147,;.01~MAR 06, 2024@09:13:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33148^1
33149^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID GERMLINE CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33146</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1904235581</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33146,;.01~VA-ONC BRCA IV ER+ MOLE ID GERMLINE CLIN TRIAL
9999999.64;+33146,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33146,;.08~YES
9999999.64;+33146,;.1~FACTOR
9999999.64;+33146,;100~NATIONAL
9999999.64;+33146,;101~VHA ONCOLOGY
9999999.64;+33146,;200~BRCA Stage IV ER+ molecular ID germline clinical trial
9999999.64;+33146,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, Germline BRCA 1/2 PV, somatic BRCA 1/2 PV, or 
germline PV in PALB2, on pathway clinical trial
9999999.65;+33147,+33146,;.01~MAR 06, 2024@09:08:48
9999999.65;+33147,+33146,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID GERMLINE OLAPARIB
9999999.65;+33148,+33146,;.01~MAR 06, 2024@09:12:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33147^1
33148^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID GERMLINE OLAPARIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>33145</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>840991247</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33145,;.01~VA-ONC BRCA IV ER+ MOLE ID GERMLINE OLAPARIB
9999999.64;+33145,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33145,;.08~YES
9999999.64;+33145,;.1~FACTOR
9999999.64;+33145,;100~NATIONAL
9999999.64;+33145,;101~VHA ONCOLOGY
9999999.64;+33145,;200~BRCA Stage IV ER+ molecular ID germline Olaparib
9999999.64;+33145,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, Germline BRCA 1/2 PV, somatic BRCA 1/2 PV, or 
germline PV in PALB2, on pathway olaparib
9999999.65;+33146,+33145,;.01~MAR 06, 2024@09:02:54
9999999.65;+33146,+33145,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA CLIN TRIAL
9999999.65;+33147,+33145,;.01~MAR 06, 2024@09:06:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33146^1
33147^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33144</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>814438402</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33144,;.01~VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN OFF PATH RSN
9999999.64;+33144,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33144,;.08~YES
9999999.64;+33144,;.1~FACTOR
9999999.64;+33144,;100~NATIONAL
9999999.64;+33144,;101~VHA ONCOLOGY
9999999.64;+33144,;200~BRCA Stage IV ER+ molecular target ID AKT/PTEN off path rsn
9999999.64;+33144,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, AKT/PTEN, off pathway reason
9999999.65;+33145,+33144,;.01~MAR 06, 2024@08:46:43
9999999.65;+33145,+33144,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN OFF PATH TX
9999999.65;+33146,+33144,;.01~MAR 06, 2024@08:52:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33145^1
33146^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33143</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3522485725</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33143,;.01~VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN OFF PATH TX
9999999.64;+33143,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33143,;.08~YES
9999999.64;+33143,;.1~FACTOR
9999999.64;+33143,;100~NATIONAL
9999999.64;+33143,;101~VHA ONCOLOGY
9999999.64;+33143,;200~BRCA Stage IV ER+ molecular target ID AKT/PTEN off path tx
9999999.64;+33143,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, AKT/PTEN, off pathway treatment
9999999.65;+33144,+33143,;.01~MAR 06, 2024@08:43:16
9999999.65;+33144,+33143,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN CLIN TRIAL
9999999.65;+33145,+33143,;.01~MAR 06, 2024@08:45:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33144^1
33145^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN FUL+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>33142</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1897048919</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33142,;.01~VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN FUL+CAP
9999999.64;+33142,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33142,;.08~YES
9999999.64;+33142,;.1~FACTOR
9999999.64;+33142,;100~NATIONAL
9999999.64;+33142,;101~VHA ONCOLOGY
9999999.64;+33142,;200~BRCA Stage IV ER+ molecular target ID AKT/PTEN FUL+CAP
9999999.64;+33142,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, AKT/PTEN, on pathway fulvestrant and capivasertib
9999999.65;+33143,+33142,;.01~MAR 06, 2024@08:21:12
9999999.65;+33143,+33142,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN CLIN TRIAL
9999999.65;+33144,+33142,;.01~MAR 06, 2024@08:29:03
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33143^1
33144^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33141</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2715738926</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33141,;.01~VA-ONC BRCA IV ER+ MOLE ID AKT/PTEN CLIN TRIAL
9999999.64;+33141,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33141,;.08~YES
9999999.64;+33141,;.1~FACTOR
9999999.64;+33141,;100~NATIONAL
9999999.64;+33141,;101~VHA ONCOLOGY
9999999.64;+33141,;200~BRCA Stage IV ER+ molecular target ID AKT/PTEN clin trial
9999999.64;+33141,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, AKT/PTEN, on pathway clinical trial
9999999.65;+33142,+33141,;.01~MAR 06, 2024@08:17:52
9999999.65;+33142,+33141,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA CLIN TRIAL
9999999.65;+33143,+33141,;.01~MAR 06, 2024@08:20:41
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33142^1
33143^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33140</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2542334115</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33140,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA OFF PATH RSN
9999999.64;+33140,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33140,;.08~YES
9999999.64;+33140,;.1~FACTOR
9999999.64;+33140,;100~NATIONAL
9999999.64;+33140,;101~VHA ONCOLOGY
9999999.64;+33140,;200~BRCA Stage IV ER+ molecular target ID PIK3ca off path reason
9999999.64;+33140,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, PIK3CA, off pathway reason
9999999.65;+33141,+33140,;.01~MAR 06, 2024@08:14:12
9999999.65;+33141,+33140,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA OFF PATH TX
9999999.65;+33142,+33140,;.01~MAR 06, 2024@08:15:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33141^1
33142^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33139</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1606668728</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33139,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA OFF PATH TX
9999999.64;+33139,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33139,;.08~YES
9999999.64;+33139,;.1~FACTOR
9999999.64;+33139,;100~NATIONAL
9999999.64;+33139,;101~VHA ONCOLOGY
9999999.64;+33139,;200~BRCA Stage IV ER+ molecular target ID PIK3ca off path treatment
9999999.64;+33139,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, PIK3CA, off pathway treatment
9999999.65;+33140,+33139,;.01~MAR 06, 2024@08:10:17
9999999.65;+33140,+33139,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA CLIN TRIAL
9999999.65;+33141,+33139,;.01~MAR 06, 2024@08:11:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33140^1
33141^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>33138</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>234866484</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33138,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+ADT
9999999.64;+33138,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33138,;.08~YES
9999999.64;+33138,;.1~FACTOR
9999999.64;+33138,;100~NATIONAL
9999999.64;+33138,;101~VHA ONCOLOGY
9999999.64;+33138,;200~BRCA Stage IV ER+ molecular target ID PIK3ca FUL+ALP+ADT
9999999.64;+33138,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, PIK3CA, pre-menopausal; on pathway fulvestrant,
alpelisib and ADT
9999999.65;+33139,+33138,;.01~MAR 06, 2024@08:07:46
9999999.65;+33139,+33138,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+OS
9999999.65;+33140,+33138,;.01~MAR 06, 2024@08:08:58
9999999.65;+33141,+33138,;.01~AUG 08, 2024@12:54:16
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33139^1
33140^2
33141^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+OS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33137</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1697040039</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33137,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA FUL+ALP+OS
9999999.64;+33137,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33137,;.08~YES
9999999.64;+33137,;.1~FACTOR
9999999.64;+33137,;100~NATIONAL
9999999.64;+33137,;101~VHA ONCOLOGY
9999999.64;+33137,;200~BRCA Stage IV ER+ molecular target ID PIK3ca FUL+ALP+OS
9999999.64;+33137,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, PIK3CA, pre-menopausal; on pathway fulvestrant,
alpelisib and OS
9999999.65;+33138,+33137,;.01~MAR 06, 2024@08:04:03
9999999.65;+33138,+33137,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ MOLE ID PIK3CA CLIN TRIAL
9999999.65;+33139,+33137,;.01~MAR 06, 2024@08:07:14
9999999.65;+33140,+33137,;.01~AUG 08, 2024@12:54:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33138^1
33139^2
33140^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ MOLE ID PIK3CA CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33136</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2936228528</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33136,;.01~VA-ONC BRCA IV ER+ MOLE ID PIK3CA CLIN TRIAL
9999999.64;+33136,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33136,;.08~YES
9999999.64;+33136,;.1~FACTOR
9999999.64;+33136,;100~NATIONAL
9999999.64;+33136,;101~VHA ONCOLOGY
9999999.64;+33136,;200~BRCA Stage IV ER+ molecular target ID PIK3ca clinical trial
9999999.64;+33136,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; molecular target identified 
after adjuvant therapy, PIK3CA, on pathway clinical trial
9999999.65;+33137,+33136,;.01~MAR 06, 2024@07:57:39
9999999.65;+33137,+33136,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < 12M PRIOR CLIN TRIAL
9999999.65;+33138,+33136,;.01~MAR 06, 2024@08:02:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33137^1
33138^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; 12M PRIOR OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33120</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1000812191</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33120,;.01~VA-ONC BRCA IV ER+ < 12M PRIOR OFF PATH RSN
9999999.64;+33120,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33120,;.08~YES
9999999.64;+33120,;.1~FACTOR
9999999.64;+33120,;100~NATIONAL
9999999.64;+33120,;101~VHA ONCOLOGY
9999999.64;+33120,;200~BRCA Stage IV ER+ <12Mos prior/new dx off path reason
9999999.64;+33120,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; less than 12 months since prior
adjuvant therapy or newly diagnosed, off pathway reason
9999999.65;+33121,+33120,;.01~MAR 05, 2024@13:57:07
9999999.65;+33121,+33120,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < 12M PRIOR OFF PATH TX
9999999.65;+33122,+33120,;.01~MAR 05, 2024@13:58:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33121^1
33122^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; 12M PRIOR OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33118</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4144427162</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33118,;.01~VA-ONC BRCA IV ER+ < 12M PRIOR OFF PATH TX
9999999.64;+33118,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33118,;.08~YES
9999999.64;+33118,;.1~FACTOR
9999999.64;+33118,;100~NATIONAL
9999999.64;+33118,;101~VHA ONCOLOGY
9999999.64;+33118,;200~BRCA Stage IV ER+ <12Mos prior/new dx off path treatment
9999999.64;+33118,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; less than 12 months since prior
adjuvant therapy or newly diagnosed, off pathway treatment
9999999.65;+33119,+33118,;.01~MAR 05, 2024@13:52:38
9999999.65;+33119,+33118,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < 12M PRIOR CLIN TRIAL
9999999.65;+33120,+33118,;.01~MAR 05, 2024@13:54:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33119^1
33120^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; 12M PRIOR FULV+RIBO</POINT_01>
<INTERNAL_ENTRY_NUMBER>33115</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3761077080</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33115,;.01~VA-ONC BRCA IV ER+ < 12M PRIOR FULV+RIBO
9999999.64;+33115,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33115,;.08~YES
9999999.64;+33115,;.1~FACTOR
9999999.64;+33115,;100~NATIONAL
9999999.64;+33115,;101~VHA ONCOLOGY
9999999.64;+33115,;200~BRCA Stage IV ER+ <12Mos prior/new dx fulvestrant+ribociclid
9999999.64;+33115,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; less than 12 months since prior
adjuvant therapy or newly diagnosed, on pathway fulvestrant and ribociclid
9999999.65;+33116,+33115,;.01~MAR 05, 2024@13:48:45
9999999.65;+33116,+33115,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ < 12M PRIOR CLIN TRIAL
9999999.65;+33117,+33115,;.01~MAR 05, 2024@13:50:26
9999999.65;+33118,+33115,;.01~MAR 05, 2024@13:54:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33116^1
33117^2
33118^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &lt; 12M PRIOR CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33114</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>701967960</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33114,;.01~VA-ONC BRCA IV ER+ < 12M PRIOR CLIN TRIAL
9999999.64;+33114,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33114,;.08~YES
9999999.64;+33114,;.1~FACTOR
9999999.64;+33114,;100~NATIONAL
9999999.64;+33114,;101~VHA ONCOLOGY
9999999.64;+33114,;200~BRCA Stage IV ER+ <12Mos prior/new dx clinical trial
9999999.64;+33114,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; less than 12 months since prior
adjuvant therapy or newly diagnosed, on pathway clinical trial
9999999.65;+33115,+33114,;.01~MAR 05, 2024@13:45:34
9999999.65;+33115,+33114,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR CLIN TRIAL
9999999.65;+33116,+33114,;.01~MAR 05, 2024@13:48:14
9999999.65;+33117,+33114,;.01~MAR 05, 2024@13:54:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33115^1
33116^2
33117^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33113</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3758589829</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33113,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR OFF PATH RSN
9999999.64;+33113,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33113,;.08~YES
9999999.64;+33113,;.1~FACTOR
9999999.64;+33113,;100~NATIONAL
9999999.64;+33113,;101~VHA ONCOLOGY
9999999.64;+33113,;200~BRCA Stage IV ER+ >12Mos prior/new dx off path reason
9999999.64;+33113,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, off pathway reason
9999999.65;+33114,+33113,;.01~MAR 05, 2024@13:41:41
9999999.65;+33114,+33113,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR OFF PATH TX
9999999.65;+33115,+33113,;.01~MAR 05, 2024@13:42:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33114^1
33115^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33112</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1259441289</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33112,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR OFF PATH TX
9999999.64;+33112,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33112,;.08~YES
9999999.64;+33112,;.1~FACTOR
9999999.64;+33112,;100~NATIONAL
9999999.64;+33112,;101~VHA ONCOLOGY
9999999.64;+33112,;200~BRCA Stage IV ER+ >12Mos prior/new dx off path treatment
9999999.64;+33112,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, off pathway treatment
9999999.65;+33113,+33112,;.01~MAR 05, 2024@13:34:07
9999999.65;+33113,+33112,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR CLIN TRIAL
9999999.65;+33114,+33112,;.01~MAR 05, 2024@13:40:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33113^1
33114^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR ANAS+RIBO+ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>33111</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3346147712</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33111,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+ADT
9999999.64;+33111,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33111,;.08~YES
9999999.64;+33111,;.1~FACTOR
9999999.64;+33111,;100~NATIONAL
9999999.64;+33111,;101~VHA ONCOLOGY
9999999.64;+33111,;200~BRCA Stage IV ER+ >12Mos prior/new dx anast+ribo+ADT
9999999.64;+33111,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, pre-menopausal; on pathway
anastrozole and ribociclib and ADT
9999999.65;+33112,+33111,;.01~MAR 05, 2024@13:23:22
9999999.65;+33112,+33111,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+OS
9999999.65;+33113,+33111,;.01~MAR 05, 2024@13:28
9999999.65;+33114,+33111,;.01~AUG 08, 2024@12:44:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33112^1
33113^2
33114^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR ANAS+RIBO+OS</POINT_01>
<INTERNAL_ENTRY_NUMBER>33110</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1467838493</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33110,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR ANAS+RIBO+OS
9999999.64;+33110,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33110,;.08~YES
9999999.64;+33110,;.1~FACTOR
9999999.64;+33110,;100~NATIONAL
9999999.64;+33110,;101~VHA ONCOLOGY
9999999.64;+33110,;200~BRCA Stage IV ER+ >12Mos prior/new dx anast+ribo+OS
9999999.64;+33110,;201~WP-start~3
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, pre-menopausal; on pathway
anastrozole and ribociclib and OS
9999999.65;+33111,+33110,;.01~MAR 05, 2024@13:19:26
9999999.65;+33111,+33110,;2~WP-start~1
Copied from VA-ONC BRCA IV ER+ > 12M PRIOR CLIN TRIAL
9999999.65;+33112,+33110,;.01~MAR 05, 2024@13:22:32
9999999.65;+33113,+33110,;.01~AUG 08, 2024@12:45:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33111^1
33112^2
33113^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ER+ &gt; 12M PRIOR CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33109</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2120574928</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33109,;.01~VA-ONC BRCA IV ER+ > 12M PRIOR CLIN TRIAL
9999999.64;+33109,;.03~VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
9999999.64;+33109,;.08~YES
9999999.64;+33109,;.1~FACTOR
9999999.64;+33109,;100~NATIONAL
9999999.64;+33109,;101~VHA ONCOLOGY
9999999.64;+33109,;200~BRCA Stage IV ER+ >12Mos prior/new dx clinical trial
9999999.64;+33109,;201~WP-start~2
Breast Cancer-Stage IV ER+ or PR+/HER2-; 12 or more months since prior 
adjuvant therapy or newly diagnosed, on pathway clinical trial
9999999.65;+33110,+33109,;.01~MAR 05, 2024@13:12:37
9999999.65;+33110,+33109,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.65;+33111,+33109,;.01~MAR 05, 2024@13:17:41
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33110^1
33111^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>33086</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>964455434</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33086,;.01~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33086,;.08~YES
9999999.64;+33086,;.1~CATEGORY
9999999.64;+33086,;100~NATIONAL
9999999.64;+33086,;101~VHA ONCOLOGY
9999999.64;+33086,;200~Breast Cancer-Stage Recurrence Clinical Pathway
9999999.64;+33086,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage Recurrence 
Clinical Pathway
9999999.65;+33087,+33086,;.01~MAR 05, 2024@06:41:41
9999999.65;+33087,+33086,;2~WP-start~1
Copied from VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY
9999999.65;+33088,+33086,;.01~MAR 05, 2024@06:42:57
9999999.65;+33089,+33086,;.01~DEC 03, 2024@13:59:12
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33087^1
33088^2
33089^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33105</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2727629657</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33105,;.01~VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD OFF PATH RSN
9999999.64;+33105,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33105,;.08~YES
9999999.64;+33105,;.1~FACTOR
9999999.64;+33105,;100~NATIONAL
9999999.64;+33105,;101~VHA ONCOLOGY
9999999.64;+33105,;200~BRCA Stage Recur neoadj tx cand prior rad off path reason
9999999.64;+33105,;201~WP-start~3
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, off pathway 
reason
9999999.65;+33106,+33105,;.01~MAR 05, 2024@11:52:07
9999999.65;+33106,+33105,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD OFF PATH TX
9999999.65;+33107,+33105,;.01~MAR 05, 2024@11:52:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33106^1
33107^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ SYST TX CANDIDATE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33104</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2605082671</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33104,;.01~VA-ONC BRCA RECUR NOT NEOADJ SYST TX CANDIDATE
9999999.64;+33104,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33104,;.08~YES
9999999.64;+33104,;.1~FACTOR
9999999.64;+33104,;.11~INACTIVE
9999999.64;+33104,;100~NATIONAL
9999999.64;+33104,;101~VHA ONCOLOGY
9999999.64;+33104,;200~BRCA Stage Recur not neoadj systemic therapy candidate
9999999.64;+33104,;201~WP-start~2
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, neither on or off pathway
9999999.65;+33105,+33104,;.01~MAR 05, 2024@11:29:07
9999999.65;+33105,+33104,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ SYST TX CANDIDATE
9999999.65;+33106,+33104,;.01~MAR 05, 2024@11:30:45
9999999.65;+33107,+33104,;.01~SEP 18, 2024@06:08:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33105^1
33106^2
33107^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ SYST TX CANDIDATE</POINT_01>
<INTERNAL_ENTRY_NUMBER>33103</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2501348054</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33103,;.01~VA-ONC BRCA RECUR NEOADJ SYST TX CANDIDATE
9999999.64;+33103,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33103,;.08~YES
9999999.64;+33103,;.1~FACTOR
9999999.64;+33103,;.11~INACTIVE
9999999.64;+33103,;100~NATIONAL
9999999.64;+33103,;101~VHA ONCOLOGY
9999999.64;+33103,;200~BRCA Stage Recur neoadj systemic therapy candidate
9999999.64;+33103,;201~WP-start~2
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, neither on or off pathway
9999999.65;+33104,+33103,;.01~MAR 05, 2024@11:24:56
9999999.65;+33104,+33103,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD CLIN TRIAL
9999999.65;+33105,+33103,;.01~MAR 05, 2024@11:28:36
9999999.65;+33106,+33103,;.01~SEP 18, 2024@06:07:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33104^1
33105^2
33106^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33102</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3107036292</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33102,;.01~VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD OFF PATH TX
9999999.64;+33102,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33102,;.08~YES
9999999.64;+33102,;.1~FACTOR
9999999.64;+33102,;100~NATIONAL
9999999.64;+33102,;101~VHA ONCOLOGY
9999999.64;+33102,;200~BRCA Stage Recur neoadj tx cand prior rad off path treatment
9999999.64;+33102,;201~WP-start~3
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, off pathway 
treatment
9999999.65;+33103,+33102,;.01~MAR 05, 2024@10:17:54
9999999.65;+33103,+33102,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD CLIN TRIAL
9999999.65;+33104,+33102,;.01~MAR 05, 2024@10:19:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33103^1
33104^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD MAST+NODE EVAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33101</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>956458002</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33101,;.01~VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD MAST+NODE EVAL
9999999.64;+33101,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33101,;.08~YES
9999999.64;+33101,;.1~FACTOR
9999999.64;+33101,;100~NATIONAL
9999999.64;+33101,;101~VHA ONCOLOGY
9999999.64;+33101,;200~BRCA Stage Recur neoadj tx cand prior rad mast+surg node eval
9999999.64;+33101,;201~WP-start~4
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, on pathway 
mastectomy and surgical nodal evaluation then refer to Medical Oncology 
to discuss adjuvant therapy
9999999.65;+33102,+33101,;.01~MAR 05, 2024@10:11:40
9999999.65;+33102,+33101,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD CLIN TRIAL
9999999.65;+33103,+33101,;.01~MAR 05, 2024@10:13:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33102^1
33103^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33100</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3675235030</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33100,;.01~VA-ONC BRCA RECUR NEOADJ TX PRIOR RAD CLIN TRIAL
9999999.64;+33100,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33100,;.08~YES
9999999.64;+33100,;.1~FACTOR
9999999.64;+33100,;100~NATIONAL
9999999.64;+33100,;101~VHA ONCOLOGY
9999999.64;+33100,;200~BRCA Stage Recur neoadj tx cand prior radiation clin trial
9999999.64;+33100,;201~WP-start~3
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, on pathway
clinical trial
9999999.65;+33101,+33100,;.01~MAR 05, 2024@10:07:58
9999999.65;+33101,+33100,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD CLIN TRIAL
9999999.65;+33102,+33100,;.01~MAR 05, 2024@10:09:47
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33101^1
33102^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33099</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1895898596</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33099,;.01~VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD OFF PATH RSN
9999999.64;+33099,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33099,;.08~YES
9999999.64;+33099,;.1~FACTOR
9999999.64;+33099,;100~NATIONAL
9999999.64;+33099,;101~VHA ONCOLOGY
9999999.64;+33099,;200~BRCA Stage Recur neoadj tx cand no prior rad off path reason
9999999.64;+33099,;201~WP-start~3
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, off
pathway reason
9999999.65;+33100,+33099,;.01~MAR 05, 2024@09:19:10
9999999.65;+33100,+33099,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD OFF PATH TX
9999999.65;+33101,+33099,;.01~MAR 05, 2024@09:20:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33100^1
33101^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33098</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1735094953</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33098,;.01~VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD OFF PATH TX
9999999.64;+33098,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33098,;.08~YES
9999999.64;+33098,;.1~FACTOR
9999999.64;+33098,;100~NATIONAL
9999999.64;+33098,;101~VHA ONCOLOGY
9999999.64;+33098,;200~BRCA Stage Recur neoadj tx cand no prior rad off path treatment
9999999.64;+33098,;201~WP-start~3
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, off
pathway treatment
9999999.65;+33099,+33098,;.01~MAR 05, 2024@09:16:35
9999999.65;+33099,+33098,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD CLIN TRIAL
9999999.65;+33100,+33098,;.01~MAR 05, 2024@09:18:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33099^1
33100^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD RESECT+NODE EVAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33097</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>780354726</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33097,;.01~VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD RESECT+NODE EVAL
9999999.64;+33097,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33097,;.08~YES
9999999.64;+33097,;.1~FACTOR
9999999.64;+33097,;100~NATIONAL
9999999.64;+33097,;101~VHA ONCOLOGY
9999999.64;+33097,;200~BRCA Stage Recur neoadj cand no prior rad surg resect+node eval
9999999.64;+33097,;201~WP-start~4
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, on pathway
surgical resection followed by radiation then refer to Medical Oncology 
to discuss adjuvant therapy
9999999.65;+33098,+33097,;.01~MAR 05, 2024@09:01:35
9999999.65;+33098,+33097,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD CLIN TRIAL
9999999.65;+33099,+33097,;.01~MAR 05, 2024@09:07:36
9999999.65;+33100,+33097,;.01~MAR 05, 2024@10:17:21
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33098^1
33099^2
33100^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33096</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3059713529</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33096,;.01~VA-ONC BRCA RECUR NEOADJ TX NO PRIOR RAD CLIN TRIAL
9999999.64;+33096,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33096,;.08~YES
9999999.64;+33096,;.1~FACTOR
9999999.64;+33096,;100~NATIONAL
9999999.64;+33096,;101~VHA ONCOLOGY
9999999.64;+33096,;200~BRCA Stage Recur neoadj tx cand no prior radiation clin trial
9999999.64;+33096,;201~WP-start~3
Breast Cancer-Stage Recurrence; candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, on pathway
clinical trial
9999999.65;+33097,+33096,;.01~MAR 05, 2024@08:58:49
9999999.65;+33097,+33096,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD CLIN TRIAL
9999999.65;+33098,+33096,;.01~MAR 05, 2024@09:00:07
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33097^1
33098^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33095</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1056271446</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33095,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD OFF PATH RSN
9999999.64;+33095,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33095,;.08~YES
9999999.64;+33095,;.1~FACTOR
9999999.64;+33095,;100~NATIONAL
9999999.64;+33095,;101~VHA ONCOLOGY
9999999.64;+33095,;200~BRCA Stage Recur not neoadj no prior rad off pathway reason
9999999.64;+33095,;201~WP-start~3
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, off 
pathway reason
9999999.65;+33096,+33095,;.01~MAR 05, 2024@08:06:51
9999999.65;+33096,+33095,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NO PRIOR RAD OFF PATH TX
9999999.65;+33097,+33095,;.01~MAR 05, 2024@08:07:28
9999999.65;+33098,+33095,;.01~MAR 05, 2024@08:41:45
9999999.65;+33099,+33095,;.01~MAR 05, 2024@08:54:24
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33096^1
33097^2
33098^3
33099^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33094</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1969858086</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33094,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD OFF PATH TX
9999999.64;+33094,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33094,;.08~YES
9999999.64;+33094,;.1~FACTOR
9999999.64;+33094,;100~NATIONAL
9999999.64;+33094,;101~VHA ONCOLOGY
9999999.64;+33094,;200~BRCA Stage Recur not neoadj no prior rad off pathway treatment
9999999.64;+33094,;201~WP-start~3
reast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, off 
pathway treatment
9999999.65;+33095,+33094,;.01~MAR 05, 2024@08:00:46
9999999.65;+33095,+33094,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NO PRIOR RAD CLIN TRIAL
9999999.65;+33096,+33094,;.01~MAR 05, 2024@08:06:19
9999999.65;+33097,+33094,;.01~MAR 05, 2024@08:40:34
9999999.65;+33098,+33094,;.01~MAR 05, 2024@08:53:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33095^1
33096^2
33097^3
33098^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD RESECT+NODE EVAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33093</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1674266550</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33093,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD RESECT+NODE EVAL
9999999.64;+33093,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33093,;.08~YES
9999999.64;+33093,;.1~FACTOR
9999999.64;+33093,;100~NATIONAL
9999999.64;+33093,;101~VHA ONCOLOGY
9999999.64;+33093,;200~BRCA Stage Recur not neoadj no prior rad surg resect+node eval
9999999.64;+33093,;201~WP-start~4
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, on 
pathway surgical resection followed by radiation then refer to medical 
oncology to discuss adjuvant therapy
9999999.65;+33094,+33093,;.01~MAR 05, 2024@07:50:59
9999999.65;+33094,+33093,;2~WP-start~1
Copied from VA-ONC BRCA RECUR NO PRIOR RAD CLIN TRIAL
9999999.65;+33095,+33093,;.01~MAR 05, 2024@07:55:51
9999999.65;+33096,+33093,;.01~MAR 05, 2024@08:39:22
9999999.65;+33097,+33093,;.01~MAR 05, 2024@08:52:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33094^1
33095^2
33096^3
33097^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33092</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>753133868</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33092,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX NO PRIOR RAD CLIN TRIAL
9999999.64;+33092,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33092,;.08~YES
9999999.64;+33092,;.1~FACTOR
9999999.64;+33092,;100~NATIONAL
9999999.64;+33092,;101~VHA ONCOLOGY
9999999.64;+33092,;200~BRCA Stage Recur not neoadj cand no prior rad clin trial
9999999.64;+33092,;201~WP-start~3
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, no prior radiation therapy, on pathway
clinical trial
9999999.65;+33093,+33092,;.01~MAR 05, 2024@07:48:04
9999999.65;+33093,+33092,;2~WP-start~1
Copied from VA-ONC BRCA RECUR PRIOR RAD CLIN TRIAL
9999999.65;+33094,+33092,;.01~MAR 05, 2024@07:49:43
9999999.65;+33095,+33092,;.01~MAR 05, 2024@08:37:18
9999999.65;+33096,+33092,;.01~MAR 05, 2024@08:49:52
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33093^1
33094^2
33095^3
33096^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33091</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1204511350</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33091,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD OFF PATH RSN
9999999.64;+33091,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33091,;.08~YES
9999999.64;+33091,;.1~FACTOR
9999999.64;+33091,;100~NATIONAL
9999999.64;+33091,;101~VHA ONCOLOGY
9999999.64;+33091,;200~BRCA Stage Recur not neoadj cand prior radiation off path reason
9999999.64;+33091,;201~WP-start~3
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, off pathway 
reason
9999999.65;+33092,+33091,;.01~MAR 05, 2024@07:46:03
9999999.65;+33092,+33091,;2~WP-start~1
Copied from VA-ONC BRCA RECUR PRIOR RAD OFF PATH TX
9999999.65;+33093,+33091,;.01~MAR 05, 2024@07:46:33
9999999.65;+33094,+33091,;.01~MAR 05, 2024@08:29:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33092^1
33093^2
33094^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33090</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2781165702</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33090,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD OFF PATH TX
9999999.64;+33090,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33090,;.08~YES
9999999.64;+33090,;.1~FACTOR
9999999.64;+33090,;100~NATIONAL
9999999.64;+33090,;101~VHA ONCOLOGY
9999999.64;+33090,;200~BRCA Stage Recur not neoadj cand prior rad off path treatment
9999999.64;+33090,;201~WP-start~3
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, off pathway 
treatment
9999999.65;+33091,+33090,;.01~MAR 05, 2024@07:42:47
9999999.65;+33091,+33090,;2~WP-start~1
Copied from VA-ONC BRCA RECUR PRIOR RAD CLIN TRIAL
9999999.65;+33092,+33090,;.01~MAR 05, 2024@07:45:02
9999999.65;+33093,+33090,;.01~MAR 05, 2024@08:25:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33091^1
33092^2
33093^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD MAST+NODE EVAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33089</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3384242449</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33089,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD MAST+NODE EVAL
9999999.64;+33089,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33089,;.08~YES
9999999.64;+33089,;.1~FACTOR
9999999.64;+33089,;100~NATIONAL
9999999.64;+33089,;101~VHA ONCOLOGY
9999999.64;+33089,;200~BRCA Stage Recur not neoadj cand prior rad mast+surg node eval
9999999.64;+33089,;201~WP-start~4
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, on pathway 
on pathway mastectomy and surgical nodal evaluation then refer to Medical 
Oncology to discuss
9999999.65;+33090,+33089,;.01~MAR 05, 2024@07:28:12
9999999.65;+33090,+33089,;2~WP-start~1
Copied from VA-ONC BRCA RECUR PRIOR RAD CLIN TRIAL
9999999.65;+33091,+33089,;.01~MAR 05, 2024@07:34:26
9999999.65;+33092,+33089,;.01~MAR 05, 2024@07:42
9999999.65;+33093,+33089,;.01~MAR 05, 2024@08:22:34
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33090^1
33091^2
33092^3
33093^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33088</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2047319212</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33088,;.01~VA-ONC BRCA RECUR NOT NEOADJ TX PRIOR RAD CLIN TRIAL
9999999.64;+33088,;.03~VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
9999999.64;+33088,;.08~YES
9999999.64;+33088,;.1~FACTOR
9999999.64;+33088,;100~NATIONAL
9999999.64;+33088,;101~VHA ONCOLOGY
9999999.64;+33088,;200~BRCA Stage Recur not neoadj tx cand prior radiation clin trial
9999999.64;+33088,;201~WP-start~3
Breast Cancer-Stage Recurrence; not a candidate for neoadjuvant systemic 
therapy, cancer location in breast, prior radiation therapy, on pathway
clinical trial
9999999.65;+33089,+33088,;.01~MAR 05, 2024@07:19:40
9999999.65;+33089,+33088,;2~WP-start~1
Copied from VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
9999999.65;+33090,+33088,;.01~MAR 05, 2024@07:24:32
9999999.65;+33091,+33088,;.01~MAR 05, 2024@07:25:43
9999999.65;+33092,+33088,;.01~MAR 05, 2024@08:15:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33089^1
33090^2
33091^3
33092^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP &lt;5 PREFER OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33370</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3607787178</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33370,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER OFF PATH RSN
9999999.64;+33370,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33370,;.08~YES
9999999.64;+33370,;.1~FACTOR
9999999.64;+33370,;100~NATIONAL
9999999.64;+33370,;101~VHA ONCOLOGY
9999999.64;+33370,;200~BRCA Adj Hormone Tx female Node+ post men+anas 5y off path rsn
9999999.64;+33370,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; after 
anastrozole for 5 years, off pathway reason
9999999.65;+33371,+33370,;.01~MAR 20, 2024@09:53:08
9999999.65;+33371,+33370,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER OFF PATH TX
9999999.65;+33372,+33370,;.01~MAR 20, 2024@09:53:45
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33371^1
33372^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP &lt;5 PREFER OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33369</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1134061240</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33369,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER OFF PATH TX
9999999.64;+33369,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33369,;.08~YES
9999999.64;+33369,;.1~FACTOR
9999999.64;+33369,;100~NATIONAL
9999999.64;+33369,;101~VHA ONCOLOGY
9999999.64;+33369,;200~BRCA Adj Hormone Tx female Node+ post men+anas 5y off path tx
9999999.64;+33369,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; after 
anastrozole for 5 years, off pathway treatment
9999999.65;+33370,+33369,;.01~MAR 20, 2024@09:49:41
9999999.65;+33370,+33369,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER CLIN TRIAL
9999999.65;+33371,+33369,;.01~MAR 20, 2024@09:51:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33370^1
33371^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP &lt;5 PREFER CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33365</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2447693456</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33365,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER CLIN TRIAL
9999999.64;+33365,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33365,;.08~YES
9999999.64;+33365,;.1~FACTOR
9999999.64;+33365,;100~NATIONAL
9999999.64;+33365,;101~VHA ONCOLOGY
9999999.64;+33365,;200~BRCA Adj Hormone Tx female Node+ post men+anas 5y clin trial
9999999.64;+33365,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, not tumor 5 cm or more or histologic grade 3; after 
anastrozole for 5 years, on pathway clinical trial
9999999.65;+33366,+33365,;.01~MAR 20, 2024@09:08:16
9999999.65;+33366,+33365,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 CLIN TRIAL
9999999.65;+33367,+33365,;.01~MAR 20, 2024@09:28:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33366^1
33367^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>33356</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3749203627</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33356,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER OFF PATH RSN
9999999.64;+33356,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33356,;.08~YES
9999999.64;+33356,;.1~FACTOR
9999999.64;+33356,;100~NATIONAL
9999999.64;+33356,;101~VHA ONCOLOGY
9999999.64;+33356,;200~BRCA Adj Hormone Tx Node+ post-men >= HER2+ prefer off path rsn
9999999.64;+33356,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3 HER2+; after 
initial anastrozole for 5 years, off pathway reason
9999999.65;+33357,+33356,;.01~MAR 20, 2024@07:04:11
9999999.65;+33357,+33356,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER OFF PATH TX
9999999.65;+33358,+33356,;.01~MAR 20, 2024@07:07:08
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33357^1
33358^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>33355</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1717852573</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33355,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER OFF PATH TX
9999999.64;+33355,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33355,;.08~YES
9999999.64;+33355,;.1~FACTOR
9999999.64;+33355,;100~NATIONAL
9999999.64;+33355,;101~VHA ONCOLOGY
9999999.64;+33355,;200~BRCA Adj Hormone Tx Node+ post-men >= HER2+ prefer off path tx
9999999.64;+33355,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3 HER2+; after 
initial anastrozole for 5 years, off pathway treatment
9999999.65;+33356,+33355,;.01~MAR 20, 2024@06:56:13
9999999.65;+33356,+33355,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER CLIN TRIAL
9999999.65;+33357,+33355,;.01~MAR 20, 2024@06:57:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33356^1
33357^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>33353</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>258316549</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+33353,;.01~VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER CLIN TRIAL
9999999.64;+33353,;.03~VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
9999999.64;+33353,;.08~YES
9999999.64;+33353,;.1~FACTOR
9999999.64;+33353,;100~NATIONAL
9999999.64;+33353,;101~VHA ONCOLOGY
9999999.64;+33353,;200~BRCA Adj Hormone Tx Node+ post-men >= HER2+ prefer clin trial 
9999999.64;+33353,;201~WP-start~4
Breast Cancer- Adjuvant Hormone Therapy Treatment; Node+, histologic 
grade 3, tumor 2cm or more, or received chemotherapy, Female, 
post-menopausal, tumor 5cm or more or histologic grade 3 HER2+; after 
initial anastrozole for 5 years, on pathway clinical trial
9999999.65;+33354,+33353,;.01~MAR 20, 2024@06:07:24
9999999.65;+33354,+33353,;2~WP-start~1
Copied from VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ ANAS 7-8Y
9999999.65;+33355,+33353,;.01~MAR 20, 2024@06:15:48
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
33354^1
33355^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR POS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>36581</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2865247472</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36581,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR POS OFF PATH RSN
9999999.64;+36581,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36581,;.08~YES
9999999.64;+36581,;.1~FACTOR
9999999.64;+36581,;100~NATIONAL
9999999.64;+36581,;101~VHA ONCOLOGY
9999999.64;+36581,;200~BRCA Stage I-III Any ER N0 ER/PR Positive Off Path TX
9999999.64;+36581,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
positve after adjuvant therapy, off pathway reason
9999999.65;+36582,+36581,;.01~AUG 03, 2024@12:16:09
9999999.65;+36582,+36581,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR POS OFF PATH TX
9999999.65;+36583,+36581,;.01~AUG 03, 2024@12:16:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36582^1
36583^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR POS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>36580</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3795674082</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36580,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR POS OFF PATH TX
9999999.64;+36580,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36580,;.08~YES
9999999.64;+36580,;.1~FACTOR
9999999.64;+36580,;100~NATIONAL
9999999.64;+36580,;101~VHA ONCOLOGY
9999999.64;+36580,;200~BRCA Stage I-III Any ER N0 ER/PR Positive Off Path TX
9999999.64;+36580,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
positve after adjuvant therapy, off pathway treatment
9999999.65;+36581,+36580,;.01~AUG 03, 2024@12:14:46
9999999.65;+36581,+36580,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR POS CLIN TRIAL
9999999.65;+36582,+36580,;.01~AUG 03, 2024@12:15:21
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36581^1
36582^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR POS FOLLOW ADJ HT</POINT_01>
<INTERNAL_ENTRY_NUMBER>36579</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1173804826</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36579,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR POS FOLLOW ADJ HT
9999999.64;+36579,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36579,;.08~YES
9999999.64;+36579,;.1~FACTOR
9999999.64;+36579,;100~NATIONAL
9999999.64;+36579,;101~VHA ONCOLOGY
9999999.64;+36579,;200~BRCA Stage I-III Any ER N0 ER/PR Positive Follow Adj HT Any
9999999.64;+36579,;201~WP-start~3
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
positve after adjuvant therapy, on pathway follow adjuvant hormone 
therapy for ER+ or PR+/HER2 Any pathway
9999999.65;+36580,+36579,;.01~AUG 03, 2024@12:11:19
9999999.65;+36580,+36579,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N0 ER/PR POS CLIN TRIAL
9999999.65;+36581,+36579,;.01~AUG 03, 2024@12:12:55
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36580^1
36581^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>36578</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2657456508</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+36578,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR POS CLIN TRIAL
9999999.64;+36578,;.03~VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
9999999.64;+36578,;.08~YES
9999999.64;+36578,;.1~FACTOR
9999999.64;+36578,;100~NATIONAL
9999999.64;+36578,;101~VHA ONCOLOGY
9999999.64;+36578,;200~BRCA Stage I-III Any ER N0 ER/PR Positive Clin Trial
9999999.64;+36578,;201~WP-start~2
Breast Cancer-Stage I-III Any ER or PR/HER2+, clinical stage N0; ER/PR 
positve after adjuvant therapy, on pathway clinical trial
9999999.65;+36579,+36578,;.01~AUG 03, 2024@12:07:12
9999999.65;+36579,+36578,;2~WP-start~1
Copied from VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL
9999999.65;+36580,+36578,;.01~AUG 03, 2024@12:08:10
9999999.65;+36581,+36578,;.01~AUG 03, 2024@12:10:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
36579^1
36580^2
36581^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER BC N0 &gt; NODE+ AX DISSECT</POINT_01>
<INTERNAL_ENTRY_NUMBER>32821</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4159249147</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32821,;.01~VA-ONC BRCA LRM AFTER BC N0 > NODE+ AX DISSECT
9999999.64;+32821,;.03~VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
9999999.64;+32821,;.08~YES
9999999.64;+32821,;.1~FACTOR
9999999.64;+32821,;100~NATIONAL
9999999.64;+32821,;101~VHA ONCOLOGY
9999999.64;+32821,;200~BRCA LRM AFTER breast conserve N0 >1 Node+ axill dissection
9999999.64;+32821,;201~WP-start~3
Breast Cancer-Local/Regional Management After Neoadjuvant Treatment, 
Node N0; breast conservation candidate, >1 Node+, on pathway clinical
trial
9999999.65;+32822,+32821,;.01~FEB 26, 2024@09:22:41
9999999.65;+32822,+32821,;2~WP-start~1
Copied from VA-ONC BRCA LRM AFTER BC N0 > NODE+ CLIN TRIAL
9999999.65;+32823,+32821,;.01~FEB 26, 2024@09:27:27
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32822^1
32823^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32771</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3071064822</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32771,;.01~VA-ONC BRCA LRM PRIOR NOT BC N1 OFF PATH RSN
9999999.64;+32771,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32771,;.08~YES
9999999.64;+32771,;.1~FACTOR
9999999.64;+32771,;100~NATIONAL
9999999.64;+32771,;101~VHA ONCOLOGY
9999999.64;+32771,;200~BRCA LRM PRIOR not breast conserve cand N1 off path reason
9999999.64;+32771,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; not a breast conservation candidate, off pathway reason
9999999.65;+32772,+32771,;.01~FEB 22, 2024@08:14:46
9999999.65;+32772,+32771,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH RSN
9999999.65;+32773,+32771,;.01~FEB 22, 2024@08:15:30
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32772^1
32773^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32770</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>370684470</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32770,;.01~VA-ONC BRCA LRM PRIOR NOT BC N1 OFF PATH TX
9999999.64;+32770,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32770,;.08~YES
9999999.64;+32770,;.1~FACTOR
9999999.64;+32770,;100~NATIONAL
9999999.64;+32770,;101~VHA ONCOLOGY
9999999.64;+32770,;200~BRCA LRM PRIOR not breast conserve cand N1 off path treatment
9999999.64;+32770,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; not a breast conservation candidate, off pathway treatment
9999999.65;+32771,+32770,;.01~FEB 22, 2024@08:13:59
9999999.65;+32771,+32770,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH TX
9999999.65;+32772,+32770,;.01~FEB 22, 2024@08:14:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32771^1
32772^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N1 MRM</POINT_01>
<INTERNAL_ENTRY_NUMBER>32769</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2982495167</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32769,;.01~VA-ONC BRCA LRM PRIOR NOT BC N1 MRM
9999999.64;+32769,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32769,;.08~YES
9999999.64;+32769,;.1~FACTOR
9999999.64;+32769,;100~NATIONAL
9999999.64;+32769,;101~VHA ONCOLOGY
9999999.64;+32769,;200~BRCA LRM PRIOR not breast conserve cand N1 MRM
9999999.64;+32769,;201~WP-start~3
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; not a breast conservation candidate, on pathway modified radical
mastectomy (includes axillary dissection)
9999999.65;+32770,+32769,;.01~FEB 22, 2024@08:11:30
9999999.65;+32770,+32769,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 MAST+AX
9999999.65;+32771,+32769,;.01~FEB 22, 2024@08:13:35
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32770^1
32771^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NOT BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32768</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2275122113</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32768,;.01~VA-ONC BRCA LRM PRIOR NOT BC N1 CLIN TRIAL
9999999.64;+32768,;.03~VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
9999999.64;+32768,;.08~YES
9999999.64;+32768,;.1~FACTOR
9999999.64;+32768,;100~NATIONAL
9999999.64;+32768,;101~VHA ONCOLOGY
9999999.64;+32768,;200~BRCA LRM PRIOR not breast conserve cand N1 clinical trial
9999999.64;+32768,;201~WP-start~2
Breast Cancer-Local/Regional Management Prior to Adjuvant Treatment, 
stage N1; not a breast conservation candidate, on pathway clinical trial
9999999.65;+32769,+32768,;.01~FEB 22, 2024@08:10:16
9999999.65;+32769,+32768,;2~WP-start~1
Copied from VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL
9999999.65;+32770,+32768,;.01~FEB 22, 2024@08:10:44
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32769^1
32770^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>32720</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>222799770</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32720,;.01~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32720,;.08~YES
9999999.64;+32720,;.1~CATEGORY
9999999.64;+32720,;100~NATIONAL
9999999.64;+32720,;101~VHA ONCOLOGY
9999999.64;+32720,;200~Breast Cancer-Stage DCIS Clinical Pathway
9999999.64;+32720,;201~WP-start~2
Category for all health factors in Breast Cancer-Stage Ductal Carcinoma 
In Situ Clinical Pathway.
9999999.65;+32721,+32720,;.01~FEB 21, 2024@06:31:08
9999999.65;+32721,+32720,;2~WP-start~1
Copied from VA-ONC ESOPH STAGE I T1A+B CLINICAL PATHWAY [C]
9999999.65;+32722,+32720,;.01~FEB 21, 2024@06:37:28
9999999.65;+32723,+32720,;.01~DEC 03, 2024@13:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32721^1
32722^2
32723^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32752</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3797015921</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32752,;.01~VA-ONC BRCA DCIS ER NEG OFF PATH RSN
9999999.64;+32752,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32752,;.08~YES
9999999.64;+32752,;.1~FACTOR
9999999.64;+32752,;100~NATIONAL
9999999.64;+32752,;101~VHA ONCOLOGY
9999999.64;+32752,;200~BRCA DCIS ER Negative Off Path Reason
9999999.64;+32752,;201~WP-start~2
Breast Cancer-Stage DCIS; ER negative post radiation, off pathway 
reason
9999999.65;+32753,+32752,;.01~FEB 21, 2024@11:46:36
9999999.65;+32753,+32752,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER NEG OFF PATH TX
9999999.65;+32754,+32752,;.01~FEB 21, 2024@11:47:13
9999999.65;+32755,+32752,;.01~MAR 22, 2024@12:52:36
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32753^1
32754^2
32755^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32751</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2937889864</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32751,;.01~VA-ONC BRCA DCIS ER NEG OFF PATH TX
9999999.64;+32751,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32751,;.08~YES
9999999.64;+32751,;.1~FACTOR
9999999.64;+32751,;100~NATIONAL
9999999.64;+32751,;101~VHA ONCOLOGY
9999999.64;+32751,;200~BRCA DCIS ER Negative Off Path Treatment
9999999.64;+32751,;201~WP-start~2
Breast Cancer-Stage DCIS; ER negative post radiation, off pathway 
treatment
9999999.65;+32752,+32751,;.01~FEB 21, 2024@11:40:12
9999999.65;+32752,+32751,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER NEG CLIN TRIAL
9999999.65;+32753,+32751,;.01~FEB 21, 2024@11:46:12
9999999.65;+32754,+32751,;.01~MAR 22, 2024@12:53:26
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32752^1
32753^2
32754^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER NEG SURVEILLANCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>32750</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3343687029</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32750,;.01~VA-ONC BRCA DCIS ER NEG SURVEILLANCE
9999999.64;+32750,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32750,;.08~YES
9999999.64;+32750,;.1~FACTOR
9999999.64;+32750,;100~NATIONAL
9999999.64;+32750,;101~VHA ONCOLOGY
9999999.64;+32750,;200~BRCA DCIS ER Negative Surveillance
9999999.64;+32750,;201~WP-start~2
Breast Cancer-Stage DCIS; ER negative post radiation, on pathway 
surveillance
9999999.65;+32751,+32750,;.01~FEB 21, 2024@11:36:34
9999999.65;+32751,+32750,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER NEG CLIN TRIAL
9999999.65;+32752,+32750,;.01~FEB 21, 2024@11:37:51
9999999.65;+32753,+32750,;.01~MAR 22, 2024@12:52:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32751^1
32752^2
32753^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32749</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2579129756</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32749,;.01~VA-ONC BRCA DCIS ER NEG CLIN TRIAL
9999999.64;+32749,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32749,;.08~YES
9999999.64;+32749,;.1~FACTOR
9999999.64;+32749,;100~NATIONAL
9999999.64;+32749,;101~VHA ONCOLOGY
9999999.64;+32749,;200~BRCA DCIS ER Negative Clinical Trial
9999999.64;+32749,;201~WP-start~2
Breast Cancer-Stage DCIS; ER negative post radiation, on pathway clinical
trial
9999999.65;+32750,+32749,;.01~FEB 21, 2024@11:34:23
9999999.65;+32750,+32749,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ PRE-MEN CLIN TRIAL
9999999.65;+32751,+32749,;.01~FEB 21, 2024@11:35:53
9999999.65;+32752,+32749,;.01~MAR 22, 2024@12:51:37
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32750^1
32751^2
32752^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN NO ANA OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32748</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3027016121</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32748,;.01~VA-ONC BRCA DCIS ER+ POST-MEN NO ANA OFF PATH RSN
9999999.64;+32748,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32748,;.08~YES
9999999.64;+32748,;.1~FACTOR
9999999.64;+32748,;100~NATIONAL
9999999.64;+32748,;101~VHA ONCOLOGY
9999999.64;+32748,;200~BRCA DCIS ER+ Post-Menopause Not Anas Cand Off Path Reason
9999999.64;+32748,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, not
anastrozole candidate, off pathway reason
9999999.65;+32749,+32748,;.01~FEB 21, 2024@11:30:45
9999999.65;+32749,+32748,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN NO ANA TAMOX+SURV
9999999.65;+32750,+32748,;.01~FEB 21, 2024@11:31:45
9999999.65;+32751,+32748,;.01~MAR 22, 2024@13:02:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32749^1
32750^2
32751^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN NO ANA OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32747</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2324640467</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32747,;.01~VA-ONC BRCA DCIS ER+ POST-MEN NO ANA OFF PATH TX
9999999.64;+32747,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32747,;.08~YES
9999999.64;+32747,;.1~FACTOR
9999999.64;+32747,;100~NATIONAL
9999999.64;+32747,;101~VHA ONCOLOGY
9999999.64;+32747,;200~BRCA DCIS ER+ Post-Menopause Not Anas Cand Off Path Tx
9999999.64;+32747,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, not
anastrozole candidate, off pathway treatment
9999999.65;+32748,+32747,;.01~FEB 21, 2024@11:28
9999999.65;+32748,+32747,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN NO ANA CLIN TRIAL
9999999.65;+32749,+32747,;.01~FEB 21, 2024@11:30:14
9999999.65;+32750,+32747,;.01~MAR 22, 2024@13:01:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32748^1
32749^2
32750^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN NO ANA TAMOX+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>32746</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>238770496</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32746,;.01~VA-ONC BRCA DCIS ER+ POST-MEN NO ANA TAMOX+SURV
9999999.64;+32746,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32746,;.08~YES
9999999.64;+32746,;.1~FACTOR
9999999.64;+32746,;100~NATIONAL
9999999.64;+32746,;101~VHA ONCOLOGY
9999999.64;+32746,;200~BRCA DCIS ER+ Post-Menopause Not Anas Cand Tamox+Surv
9999999.64;+32746,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, not
anastrozole candidate, on pathway tamoxifen then surveillance
9999999.65;+32747,+32746,;.01~FEB 21, 2024@11:22:17
9999999.65;+32747,+32746,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN NO ANA CLIN TRIAL
9999999.65;+32748,+32746,;.01~FEB 21, 2024@11:24:51
9999999.65;+32749,+32746,;.01~MAR 22, 2024@13:01:15
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32747^1
32748^2
32749^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN NO ANA CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32745</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4065311037</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32745,;.01~VA-ONC BRCA DCIS ER+ POST-MEN NO ANA CLIN TRIAL
9999999.64;+32745,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32745,;.08~YES
9999999.64;+32745,;.1~FACTOR
9999999.64;+32745,;100~NATIONAL
9999999.64;+32745,;101~VHA ONCOLOGY
9999999.64;+32745,;200~BRCA DCIS ER+ Post-Menopause Not Anas Cand Clin Trial
9999999.64;+32745,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, not
anastrozole candidate, on pathway clinical trial
9999999.65;+32746,+32745,;.01~FEB 21, 2024@11:18
9999999.65;+32746,+32745,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN ANA CLIN TRIAL
9999999.65;+32747,+32745,;.01~FEB 21, 2024@11:21:37
9999999.65;+32748,+32745,;.01~MAR 22, 2024@13:00:31
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32746^1
32747^2
32748^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN ANA OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32744</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2195714502</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32744,;.01~VA-ONC BRCA DCIS ER+ POST-MEN ANA OFF PATH RSN
9999999.64;+32744,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32744,;.08~YES
9999999.64;+32744,;.1~FACTOR
9999999.64;+32744,;100~NATIONAL
9999999.64;+32744,;101~VHA ONCOLOGY
9999999.64;+32744,;200~BRCA DCIS ER+ Post-Menopause Anas Cand Off Path Reason
9999999.64;+32744,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, anastrozole 
candidate, off pathway reason
9999999.65;+32745,+32744,;.01~FEB 21, 2024@10:27:28
9999999.65;+32745,+32744,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN ANA OFF PATH TX
9999999.65;+32746,+32744,;.01~FEB 21, 2024@10:29:18
9999999.65;+32747,+32744,;.01~MAR 22, 2024@12:55:29
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32745^1
32746^2
32747^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN ANA OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32743</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2753432248</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32743,;.01~VA-ONC BRCA DCIS ER+ POST-MEN ANA OFF PATH TX
9999999.64;+32743,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32743,;.08~YES
9999999.64;+32743,;.1~FACTOR
9999999.64;+32743,;100~NATIONAL
9999999.64;+32743,;101~VHA ONCOLOGY
9999999.64;+32743,;200~BRCA DCIS ER+ Post-Menopause Anas Cand Off Path Treatment
9999999.64;+32743,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, anastrozole 
candidate, off pathway treatment
9999999.65;+32744,+32743,;.01~FEB 21, 2024@10:09:20
9999999.65;+32744,+32743,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN ANA CLIN TRIAL
9999999.65;+32745,+32743,;.01~FEB 21, 2024@10:11:13
9999999.65;+32746,+32743,;.01~MAR 22, 2024@12:56
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32744^1
32745^2
32746^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN ANASTROZOLE</POINT_01>
<INTERNAL_ENTRY_NUMBER>32742</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3626632178</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32742,;.01~VA-ONC BRCA DCIS ER+ POST-MEN ANASTROZOLE
9999999.64;+32742,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32742,;.08~YES
9999999.64;+32742,;.1~FACTOR
9999999.64;+32742,;100~NATIONAL
9999999.64;+32742,;101~VHA ONCOLOGY
9999999.64;+32742,;200~BRCA DCIS ER+ Post-Menopause Anastrozole+Surveillance
9999999.64;+32742,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, anastrozole 
candidate, on pathway anastrozole then surveillance
9999999.65;+32743,+32742,;.01~FEB 21, 2024@10:04:50
9999999.65;+32743,+32742,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ POST-MEN ANA CLIN TRIAL
9999999.65;+32744,+32742,;.01~FEB 21, 2024@10:06:26
9999999.65;+32745,+32742,;.01~FEB 21, 2024@11:15:58
9999999.65;+32746,+32742,;.01~MAR 22, 2024@12:58:58
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32743^1
32744^2
32745^3
32746^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ POST-MEN ANA CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32741</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3845203517</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32741,;.01~VA-ONC BRCA DCIS ER+ POST-MEN ANA CLIN TRIAL
9999999.64;+32741,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32741,;.08~YES
9999999.64;+32741,;.1~FACTOR
9999999.64;+32741,;100~NATIONAL
9999999.64;+32741,;101~VHA ONCOLOGY
9999999.64;+32741,;200~BRCA DCIS ER+ Post-Menopause Anas Cand Clinical Trial
9999999.64;+32741,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, post-menopause, anastrozole 
candidate, on pathway clinical trial
9999999.65;+32742,+32741,;.01~FEB 21, 2024@10:01:27
9999999.65;+32742,+32741,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ PRE-MEN CLIN TRIAL
9999999.65;+32743,+32741,;.01~FEB 21, 2024@10:03:52
9999999.65;+32744,+32741,;.01~MAR 22, 2024@12:55:04
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32742^1
32743^2
32744^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ PRE-MEN OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32740</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2241520626</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32740,;.01~VA-ONC BRCA DCIS ER+ PRE-MEN OFF PATH RSN
9999999.64;+32740,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32740,;.08~YES
9999999.64;+32740,;.1~FACTOR
9999999.64;+32740,;100~NATIONAL
9999999.64;+32740,;101~VHA ONCOLOGY
9999999.64;+32740,;200~BRCA DCIS ER+ Pre-Menopause Off Path Reason
9999999.64;+32740,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, pre-menopause, off pathway 
reason
9999999.65;+32741,+32740,;.01~FEB 21, 2024@09:26:40
9999999.65;+32741,+32740,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ PRE-MEN OFF PATH TX
9999999.65;+32742,+32740,;.01~FEB 21, 2024@09:27:24
9999999.65;+32743,+32740,;.01~MAR 22, 2024@13:03:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32741^1
32742^2
32743^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ PRE-MEN OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32739</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>820682067</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32739,;.01~VA-ONC BRCA DCIS ER+ PRE-MEN OFF PATH TX
9999999.64;+32739,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32739,;.08~YES
9999999.64;+32739,;.1~FACTOR
9999999.64;+32739,;100~NATIONAL
9999999.64;+32739,;101~VHA ONCOLOGY
9999999.64;+32739,;200~BRCA DCIS ER+ Pre-Menopause Off Path Treatment
9999999.64;+32739,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, pre-menopause, off pathway 
treatment
9999999.65;+32740,+32739,;.01~FEB 21, 2024@09:19:27
9999999.65;+32740,+32739,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ PRE-MEN CLIN TRIAL
9999999.65;+32741,+32739,;.01~FEB 21, 2024@09:22:29
9999999.65;+32742,+32739,;.01~FEB 21, 2024@09:28:24
9999999.65;+32743,+32739,;.01~MAR 22, 2024@13:04:51
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32740^1
32741^2
32742^3
32743^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ PRE-MEN TAMOX+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>32738</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3849996764</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32738,;.01~VA-ONC BRCA DCIS ER+ PRE-MEN TAMOX+SURV
9999999.64;+32738,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32738,;.08~YES
9999999.64;+32738,;.1~FACTOR
9999999.64;+32738,;100~NATIONAL
9999999.64;+32738,;101~VHA ONCOLOGY
9999999.64;+32738,;200~BRCA DCIS ER+ Pre-Menopause Tamoxifen+Surveillance
9999999.64;+32738,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, pre-menopause, on pathway
tamoxifen then surveillance
9999999.65;+32739,+32738,;.01~FEB 21, 2024@09:15:24
9999999.65;+32739,+32738,;2~WP-start~1
Copied from VA-ONC BRCA DCIS ER+ PRE-MEN CLIN TRIAL
9999999.65;+32740,+32738,;.01~FEB 21, 2024@09:18:04
9999999.65;+32741,+32738,;.01~MAR 22, 2024@13:05:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32739^1
32740^2
32741^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS ER+ PRE-MEN CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32737</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>890419559</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32737,;.01~VA-ONC BRCA DCIS ER+ PRE-MEN CLIN TRIAL
9999999.64;+32737,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32737,;.08~YES
9999999.64;+32737,;.1~FACTOR
9999999.64;+32737,;100~NATIONAL
9999999.64;+32737,;101~VHA ONCOLOGY
9999999.64;+32737,;200~BRCA DCIS ER+ Pre-Menopause Clinical Trial
9999999.64;+32737,;201~WP-start~2
Breast Cancer-Stage DCIS; ER+ post radiation, pre-menopause, on pathway
clinical trial
9999999.65;+32738,+32737,;.01~FEB 21, 2024@09:02:16
9999999.65;+32738,+32737,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG < 2 CLIN TRIAL
9999999.65;+32739,+32737,;.01~FEB 21, 2024@09:14:13
9999999.65;+32740,+32737,;.01~MAR 22, 2024@13:03:23
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32738^1
32739^2
32740^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &lt; 2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32736</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3821640773</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32736,;.01~VA-ONC BRCA DCIS MARG < 2 OFF PATH RSN
9999999.64;+32736,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32736,;.08~YES
9999999.64;+32736,;.1~FACTOR
9999999.64;+32736,;100~NATIONAL
9999999.64;+32736,;101~VHA ONCOLOGY
9999999.64;+32736,;200~BRCA DCIS Margins <2mm Off Path Reason
9999999.64;+32736,;201~WP-start~1
Breast Cancer-Stage DCIS; margins achieved < 2mm, off pathway reason
9999999.65;+32737,+32736,;.01~FEB 21, 2024@08:34:26
9999999.65;+32737,+32736,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG < 2 OFF PATH TX
9999999.65;+32738,+32736,;.01~FEB 21, 2024@08:35:16
9999999.65;+32739,+32736,;.01~MAR 22, 2024@13:13:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32737^1
32738^2
32739^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &lt; 2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32735</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2769033756</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32735,;.01~VA-ONC BRCA DCIS MARG < 2 OFF PATH TX
9999999.64;+32735,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32735,;.08~YES
9999999.64;+32735,;.1~FACTOR
9999999.64;+32735,;100~NATIONAL
9999999.64;+32735,;101~VHA ONCOLOGY
9999999.64;+32735,;200~BRCA DCIS Margins <2mm Off Path Treatment
9999999.64;+32735,;201~WP-start~1
Breast Cancer-Stage DCIS; margins achieved < 2mm, off pathway treatment
9999999.65;+32736,+32735,;.01~FEB 21, 2024@08:31:25
9999999.65;+32736,+32735,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG < 2 CLIN TRIAL
9999999.65;+32737,+32735,;.01~FEB 21, 2024@08:33:30
9999999.65;+32738,+32735,;.01~MAR 22, 2024@13:13:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32736^1
32737^2
32738^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &lt; 2 CLEARANCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>32734</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4013817193</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32734,;.01~VA-ONC BRCA DCIS MARG < 2 CLEARANCE
9999999.64;+32734,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32734,;.08~YES
9999999.64;+32734,;.1~FACTOR
9999999.64;+32734,;100~NATIONAL
9999999.64;+32734,;101~VHA ONCOLOGY
9999999.64;+32734,;200~BRCA DCIS Margins <2mm Marg Clearance+Rad+Med Onc
9999999.64;+32734,;201~WP-start~2
Breast Cancer-Stage DCIS; margins achieved < 2mm, on pathway margin 
clearance then radiation followed by referral to medical oncology
9999999.65;+32735,+32734,;.01~FEB 21, 2024@08:19:21
9999999.65;+32735,+32734,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG > 2 RADIATION
9999999.65;+32736,+32734,;.01~FEB 21, 2024@08:28:56
9999999.65;+32737,+32734,;.01~MAR 22, 2024@13:12:07
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32735^1
32736^2
32737^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &lt; 2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32733</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4284137397</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32733,;.01~VA-ONC BRCA DCIS MARG < 2 CLIN TRIAL
9999999.64;+32733,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32733,;.08~YES
9999999.64;+32733,;.1~FACTOR
9999999.64;+32733,;100~NATIONAL
9999999.64;+32733,;101~VHA ONCOLOGY
9999999.64;+32733,;200~BRCA DCIS Margins <2mm Clinical Trial
9999999.64;+32733,;201~WP-start~2
Breast Cancer-Stage DCIS; margins achieved < 2mm, on pathway
clinical trial
9999999.65;+32734,+32733,;.01~FEB 21, 2024@08:16:30
9999999.65;+32734,+32733,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG > 2 CLIN TRIAL
9999999.65;+32735,+32733,;.01~FEB 21, 2024@08:18:11
9999999.65;+32736,+32733,;.01~MAR 22, 2024@13:12:39
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32734^1
32735^2
32736^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &gt; 2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32732</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2659399166</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32732,;.01~VA-ONC BRCA DCIS MARG > 2 OFF PATH RSN
9999999.64;+32732,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32732,;.08~YES
9999999.64;+32732,;.1~FACTOR
9999999.64;+32732,;100~NATIONAL
9999999.64;+32732,;101~VHA ONCOLOGY
9999999.64;+32732,;200~BRCA DCIS Margins >2mm Off Path Reason
9999999.64;+32732,;201~WP-start~2
Breast Cancer-Stage DCIS; margins achieved 2mm or more, off pathway 
reason
9999999.65;+32733,+32732,;.01~FEB 21, 2024@08:10:48
9999999.65;+32733,+32732,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG > 2 OFF PATH TX
9999999.65;+32734,+32732,;.01~FEB 21, 2024@08:12:43
9999999.65;+32735,+32732,;.01~MAR 22, 2024@13:16:06
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32733^1
32734^2
32735^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &gt; 2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32731</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1075636706</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32731,;.01~VA-ONC BRCA DCIS MARG > 2 OFF PATH TX
9999999.64;+32731,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32731,;.08~YES
9999999.64;+32731,;.1~FACTOR
9999999.64;+32731,;100~NATIONAL
9999999.64;+32731,;101~VHA ONCOLOGY
9999999.64;+32731,;200~BRCA DCIS Margins >2mm Off Path Treatment
9999999.64;+32731,;201~WP-start~2
Breast Cancer-Stage DCIS; margins achieved 2mm or more, off pathway 
treatment
9999999.65;+32732,+32731,;.01~FEB 21, 2024@08:07:36
9999999.65;+32732,+32731,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG > 2 CLIN TRIAL
9999999.65;+32733,+32731,;.01~FEB 21, 2024@08:10:07
9999999.65;+32734,+32731,;.01~MAR 22, 2024@13:17
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32732^1
32733^2
32734^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &gt; 2 RAD+REFER MED ONC</POINT_01>
<INTERNAL_ENTRY_NUMBER>32730</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3565942220</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32730,;.01~VA-ONC BRCA DCIS MARG > 2 RAD+REFER MED ONC
9999999.64;+32730,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32730,;.08~YES
9999999.64;+32730,;.1~FACTOR
9999999.64;+32730,;100~NATIONAL
9999999.64;+32730,;101~VHA ONCOLOGY
9999999.64;+32730,;200~BRCA DCIS Margins >2mm Radiation+Refer to Med Onc
9999999.64;+32730,;201~WP-start~2
Breast Cancer-Stage DCIS; margins achieved 2mm or more, on pathway
radiation then refer to medical oncology
9999999.65;+32731,+32730,;.01~FEB 21, 2024@08:02:39
9999999.65;+32731,+32730,;2~WP-start~1
Copied from VA-ONC BRCA DCIS MARG > 2 CLIN TRIAL
9999999.65;+32732,+32730,;.01~FEB 21, 2024@08:07
9999999.65;+32733,+32730,;.01~MAR 22, 2024@13:19:01
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32731^1
32732^2
32733^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS MARG &gt; 2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32729</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2065785289</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32729,;.01~VA-ONC BRCA DCIS MARG > 2 CLIN TRIAL
9999999.64;+32729,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32729,;.08~YES
9999999.64;+32729,;.1~FACTOR
9999999.64;+32729,;100~NATIONAL
9999999.64;+32729,;101~VHA ONCOLOGY
9999999.64;+32729,;200~BRCA DCIS Margins >2mm Clinical Trial
9999999.64;+32729,;201~WP-start~2
Breast Cancer-Stage DCIS; margins achieved 2mm or more, on pathway
clinical trial
9999999.65;+32730,+32729,;.01~FEB 21, 2024@07:58:03
9999999.65;+32730,+32729,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE CLIN TRIAL
9999999.65;+32731,+32729,;.01~FEB 21, 2024@08:01:12
9999999.65;+32732,+32729,;.01~MAR 22, 2024@13:15:14
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32730^1
32731^2
32732^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE NO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32728</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1388983473</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32728,;.01~VA-ONC BRCA DCIS CONSERVE NO OFF PATH RSN
9999999.64;+32728,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32728,;.08~YES
9999999.64;+32728,;.1~FACTOR
9999999.64;+32728,;100~NATIONAL
9999999.64;+32728,;101~VHA ONCOLOGY
9999999.64;+32728,;200~BRCA DCIS Not Breast Conserve Candidate Off Path Reason
9999999.64;+32728,;201~WP-start~2
Breast Cancer-Stage DCIS; not a breast conservation candidate, off pathway
reason
9999999.65;+32729,+32728,;.01~FEB 21, 2024@07:48:41
9999999.65;+32729,+32728,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE NO OFF PATH TX
9999999.65;+32730,+32728,;.01~FEB 21, 2024@07:49:40
9999999.65;+32731,+32728,;.01~MAR 22, 2024@12:50:25
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32729^1
32730^2
32731^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE NO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32727</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1344062329</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32727,;.01~VA-ONC BRCA DCIS CONSERVE NO OFF PATH TX
9999999.64;+32727,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32727,;.08~YES
9999999.64;+32727,;.1~FACTOR
9999999.64;+32727,;100~NATIONAL
9999999.64;+32727,;101~VHA ONCOLOGY
9999999.64;+32727,;200~BRCA DCIS Not Breast Conserve Candidate Off Path Treatment
9999999.64;+32727,;201~WP-start~2
Breast Cancer-Stage DCIS; not a breast conservation candidate, off pathway
treatment
9999999.65;+32728,+32727,;.01~FEB 21, 2024@07:45:17
9999999.65;+32728,+32727,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE OFF PATH TX
9999999.65;+32729,+32727,;.01~FEB 21, 2024@07:48:06
9999999.65;+32730,+32727,;.01~MAR 22, 2024@12:49:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32728^1
32729^2
32730^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE NO TO PLASTIC</POINT_01>
<INTERNAL_ENTRY_NUMBER>32726</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>994930547</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32726,;.01~VA-ONC BRCA DCIS CONSERVE NO TO PLASTIC
9999999.64;+32726,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32726,;.08~YES
9999999.64;+32726,;.1~FACTOR
9999999.64;+32726,;100~NATIONAL
9999999.64;+32726,;101~VHA ONCOLOGY
9999999.64;+32726,;200~BRCA DCIS Not Breast Conserve Candidate Refer Plastic Surgery
9999999.64;+32726,;201~WP-start~3
Breast Cancer-Stage DCIS; not a breast conservation candidate, on pathway
refer to plastic surgery for unilateral mastectomy and sentinel node 
biopsy the refer to medical oncology for risk reduction discussion
9999999.65;+32727,+32726,;.01~FEB 21, 2024@07:42:14
9999999.65;+32727,+32726,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE LUMPECT+RAD ONC
9999999.65;+32728,+32726,;.01~FEB 21, 2024@07:43:45
9999999.65;+32729,+32726,;.01~FEB 21, 2024@08:56:15
9999999.65;+32730,+32726,;.01~MAR 22, 2024@12:49:10
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32727^1
32728^2
32729^3
32730^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE NO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32725</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2387844533</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32725,;.01~VA-ONC BRCA DCIS CONSERVE NO CLIN TRIAL
9999999.64;+32725,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32725,;.08~YES
9999999.64;+32725,;.1~FACTOR
9999999.64;+32725,;100~NATIONAL
9999999.64;+32725,;101~VHA ONCOLOGY
9999999.64;+32725,;200~BRCA DCIS Not Breast Conserve Candidate Clinical Trial
9999999.64;+32725,;201~WP-start~2
Breast Cancer-Stage DCIS; not a breast conservation candidate, on pathway
clinical trial
9999999.65;+32726,+32725,;.01~FEB 21, 2024@07:29:11
9999999.65;+32726,+32725,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE CLIN TRIAL
9999999.65;+32727,+32725,;.01~FEB 21, 2024@07:33:34
9999999.65;+32728,+32725,;.01~MAR 22, 2024@12:48:42
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32726^1
32727^2
32728^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>32724</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4660935</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32724,;.01~VA-ONC BRCA DCIS CONSERVE OFF PATH RSN
9999999.64;+32724,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32724,;.08~YES
9999999.64;+32724,;.1~FACTOR
9999999.64;+32724,;100~NATIONAL
9999999.64;+32724,;101~VHA ONCOLOGY
9999999.64;+32724,;200~BRCA DCIS Breast Conserve Candidate Off Path Reason
9999999.64;+32724,;201~WP-start~2
Breast Cancer-Stage DCIS; breast conservation candidate, off pathway 
reason
9999999.65;+32725,+32724,;.01~FEB 21, 2024@07:19:25
9999999.65;+32725,+32724,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE OFF PATH TX
9999999.65;+32726,+32724,;.01~FEB 21, 2024@07:22:32
9999999.65;+32727,+32724,;.01~MAR 22, 2024@12:47:43
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32725^1
32726^2
32727^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>32723</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1794436834</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32723,;.01~VA-ONC BRCA DCIS CONSERVE OFF PATH TX
9999999.64;+32723,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32723,;.08~YES
9999999.64;+32723,;.1~FACTOR
9999999.64;+32723,;100~NATIONAL
9999999.64;+32723,;101~VHA ONCOLOGY
9999999.64;+32723,;200~BRCA DCIS Breast Conserve Candidate Off Path Treatment 
9999999.64;+32723,;201~WP-start~2
Breast Cancer-Stage DCIS; breast conservation candidate, off pathway 
treatment
9999999.65;+32724,+32723,;.01~FEB 21, 2024@07:15:32
9999999.65;+32724,+32723,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE CLIN TRIAL
9999999.65;+32725,+32723,;.01~FEB 21, 2024@07:18:53
9999999.65;+32726,+32723,;.01~MAR 22, 2024@12:47:13
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32724^1
32725^2
32726^3
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE LUMPECT+RAD ONC</POINT_01>
<INTERNAL_ENTRY_NUMBER>32722</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1508939243</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32722,;.01~VA-ONC BRCA DCIS CONSERVE LUMPECT+RAD ONC
9999999.64;+32722,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32722,;.08~YES
9999999.64;+32722,;.1~FACTOR
9999999.64;+32722,;100~NATIONAL
9999999.64;+32722,;101~VHA ONCOLOGY
9999999.64;+32722,;200~BRCA DCIS Breast Conserve Candidate Lumpect+Refer Rad Onc
9999999.64;+32722,;201~WP-start~2
Breast Cancer-Stage DCIS;breast conservation candidate, on pathway
lumpectomy then refer to radiation oncology.
9999999.65;+32723,+32722,;.01~FEB 21, 2024@07:10:42
9999999.65;+32723,+32722,;2~WP-start~1
Copied from VA-ONC BRCA DCIS CONSERVE CLIN TRIAL
9999999.65;+32724,+32722,;.01~FEB 21, 2024@07:13:41
9999999.65;+32725,+32722,;.01~FEB 21, 2024@07:26:57
9999999.65;+32726,+32722,;.01~MAR 22, 2024@12:46:32
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32723^1
32724^2
32725^3
32726^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-ONC BRCA DCIS CONSERVE CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>32721</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3325326017</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+32721,;.01~VA-ONC BRCA DCIS CONSERVE CLIN TRIAL
9999999.64;+32721,;.03~VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
9999999.64;+32721,;.08~YES
9999999.64;+32721,;.1~FACTOR
9999999.64;+32721,;100~NATIONAL
9999999.64;+32721,;101~VHA ONCOLOGY
9999999.64;+32721,;200~BRCA DCIS Breast Conserve Candidate Clinical Trial
9999999.64;+32721,;201~WP-start~2
Breast Cancer-Stage DCIS; breast conservation candidate, on pathway
clinical trial
9999999.65;+32722,+32721,;.01~FEB 21, 2024@07:02:02
9999999.65;+32722,+32721,;2~WP-start~1
Copied from VA-ONC ESOPH STAGE I T1B SURG CLIN TRIAL
9999999.65;+32723,+32721,;.01~FEB 21, 2024@07:06:52
9999999.65;+32724,+32721,;.01~FEB 21, 2024@07:23:45
9999999.65;+32725,+32721,;.01~MAR 22, 2024@12:45:57
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
32722^1
32723^2
32724^3
32725^4
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER SPONSOR</FILE_NAME>
<FILE_NUMBER>811.6</FILE_NUMBER>
<POINT_01>VHA ONCOLOGY</POINT_01>
<INTERNAL_ENTRY_NUMBER>39</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2932841009</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.6;+39,;.01~VHA ONCOLOGY
811.6;+39,;100~NATIONAL
811.63;+40,+39,;.01~06/09/2026@08:52:54
811.63;+40,+39,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
40^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER COMPUTED FINDINGS</FILE_NAME>
<FILE_NUMBER>811.4</FILE_NUMBER>
<POINT_01>VA-SEX</POINT_01>
<INTERNAL_ENTRY_NUMBER>34</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1887914893</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.4;+34,;.01~VA-SEX
811.4;+34,;.02~PXRMPDEM
811.4;+34,;.03~SEX
811.4;+34,;.04~VA-Patient Sex
811.4;+34,;1~WP-start~2
This is a single occurrence computed finding that returns a
patient's sex as either "F" for female or "M" for male.
811.4;+34,;5~SINGLE
811.4;+34,;100~NATIONAL
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-REMINDER UPDATE_2_0_483A</POINT_01>
<INTERNAL_ENTRY_NUMBER>3513</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3563694951</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+3513,;.01~VA-REMINDER UPDATE_2_0_483A
811.5;+3513,;100~NATIONAL
811.52;+3514,+3513,;.01~HF.VA-UPDATE_2_0_483A
811.52;+3514,+3513,;11~0
811.52;+3514,+3513,;15~NO
811.53;+3515,+3513,;.01~06/09/2026@08:52:54
811.53;+3515,+3513,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
3514^1
3515^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-ONC BRCA MALE RT</POINT_01>
<INTERNAL_ENTRY_NUMBER>2901</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>648883473</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+2901,;.01~VA-ONC BRCA MALE RT
811.5;+2901,;100~NATIONAL
811.5;+2901,;101~VHA ONCOLOGY
811.52;+2902,+2901,;.01~CF.VA-SEX
811.52;+2902,+2901,;14~I V="M"
811.52;+2902,+2901,;15~NO
811.52;+2902,+2901,;22~I V="M"
811.53;+2903,+2901,;.01~06/09/2026@08:52:54
811.53;+2903,+2901,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
2902^1
2903^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH SUMMARY COMPONENT</FILE_NAME>
<FILE_NUMBER>142.1</FILE_NUMBER>
<POINT_01>PCE HEALTH FACTORS SELECTED</POINT_01>
<INTERNAL_ENTRY_NUMBER>203</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1531877056</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
142.1;+203,;.01~PCE HEALTH FACTORS SELECTED
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH SUMMARY TYPE</FILE_NAME>
<FILE_NUMBER>142</FILE_NUMBER>
<POINT_01>VA-ONCOLOGY PATHWAYS BREAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>2742</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1154826826</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
142;+2742,;.01~VA-ONCOLOGY PATHWAYS BREAST
142;+2742,;.02~VA-ONCOLOGY PATHWAYS BREAST
142;+2742,;.08~yes
142;+2742,;99~67683,34141
142;+2742,;100~NO SSN
142.01;+2743,+2742,;.01~5
142.01;+2743,+2742,;1~PCE HEALTH FACTORS SELECTED
142.01;+2743,+2742,;2~1
142.01;+2743,+2742,;5~Health Factor Select
142.14;+2744,+2743,+2742,;.01~F.VA-ONC BRCA STAGE DCIS CLINICAL PATHWAY [C]
142.14;+2745,+2743,+2742,;.01~F.VA-ONC BRCA STAGE IV ANY ER CLINICAL PATHWAY [C]
142.14;+2746,+2743,+2742,;.01~F.VA-ONC BRCA STAGE IV ER- CLINICAL PATHWAY [C]
142.14;+2747,+2743,+2742,;.01~F.VA-ONC BREAST TUMOR GENOMIC TESTING [C]
142.14;+2748,+2743,+2742,;.01~F.VA-ONC BRCA GERMLINE TESTING PATHWAY [C]
142.14;+2749,+2743,+2742,;.01~F.VA-ONC BRCA ADJ HORMONE TX HER2 NEG CLINICAL PATHWAY [C]
142.14;+2750,+2743,+2742,;.01~F.VA-ONC BRCA LRM PRIOR TX CLINICAL PATHWAY [C]
142.14;+2751,+2743,+2742,;.01~F.VA-ONC BRCA LRM AFTER TX CLINICAL PATHWAY [C]
142.14;+2752,+2743,+2742,;.01~F.VA-ONC BRCA STAGE I-III ER+ CLINICAL PATHWAY [C]
142.14;+2753,+2743,+2742,;.01~F.VA-ONC BRCA STAGE I-III ANY ER CLINICAL PATHWAY [C]
142.14;+2754,+2743,+2742,;.01~F.VA-ONC BRCA STAGE I-III ER- CLINICAL PATHWAY [C]
142.14;+2755,+2743,+2742,;.01~F.VA-ONC BRCA ADJ HORMONE CLINICAL PATHWAY [C]
142.14;+2756,+2743,+2742,;.01~F.VA-ONC BRCA STAGE RECURRENCE CLINICAL PATHWAY [C]
142.14;+2757,+2743,+2742,;.01~F.VA-ONC BRCA STAGE IV ER+ CLINICAL PATHWAY [C]
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
2743^5
2744^1
2745^10
2746^11
2747^12
2748^13
2749^14
2750^2
2751^3
2752^4
2753^5
2754^6
2755^7
2756^8
2757^9
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH SUMMARY OBJECTS</FILE_NAME>
<FILE_NUMBER>142.5</FILE_NUMBER>
<POINT_01>VA-ONCOLOGY PATHWAYS BREAST (TIU)</POINT_01>
<INTERNAL_ENTRY_NUMBER>6600771</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4233354923</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
142.5;+6600771,;.01~VA-ONCOLOGY PATHWAYS BREAST (TIU)
142.5;+6600771,;.03~VA-ONCOLOGY PATHWAYS BREAST
142.5;+6600771,;.05~YES
142.5;+6600771,;.06~YES
142.5;+6600771,;.07~NO
142.5;+6600771,;.08~NO
142.5;+6600771,;.09~NO
142.5;+6600771,;.1~NO
142.5;+6600771,;.11~NO
142.5;+6600771,;.12~NO
142.5;+6600771,;.13~NO
142.5;+6600771,;.14~NO
142.5;+6600771,;.15~NO
142.5;+6600771,;.16~NO
142.5;+6600771,;.18~DEC 27, 2023@08:06:13
142.5;+6600771,;.19~APR 02, 2024@09:45:17
142.5;+6600771,;.2~NO
142.5;+6600771,;2~No Breast pathways data found
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>TIU DOCUMENT DEFINITION</FILE_NAME>
<FILE_NUMBER>8925.1</FILE_NUMBER>
<POINT_01>VA-ONCOLOGY PATHWAYS BREAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>6758</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3368667701</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
8925.1;+6758,;.01~VA-ONCOLOGY PATHWAYS BREAST
8925.1;+6758,;.03~VA-ONCOLOGY PATHWAYS BREAST
8925.1;+6758,;.04~OBJECT
8925.1;+6758,;.07~ACTIVE
8925.1;+6758,;9~S X=$$TIU^GMTSOBJ(DFN,VA-ONCOLOGY PATHWAYS BREAST (TIU))
8925.1;+6758,;99~
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC OFF PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>45345</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1161991404</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+45345,;.01~VA-ONC OFF PATHWAY
801.41;+45345,;4~prompt
801.41;+45345,;24~   
801.41;+45345,;46~COM
801.41;+45345,;100~NATIONAL
801.4145;+45346,+45345,;.01~1
801.4145;+45346,+45345,;2~Patient preference/declined
801.4145;+45347,+45345,;.01~2
801.4145;+45347,+45345,;2~Toxicity and/or comorbidity
801.4145;+45348,+45345,;.01~3
801.4145;+45348,+45345,;2~Prior treatment continued
801.4145;+45349,+45345,;.01~4
801.4145;+45349,+45345,;2~Prior treatment precludes
801.4145;+45350,+45345,;.01~5
801.4145;+45350,+45345,;2~Pathway guidance needs update
801.4145;+45351,+45345,;.01~6
801.4145;+45351,+45345,;2~Patient barriers
801.4145;+45352,+45345,;.01~8
801.4145;+45352,+45345,;2~Other:
801.4145;+45353,+45345,;.01~7
801.4145;+45353,+45345,;2~Treatment unavailable
801.44;+45354,+45345,;.01~06/09/2026@08:52:54
801.44;+45354,+45345,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
45346^1
45347^2
45348^3
45349^4
45350^5
45351^6
45352^8
45353^9
45354^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>79455</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3959460796</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79455,;.01~VA-ONC BRCA IV ANY ER NO CHEMO OFF PATH RSN
801.41;+79455,;4~dialog element
801.41;+79455,;15~HF.VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH RSN
801.41;+79455,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+79455,;51~SUPPRESS
801.41;+79455,;100~NATIONAL
801.412;+79456,+79455,;.01~5
801.412;+79456,+79455,;2~VA-ONC OFF PATHWAY
801.412;+79456,+79455,;7~YES
801.412;+79456,+79455,;9~YES
801.44;+79457,+79455,;.01~06/09/2026@08:52:54
801.44;+79457,+79455,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79456^1
79457^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BLANK</POINT_01>
<INTERNAL_ENTRY_NUMBER>46240</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>274383172</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+46240,;.01~VA-ONC BLANK
801.41;+46240,;4~prompt
801.41;+46240,;24~   
801.41;+46240,;46~COM
801.41;+46240,;100~NATIONAL
801.44;+46241,+46240,;.01~06/09/2026@08:52:54
801.44;+46241,+46240,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
46241^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>79454</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2886792766</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79454,;.01~VA-ONC BRCA IV ANY ER NO CHEMO OFF PATH TX
801.41;+79454,;4~dialog element
801.41;+79454,;15~HF.VA-ONC BRCA IV ANY ER NOT CHEMO OFF PATH TX
801.41;+79454,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+79454,;51~SUPPRESS
801.41;+79454,;100~NATIONAL
801.412;+79455,+79454,;.01~5
801.412;+79455,+79454,;2~VA-ONC BLANK
801.412;+79455,+79454,;7~YES
801.412;+79455,+79454,;9~YES
801.44;+79456,+79454,;.01~06/09/2026@08:52:54
801.44;+79456,+79454,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79455^1
79456^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER NO CHEMO OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>79453</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2381268266</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79453,;.01~VA-GP ONC BRCA IV ANY ER NO CHEMO OFF PTHWY
801.41;+79453,;4~dialog group
801.41;+79453,;6~YES
801.41;+79453,;7~2
801.41;+79453,;23~YES
801.41;+79453,;25~WP-start~1
Off pathway:
801.41;+79453,;52~INDENT
801.41;+79453,;100~NATIONAL
801.412;+79454,+79453,;.01~10
801.412;+79454,+79453,;2~VA-ONC BRCA IV ANY ER NO CHEMO OFF PATH TX
801.412;+79455,+79453,;.01~20
801.412;+79455,+79453,;2~VA-ONC BRCA IV ANY ER NO CHEMO OFF PATH RSN
801.44;+79456,+79453,;.01~06/09/2026@08:52:54
801.44;+79456,+79453,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79454^1
79455^2
79456^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC CLINICAL TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>45369</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>475371082</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+45369,;.01~VA-ONC CLINICAL TRIAL
801.41;+45369,;4~prompt
801.41;+45369,;24~Clinical Trial:
801.41;+45369,;46~COM
801.41;+45369,;100~NATIONAL
801.44;+45370,+45369,;.01~06/09/2026@08:52:54
801.44;+45370,+45369,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
45370^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>79452</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2947578342</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79452,;.01~VA-ONC BRCA IV ANY ER NO CHEMO CLIN TRIAL
801.41;+79452,;4~dialog element
801.41;+79452,;15~HF.VA-ONC BRCA IV ANY ER NOT CHEMO CLIN TRIAL
801.41;+79452,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+79452,;35~WP-start~1
Veteran has elected to pursue:
801.41;+79452,;100~NATIONAL
801.412;+79453,+79452,;.01~5
801.412;+79453,+79452,;2~VA-ONC CLINICAL TRIAL
801.412;+79453,+79452,;9~YES
801.44;+79454,+79452,;.01~06/09/2026@08:52:54
801.44;+79454,+79452,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79453^1
79454^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR IV ANY ER/PR NO CHEMO ABE+TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>77264</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1529992403</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77264,;.01~VA-ONC BR IV ANY ER/PR NO CHEMO ABE+TRAS
801.41;+77264,;4~dialog element
801.41;+77264,;15~HF.VA-ONC BRCA IV ANY ER NOT CHEMO ABE+TRAS+FUL
801.41;+77264,;25~WP-start~1
Abemaciclib and trastuzumab plus fulvestrant if HR+
801.41;+77264,;35~WP-start~2
Veteran has elected to pursue treatment with ABEMACICLIB and TRASTUZUMAB 
plus FULVESTRANT if HR+. 
801.41;+77264,;100~NATIONAL
801.44;+77265,+77264,;.01~06/09/2026@08:52:54
801.44;+77265,+77264,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77265^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR IV ANY ER/PR NO CHEMO TRAS+LAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>77263</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2133198042</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77263,;.01~VA-ONC BR IV ANY ER/PR NO CHEMO TRAS+LAP
801.41;+77263,;4~dialog element
801.41;+77263,;15~HF.VA-ONC BRCA IV ANY ER NOT CHEMO TRAS+LAP
801.41;+77263,;25~WP-start~1
Trastuzumab and lapatinib
801.41;+77263,;35~WP-start~1
Veteran has elected to pursue treatment with TRASTUZUMAB and LAPATINIB.
801.41;+77263,;100~NATIONAL
801.44;+77264,+77263,;.01~06/09/2026@08:52:54
801.44;+77264,+77263,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77264^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR NO CHEMO</POINT_01>
<INTERNAL_ENTRY_NUMBER>77262</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3773464254</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77262,;.01~VA-GP ONC BRCA IV ANY ER/PR NO CHEMO
801.41;+77262,;4~dialog group
801.41;+77262,;6~YES
801.41;+77262,;7~2
801.41;+77262,;9~ONE SELECTION ONLY
801.41;+77262,;25~WP-start~1
Not a candidate for chemotherapy:
801.41;+77262,;35~WP-start~1
Not a Candidate for Chemotherapy:
801.41;+77262,;52~INDENT
801.41;+77262,;100~NATIONAL
801.412;+77263,+77262,;.01~10
801.412;+77263,+77262,;2~VA-ONC BR IV ANY ER/PR NO CHEMO TRAS+LAP
801.412;+77264,+77262,;.01~20
801.412;+77264,+77262,;2~VA-ONC BR IV ANY ER/PR NO CHEMO ABE+TRAS
801.412;+77265,+77262,;.01~5
801.412;+77265,+77262,;2~VA-ONC BRCA IV ANY ER NO CHEMO CLIN TRIAL
801.412;+77266,+77262,;.01~30
801.412;+77266,+77262,;2~VA-GP ONC BRCA IV ANY ER NO CHEMO OFF PTHWY
801.44;+77267,+77262,;.01~06/09/2026@08:52:54
801.44;+77267,+77262,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77263^1
77264^2
77265^3
77266^4
77267^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR IV ANY ER/PR CHEMO NER+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>77256</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>595789501</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77256,;.01~VA-ONC BR IV ANY ER/PR CHEMO NER+CAP
801.41;+77256,;4~dialog element
801.41;+77256,;15~HF.VA-ONC BRCA IV ANY ER CHEMO NERA+CAP
801.41;+77256,;25~WP-start~1
Capecitabine and neratinib
801.41;+77256,;35~WP-start~1
Veteran has elected to pursue treatment with CAPECITABINE and NERATINIB.
801.41;+77256,;100~NATIONAL
801.44;+77257,+77256,;.01~06/09/2026@08:52:54
801.44;+77257,+77256,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77257^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR IV ANY ER/PR CHEMO TRAS+CHEMO</POINT_01>
<INTERNAL_ENTRY_NUMBER>77260</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1542573853</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77260,;.01~VA-ONC BR IV ANY ER/PR CHEMO TRAS+CHEMO
801.41;+77260,;4~dialog element
801.41;+77260,;15~HF.VA-ONC BRCA IV ANY ER CHEMO TRAS+OTHER CHEMO
801.41;+77260,;25~WP-start~1
Trastuzumab and chemotherapy
801.41;+77260,;35~WP-start~1
Veteran has elected to pursue treatment with TRASTUZUMAB and CHEMOTHERAPY.
801.41;+77260,;100~NATIONAL
801.44;+77261,+77260,;.01~06/09/2026@08:52:54
801.44;+77261,+77260,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77261^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>79451</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2715073848</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79451,;.01~VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
801.41;+79451,;4~dialog element
801.41;+79451,;15~HF.VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
801.41;+79451,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+79451,;35~WP-start~1
Veteran has elected to pursue:
801.41;+79451,;100~NATIONAL
801.412;+79452,+79451,;.01~5
801.412;+79452,+79451,;2~VA-ONC CLINICAL TRIAL
801.412;+79452,+79451,;9~YES
801.44;+79453,+79451,;.01~06/09/2026@08:52:54
801.44;+79453,+79451,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79452^1
79453^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>79450</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3817948927</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79450,;.01~VA-ONC BRCA IV ANY ER CHEMO OFF PATH RSN
801.41;+79450,;4~dialog element
801.41;+79450,;15~HF.VA-ONC BRCA IV ANY ER CHEMO OFF PATH RSN
801.41;+79450,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+79450,;51~SUPPRESS
801.41;+79450,;100~NATIONAL
801.412;+79451,+79450,;.01~5
801.412;+79451,+79450,;2~VA-ONC OFF PATHWAY
801.412;+79451,+79450,;7~YES
801.412;+79451,+79450,;9~YES
801.44;+79452,+79450,;.01~06/09/2026@08:52:54
801.44;+79452,+79450,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79451^1
79452^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>79449</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4203509728</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79449,;.01~VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX
801.41;+79449,;4~dialog element
801.41;+79449,;15~HF.VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX
801.41;+79449,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+79449,;51~SUPPRESS
801.41;+79449,;100~NATIONAL
801.412;+79450,+79449,;.01~5
801.412;+79450,+79449,;2~VA-ONC BLANK
801.412;+79450,+79449,;7~YES
801.412;+79450,+79449,;9~YES
801.44;+79451,+79449,;.01~06/09/2026@08:52:54
801.44;+79451,+79449,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79450^1
79451^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER CHEMO OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>79448</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3095096089</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79448,;.01~VA-GP ONC BRCA IV ANY ER CHEMO OFF PTHWY
801.41;+79448,;4~dialog group
801.41;+79448,;6~YES
801.41;+79448,;7~2
801.41;+79448,;23~YES
801.41;+79448,;25~WP-start~1
Off pathway:
801.41;+79448,;52~INDENT
801.41;+79448,;100~NATIONAL
801.412;+79449,+79448,;.01~10
801.412;+79449,+79448,;2~VA-ONC BRCA IV ANY ER CHEMO OFF PATH TX
801.412;+79450,+79448,;.01~20
801.412;+79450,+79448,;2~VA-ONC BRCA IV ANY ER CHEMO OFF PATH RSN
801.44;+79451,+79448,;.01~06/09/2026@08:52:54
801.44;+79451,+79448,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79449^1
79450^2
79451^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR IV ANY ER/PR CHEMO LAP+CAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>77259</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2899255264</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77259,;.01~VA-ONC BR IV ANY ER/PR CHEMO LAP+CAP
801.41;+77259,;4~dialog element
801.41;+77259,;15~HF.VA-ONC BRCA IV ANY ER CHEMO LAP+CAP
801.41;+77259,;25~WP-start~1
Capecitabine and lapatinib
801.41;+77259,;35~WP-start~1
Veteran has elected to pursue treatment with CAPECITABINE and LAPATINIB.
801.41;+77259,;100~NATIONAL
801.44;+77260,+77259,;.01~06/09/2026@08:52:54
801.44;+77260,+77259,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77260^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR CHEMO</POINT_01>
<INTERNAL_ENTRY_NUMBER>77254</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>206796278</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77254,;.01~VA-GP ONC BRCA IV ANY ER/PR CHEMO
801.41;+77254,;4~dialog group
801.41;+77254,;5~(Select All Apply)
801.41;+77254,;6~YES
801.41;+77254,;7~2
801.41;+77254,;9~ONE OR MORE SELECTIONS
801.41;+77254,;25~WP-start~1
Candidate for Chemotherapy:
801.41;+77254,;35~WP-start~1
Candidate for Chemotherapy:
801.41;+77254,;52~INDENT
801.41;+77254,;100~NATIONAL
801.412;+77255,+77254,;.01~30
801.412;+77255,+77254,;2~VA-ONC BR IV ANY ER/PR CHEMO LAP+CAP
801.412;+77256,+77254,;.01~60
801.412;+77256,+77254,;2~VA-GP ONC BRCA IV ANY ER CHEMO OFF PTHWY
801.412;+77257,+77254,;.01~5
801.412;+77257,+77254,;2~VA-ONC BRCA IV ANY ER CHEMO CLIN TRIAL
801.412;+77258,+77254,;.01~10
801.412;+77258,+77254,;2~VA-ONC BR IV ANY ER/PR CHEMO TRAS+CHEMO
801.412;+77259,+77254,;.01~20
801.412;+77259,+77254,;2~VA-ONC BR IV ANY ER/PR CHEMO NER+CAP
801.44;+77260,+77254,;.01~06/09/2026@08:52:54
801.44;+77260,+77254,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77255^3
77256^6
77257^7
77258^8
77259^9
77260^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR CHEMO FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>77255</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1349973775</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77255,;.01~VA-GP ONC BRCA IV ANY ER/PR CHEMO FN
801.41;+77255,;4~dialog group
801.41;+77255,;6~YES
801.41;+77255,;7~2
801.41;+77255,;9~NONE OR ONE SELECTION
801.41;+77255,;23~YES
801.41;+77255,;25~WP-start~2
++  Chemotherapy includes vinorelbine, docetaxel, carboplatin, eribulin,
    gemcitabine, capecitabine. ++
801.41;+77255,;51~SUPPRESS
801.41;+77255,;52~INDENT
801.41;+77255,;100~NATIONAL
801.412;+77256,+77255,;.01~20
801.412;+77256,+77255,;2~VA-GP ONC BRCA IV ANY ER/PR CHEMO
801.412;+77257,+77255,;.01~40
801.412;+77257,+77255,;2~VA-GP ONC BRCA IV ANY ER/PR NO CHEMO
801.44;+77258,+77255,;.01~06/09/2026@08:52:54
801.44;+77258,+77255,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77256^1
77257^2
77258^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR AFTER TRAS TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>77253</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1340586794</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77253,;.01~VA-GP ONC BRCA IV ANY ER/PR AFTER TRAS TX
801.41;+77253,;4~dialog group
801.41;+77253,;6~NO
801.41;+77253,;23~YES
801.41;+77253,;25~WP-start~1
AFTER Progression - 3rd Line Therapy:
801.41;+77253,;51~SUPPRESS
801.41;+77253,;100~NATIONAL
801.412;+77254,+77253,;.01~5
801.412;+77254,+77253,;2~VA-GP ONC BRCA IV ANY ER/PR CHEMO FN
801.44;+77255,+77253,;.01~06/09/2026@08:52:54
801.44;+77255,+77253,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77254^2
77255^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS TRAS MAINT RX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108513</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2735867466</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108513,;.01~VA-ONC BRCA IV ANY ER NO METS TRAS MAINT RX
801.41;+108513,;4~dialog element
801.41;+108513,;25~WP-start~2
- Tucatinib, trastuzumab, and capecitabine, and then:
\\- Ado-trastuzumab emtansine
801.41;+108513,;51~SUPPRESS
801.41;+108513,;100~NATIONAL
801.44;+108514,+108513,;.01~06/09/2026@08:52:54
801.44;+108514,+108513,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108514^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER NO METS TRAS/PER/DOC+MAINT</POINT_01>
<INTERNAL_ENTRY_NUMBER>108512</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1709072177</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108512,;.01~VA-GP ONC BRCA IV ANY ER NO METS TRAS/PER/DOC+MAINT
801.41;+108512,;4~dialog group
801.41;+108512,;6~YES
801.41;+108512,;7~2
801.41;+108512,;15~HF.VA-ONC BRCA IV ANY ER NO METS TUC/PERT/DOCE+
801.41;+108512,;25~WP-start~2
Trastuzumab, pertuzumab, and docetaxel (4-6 mo. max response), followed
by:
801.41;+108512,;35~WP-start~2
Veteran has elected to pursue treatment with TRASTUZUMAB, PERTUZUMAB, and 
DOCETAXEL (4-6 months max response) FOLLOWED by:
801.41;+108512,;100~NATIONAL
801.412;+108513,+108512,;.01~10
801.412;+108513,+108512,;2~VA-ONC BRCA IV ANY ER NO METS TRAS MAINT RX
801.44;+108514,+108512,;.01~06/09/2026@08:52:54
801.44;+108514,+108512,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108513^1
108514^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>79445</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4009859656</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79445,;.01~VA-ONC BRCA IV ANY ER NO METS OFF PATH RSN
801.41;+79445,;4~dialog element
801.41;+79445,;15~HF.VA-ONC BRCA IV ANY ER NO METS OFF PATH RSN
801.41;+79445,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+79445,;51~SUPPRESS
801.41;+79445,;100~NATIONAL
801.412;+79446,+79445,;.01~5
801.412;+79446,+79445,;2~VA-ONC OFF PATHWAY
801.412;+79446,+79445,;7~YES
801.412;+79446,+79445,;9~YES
801.44;+79447,+79445,;.01~06/09/2026@08:52:54
801.44;+79447,+79445,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79446^1
79447^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>79444</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3962483415</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79444,;.01~VA-ONC BRCA IV ANY ER NO METS OFF PATH TX
801.41;+79444,;4~dialog element
801.41;+79444,;15~HF.VA-ONC BRCA IV ANY ER NO METS OFF PATH TX
801.41;+79444,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+79444,;51~SUPPRESS
801.41;+79444,;100~NATIONAL
801.412;+79445,+79444,;.01~5
801.412;+79445,+79444,;2~VA-ONC BLANK
801.412;+79445,+79444,;7~YES
801.412;+79445,+79444,;9~YES
801.44;+79446,+79444,;.01~06/09/2026@08:52:54
801.44;+79446,+79444,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79445^1
79446^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER NO METS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>79443</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3966110324</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79443,;.01~VA-GP ONC BRCA IV ANY ER NO METS OFF PTHWY
801.41;+79443,;4~dialog group
801.41;+79443,;6~YES
801.41;+79443,;7~2
801.41;+79443,;23~YES
801.41;+79443,;25~WP-start~1
Off pathway:
801.41;+79443,;52~INDENT
801.41;+79443,;100~NATIONAL
801.412;+79444,+79443,;.01~10
801.412;+79444,+79443,;2~VA-ONC BRCA IV ANY ER NO METS OFF PATH TX
801.412;+79445,+79443,;.01~20
801.412;+79445,+79443,;2~VA-ONC BRCA IV ANY ER NO METS OFF PATH RSN
801.44;+79446,+79443,;.01~06/09/2026@08:52:54
801.44;+79446,+79443,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79444^1
79445^2
79446^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>79446</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>897759100</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79446,;.01~VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL
801.41;+79446,;4~dialog element
801.41;+79446,;15~HF.VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL
801.41;+79446,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+79446,;35~WP-start~1
Veteran has elected to pursue:
801.41;+79446,;100~NATIONAL
801.412;+79447,+79446,;.01~5
801.412;+79447,+79446,;2~VA-ONC CLINICAL TRIAL
801.412;+79447,+79446,;9~YES
801.44;+79448,+79446,;.01~06/09/2026@08:52:54
801.44;+79448,+79446,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79447^1
79448^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR NO BRAIN METS</POINT_01>
<INTERNAL_ENTRY_NUMBER>77204</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2685080375</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77204,;.01~VA-GP ONC BRCA IV ANY ER/PR NO BRAIN METS
801.41;+77204,;4~dialog group
801.41;+77204,;6~YES
801.41;+77204,;7~2
801.41;+77204,;9~ONE SELECTION ONLY
801.41;+77204,;25~WP-start~1
No brain metastases:
801.41;+77204,;35~WP-start~1
No Brain Metastases:
801.41;+77204,;52~INDENT
801.41;+77204,;100~NATIONAL
801.412;+77205,+77204,;.01~5
801.412;+77205,+77204,;2~VA-ONC BRCA IV ANY ER NO METS CLIN TRIAL
801.412;+77206,+77204,;.01~20
801.412;+77206,+77204,;2~VA-GP ONC BRCA IV ANY ER NO METS OFF PTHWY
801.412;+77207,+77204,;.01~10
801.412;+77207,+77204,;2~VA-GP ONC BRCA IV ANY ER NO METS TRAS/PER/DOC+MAINT
801.44;+77208,+77204,;.01~06/09/2026@08:52:54
801.44;+77208,+77204,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77205^2
77206^3
77207^4
77208^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER/PR BM+ TUC MAINT RX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108511</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2865230747</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108511,;.01~VA-ONC BRCA IV ANY ER/PR BM+ TUC MAINT RX
801.41;+108511,;4~dialog element
801.41;+108511,;25~WP-start~2
- Trastuzumab, pertuzumab, and docetaxel (4-6 mo. max response), and then:
\\- Ado-trastuzumab emtansine
801.41;+108511,;51~SUPPRESS
801.41;+108511,;100~NATIONAL
801.44;+108512,+108511,;.01~06/09/2026@08:52:54
801.44;+108512,+108511,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108512^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER METS TUC/TRAS/CAP+MAINT</POINT_01>
<INTERNAL_ENTRY_NUMBER>108510</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1226351829</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108510,;.01~VA-GP ONC BRCA IV ANY ER METS TUC/TRAS/CAP+MAINT
801.41;+108510,;4~dialog group
801.41;+108510,;6~YES
801.41;+108510,;7~2
801.41;+108510,;15~HF.VA-ONC BRCA IV ANY ER METS TUC/TRAS/CAP+
801.41;+108510,;25~WP-start~1
Tucatinib, trastuzumab, and capecitabine, followed by:
801.41;+108510,;35~WP-start~2
Veteran has elected to pursue treatment with TUCATINIB, TRASTUZUMAB, and 
CAPECITABINE FOLLOWED by:
801.41;+108510,;100~NATIONAL
801.412;+108511,+108510,;.01~5
801.412;+108511,+108510,;2~VA-ONC BRCA IV ANY ER/PR BM+ TUC MAINT RX
801.44;+108512,+108510,;.01~06/09/2026@08:52:54
801.44;+108512,+108510,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108511^1
108512^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>79439</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3729969816</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79439,;.01~VA-ONC BRCA IV ANY ER METS CLIN TRIAL
801.41;+79439,;4~dialog element
801.41;+79439,;15~HF.VA-ONC BRCA IV ANY ER METS CLIN TRIAL
801.41;+79439,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+79439,;35~WP-start~1
Veteran has elected to pursue:
801.41;+79439,;100~NATIONAL
801.412;+79440,+79439,;.01~5
801.412;+79440,+79439,;2~VA-ONC CLINICAL TRIAL
801.412;+79440,+79439,;9~YES
801.44;+79441,+79439,;.01~06/09/2026@08:52:54
801.44;+79441,+79439,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79440^1
79441^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC RADIATION ONCOLOGY CONSULT</POINT_01>
<INTERNAL_ENTRY_NUMBER>57669</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1031719635</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+57669,;.01~VA-ONC RADIATION ONCOLOGY CONSULT
801.41;+57669,;4~dialog element
801.41;+57669,;51~SUPPRESS
801.41;+57669,;100~NATIONAL
801.44;+57670,+57669,;.01~06/09/2026@08:52:54
801.44;+57670,+57669,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
57670^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>79441</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>557671094</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79441,;.01~VA-ONC BRCA IV ANY ER METS OFF PATH RSN
801.41;+79441,;4~dialog element
801.41;+79441,;15~HF.VA-ONC BRCA IV ANY ER METS OFF PATH RSN
801.41;+79441,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+79441,;51~SUPPRESS
801.41;+79441,;100~NATIONAL
801.412;+79442,+79441,;.01~5
801.412;+79442,+79441,;2~VA-ONC OFF PATHWAY
801.412;+79442,+79441,;7~YES
801.412;+79442,+79441,;9~YES
801.44;+79443,+79441,;.01~06/09/2026@08:52:54
801.44;+79443,+79441,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79442^1
79443^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER METS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>79440</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2178415459</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79440,;.01~VA-ONC BRCA IV ANY ER METS OFF PATH TX
801.41;+79440,;4~dialog element
801.41;+79440,;15~HF.VA-ONC BRCA IV ANY ER METS OFF PATH TX
801.41;+79440,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+79440,;51~SUPPRESS
801.41;+79440,;100~NATIONAL
801.412;+79441,+79440,;.01~5
801.412;+79441,+79440,;2~VA-ONC BLANK
801.412;+79441,+79440,;7~YES
801.412;+79441,+79440,;9~YES
801.44;+79442,+79440,;.01~06/09/2026@08:52:54
801.44;+79442,+79440,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79441^1
79442^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER METS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>79442</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1623942408</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79442,;.01~VA-GP ONC BRCA IV ANY ER METS OFF PTHWY
801.41;+79442,;4~dialog group
801.41;+79442,;6~YES
801.41;+79442,;7~2
801.41;+79442,;23~YES
801.41;+79442,;25~WP-start~1
Off pathway:
801.41;+79442,;52~INDENT
801.41;+79442,;100~NATIONAL
801.412;+79443,+79442,;.01~10
801.412;+79443,+79442,;2~VA-ONC BRCA IV ANY ER METS OFF PATH TX
801.412;+79444,+79442,;.01~20
801.412;+79444,+79442,;2~VA-ONC BRCA IV ANY ER METS OFF PATH RSN
801.44;+79445,+79442,;.01~06/09/2026@08:52:54
801.44;+79445,+79442,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79443^1
79444^2
79445^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR BRAIN METS</POINT_01>
<INTERNAL_ENTRY_NUMBER>77199</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3687815199</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77199,;.01~VA-GP ONC BRCA IV ANY ER/PR BRAIN METS
801.41;+77199,;4~dialog group
801.41;+77199,;6~YES
801.41;+77199,;7~2
801.41;+77199,;9~NONE OR ONE SELECTION
801.41;+77199,;25~WP-start~1
Brain metastases:
801.41;+77199,;35~WP-start~1
Brain Metastases:
801.41;+77199,;52~INDENT
801.41;+77199,;100~NATIONAL
801.412;+77200,+77199,;.01~20
801.412;+77200,+77199,;2~VA-GP ONC BRCA IV ANY ER METS OFF PTHWY
801.412;+77201,+77199,;.01~5
801.412;+77201,+77199,;2~VA-ONC RADIATION ONCOLOGY CONSULT
801.412;+77202,+77199,;.01~10
801.412;+77202,+77199,;2~VA-ONC BRCA IV ANY ER METS CLIN TRIAL
801.412;+77203,+77199,;.01~15
801.412;+77203,+77199,;2~VA-GP ONC BRCA IV ANY ER METS TUC/TRAS/CAP+MAINT
801.44;+77204,+77199,;.01~06/09/2026@08:52:54
801.44;+77204,+77199,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77200^3
77201^4
77202^5
77203^6
77204^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR AFTER BM FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>77198</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3070021838</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77198,;.01~VA-GP ONC BRCA IV ANY ER/PR AFTER BM FN
801.41;+77198,;4~dialog group
801.41;+77198,;6~YES
801.41;+77198,;7~2
801.41;+77198,;9~NONE OR ONE SELECTION
801.41;+77198,;23~YES
801.41;+77198,;25~WP-start~3
++ If Brain Metastases: refer to Radiation Oncology; fam-trastuzumab 
   deruxtecan and tucatinib trastuzumab capecitabine are preferred in 
   patients with brain metastases. ++
801.41;+77198,;51~SUPPRESS
801.41;+77198,;52~INDENT
801.41;+77198,;100~NATIONAL
801.412;+77199,+77198,;.01~20
801.412;+77199,+77198,;2~VA-GP ONC BRCA IV ANY ER/PR BRAIN METS
801.412;+77200,+77198,;.01~40
801.412;+77200,+77198,;2~VA-GP ONC BRCA IV ANY ER/PR NO BRAIN METS
801.44;+77201,+77198,;.01~06/09/2026@08:52:54
801.44;+77201,+77198,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77199^1
77200^2
77201^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR AFTER FAM-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>77195</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1631636450</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77195,;.01~VA-GP ONC BRCA IV ANY ER/PR AFTER FAM-TRAS
801.41;+77195,;4~dialog group
801.41;+77195,;6~YES
801.41;+77195,;23~YES
801.41;+77195,;25~WP-start~1
AFTER Progression - Next Line Therapy:
801.41;+77195,;51~SUPPRESS
801.41;+77195,;100~NATIONAL
801.412;+77196,+77195,;.01~10
801.412;+77196,+77195,;2~VA-GP ONC BRCA IV ANY ER/PR AFTER BM FN
801.44;+77197,+77195,;.01~06/09/2026@08:52:54
801.44;+77197,+77195,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77196^1
77197^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108508</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2927624835</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108508,;.01~VA-ONC BRCA IV ANY ER OFF PATH RSN
801.41;+108508,;4~dialog element
801.41;+108508,;15~HF.VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH RSN
801.41;+108508,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108508,;51~SUPPRESS
801.41;+108508,;100~NATIONAL
801.412;+108509,+108508,;.01~5
801.412;+108509,+108508,;2~VA-ONC OFF PATHWAY
801.412;+108509,+108508,;7~YES
801.412;+108509,+108508,;9~YES
801.44;+108510,+108508,;.01~06/09/2026@08:52:54
801.44;+108510,+108508,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108509^1
108510^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108507</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2174413626</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108507,;.01~VA-ONC BRCA IV ANY ER OFF PATH TX
801.41;+108507,;4~dialog element
801.41;+108507,;15~HF.VA-ONC BRCA IV ANY ER INITIAL RX OFF PATH TX
801.41;+108507,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108507,;51~SUPPRESS
801.41;+108507,;100~NATIONAL
801.412;+108508,+108507,;.01~5
801.412;+108508,+108507,;2~VA-ONC BLANK
801.412;+108508,+108507,;7~YES
801.412;+108508,+108507,;9~YES
801.44;+108509,+108507,;.01~06/09/2026@08:52:54
801.44;+108509,+108507,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108508^1
108509^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108506</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1932345503</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108506,;.01~VA-GP ONC BRCA IV ANY ER OFF PTHWY
801.41;+108506,;4~dialog group
801.41;+108506,;6~YES
801.41;+108506,;7~2
801.41;+108506,;23~YES
801.41;+108506,;25~WP-start~1
Off pathway:
801.41;+108506,;52~INDENT
801.41;+108506,;100~NATIONAL
801.412;+108507,+108506,;.01~10
801.412;+108507,+108506,;2~VA-ONC BRCA IV ANY ER OFF PATH TX
801.412;+108508,+108506,;.01~20
801.412;+108508,+108506,;2~VA-ONC BRCA IV ANY ER OFF PATH RSN
801.44;+108509,+108506,;.01~06/09/2026@08:52:54
801.44;+108509,+108506,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108507^1
108508^2
108509^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER FAM-TRAS+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>108505</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3999931575</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108505,;.01~VA-ONC BRCA IV ANY ER FAM-TRAS+PERT
801.41;+108505,;4~dialog element
801.41;+108505,;15~HF.VA-ONC BRCA IV ANY ER INITIAL RX FAM-T-DXD+PERT
801.41;+108505,;25~WP-start~1
Fam-trastuzumab deruxtecan and pertuzumab
801.41;+108505,;35~WP-start~2
Veteran has elected to pursue TREATMENT with FAM-TRASTUZUMAB DERUXTECAN 
and PERTUZUMAB.
801.41;+108505,;100~NATIONAL
801.44;+108506,+108505,;.01~06/09/2026@08:52:54
801.44;+108506,+108505,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108506^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA IV ANY ER CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108504</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>649004872</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108504,;.01~VA-ONC BRCA IV ANY ER CLIN TRIAL
801.41;+108504,;4~dialog element
801.41;+108504,;15~HF.VA-ONC BRCA IV ANY ER INITIAL RX CLIN TRIAL
801.41;+108504,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108504,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108504,;100~NATIONAL
801.412;+108505,+108504,;.01~5
801.412;+108505,+108504,;2~VA-ONC CLINICAL TRIAL
801.412;+108505,+108504,;9~YES
801.44;+108506,+108504,;.01~06/09/2026@08:52:54
801.44;+108506,+108504,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108505^1
108506^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA IV ANY ER/PR ADJ TAX TX 12M</POINT_01>
<INTERNAL_ENTRY_NUMBER>75967</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2805261516</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+75967,;.01~VA-GP ONC BRCA IV ANY ER/PR ADJ TAX TX 12M
801.41;+75967,;4~dialog group
801.41;+75967,;6~YES
801.41;+75967,;7~2
801.41;+75967,;9~NONE OR ONE SELECTION
801.41;+75967,;23~YES
801.41;+75967,;25~WP-start~2
++ Fam-trastuzumab-Deruxtecan: avoid in pneumonitis, Interstitial Lung
   Disease (ILD). ++
801.41;+75967,;51~SUPPRESS
801.41;+75967,;52~INDENT
801.41;+75967,;100~NATIONAL
801.412;+75968,+75967,;.01~10
801.412;+75968,+75967,;2~VA-ONC BRCA IV ANY ER CLIN TRIAL
801.412;+75969,+75967,;.01~20
801.412;+75969,+75967,;2~VA-ONC BRCA IV ANY ER FAM-TRAS+PERT
801.412;+75970,+75967,;.01~30
801.412;+75970,+75967,;2~VA-GP ONC BRCA IV ANY ER OFF PTHWY
801.44;+75971,+75967,;.01~06/09/2026@08:52:54
801.44;+75971,+75967,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
75968^1
75969^2
75970^3
75971^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BREAST CA IV ANY ER/PR GERMLINE TEST</POINT_01>
<INTERNAL_ENTRY_NUMBER>75966</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1081680658</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+75966,;.01~VA-ONC BREAST CA IV ANY ER/PR GERMLINE TEST
801.41;+75966,;4~dialog element
801.41;+75966,;23~YES
801.41;+75966,;25~WP-start~1
- Perform germline testing and CGP testing
801.41;+75966,;51~SUPPRESS
801.41;+75966,;100~NATIONAL
801.44;+75967,+75966,;.01~06/09/2026@08:52:54
801.44;+75967,+75966,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
75967^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>PXRM GF VIEW BUTTON</POINT_01>
<INTERNAL_ENTRY_NUMBER>38861</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1501895938</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+38861,;.01~PXRM GF VIEW BUTTON
801.41;+38861,;4~prompt
801.41;+38861,;23~YES
801.41;+38861,;24~View Data
801.41;+38861,;46~GF_VIEW
801.41;+38861,;100~NATIONAL
801.44;+38862,+38861,;.01~06/09/2026@08:52:54
801.44;+38862,+38861,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
38862^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR CA IV ANY ER/PR FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>75954</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>233671382</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+75954,;.01~VA-ONC BR CA IV ANY ER/PR FN
801.41;+75954,;4~dialog element
801.41;+75954,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+75954,;23~YES
801.41;+75954,;25~WP-start~2
++ If patient ER/PR+: add anastrozole and OS or ADT when receiving HER2
   directed therapy. ++
801.41;+75954,;35~WP-start~23
 (a)If Bone Metastases: prescribe zoledronic acid; prescribe denosumab if
 \\    contraindication; vitamin D and dental evaluation; if symptomatic,
refer\\    to Radiation Oncology.\\
 
 (b)If Brain Metastases: refer to Radiation Oncology; fam-trastuzumab 
 \\    deruxtecan and tucatinib trastuzumab capecitabine are preferred
in\\    patients with brain metastases.\\
 
 (c)If MSI High or TMB 10 or more: pembrolizumab is recommended to be
given\\    after endocrine therapy.\\
 
 (d)Evaluate Cardiovascular Risk Factors with baseline LVEF (with\\    
ECHO or MUGA) and CMP; monitor LVEF every 3 months during therapy.\\
 
 (e)Fam-trastuzumab-Deruxtecan: avoid in pneumonitis, Interstitial Lung
\\    Disease (ILD).\\
 
 (f)Multiple Combinations of HER2 Directed Therapies and chemotherapy are
FDA\\    approved but optimal sequencing unknown; consider performance
status and\\    toxicity profile.\\
 
 (g)Chemotherapy includes vinorelbine, docetaxel/paclitaxel +/- 
carboplatin,\\    eribulin, gemcitabine, capecitabine.
801.41;+75954,;51~SUPPRESS
801.41;+75954,;100~NATIONAL
801.412;+75955,+75954,;.01~5
801.412;+75955,+75954,;2~PXRM GF VIEW BUTTON
801.412;+75955,+75954,;6~VIEW Any ER/PR and HER2+ Footnote
801.44;+75956,+75954,;.01~06/09/2026@08:52:54
801.44;+75956,+75954,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
75955^1
75956^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA IV ANY ER/PR/HER2+</POINT_01>
<INTERNAL_ENTRY_NUMBER>75947</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2062900084</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+75947,;.01~VA-GP ONC BREAST CA IV ANY ER/PR/HER2+
801.41;+75947,;4~dialog group
801.41;+75947,;6~YES
801.41;+75947,;15~HF.VA-ONC BRCA STG IV ANY ER/PR/HER2+ CLINICAL PATHWAY
801.41;+75947,;25~WP-start~1
Any ER/PR and HER2+ Clinical Pathway:
801.41;+75947,;35~WP-start~3
VA National Breast Cancer - Stage IV Any ER/PR and HER2+\\  Clinical 
Pathway\\
========================================================
801.41;+75947,;100~NATIONAL
801.41;+75947,;101~VHA ONCOLOGY
801.412;+75948,+75947,;.01~10
801.412;+75948,+75947,;2~VA-ONC BR CA IV ANY ER/PR FN
801.412;+75949,+75947,;.01~20
801.412;+75949,+75947,;2~VA-ONC BREAST CA IV ANY ER/PR GERMLINE TEST
801.412;+75950,+75947,;.01~30
801.412;+75950,+75947,;2~VA-GP ONC BRCA IV ANY ER/PR ADJ TAX TX 12M
801.412;+75951,+75947,;.01~40
801.412;+75951,+75947,;2~VA-GP ONC BRCA IV ANY ER/PR AFTER FAM-TRAS
801.412;+75952,+75947,;.01~50
801.412;+75952,+75947,;2~VA-GP ONC BRCA IV ANY ER/PR AFTER TRAS TX
801.44;+75953,+75947,;.01~06/09/2026@08:52:54
801.44;+75953,+75947,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
75948^1
75949^2
75950^3
75951^4
75952^5
75953^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA MT PTHWY GERMLINE OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>77969</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>568602046</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77969,;.01~VA-ONC BRCA MT PTHWY GERMLINE OFF PTHWY
801.41;+77969,;4~dialog element
801.41;+77969,;15~HF.VA-ONC BRCA GERMLINE TEST NOT ORDERED OFF PATH RSN
801.41;+77969,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+77969,;51~SUPPRESS
801.41;+77969,;100~NATIONAL
801.412;+77970,+77969,;.01~5
801.412;+77970,+77969,;2~VA-ONC OFF PATHWAY
801.412;+77970,+77969,;7~YES
801.412;+77970,+77969,;9~YES
801.44;+77971,+77969,;.01~06/09/2026@08:52:54
801.44;+77971,+77969,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77970^1
77971^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA PTHWY GERM ORDER OFF PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>77970</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2860520154</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77970,;.01~VA-GP ONC BRCA PTHWY GERM ORDER OFF PATHWAY
801.41;+77970,;4~dialog group
801.41;+77970,;6~YES
801.41;+77970,;7~2
801.41;+77970,;25~WP-start~2
I do not intend to get consent/order germline genetic testing for this
Veteran (off pathway):
801.41;+77970,;35~WP-start~1
CONSENT DISCUSSION/GERMLINE GENETIC testing NOT DONE for this Veteran.
801.41;+77970,;52~INDENT
801.41;+77970,;100~NATIONAL
801.412;+77971,+77970,;.01~10
801.412;+77971,+77970,;2~VA-ONC BRCA MT PTHWY GERMLINE OFF PTHWY
801.44;+77972,+77970,;.01~06/09/2026@08:52:54
801.44;+77972,+77970,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77971^1
77972^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA MT DECLINE GERMLINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>77966</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1261522601</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77966,;.01~VA-ONC BRCA MT DECLINE GERMLINE
801.41;+77966,;4~dialog element
801.41;+77966,;15~HF.VA-ONC BRCA GERMLINE TEST DECLINED
801.41;+77966,;25~WP-start~1
Veteran declined testing
801.41;+77966,;35~WP-start~1
Veteran DECLINED GERMLINE GENETIC testing.
801.41;+77966,;100~NATIONAL
801.4118;+77967,+77966,;.01~HF.VA-CCGS GERMLINE TESTING DECLINED
801.44;+77968,+77966,;.01~06/09/2026@08:52:54
801.44;+77968,+77966,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77967^1
77968^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA MT GERMLINE CONSENT FUTURE</POINT_01>
<INTERNAL_ENTRY_NUMBER>77968</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>88049975</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77968,;.01~VA-ONC BRCA MT GERMLINE CONSENT FUTURE
801.41;+77968,;4~dialog element
801.41;+77968,;15~HF.VA-ONC BRCA GERMLINE TEST CONSENT DISCUSSION IN FUTURE
801.41;+77968,;25~WP-start~1
Consent in future {FLD:VA-ONC NEITHER ON/OFF}
801.41;+77968,;35~WP-start~1
Germline genetic testing will be addressed at a FUTURE date.
801.41;+77968,;100~NATIONAL
801.44;+77969,+77968,;.01~06/09/2026@08:52:54
801.44;+77969,+77968,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77969^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA MT GERMLINE PREVIOUSLY ORDERED</POINT_01>
<INTERNAL_ENTRY_NUMBER>77967</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1521841727</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77967,;.01~VA-ONC BRCA MT GERMLINE PREVIOUSLY ORDERED
801.41;+77967,;4~dialog element
801.41;+77967,;15~HF.VA-ONC BRCA GERMLINE TEST ORDERED
801.41;+77967,;25~WP-start~1
Previously ordered
801.41;+77967,;35~WP-start~1
GERMLINE GENETIC testing PREVIOUSLY ORDERED.
801.41;+77967,;100~NATIONAL
801.44;+77968,+77967,;.01~06/09/2026@08:52:54
801.44;+77968,+77967,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77968^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA GERMLINE CONSENT AND ORDER</POINT_01>
<INTERNAL_ENTRY_NUMBER>77959</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1267496764</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77959,;.01~VA-GP ONC BRCA GERMLINE CONSENT AND ORDER
801.41;+77959,;4~dialog group
801.41;+77959,;6~YES
801.41;+77959,;7~2
801.41;+77959,;9~ONE SELECTION ONLY
801.41;+77959,;15~HF.VA-ONC BRCA GERMLINE TEST ORDERED
801.41;+77959,;25~WP-start~1
Order/Refer to Genetics:
801.41;+77959,;100~LOCAL
801.44;+77960,+77959,;.01~06/09/2026@08:52:54
801.44;+77960,+77959,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77960^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA PTHWY MOLECULAR GERMLINE MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>77957</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3261263561</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77957,;.01~VA-GP ONC BRCA PTHWY MOLECULAR GERMLINE MAIN
801.41;+77957,;4~dialog group
801.41;+77957,;6~YES
801.41;+77957,;7~2
801.41;+77957,;9~NONE OR ONE SELECTION
801.41;+77957,;25~WP-start~1
Germline Genetic Testing:
801.41;+77957,;52~INDENT
801.41;+77957,;100~NATIONAL
801.4118;+77958,+77957,;.01~HF.VA-ONC BRCA GERMLINE TESTING
801.412;+77959,+77957,;.01~30
801.412;+77959,+77957,;2~VA-GP ONC BRCA GERMLINE CONSENT AND ORDER
801.412;+77960,+77957,;.01~50
801.412;+77960,+77957,;2~VA-ONC BRCA MT GERMLINE PREVIOUSLY ORDERED
801.412;+77961,+77957,;.01~60
801.412;+77961,+77957,;2~VA-ONC BRCA MT GERMLINE CONSENT FUTURE
801.412;+77962,+77957,;.01~70
801.412;+77962,+77957,;2~VA-ONC BRCA MT DECLINE GERMLINE
801.412;+77963,+77957,;.01~80
801.412;+77963,+77957,;2~VA-GP ONC BRCA PTHWY GERM ORDER OFF PATHWAY
801.44;+77964,+77957,;.01~06/09/2026@08:52:54
801.44;+77964,+77957,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77958^1
77959^17
77960^18
77961^19
77962^20
77963^21
77964^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA PERFORM GERMLINE TEST</POINT_01>
<INTERNAL_ENTRY_NUMBER>78791</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3705186760</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78791,;.01~VA-GP ONC BRCA PERFORM GERMLINE TEST
801.41;+78791,;4~dialog group
801.41;+78791,;6~YES
801.41;+78791,;7~2
801.41;+78791,;9~NO SELECTION REQUIRED
801.41;+78791,;23~YES
801.41;+78791,;25~WP-start~1
Perform Germline Testing as indicated:
801.41;+78791,;51~SUPPRESS
801.41;+78791,;100~NATIONAL
801.412;+78792,+78791,;.01~20
801.412;+78792,+78791,;2~VA-GP ONC BRCA PTHWY MOLECULAR GERMLINE MAIN
801.44;+78793,+78791,;.01~06/09/2026@08:52:54
801.44;+78793,+78791,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78792^1
78793^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR CA WORKUP VIEW BOX FULL</POINT_01>
<INTERNAL_ENTRY_NUMBER>70986</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2939857939</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+70986,;.01~VA-ONC BR CA WORKUP VIEW BOX FULL
801.41;+70986,;4~dialog element
801.41;+70986,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+70986,;23~YES
801.41;+70986,;25~WP-start~2
Breast Cancer-Workup\\
++ after biopsy-proven invasive cancer ++
801.41;+70986,;35~WP-start~35
*********************************************************************\\
1. Family history evaluation\\
2. Breast and axillary exam\\
3. Diagnostic mammogram and/or ultrasound\\
   ++ Diagnostic Imaging if not previously performed; MRI not routinely\\ 
     recommended ++\\
4. ER/PR and HER2 testing\\
   ++ ER/PR and HER2 Testing follow Pathology pathway for in-depth\\    
  information ++\\
5. Evaluate pre-menopausal women for fertility counseling and OFS for
\\   ovarian preservation\\
6. Perform germline testing\\
*********************************************************************\\
\\++ Metastatic Disease confirmation by biopsy; symptoms include 
neurological\\   symptoms, persistent cough, abnormal blood counts,
abnormal LFTs, bone pain;\\   if neurological symptoms, perform brain MRI
with contrast. ++
 
YES SYMPTOMS:\\
Symptoms of metastatic disease or Stage III:\\
> PET/CT\\
  ++ If unavailable, perform CT chest/abdomen/pelvis with bone scan. ++
\\ > If metastatic disease found, follow appropriate staged pathway
\\ > If No metastatic disease found:\\
   Nodes found on axillary exam or triple negative or HER2+?\\
   >> If YES, then axillary ultrasound +/- biopsy with clip placement and 
\\      follow appropriately staged pathway\\
   >> If NO, then follow appropriately staged pathway
 
NO SYMPTOMS:\\
 No symptoms of metastatic disease or Stage III:\\
   Nodes found on axillary exam or triple negative or HER2+?\\
   >> If YES, then axillary ultrasound +/- biopsy with clip placement and 
\\      follow appropriately staged pathway\\
   >> If NO, then follow appropriately staged pathway
801.41;+70986,;51~SUPPRESS
801.41;+70986,;100~NATIONAL
801.412;+70987,+70986,;.01~5
801.412;+70987,+70986,;2~PXRM GF VIEW BUTTON
801.412;+70987,+70986,;6~VIEW Workup Eval/Exams
801.412;+70987,+70986,;8~YES
801.44;+70988,+70986,;.01~06/09/2026@08:52:54
801.44;+70988,+70986,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
70987^1
70988^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA STG I-III WORKUP/GERMLINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>88690</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4142740182</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+88690,;.01~VA-GP ONC BRCA STG I-III WORKUP/GERMLINE
801.41;+88690,;4~dialog group
801.41;+88690,;6~YES
801.41;+88690,;51~SUPPRESS
801.41;+88690,;100~NATIONAL
801.412;+88691,+88690,;.01~20
801.412;+88691,+88690,;2~VA-ONC BR CA WORKUP VIEW BOX FULL
801.412;+88692,+88690,;.01~40
801.412;+88692,+88690,;2~VA-GP ONC BRCA PERFORM GERMLINE TEST
801.44;+88693,+88690,;.01~06/09/2026@08:52:55
801.44;+88693,+88690,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
88691^1
88692^2
88693^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LOW/POST Y1-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108743</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>905744831</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108743,;.01~VA-ONC BRCA ADJ HT LOW/POST Y1-5 OFF PATH RSN
801.41;+108743,;4~dialog element
801.41;+108743,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH RSN
801.41;+108743,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108743,;51~SUPPRESS
801.41;+108743,;100~NATIONAL
801.412;+108744,+108743,;.01~5
801.412;+108744,+108743,;2~VA-ONC OFF PATHWAY
801.412;+108744,+108743,;7~YES
801.412;+108744,+108743,;9~YES
801.44;+108745,+108743,;.01~06/09/2026@08:52:55
801.44;+108745,+108743,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108744^1
108745^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LOW/POST Y1-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108741</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1612953422</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108741,;.01~VA-ONC BRCA ADJ HT LOW/POST Y1-5 OFF PATH TX
801.41;+108741,;4~dialog element
801.41;+108741,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 OFF PATH TX
801.41;+108741,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108741,;51~SUPPRESS
801.41;+108741,;100~NATIONAL
801.412;+108742,+108741,;.01~5
801.412;+108742,+108741,;2~VA-ONC BLANK
801.412;+108742,+108741,;7~YES
801.412;+108742,+108741,;9~YES
801.44;+108743,+108741,;.01~06/09/2026@08:52:55
801.44;+108743,+108741,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108742^1
108743^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LOW/POST Y1-5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108739</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3308478803</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108739,;.01~VA-GP ONC BRCA ADJ HT LOW/POST Y1-5 OFF PTHWY
801.41;+108739,;4~dialog group
801.41;+108739,;6~YES
801.41;+108739,;7~2
801.41;+108739,;23~YES
801.41;+108739,;25~WP-start~1
Off pathway:
801.41;+108739,;52~INDENT
801.41;+108739,;100~NATIONAL
801.412;+108740,+108739,;.01~10
801.412;+108740,+108739,;2~VA-ONC BRCA ADJ HT LOW/POST Y1-5 OFF PATH TX
801.412;+108741,+108739,;.01~20
801.412;+108741,+108739,;2~VA-ONC BRCA ADJ HT LOW/POST Y1-5 OFF PATH RSN
801.44;+108742,+108739,;.01~06/09/2026@08:52:55
801.44;+108742,+108739,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108740^1
108741^2
108742^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LOW/POST Y1-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108737</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3078004618</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108737,;.01~VA-ONC BRCA ADJ HT LOW/POST Y1-5 CLIN TRIAL
801.41;+108737,;4~dialog element
801.41;+108737,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 CLIN TRIAL
801.41;+108737,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108737,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108737,;100~NATIONAL
801.412;+108738,+108737,;.01~5
801.412;+108738,+108737,;2~VA-ONC CLINICAL TRIAL
801.412;+108738,+108737,;9~YES
801.44;+108739,+108737,;.01~06/09/2026@08:52:55
801.44;+108739,+108737,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108738^1
108739^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LR POST 1-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101282</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1223959629</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101282,;.01~VA-ONC BRCA ADJ HT LR POST 1-5 TAM
801.41;+101282,;4~dialog element
801.41;+101282,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 TAM+SURV
801.41;+101282,;25~WP-start~1
Tamoxifen followed by surveillance
801.41;+101282,;35~WP-start~2
-For years 1-5, Veteran has elected to pursue TREATMENT with TAMOXIFEN 
 followed by SURVEILLANCE.
801.41;+101282,;100~NATIONAL
801.44;+101283,+101282,;.01~06/09/2026@08:52:55
801.44;+101283,+101282,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101283^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LR POST 1-5 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101281</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4294320578</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101281,;.01~VA-ONC BRCA ADJ HT LR POST 1-5 ANA
801.41;+101281,;4~dialog element
801.41;+101281,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PST-M Y1-5 ANA+SURV
801.41;+101281,;25~WP-start~1
Anastrozole followed by surveillance
801.41;+101281,;35~WP-start~2
-For years 1-5, Veteran has elected to pursue TREATMENT with ANASTROZOLE 
 followed by SURVEILLANCE.
801.41;+101281,;100~NATIONAL
801.44;+101282,+101281,;.01~06/09/2026@08:52:55
801.44;+101282,+101281,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101282^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LR POST Y1-5</POINT_01>
<INTERNAL_ENTRY_NUMBER>101280</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1081853971</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101280,;.01~VA-GP ONC BRCA ADJ HT LR POST Y1-5
801.41;+101280,;4~dialog group
801.41;+101280,;5~Years 1-5:
801.41;+101280,;6~YES
801.41;+101280,;7~2
801.41;+101280,;9~NONE OR ONE SELECTION
801.41;+101280,;51~SUPPRESS
801.41;+101280,;52~INDENT
801.41;+101280,;100~NATIONAL
801.412;+101281,+101280,;.01~20
801.412;+101281,+101280,;2~VA-ONC BRCA ADJ HT LR POST 1-5 ANA
801.412;+101282,+101280,;.01~30
801.412;+101282,+101280,;2~VA-ONC BRCA ADJ HT LR POST 1-5 TAM
801.412;+101283,+101280,;.01~10
801.412;+101283,+101280,;2~VA-ONC BRCA ADJ HT LOW/POST Y1-5 CLIN TRIAL
801.412;+101284,+101280,;.01~40
801.412;+101284,+101280,;2~VA-GP ONC BRCA ADJ HT LOW/POST Y1-5 OFF PTHWY
801.44;+101285,+101280,;.01~06/09/2026@08:52:55
801.44;+101285,+101280,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101281^1
101282^2
101283^3
101284^4
101285^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LR POSTMEN</POINT_01>
<INTERNAL_ENTRY_NUMBER>101269</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>494640792</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101269,;.01~VA-GP ONC BRCA ADJ HT LR POSTMEN
801.41;+101269,;4~dialog group
801.41;+101269,;25~WP-start~1
Post-menopausal at diagnosis or not male:
801.41;+101269,;100~NATIONAL
801.412;+101270,+101269,;.01~10
801.412;+101270,+101269,;2~VA-GP ONC BRCA ADJ HT LR POST Y1-5
801.44;+101271,+101269,;.01~06/09/2026@08:52:55
801.44;+101271,+101269,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101270^1
101271^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108744</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>358344718</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108744,;.01~VA-ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PATH RSN
801.41;+108744,;4~dialog element
801.41;+108744,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH RSN
801.41;+108744,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108744,;51~SUPPRESS
801.41;+108744,;100~NATIONAL
801.412;+108745,+108744,;.01~5
801.412;+108745,+108744,;2~VA-ONC OFF PATHWAY
801.412;+108745,+108744,;7~YES
801.412;+108745,+108744,;9~YES
801.44;+108746,+108744,;.01~06/09/2026@08:52:55
801.44;+108746,+108744,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108745^1
108746^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108742</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4129474194</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108742,;.01~VA-ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PATH TX
801.41;+108742,;4~dialog element
801.41;+108742,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OFF PATH TX
801.41;+108742,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108742,;51~SUPPRESS
801.41;+108742,;100~NATIONAL
801.412;+108743,+108742,;.01~5
801.412;+108743,+108742,;2~VA-ONC BLANK
801.412;+108743,+108742,;7~YES
801.412;+108743,+108742,;9~YES
801.44;+108744,+108742,;.01~06/09/2026@08:52:55
801.44;+108744,+108742,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108743^1
108744^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108740</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2271893724</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108740,;.01~VA-GP ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PTHWY
801.41;+108740,;4~dialog group
801.41;+108740,;6~YES
801.41;+108740,;7~2
801.41;+108740,;23~YES
801.41;+108740,;25~WP-start~1
Off pathway:
801.41;+108740,;52~INDENT
801.41;+108740,;100~NATIONAL
801.412;+108741,+108740,;.01~10
801.412;+108741,+108740,;2~VA-ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PATH TX
801.412;+108742,+108740,;.01~20
801.412;+108742,+108740,;2~VA-ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PATH RSN
801.44;+108743,+108740,;.01~06/09/2026@08:52:55
801.44;+108743,+108740,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108741^1
108742^2
108743^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LOW/PRE Y1-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108738</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>830876773</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108738,;.01~VA-ONC BRCA ADJ HT LOW/PRE Y1-5 CLIN TRIAL
801.41;+108738,;4~dialog element
801.41;+108738,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 CLIN TRIAL
801.41;+108738,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108738,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108738,;100~NATIONAL
801.412;+108739,+108738,;.01~5
801.412;+108739,+108738,;2~VA-ONC CLINICAL TRIAL
801.412;+108739,+108738,;9~YES
801.44;+108740,+108738,;.01~06/09/2026@08:52:55
801.44;+108740,+108738,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108739^1
108740^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 AI/ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>107023</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3646770108</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+107023,;.01~VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 AI/ADT
801.41;+107023,;4~dialog element
801.41;+107023,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 ADT+ANA/SURV
801.41;+107023,;25~WP-start~1
ADT + Anastrozole followed by surveillance
801.41;+107023,;35~WP-start~2
-For years 1-5, Veteran has elected pursue TREATMENT with Androgen 
 Deprivation Therapy plus ANASTROZOLE followed by SURVEILLANCE.
801.41;+107023,;100~NATIONAL
801.44;+107024,+107023,;.01~06/09/2026@08:52:55
801.44;+107024,+107023,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
107024^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 AI/OS</POINT_01>
<INTERNAL_ENTRY_NUMBER>107022</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3896760330</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+107022,;.01~VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 AI/OS
801.41;+107022,;4~dialog element
801.41;+107022,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 OS+ANA/SURV
801.41;+107022,;25~WP-start~1
OS + Anastrazole followed by surveillance
801.41;+107022,;35~WP-start~2
-For years 1-5, Veteran has elected pursue TREATMENT with Ovarian 
 Suppression (OS) plus ANASTROZOLE followed by SURVEILLANCE.
801.41;+107022,;100~NATIONAL
801.44;+107023,+107022,;.01~06/09/2026@08:52:55
801.44;+107023,+107022,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
107023^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101270</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3081738717</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101270,;.01~VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 TAM
801.41;+101270,;4~dialog element
801.41;+101270,;15~HF.VA-ONC BRCA ADJ HT HER2- LOW/PRE-M Y1-5 TAM
801.41;+101270,;25~WP-start~1
Tamoxifen followed by surveillance
801.41;+101270,;35~WP-start~2
-For years 1-5, Veteran has elected pursue TREATMENT with TAMOXIFEN 
 followed by SURVEILLANCE.
801.41;+101270,;100~NATIONAL
801.44;+101271,+101270,;.01~06/09/2026@08:52:55
801.44;+101271,+101270,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101271^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LR PRE/MALE Y1-5</POINT_01>
<INTERNAL_ENTRY_NUMBER>101271</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>189902571</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101271,;.01~VA-GP ONC BRCA ADJ HT LR PRE/MALE Y1-5
801.41;+101271,;4~dialog group
801.41;+101271,;5~Years 1-5:
801.41;+101271,;6~YES
801.41;+101271,;7~2
801.41;+101271,;9~NONE OR ONE SELECTION
801.41;+101271,;51~SUPPRESS
801.41;+101271,;52~INDENT
801.41;+101271,;100~NATIONAL
801.412;+101272,+101271,;.01~20
801.412;+101272,+101271,;2~VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 TAM
801.412;+101273,+101271,;.01~30
801.412;+101273,+101271,;2~VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 AI/OS
801.412;+101274,+101271,;.01~40
801.412;+101274,+101271,;2~VA-ONC BRCA ADJ HT LR PRE/MALE 1-5 AI/ADT
801.412;+101275,+101271,;.01~10
801.412;+101275,+101271,;2~VA-ONC BRCA ADJ HT LOW/PRE Y1-5 CLIN TRIAL
801.412;+101276,+101271,;.01~50
801.412;+101276,+101271,;2~VA-GP ONC BRCA ADJ HT LOW/PRE Y1-5 OFF PTHWY
801.44;+101277,+101271,;.01~06/09/2026@08:52:55
801.44;+101277,+101271,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101272^1
101273^2
101274^3
101275^4
101276^5
101277^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LR PRE/MALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101268</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1899915060</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101268,;.01~VA-GP ONC BRCA ADJ HT LR PRE/MALE
801.41;+101268,;4~dialog group
801.41;+101268,;25~WP-start~1
Pre-menopausal at diagnosis or male:
801.41;+101268,;100~NATIONAL
801.412;+101269,+101268,;.01~10
801.412;+101269,+101268,;2~VA-GP ONC BRCA ADJ HT LR PRE/MALE Y1-5
801.44;+101270,+101268,;.01~06/09/2026@08:52:55
801.44;+101270,+101268,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101269^1
101270^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT LOW RISK</POINT_01>
<INTERNAL_ENTRY_NUMBER>101236</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>24500603</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101236,;.01~VA-GP ONC BRCA ADJ HT LOW RISK
801.41;+101236,;4~dialog group
801.41;+101236,;6~YES
801.41;+101236,;7~2
801.41;+101236,;9~ONE SELECTION ONLY
801.41;+101236,;25~WP-start~1
Low risk:
801.41;+101236,;52~INDENT
801.41;+101236,;100~NATIONAL
801.412;+101237,+101236,;.01~15
801.412;+101237,+101236,;2~VA-GP ONC BRCA ADJ HT LR PRE/MALE
801.412;+101238,+101236,;.01~30
801.412;+101238,+101236,;2~VA-GP ONC BRCA ADJ HT LR POSTMEN
801.44;+101239,+101236,;.01~06/09/2026@08:52:55
801.44;+101239,+101236,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101237^1
101238^2
101239^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y6-8 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108736</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1497088158</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108736,;.01~VA-ONC BRCA ADJ HT INT/POST Y6-8 OFF PATH RSN
801.41;+108736,;4~dialog element
801.41;+108736,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH RSN
801.41;+108736,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108736,;51~SUPPRESS
801.41;+108736,;100~NATIONAL
801.412;+108737,+108736,;.01~5
801.412;+108737,+108736,;2~VA-ONC OFF PATHWAY
801.412;+108737,+108736,;7~YES
801.412;+108737,+108736,;9~YES
801.44;+108738,+108736,;.01~06/09/2026@08:52:55
801.44;+108738,+108736,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108737^1
108738^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y6-8 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108735</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1961371460</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108735,;.01~VA-ONC BRCA ADJ HT INT/POST Y6-8 OFF PATH TX
801.41;+108735,;4~dialog element
801.41;+108735,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 OFF PATH TX
801.41;+108735,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108735,;51~SUPPRESS
801.41;+108735,;100~NATIONAL
801.412;+108736,+108735,;.01~5
801.412;+108736,+108735,;2~VA-ONC BLANK
801.412;+108736,+108735,;7~YES
801.412;+108736,+108735,;9~YES
801.44;+108737,+108735,;.01~06/09/2026@08:52:55
801.44;+108737,+108735,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108736^1
108737^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INT/POST Y6-8 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108726</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2185751880</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108726,;.01~VA-GP ONC BRCA ADJ HT INT/POST Y6-8 OFF PTHWY
801.41;+108726,;4~dialog group
801.41;+108726,;6~YES
801.41;+108726,;7~2
801.41;+108726,;23~YES
801.41;+108726,;25~WP-start~1
Off pathway:
801.41;+108726,;52~INDENT
801.41;+108726,;100~NATIONAL
801.412;+108727,+108726,;.01~10
801.412;+108727,+108726,;2~VA-ONC BRCA ADJ HT INT/POST Y6-8 OFF PATH TX
801.412;+108728,+108726,;.01~20
801.412;+108728,+108726,;2~VA-ONC BRCA ADJ HT INT/POST Y6-8 OFF PATH RSN
801.44;+108729,+108726,;.01~06/09/2026@08:52:55
801.44;+108729,+108726,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108727^1
108728^2
108729^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108723</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3863821410</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108723,;.01~VA-ONC BRCA ADJ HT INT/POST Y6-8 CLIN TRIAL
801.41;+108723,;4~dialog element
801.41;+108723,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 CLIN TRIAL
801.41;+108723,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108723,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108723,;100~NATIONAL
801.412;+108724,+108723,;.01~5
801.412;+108724,+108723,;2~VA-ONC CLINICAL TRIAL
801.412;+108724,+108723,;9~YES
801.44;+108725,+108723,;.01~06/09/2026@08:52:55
801.44;+108725,+108723,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108724^1
108725^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-BRCA ADJ HT IR POST 6-8 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101310</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1533216182</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101310,;.01~VA-BRCA ADJ HT IR POST 6-8 TAM
801.41;+101310,;4~dialog element
801.41;+101310,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 TAM+SURV
801.41;+101310,;25~WP-start~1
Tamoxifen followed by surveillance
801.41;+101310,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with TAMOXEN 
 followed by SURVEILLANCE.
801.41;+101310,;100~NATIONAL
801.44;+101311,+101310,;.01~06/09/2026@08:52:55
801.44;+101311,+101310,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101311^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-BRCA ADJ HT IR POST 6-8 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101309</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1808708246</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101309,;.01~VA-BRCA ADJ HT IR POST 6-8 ANA
801.41;+101309,;4~dialog element
801.41;+101309,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y6-8 ANA+SURV
801.41;+101309,;25~WP-start~1
Anastrozole followed by surveillance
801.41;+101309,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with ANASTROZOLE 
 followed by SURVEILLANCE.
801.41;+101309,;100~NATIONAL
801.44;+101310,+101309,;.01~06/09/2026@08:52:55
801.44;+101310,+101309,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101310^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR POST Y6-8</POINT_01>
<INTERNAL_ENTRY_NUMBER>101304</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3411851184</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101304,;.01~VA-GP ONC BRCA ADJ HT IR POST Y6-8
801.41;+101304,;4~dialog group
801.41;+101304,;5~Years 6-8:
801.41;+101304,;6~YES
801.41;+101304,;7~2
801.41;+101304,;9~NONE OR ONE SELECTION
801.41;+101304,;23~YES
801.41;+101304,;25~WP-start~1
Veteran preference after shared decision making:
801.41;+101304,;51~SUPPRESS
801.41;+101304,;52~INDENT
801.41;+101304,;100~NATIONAL
801.412;+101305,+101304,;.01~20
801.412;+101305,+101304,;2~VA-BRCA ADJ HT IR POST 6-8 ANA
801.412;+101306,+101304,;.01~30
801.412;+101306,+101304,;2~VA-BRCA ADJ HT IR POST 6-8 TAM
801.412;+101307,+101304,;.01~10
801.412;+101307,+101304,;2~VA-ONC BRCA ADJ HT INT/POST Y6-8 CLIN TRIAL
801.412;+101308,+101304,;.01~40
801.412;+101308,+101304,;2~VA-GP ONC BRCA ADJ HT INT/POST Y6-8 OFF PTHWY
801.44;+101309,+101304,;.01~06/09/2026@08:52:55
801.44;+101309,+101304,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101305^1
101306^2
101307^3
101308^4
101309^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y4-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108734</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3414441127</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108734,;.01~VA-ONC BRCA ADJ HT INT/POST Y4-5 OFF PATH RSN
801.41;+108734,;4~dialog element
801.41;+108734,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH RSN
801.41;+108734,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108734,;51~SUPPRESS
801.41;+108734,;100~NATIONAL
801.412;+108735,+108734,;.01~5
801.412;+108735,+108734,;2~VA-ONC OFF PATHWAY
801.412;+108735,+108734,;7~YES
801.412;+108735,+108734,;9~YES
801.44;+108736,+108734,;.01~06/09/2026@08:52:55
801.44;+108736,+108734,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108735^1
108736^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y4-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108733</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>470784138</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108733,;.01~VA-ONC BRCA ADJ HT INT/POST Y4-5 OFF PATH TX
801.41;+108733,;4~dialog element
801.41;+108733,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 OFF PATH TX
801.41;+108733,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108733,;51~SUPPRESS
801.41;+108733,;100~NATIONAL
801.412;+108734,+108733,;.01~5
801.412;+108734,+108733,;2~VA-ONC BLANK
801.412;+108734,+108733,;7~YES
801.412;+108734,+108733,;9~YES
801.44;+108735,+108733,;.01~06/09/2026@08:52:55
801.44;+108735,+108733,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108734^1
108735^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INT/POST Y4-5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108725</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>620869513</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108725,;.01~VA-GP ONC BRCA ADJ HT INT/POST Y4-5 OFF PTHWY
801.41;+108725,;4~dialog group
801.41;+108725,;6~YES
801.41;+108725,;7~2
801.41;+108725,;23~YES
801.41;+108725,;25~WP-start~1
Off pathway:
801.41;+108725,;52~INDENT
801.41;+108725,;100~NATIONAL
801.412;+108726,+108725,;.01~10
801.412;+108726,+108725,;2~VA-ONC BRCA ADJ HT INT/POST Y4-5 OFF PATH TX
801.412;+108727,+108725,;.01~20
801.412;+108727,+108725,;2~VA-ONC BRCA ADJ HT INT/POST Y4-5 OFF PATH RSN
801.44;+108728,+108725,;.01~06/09/2026@08:52:55
801.44;+108728,+108725,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108726^1
108727^2
108728^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y4-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108722</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1133622512</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108722,;.01~VA-ONC BRCA ADJ HT INT/POST Y4-5 CLIN TRIAL
801.41;+108722,;4~dialog element
801.41;+108722,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 CLIN TRIAL
801.41;+108722,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108722,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108722,;100~NATIONAL
801.412;+108723,+108722,;.01~5
801.412;+108723,+108722,;2~VA-ONC CLINICAL TRIAL
801.412;+108723,+108722,;9~YES
801.44;+108724,+108722,;.01~06/09/2026@08:52:55
801.44;+108724,+108722,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108723^1
108724^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-BRCA ADJ HT IR POST 4-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101308</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>578069321</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101308,;.01~VA-BRCA ADJ HT IR POST 4-5 TAM
801.41;+101308,;4~dialog element
801.41;+101308,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 TAM
801.41;+101308,;25~WP-start~1
Tamoxifen
801.41;+101308,;35~WP-start~1
-For years 4-5, Veteran has elected to pursue TREATMENT with TAMOXIFEN.
801.41;+101308,;100~NATIONAL
801.44;+101309,+101308,;.01~06/09/2026@08:52:55
801.44;+101309,+101308,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101309^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-BRCA ADJ HT IR POST 4-5 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101307</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3826907568</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101307,;.01~VA-BRCA ADJ HT IR POST 4-5 ANA
801.41;+101307,;4~dialog element
801.41;+101307,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y4-5 ANA
801.41;+101307,;25~WP-start~1
Anastrozole
801.41;+101307,;35~WP-start~1
-For years 4-5, Veteran has elected to pursue TREATMENT with ANASTROZOLE.
801.41;+101307,;100~NATIONAL
801.44;+101308,+101307,;.01~06/09/2026@08:52:55
801.44;+101308,+101307,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101308^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR POST Y4-5</POINT_01>
<INTERNAL_ENTRY_NUMBER>101303</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2871556400</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101303,;.01~VA-GP ONC BRCA ADJ HT IR POST Y4-5
801.41;+101303,;4~dialog group
801.41;+101303,;5~Years 4-5:
801.41;+101303,;6~YES
801.41;+101303,;7~2
801.41;+101303,;9~NONE OR ONE SELECTION
801.41;+101303,;51~SUPPRESS
801.41;+101303,;52~INDENT
801.41;+101303,;100~NATIONAL
801.412;+101304,+101303,;.01~20
801.412;+101304,+101303,;2~VA-BRCA ADJ HT IR POST 4-5 ANA
801.412;+101305,+101303,;.01~30
801.412;+101305,+101303,;2~VA-BRCA ADJ HT IR POST 4-5 TAM
801.412;+101306,+101303,;.01~10
801.412;+101306,+101303,;2~VA-ONC BRCA ADJ HT INT/POST Y4-5 CLIN TRIAL
801.412;+101307,+101303,;.01~40
801.412;+101307,+101303,;2~VA-GP ONC BRCA ADJ HT INT/POST Y4-5 OFF PTHWY
801.44;+101308,+101303,;.01~06/09/2026@08:52:55
801.44;+101308,+101303,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101304^1
101305^2
101306^3
101307^4
101308^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y1-3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108732</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3622752586</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108732,;.01~VA-ONC BRCA ADJ HT INT/POST Y1-3 OFF PATH RSN
801.41;+108732,;4~dialog element
801.41;+108732,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH RSN
801.41;+108732,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108732,;51~SUPPRESS
801.41;+108732,;100~NATIONAL
801.412;+108733,+108732,;.01~5
801.412;+108733,+108732,;2~VA-ONC OFF PATHWAY
801.412;+108733,+108732,;7~YES
801.412;+108733,+108732,;9~YES
801.44;+108734,+108732,;.01~06/09/2026@08:52:55
801.44;+108734,+108732,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108733^1
108734^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y1-3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108730</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1188064573</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108730,;.01~VA-ONC BRCA ADJ HT INT/POST Y1-3 OFF PATH TX
801.41;+108730,;4~dialog element
801.41;+108730,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 OFF PATH TX
801.41;+108730,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108730,;51~SUPPRESS
801.41;+108730,;100~NATIONAL
801.412;+108731,+108730,;.01~5
801.412;+108731,+108730,;2~VA-ONC BLANK
801.412;+108731,+108730,;7~YES
801.412;+108731,+108730,;9~YES
801.44;+108732,+108730,;.01~06/09/2026@08:52:55
801.44;+108732,+108730,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108731^1
108732^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INT/POST Y1-3 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108724</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>211267628</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108724,;.01~VA-GP ONC BRCA ADJ HT INT/POST Y1-3 OFF PTHWY
801.41;+108724,;4~dialog group
801.41;+108724,;6~YES
801.41;+108724,;7~2
801.41;+108724,;23~YES
801.41;+108724,;25~WP-start~1
Off pathway:
801.41;+108724,;52~INDENT
801.41;+108724,;100~NATIONAL
801.412;+108725,+108724,;.01~10
801.412;+108725,+108724,;2~VA-ONC BRCA ADJ HT INT/POST Y1-3 OFF PATH TX
801.412;+108726,+108724,;.01~20
801.412;+108726,+108724,;2~VA-ONC BRCA ADJ HT INT/POST Y1-3 OFF PATH RSN
801.44;+108727,+108724,;.01~06/09/2026@08:52:55
801.44;+108727,+108724,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108725^1
108726^2
108727^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/POST Y1-3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108721</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2326953833</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108721,;.01~VA-ONC BRCA ADJ HT INT/POST Y1-3 CLIN TRIAL
801.41;+108721,;4~dialog element
801.41;+108721,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 CLIN TRIAL
801.41;+108721,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108721,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108721,;100~NATIONAL
801.412;+108722,+108721,;.01~5
801.412;+108722,+108721,;2~VA-ONC CLINICAL TRIAL
801.412;+108722,+108721,;9~YES
801.44;+108723,+108721,;.01~06/09/2026@08:52:55
801.44;+108723,+108721,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108722^1
108723^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-BRCA ADJ HT IR POST 1-3 TAM/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>101306</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>483378497</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101306,;.01~VA-BRCA ADJ HT IR POST 1-3 TAM/RIB
801.41;+101306,;4~dialog element
801.41;+101306,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 TAM/RIB
801.41;+101306,;25~WP-start~1
Tamoxifen + ribociclib
801.41;+101306,;35~WP-start~2
-For years 1-3, Veteran has elected to pursue TREATMENT with TAMOXIFEN and
 RIBOCICLIB.
801.41;+101306,;100~NATIONAL
801.44;+101307,+101306,;.01~06/09/2026@08:52:55
801.44;+101307,+101306,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101307^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-BRCA ADJ HT IR POST 1-3 ANA/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>101305</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2555905074</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101305,;.01~VA-BRCA ADJ HT IR POST 1-3 ANA/RIB
801.41;+101305,;4~dialog element
801.41;+101305,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PST-M Y1-3 ANA/RIB
801.41;+101305,;25~WP-start~1
Anastrozole + ribociclib
801.41;+101305,;35~WP-start~2
-For years 1-3, Veteran has elected to pursue TREATMENT with ANASTROZOLE 
 with RIBOCICLIB.
801.41;+101305,;100~NATIONAL
801.44;+101306,+101305,;.01~06/09/2026@08:52:55
801.44;+101306,+101305,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101306^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR POST Y1-3</POINT_01>
<INTERNAL_ENTRY_NUMBER>101302</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2479218043</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101302,;.01~VA-GP ONC BRCA ADJ HT IR POST Y1-3
801.41;+101302,;4~dialog group
801.41;+101302,;5~Years 1-3:
801.41;+101302,;6~YES
801.41;+101302,;7~2
801.41;+101302,;9~NONE OR ONE SELECTION
801.41;+101302,;51~SUPPRESS
801.41;+101302,;52~INDENT
801.41;+101302,;100~NATIONAL
801.412;+101303,+101302,;.01~20
801.412;+101303,+101302,;2~VA-BRCA ADJ HT IR POST 1-3 ANA/RIB
801.412;+101304,+101302,;.01~30
801.412;+101304,+101302,;2~VA-BRCA ADJ HT IR POST 1-3 TAM/RIB
801.412;+101305,+101302,;.01~10
801.412;+101305,+101302,;2~VA-ONC BRCA ADJ HT INT/POST Y1-3 CLIN TRIAL
801.412;+101306,+101302,;.01~40
801.412;+101306,+101302,;2~VA-GP ONC BRCA ADJ HT INT/POST Y1-3 OFF PTHWY
801.44;+101307,+101302,;.01~06/09/2026@08:52:55
801.44;+101307,+101302,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101303^1
101304^2
101305^3
101306^4
101307^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR POSTMEN</POINT_01>
<INTERNAL_ENTRY_NUMBER>101301</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2225187922</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101301,;.01~VA-GP ONC BRCA ADJ HT IR POSTMEN
801.41;+101301,;4~dialog group
801.41;+101301,;25~WP-start~1
Post-menopausal at diagnosis or not male:
801.41;+101301,;100~NATIONAL
801.412;+101302,+101301,;.01~10
801.412;+101302,+101301,;2~VA-GP ONC BRCA ADJ HT IR POST Y1-3
801.412;+101303,+101301,;.01~30
801.412;+101303,+101301,;2~VA-GP ONC BRCA ADJ HT IR POST Y4-5
801.412;+101304,+101301,;.01~50
801.412;+101304,+101301,;2~VA-GP ONC BRCA ADJ HT IR POST Y6-8
801.44;+101305,+101301,;.01~06/09/2026@08:52:55
801.44;+101305,+101301,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101302^1
101303^2
101304^3
101305^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y6-8 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108719</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>819011953</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108719,;.01~VA-ONC BRCA ADJ HT INT/PRE Y6-8 OFF PATH RSN
801.41;+108719,;4~dialog element
801.41;+108719,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH RSN
801.41;+108719,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108719,;51~SUPPRESS
801.41;+108719,;100~NATIONAL
801.412;+108720,+108719,;.01~5
801.412;+108720,+108719,;2~VA-ONC OFF PATHWAY
801.412;+108720,+108719,;7~YES
801.412;+108720,+108719,;9~YES
801.44;+108721,+108719,;.01~06/09/2026@08:52:55
801.44;+108721,+108719,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108720^1
108721^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y6-8 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108716</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4208664023</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108716,;.01~VA-ONC BRCA ADJ HT INT/PRE Y6-8 OFF PATH TX
801.41;+108716,;4~dialog element
801.41;+108716,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 OFF PTH TX
801.41;+108716,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108716,;51~SUPPRESS
801.41;+108716,;100~NATIONAL
801.412;+108717,+108716,;.01~5
801.412;+108717,+108716,;2~VA-ONC BLANK
801.412;+108717,+108716,;7~YES
801.412;+108717,+108716,;9~YES
801.44;+108718,+108716,;.01~06/09/2026@08:52:55
801.44;+108718,+108716,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108717^1
108718^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INT/PRE Y6-8 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108713</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>898159529</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108713,;.01~VA-GP ONC BRCA ADJ HT INT/PRE Y6-8 OFF PTHWY
801.41;+108713,;4~dialog group
801.41;+108713,;6~YES
801.41;+108713,;7~2
801.41;+108713,;23~YES
801.41;+108713,;25~WP-start~1
Off pathway:
801.41;+108713,;52~INDENT
801.41;+108713,;100~NATIONAL
801.412;+108714,+108713,;.01~10
801.412;+108714,+108713,;2~VA-ONC BRCA ADJ HT INT/PRE Y6-8 OFF PATH TX
801.412;+108715,+108713,;.01~20
801.412;+108715,+108713,;2~VA-ONC BRCA ADJ HT INT/PRE Y6-8 OFF PATH RSN
801.44;+108716,+108713,;.01~06/09/2026@08:52:55
801.44;+108716,+108713,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108714^1
108715^2
108716^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108710</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3535167130</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108710,;.01~VA-ONC BRCA ADJ HT INT/PRE Y6-8 CLIN TRIAL
801.41;+108710,;4~dialog element
801.41;+108710,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 CLIN TRIAL
801.41;+108710,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108710,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108710,;100~NATIONAL
801.412;+108711,+108710,;.01~5
801.412;+108711,+108710,;2~VA-ONC CLINICAL TRIAL
801.412;+108711,+108710,;9~YES
801.44;+108712,+108710,;.01~06/09/2026@08:52:55
801.44;+108712,+108710,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108711^1
108712^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 6-8 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101300</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4055621937</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101300,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 6-8 TAM
801.41;+101300,;4~dialog element
801.41;+101300,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 TAM+SURV
801.41;+101300,;25~WP-start~1
Tamoxifen followed by surveillance
801.41;+101300,;35~WP-start~2
For years 6-8, Veteran has elected to pursue TREATMENT with TAMOXIFEN 
followed by SURVEILLANCE.
801.41;+101300,;100~NATIONAL
801.44;+101301,+101300,;.01~06/09/2026@08:52:55
801.44;+101301,+101300,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101301^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 6-8 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101299</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1995147501</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101299,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 6-8 ANA
801.41;+101299,;4~dialog element
801.41;+101299,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y6-8 ANA+SURV
801.41;+101299,;25~WP-start~1
Anastrozole followed by surveillance
801.41;+101299,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with ANASTROZOLE
 followed by SURVEILLANCE.
801.41;+101299,;100~NATIONAL
801.44;+101300,+101299,;.01~06/09/2026@08:52:55
801.44;+101300,+101299,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101300^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR PRE/MALE Y6-8</POINT_01>
<INTERNAL_ENTRY_NUMBER>101294</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1321785441</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101294,;.01~VA-GP ONC BRCA ADJ HT IR PRE/MALE Y6-8
801.41;+101294,;4~dialog group
801.41;+101294,;5~Years 6-8:
801.41;+101294,;6~YES
801.41;+101294,;7~2
801.41;+101294,;9~NONE OR ONE SELECTION
801.41;+101294,;23~YES
801.41;+101294,;25~WP-start~1
Veteran preference after shared decision making:
801.41;+101294,;51~SUPPRESS
801.41;+101294,;52~INDENT
801.41;+101294,;100~NATIONAL
801.412;+101295,+101294,;.01~20
801.412;+101295,+101294,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 6-8 ANA
801.412;+101296,+101294,;.01~30
801.412;+101296,+101294,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 6-8 TAM
801.412;+101297,+101294,;.01~10
801.412;+101297,+101294,;2~VA-ONC BRCA ADJ HT INT/PRE Y6-8 CLIN TRIAL
801.412;+101298,+101294,;.01~40
801.412;+101298,+101294,;2~VA-GP ONC BRCA ADJ HT INT/PRE Y6-8 OFF PTHWY
801.44;+101299,+101294,;.01~06/09/2026@08:52:55
801.44;+101299,+101294,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101295^1
101296^2
101297^3
101298^4
101299^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y4-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108718</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1570997181</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108718,;.01~VA-ONC BRCA ADJ HT INT/PRE Y4-5 OFF PATH RSN
801.41;+108718,;4~dialog element
801.41;+108718,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH RSN
801.41;+108718,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108718,;51~SUPPRESS
801.41;+108718,;100~NATIONAL
801.412;+108719,+108718,;.01~5
801.412;+108719,+108718,;2~VA-ONC OFF PATHWAY
801.412;+108719,+108718,;7~YES
801.412;+108719,+108718,;9~YES
801.44;+108720,+108718,;.01~06/09/2026@08:52:55
801.44;+108720,+108718,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108719^1
108720^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y4-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108715</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3235326725</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108715,;.01~VA-ONC BRCA ADJ HT INT/PRE Y4-5 OFF PATH TX
801.41;+108715,;4~dialog element
801.41;+108715,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OFF PTH TX
801.41;+108715,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108715,;51~SUPPRESS
801.41;+108715,;100~NATIONAL
801.412;+108716,+108715,;.01~5
801.412;+108716,+108715,;2~VA-ONC BLANK
801.412;+108716,+108715,;7~YES
801.412;+108716,+108715,;9~YES
801.44;+108717,+108715,;.01~06/09/2026@08:52:55
801.44;+108717,+108715,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108716^1
108717^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INT/PRE Y4-5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108712</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3786363434</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108712,;.01~VA-GP ONC BRCA ADJ HT INT/PRE Y4-5 OFF PTHWY
801.41;+108712,;4~dialog group
801.41;+108712,;6~YES
801.41;+108712,;7~2
801.41;+108712,;23~YES
801.41;+108712,;25~WP-start~1
Off pathway:
801.41;+108712,;52~INDENT
801.41;+108712,;100~NATIONAL
801.412;+108713,+108712,;.01~10
801.412;+108713,+108712,;2~VA-ONC BRCA ADJ HT INT/PRE Y4-5 OFF PATH TX
801.412;+108714,+108712,;.01~20
801.412;+108714,+108712,;2~VA-ONC BRCA ADJ HT INT/PRE Y4-5 OFF PATH RSN
801.44;+108715,+108712,;.01~06/09/2026@08:52:55
801.44;+108715,+108712,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108713^1
108714^2
108715^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y4-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108709</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2003490312</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108709,;.01~VA-ONC BRCA ADJ HT INT/PRE Y4-5 CLIN TRIAL
801.41;+108709,;4~dialog element
801.41;+108709,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 CLIN TRIAL
801.41;+108709,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108709,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108709,;100~NATIONAL
801.412;+108710,+108709,;.01~5
801.412;+108710,+108709,;2~VA-ONC CLINICAL TRIAL
801.412;+108710,+108709,;9~YES
801.44;+108711,+108709,;.01~06/09/2026@08:52:55
801.44;+108711,+108709,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108710^1
108711^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 ADT/TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101298</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>227443147</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101298,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 ADT/TAM
801.41;+101298,;4~dialog element
801.41;+101298,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 ADT+TAM
801.41;+101298,;25~WP-start~1
ADT + Tamoxifen
801.41;+101298,;35~WP-start~2
-For years 4-5, Veteran has elected to pursue TREATMENT with Androgen 
 Deprivation Therapy (ADT) plus TAMOXIFEN.
801.41;+101298,;100~NATIONAL
801.44;+101299,+101298,;.01~06/09/2026@08:52:55
801.44;+101299,+101298,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101299^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 OS/TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101297</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2898160869</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101297,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 OS/TAM
801.41;+101297,;4~dialog element
801.41;+101297,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+TAM
801.41;+101297,;25~WP-start~1
OS + Tamoxifen
801.41;+101297,;35~WP-start~2
-For years 4-5, Veteran has elected to pursue TREATMENT with Ovarian 
 Suppression (OS) plus TAMOXIFEN.
801.41;+101297,;100~NATIONAL
801.44;+101298,+101297,;.01~06/09/2026@08:52:55
801.44;+101298,+101297,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101298^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 ADT/ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101296</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2309912278</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101296,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 ADT/ANA
801.41;+101296,;4~dialog element
801.41;+101296,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 ADT+ANA
801.41;+101296,;25~WP-start~1
ADT + Anastrozole
801.41;+101296,;35~WP-start~2
-For years 4-5, Veteran has elected to pursue TREATMENT with Androgen 
 Deprivation Therapy (ADT) plus ANASTROZOLE.
801.41;+101296,;100~NATIONAL
801.44;+101297,+101296,;.01~06/09/2026@08:52:55
801.44;+101297,+101296,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101297^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 OS/ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101295</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>276406376</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101295,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 OS/ANA
801.41;+101295,;4~dialog element
801.41;+101295,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y4-5 OS+ANA
801.41;+101295,;25~WP-start~1
OS + Anastrozole
801.41;+101295,;35~WP-start~2
-For years 4-5, Veteran has elected to pursue TREATMENT with Ovarian
 Suppression (OS) plus ANASTROZOLE.
801.41;+101295,;100~NATIONAL
801.44;+101296,+101295,;.01~06/09/2026@08:52:55
801.44;+101296,+101295,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101296^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR PRE/MALE Y4-5</POINT_01>
<INTERNAL_ENTRY_NUMBER>101293</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3972990781</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101293,;.01~VA-GP ONC BRCA ADJ HT IR PRE/MALE Y4-5
801.41;+101293,;4~dialog group
801.41;+101293,;5~Years 4-5:
801.41;+101293,;6~YES
801.41;+101293,;7~2
801.41;+101293,;9~NONE OR ONE SELECTION
801.41;+101293,;51~SUPPRESS
801.41;+101293,;52~INDENT
801.41;+101293,;100~NATIONAL
801.412;+101294,+101293,;.01~20
801.412;+101294,+101293,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 OS/ANA
801.412;+101295,+101293,;.01~30
801.412;+101295,+101293,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 ADT/ANA
801.412;+101296,+101293,;.01~40
801.412;+101296,+101293,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 OS/TAM
801.412;+101297,+101293,;.01~50
801.412;+101297,+101293,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 4-5 ADT/TAM
801.412;+101298,+101293,;.01~10
801.412;+101298,+101293,;2~VA-ONC BRCA ADJ HT INT/PRE Y4-5 CLIN TRIAL
801.412;+101299,+101293,;.01~60
801.412;+101299,+101293,;2~VA-GP ONC BRCA ADJ HT INT/PRE Y4-5 OFF PTHWY
801.44;+101300,+101293,;.01~06/09/2026@08:52:55
801.44;+101300,+101293,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101294^1
101295^2
101296^3
101297^4
101298^5
101299^6
101300^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y1-3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108717</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2698288459</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108717,;.01~VA-ONC BRCA ADJ HT INT/PRE Y1-3 OFF PATH RSN
801.41;+108717,;4~dialog element
801.41;+108717,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH RSN
801.41;+108717,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108717,;51~SUPPRESS
801.41;+108717,;100~NATIONAL
801.412;+108718,+108717,;.01~5
801.412;+108718,+108717,;2~VA-ONC OFF PATHWAY
801.412;+108718,+108717,;7~YES
801.412;+108718,+108717,;9~YES
801.44;+108719,+108717,;.01~06/09/2026@08:52:55
801.44;+108719,+108717,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108718^1
108719^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y1-3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108714</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1800197460</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108714,;.01~VA-ONC BRCA ADJ HT INT/PRE Y1-3 OFF PATH TX
801.41;+108714,;4~dialog element
801.41;+108714,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OFF PATH TX
801.41;+108714,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108714,;51~SUPPRESS
801.41;+108714,;100~NATIONAL
801.412;+108715,+108714,;.01~5
801.412;+108715,+108714,;2~VA-ONC BLANK
801.412;+108715,+108714,;7~YES
801.412;+108715,+108714,;9~YES
801.44;+108716,+108714,;.01~06/09/2026@08:52:55
801.44;+108716,+108714,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108715^1
108716^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INT/PRE Y1-3 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108711</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2002018209</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108711,;.01~VA-GP ONC BRCA ADJ HT INT/PRE Y1-3 OFF PTHWY
801.41;+108711,;4~dialog group
801.41;+108711,;6~YES
801.41;+108711,;7~2
801.41;+108711,;23~YES
801.41;+108711,;25~WP-start~1
Off pathway:
801.41;+108711,;52~INDENT
801.41;+108711,;100~NATIONAL
801.412;+108712,+108711,;.01~10
801.412;+108712,+108711,;2~VA-ONC BRCA ADJ HT INT/PRE Y1-3 OFF PATH TX
801.412;+108713,+108711,;.01~20
801.412;+108713,+108711,;2~VA-ONC BRCA ADJ HT INT/PRE Y1-3 OFF PATH RSN
801.44;+108714,+108711,;.01~06/09/2026@08:52:55
801.44;+108714,+108711,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108712^1
108713^2
108714^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT INT/PRE Y1-3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108708</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3192462737</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108708,;.01~VA-ONC BRCA ADJ HT INT/PRE Y1-3 CLIN TRIAL
801.41;+108708,;4~dialog element
801.41;+108708,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 CLIN TRIAL
801.41;+108708,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108708,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108708,;100~NATIONAL
801.412;+108709,+108708,;.01~5
801.412;+108709,+108708,;2~VA-ONC CLINICAL TRIAL
801.412;+108709,+108708,;9~YES
801.44;+108710,+108708,;.01~06/09/2026@08:52:55
801.44;+108710,+108708,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108709^1
108710^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 ADT/ANA/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>106174</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2947347263</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106174,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 ADT/ANA/RIB
801.41;+106174,;4~dialog element
801.41;+106174,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 ADT+ANA/RIB
801.41;+106174,;25~WP-start~1
ADT + Anastrozole with ribociclib
801.41;+106174,;35~WP-start~2
-For years 1-3, Veteran has elected to pursue TREATMENT with Androgen 
 Deprivation Therapy (ADT) plus ANASTROZOLE with RIBOCICLIB.
801.41;+106174,;100~NATIONAL
801.44;+106175,+106174,;.01~06/09/2026@08:52:55
801.44;+106175,+106174,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106175^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 OS/TAM/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>101291</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3311161309</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101291,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 OS/TAM/RIB
801.41;+101291,;4~dialog element
801.41;+101291,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+TAM/RIB
801.41;+101291,;25~WP-start~1
OS + Tamoxifen with ribociclib
801.41;+101291,;35~WP-start~2
-For years 1-3, Veteran has elected to pursue TREATMENT with Ovarian
 Suppression (OS) plus TAMOXIFEN with RIBOCICLIB.
801.41;+101291,;100~NATIONAL
801.44;+101292,+101291,;.01~06/09/2026@08:52:55
801.44;+101292,+101291,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101292^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 ADT/TAM/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>106181</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2516655318</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106181,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 ADT/TAM/RIB
801.41;+106181,;4~dialog element
801.41;+106181,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 ADT+TAM/RIB
801.41;+106181,;25~WP-start~1
ADT + Tamoxifen with ribociclib
801.41;+106181,;35~WP-start~2
-For years 1-3, Veteran has elected to pursue TREATMENT with Androgen
 Deprivation Therapy (ADT) plus TAMOXIFEN with RIBOCICLIB.
801.41;+106181,;100~NATIONAL
801.44;+106182,+106181,;.01~06/09/2026@08:52:55
801.44;+106182,+106181,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106182^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 OS/ANA/RIB</POINT_01>
<INTERNAL_ENTRY_NUMBER>101286</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>594187136</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101286,;.01~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 OS/ANA/RIB
801.41;+101286,;4~dialog element
801.41;+101286,;15~HF.VA-ONC BRCA ADJ HT HER2- INT/PRE-M Y1-3 OS+ANA/RIB
801.41;+101286,;25~WP-start~1
OS + Anastrozole with ribociclib
801.41;+101286,;35~WP-start~2
-For years 1-3, Veteran has elected to pursue TREATMENT with 
 Ovarian Suppression (OS) plus ANASTROZOLE with RIBOCICLIB.
801.41;+101286,;100~NATIONAL
801.44;+101287,+101286,;.01~06/09/2026@08:52:55
801.44;+101287,+101286,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101287^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR PRE/MALE Y1-3</POINT_01>
<INTERNAL_ENTRY_NUMBER>101284</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2392542870</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101284,;.01~VA-GP ONC BRCA ADJ HT IR PRE/MALE Y1-3
801.41;+101284,;4~dialog group
801.41;+101284,;5~Years 1-3:
801.41;+101284,;6~YES
801.41;+101284,;7~2
801.41;+101284,;9~NONE OR ONE SELECTION
801.41;+101284,;51~SUPPRESS
801.41;+101284,;52~INDENT
801.41;+101284,;100~NATIONAL
801.412;+101285,+101284,;.01~20
801.412;+101285,+101284,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 OS/ANA/RIB
801.412;+101286,+101284,;.01~60
801.412;+101286,+101284,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 ADT/ANA/RIB
801.412;+101287,+101284,;.01~10
801.412;+101287,+101284,;2~VA-ONC BRCA ADJ HT INT/PRE Y1-3 CLIN TRIAL
801.412;+101288,+101284,;.01~90
801.412;+101288,+101284,;2~VA-GP ONC BRCA ADJ HT INT/PRE Y1-3 OFF PTHWY
801.412;+101289,+101284,;.01~80
801.412;+101289,+101284,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 ADT/TAM/RIB
801.412;+101290,+101284,;.01~40
801.412;+101290,+101284,;2~VA-ONC BRCA ADJ HT IR PRE/MALE 1-3 OS/TAM/RIB
801.44;+101291,+101284,;.01~06/09/2026@08:52:55
801.44;+101291,+101284,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101285^1
101286^11
101287^12
101288^13
101289^7
101290^9
101291^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT IR PRE/MALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101283</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1653602746</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101283,;.01~VA-GP ONC BRCA ADJ HT IR PRE/MALE
801.41;+101283,;4~dialog group
801.41;+101283,;25~WP-start~1
Pre-menopausal at diagnosis or male:
801.41;+101283,;100~NATIONAL
801.412;+101284,+101283,;.01~10
801.412;+101284,+101283,;2~VA-GP ONC BRCA ADJ HT IR PRE/MALE Y1-3
801.412;+101285,+101283,;.01~30
801.412;+101285,+101283,;2~VA-GP ONC BRCA ADJ HT IR PRE/MALE Y4-5
801.412;+101286,+101283,;.01~50
801.412;+101286,+101283,;2~VA-GP ONC BRCA ADJ HT IR PRE/MALE Y6-8
801.44;+101287,+101283,;.01~06/09/2026@08:52:55
801.44;+101287,+101283,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101284^1
101285^2
101286^3
101287^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT INTERMED RISK</POINT_01>
<INTERNAL_ENTRY_NUMBER>101235</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2798335548</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101235,;.01~VA-GP ONC BRCA ADJ HT INTERMED RISK
801.41;+101235,;4~dialog group
801.41;+101235,;6~YES
801.41;+101235,;7~2
801.41;+101235,;9~ONE SELECTION ONLY
801.41;+101235,;25~WP-start~1
Intermediate risk:
801.41;+101235,;52~INDENT
801.41;+101235,;100~NATIONAL
801.412;+101236,+101235,;.01~15
801.412;+101236,+101235,;2~VA-GP ONC BRCA ADJ HT IR PRE/MALE
801.412;+101237,+101235,;.01~30
801.412;+101237,+101235,;2~VA-GP ONC BRCA ADJ HT IR POSTMEN
801.44;+101238,+101235,;.01~06/09/2026@08:52:55
801.44;+101238,+101235,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101236^1
101237^2
101238^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108703</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3074249250</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108703,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PATH RSN
801.41;+108703,;4~dialog element
801.41;+108703,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH RSN
801.41;+108703,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108703,;51~SUPPRESS
801.41;+108703,;100~NATIONAL
801.412;+108704,+108703,;.01~5
801.412;+108704,+108703,;2~VA-ONC OFF PATHWAY
801.412;+108704,+108703,;7~YES
801.412;+108704,+108703,;9~YES
801.44;+108705,+108703,;.01~06/09/2026@08:52:55
801.44;+108705,+108703,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108704^1
108705^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108702</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2636092985</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108702,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PATH TX
801.41;+108702,;4~dialog element
801.41;+108702,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OFF PATH TX
801.41;+108702,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108702,;51~SUPPRESS
801.41;+108702,;100~NATIONAL
801.412;+108703,+108702,;.01~5
801.412;+108703,+108702,;2~VA-ONC BLANK
801.412;+108703,+108702,;7~YES
801.412;+108703,+108702,;9~YES
801.44;+108704,+108702,;.01~06/09/2026@08:52:55
801.44;+108704,+108702,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108703^1
108704^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108697</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3195992991</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108697,;.01~VA-GP ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PTHWY
801.41;+108697,;4~dialog group
801.41;+108697,;6~YES
801.41;+108697,;7~2
801.41;+108697,;23~YES
801.41;+108697,;25~WP-start~1
Off pathway:
801.41;+108697,;52~INDENT
801.41;+108697,;100~NATIONAL
801.412;+108698,+108697,;.01~10
801.412;+108698,+108697,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PATH TX
801.412;+108699,+108697,;.01~20
801.412;+108699,+108697,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PATH RSN
801.44;+108700,+108697,;.01~06/09/2026@08:52:55
801.44;+108700,+108697,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108698^1
108699^2
108700^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108693</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>216574899</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108693,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 CLIN TRIAL
801.41;+108693,;4~dialog element
801.41;+108693,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 CLIN TRIAL
801.41;+108693,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108693,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108693,;100~NATIONAL
801.412;+108694,+108693,;.01~5
801.412;+108694,+108693,;2~VA-ONC CLINICAL TRIAL
801.412;+108694,+108693,;9~YES
801.44;+108695,+108693,;.01~06/09/2026@08:52:55
801.44;+108695,+108693,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108694^1
108695^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR POST 6-8 AI/OS</POINT_01>
<INTERNAL_ENTRY_NUMBER>101267</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1555689231</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101267,;.01~VA-ONC BRCA ADJ HT HR POST 6-8 AI/OS
801.41;+101267,;4~dialog element
801.41;+101267,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 OS+ANA/SURV
801.41;+101267,;25~WP-start~1
OS + Anastrazole followed by surveillance
801.41;+101267,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with Ovarian
 Suppression (OS) plus ANASTROZOLE followed by SURVEILLANCE.
801.41;+101267,;100~NATIONAL
801.44;+101268,+101267,;.01~06/09/2026@08:52:55
801.44;+101268,+101267,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101268^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR POST 6-8 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101266</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2666497336</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101266,;.01~VA-ONC BRCA ADJ HT HR POST 6-8 TAM
801.41;+101266,;4~dialog element
801.41;+101266,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y6-8 TAM+SURV
801.41;+101266,;25~WP-start~1
Tamoxifen followed by surveillance
801.41;+101266,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with TAMOXIFEN 
 followed by SURVEILLANCE.
801.41;+101266,;100~NATIONAL
801.44;+101267,+101266,;.01~06/09/2026@08:52:55
801.44;+101267,+101266,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101267^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR POST Y6-8</POINT_01>
<INTERNAL_ENTRY_NUMBER>101261</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>480905815</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101261,;.01~VA-GP ONC BRCA ADJ HT HR POST Y6-8
801.41;+101261,;4~dialog group
801.41;+101261,;5~Years 6-8:
801.41;+101261,;6~YES
801.41;+101261,;7~2
801.41;+101261,;9~NONE OR ONE SELECTION
801.41;+101261,;51~SUPPRESS
801.41;+101261,;52~INDENT
801.41;+101261,;100~NATIONAL
801.412;+101262,+101261,;.01~20
801.412;+101262,+101261,;2~VA-ONC BRCA ADJ HT HR POST 6-8 TAM
801.412;+101263,+101261,;.01~30
801.412;+101263,+101261,;2~VA-ONC BRCA ADJ HT HR POST 6-8 AI/OS
801.412;+101264,+101261,;.01~10
801.412;+101264,+101261,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y6-8 CLIN TRIAL
801.412;+101265,+101261,;.01~40
801.412;+101265,+101261,;2~VA-GP ONC BRCA ADJ HT HI-RISK/POST Y6-8 OFF PTHWY
801.44;+101266,+101261,;.01~06/09/2026@08:52:55
801.44;+101266,+101261,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101262^1
101263^2
101264^3
101265^4
101266^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108701</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1265559761</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108701,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PATH RSN
801.41;+108701,;4~dialog element
801.41;+108701,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH RSN
801.41;+108701,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108701,;51~SUPPRESS
801.41;+108701,;100~NATIONAL
801.412;+108702,+108701,;.01~5
801.412;+108702,+108701,;2~VA-ONC OFF PATHWAY
801.412;+108702,+108701,;7~YES
801.412;+108702,+108701,;9~YES
801.44;+108703,+108701,;.01~06/09/2026@08:52:55
801.44;+108703,+108701,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108702^1
108703^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108700</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4083142405</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108700,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PATH TX
801.41;+108700,;4~dialog element
801.41;+108700,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 OFF PATH TX
801.41;+108700,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108700,;51~SUPPRESS
801.41;+108700,;100~NATIONAL
801.412;+108701,+108700,;.01~5
801.412;+108701,+108700,;2~VA-ONC BLANK
801.412;+108701,+108700,;7~YES
801.412;+108701,+108700,;9~YES
801.44;+108702,+108700,;.01~06/09/2026@08:52:55
801.44;+108702,+108700,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108701^1
108702^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108696</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>427407368</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108696,;.01~VA-GP ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PTHWY
801.41;+108696,;4~dialog group
801.41;+108696,;6~YES
801.41;+108696,;7~2
801.41;+108696,;23~YES
801.41;+108696,;25~WP-start~1
Off pathway:
801.41;+108696,;52~INDENT
801.41;+108696,;100~NATIONAL
801.412;+108697,+108696,;.01~10
801.412;+108697,+108696,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PATH TX
801.412;+108698,+108696,;.01~20
801.412;+108698,+108696,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PATH RSN
801.44;+108699,+108696,;.01~06/09/2026@08:52:55
801.44;+108699,+108696,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108697^1
108698^2
108699^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108692</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3521540127</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108692,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 CLIN TRIAL
801.41;+108692,;4~dialog element
801.41;+108692,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 CLIN TRIAL
801.41;+108692,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108692,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108692,;100~NATIONAL
801.412;+108693,+108692,;.01~5
801.412;+108693,+108692,;2~VA-ONC CLINICAL TRIAL
801.412;+108693,+108692,;9~YES
801.44;+108694,+108692,;.01~06/09/2026@08:52:55
801.44;+108694,+108692,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108693^1
108694^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR POST 3-5 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>106219</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2127452555</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106219,;.01~VA-ONC BRCA ADJ HT HR POST 3-5 TAM
801.41;+106219,;4~dialog element
801.41;+106219,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 TAM
801.41;+106219,;25~WP-start~1
Tamoxifen
801.41;+106219,;35~WP-start~1
-For years 3-5, Veteran has elected to pursue TREATMENT with TAMOXIFEN.
801.41;+106219,;100~NATIONAL
801.44;+106220,+106219,;.01~06/09/2026@08:52:55
801.44;+106220,+106219,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106220^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR POST 3-5 ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101265</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2463613092</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101265,;.01~VA-ONC BRCA ADJ HT HR POST 3-5 ANA
801.41;+101265,;4~dialog element
801.41;+101265,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y3-5 ANA
801.41;+101265,;25~WP-start~1
Anastrozole
801.41;+101265,;35~WP-start~1
-For years 3-5, Veteran has elected to pursue TREATMENT with ANASTRAZOLE.
801.41;+101265,;100~NATIONAL
801.44;+101266,+101265,;.01~06/09/2026@08:52:55
801.44;+101266,+101265,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101266^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR POST Y3-5</POINT_01>
<INTERNAL_ENTRY_NUMBER>101260</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4225888238</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101260,;.01~VA-GP ONC BRCA ADJ HT HR POST Y3-5
801.41;+101260,;4~dialog group
801.41;+101260,;5~Years 3-5:
801.41;+101260,;6~YES
801.41;+101260,;7~2
801.41;+101260,;9~NONE OR ONE SELECTION
801.41;+101260,;51~SUPPRESS
801.41;+101260,;52~INDENT
801.41;+101260,;100~NATIONAL
801.412;+101261,+101260,;.01~20
801.412;+101261,+101260,;2~VA-ONC BRCA ADJ HT HR POST 3-5 ANA
801.412;+101262,+101260,;.01~30
801.412;+101262,+101260,;2~VA-ONC BRCA ADJ HT HR POST 3-5 TAM
801.412;+101263,+101260,;.01~10
801.412;+101263,+101260,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y3-5 CLIN TRIAL
801.412;+101264,+101260,;.01~40
801.412;+101264,+101260,;2~VA-GP ONC BRCA ADJ HT HI-RISK/POST Y3-5 OFF PTHWY
801.44;+101265,+101260,;.01~06/09/2026@08:52:55
801.44;+101265,+101260,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101261^1
101262^2
101263^3
101264^4
101265^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108699</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>315569991</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108699,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PATH RSN
801.41;+108699,;4~dialog element
801.41;+108699,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH RSN
801.41;+108699,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108699,;51~SUPPRESS
801.41;+108699,;100~NATIONAL
801.412;+108700,+108699,;.01~5
801.412;+108700,+108699,;2~VA-ONC OFF PATHWAY
801.412;+108700,+108699,;7~YES
801.412;+108700,+108699,;9~YES
801.44;+108701,+108699,;.01~06/09/2026@08:52:55
801.44;+108701,+108699,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108700^1
108701^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108698</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3817611909</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108698,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PATH TX
801.41;+108698,;4~dialog element
801.41;+108698,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 OFF PATH TX
801.41;+108698,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108698,;51~SUPPRESS
801.41;+108698,;100~NATIONAL
801.412;+108699,+108698,;.01~5
801.412;+108699,+108698,;2~VA-ONC BLANK
801.412;+108699,+108698,;7~YES
801.412;+108699,+108698,;9~YES
801.44;+108700,+108698,;.01~06/09/2026@08:52:55
801.44;+108700,+108698,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108699^1
108700^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108695</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1385464655</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108695,;.01~VA-GP ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PTHWY
801.41;+108695,;4~dialog group
801.41;+108695,;6~YES
801.41;+108695,;7~2
801.41;+108695,;23~YES
801.41;+108695,;25~WP-start~1
Off pathway:
801.41;+108695,;52~INDENT
801.41;+108695,;100~NATIONAL
801.412;+108696,+108695,;.01~10
801.412;+108696,+108695,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PATH TX
801.412;+108697,+108695,;.01~20
801.412;+108697,+108695,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PATH RSN
801.44;+108698,+108695,;.01~06/09/2026@08:52:55
801.44;+108698,+108695,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108696^1
108697^2
108698^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108691</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2255703173</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108691,;.01~VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 CLIN TRIAL
801.41;+108691,;4~dialog element
801.41;+108691,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 CLIN TRIAL
801.41;+108691,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108691,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108691,;100~NATIONAL
801.412;+108692,+108691,;.01~5
801.412;+108692,+108691,;2~VA-ONC CLINICAL TRIAL
801.412;+108692,+108691,;9~YES
801.44;+108693,+108691,;.01~06/09/2026@08:52:55
801.44;+108693,+108691,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108692^1
108693^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR POST 1-2 TAM/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101263</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3760879671</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101263,;.01~VA-ONC BRCA ADJ HT HR POST 1-2 TAM/ABE
801.41;+101263,;4~dialog element
801.41;+101263,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 TAM/ABE
801.41;+101263,;25~WP-start~1
Tamoxifen and abemaciclib
801.41;+101263,;35~WP-start~2
-For years 1-2, Veteran has elected to pursue TREATMENT with TAMOXIFEN 
 and ABEMACICLIB.
801.41;+101263,;100~NATIONAL
801.44;+101264,+101263,;.01~06/09/2026@08:52:55
801.44;+101264,+101263,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101264^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR POST 1-2 ANA/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101262</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1665835331</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101262,;.01~VA-ONC BRCA ADJ HT HR POST 1-2 ANA/ABE
801.41;+101262,;4~dialog element
801.41;+101262,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PST-M Y1-2 ANA/ABE
801.41;+101262,;25~WP-start~1
Anastrozole and abemaciclib
801.41;+101262,;35~WP-start~2
-For years 1-2, Veteran has elected to pursue TREATMENT with ANASTROZOLE
 and ABEMACICLIB.
801.41;+101262,;100~NATIONAL
801.44;+101263,+101262,;.01~06/09/2026@08:52:55
801.44;+101263,+101262,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101263^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR POST Y1-2</POINT_01>
<INTERNAL_ENTRY_NUMBER>101259</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3202328199</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101259,;.01~VA-GP ONC BRCA ADJ HT HR POST Y1-2
801.41;+101259,;4~dialog group
801.41;+101259,;5~Years 1-2:
801.41;+101259,;6~YES
801.41;+101259,;7~2
801.41;+101259,;9~NONE OR ONE SELECTION
801.41;+101259,;51~SUPPRESS
801.41;+101259,;52~INDENT
801.41;+101259,;100~NATIONAL
801.412;+101260,+101259,;.01~20
801.412;+101260,+101259,;2~VA-ONC BRCA ADJ HT HR POST 1-2 ANA/ABE
801.412;+101261,+101259,;.01~30
801.412;+101261,+101259,;2~VA-ONC BRCA ADJ HT HR POST 1-2 TAM/ABE
801.412;+101262,+101259,;.01~10
801.412;+101262,+101259,;2~VA-ONC BRCA ADJ HT HI-RISK/POST Y1-2 CLIN TRIAL
801.412;+101263,+101259,;.01~40
801.412;+101263,+101259,;2~VA-GP ONC BRCA ADJ HT HI-RISK/POST Y1-2 OFF PTHWY
801.44;+101264,+101259,;.01~06/09/2026@08:52:55
801.44;+101264,+101259,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101260^1
101261^2
101262^3
101263^4
101264^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR POSTMEN</POINT_01>
<INTERNAL_ENTRY_NUMBER>101239</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2166849021</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101239,;.01~VA-GP ONC BRCA ADJ HT HR POSTMEN
801.41;+101239,;4~dialog group
801.41;+101239,;25~WP-start~1
Post-menopausal at diagnosis or not male:
801.41;+101239,;100~NATIONAL
801.412;+101240,+101239,;.01~10
801.412;+101240,+101239,;2~VA-GP ONC BRCA ADJ HT HR POST Y1-2
801.412;+101241,+101239,;.01~30
801.412;+101241,+101239,;2~VA-GP ONC BRCA ADJ HT HR POST Y3-5
801.412;+101242,+101239,;.01~50
801.412;+101242,+101239,;2~VA-GP ONC BRCA ADJ HT HR POST Y6-8
801.44;+101243,+101239,;.01~06/09/2026@08:52:55
801.44;+101243,+101239,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101240^1
101241^2
101242^3
101243^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108683</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1774462125</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108683,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PATH RSN
801.41;+108683,;4~dialog element
801.41;+108683,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH RSN
801.41;+108683,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108683,;51~SUPPRESS
801.41;+108683,;100~NATIONAL
801.412;+108684,+108683,;.01~5
801.412;+108684,+108683,;2~VA-ONC OFF PATHWAY
801.412;+108684,+108683,;7~YES
801.412;+108684,+108683,;9~YES
801.44;+108685,+108683,;.01~06/09/2026@08:52:55
801.44;+108685,+108683,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108684^1
108685^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108687</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>673058367</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108687,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PATH TX
801.41;+108687,;4~dialog element
801.41;+108687,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OFF PTH TX
801.41;+108687,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108687,;51~SUPPRESS
801.41;+108687,;100~NATIONAL
801.412;+108688,+108687,;.01~5
801.412;+108688,+108687,;2~VA-ONC BLANK
801.412;+108688,+108687,;7~YES
801.412;+108688,+108687,;9~YES
801.44;+108689,+108687,;.01~06/09/2026@08:52:55
801.44;+108689,+108687,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108688^1
108689^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108690</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1323704053</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108690,;.01~VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PTHWY
801.41;+108690,;4~dialog group
801.41;+108690,;6~YES
801.41;+108690,;7~2
801.41;+108690,;23~YES
801.41;+108690,;25~WP-start~1
Off pathway:
801.41;+108690,;52~INDENT
801.41;+108690,;100~NATIONAL
801.412;+108691,+108690,;.01~10
801.412;+108691,+108690,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PATH TX
801.412;+108692,+108690,;.01~20
801.412;+108692,+108690,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PATH RSN
801.44;+108693,+108690,;.01~06/09/2026@08:52:55
801.44;+108693,+108690,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108691^1
108692^2
108693^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108636</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2727346765</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108636,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 CLIN TRIAL
801.41;+108636,;4~dialog element
801.41;+108636,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 CLIN TRIAL
801.41;+108636,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108636,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108636,;100~NATIONAL
801.412;+108637,+108636,;.01~5
801.412;+108637,+108636,;2~VA-ONC CLINICAL TRIAL
801.412;+108637,+108636,;9~YES
801.44;+108638,+108636,;.01~06/09/2026@08:52:55
801.44;+108638,+108636,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108637^1
108638^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 AI/OS</POINT_01>
<INTERNAL_ENTRY_NUMBER>101258</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4094518410</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101258,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 AI/OS
801.41;+101258,;4~dialog element
801.41;+101258,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 OS+ANA/SURV
801.41;+101258,;25~WP-start~1
OS + Anastrazole followed by surveillance
801.41;+101258,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with Ovarian 
 Suppression (OS) plus ANASTROZOLE followed by SURVEILLANCE.
801.41;+101258,;100~NATIONAL
801.44;+101259,+101258,;.01~06/09/2026@08:52:55
801.44;+101259,+101258,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101259^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 AI/ADT</POINT_01>
<INTERNAL_ENTRY_NUMBER>101257</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1572485270</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101257,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 AI/ADT
801.41;+101257,;4~dialog element
801.41;+101257,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 ADT+ANA/SURV
801.41;+101257,;25~WP-start~1
ADT + Anastrazole followed by surveillance
801.41;+101257,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with Androgen 
 Deprivation Therapy (ADT) plus ANASTROZOLE followed by SURVEILLANCE.
801.41;+101257,;100~NATIONAL
801.44;+101258,+101257,;.01~06/09/2026@08:52:56
801.44;+101258,+101257,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101258^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>101256</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2859673754</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101256,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 TAM
801.41;+101256,;4~dialog element
801.41;+101256,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y6-8 TAM+SURV
801.41;+101256,;25~WP-start~1
Tamoxifen followed by surveillance
801.41;+101256,;35~WP-start~2
-For years 6-8, Veteran has elected to pursue TREATMENT with TAMOXIFEN 
 followed by SURVEILLANCE.
801.41;+101256,;100~NATIONAL
801.44;+101257,+101256,;.01~06/09/2026@08:52:56
801.44;+101257,+101256,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101257^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR PRE/MALE Y6-8</POINT_01>
<INTERNAL_ENTRY_NUMBER>101253</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1561667658</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101253,;.01~VA-GP ONC BRCA ADJ HT HR PRE/MALE Y6-8
801.41;+101253,;4~dialog group
801.41;+101253,;5~Years 6-8:
801.41;+101253,;6~YES
801.41;+101253,;7~2
801.41;+101253,;9~NONE OR ONE SELECTION
801.41;+101253,;51~SUPPRESS
801.41;+101253,;52~INDENT
801.41;+101253,;100~NATIONAL
801.412;+101254,+101253,;.01~20
801.412;+101254,+101253,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 TAM
801.412;+101255,+101253,;.01~30
801.412;+101255,+101253,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 AI/ADT
801.412;+101256,+101253,;.01~40
801.412;+101256,+101253,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 6-8 AI/OS
801.412;+101257,+101253,;.01~10
801.412;+101257,+101253,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y6-8 CLIN TRIAL
801.412;+101258,+101253,;.01~50
801.412;+101258,+101253,;2~VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y6-8 OFF PTHWY
801.44;+101259,+101253,;.01~06/09/2026@08:52:56
801.44;+101259,+101253,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101254^1
101255^2
101256^3
101257^4
101258^5
101259^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108635</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2141116897</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108635,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 CLIN TRIAL
801.41;+108635,;4~dialog element
801.41;+108635,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 CLIN TRIAL
801.41;+108635,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108635,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108635,;100~NATIONAL
801.412;+108636,+108635,;.01~5
801.412;+108636,+108635,;2~VA-ONC CLINICAL TRIAL
801.412;+108636,+108635,;9~YES
801.44;+108637,+108635,;.01~06/09/2026@08:52:56
801.44;+108637,+108635,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108636^1
108637^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108675</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2213981174</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108675,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PATH RSN
801.41;+108675,;4~dialog element
801.41;+108675,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH RSN
801.41;+108675,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108675,;51~SUPPRESS
801.41;+108675,;100~NATIONAL
801.412;+108676,+108675,;.01~5
801.412;+108676,+108675,;2~VA-ONC OFF PATHWAY
801.412;+108676,+108675,;7~YES
801.412;+108676,+108675,;9~YES
801.44;+108677,+108675,;.01~06/09/2026@08:52:56
801.44;+108677,+108675,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108676^1
108677^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108685</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>54646184</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108685,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PATH TX
801.41;+108685,;4~dialog element
801.41;+108685,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OFF PTH TX
801.41;+108685,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108685,;51~SUPPRESS
801.41;+108685,;100~NATIONAL
801.412;+108686,+108685,;.01~5
801.412;+108686,+108685,;2~VA-ONC BLANK
801.412;+108686,+108685,;7~YES
801.412;+108686,+108685,;9~YES
801.44;+108687,+108685,;.01~06/09/2026@08:52:56
801.44;+108687,+108685,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108686^1
108687^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108689</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>185285595</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108689,;.01~VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PTHWY
801.41;+108689,;4~dialog group
801.41;+108689,;6~YES
801.41;+108689,;7~2
801.41;+108689,;23~YES
801.41;+108689,;25~WP-start~1
Off pathway:
801.41;+108689,;52~INDENT
801.41;+108689,;100~NATIONAL
801.412;+108690,+108689,;.01~10
801.412;+108690,+108689,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PATH TX
801.412;+108691,+108689,;.01~20
801.412;+108691,+108689,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PATH RSN
801.44;+108692,+108689,;.01~06/09/2026@08:52:56
801.44;+108692,+108689,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108690^1
108691^2
108692^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 ADT/TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>106218</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2274696797</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106218,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 ADT/TAM
801.41;+106218,;4~dialog element
801.41;+106218,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 ADT+TAM
801.41;+106218,;25~WP-start~1
ADT + Tamoxifen
801.41;+106218,;35~WP-start~2
-For years 3-5, Veteran has elected to pursue TREATMENT with Androgen 
 Deprivation Therapy (ADT) plus TAMOXIFEN.
801.41;+106218,;100~NATIONAL
801.44;+106219,+106218,;.01~06/09/2026@08:52:56
801.44;+106219,+106218,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106219^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 OS/TAM</POINT_01>
<INTERNAL_ENTRY_NUMBER>106217</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>46155397</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106217,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 OS/TAM
801.41;+106217,;4~dialog element
801.41;+106217,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+TAM
801.41;+106217,;25~WP-start~1
OS + Tamoxifen  
801.41;+106217,;35~WP-start~2
-For years 3-5, Veteran has elected pursue TREATMENT with Ovarian
 Suppression (OS) plus TAMOXIFEN.
801.41;+106217,;100~NATIONAL
801.44;+106218,+106217,;.01~06/09/2026@08:52:56
801.44;+106218,+106217,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106218^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 ADT/ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101252</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2842884642</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101252,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 ADT/ANA
801.41;+101252,;4~dialog element
801.41;+101252,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 ADT+ANA
801.41;+101252,;25~WP-start~1
ADT + Anastrozole
801.41;+101252,;35~WP-start~2
-For years 3-5, Veteran has elected to pursue TREATMENT with Androgen 
 Deprivation Therapy (ADT) plus ANASTROZOLE.
801.41;+101252,;100~NATIONAL
801.44;+101253,+101252,;.01~06/09/2026@08:52:56
801.44;+101253,+101252,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101253^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 OS/ANA</POINT_01>
<INTERNAL_ENTRY_NUMBER>101251</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1619473723</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101251,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 OS/ANA
801.41;+101251,;4~dialog element
801.41;+101251,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y3-5 OS+ANA
801.41;+101251,;25~WP-start~1
OS + Anastrozole 
801.41;+101251,;35~WP-start~2
-For years 3-5, Veteran has elected pursue TREATMENT with Ovarian
 Suppression (OS) plus ANASTROZOLE.
801.41;+101251,;100~NATIONAL
801.44;+101252,+101251,;.01~06/09/2026@08:52:56
801.44;+101252,+101251,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101252^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR PRE/MALE Y3-5</POINT_01>
<INTERNAL_ENTRY_NUMBER>101250</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3976199175</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101250,;.01~VA-GP ONC BRCA ADJ HT HR PRE/MALE Y3-5
801.41;+101250,;4~dialog group
801.41;+101250,;5~Years 3-5:
801.41;+101250,;6~YES
801.41;+101250,;7~2
801.41;+101250,;9~NONE OR ONE SELECTION
801.41;+101250,;51~SUPPRESS
801.41;+101250,;52~INDENT
801.41;+101250,;100~NATIONAL
801.412;+101251,+101250,;.01~20
801.412;+101251,+101250,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 OS/ANA
801.412;+101252,+101250,;.01~30
801.412;+101252,+101250,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 ADT/ANA
801.412;+101253,+101250,;.01~40
801.412;+101253,+101250,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 OS/TAM
801.412;+101254,+101250,;.01~50
801.412;+101254,+101250,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 3-5 ADT/TAM
801.412;+101255,+101250,;.01~60
801.412;+101255,+101250,;2~VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y3-5 OFF PTHWY
801.412;+101256,+101250,;.01~10
801.412;+101256,+101250,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y3-5 CLIN TRIAL
801.44;+101257,+101250,;.01~06/09/2026@08:52:56
801.44;+101257,+101250,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101251^1
101252^2
101253^3
101254^4
101255^5
101256^6
101257^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>108634</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>671868283</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108634,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 CLIN TRIAL
801.41;+108634,;4~dialog element
801.41;+108634,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 CLIN TRIAL
801.41;+108634,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+108634,;35~WP-start~1
Veteran has elected to pursue:
801.41;+108634,;100~NATIONAL
801.412;+108635,+108634,;.01~5
801.412;+108635,+108634,;2~VA-ONC CLINICAL TRIAL
801.412;+108635,+108634,;9~YES
801.44;+108636,+108634,;.01~06/09/2026@08:52:56
801.44;+108636,+108634,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108635^1
108636^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108637</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>80699904</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108637,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PATH RSN
801.41;+108637,;4~dialog element
801.41;+108637,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH RSN
801.41;+108637,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+108637,;51~SUPPRESS
801.41;+108637,;100~NATIONAL
801.412;+108638,+108637,;.01~5
801.412;+108638,+108637,;2~VA-ONC OFF PATHWAY
801.412;+108638,+108637,;7~YES
801.412;+108638,+108637,;9~YES
801.44;+108639,+108637,;.01~06/09/2026@08:52:56
801.44;+108639,+108637,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108638^1
108639^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>108638</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2313454792</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108638,;.01~VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PATH TX
801.41;+108638,;4~dialog element
801.41;+108638,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OFF PATH TX
801.41;+108638,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+108638,;51~SUPPRESS
801.41;+108638,;100~NATIONAL
801.412;+108639,+108638,;.01~5
801.412;+108639,+108638,;2~VA-ONC BLANK
801.412;+108639,+108638,;7~YES
801.412;+108639,+108638,;9~YES
801.44;+108640,+108638,;.01~06/09/2026@08:52:56
801.44;+108640,+108638,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108639^1
108640^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>108639</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1408824098</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108639,;.01~VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PTHWY
801.41;+108639,;4~dialog group
801.41;+108639,;6~YES
801.41;+108639,;7~2
801.41;+108639,;23~YES
801.41;+108639,;25~WP-start~1
Off pathway:
801.41;+108639,;52~INDENT
801.41;+108639,;100~NATIONAL
801.412;+108640,+108639,;.01~10
801.412;+108640,+108639,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PATH TX
801.412;+108641,+108639,;.01~20
801.412;+108641,+108639,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PATH RSN
801.44;+108642,+108639,;.01~06/09/2026@08:52:56
801.44;+108642,+108639,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108640^1
108641^2
108642^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 ADT/TAM/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>106216</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2837101950</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106216,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 ADT/TAM/ABE
801.41;+106216,;4~dialog element
801.41;+106216,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 ADT+TAM/ABE
801.41;+106216,;25~WP-start~1
ADT + Tamoxifen and abemaciclib 
801.41;+106216,;35~WP-start~2
-For years 1-2, Veteran has elected to pursue TREATMENT with Androgen
 Deprivation Therapy (ADT) plus TAMOXIFEN and ABEMACICLIB.
801.41;+106216,;100~NATIONAL
801.44;+106217,+106216,;.01~06/09/2026@08:52:56
801.44;+106217,+106216,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106217^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 OS/TAM/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>106215</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3543923206</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106215,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 OS/TAM/ABE
801.41;+106215,;4~dialog element
801.41;+106215,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+TAM/ABE
801.41;+106215,;25~WP-start~1
OS + Tamoxifen and abemaciclib
801.41;+106215,;35~WP-start~2
-For years 1-2, Veteran has elected to pursue TREATMENT with Ovarian
 Suppression (OS) plus TAMOXIFEN and ABEMACICLIB.
801.41;+106215,;100~NATIONAL
801.44;+106216,+106215,;.01~06/09/2026@08:52:56
801.44;+106216,+106215,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106216^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 ADT/ANA/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101249</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3810133671</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101249,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 ADT/ANA/ABE
801.41;+101249,;4~dialog element
801.41;+101249,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 ADT+ANA/ABE
801.41;+101249,;25~WP-start~1
ADT + Anastrozole and abemaciclib 
801.41;+101249,;35~WP-start~2
-For years 1-2, Veteran has elected to pursue TREATMENT with Androgen
 Deprivation Therapy (ADT) plus ANASTROZOLE and ABEMACICLIB.
801.41;+101249,;100~NATIONAL
801.44;+101250,+101249,;.01~06/09/2026@08:52:56
801.44;+101250,+101249,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101250^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 OS/ANA/ABE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101248</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3433988646</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101248,;.01~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 OS/ANA/ABE
801.41;+101248,;4~dialog element
801.41;+101248,;15~HF.VA-ONC BRCA ADJ HT HER2- HIGH/PRE-M Y1-2 OS+ANA/ABE
801.41;+101248,;25~WP-start~1
OS + Anastrozole and abemaciclib
801.41;+101248,;35~WP-start~2
-For years 1-2, Veteran has elected to pursue TREATMENT with Ovarian
 Suppression (OS) plus ANASTROZOLE and ABEMACICLIB.
801.41;+101248,;100~NATIONAL
801.44;+101249,+101248,;.01~06/09/2026@08:52:56
801.44;+101249,+101248,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101249^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR PRE/MALE Y1-2</POINT_01>
<INTERNAL_ENTRY_NUMBER>101247</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1315155857</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101247,;.01~VA-GP ONC BRCA ADJ HT HR PRE/MALE Y1-2
801.41;+101247,;4~dialog group
801.41;+101247,;5~Years 1-2:
801.41;+101247,;6~YES
801.41;+101247,;7~2
801.41;+101247,;9~NONE OR ONE SELECTION
801.41;+101247,;51~SUPPRESS
801.41;+101247,;52~INDENT
801.41;+101247,;100~NATIONAL
801.412;+101248,+101247,;.01~20
801.412;+101248,+101247,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 OS/ANA/ABE
801.412;+101249,+101247,;.01~30
801.412;+101249,+101247,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 ADT/ANA/ABE
801.412;+101250,+101247,;.01~40
801.412;+101250,+101247,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 OS/TAM/ABE
801.412;+101251,+101247,;.01~50
801.412;+101251,+101247,;2~VA-ONC BRCA ADJ HT HR PRE/MALE 1-2 ADT/TAM/ABE
801.412;+101252,+101247,;.01~60
801.412;+101252,+101247,;2~VA-GP ONC BRCA ADJ HT HI-RISK/PRE Y1-2 OFF PTHWY
801.412;+101253,+101247,;.01~10
801.412;+101253,+101247,;2~VA-ONC BRCA ADJ HT HI-RISK/PRE Y1-2 CLIN TRIAL
801.44;+101254,+101247,;.01~06/09/2026@08:52:56
801.44;+101254,+101247,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101248^1
101249^2
101250^3
101251^4
101252^5
101253^6
101254^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HR PRE/MALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>101238</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3912902460</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101238,;.01~VA-GP ONC BRCA ADJ HT HR PRE/MALE
801.41;+101238,;4~dialog group
801.41;+101238,;25~WP-start~1
Pre-menopausal at diagnosis or male:
801.41;+101238,;100~NATIONAL
801.412;+101239,+101238,;.01~10
801.412;+101239,+101238,;2~VA-GP ONC BRCA ADJ HT HR PRE/MALE Y1-2
801.412;+101240,+101238,;.01~30
801.412;+101240,+101238,;2~VA-GP ONC BRCA ADJ HT HR PRE/MALE Y3-5
801.412;+101241,+101238,;.01~50
801.412;+101241,+101238,;2~VA-GP ONC BRCA ADJ HT HR PRE/MALE Y6-8
801.44;+101242,+101238,;.01~06/09/2026@08:52:56
801.44;+101242,+101238,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101239^1
101240^2
101241^3
101242^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT HIGH RISK</POINT_01>
<INTERNAL_ENTRY_NUMBER>101234</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>198839374</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101234,;.01~VA-GP ONC BRCA ADJ HT HIGH RISK
801.41;+101234,;4~dialog group
801.41;+101234,;6~YES
801.41;+101234,;7~2
801.41;+101234,;9~ONE SELECTION ONLY
801.41;+101234,;25~WP-start~1
High risk:
801.41;+101234,;52~INDENT
801.41;+101234,;100~NATIONAL
801.412;+101235,+101234,;.01~15
801.412;+101235,+101234,;2~VA-GP ONC BRCA ADJ HT HR PRE/MALE
801.412;+101236,+101234,;.01~30
801.412;+101236,+101234,;2~VA-GP ONC BRCA ADJ HT HR POSTMEN
801.44;+101237,+101234,;.01~06/09/2026@08:52:56
801.44;+101237,+101234,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101235^1
101236^2
101237^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ ER+/PR+/HER2- MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>101233</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>838715047</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101233,;.01~VA-GP ONC BRCA ADJ ER+/PR+/HER2- MAIN
801.41;+101233,;4~dialog group
801.41;+101233,;5~Risk level:
801.41;+101233,;6~YES
801.41;+101233,;9~NONE OR ONE SELECTION
801.41;+101233,;51~SUPPRESS
801.41;+101233,;100~NATIONAL
801.412;+101234,+101233,;.01~20
801.412;+101234,+101233,;2~VA-GP ONC BRCA ADJ HT HIGH RISK
801.412;+101235,+101233,;.01~40
801.412;+101235,+101233,;2~VA-GP ONC BRCA ADJ HT INTERMED RISK
801.412;+101236,+101233,;.01~60
801.412;+101236,+101233,;2~VA-GP ONC BRCA ADJ HT LOW RISK
801.44;+101237,+101233,;.01~06/09/2026@08:52:56
801.44;+101237,+101233,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101234^1
101235^2
101236^3
101237^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT RISK LEVEL FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>101227</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2032610329</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101227,;.01~VA-ONC BRCA ADJ HT RISK LEVEL FN
801.41;+101227,;4~dialog element
801.41;+101227,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+101227,;23~YES
801.41;+101227,;25~WP-start~4
++ If post-menopausal Veteran, zolendronic acid every 6 months for 3 
years ++
   OS = Ovarian Suppression
   ADT = Androgen Deprivation Therapy
801.41;+101227,;35~WP-start~30
Risk level:\\
  High risk = >4 nodes or Grade 3 or over 5cm.\\
  
  Intermediate risk = 1-3 nodes positive and Grade 2 or less or node 
\\   negative plus 2cm or more and Grade 2 or more or 21 gene recurrence
score\\   over 26 or high mammaprint or k i-67 over 67% ribosomes.\\
  
  Low risk = all others not meeting criteria for intermediate or high 
risk.
 
 (d)Menopausal defined as patient that is greater than or equal to 
60 years of\\    age; greater than or equal to 1 year amenorrhea (not
medically induced);\\    history of Bilateral Salpingo-Oophorect (BSO); or
confirmed with labs.\\    If POST-MENOPAUSAL patient, Zolendronic Acid
every 6 months for 3 years.\\
 
 (e)Ovarian Suppression (OS) includes surgical or medical suppression.
 
 (f)Anastrozole: only for post menopausal women or women undergoing 
ovarian\\    suppression; evaluate baseline bone density; promote 
weight-bearing\\    exercise, smoking cessation, reduced alcohol intake, 
and calcium/vitamin D\\    supplementation; if not a candidate for 
anastrozole, tamoxifen is an\\    alternative; if patients do not tolerate
one AI, any AI is a suitable\\    alternative.
 
 (g)Tamoxifen: avoid if prior history of DVT or known hypercoagulability; 
\\    if contraindication to tamoxifen in men, prescribe AI with ADT; if 
\\    contraindiation to tamoxifen in women, prescribe AI with OS;
patients\\    should use effective nonhormonal contraception or barrier
last dose.
801.41;+101227,;51~SUPPRESS
801.41;+101227,;100~NATIONAL
801.412;+101228,+101227,;.01~5
801.412;+101228,+101227,;2~PXRM GF VIEW BUTTON
801.412;+101228,+101227,;6~VIEW Footnote
801.44;+101229,+101227,;.01~06/09/2026@08:52:56
801.44;+101229,+101227,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101228^1
101229^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA ADJ HT ER+/PR+/HER2-</POINT_01>
<INTERNAL_ENTRY_NUMBER>101223</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3293927442</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+101223,;.01~VA-GP ONC BREAST CA ADJ HT ER+/PR+/HER2-
801.41;+101223,;4~dialog group
801.41;+101223,;7~2
801.41;+101223,;25~WP-start~1
Adjuvant Hormone Therapy for ER+ or PR+/HER2-:
801.41;+101223,;35~WP-start~1
\\Adjuvant Hormone Therapy for ER+ or PR+/HER2-:
801.41;+101223,;52~INDENT
801.41;+101223,;100~NATIONAL
801.41;+101223,;101~VHA ONCOLOGY
801.412;+101224,+101223,;.01~10
801.412;+101224,+101223,;2~VA-ONC BRCA ADJ HT RISK LEVEL FN
801.412;+101225,+101223,;.01~30
801.412;+101225,+101223,;2~VA-GP ONC BRCA ADJ ER+/PR+/HER2- MAIN
801.44;+101226,+101223,;.01~06/09/2026@08:52:56
801.44;+101226,+101223,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
101224^1
101225^2
101226^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG MALE OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78787</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>360619751</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78787,;.01~VA-ONC BRCA ADJ HT NEG MALE OFF PATH RSN
801.41;+78787,;4~dialog element
801.41;+78787,;15~HF.VA-ONC BRCA ADJ HT MALE NODE- OFF PATH RSN
801.41;+78787,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78787,;51~SUPPRESS
801.41;+78787,;100~NATIONAL
801.412;+78788,+78787,;.01~5
801.412;+78788,+78787,;2~VA-ONC OFF PATHWAY
801.412;+78788,+78787,;7~YES
801.412;+78788,+78787,;9~YES
801.44;+78789,+78787,;.01~06/09/2026@08:52:56
801.44;+78789,+78787,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78788^1
78789^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG MALE OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78786</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1583848093</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78786,;.01~VA-ONC BRCA ADJ HT NEG MALE OFF PATH TX
801.41;+78786,;4~dialog element
801.41;+78786,;15~HF.VA-ONC BRCA ADJ HT MALE NODE- OFF PATH TX
801.41;+78786,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78786,;51~SUPPRESS
801.41;+78786,;100~NATIONAL
801.412;+78787,+78786,;.01~5
801.412;+78787,+78786,;2~VA-ONC BLANK
801.412;+78787,+78786,;7~YES
801.412;+78787,+78786,;9~YES
801.44;+78788,+78786,;.01~06/09/2026@08:52:56
801.44;+78788,+78786,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78787^1
78788^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NEG MALE OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78785</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>988164454</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78785,;.01~VA-GP ONC BRCA ADJ HT NEG MALE OFF PTHWY
801.41;+78785,;4~dialog group
801.41;+78785,;6~YES
801.41;+78785,;7~2
801.41;+78785,;23~YES
801.41;+78785,;25~WP-start~1
Off pathway:
801.41;+78785,;52~INDENT
801.41;+78785,;100~NATIONAL
801.412;+78786,+78785,;.01~10
801.412;+78786,+78785,;2~VA-ONC BRCA ADJ HT NEG MALE OFF PATH TX
801.412;+78787,+78785,;.01~20
801.412;+78787,+78785,;2~VA-ONC BRCA ADJ HT NEG MALE OFF PATH RSN
801.44;+78788,+78785,;.01~06/09/2026@08:52:56
801.44;+78788,+78785,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78786^1
78787^2
78788^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG MALE CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78784</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2318157509</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78784,;.01~VA-ONC BRCA ADJ HT NEG MALE CLIN TRIAL
801.41;+78784,;4~dialog element
801.41;+78784,;15~HF.VA-ONC BRCA ADJ HT MALE NODE- CLIN TRIAL
801.41;+78784,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78784,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78784,;100~NATIONAL
801.412;+78785,+78784,;.01~5
801.412;+78785,+78784,;2~VA-ONC CLINICAL TRIAL
801.412;+78785,+78784,;9~YES
801.44;+78786,+78784,;.01~06/09/2026@08:52:56
801.44;+78786,+78784,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78785^1
78786^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA TAMOXIFEN FN2</POINT_01>
<INTERNAL_ENTRY_NUMBER>73851</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3705527584</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73851,;.01~VA-ONC BRCA TAMOXIFEN FN2
801.41;+73851,;4~dialog element
801.41;+73851,;23~YES
801.41;+73851,;25~WP-start~5
++ Avoid tamoxifen if prior history of DVT or known hypercoagulability; 
if contraindication\\   to tamoxifen in males, prescribe AI with ADT;
patients should use effective\\   nonhormonal contraception or barrier
contraceptive during tamoxifen therapy;\\   continue for 2 months after
last dose. ++
801.41;+73851,;51~SUPPRESS
801.41;+73851,;100~NATIONAL
801.44;+73852,+73851,;.01~06/09/2026@08:52:56
801.44;+73852,+73851,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73852^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO MALE TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73850</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3550042365</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73850,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO MALE TAMOX
801.41;+73850,;4~dialog group
801.41;+73850,;7~2
801.41;+73850,;15~HF.VA-ONC BRCA ADJ HT MALE NODE- TAMOX
801.41;+73850,;25~WP-start~1
Tamoxifen (5 years)
801.41;+73850,;35~WP-start~1
Veteran has elected to pursue treatment with TAMOXIFEN for 5 Years.
801.41;+73850,;100~NATIONAL
801.412;+73851,+73850,;.01~5
801.412;+73851,+73850,;2~VA-ONC BRCA TAMOXIFEN FN2
801.44;+73852,+73850,;.01~06/09/2026@08:52:56
801.44;+73852,+73850,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73851^1
73852^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO MALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73849</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1937407000</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73849,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO MALE
801.41;+73849,;4~dialog group
801.41;+73849,;6~YES
801.41;+73849,;7~2
801.41;+73849,;9~ONE SELECTION ONLY
801.41;+73849,;25~WP-start~1
Male:
801.41;+73849,;51~SUPPRESS
801.41;+73849,;100~NATIONAL
801.412;+73850,+73849,;.01~10
801.412;+73850,+73849,;2~VA-GP ONC BRCA ADJ HT NODE+ NO MALE TAMOX
801.412;+73851,+73849,;.01~5
801.412;+73851,+73849,;2~VA-ONC BRCA ADJ HT NEG MALE CLIN TRIAL
801.412;+73852,+73849,;.01~20
801.412;+73852,+73849,;2~VA-GP ONC BRCA ADJ HT NEG MALE OFF PTHWY
801.44;+73853,+73849,;.01~06/09/2026@08:52:56
801.44;+73853,+73849,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73850^1
73851^2
73852^3
73853^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG POST OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78783</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>780049520</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78783,;.01~VA-ONC BRCA ADJ HT NEG POST OFF PATH RSN
801.41;+78783,;4~dialog element
801.41;+78783,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH RSN
801.41;+78783,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78783,;51~SUPPRESS
801.41;+78783,;100~NATIONAL
801.412;+78784,+78783,;.01~5
801.412;+78784,+78783,;2~VA-ONC OFF PATHWAY
801.412;+78784,+78783,;7~YES
801.412;+78784,+78783,;9~YES
801.44;+78785,+78783,;.01~06/09/2026@08:52:56
801.44;+78785,+78783,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78784^1
78785^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG POST OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78782</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>881216776</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78782,;.01~VA-ONC BRCA ADJ HT NEG POST OFF PATH TX
801.41;+78782,;4~dialog element
801.41;+78782,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP OFF PATH TX
801.41;+78782,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78782,;51~SUPPRESS
801.41;+78782,;100~NATIONAL
801.412;+78783,+78782,;.01~5
801.412;+78783,+78782,;2~VA-ONC BLANK
801.412;+78783,+78782,;7~YES
801.412;+78783,+78782,;9~YES
801.44;+78784,+78782,;.01~06/09/2026@08:52:56
801.44;+78784,+78782,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78783^1
78784^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NEG POST OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78781</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1981900414</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78781,;.01~VA-GP ONC BRCA ADJ HT NEG POST OFF PTHWY
801.41;+78781,;4~dialog group
801.41;+78781,;6~YES
801.41;+78781,;7~2
801.41;+78781,;23~YES
801.41;+78781,;25~WP-start~1
Off pathway:
801.41;+78781,;52~INDENT
801.41;+78781,;100~NATIONAL
801.412;+78782,+78781,;.01~10
801.412;+78782,+78781,;2~VA-ONC BRCA ADJ HT NEG POST OFF PATH TX
801.412;+78783,+78781,;.01~20
801.412;+78783,+78781,;2~VA-ONC BRCA ADJ HT NEG POST OFF PATH RSN
801.44;+78784,+78781,;.01~06/09/2026@08:52:56
801.44;+78784,+78781,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78782^1
78783^2
78784^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG POST CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78780</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2345464550</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78780,;.01~VA-ONC BRCA ADJ HT NEG POST CLIN TRIAL
801.41;+78780,;4~dialog element
801.41;+78780,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP CLIN TRIAL
801.41;+78780,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78780,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78780,;100~NATIONAL
801.412;+78781,+78780,;.01~5
801.412;+78781,+78780,;2~VA-ONC CLINICAL TRIAL
801.412;+78781,+78780,;9~YES
801.44;+78782,+78780,;.01~06/09/2026@08:52:56
801.44;+78782,+78780,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78781^1
78782^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NO POST-MP ANAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>73857</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1032736033</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73857,;.01~VA-GP ONC BRCA ADJ HT NO POST-MP ANAST
801.41;+73857,;4~dialog group
801.41;+73857,;6~YES
801.41;+73857,;7~2
801.41;+73857,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- POST-MP ANAS
801.41;+73857,;25~WP-start~1
Anastrozole (5 years)
801.41;+73857,;35~WP-start~1
Veteran has elected to pursue TREATMENT with ANASTROZOLE for 5 Years.
801.41;+73857,;100~NATIONAL
801.44;+73858,+73857,;.01~06/09/2026@08:52:56
801.44;+73858,+73857,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73858^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO POST-MEN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73856</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3038413336</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73856,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO POST-MEN
801.41;+73856,;4~dialog group
801.41;+73856,;6~YES
801.41;+73856,;7~2
801.41;+73856,;9~ONE SELECTION ONLY
801.41;+73856,;25~WP-start~1
Post-menopause:
801.41;+73856,;100~NATIONAL
801.412;+73857,+73856,;.01~10
801.412;+73857,+73856,;2~VA-GP ONC BRCA ADJ HT NO POST-MP ANAST
801.412;+73858,+73856,;.01~5
801.412;+73858,+73856,;2~VA-ONC BRCA ADJ HT NEG POST CLIN TRIAL
801.412;+73859,+73856,;.01~20
801.412;+73859,+73856,;2~VA-GP ONC BRCA ADJ HT NEG POST OFF PTHWY
801.44;+73860,+73856,;.01~06/09/2026@08:52:56
801.44;+73860,+73856,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73857^1
73858^2
73859^3
73860^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG PRE OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78779</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3483384297</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78779,;.01~VA-ONC BRCA ADJ HT NEG PRE OFF PATH RSN
801.41;+78779,;4~dialog element
801.41;+78779,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH RSN
801.41;+78779,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78779,;51~SUPPRESS
801.41;+78779,;100~NATIONAL
801.412;+78780,+78779,;.01~5
801.412;+78780,+78779,;2~VA-ONC OFF PATHWAY
801.412;+78780,+78779,;7~YES
801.412;+78780,+78779,;9~YES
801.44;+78781,+78779,;.01~06/09/2026@08:52:56
801.44;+78781,+78779,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78780^1
78781^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG PRE OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78778</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4194559086</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78778,;.01~VA-ONC BRCA ADJ HT NEG PRE OFF PATH TX
801.41;+78778,;4~dialog element
801.41;+78778,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP OFF PATH TX
801.41;+78778,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78778,;51~SUPPRESS
801.41;+78778,;100~NATIONAL
801.412;+78779,+78778,;.01~5
801.412;+78779,+78778,;2~VA-ONC BLANK
801.412;+78779,+78778,;7~YES
801.412;+78779,+78778,;9~YES
801.44;+78780,+78778,;.01~06/09/2026@08:52:56
801.44;+78780,+78778,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78779^1
78780^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NEG PRE OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78776</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>669312706</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78776,;.01~VA-GP ONC BRCA ADJ HT NEG PRE OFF PTHWY
801.41;+78776,;4~dialog group
801.41;+78776,;6~YES
801.41;+78776,;7~2
801.41;+78776,;23~YES
801.41;+78776,;25~WP-start~1
Off pathway:
801.41;+78776,;52~INDENT
801.41;+78776,;100~NATIONAL
801.412;+78777,+78776,;.01~10
801.412;+78777,+78776,;2~VA-ONC BRCA ADJ HT NEG PRE OFF PATH TX
801.412;+78778,+78776,;.01~20
801.412;+78778,+78776,;2~VA-ONC BRCA ADJ HT NEG PRE OFF PATH RSN
801.44;+78779,+78776,;.01~06/09/2026@08:52:56
801.44;+78779,+78776,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78777^1
78778^2
78779^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT NEG PRE CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78777</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3954681530</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78777,;.01~VA-ONC BRCA ADJ HT NEG PRE CLIN TRIAL
801.41;+78777,;4~dialog element
801.41;+78777,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP CLIN TRIAL
801.41;+78777,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78777,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78777,;100~NATIONAL
801.412;+78778,+78777,;.01~5
801.412;+78778,+78777,;2~VA-ONC CLINICAL TRIAL
801.412;+78778,+78777,;9~YES
801.44;+78779,+78777,;.01~06/09/2026@08:52:56
801.44;+78779,+78777,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78778^1
78779^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NO PRE-MP TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73855</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3766000394</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73855,;.01~VA-GP ONC BRCA ADJ HT NO PRE-MP TAMOX
801.41;+73855,;4~dialog group
801.41;+73855,;7~2
801.41;+73855,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE- PRE-MP TAMOX
801.41;+73855,;25~WP-start~1
Tamoxifen (5 years)
801.41;+73855,;35~WP-start~1
Veteran has elected to pursue TREATMENT with TAMOXIFEN for 5 Years.
801.41;+73855,;100~NATIONAL
801.44;+73856,+73855,;.01~06/09/2026@08:52:56
801.44;+73856,+73855,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73856^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO PRE-MEN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73854</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3498355057</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73854,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO PRE-MEN
801.41;+73854,;4~dialog group
801.41;+73854,;6~YES
801.41;+73854,;7~2
801.41;+73854,;9~ONE SELECTION ONLY
801.41;+73854,;25~WP-start~1
Pre-menopause:
801.41;+73854,;100~NATIONAL
801.412;+73855,+73854,;.01~10
801.412;+73855,+73854,;2~VA-GP ONC BRCA ADJ HT NO PRE-MP TAMOX
801.412;+73856,+73854,;.01~5
801.412;+73856,+73854,;2~VA-ONC BRCA ADJ HT NEG PRE CLIN TRIAL
801.412;+73857,+73854,;.01~20
801.412;+73857,+73854,;2~VA-GP ONC BRCA ADJ HT NEG PRE OFF PTHWY
801.44;+73858,+73854,;.01~06/09/2026@08:52:56
801.44;+73858,+73854,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73855^1
73856^2
73857^3
73858^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ NO MP SUBMAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>93079</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2085555171</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+93079,;.01~VA-GP ONC BRCA HT NODE+ NO MP SUBMAIN
801.41;+93079,;4~dialog group
801.41;+93079,;6~YES
801.41;+93079,;9~ONE SELECTION ONLY
801.41;+93079,;51~SUPPRESS
801.41;+93079,;100~NATIONAL
801.412;+93080,+93079,;.01~20
801.412;+93080,+93079,;2~VA-GP ONC BRCA ADJ HT NODE+ NO PRE-MEN
801.412;+93081,+93079,;.01~40
801.412;+93081,+93079,;2~VA-GP ONC BRCA ADJ HT NODE+ NO POST-MEN
801.44;+93082,+93079,;.01~06/09/2026@08:52:56
801.44;+93082,+93079,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
93080^1
93081^2
93082^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ANAS+TAMOX FOOTNOTE</POINT_01>
<INTERNAL_ENTRY_NUMBER>93074</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1163091010</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+93074,;.01~VA-ONC BRCA ANAS+TAMOX FOOTNOTE
801.41;+93074,;4~dialog element
801.41;+93074,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+93074,;23~YES
801.41;+93074,;25~WP-start~1
OS, Anastrozole and Tamoxifen Footnote:\\
801.41;+93074,;35~WP-start~14
++ Ovarian Suppression (OS): includes surgical or medical suppression.\\
 
   Anastrozole: only for post-menopausal females or females undergoing
ovarian\\   suppression; evaluate baseline bone density; promote
weight-bearing exercise,\\   smoking cessation, reduced alcohol intake,
and calcium/vitamin D\\   supplementation; if not a candidate for
anastrozole, tamoxifen is an\\   alternative; if patients do not tolerate
one AI, any AI is a suitable\\   alternative. \\
 
   Tamoxifen: avoid if prior history of DVT or known
hypercoagulability;\\   if contraindication to tamoxifen in males,
prescribe AI with ADT; patients\\   should use effective nonhormonal
contraception or barrier contraceptive\\   during tamoxifen therapy;
continue for 2 months after last dose. ++
801.41;+93074,;51~SUPPRESS
801.41;+93074,;100~NATIONAL
801.412;+93075,+93074,;.01~5
801.412;+93075,+93074,;2~PXRM GF VIEW BUTTON
801.412;+93075,+93074,;6~VIEW Footnote
801.412;+93075,+93074,;8~YES
801.44;+93076,+93074,;.01~06/09/2026@08:52:56
801.44;+93076,+93074,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
93075^1
93076^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO MENOPAUSE FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73853</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2612646159</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73853,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO MENOPAUSE FN
801.41;+73853,;4~dialog group
801.41;+73853,;7~2
801.41;+73853,;23~YES
801.41;+73853,;25~WP-start~6
++ Menopausal defined as patient that is greater than or equal to 
60 years of\\   age; greater than or equal to 1 year amenorrhea (not
medically induced);\\   history of Bilateral Salpingo-Oophorect (BSO); or
confirmed with labs.\\   IF POST-MENOPAUSAL patient, Zolendronic Acid
every 6 months for 3 years. ++\\   
   =======================================================================
801.41;+73853,;51~SUPPRESS
801.41;+73853,;52~INDENT
801.41;+73853,;100~NATIONAL
801.412;+73854,+73853,;.01~5
801.412;+73854,+73853,;2~VA-ONC BRCA ANAS+TAMOX FOOTNOTE
801.412;+73855,+73853,;.01~15
801.412;+73855,+73853,;2~VA-GP ONC BRCA HT NODE+ NO MP SUBMAIN
801.44;+73856,+73853,;.01~06/09/2026@08:52:56
801.44;+73856,+73853,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73854^1
73855^2
73856^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO MP STATUS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73852</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>576882400</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73852,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO MP STATUS
801.41;+73852,;4~dialog group
801.41;+73852,;25~WP-start~1
Menopausal Status at Diagnosis:
801.41;+73852,;51~SUPPRESS
801.41;+73852,;100~NATIONAL
801.412;+73853,+73852,;.01~20
801.412;+73853,+73852,;2~VA-GP ONC BRCA ADJ HT NODE+ NO MENOPAUSE FN
801.44;+73854,+73852,;.01~06/09/2026@08:52:56
801.44;+73854,+73852,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73853^1
73854^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO FEMALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73848</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3391351553</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73848,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO FEMALE
801.41;+73848,;4~dialog group
801.41;+73848,;6~YES
801.41;+73848,;25~WP-start~1
Female:
801.41;+73848,;51~SUPPRESS
801.41;+73848,;100~NATIONAL
801.41143;+73849,+73848,;.01~1
801.41143;+73849,+73848,;1~RT.VA-ONC BRCA MALE RT
801.41143;+73849,+73848,;2~TRUE
801.41143;+73849,+73848,;3~REPLACE
801.41143;+73849,+73848,;4~VA-GP ONC BRCA ADJ HT NODE+ NO MALE
801.412;+73850,+73848,;.01~10
801.412;+73850,+73848,;2~VA-GP ONC BRCA ADJ HT NODE+ NO MP STATUS
801.44;+73851,+73848,;.01~06/09/2026@08:52:56
801.44;+73851,+73848,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73849^1
73850^1
73851^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ NO MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73845</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>995718478</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73845,;.01~VA-GP ONC BRCA ADJ HT NODE+ NO MAIN
801.41;+73845,;4~dialog group
801.41;+73845,;7~2
801.41;+73845,;25~WP-start~1
No:
801.41;+73845,;52~INDENT
801.41;+73845,;100~NATIONAL
801.412;+73846,+73845,;.01~10
801.412;+73846,+73845,;2~VA-GP ONC BRCA ADJ HT NODE+ NO FEMALE
801.44;+73847,+73845,;.01~06/09/2026@08:52:56
801.44;+73847,+73845,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73846^1
73847^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE &lt;5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78768</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2665259461</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78768,;.01~VA-ONC BRCA ADJ HT MALE <5 OFF PATH RSN
801.41;+78768,;4~dialog element
801.41;+78768,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 OFF PATH RSN
801.41;+78768,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78768,;51~SUPPRESS
801.41;+78768,;100~NATIONAL
801.412;+78769,+78768,;.01~5
801.412;+78769,+78768,;2~VA-ONC OFF PATHWAY
801.412;+78769,+78768,;7~YES
801.412;+78769,+78768,;9~YES
801.44;+78770,+78768,;.01~06/09/2026@08:52:56
801.44;+78770,+78768,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78769^1
78770^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE &lt;5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78767</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1923145735</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78767,;.01~VA-ONC BRCA ADJ HT MALE <5 OFF PATH TX
801.41;+78767,;4~dialog element
801.41;+78767,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 OFF PATH TX
801.41;+78767,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78767,;51~SUPPRESS
801.41;+78767,;100~NATIONAL
801.412;+78768,+78767,;.01~5
801.412;+78768,+78767,;2~VA-ONC BLANK
801.412;+78768,+78767,;7~YES
801.412;+78768,+78767,;9~YES
801.44;+78769,+78767,;.01~06/09/2026@08:52:56
801.44;+78769,+78767,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78768^1
78769^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT MALE &lt;5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78766</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>711667983</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78766,;.01~VA-GP ONC BRCA ADJ HT MALE <5 OFF PTHWY
801.41;+78766,;4~dialog group
801.41;+78766,;6~YES
801.41;+78766,;7~2
801.41;+78766,;23~YES
801.41;+78766,;25~WP-start~1
Off pathway:
801.41;+78766,;52~INDENT
801.41;+78766,;100~NATIONAL
801.412;+78767,+78766,;.01~10
801.412;+78767,+78766,;2~VA-ONC BRCA ADJ HT MALE <5 OFF PATH TX
801.412;+78768,+78766,;.01~20
801.412;+78768,+78766,;2~VA-ONC BRCA ADJ HT MALE <5 OFF PATH RSN
801.44;+78769,+78766,;.01~06/09/2026@08:52:56
801.44;+78769,+78766,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78767^1
78768^2
78769^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE &lt;5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78765</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4036241452</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78765,;.01~VA-ONC BRCA ADJ HT MALE <5 CLIN TRIAL
801.41;+78765,;4~dialog element
801.41;+78765,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 CLIN TRIAL
801.41;+78765,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78765,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78765,;100~NATIONAL
801.412;+78766,+78765,;.01~5
801.412;+78766,+78765,;2~VA-ONC CLINICAL TRIAL
801.412;+78766,+78765,;9~YES
801.44;+78767,+78765,;.01~06/09/2026@08:52:56
801.44;+78767,+78765,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78766^1
78767^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ANAS+TAMOX FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73877</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2665884992</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73877,;.01~VA-ONC BRCA ANAS+TAMOX FN
801.41;+73877,;4~dialog element
801.41;+73877,;23~YES
801.41;+73877,;25~WP-start~5
++ Avoid tamoxifen if prior history of DVT or known
hypercoagulability; if\\   contraindication to tamoxifen in men,
prescribe AI with ADT; patients\\   should use effective nonhormonal
contraception or barrier contraceptive\\   during tamoxifen therapy;
continue for 2 months after last dose. ++
801.41;+73877,;51~SUPPRESS
801.41;+73877,;100~NATIONAL
801.44;+73878,+73877,;.01~06/09/2026@08:52:56
801.44;+73878,+73877,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73878^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT MALE TUMOR NO TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73880</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1159742408</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73880,;.01~VA-GP ONC BRCA HT MALE TUMOR NO TAMOX
801.41;+73880,;4~dialog group
801.41;+73880,;7~2
801.41;+73880,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ TUMOR<5 TAMOX
801.41;+73880,;25~WP-start~1
Tamoxifen (7-8 Years Total)
801.41;+73880,;35~WP-start~2
Veteran has elected to pursue treatment with TAMOXIFEN for 7-8 Years
Total.
801.41;+73880,;100~NATIONAL
801.412;+73881,+73880,;.01~10
801.412;+73881,+73880,;2~VA-ONC BRCA ANAS+TAMOX FN
801.44;+73882,+73880,;.01~06/09/2026@08:52:56
801.44;+73882,+73880,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73881^1
73882^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ MALE TUMOR NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73874</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3234657705</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73874,;.01~VA-GP ONC BRCA HT NODE+ MALE TUMOR NO
801.41;+73874,;4~dialog group
801.41;+73874,;6~YES
801.41;+73874,;7~2
801.41;+73874,;9~ONE SELECTION ONLY
801.41;+73874,;25~WP-start~1
Tumor LESS THAN 5cm or Histologic Grade LESS THAN 3:
801.41;+73874,;100~NATIONAL
801.412;+73875,+73874,;.01~10
801.412;+73875,+73874,;2~VA-GP ONC BRCA HT MALE TUMOR NO TAMOX
801.412;+73876,+73874,;.01~5
801.412;+73876,+73874,;2~VA-ONC BRCA ADJ HT MALE <5 CLIN TRIAL
801.412;+73877,+73874,;.01~20
801.412;+73877,+73874,;2~VA-GP ONC BRCA ADJ HT MALE <5 OFF PTHWY
801.44;+73878,+73874,;.01~06/09/2026@08:52:56
801.44;+73878,+73874,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73875^1
73876^2
73877^3
73878^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE HER- OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78755</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>736094999</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78755,;.01~VA-ONC BRCA ADJ HT MALE HER- OFF PATH RSN
801.41;+78755,;4~dialog element
801.41;+78755,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH RSN
801.41;+78755,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78755,;51~SUPPRESS
801.41;+78755,;100~NATIONAL
801.412;+78756,+78755,;.01~5
801.412;+78756,+78755,;2~VA-ONC OFF PATHWAY
801.412;+78756,+78755,;7~YES
801.412;+78756,+78755,;9~YES
801.44;+78757,+78755,;.01~06/09/2026@08:52:56
801.44;+78757,+78755,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78756^1
78757^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE HER- OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78754</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>479375542</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78754,;.01~VA-ONC BRCA ADJ HT MALE HER- OFF PATH TX
801.41;+78754,;4~dialog element
801.41;+78754,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2- OFF PATH TX
801.41;+78754,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78754,;51~SUPPRESS
801.41;+78754,;100~NATIONAL
801.412;+78755,+78754,;.01~5
801.412;+78755,+78754,;2~VA-ONC BLANK
801.412;+78755,+78754,;7~YES
801.412;+78755,+78754,;9~YES
801.44;+78756,+78754,;.01~06/09/2026@08:52:56
801.44;+78756,+78754,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78755^1
78756^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT MALE HER- OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78753</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2209213964</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78753,;.01~VA-GP ONC BRCA ADJ HT MALE HER- OFF PTHWY
801.41;+78753,;4~dialog group
801.41;+78753,;6~YES
801.41;+78753,;7~2
801.41;+78753,;23~YES
801.41;+78753,;25~WP-start~1
Off pathway:
801.41;+78753,;52~INDENT
801.41;+78753,;100~NATIONAL
801.412;+78754,+78753,;.01~10
801.412;+78754,+78753,;2~VA-ONC BRCA ADJ HT MALE HER- OFF PATH TX
801.412;+78755,+78753,;.01~20
801.412;+78755,+78753,;2~VA-ONC BRCA ADJ HT MALE HER- OFF PATH RSN
801.44;+78756,+78753,;.01~06/09/2026@08:52:56
801.44;+78756,+78753,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78754^1
78755^2
78756^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE HER- CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78752</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>227095131</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78752,;.01~VA-ONC BRCA ADJ HT MALE HER- CLIN TRIAL
801.41;+78752,;4~dialog element
801.41;+78752,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2- CLIN TRIAL
801.41;+78752,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78752,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78752,;100~NATIONAL
801.412;+78753,+78752,;.01~5
801.412;+78753,+78752,;2~VA-ONC CLINICAL TRIAL
801.412;+78753,+78752,;9~YES
801.44;+78754,+78752,;.01~06/09/2026@08:52:56
801.44;+78754,+78752,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78753^1
78754^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT MALE HER2+ NO THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73879</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3695432366</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73879,;.01~VA-GP ONC BRCA HT MALE HER2+ NO THERAPY
801.41;+73879,;4~dialog group
801.41;+73879,;7~2
801.41;+73879,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2- ADT+ANAS+ABE+
801.41;+73879,;25~WP-start~2
Androgen Deprivation Therapy (ADT), Anastrozole, and Abemaciclib (Years
1-2); then Tamoxifen (Years 3-8)
801.41;+73879,;35~WP-start~2
Veteran has elected to pursue treatment with ADT, ANASTROZOLE, and
ABEMACICLIB in Years 1-2; then TAMOXIFEN in Years 3-8.
801.41;+73879,;100~NATIONAL
801.412;+73880,+73879,;.01~5
801.412;+73880,+73879,;2~VA-ONC BRCA ANAS+TAMOX FN
801.44;+73881,+73879,;.01~06/09/2026@08:52:56
801.44;+73881,+73879,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73880^1
73881^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT MALE HER2+ NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73878</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3154776838</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73878,;.01~VA-GP ONC BRCA HT MALE HER2+ NO
801.41;+73878,;4~dialog group
801.41;+73878,;6~YES
801.41;+73878,;7~2
801.41;+73878,;9~ONE SELECTION ONLY
801.41;+73878,;25~WP-start~1
HER2-:
801.41;+73878,;100~NATIONAL
801.412;+73879,+73878,;.01~10
801.412;+73879,+73878,;2~VA-GP ONC BRCA HT MALE HER2+ NO THERAPY
801.412;+73880,+73878,;.01~5
801.412;+73880,+73878,;2~VA-ONC BRCA ADJ HT MALE HER- CLIN TRIAL
801.412;+73881,+73878,;.01~20
801.412;+73881,+73878,;2~VA-GP ONC BRCA ADJ HT MALE HER- OFF PTHWY
801.44;+73882,+73878,;.01~06/09/2026@08:52:56
801.44;+73882,+73878,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73879^1
73880^2
73881^3
73882^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE HER+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78751</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>902550400</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78751,;.01~VA-ONC BRCA ADJ HT MALE HER+ OFF PATH RSN
801.41;+78751,;4~dialog element
801.41;+78751,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH RSN
801.41;+78751,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78751,;51~SUPPRESS
801.41;+78751,;100~NATIONAL
801.412;+78752,+78751,;.01~5
801.412;+78752,+78751,;2~VA-ONC OFF PATHWAY
801.412;+78752,+78751,;7~YES
801.412;+78752,+78751,;9~YES
801.44;+78753,+78751,;.01~06/09/2026@08:52:56
801.44;+78753,+78751,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78752^1
78753^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE HER+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78750</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1355624648</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78750,;.01~VA-ONC BRCA ADJ HT MALE HER+ OFF PATH TX
801.41;+78750,;4~dialog element
801.41;+78750,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2+ OFF PATH TX
801.41;+78750,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78750,;51~SUPPRESS
801.41;+78750,;100~NATIONAL
801.412;+78751,+78750,;.01~5
801.412;+78751,+78750,;2~VA-ONC BLANK
801.412;+78751,+78750,;7~YES
801.412;+78751,+78750,;9~YES
801.44;+78752,+78750,;.01~06/09/2026@08:52:56
801.44;+78752,+78750,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78751^1
78752^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT MALE HER+ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78749</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3759546102</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78749,;.01~VA-GP ONC BRCA ADJ HT MALE HER+ OFF PTHWY
801.41;+78749,;4~dialog group
801.41;+78749,;6~YES
801.41;+78749,;7~2
801.41;+78749,;23~YES
801.41;+78749,;25~WP-start~1
Off pathway:
801.41;+78749,;52~INDENT
801.41;+78749,;100~NATIONAL
801.412;+78750,+78749,;.01~10
801.412;+78750,+78749,;2~VA-ONC BRCA ADJ HT MALE HER+ OFF PATH TX
801.412;+78751,+78749,;.01~20
801.412;+78751,+78749,;2~VA-ONC BRCA ADJ HT MALE HER+ OFF PATH RSN
801.44;+78752,+78749,;.01~06/09/2026@08:52:56
801.44;+78752,+78749,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78750^1
78751^2
78752^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT MALE HER+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78748</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1261833873</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78748,;.01~VA-ONC BRCA ADJ HT MALE HER+ CLIN TRIAL
801.41;+78748,;4~dialog element
801.41;+78748,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2+ CLIN TRIAL
801.41;+78748,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78748,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78748,;100~NATIONAL
801.412;+78749,+78748,;.01~5
801.412;+78749,+78748,;2~VA-ONC CLINICAL TRIAL
801.412;+78749,+78748,;9~YES
801.44;+78750,+78748,;.01~06/09/2026@08:52:56
801.44;+78750,+78748,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78749^1
78750^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT MALE HER2+ TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73876</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>83724516</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73876,;.01~VA-GP ONC BRCA HT MALE HER2+ TAMOX
801.41;+73876,;4~dialog group
801.41;+73876,;7~2
801.41;+73876,;15~HF.VA-ONC BRCA ADJ HT MALE NODE+ HER2+ TAMOX
801.41;+73876,;25~WP-start~1
Tamoxifen (7-8 Years Total)
801.41;+73876,;35~WP-start~2
Veteran has elected to pursue treatment with TAMOXIFEN for 7-8 Years
Total.
801.41;+73876,;100~NATIONAL
801.412;+73877,+73876,;.01~10
801.412;+73877,+73876,;2~VA-ONC BRCA ANAS+TAMOX FN
801.44;+73878,+73876,;.01~06/09/2026@08:52:56
801.44;+73878,+73876,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73877^1
73878^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT MALE HER2+ YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73875</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2945239299</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73875,;.01~VA-GP ONC BRCA HT MALE HER2+ YES
801.41;+73875,;4~dialog group
801.41;+73875,;6~YES
801.41;+73875,;7~2
801.41;+73875,;9~ONE SELECTION ONLY
801.41;+73875,;25~WP-start~1
HER2+:
801.41;+73875,;100~NATIONAL
801.412;+73876,+73875,;.01~10
801.412;+73876,+73875,;2~VA-GP ONC BRCA HT MALE HER2+ TAMOX
801.412;+73877,+73875,;.01~5
801.412;+73877,+73875,;2~VA-ONC BRCA ADJ HT MALE HER+ CLIN TRIAL
801.412;+73878,+73875,;.01~20
801.412;+73878,+73875,;2~VA-GP ONC BRCA ADJ HT MALE HER+ OFF PTHWY
801.44;+73879,+73875,;.01~06/09/2026@08:52:56
801.44;+73879,+73875,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73876^1
73877^2
73878^3
73879^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ MALE TUMOR YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73873</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2456929612</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73873,;.01~VA-GP ONC BRCA HT NODE+ MALE TUMOR YES
801.41;+73873,;4~dialog group
801.41;+73873,;7~2
801.41;+73873,;9~ONE SELECTION ONLY
801.41;+73873,;25~WP-start~1
Tumor 5cm or more or Histologic Grade 3:
801.41;+73873,;100~NATIONAL
801.412;+73874,+73873,;.01~10
801.412;+73874,+73873,;2~VA-GP ONC BRCA HT MALE HER2+ YES
801.412;+73875,+73873,;.01~20
801.412;+73875,+73873,;2~VA-GP ONC BRCA HT MALE HER2+ NO
801.44;+73876,+73873,;.01~06/09/2026@08:52:56
801.44;+73876,+73873,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73874^1
73875^2
73876^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ MALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73872</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>911468517</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73872,;.01~VA-GP ONC BRCA ADJ HT NODE+ MALE
801.41;+73872,;4~dialog group
801.41;+73872,;6~YES
801.41;+73872,;7~2
801.41;+73872,;9~ONE SELECTION ONLY
801.41;+73872,;25~WP-start~1
Male:
801.41;+73872,;51~SUPPRESS
801.41;+73872,;100~NATIONAL
801.412;+73873,+73872,;.01~20
801.412;+73873,+73872,;2~VA-GP ONC BRCA HT NODE+ MALE TUMOR YES
801.412;+73874,+73872,;.01~40
801.412;+73874,+73872,;2~VA-GP ONC BRCA HT NODE+ MALE TUMOR NO
801.44;+73875,+73872,;.01~06/09/2026@08:52:56
801.44;+73875,+73872,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73873^1
73874^2
73875^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST &lt;5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78746</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4146478071</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78746,;.01~VA-ONC BRCA ADJ HT POST <5 OFF PATH RSN
801.41;+78746,;4~dialog element
801.41;+78746,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 OFF PATH RSN
801.41;+78746,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78746,;51~SUPPRESS
801.41;+78746,;100~NATIONAL
801.412;+78747,+78746,;.01~5
801.412;+78747,+78746,;2~VA-ONC OFF PATHWAY
801.412;+78747,+78746,;7~YES
801.412;+78747,+78746,;9~YES
801.44;+78748,+78746,;.01~06/09/2026@08:52:56
801.44;+78748,+78746,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78747^1
78748^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST &lt;5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78744</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1867978074</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78744,;.01~VA-ONC BRCA ADJ HT POST <5 OFF PATH TX
801.41;+78744,;4~dialog element
801.41;+78744,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 OFF PATH TX
801.41;+78744,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78744,;51~SUPPRESS
801.41;+78744,;100~NATIONAL
801.412;+78745,+78744,;.01~5
801.412;+78745,+78744,;2~VA-ONC BLANK
801.412;+78745,+78744,;7~YES
801.412;+78745,+78744,;9~YES
801.44;+78746,+78744,;.01~06/09/2026@08:52:56
801.44;+78746,+78744,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78745^1
78746^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT POST &lt;5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78743</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3871715072</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78743,;.01~VA-GP ONC BRCA ADJ HT POST <5 OFF PTHWY
801.41;+78743,;4~dialog group
801.41;+78743,;6~YES
801.41;+78743,;7~2
801.41;+78743,;23~YES
801.41;+78743,;25~WP-start~1
Off pathway:
801.41;+78743,;52~INDENT
801.41;+78743,;100~NATIONAL
801.412;+78744,+78743,;.01~10
801.412;+78744,+78743,;2~VA-ONC BRCA ADJ HT POST <5 OFF PATH TX
801.412;+78745,+78743,;.01~20
801.412;+78745,+78743,;2~VA-ONC BRCA ADJ HT POST <5 OFF PATH RSN
801.44;+78746,+78743,;.01~06/09/2026@08:52:56
801.44;+78746,+78743,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78744^1
78745^2
78746^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST &lt;5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78742</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1532715555</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78742,;.01~VA-ONC BRCA ADJ HT POST <5 CLIN TRIAL
801.41;+78742,;4~dialog element
801.41;+78742,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 CLIN TRIAL
801.41;+78742,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78742,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78742,;100~NATIONAL
801.412;+78743,+78742,;.01~5
801.412;+78743,+78742,;2~VA-ONC CLINICAL TRIAL
801.412;+78743,+78742,;9~YES
801.44;+78744,+78742,;.01~06/09/2026@08:52:56
801.44;+78744,+78742,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78743^1
78744^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA HT NODE+ POST ANAST SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>73966</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>590820074</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73966,;.01~VA-ONC BRCA HT NODE+ POST ANAST SURV
801.41;+73966,;4~dialog element
801.41;+73966,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER SURV
801.41;+73966,;25~WP-start~1
Surveillance
801.41;+73966,;35~WP-start~1
Veteran has elected to pursue SURVEILLANCE.
801.41;+73966,;100~NATIONAL
801.44;+73967,+73966,;.01~06/09/2026@08:52:56
801.44;+73967,+73966,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73967^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST ANAST TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73965</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2569025980</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73965,;.01~VA-GP ONC BRCA HT NODE+ POST ANAST TAMOX
801.41;+73965,;4~dialog group
801.41;+73965,;7~2
801.41;+73965,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER TAMOX
801.41;+73965,;25~WP-start~1
Tamoxifen (7-8 Years Total)
801.41;+73965,;35~WP-start~2
Veteran has elected to pursue TREATMENT with TAMOXIFEN for 7-8 Years
Total.
801.41;+73965,;100~NATIONAL
801.44;+73966,+73965,;.01~06/09/2026@08:52:56
801.44;+73966,+73965,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73966^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST ANAST CONT 7-8</POINT_01>
<INTERNAL_ENTRY_NUMBER>73964</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3943724157</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73964,;.01~VA-GP ONC BRCA HT NODE+ POST ANAST CONT 7-8
801.41;+73964,;4~dialog group
801.41;+73964,;7~2
801.41;+73964,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP <5 PREFER ANAS
801.41;+73964,;25~WP-start~1
Anastrozole (7-8 Years Total)
801.41;+73964,;35~WP-start~2
Veteran has elected to continue TREATMENT with ANASTROZOLE Therapy for 7-8
Years Total.
801.41;+73964,;100~NATIONAL
801.44;+73965,+73964,;.01~06/09/2026@08:52:56
801.44;+73965,+73964,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73965^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST ANAST PREF</POINT_01>
<INTERNAL_ENTRY_NUMBER>73963</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2714415273</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73963,;.01~VA-GP ONC BRCA HT NODE+ POST ANAST PREF
801.41;+73963,;4~dialog group
801.41;+73963,;6~YES
801.41;+73963,;7~2
801.41;+73963,;9~ONE SELECTION ONLY
801.41;+73963,;25~WP-start~1
Patient Preference After Shared Decision Making:
801.41;+73963,;51~SUPPRESS
801.41;+73963,;52~INDENT
801.41;+73963,;100~NATIONAL
801.412;+73964,+73963,;.01~10
801.412;+73964,+73963,;2~VA-GP ONC BRCA HT NODE+ POST ANAST CONT 7-8
801.412;+73965,+73963,;.01~20
801.412;+73965,+73963,;2~VA-GP ONC BRCA HT NODE+ POST ANAST TAMOX
801.412;+73966,+73963,;.01~30
801.412;+73966,+73963,;2~VA-ONC BRCA HT NODE+ POST ANAST SURV
801.44;+73967,+73963,;.01~06/09/2026@08:52:56
801.44;+73967,+73963,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73964^1
73965^2
73966^3
73967^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST TUMOR ANAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>73962</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1178026772</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73962,;.01~VA-GP ONC BRCA HT NODE+ POST TUMOR ANAST
801.41;+73962,;4~dialog group
801.41;+73962,;7~2
801.41;+73962,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP TUMOR<5 ANAST
801.41;+73962,;25~WP-start~1
Anastrozole (5 Years):
801.41;+73962,;35~WP-start~1
Veteran has elected to pursue TREATMENT with ANASTROZOLE for 5 Years.
801.41;+73962,;100~NATIONAL
801.412;+73963,+73962,;.01~10
801.412;+73963,+73962,;2~VA-GP ONC BRCA HT NODE+ POST ANAST PREF
801.44;+73964,+73962,;.01~06/09/2026@08:52:56
801.44;+73964,+73962,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73963^2
73964^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST TUMOR NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73961</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3886457585</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73961,;.01~VA-GP ONC BRCA HT NODE+ POST TUMOR NO
801.41;+73961,;4~dialog group
801.41;+73961,;6~YES
801.41;+73961,;7~2
801.41;+73961,;9~ONE SELECTION ONLY
801.41;+73961,;25~WP-start~1
Tumor LESS THAN 5cm or Histologic Grade LESS THAN 3:
801.41;+73961,;100~NATIONAL
801.412;+73962,+73961,;.01~10
801.412;+73962,+73961,;2~VA-GP ONC BRCA HT NODE+ POST TUMOR ANAST
801.412;+73963,+73961,;.01~5
801.412;+73963,+73961,;2~VA-ONC BRCA ADJ HT POST <5 CLIN TRIAL
801.412;+73964,+73961,;.01~20
801.412;+73964,+73961,;2~VA-GP ONC BRCA ADJ HT POST <5 OFF PTHWY
801.44;+73965,+73961,;.01~06/09/2026@08:52:56
801.44;+73965,+73961,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73962^1
73963^2
73964^3
73965^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST HER NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78735</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3711807914</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78735,;.01~VA-ONC BRCA ADJ HT POST HER NEG OFF PATH RSN
801.41;+78735,;4~dialog element
801.41;+78735,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH RSN
801.41;+78735,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78735,;51~SUPPRESS
801.41;+78735,;100~NATIONAL
801.412;+78736,+78735,;.01~5
801.412;+78736,+78735,;2~VA-ONC OFF PATHWAY
801.412;+78736,+78735,;7~YES
801.412;+78736,+78735,;9~YES
801.44;+78737,+78735,;.01~06/09/2026@08:52:56
801.44;+78737,+78735,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78736^1
78737^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST HER NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78736</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3890280890</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78736,;.01~VA-ONC BRCA ADJ HT POST HER NEG OFF PATH TX
801.41;+78736,;4~dialog element
801.41;+78736,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- OFF PATH TX
801.41;+78736,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78736,;51~SUPPRESS
801.41;+78736,;100~NATIONAL
801.412;+78737,+78736,;.01~5
801.412;+78737,+78736,;2~VA-ONC BLANK
801.412;+78737,+78736,;7~YES
801.412;+78737,+78736,;9~YES
801.44;+78738,+78736,;.01~06/09/2026@08:52:56
801.44;+78738,+78736,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78737^1
78738^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT POST HER NEG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78738</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1870781076</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78738,;.01~VA-GP ONC BRCA ADJ HT POST HER NEG OFF PTHWY
801.41;+78738,;4~dialog group
801.41;+78738,;6~YES
801.41;+78738,;7~2
801.41;+78738,;23~YES
801.41;+78738,;25~WP-start~1
Off pathway:
801.41;+78738,;52~INDENT
801.41;+78738,;100~NATIONAL
801.412;+78739,+78738,;.01~10
801.412;+78739,+78738,;2~VA-ONC BRCA ADJ HT POST HER NEG OFF PATH TX
801.412;+78740,+78738,;.01~20
801.412;+78740,+78738,;2~VA-ONC BRCA ADJ HT POST HER NEG OFF PATH RSN
801.44;+78741,+78738,;.01~06/09/2026@08:52:56
801.44;+78741,+78738,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78739^1
78740^2
78741^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST HER NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78739</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>115201801</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78739,;.01~VA-ONC BRCA ADJ HT POST HER NEG CLIN TRIAL
801.41;+78739,;4~dialog element
801.41;+78739,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- CLIN TRIAL
801.41;+78739,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78739,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78739,;100~NATIONAL
801.412;+78740,+78739,;.01~5
801.412;+78740,+78739,;2~VA-ONC CLINICAL TRIAL
801.412;+78740,+78739,;9~YES
801.44;+78741,+78739,;.01~06/09/2026@08:52:56
801.44;+78741,+78739,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78740^1
78741^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ NO THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73974</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>46866962</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73974,;.01~VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ NO THERAPY
801.41;+73974,;4~dialog group
801.41;+73974,;7~2
801.41;+73974,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2- ANAS+ABE+ANAS
801.41;+73974,;25~WP-start~1
Anastrozole and Abemaciclib (Years 1-2); then Anastrozole (Years 3-5)
801.41;+73974,;35~WP-start~2
Veteran has elected to pursue TREATMENT with ANASTROZOLE and ABEMACICLIB
in Years 1-2; then ANASTROZOLE for Years 3-5.
801.41;+73974,;100~NATIONAL
801.44;+73975,+73974,;.01~06/09/2026@08:52:56
801.44;+73975,+73974,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73975^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73968</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>668727760</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73968,;.01~VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ NO
801.41;+73968,;4~dialog group
801.41;+73968,;6~YES
801.41;+73968,;7~2
801.41;+73968,;9~ONE SELECTION ONLY
801.41;+73968,;25~WP-start~1
HER2-:
801.41;+73968,;100~NATIONAL
801.412;+73969,+73968,;.01~10
801.412;+73969,+73968,;2~VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ NO THERAPY
801.412;+73970,+73968,;.01~5
801.412;+73970,+73968,;2~VA-ONC BRCA ADJ HT POST HER NEG CLIN TRIAL
801.412;+73971,+73968,;.01~20
801.412;+73971,+73968,;2~VA-GP ONC BRCA ADJ HT POST HER NEG OFF PTHWY
801.44;+73972,+73968,;.01~06/09/2026@08:52:56
801.44;+73972,+73968,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73969^1
73970^2
73971^3
73972^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST HER+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78734</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>244855497</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78734,;.01~VA-ONC BRCA ADJ HT POST HER+ OFF PATH RSN
801.41;+78734,;4~dialog element
801.41;+78734,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH RSN
801.41;+78734,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78734,;51~SUPPRESS
801.41;+78734,;100~NATIONAL
801.412;+78735,+78734,;.01~5
801.412;+78735,+78734,;2~VA-ONC OFF PATHWAY
801.412;+78735,+78734,;7~YES
801.412;+78735,+78734,;9~YES
801.44;+78736,+78734,;.01~06/09/2026@08:52:57
801.44;+78736,+78734,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78735^1
78736^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST HER+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78733</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>204665044</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78733,;.01~VA-ONC BRCA ADJ HT POST HER+ OFF PATH TX
801.41;+78733,;4~dialog element
801.41;+78733,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ OFF PATH TX
801.41;+78733,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78733,;51~SUPPRESS
801.41;+78733,;100~NATIONAL
801.412;+78734,+78733,;.01~5
801.412;+78734,+78733,;2~VA-ONC BLANK
801.412;+78734,+78733,;7~YES
801.412;+78734,+78733,;9~YES
801.44;+78735,+78733,;.01~06/09/2026@08:52:57
801.44;+78735,+78733,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78734^1
78735^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT POST HER+ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78732</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>944688702</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78732,;.01~VA-GP ONC BRCA ADJ HT POST HER+ OFF PTHWY
801.41;+78732,;4~dialog group
801.41;+78732,;6~YES
801.41;+78732,;7~2
801.41;+78732,;23~YES
801.41;+78732,;25~WP-start~1
Off pathway:
801.41;+78732,;52~INDENT
801.41;+78732,;100~NATIONAL
801.412;+78733,+78732,;.01~10
801.412;+78733,+78732,;2~VA-ONC BRCA ADJ HT POST HER+ OFF PATH TX
801.412;+78734,+78732,;.01~20
801.412;+78734,+78732,;2~VA-ONC BRCA ADJ HT POST HER+ OFF PATH RSN
801.44;+78735,+78732,;.01~06/09/2026@08:52:57
801.44;+78735,+78732,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78733^1
78734^2
78735^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POST HER+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>75546</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>345840891</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+75546,;.01~VA-ONC BRCA ADJ HT POST HER+ CLIN TRIAL
801.41;+75546,;4~dialog element
801.41;+75546,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ CLIN TRIAL
801.41;+75546,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+75546,;35~WP-start~1
Veteran has elected to pursue:
801.41;+75546,;100~NATIONAL
801.412;+75547,+75546,;.01~5
801.412;+75547,+75546,;2~VA-ONC CLINICAL TRIAL
801.412;+75547,+75546,;9~YES
801.44;+75548,+75546,;.01~06/09/2026@08:52:57
801.44;+75548,+75546,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
75547^1
75548^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA HT NODE+ HER2+ ANAST SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>73973</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4243703344</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73973,;.01~VA-ONC BRCA HT NODE+ HER2+ ANAST SURV
801.41;+73973,;4~dialog element
801.41;+73973,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER SURV
801.41;+73973,;25~WP-start~1
Surveillance
801.41;+73973,;35~WP-start~1
Veteran has elected to pursue SURVEILLANCE.
801.41;+73973,;100~NATIONAL
801.44;+73974,+73973,;.01~06/09/2026@08:52:57
801.44;+73974,+73973,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73974^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ HER2+ ANAST CONT 7-8</POINT_01>
<INTERNAL_ENTRY_NUMBER>73971</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1650467313</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73971,;.01~VA-GP ONC BRCA HT NODE+ HER2+ ANAST CONT 7-8
801.41;+73971,;4~dialog group
801.41;+73971,;7~2
801.41;+73971,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER ANAS 7-8Y
801.41;+73971,;25~WP-start~1
Anastrozole (7-8 Years Total)
801.41;+73971,;35~WP-start~2
Veteran has elected to continue TREATMENT with ANASTROZOLE for 7-8 Years
Total.
801.41;+73971,;100~NATIONAL
801.44;+73972,+73971,;.01~06/09/2026@08:52:57
801.44;+73972,+73971,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73972^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ HER2+ ANAST TAMOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73972</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2375375120</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73972,;.01~VA-GP ONC BRCA HT NODE+ HER2+ ANAST TAMOX
801.41;+73972,;4~dialog group
801.41;+73972,;7~2
801.41;+73972,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP PREFER TAMO 7-8Y
801.41;+73972,;25~WP-start~1
Tamoxifen (7-8 Years Total)
801.41;+73972,;35~WP-start~2
Veteran has elected to pursue TREATMENT with TAMOXIFEN for 7-8 Years
Total.
801.41;+73972,;100~NATIONAL
801.44;+73973,+73972,;.01~06/09/2026@08:52:57
801.44;+73973,+73972,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73973^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ HER2+ ANAST PREFER</POINT_01>
<INTERNAL_ENTRY_NUMBER>73970</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>281392503</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73970,;.01~VA-GP ONC BRCA HT NODE+ HER2+ ANAST PREFER
801.41;+73970,;4~dialog group
801.41;+73970,;6~YES
801.41;+73970,;7~2
801.41;+73970,;9~ONE SELECTION ONLY
801.41;+73970,;23~NO
801.41;+73970,;25~WP-start~1
Patient Preference After Shared Decision Making:
801.41;+73970,;51~SUPPRESS
801.41;+73970,;52~INDENT
801.41;+73970,;100~NATIONAL
801.412;+73971,+73970,;.01~20
801.412;+73971,+73970,;2~VA-GP ONC BRCA HT NODE+ HER2+ ANAST TAMOX
801.412;+73972,+73970,;.01~10
801.412;+73972,+73970,;2~VA-GP ONC BRCA HT NODE+ HER2+ ANAST CONT 7-8
801.412;+73973,+73970,;.01~30
801.412;+73973,+73970,;2~VA-ONC BRCA HT NODE+ HER2+ ANAST SURV
801.44;+73974,+73970,;.01~06/09/2026@08:52:57
801.44;+73974,+73970,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73971^4
73972^5
73973^6
73974^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ TUMOR HER2+ YES ANAST</POINT_01>
<INTERNAL_ENTRY_NUMBER>73969</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2193161381</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73969,;.01~VA-GP ONC BRCA HT NODE+ TUMOR HER2+ YES ANAST
801.41;+73969,;4~dialog group
801.41;+73969,;7~2
801.41;+73969,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ POST MP HER2+ ANAS 5Y
801.41;+73969,;25~WP-start~1
Anastrozole (5 Years):
801.41;+73969,;35~WP-start~1
Veteran has elected to pursue TREATMENT with ANASTROZOLE for 5 Years.
801.41;+73969,;100~NATIONAL
801.412;+73970,+73969,;.01~10
801.412;+73970,+73969,;2~VA-GP ONC BRCA HT NODE+ HER2+ ANAST PREFER
801.44;+73971,+73969,;.01~06/09/2026@08:52:57
801.44;+73971,+73969,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73970^2
73971^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73967</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3498388101</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73967,;.01~VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ YES
801.41;+73967,;4~dialog group
801.41;+73967,;6~YES
801.41;+73967,;7~2
801.41;+73967,;9~ONE SELECTION ONLY
801.41;+73967,;25~WP-start~1
HER2+:
801.41;+73967,;100~NATIONAL
801.412;+73968,+73967,;.01~10
801.412;+73968,+73967,;2~VA-GP ONC BRCA HT NODE+ TUMOR HER2+ YES ANAST
801.412;+73969,+73967,;.01~5
801.412;+73969,+73967,;2~VA-ONC BRCA ADJ HT POST HER+ CLIN TRIAL
801.412;+73970,+73967,;.01~20
801.412;+73970,+73967,;2~VA-GP ONC BRCA ADJ HT POST HER+ OFF PTHWY
801.44;+73971,+73967,;.01~06/09/2026@08:52:57
801.44;+73971,+73967,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73968^1
73969^2
73970^3
73971^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ POST TUMOR YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73960</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>69980690</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73960,;.01~VA-GP ONC BRCA HT NODE+ POST TUMOR YES
801.41;+73960,;4~dialog group
801.41;+73960,;6~YES
801.41;+73960,;7~2
801.41;+73960,;9~ONE SELECTION ONLY
801.41;+73960,;25~WP-start~1
Tumor 5cm or more or Histologic Grade 3:
801.41;+73960,;100~NATIONAL
801.412;+73961,+73960,;.01~10
801.412;+73961,+73960,;2~VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ YES
801.412;+73962,+73960,;.01~20
801.412;+73962,+73960,;2~VA-GP ONC BRCA HT NODE+ POST TUMOR HER2+ NO
801.44;+73963,+73960,;.01~06/09/2026@08:52:57
801.44;+73963,+73960,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73961^1
73962^2
73963^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ YES POST-MP</POINT_01>
<INTERNAL_ENTRY_NUMBER>73863</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2186507106</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73863,;.01~VA-GP ONC BRCA HT NODE+ YES POST-MP
801.41;+73863,;4~dialog group
801.41;+73863,;6~YES
801.41;+73863,;7~2
801.41;+73863,;9~ONE SELECTION ONLY
801.41;+73863,;25~WP-start~1
Post-menopause:
801.41;+73863,;100~NATIONAL
801.412;+73864,+73863,;.01~20
801.412;+73864,+73863,;2~VA-GP ONC BRCA HT NODE+ POST TUMOR YES
801.412;+73865,+73863,;.01~40
801.412;+73865,+73863,;2~VA-GP ONC BRCA HT NODE+ POST TUMOR NO
801.44;+73866,+73863,;.01~06/09/2026@08:52:57
801.44;+73866,+73863,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73864^1
73865^2
73866^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT PRE &lt;5 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78721</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3236237401</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78721,;.01~VA-ONC BRCA ADJ HT PRE <5 OFF PATH RSN
801.41;+78721,;4~dialog element
801.41;+78721,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OFF PATH RSN
801.41;+78721,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78721,;51~SUPPRESS
801.41;+78721,;100~NATIONAL
801.412;+78722,+78721,;.01~5
801.412;+78722,+78721,;2~VA-ONC OFF PATHWAY
801.412;+78722,+78721,;7~YES
801.412;+78722,+78721,;9~YES
801.44;+78723,+78721,;.01~06/09/2026@08:52:57
801.44;+78723,+78721,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78722^1
78723^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT PRE &lt;5 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78719</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1272263359</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78719,;.01~VA-ONC BRCA ADJ HT PRE <5 OFF PATH TX
801.41;+78719,;4~dialog element
801.41;+78719,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OFF PATH TX
801.41;+78719,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78719,;51~SUPPRESS
801.41;+78719,;100~NATIONAL
801.412;+78720,+78719,;.01~5
801.412;+78720,+78719,;2~VA-ONC BLANK
801.412;+78720,+78719,;7~YES
801.412;+78720,+78719,;9~YES
801.44;+78721,+78719,;.01~06/09/2026@08:52:57
801.44;+78721,+78719,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78720^1
78721^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT PRE &lt;5 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78718</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>366969323</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78718,;.01~VA-GP ONC BRCA ADJ HT PRE <5 OFF PTHWY
801.41;+78718,;4~dialog group
801.41;+78718,;6~YES
801.41;+78718,;7~2
801.41;+78718,;23~YES
801.41;+78718,;25~WP-start~1
Off pathway:
801.41;+78718,;52~INDENT
801.41;+78718,;100~NATIONAL
801.412;+78719,+78718,;.01~10
801.412;+78719,+78718,;2~VA-ONC BRCA ADJ HT PRE <5 OFF PATH TX
801.412;+78720,+78718,;.01~20
801.412;+78720,+78718,;2~VA-ONC BRCA ADJ HT PRE <5 OFF PATH RSN
801.44;+78721,+78718,;.01~06/09/2026@08:52:57
801.44;+78721,+78718,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78719^1
78720^2
78721^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT PRE &lt;5 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78717</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>775501539</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78717,;.01~VA-ONC BRCA ADJ HT PRE <5 CLIN TRIAL
801.41;+78717,;4~dialog element
801.41;+78717,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 CLIN TRIAL
801.41;+78717,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78717,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78717,;100~NATIONAL
801.412;+78718,+78717,;.01~5
801.412;+78718,+78717,;2~VA-ONC CLINICAL TRIAL
801.412;+78718,+78717,;9~YES
801.44;+78719,+78717,;.01~06/09/2026@08:52:57
801.44;+78719,+78717,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78718^1
78719^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT PRE MP TUMOR NO TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73866</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1255507101</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73866,;.01~VA-GP ONC BRCA HT PRE MP TUMOR NO TX
801.41;+73866,;4~dialog group
801.41;+73866,;7~2
801.41;+73866,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP TUMOR<5 OS+ANA+
801.41;+73866,;25~WP-start~2
Ovarian Suppression (OS) and Anastrozole (Years 1-5); then Tamoxifen
(Years 6-8)
801.41;+73866,;35~WP-start~2
Veteran has elected to pursue TREATMENT with OVARIAN SUPPRESSION and
ANASTROZOLE during years 1-5; then TAMOXIFEN during years 6-8.
801.41;+73866,;100~NATIONAL
801.44;+73867,+73866,;.01~06/09/2026@08:52:57
801.44;+73867,+73866,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73867^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ FEMALE PRE TUMOR NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73865</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3424638719</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73865,;.01~VA-GP ONC BRCA HT NODE+ FEMALE PRE TUMOR NO
801.41;+73865,;4~dialog group
801.41;+73865,;7~2
801.41;+73865,;9~ONE SELECTION ONLY
801.41;+73865,;25~WP-start~1
Tumor LESS THAN 5cm or Histologic Grade LESS THAN 3:
801.41;+73865,;100~NATIONAL
801.412;+73866,+73865,;.01~10
801.412;+73866,+73865,;2~VA-GP ONC BRCA HT PRE MP TUMOR NO TX
801.412;+73867,+73865,;.01~5
801.412;+73867,+73865,;2~VA-ONC BRCA ADJ HT PRE <5 CLIN TRIAL
801.412;+73868,+73865,;.01~20
801.412;+73868,+73865,;2~VA-GP ONC BRCA ADJ HT PRE <5 OFF PTHWY
801.44;+73869,+73865,;.01~06/09/2026@08:52:57
801.44;+73869,+73865,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73866^1
73867^2
73868^3
73869^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT ER+ PRE HER NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78708</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1593125835</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78708,;.01~VA-ONC BRCA ADJ HT ER+ PRE HER NEG OFF PATH RSN
801.41;+78708,;4~dialog element
801.41;+78708,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH RSN
801.41;+78708,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78708,;51~SUPPRESS
801.41;+78708,;100~NATIONAL
801.412;+78709,+78708,;.01~5
801.412;+78709,+78708,;2~VA-ONC OFF PATHWAY
801.412;+78709,+78708,;7~YES
801.412;+78709,+78708,;9~YES
801.44;+78710,+78708,;.01~06/09/2026@08:52:57
801.44;+78710,+78708,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78709^1
78710^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT ER+ PRE HER NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78707</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3311623695</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78707,;.01~VA-ONC BRCA ADJ HT ER+ PRE HER NEG OFF PATH TX
801.41;+78707,;4~dialog element
801.41;+78707,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OFF PATH TX
801.41;+78707,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78707,;51~SUPPRESS
801.41;+78707,;100~NATIONAL
801.412;+78708,+78707,;.01~5
801.412;+78708,+78707,;2~VA-ONC BLANK
801.412;+78708,+78707,;7~YES
801.412;+78708,+78707,;9~YES
801.44;+78709,+78707,;.01~06/09/2026@08:52:57
801.44;+78709,+78707,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78708^1
78709^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT ER+ PRE HER NEG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78705</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>51378135</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78705,;.01~VA-GP ONC BRCA ADJ HT ER+ PRE HER NEG OFF PTHWY
801.41;+78705,;4~dialog group
801.41;+78705,;6~YES
801.41;+78705,;7~2
801.41;+78705,;23~YES
801.41;+78705,;25~WP-start~1
Off pathway:
801.41;+78705,;52~INDENT
801.41;+78705,;100~NATIONAL
801.412;+78706,+78705,;.01~10
801.412;+78706,+78705,;2~VA-ONC BRCA ADJ HT ER+ PRE HER NEG OFF PATH TX
801.412;+78707,+78705,;.01~20
801.412;+78707,+78705,;2~VA-ONC BRCA ADJ HT ER+ PRE HER NEG OFF PATH RSN
801.44;+78708,+78705,;.01~06/09/2026@08:52:57
801.44;+78708,+78705,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78706^1
78707^2
78708^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT ER+ PRE HER NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78704</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>92650301</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78704,;.01~VA-ONC BRCA ADJ HT ER+ PRE HER NEG CLIN TRIAL
801.41;+78704,;4~dialog element
801.41;+78704,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- CLIN TRIAL
801.41;+78704,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78704,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78704,;100~NATIONAL
801.412;+78705,+78704,;.01~5
801.412;+78705,+78704,;2~VA-ONC CLINICAL TRIAL
801.412;+78705,+78704,;9~YES
801.44;+78706,+78704,;.01~06/09/2026@08:52:57
801.44;+78706,+78704,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78705^1
78706^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT PRE HER2+ NO TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73871</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1295410759</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73871,;.01~VA-GP ONC BRCA HT PRE HER2+ NO TX
801.41;+73871,;4~dialog group
801.41;+73871,;7~2
801.41;+73871,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2- OS+ANA+ABE+
801.41;+73871,;25~WP-start~2
Ovarian Suppression (OS), Anastrozole, and Abemaciclib (Years 1-2); then 
OS and Anastrozole (Years 3-5); then Tamoxifen (Years 6-8)
801.41;+73871,;35~WP-start~3
Veteran has elected to pursue TREATMENT with OVARIAN SUPPRESSION (OS),
ANASTROZOLE, and ABEMACICLIB during Years 1-2; then OS and ANASTROZOLE
during Years 3-5; then TAMOXIFEN during Years 6-8.
801.41;+73871,;100~NATIONAL
801.44;+73872,+73871,;.01~06/09/2026@08:52:57
801.44;+73872,+73871,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73872^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA AHT FEMALE PRE HER+ NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73869</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4066797846</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73869,;.01~VA-GP ONC BRCA AHT FEMALE PRE HER+ NO
801.41;+73869,;4~dialog group
801.41;+73869,;6~YES
801.41;+73869,;7~2
801.41;+73869,;9~ONE SELECTION ONLY
801.41;+73869,;25~WP-start~1
HER2-:
801.41;+73869,;100~NATIONAL
801.412;+73870,+73869,;.01~10
801.412;+73870,+73869,;2~VA-GP ONC BRCA HT PRE HER2+ NO TX
801.412;+73871,+73869,;.01~5
801.412;+73871,+73869,;2~VA-ONC BRCA ADJ HT ER+ PRE HER NEG CLIN TRIAL
801.412;+73872,+73869,;.01~20
801.412;+73872,+73869,;2~VA-GP ONC BRCA ADJ HT ER+ PRE HER NEG OFF PTHWY
801.44;+73873,+73869,;.01~06/09/2026@08:52:57
801.44;+73873,+73869,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73870^1
73871^2
73872^3
73873^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POS PRE HER+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78702</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1880350512</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78702,;.01~VA-ONC BRCA ADJ HT POS PRE HER+ OFF PATH RSN
801.41;+78702,;4~dialog element
801.41;+78702,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH RSN
801.41;+78702,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78702,;51~SUPPRESS
801.41;+78702,;100~NATIONAL
801.412;+78703,+78702,;.01~5
801.412;+78703,+78702,;2~VA-ONC OFF PATHWAY
801.412;+78703,+78702,;7~YES
801.412;+78703,+78702,;9~YES
801.44;+78704,+78702,;.01~06/09/2026@08:52:57
801.44;+78704,+78702,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78703^1
78704^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POS PRE HER+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78701</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1154536905</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78701,;.01~VA-ONC BRCA ADJ HT POS PRE HER+ OFF PATH TX
801.41;+78701,;4~dialog element
801.41;+78701,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OFF PATH TX
801.41;+78701,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78701,;51~SUPPRESS
801.41;+78701,;100~NATIONAL
801.412;+78702,+78701,;.01~5
801.412;+78702,+78701,;2~VA-ONC BLANK
801.412;+78702,+78701,;7~YES
801.412;+78702,+78701,;9~YES
801.44;+78703,+78701,;.01~06/09/2026@08:52:57
801.44;+78703,+78701,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78702^1
78703^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT POS PRE HER+ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78700</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2551800733</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78700,;.01~VA-GP ONC BRCA ADJ HT POS PRE HER+ OFF PTHWY
801.41;+78700,;4~dialog group
801.41;+78700,;6~YES
801.41;+78700,;7~2
801.41;+78700,;23~YES
801.41;+78700,;25~WP-start~1
Off pathway:
801.41;+78700,;52~INDENT
801.41;+78700,;100~NATIONAL
801.412;+78701,+78700,;.01~10
801.412;+78701,+78700,;2~VA-ONC BRCA ADJ HT POS PRE HER+ OFF PATH TX
801.412;+78702,+78700,;.01~20
801.412;+78702,+78700,;2~VA-ONC BRCA ADJ HT POS PRE HER+ OFF PATH RSN
801.44;+78703,+78700,;.01~06/09/2026@08:52:57
801.44;+78703,+78700,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78701^1
78702^2
78703^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA ADJ HT POS PRE HER+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78699</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>997995256</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78699,;.01~VA-ONC BRCA ADJ HT POS PRE HER+ CLIN TRIAL
801.41;+78699,;4~dialog element
801.41;+78699,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ CLIN TRIAL
801.41;+78699,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78699,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78699,;100~NATIONAL
801.412;+78700,+78699,;.01~5
801.412;+78700,+78699,;2~VA-ONC CLINICAL TRIAL
801.412;+78700,+78699,;9~YES
801.44;+78701,+78699,;.01~06/09/2026@08:52:57
801.44;+78701,+78699,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78700^1
78701^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT PRE HER2+ YES TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73870</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>364059239</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73870,;.01~VA-GP ONC BRCA HT PRE HER2+ YES TX
801.41;+73870,;4~dialog group
801.41;+73870,;7~2
801.41;+73870,;15~HF.VA-ONC BRCA ADJ HT FEMALE NODE+ PRE MP HER2+ OS+ANA+TAM
801.41;+73870,;25~WP-start~2
Ovarian Suppression (OS) and Anastrozole (Years 1-5); then Tamoxifen
(Years 6-8)
801.41;+73870,;35~WP-start~2
Veteran has elected to pursue TREATMENT with OVARIAN SUPPRESSION (OS) and
ANASTROZOLE during years 1-5; then TAMOXIFEN during years 6-8.
801.41;+73870,;100~NATIONAL
801.44;+73871,+73870,;.01~06/09/2026@08:52:57
801.44;+73871,+73870,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73871^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA AHT FEMALE PRE HER+ YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73868</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2748760247</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73868,;.01~VA-GP ONC BRCA AHT FEMALE PRE HER+ YES
801.41;+73868,;4~dialog group
801.41;+73868,;6~YES
801.41;+73868,;7~2
801.41;+73868,;9~ONE SELECTION ONLY
801.41;+73868,;25~WP-start~1
HER2+:
801.41;+73868,;100~NATIONAL
801.412;+73869,+73868,;.01~10
801.412;+73869,+73868,;2~VA-GP ONC BRCA HT PRE HER2+ YES TX
801.412;+73870,+73868,;.01~5
801.412;+73870,+73868,;2~VA-ONC BRCA ADJ HT POS PRE HER+ CLIN TRIAL
801.412;+73871,+73868,;.01~20
801.412;+73871,+73868,;2~VA-GP ONC BRCA ADJ HT POS PRE HER+ OFF PTHWY
801.44;+73872,+73868,;.01~06/09/2026@08:52:57
801.44;+73872,+73868,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73869^1
73870^2
73871^3
73872^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ FEMALE PRE TUMOR YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73864</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1554746863</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73864,;.01~VA-GP ONC BRCA HT NODE+ FEMALE PRE TUMOR YES
801.41;+73864,;4~dialog group
801.41;+73864,;7~2
801.41;+73864,;9~ONE SELECTION ONLY
801.41;+73864,;25~WP-start~1
Tumor 5cm or more or Histologic Grade 3:
801.41;+73864,;100~NATIONAL
801.412;+73865,+73864,;.01~20
801.412;+73865,+73864,;2~VA-GP ONC BRCA AHT FEMALE PRE HER+ YES
801.412;+73866,+73864,;.01~40
801.412;+73866,+73864,;2~VA-GP ONC BRCA AHT FEMALE PRE HER+ NO
801.44;+73867,+73864,;.01~06/09/2026@08:52:57
801.44;+73867,+73864,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73865^1
73866^2
73867^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ YES PRE-MP</POINT_01>
<INTERNAL_ENTRY_NUMBER>73862</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3187653076</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73862,;.01~VA-GP ONC BRCA HT NODE+ YES PRE-MP
801.41;+73862,;4~dialog group
801.41;+73862,;6~YES
801.41;+73862,;7~2
801.41;+73862,;9~ONE SELECTION ONLY
801.41;+73862,;25~WP-start~1
Pre-menopause:
801.41;+73862,;100~NATIONAL
801.412;+73863,+73862,;.01~10
801.412;+73863,+73862,;2~VA-GP ONC BRCA HT NODE+ FEMALE PRE TUMOR YES
801.412;+73864,+73862,;.01~20
801.412;+73864,+73862,;2~VA-GP ONC BRCA HT NODE+ FEMALE PRE TUMOR NO
801.44;+73865,+73862,;.01~06/09/2026@08:52:57
801.44;+73865,+73862,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73863^1
73864^2
73865^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ MP SUBMAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>93075</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>153306170</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+93075,;.01~VA-GP ONC BRCA HT NODE+ MP SUBMAIN
801.41;+93075,;4~dialog group
801.41;+93075,;6~YES
801.41;+93075,;9~ONE SELECTION ONLY
801.41;+93075,;51~SUPPRESS
801.41;+93075,;100~NATIONAL
801.412;+93076,+93075,;.01~20
801.412;+93076,+93075,;2~VA-GP ONC BRCA HT NODE+ YES PRE-MP
801.412;+93077,+93075,;.01~40
801.412;+93077,+93075,;2~VA-GP ONC BRCA HT NODE+ YES POST-MP
801.44;+93078,+93075,;.01~06/09/2026@08:52:57
801.44;+93078,+93075,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
93076^1
93077^2
93078^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ YES MP FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73861</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3249584889</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73861,;.01~VA-GP ONC BRCA HT NODE+ YES MP FN
801.41;+73861,;4~dialog group
801.41;+73861,;7~2
801.41;+73861,;23~YES
801.41;+73861,;25~WP-start~6
++ Menopausal defined as patient that is greater than or equal to 
60 years of\\   age; greater than or equal to 1 year amenorrhea (not
medically induced);\\   history of Bilateral Salpingo-Oophorect (BSO); or
confirmed with labs.\\   IF POST-MENOPAUSAL patient, Zolendronic Acid
every 6 months for 3 years. ++\\   
   =======================================================================
801.41;+73861,;51~SUPPRESS
801.41;+73861,;52~INDENT
801.41;+73861,;100~NATIONAL
801.412;+73862,+73861,;.01~5
801.412;+73862,+73861,;2~VA-ONC BRCA ANAS+TAMOX FOOTNOTE
801.412;+73863,+73861,;.01~15
801.412;+73863,+73861,;2~VA-GP ONC BRCA HT NODE+ MP SUBMAIN
801.44;+73864,+73861,;.01~06/09/2026@08:52:57
801.44;+73864,+73861,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73862^3
73863^4
73864^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA HT NODE+ MP STATUS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73860</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3503300290</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73860,;.01~VA-GP ONC BRCA HT NODE+ MP STATUS
801.41;+73860,;4~dialog group
801.41;+73860,;9~ONE SELECTION ONLY
801.41;+73860,;25~WP-start~1
Menopause Status at Diagnosis:
801.41;+73860,;51~SUPPRESS
801.41;+73860,;100~NATIONAL
801.412;+73861,+73860,;.01~20
801.412;+73861,+73860,;2~VA-GP ONC BRCA HT NODE+ YES MP FN
801.44;+73862,+73860,;.01~06/09/2026@08:52:57
801.44;+73862,+73860,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73861^1
73862^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ YES FEMALE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73859</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>936316772</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73859,;.01~VA-GP ONC BRCA ADJ HT NODE+ YES FEMALE
801.41;+73859,;4~dialog group
801.41;+73859,;6~YES
801.41;+73859,;25~WP-start~1
Female:
801.41;+73859,;51~SUPPRESS
801.41;+73859,;100~NATIONAL
801.41143;+73860,+73859,;.01~1
801.41143;+73860,+73859,;1~RT.VA-ONC BRCA MALE RT
801.41143;+73860,+73859,;2~TRUE
801.41143;+73860,+73859,;3~REPLACE
801.41143;+73860,+73859,;4~VA-GP ONC BRCA ADJ HT NODE+ MALE
801.412;+73861,+73859,;.01~20
801.412;+73861,+73859,;2~VA-GP ONC BRCA HT NODE+ MP STATUS
801.44;+73862,+73859,;.01~06/09/2026@08:52:57
801.44;+73862,+73859,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73860^1
73861^1
73862^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE+ YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73844</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2274372469</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73844,;.01~VA-GP ONC BRCA ADJ HT NODE+ YES
801.41;+73844,;4~dialog group
801.41;+73844,;7~2
801.41;+73844,;25~WP-start~1
Yes:
801.41;+73844,;52~INDENT
801.41;+73844,;100~NATIONAL
801.412;+73845,+73844,;.01~10
801.412;+73845,+73844,;2~VA-GP ONC BRCA ADJ HT NODE+ YES FEMALE
801.44;+73846,+73844,;.01~06/09/2026@08:52:57
801.44;+73846,+73844,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73845^1
73846^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA ADJ HT NODE MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>79424</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3714730548</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79424,;.01~VA-GP ONC BRCA ADJ HT NODE MAIN
801.41;+79424,;4~dialog group
801.41;+79424,;6~YES
801.41;+79424,;7~2
801.41;+79424,;9~ONE SELECTION ONLY
801.41;+79424,;25~WP-start~2
Node positive, histologic Grade 3, tumor greater than or equal to 2cm, or 
received chemotherapy?
801.41;+79424,;51~SUPPRESS
801.41;+79424,;52~INDENT
801.41;+79424,;100~NATIONAL
801.412;+79425,+79424,;.01~20
801.412;+79425,+79424,;2~VA-GP ONC BRCA ADJ HT NODE+ YES
801.412;+79426,+79424,;.01~40
801.412;+79426,+79424,;2~VA-GP ONC BRCA ADJ HT NODE+ NO MAIN
801.44;+79427,+79424,;.01~06/09/2026@08:52:57
801.44;+79427,+79424,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79425^1
79426^2
79427^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA ADJ HT ER+/PR+/HER2 ANY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73815</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>286976275</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73815,;.01~VA-GP ONC BREAST CA ADJ HT ER+/PR+/HER2 ANY
801.41;+73815,;4~dialog group
801.41;+73815,;7~2
801.41;+73815,;15~HF.VA-ONC BRCA ADJ HORMONE TX CLINICAL PATHWAY
801.41;+73815,;25~WP-start~1
Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any:
801.41;+73815,;35~WP-start~1
\\Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any:
801.41;+73815,;52~INDENT
801.41;+73815,;100~NATIONAL
801.412;+73816,+73815,;.01~20
801.412;+73816,+73815,;2~VA-GP ONC BRCA ADJ HT NODE MAIN
801.44;+73817,+73815,;.01~06/09/2026@08:52:57
801.44;+73817,+73815,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73816^1
73817^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC &gt;T3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78967</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2368471253</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78967,;.01~VA-ONC BRCA LRM AFT NO BC >T3 CLIN TRIAL
801.41;+78967,;4~dialog element
801.41;+78967,;15~HF.VA-ONC BRCA LRM AFTER NOT BC NEG MARG CLIN TRIAL
801.41;+78967,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78967,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78967,;100~NATIONAL
801.412;+78968,+78967,;.01~5
801.412;+78968,+78967,;2~VA-ONC CLINICAL TRIAL
801.412;+78968,+78967,;9~YES
801.44;+78969,+78967,;.01~06/09/2026@08:52:57
801.44;+78969,+78967,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78968^1
78969^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC &gt;T3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78970</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4075801294</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78970,;.01~VA-ONC BRCA LRM AFT NO BC >T3 OFF PATH RSN
801.41;+78970,;4~dialog element
801.41;+78970,;15~HF.VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH RSN
801.41;+78970,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78970,;51~SUPPRESS
801.41;+78970,;100~NATIONAL
801.412;+78971,+78970,;.01~5
801.412;+78971,+78970,;2~VA-ONC OFF PATHWAY
801.412;+78971,+78970,;7~YES
801.412;+78971,+78970,;9~YES
801.44;+78972,+78970,;.01~06/09/2026@08:52:57
801.44;+78972,+78970,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78971^1
78972^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC &gt;T3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78969</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>59280893</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78969,;.01~VA-ONC BRCA LRM AFT NO BC >T3 OFF PATH TX
801.41;+78969,;4~dialog element
801.41;+78969,;15~HF.VA-ONC BRCA LRM AFTER NOT BC NEG MARG OFF PATH TX
801.41;+78969,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78969,;51~SUPPRESS
801.41;+78969,;100~NATIONAL
801.412;+78970,+78969,;.01~5
801.412;+78970,+78969,;2~VA-ONC BLANK
801.412;+78970,+78969,;7~YES
801.412;+78970,+78969,;9~YES
801.44;+78971,+78969,;.01~06/09/2026@08:52:57
801.44;+78971,+78969,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78970^1
78971^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT NO BC &gt;T3 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78968</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2016908876</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78968,;.01~VA-GP ONC BRCA LRM AFT NO BC >T3 OFF PTHWY
801.41;+78968,;4~dialog group
801.41;+78968,;6~YES
801.41;+78968,;7~2
801.41;+78968,;23~YES
801.41;+78968,;25~WP-start~1
Off pathway:
801.41;+78968,;52~INDENT
801.41;+78968,;100~NATIONAL
801.412;+78969,+78968,;.01~10
801.412;+78969,+78968,;2~VA-ONC BRCA LRM AFT NO BC >T3 OFF PATH TX
801.412;+78970,+78968,;.01~20
801.412;+78970,+78968,;2~VA-ONC BRCA LRM AFT NO BC >T3 OFF PATH RSN
801.44;+78971,+78968,;.01~06/09/2026@08:52:57
801.44;+78971,+78968,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78969^1
78970^2
78971^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER T3 RAD+PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73323</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2265694084</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73323,;.01~VA-GP ONC BRCA LRM AFTER T3 RAD+PTHWY
801.41;+73323,;4~dialog group
801.41;+73323,;15~HF.VA-ONC BRCA LRM AFTER NOT BC NEG MARG RAD+I-III PTHWY
801.41;+73323,;25~WP-start~1
Radiation then Follow appropriate Stage I-III Pathway
801.41;+73323,;35~WP-start~2
Veteran has elected to pursue TREATMENT with RADIATION and then FOLLOW the
Appropriate Stage I-III PATHWAY.
801.41;+73323,;100~NATIONAL
801.412;+73324,+73323,;.01~10
801.412;+73324,+73323,;2~VA-ONC RADIATION ONCOLOGY CONSULT
801.44;+73325,+73323,;.01~06/09/2026@08:52:57
801.44;+73325,+73323,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73324^1
73325^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER T3 NI GREATER</POINT_01>
<INTERNAL_ENTRY_NUMBER>73319</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2975332207</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73319,;.01~VA-GP ONC BRCA LRM AFTER T3 NI GREATER
801.41;+73319,;4~dialog group
801.41;+73319,;6~YES
801.41;+73319,;7~2
801.41;+73319,;9~ONE SELECTION ONLY
801.41;+73319,;25~WP-start~1
N1 or more OR T3 or more:
801.41;+73319,;51~SUPPRESS
801.41;+73319,;100~NATIONAL
801.412;+73320,+73319,;.01~10
801.412;+73320,+73319,;2~VA-GP ONC BRCA LRM AFTER T3 RAD+PTHWY
801.412;+73321,+73319,;.01~30
801.412;+73321,+73319,;2~VA-GP ONC BRCA LRM AFT NO BC >T3 OFF PTHWY
801.412;+73322,+73319,;.01~5
801.412;+73322,+73319,;2~VA-ONC BRCA LRM AFT NO BC >T3 CLIN TRIAL
801.44;+73323,+73319,;.01~06/09/2026@08:52:57
801.44;+73323,+73319,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73320^3
73321^5
73322^6
73323^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER T3 OR N1</POINT_01>
<INTERNAL_ENTRY_NUMBER>73318</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3363260854</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73318,;.01~VA-GP ONC BRCA LRM AFTER T3 OR N1
801.41;+73318,;4~dialog group
801.41;+73318,;23~YES
801.41;+73318,;25~WP-start~1
++ IF LESS than N1 or T3 - Follow appropriate Stage I-III Pathway. ++
801.41;+73318,;51~SUPPRESS
801.41;+73318,;100~NATIONAL
801.412;+73319,+73318,;.01~10
801.412;+73319,+73318,;2~VA-GP ONC BRCA LRM AFTER T3 NI GREATER
801.44;+73320,+73318,;.01~06/09/2026@08:52:57
801.44;+73320,+73318,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73319^3
73320^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER PROCEED TO MARGINS</POINT_01>
<INTERNAL_ENTRY_NUMBER>79953</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1837117461</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+79953,;.01~VA-GP ONC BRCA LRM AFTER PROCEED TO MARGINS
801.41;+79953,;4~dialog group
801.41;+79953,;6~YES
801.41;+79953,;7~2
801.41;+79953,;25~WP-start~1
++ Proceed to Margin Clearance. ++
801.41;+79953,;35~WP-start~1
After Margin Clearance:
801.41;+79953,;51~SUPPRESS
801.41;+79953,;52~INDENT
801.41;+79953,;100~NATIONAL
801.412;+79954,+79953,;.01~10
801.412;+79954,+79953,;2~VA-GP ONC BRCA LRM AFTER T3 OR N1
801.44;+79955,+79953,;.01~06/09/2026@08:52:57
801.44;+79955,+79953,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
79954^1
79955^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER MAST NEG MARGINS NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>38427</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2146359433</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+38427,;.01~VA-GP ONC BRCA LRM AFTER MAST NEG MARGINS NO
801.41;+38427,;4~dialog group
801.41;+38427,;15~HF.VA-ONC BRCA LRM AFTER NOT BC S/P MAST NO NEG MARGIN
801.41;+38427,;25~WP-start~1
Positive Margins:
801.41;+38427,;100~NATIONAL
801.412;+38428,+38427,;.01~10
801.412;+38428,+38427,;2~VA-GP ONC BRCA LRM AFTER PROCEED TO MARGINS
801.44;+38429,+38427,;.01~06/09/2026@08:52:57
801.44;+38429,+38427,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
38428^1
38429^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER MAST NEG MARGINS YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73317</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2915288771</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73317,;.01~VA-GP ONC BRCA LRM AFTER MAST NEG MARGINS YES
801.41;+73317,;4~dialog group
801.41;+73317,;7~2
801.41;+73317,;15~HF.VA-ONC BRCA LRM AFTER NOT BC S/P MAST NEG MARGIN 
801.41;+73317,;25~WP-start~1
Negative Margins (defined as no tumor on ink):
801.41;+73317,;35~WP-start~1
Negative Margins:
801.41;+73317,;100~NATIONAL
801.412;+73318,+73317,;.01~20
801.412;+73318,+73317,;2~VA-GP ONC BRCA LRM AFTER T3 OR N1
801.44;+73319,+73317,;.01~06/09/2026@08:52:57
801.44;+73319,+73317,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73318^1
73319^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER MAST MARGINS MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73315</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2546431405</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73315,;.01~VA-GP ONC BRCA LRM AFTER MAST MARGINS MAIN
801.41;+73315,;4~dialog group
801.41;+73315,;6~YES
801.41;+73315,;7~2
801.41;+73315,;9~ONE SELECTION ONLY
801.41;+73315,;23~YES
801.41;+73315,;25~WP-start~1
Margins AFTER mastectomy and node dissection:
801.41;+73315,;100~NATIONAL
801.412;+73316,+73315,;.01~20
801.412;+73316,+73315,;2~VA-GP ONC BRCA LRM AFTER MAST NEG MARGINS YES
801.412;+73317,+73315,;.01~40
801.412;+73317,+73315,;2~VA-GP ONC BRCA LRM AFTER MAST NEG MARGINS NO
801.44;+73318,+73315,;.01~06/09/2026@08:52:57
801.44;+73318,+73315,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73316^1
73317^2
73318^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78965</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2600224989</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78965,;.01~VA-ONC BRCA LRM AFT NO BC N1 OFF PATH RSN
801.41;+78965,;4~dialog element
801.41;+78965,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH RSN
801.41;+78965,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78965,;51~SUPPRESS
801.41;+78965,;100~NATIONAL
801.412;+78966,+78965,;.01~5
801.412;+78966,+78965,;2~VA-ONC OFF PATHWAY
801.412;+78966,+78965,;7~YES
801.412;+78966,+78965,;9~YES
801.44;+78967,+78965,;.01~06/09/2026@08:52:57
801.44;+78967,+78965,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78966^1
78967^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78964</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2947718991</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78964,;.01~VA-ONC BRCA LRM AFT NO BC N1 OFF PATH TX
801.41;+78964,;4~dialog element
801.41;+78964,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N1 OFF PATH TX
801.41;+78964,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78964,;51~SUPPRESS
801.41;+78964,;100~NATIONAL
801.412;+78965,+78964,;.01~5
801.412;+78965,+78964,;2~VA-ONC BLANK
801.412;+78965,+78964,;7~YES
801.412;+78965,+78964,;9~YES
801.44;+78966,+78964,;.01~06/09/2026@08:52:57
801.44;+78966,+78964,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78965^1
78966^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT NO BC N1 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78963</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1732975097</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78963,;.01~VA-GP ONC BRCA LRM AFT NO BC N1 OFF PTHWY
801.41;+78963,;4~dialog group
801.41;+78963,;6~YES
801.41;+78963,;7~2
801.41;+78963,;23~YES
801.41;+78963,;25~WP-start~1
Off pathway:
801.41;+78963,;52~INDENT
801.41;+78963,;100~NATIONAL
801.412;+78964,+78963,;.01~10
801.412;+78964,+78963,;2~VA-ONC BRCA LRM AFT NO BC N1 OFF PATH TX
801.412;+78965,+78963,;.01~20
801.412;+78965,+78963,;2~VA-ONC BRCA LRM AFT NO BC N1 OFF PATH RSN
801.44;+78966,+78963,;.01~06/09/2026@08:52:57
801.44;+78966,+78963,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78964^1
78965^2
78966^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78962</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2340286772</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78962,;.01~VA-ONC BRCA LRM AFT NO BC N1 CLIN TRIAL
801.41;+78962,;4~dialog element
801.41;+78962,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N1 CLIN TRIAL
801.41;+78962,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78962,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78962,;100~NATIONAL
801.412;+78963,+78962,;.01~5
801.412;+78963,+78962,;2~VA-ONC CLINICAL TRIAL
801.412;+78963,+78962,;9~YES
801.44;+78964,+78962,;.01~06/09/2026@08:52:57
801.44;+78964,+78962,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78963^1
78964^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER N1 MRM</POINT_01>
<INTERNAL_ENTRY_NUMBER>73313</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>11526758</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73313,;.01~VA-ONC BRCA LRM AFTER N1 MRM
801.41;+73313,;4~dialog element
801.41;+73313,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N1 MRM
801.41;+73313,;25~WP-start~2
Modified radical mastectomy (MRM)\\
++ MRM includes axillary dissection. ++
801.41;+73313,;35~WP-start~1
Veteran has elected to pursue MODIFIED RADICAL MASTECTOMY.
801.41;+73313,;100~NATIONAL
801.44;+73314,+73313,;.01~06/09/2026@08:52:57
801.44;+73314,+73313,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73314^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER CONSERVE NO N1</POINT_01>
<INTERNAL_ENTRY_NUMBER>73312</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1381226929</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73312,;.01~VA-GP ONC BRCA LRM AFTER CONSERVE NO N1
801.41;+73312,;4~dialog group
801.41;+73312,;6~YES
801.41;+73312,;7~2
801.41;+73312,;9~ONE SELECTION ONLY
801.41;+73312,;25~WP-start~1
Nodal Status, N1:
801.41;+73312,;100~NATIONAL
801.412;+73313,+73312,;.01~10
801.412;+73313,+73312,;2~VA-ONC BRCA LRM AFTER N1 MRM
801.412;+73314,+73312,;.01~5
801.412;+73314,+73312,;2~VA-ONC BRCA LRM AFT NO BC N1 CLIN TRIAL
801.412;+73315,+73312,;.01~20
801.412;+73315,+73312,;2~VA-GP ONC BRCA LRM AFT NO BC N1 OFF PTHWY
801.44;+73316,+73312,;.01~06/09/2026@08:52:57
801.44;+73316,+73312,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73313^1
73314^2
73315^3
73316^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78959</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3068242959</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78959,;.01~VA-ONC BRCA LRM AFT NO BC N0 OFF PATH RSN
801.41;+78959,;4~dialog element
801.41;+78959,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH RSN
801.41;+78959,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78959,;51~SUPPRESS
801.41;+78959,;100~NATIONAL
801.412;+78960,+78959,;.01~5
801.412;+78960,+78959,;2~VA-ONC OFF PATHWAY
801.412;+78960,+78959,;7~YES
801.412;+78960,+78959,;9~YES
801.44;+78961,+78959,;.01~06/09/2026@08:52:57
801.44;+78961,+78959,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78960^1
78961^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78958</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1682222320</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78958,;.01~VA-ONC BRCA LRM AFT NO BC N0 OFF PATH TX
801.41;+78958,;4~dialog element
801.41;+78958,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 OFF PATH TX
801.41;+78958,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78958,;51~SUPPRESS
801.41;+78958,;100~NATIONAL
801.412;+78959,+78958,;.01~5
801.412;+78959,+78958,;2~VA-ONC BLANK
801.412;+78959,+78958,;7~YES
801.412;+78959,+78958,;9~YES
801.44;+78960,+78958,;.01~06/09/2026@08:52:57
801.44;+78960,+78958,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78959^1
78960^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT NO BC N0 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78957</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2013245906</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78957,;.01~VA-GP ONC BRCA LRM AFT NO BC N0 OFF PTHWY
801.41;+78957,;4~dialog group
801.41;+78957,;6~YES
801.41;+78957,;7~2
801.41;+78957,;23~YES
801.41;+78957,;25~WP-start~1
Off pathway:
801.41;+78957,;52~INDENT
801.41;+78957,;100~NATIONAL
801.412;+78958,+78957,;.01~10
801.412;+78958,+78957,;2~VA-ONC BRCA LRM AFT NO BC N0 OFF PATH TX
801.412;+78959,+78957,;.01~20
801.412;+78959,+78957,;2~VA-ONC BRCA LRM AFT NO BC N0 OFF PATH RSN
801.44;+78960,+78957,;.01~06/09/2026@08:52:57
801.44;+78960,+78957,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78958^1
78959^2
78960^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78956</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3542908846</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78956,;.01~VA-ONC BRCA LRM AFT NO BC N0 CLIN TRIAL
801.41;+78956,;4~dialog element
801.41;+78956,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 CLIN TRIAL
801.41;+78956,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78956,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78956,;100~NATIONAL
801.412;+78957,+78956,;.01~5
801.412;+78957,+78956,;2~VA-ONC CLINICAL TRIAL
801.412;+78957,+78956,;9~YES
801.44;+78958,+78956,;.01~06/09/2026@08:52:57
801.44;+78958,+78956,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78957^1
78958^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N0 POS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78982</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2303374840</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78982,;.01~VA-ONC BRCA LRM AFT NO BC N0 POS OFF PATH RSN
801.41;+78982,;4~dialog element
801.41;+78982,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ OFF PATH RSN
801.41;+78982,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78982,;51~SUPPRESS
801.41;+78982,;100~NATIONAL
801.412;+78983,+78982,;.01~5
801.412;+78983,+78982,;2~VA-ONC OFF PATHWAY
801.412;+78983,+78982,;7~YES
801.412;+78983,+78982,;9~YES
801.44;+78984,+78982,;.01~06/09/2026@08:52:57
801.44;+78984,+78982,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78983^1
78984^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N0 POS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78980</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3601950760</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78980,;.01~VA-ONC BRCA LRM AFT NO BC N0 POS OFF PATH TX
801.41;+78980,;4~dialog element
801.41;+78980,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ OFF PATH TX
801.41;+78980,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78980,;51~SUPPRESS
801.41;+78980,;100~NATIONAL
801.412;+78981,+78980,;.01~5
801.412;+78981,+78980,;2~VA-ONC BLANK
801.412;+78981,+78980,;7~YES
801.412;+78981,+78980,;9~YES
801.44;+78982,+78980,;.01~06/09/2026@08:52:57
801.44;+78982,+78980,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78981^1
78982^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT NO BC N0 POS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78979</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2587779053</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78979,;.01~VA-GP ONC BRCA LRM AFT NO BC N0 POS OFF PTHWY
801.41;+78979,;4~dialog group
801.41;+78979,;6~YES
801.41;+78979,;7~2
801.41;+78979,;23~YES
801.41;+78979,;25~WP-start~1
Off pathway:
801.41;+78979,;52~INDENT
801.41;+78979,;100~NATIONAL
801.412;+78980,+78979,;.01~10
801.412;+78980,+78979,;2~VA-ONC BRCA LRM AFT NO BC N0 POS OFF PATH TX
801.412;+78981,+78979,;.01~20
801.412;+78981,+78979,;2~VA-ONC BRCA LRM AFT NO BC N0 POS OFF PATH RSN
801.44;+78982,+78979,;.01~06/09/2026@08:52:57
801.44;+78982,+78979,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78980^1
78981^2
78982^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT NO BC N0 POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78978</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1098747272</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78978,;.01~VA-ONC BRCA LRM AFT NO BC N0 POS CLIN TRIAL
801.41;+78978,;4~dialog element
801.41;+78978,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ CLIN TRIAL
801.41;+78978,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78978,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78978,;100~NATIONAL
801.412;+78979,+78978,;.01~5
801.412;+78979,+78978,;2~VA-ONC CLINICAL TRIAL
801.412;+78979,+78978,;9~YES
801.44;+78980,+78978,;.01~06/09/2026@08:52:57
801.44;+78980,+78978,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78979^1
78980^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTR ADJ MAST AX DISSECT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73310</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2104022956</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73310,;.01~VA-ONC BRCA LRM AFTR ADJ MAST AX DISSECT
801.41;+73310,;4~dialog element
801.41;+73310,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 > NODE+ AX DISSECT
801.41;+73310,;25~WP-start~1
Axillary dissection
801.41;+73310,;35~WP-start~1
Veteran has elected to pursue AXILLARY DISSECTION.
801.41;+73310,;100~NATIONAL
801.44;+73311,+73310,;.01~06/09/2026@08:52:57
801.44;+73311,+73310,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73311^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ MAST POS YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73309</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2262728901</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73309,;.01~VA-GP ONC BRCA LRM AFTER ADJ MAST POS YES
801.41;+73309,;4~dialog group
801.41;+73309,;6~YES
801.41;+73309,;7~2
801.41;+73309,;9~ONE SELECTION ONLY
801.41;+73309,;25~WP-start~1
1 or more node positive:
801.41;+73309,;51~SUPPRESS
801.41;+73309,;100~NATIONAL
801.412;+73310,+73309,;.01~10
801.412;+73310,+73309,;2~VA-ONC BRCA LRM AFTR ADJ MAST AX DISSECT
801.412;+73311,+73309,;.01~5
801.412;+73311,+73309,;2~VA-ONC BRCA LRM AFT NO BC N0 POS CLIN TRIAL
801.412;+73312,+73309,;.01~20
801.412;+73312,+73309,;2~VA-GP ONC BRCA LRM AFT NO BC N0 POS OFF PTHWY
801.44;+73313,+73309,;.01~06/09/2026@08:52:57
801.44;+73313,+73309,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73310^1
73311^2
73312^3
73313^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ MAST+SENT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73308</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2495210453</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73308,;.01~VA-GP ONC BRCA LRM AFTER ADJ MAST+SENT
801.41;+73308,;4~dialog group
801.41;+73308,;6~YES
801.41;+73308,;7~2
801.41;+73308,;9~NONE OR ONE SELECTION
801.41;+73308,;15~HF.VA-ONC BRCA LRM AFTER NOT BC N0 MAST+NODE BX
801.41;+73308,;25~WP-start~2
Mastectomy with sentinel node biopsy:\\
++ IF LESS than 1 node positive, proceed to negative margins option. ++
801.41;+73308,;35~WP-start~1
Mastectomy with sentinel node biopsy:
801.41;+73308,;100~NATIONAL
801.412;+73309,+73308,;.01~10
801.412;+73309,+73308,;2~VA-GP ONC BRCA LRM AFTER ADJ MAST POS YES
801.44;+73310,+73308,;.01~06/09/2026@08:52:57
801.44;+73310,+73308,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73309^1
73310^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER CONSERVE NO N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73306</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2195856833</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73306,;.01~VA-GP ONC BRCA LRM AFTER CONSERVE NO N0
801.41;+73306,;4~dialog group
801.41;+73306,;6~YES
801.41;+73306,;7~2
801.41;+73306,;9~ONE SELECTION ONLY
801.41;+73306,;25~WP-start~1
Nodal Status N0:
801.41;+73306,;52~INDENT
801.41;+73306,;100~NATIONAL
801.412;+73307,+73306,;.01~10
801.412;+73307,+73306,;2~VA-GP ONC BRCA LRM AFTER ADJ MAST+SENT
801.412;+73308,+73306,;.01~5
801.412;+73308,+73306,;2~VA-ONC BRCA LRM AFT NO BC N0 CLIN TRIAL
801.412;+73309,+73306,;.01~20
801.412;+73309,+73306,;2~VA-GP ONC BRCA LRM AFT NO BC N0 OFF PTHWY
801.44;+73310,+73306,;.01~06/09/2026@08:52:57
801.44;+73310,+73306,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73307^1
73308^2
73309^3
73310^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ CONSERVE NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73245</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1775795215</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73245,;.01~VA-GP ONC BRCA LRM AFTER ADJ CONSERVE NO
801.41;+73245,;4~dialog group
801.41;+73245,;6~YES
801.41;+73245,;7~2
801.41;+73245,;9~ONE SELECTION ONLY
801.41;+73245,;25~WP-start~1
Not a candidate for breast conservation:
801.41;+73245,;52~INDENT
801.41;+73245,;100~NATIONAL
801.412;+73246,+73245,;.01~10
801.412;+73246,+73245,;2~VA-GP ONC BRCA LRM AFTER CONSERVE NO N0
801.412;+73247,+73245,;.01~20
801.412;+73247,+73245,;2~VA-GP ONC BRCA LRM AFTER CONSERVE NO N1
801.412;+73248,+73245,;.01~30
801.412;+73248,+73245,;2~VA-GP ONC BRCA LRM AFTER MAST MARGINS MAIN
801.44;+73249,+73245,;.01~06/09/2026@08:52:57
801.44;+73249,+73245,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73246^1
73247^2
73248^3
73249^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78951</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2970165019</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78951,;.01~VA-ONC BRCA LRM AFT BC NEG MARG OFF PATH RSN
801.41;+78951,;4~dialog element
801.41;+78951,;15~HF.VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH RSN
801.41;+78951,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78951,;51~SUPPRESS
801.41;+78951,;100~NATIONAL
801.412;+78952,+78951,;.01~5
801.412;+78952,+78951,;2~VA-ONC OFF PATHWAY
801.412;+78952,+78951,;7~YES
801.412;+78952,+78951,;9~YES
801.44;+78953,+78951,;.01~06/09/2026@08:52:57
801.44;+78953,+78951,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78952^1
78953^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78950</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1097925271</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78950,;.01~VA-ONC BRCA LRM AFT BC NEG MARG OFF PATH TX
801.41;+78950,;4~dialog element
801.41;+78950,;15~HF.VA-ONC BRCA LRM AFTER BC NEG MARG OFF PATH TX
801.41;+78950,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78950,;51~SUPPRESS
801.41;+78950,;100~NATIONAL
801.412;+78951,+78950,;.01~5
801.412;+78951,+78950,;2~VA-ONC BLANK
801.412;+78951,+78950,;7~YES
801.412;+78951,+78950,;9~YES
801.44;+78952,+78950,;.01~06/09/2026@08:52:57
801.44;+78952,+78950,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78951^1
78952^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT BC NEG MARG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78949</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3137081257</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78949,;.01~VA-GP ONC BRCA LRM AFT BC NEG MARG OFF PTHWY
801.41;+78949,;4~dialog group
801.41;+78949,;6~YES
801.41;+78949,;7~2
801.41;+78949,;23~YES
801.41;+78949,;25~WP-start~1
Off pathway:
801.41;+78949,;52~INDENT
801.41;+78949,;100~NATIONAL
801.412;+78950,+78949,;.01~10
801.412;+78950,+78949,;2~VA-ONC BRCA LRM AFT BC NEG MARG OFF PATH TX
801.412;+78951,+78949,;.01~20
801.412;+78951,+78949,;2~VA-ONC BRCA LRM AFT BC NEG MARG OFF PATH RSN
801.44;+78952,+78949,;.01~06/09/2026@08:52:57
801.44;+78952,+78949,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78950^1
78951^2
78952^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78948</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3736523782</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78948,;.01~VA-ONC BRCA LRM AFT BC NEG MARG CLIN TRIAL
801.41;+78948,;4~dialog element
801.41;+78948,;15~HF.VA-ONC BRCA LRM AFTER BC NEG MARG CLIN TRIAL
801.41;+78948,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78948,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78948,;100~NATIONAL
801.412;+78949,+78948,;.01~5
801.412;+78949,+78948,;2~VA-ONC CLINICAL TRIAL
801.412;+78949,+78948,;9~YES
801.44;+78950,+78948,;.01~06/09/2026@08:52:57
801.44;+78950,+78948,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78949^1
78950^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER NEG MARG FOLLOW PTHWY+RAD</POINT_01>
<INTERNAL_ENTRY_NUMBER>73277</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1950868606</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73277,;.01~VA-GP ONC BRCA LRM AFTER NEG MARG FOLLOW PTHWY+RAD
801.41;+73277,;4~dialog group
801.41;+73277,;7~2
801.41;+73277,;15~HF.VA-ONC BRCA LRM AFTER BC NEG MARG RAD+I-III PTHWY
801.41;+73277,;25~WP-start~1
Radiation then Follow appropriate Stage I-III Pathway
801.41;+73277,;35~WP-start~2
Veteran has elected to pursue TREATMENT with RADIATION and then FOLLOW the
Appropriate STAGE I-III PATHWAY.
801.41;+73277,;100~NATIONAL
801.412;+73278,+73277,;.01~10
801.412;+73278,+73277,;2~VA-ONC RADIATION ONCOLOGY CONSULT
801.44;+73279,+73277,;.01~06/09/2026@08:52:57
801.44;+73279,+73277,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73278^1
73279^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER NEG MARGINS YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73276</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>57377380</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73276,;.01~VA-GP ONC BRCA LRM AFTER NEG MARGINS YES
801.41;+73276,;4~dialog group
801.41;+73276,;6~YES
801.41;+73276,;7~2
801.41;+73276,;9~NONE OR ONE SELECTION
801.41;+73276,;25~WP-start~1
Negative Margins (defined as no tumor on ink):
801.41;+73276,;35~WP-start~1
Negative Margins:
801.41;+73276,;100~NATIONAL
801.412;+73277,+73276,;.01~10
801.412;+73277,+73276,;2~VA-GP ONC BRCA LRM AFTER NEG MARG FOLLOW PTHWY+RAD
801.412;+73278,+73276,;.01~5
801.412;+73278,+73276,;2~VA-ONC BRCA LRM AFT BC NEG MARG CLIN TRIAL
801.412;+73279,+73276,;.01~30
801.412;+73279,+73276,;2~VA-GP ONC BRCA LRM AFT BC NEG MARG OFF PTHWY
801.44;+73280,+73276,;.01~06/09/2026@08:52:57
801.44;+73280,+73276,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73277^1
73278^3
73279^4
73280^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC POS MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78954</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1449979248</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78954,;.01~VA-ONC BRCA LRM AFT BC POS MARG OFF PATH RSN
801.41;+78954,;4~dialog element
801.41;+78954,;15~HF.VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH RSN
801.41;+78954,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78954,;51~SUPPRESS
801.41;+78954,;100~NATIONAL
801.412;+78955,+78954,;.01~5
801.412;+78955,+78954,;2~VA-ONC OFF PATHWAY
801.412;+78955,+78954,;7~YES
801.412;+78955,+78954,;9~YES
801.44;+78956,+78954,;.01~06/09/2026@08:52:57
801.44;+78956,+78954,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78955^1
78956^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC POS MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78953</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2021321760</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78953,;.01~VA-ONC BRCA LRM AFT BC POS MARG OFF PATH TX
801.41;+78953,;4~dialog element
801.41;+78953,;15~HF.VA-ONC BRCA LRM AFTER BC NO NEG MARG OFF PATH TX
801.41;+78953,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78953,;51~SUPPRESS
801.41;+78953,;100~NATIONAL
801.412;+78954,+78953,;.01~5
801.412;+78954,+78953,;2~VA-ONC BLANK
801.412;+78954,+78953,;7~YES
801.412;+78954,+78953,;9~YES
801.44;+78955,+78953,;.01~06/09/2026@08:52:57
801.44;+78955,+78953,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78954^1
78955^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA AFT BC POS MARG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78952</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4114250324</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78952,;.01~VA-GP ONC BRCA AFT BC POS MARG OFF PTHWY
801.41;+78952,;4~dialog group
801.41;+78952,;6~YES
801.41;+78952,;7~2
801.41;+78952,;23~YES
801.41;+78952,;25~WP-start~1
Off pathway:
801.41;+78952,;52~INDENT
801.41;+78952,;100~NATIONAL
801.412;+78953,+78952,;.01~10
801.412;+78953,+78952,;2~VA-ONC BRCA LRM AFT BC POS MARG OFF PATH TX
801.412;+78954,+78952,;.01~20
801.412;+78954,+78952,;2~VA-ONC BRCA LRM AFT BC POS MARG OFF PATH RSN
801.44;+78955,+78952,;.01~06/09/2026@08:52:57
801.44;+78955,+78952,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78953^1
78954^2
78955^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC POS MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78955</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1291951212</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78955,;.01~VA-ONC BRCA LRM AFT BC POS MARG CLIN TRIAL
801.41;+78955,;4~dialog element
801.41;+78955,;15~HF.VA-ONC BRCA LRM AFTER BC NO NEG MARG CLIN TRIAL
801.41;+78955,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78955,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78955,;100~NATIONAL
801.412;+78956,+78955,;.01~5
801.412;+78956,+78955,;2~VA-ONC CLINICAL TRIAL
801.412;+78956,+78955,;9~YES
801.44;+78957,+78955,;.01~06/09/2026@08:52:57
801.44;+78957,+78955,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78956^1
78957^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER NEG MARGIN CLEARANCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73280</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>132493908</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73280,;.01~VA-ONC BRCA LRM AFTER NEG MARGIN CLEARANCE
801.41;+73280,;4~dialog element
801.41;+73280,;15~HF.VA-ONC BRCA LRM AFTER BC NO NEG MARG CLEAR+RAD+I-III PTHWY
801.41;+73280,;25~WP-start~2
Margin clearance followed by radiation; then Follow appropriate Stage
I-III Pathway
801.41;+73280,;35~WP-start~2
Veteran has elected to pursue MARGIN CLEARANCE followed by RADIATION and
then FOLLOW the Appropriate Stage I-III PATHWAY.
801.41;+73280,;100~NATIONAL
801.44;+73281,+73280,;.01~06/09/2026@08:52:57
801.44;+73281,+73280,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73281^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER NEG MARGINS NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73279</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2856999484</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73279,;.01~VA-GP ONC BRCA LRM AFTER NEG MARGINS NO
801.41;+73279,;4~dialog group
801.41;+73279,;6~YES
801.41;+73279,;7~2
801.41;+73279,;9~ONE SELECTION ONLY
801.41;+73279,;25~WP-start~1
Positive Margins:
801.41;+73279,;100~NATIONAL
801.412;+73280,+73279,;.01~10
801.412;+73280,+73279,;2~VA-ONC BRCA LRM AFTER NEG MARGIN CLEARANCE
801.412;+73281,+73279,;.01~5
801.412;+73281,+73279,;2~VA-ONC BRCA LRM AFT BC POS MARG CLIN TRIAL
801.412;+73282,+73279,;.01~20
801.412;+73282,+73279,;2~VA-GP ONC BRCA AFT BC POS MARG OFF PTHWY
801.44;+73283,+73279,;.01~06/09/2026@08:52:57
801.44;+73283,+73279,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73280^1
73281^2
73282^3
73283^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER LUMP+AX MARGINS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73275</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2480813010</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73275,;.01~VA-GP ONC BRCA LRM AFTER LUMP+AX MARGINS
801.41;+73275,;4~dialog group
801.41;+73275,;6~YES
801.41;+73275,;7~2
801.41;+73275,;9~ONE SELECTION ONLY
801.41;+73275,;23~YES
801.41;+73275,;25~WP-start~1
Margins AFTER lumpectomy and node dissection:
801.41;+73275,;100~NATIONAL
801.412;+73276,+73275,;.01~30
801.412;+73276,+73275,;2~VA-GP ONC BRCA LRM AFTER NEG MARGINS NO
801.412;+73277,+73275,;.01~20
801.412;+73277,+73275,;2~VA-GP ONC BRCA LRM AFTER NEG MARGINS YES
801.44;+73278,+73275,;.01~06/09/2026@08:52:57
801.44;+73278,+73275,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73276^3
73277^4
73278^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78947</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>512596557</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78947,;.01~VA-ONC BRCA LRM AFT BC N1 OFF PATH RSN
801.41;+78947,;4~dialog element
801.41;+78947,;15~HF.VA-ONC BRCA LRM AFTER BC N1 OFF PATH RSN
801.41;+78947,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78947,;51~SUPPRESS
801.41;+78947,;100~NATIONAL
801.412;+78948,+78947,;.01~5
801.412;+78948,+78947,;2~VA-ONC OFF PATHWAY
801.412;+78948,+78947,;7~YES
801.412;+78948,+78947,;9~YES
801.44;+78949,+78947,;.01~06/09/2026@08:52:57
801.44;+78949,+78947,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78948^1
78949^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78946</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2116338417</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78946,;.01~VA-ONC BRCA LRM AFT BC N1 OFF PATH TX
801.41;+78946,;4~dialog element
801.41;+78946,;15~HF.VA-ONC BRCA LRM AFTER BC N1 OFF PATH TX
801.41;+78946,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78946,;51~SUPPRESS
801.41;+78946,;100~NATIONAL
801.412;+78947,+78946,;.01~5
801.412;+78947,+78946,;2~VA-ONC BLANK
801.412;+78947,+78946,;7~YES
801.412;+78947,+78946,;9~YES
801.44;+78948,+78946,;.01~06/09/2026@08:52:57
801.44;+78948,+78946,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78947^1
78948^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT BC N1 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78944</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1232750550</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78944,;.01~VA-GP ONC BRCA LRM AFT BC N1 OFF PTHWY
801.41;+78944,;4~dialog group
801.41;+78944,;6~YES
801.41;+78944,;7~2
801.41;+78944,;23~YES
801.41;+78944,;25~WP-start~1
Off pathway:
801.41;+78944,;52~INDENT
801.41;+78944,;100~NATIONAL
801.412;+78945,+78944,;.01~10
801.412;+78945,+78944,;2~VA-ONC BRCA LRM AFT BC N1 OFF PATH TX
801.412;+78946,+78944,;.01~20
801.412;+78946,+78944,;2~VA-ONC BRCA LRM AFT BC N1 OFF PATH RSN
801.44;+78947,+78944,;.01~06/09/2026@08:52:57
801.44;+78947,+78944,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78945^1
78946^2
78947^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78945</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2335607686</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78945,;.01~VA-ONC BRCA LRM AFT BC N1 CLIN TRIAL
801.41;+78945,;4~dialog element
801.41;+78945,;15~HF.VA-ONC BRCA LRM AFTER BC N1 CLIN TRIAL
801.41;+78945,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78945,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78945,;100~NATIONAL
801.412;+78946,+78945,;.01~5
801.412;+78946,+78945,;2~VA-ONC CLINICAL TRIAL
801.412;+78946,+78945,;9~YES
801.44;+78947,+78945,;.01~06/09/2026@08:52:57
801.44;+78947,+78945,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78946^1
78947^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTER ADJ LUMP+AX NODE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73271</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1810145810</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73271,;.01~VA-ONC BRCA LRM AFTER ADJ LUMP+AX NODE
801.41;+73271,;4~dialog element
801.41;+73271,;15~HF.VA-ONC BRCA LRM AFTER BC N1 LUMP+AX NODE DS
801.41;+73271,;25~WP-start~1
Lumpectomy and axillary node dissection
801.41;+73271,;35~WP-start~1
Veteran has elected to pursue LUMPECTOMY and AXILLARY NODE DISSECTION.
801.41;+73271,;100~NATIONAL
801.44;+73272,+73271,;.01~06/09/2026@08:52:58
801.44;+73272,+73271,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73272^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ NODE N1</POINT_01>
<INTERNAL_ENTRY_NUMBER>73270</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2159339991</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73270,;.01~VA-GP ONC BRCA LRM AFTER ADJ NODE N1
801.41;+73270,;4~dialog group
801.41;+73270,;6~YES
801.41;+73270,;7~2
801.41;+73270,;9~ONE SELECTION ONLY
801.41;+73270,;25~WP-start~1
Nodal Status, N1:
801.41;+73270,;100~NATIONAL
801.412;+73271,+73270,;.01~10
801.412;+73271,+73270,;2~VA-ONC BRCA LRM AFTER ADJ LUMP+AX NODE
801.412;+73272,+73270,;.01~5
801.412;+73272,+73270,;2~VA-ONC BRCA LRM AFT BC N1 CLIN TRIAL
801.412;+73273,+73270,;.01~20
801.412;+73273,+73270,;2~VA-GP ONC BRCA LRM AFT BC N1 OFF PTHWY
801.44;+73274,+73270,;.01~06/09/2026@08:52:58
801.44;+73274,+73270,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73271^1
73272^2
73273^3
73274^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78943</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3913862779</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78943,;.01~VA-ONC BRCA LRM AFT BC N0 OFF PATH RSN
801.41;+78943,;4~dialog element
801.41;+78943,;15~HF.VA-ONC BRCA LRM AFTER BC N0 OFF PATH RSN
801.41;+78943,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78943,;51~SUPPRESS
801.41;+78943,;100~NATIONAL
801.412;+78944,+78943,;.01~5
801.412;+78944,+78943,;2~VA-ONC OFF PATHWAY
801.412;+78944,+78943,;7~YES
801.412;+78944,+78943,;9~YES
801.44;+78945,+78943,;.01~06/09/2026@08:52:58
801.44;+78945,+78943,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78944^1
78945^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78942</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2277008957</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78942,;.01~VA-ONC BRCA LRM AFT BC N0 OFF PATH TX
801.41;+78942,;4~dialog element
801.41;+78942,;15~HF.VA-ONC BRCA LRM AFTER BC N0 OFF PATH TX
801.41;+78942,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78942,;51~SUPPRESS
801.41;+78942,;100~NATIONAL
801.412;+78943,+78942,;.01~5
801.412;+78943,+78942,;2~VA-ONC BLANK
801.412;+78943,+78942,;7~YES
801.412;+78943,+78942,;9~YES
801.44;+78944,+78942,;.01~06/09/2026@08:52:58
801.44;+78944,+78942,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78943^1
78944^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT BC N0 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78941</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>570106120</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78941,;.01~VA-GP ONC BRCA LRM AFT BC N0 OFF PTHWY
801.41;+78941,;4~dialog group
801.41;+78941,;6~YES
801.41;+78941,;7~2
801.41;+78941,;23~YES
801.41;+78941,;25~WP-start~1
Off pathway:
801.41;+78941,;52~INDENT
801.41;+78941,;100~NATIONAL
801.412;+78942,+78941,;.01~10
801.412;+78942,+78941,;2~VA-ONC BRCA LRM AFT BC N0 OFF PATH TX
801.412;+78943,+78941,;.01~20
801.412;+78943,+78941,;2~VA-ONC BRCA LRM AFT BC N0 OFF PATH RSN
801.44;+78944,+78941,;.01~06/09/2026@08:52:58
801.44;+78944,+78941,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78942^1
78943^2
78944^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78940</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3471326953</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78940,;.01~VA-ONC BRCA LRM AFT BC N0 CLIN TRIAL
801.41;+78940,;4~dialog element
801.41;+78940,;15~HF.VA-ONC BRCA LRM AFTER BC N0 CLIN TRIAL
801.41;+78940,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78940,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78940,;100~NATIONAL
801.412;+78941,+78940,;.01~5
801.412;+78941,+78940,;2~VA-ONC CLINICAL TRIAL
801.412;+78941,+78940,;9~YES
801.44;+78942,+78940,;.01~06/09/2026@08:52:58
801.44;+78942,+78940,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78941^1
78942^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N0 POS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78973</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>88614341</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78973,;.01~VA-ONC BRCA LRM AFT BC N0 POS OFF PATH RSN
801.41;+78973,;4~dialog element
801.41;+78973,;15~HF.VA-ONC BRCA LRM AFTER BC N0 > NODE+ OFF PATH RSN
801.41;+78973,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78973,;51~SUPPRESS
801.41;+78973,;100~NATIONAL
801.412;+78974,+78973,;.01~5
801.412;+78974,+78973,;2~VA-ONC OFF PATHWAY
801.412;+78974,+78973,;7~YES
801.412;+78974,+78973,;9~YES
801.44;+78975,+78973,;.01~06/09/2026@08:52:58
801.44;+78975,+78973,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78974^1
78975^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N0 POS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78974</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4097017179</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78974,;.01~VA-ONC BRCA LRM AFT BC N0 POS OFF PATH TX
801.41;+78974,;4~dialog element
801.41;+78974,;15~HF.VA-ONC BRCA LRM AFTER BC N0 > NODE+ OFF PATH TX
801.41;+78974,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78974,;51~SUPPRESS
801.41;+78974,;100~NATIONAL
801.412;+78975,+78974,;.01~5
801.412;+78975,+78974,;2~VA-ONC BLANK
801.412;+78975,+78974,;7~YES
801.412;+78975,+78974,;9~YES
801.44;+78976,+78974,;.01~06/09/2026@08:52:58
801.44;+78976,+78974,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78975^1
78976^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFT BC N0 POS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78972</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>34721630</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78972,;.01~VA-GP ONC BRCA LRM AFT BC N0 POS OFF PTHWY
801.41;+78972,;4~dialog group
801.41;+78972,;6~YES
801.41;+78972,;7~2
801.41;+78972,;23~YES
801.41;+78972,;25~WP-start~1
Off pathway:
801.41;+78972,;52~INDENT
801.41;+78972,;100~NATIONAL
801.412;+78973,+78972,;.01~10
801.412;+78973,+78972,;2~VA-ONC BRCA LRM AFT BC N0 POS OFF PATH TX
801.412;+78974,+78972,;.01~20
801.412;+78974,+78972,;2~VA-ONC BRCA LRM AFT BC N0 POS OFF PATH RSN
801.44;+78975,+78972,;.01~06/09/2026@08:52:58
801.44;+78975,+78972,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78973^1
78974^2
78975^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFT BC N0 POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78971</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1854582182</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78971,;.01~VA-ONC BRCA LRM AFT BC N0 POS CLIN TRIAL
801.41;+78971,;4~dialog element
801.41;+78971,;15~HF.VA-ONC BRCA LRM AFTER BC N0 > NODE+ CLIN TRIAL
801.41;+78971,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78971,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78971,;100~NATIONAL
801.412;+78972,+78971,;.01~5
801.412;+78972,+78971,;2~VA-ONC CLINICAL TRIAL
801.412;+78972,+78971,;9~YES
801.44;+78973,+78971,;.01~06/09/2026@08:52:58
801.44;+78973,+78971,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78972^1
78973^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM AFTR ADJ LUMP AX DISSECT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73263</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1175027525</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73263,;.01~VA-ONC BRCA LRM AFTR ADJ LUMP AX DISSECT
801.41;+73263,;4~dialog element
801.41;+73263,;25~WP-start~1
Axillary dissection then proceed to Negative Margins option
801.41;+73263,;35~WP-start~1
Veteran has elected to pursue AXILLARY DISSECTION.
801.41;+73263,;100~NATIONAL
801.44;+73264,+73263,;.01~06/09/2026@08:52:58
801.44;+73264,+73263,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73264^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ LUMP POS YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73262</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1136117194</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73262,;.01~VA-GP ONC BRCA LRM AFTER ADJ LUMP POS YES
801.41;+73262,;4~dialog group
801.41;+73262,;6~YES
801.41;+73262,;7~2
801.41;+73262,;9~ONE SELECTION ONLY
801.41;+73262,;25~WP-start~1
1 or more node positive:
801.41;+73262,;51~SUPPRESS
801.41;+73262,;100~NATIONAL
801.412;+73263,+73262,;.01~10
801.412;+73263,+73262,;2~VA-ONC BRCA LRM AFTR ADJ LUMP AX DISSECT
801.412;+73264,+73262,;.01~5
801.412;+73264,+73262,;2~VA-ONC BRCA LRM AFT BC N0 POS CLIN TRIAL
801.412;+73265,+73262,;.01~20
801.412;+73265,+73262,;2~VA-GP ONC BRCA LRM AFT BC N0 POS OFF PTHWY
801.44;+73266,+73262,;.01~06/09/2026@08:52:58
801.44;+73266,+73262,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73263^1
73264^2
73265^3
73266^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ LUMP+SENT BX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73249</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3562837809</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73249,;.01~VA-GP ONC BRCA LRM AFTER ADJ LUMP+SENT BX
801.41;+73249,;4~dialog group
801.41;+73249,;6~YES
801.41;+73249,;7~2
801.41;+73249,;9~NONE OR ONE SELECTION
801.41;+73249,;15~HF.VA-ONC BRCA LRM AFTER BC N0 LUMP+NODE BX+REMOVAL
801.41;+73249,;25~WP-start~2
Lumpectomy, sentinel node biopsy, and removal of clipped node:\\
++ IF LESS than 1 node positive - proceed to Negative Margins option. ++
801.41;+73249,;35~WP-start~1
Lumpectomy, sentinel node biopsy, and removal of clipped node:
801.41;+73249,;100~NATIONAL
801.412;+73250,+73249,;.01~20
801.412;+73250,+73249,;2~VA-GP ONC BRCA LRM AFTER ADJ LUMP POS YES
801.44;+73251,+73249,;.01~06/09/2026@08:52:58
801.44;+73251,+73249,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73250^1
73251^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ NODE N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73248</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1176234807</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73248,;.01~VA-GP ONC BRCA LRM AFTER ADJ NODE N0
801.41;+73248,;4~dialog group
801.41;+73248,;6~YES
801.41;+73248,;7~2
801.41;+73248,;9~ONE SELECTION ONLY
801.41;+73248,;25~WP-start~1
Nodal Status, N0:
801.41;+73248,;100~NATIONAL
801.412;+73249,+73248,;.01~10
801.412;+73249,+73248,;2~VA-GP ONC BRCA LRM AFTER ADJ LUMP+SENT BX
801.412;+73250,+73248,;.01~5
801.412;+73250,+73248,;2~VA-ONC BRCA LRM AFT BC N0 CLIN TRIAL
801.412;+73251,+73248,;.01~20
801.412;+73251,+73248,;2~VA-GP ONC BRCA LRM AFT BC N0 OFF PTHWY
801.44;+73252,+73248,;.01~06/09/2026@08:52:58
801.44;+73252,+73248,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73249^1
73250^2
73251^3
73252^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ CONSERVE YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73244</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2652967</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73244,;.01~VA-GP ONC BRCA LRM AFTER ADJ CONSERVE YES
801.41;+73244,;4~dialog group
801.41;+73244,;6~YES
801.41;+73244,;7~2
801.41;+73244,;9~ONE SELECTION ONLY
801.41;+73244,;25~WP-start~1
Candidate for breast conservation:
801.41;+73244,;52~INDENT
801.41;+73244,;100~NATIONAL
801.412;+73245,+73244,;.01~10
801.412;+73245,+73244,;2~VA-GP ONC BRCA LRM AFTER ADJ NODE N0
801.412;+73246,+73244,;.01~20
801.412;+73246,+73244,;2~VA-GP ONC BRCA LRM AFTER ADJ NODE N1
801.412;+73247,+73244,;.01~30
801.412;+73247,+73244,;2~VA-GP ONC BRCA LRM AFTER LUMP+AX MARGINS
801.44;+73248,+73244,;.01~06/09/2026@08:52:58
801.44;+73248,+73244,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73245^1
73246^2
73247^3
73248^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM AFTER ADJ CLIN RESPONSE FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73240</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2793406607</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73240,;.01~VA-GP ONC BRCA LRM AFTER ADJ CLIN RESPONSE FN
801.41;+73240,;4~dialog group
801.41;+73240,;6~YES
801.41;+73240,;7~2
801.41;+73240,;9~NONE OR ONE SELECTION
801.41;+73240,;25~WP-start~8
Clinical Response to Neoadjuvant Therapy:\\
++ Determined by exam and/or imaging.
   IF NO clinical response - continue with Multidisciplinary Discussion.
 
   Breast Conservation - ineligibility includes disease crossing   
   quadrants, inability to obtain clear margins without mastectomy,
   or patient is not candidate for radiation; early referral to
   Plastic Surgery is recommended. ++
801.41;+73240,;35~WP-start~1
Clinical response to neoadjuvant therapy:
801.41;+73240,;51~SUPPRESS
801.41;+73240,;52~INDENT
801.41;+73240,;100~NATIONAL
801.412;+73241,+73240,;.01~20
801.412;+73241,+73240,;2~VA-GP ONC BRCA LRM AFTER ADJ CONSERVE YES
801.412;+73242,+73240,;.01~40
801.412;+73242,+73240,;2~VA-GP ONC BRCA LRM AFTER ADJ CONSERVE NO
801.44;+73243,+73240,;.01~06/09/2026@08:52:58
801.44;+73243,+73240,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73241^1
73242^2
73243^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA LRM AFTER ADJUVANT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73234</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2500808202</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73234,;.01~VA-GP ONC BREAST CA LRM AFTER ADJUVANT
801.41;+73234,;4~dialog group
801.41;+73234,;7~2
801.41;+73234,;15~HF.VA-ONC BRCA LRM AFTER NEOADJ TX CLINICAL PATHWAY
801.41;+73234,;25~WP-start~1
Local/Regional Management AFTER Neoadjuvant Treatment:
801.41;+73234,;35~WP-start~1
\\Local/Regional Management AFTER Neoadjuvant Treatment:
801.41;+73234,;52~INDENT
801.41;+73234,;100~NATIONAL
801.412;+73235,+73234,;.01~10
801.412;+73235,+73234,;2~VA-GP ONC BRCA LRM AFTER ADJ CLIN RESPONSE FN
801.44;+73236,+73234,;.01~06/09/2026@08:52:58
801.44;+73236,+73234,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73235^1
73236^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRCA PRIOR ADJ FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108487</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3128363434</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108487,;.01~VA-ONC BRCA LRM PRCA PRIOR ADJ FN
801.41;+108487,;4~dialog element
801.41;+108487,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+108487,;23~YES
801.41;+108487,;25~WP-start~1
Breast conservation: 
801.41;+108487,;35~WP-start~27
 Breast Conservation ineligibility - includes disease crossing quadrants, 
\\ inability to obtain clear margins without mastectomy, or patient is
not\\ candidate for radiation; if mastectomy early referral to Plastic
Surgery\\ is recommended; if lumpectomy early referral to Radiation
Oncology\\ is recommended; same treatment for male patients, however
it is\\ recognized that the majority of male patients will elect for
mastectomy. 
 
 Sentinel Node Biopsy not routinely recommended if patient age greater 
than\\ 69 and T1 ER+/HER2- tumors; if between ages 50-69 and T1 
ER+/HER2-,\\ consider consultation with Radiation Oncology prior to 
surgery or possible\\ omission of sentinel-node biopsy if ultrasound 
confirms negative node.
 
 Axillary Dissection - includes complete level I/II clearance. 
 
 Negative Margins - defined as no tumor on ink.
 
 Radiation if patient less than or equal to T2 and less than or equal 
to 2\\ positive nodes patient can opt for nodal radiation in lieu of 
axillary\\ dissection; in patients where (only) whole breast RT is
planned,\\ hypofractionated treatment is preferred over conventional
fractionation;\\ in select cases Accelerated Partial Breast Irradiation
(APBI) is an\\ acceptable treatment option.
 
 N1 Disease - recommend neoadjuvant chemotherapy for HER2+ and TNBC 
patients.
801.41;+108487,;51~SUPPRESS
801.41;+108487,;100~NATIONAL
801.412;+108488,+108487,;.01~5
801.412;+108488,+108487,;2~PXRM GF VIEW BUTTON
801.412;+108488,+108487,;6~VIEW LRM Prior to Adjuvant Tx Footnote
801.44;+108489,+108487,;.01~06/09/2026@08:52:58
801.44;+108489,+108487,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108488^1
108489^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NO BC &gt;T3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78892</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1706890127</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78892,;.01~VA-ONC BRCA LRM PRIOR NO BC >T3 OFF PATH RSN
801.41;+78892,;4~dialog element
801.41;+78892,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 OFF PATH RSN
801.41;+78892,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78892,;51~SUPPRESS
801.41;+78892,;100~NATIONAL
801.412;+78893,+78892,;.01~5
801.412;+78893,+78892,;2~VA-ONC OFF PATHWAY
801.412;+78893,+78892,;7~YES
801.412;+78893,+78892,;9~YES
801.44;+78894,+78892,;.01~06/09/2026@08:52:58
801.44;+78894,+78892,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78893^1
78894^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NO BC &gt;T3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78891</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>206541579</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78891,;.01~VA-ONC BRCA LRM PRIOR NO BC >T3 OFF PATH TX
801.41;+78891,;4~dialog element
801.41;+78891,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 OFF PATH TX
801.41;+78891,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78891,;51~SUPPRESS
801.41;+78891,;100~NATIONAL
801.412;+78892,+78891,;.01~5
801.412;+78892,+78891,;2~VA-ONC BLANK
801.412;+78892,+78891,;7~YES
801.412;+78892,+78891,;9~YES
801.44;+78893,+78891,;.01~06/09/2026@08:52:58
801.44;+78893,+78891,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78892^1
78893^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR NO BC &gt;T3 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78890</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2790898194</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78890,;.01~VA-GP ONC BRCA LRM PRIOR NO BC >T3 OFF PTHWY
801.41;+78890,;4~dialog group
801.41;+78890,;6~YES
801.41;+78890,;7~2
801.41;+78890,;23~YES
801.41;+78890,;25~WP-start~1
Off pathway:
801.41;+78890,;52~INDENT
801.41;+78890,;100~NATIONAL
801.412;+78891,+78890,;.01~10
801.412;+78891,+78890,;2~VA-ONC BRCA LRM PRIOR NO BC >T3 OFF PATH TX
801.412;+78892,+78890,;.01~20
801.412;+78892,+78890,;2~VA-ONC BRCA LRM PRIOR NO BC >T3 OFF PATH RSN
801.44;+78893,+78890,;.01~06/09/2026@08:52:58
801.44;+78893,+78890,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78891^1
78892^2
78893^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NO BC &gt;T3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78889</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2116351169</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78889,;.01~VA-ONC BRCA LRM PRIOR NO BC >T3 CLIN TRIAL
801.41;+78889,;4~dialog element
801.41;+78889,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 CLIN TRIAL
801.41;+78889,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78889,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78889,;100~NATIONAL
801.412;+78890,+78889,;.01~5
801.412;+78890,+78889,;2~VA-ONC CLINICAL TRIAL
801.412;+78890,+78889,;9~YES
801.44;+78891,+78889,;.01~06/09/2026@08:52:58
801.44;+78891,+78889,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78890^1
78891^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM RADIATION FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73144</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>915334317</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73144,;.01~VA-ONC BRCA LRM RADIATION FN
801.41;+73144,;3~DISABLE AND DO NOT SEND MESSAGE
801.41;+73144,;4~dialog element
801.41;+73144,;23~YES
801.41;+73144,;25~WP-start~6
++ Radiation if patient less than or equal to T2 and less than or equal 
to 2 positive nodes\\   patient can opt for nodal radiation in lieu of 
axillary dissection; in patients where (only)\\   whole breast RT is
planned, hypofractionated treatment is preferred over conventional
\\   fractionation; in select cases Accelerated Partial Breast Irradiation
(APBI) is an\\   acceptable treatment option. ++
801.41;+73144,;51~SUPPRESS
801.41;+73144,;100~NATIONAL
801.44;+73145,+73144,;.01~06/09/2026@08:52:58
801.44;+73145,+73144,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73145^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR T3N1 FOLLOW PTHWY+RAD</POINT_01>
<INTERNAL_ENTRY_NUMBER>73196</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2225176523</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73196,;.01~VA-GP ONC BRCA LRM PRIOR T3N1 FOLLOW PTHWY+RAD
801.41;+73196,;4~dialog group
801.41;+73196,;7~2
801.41;+73196,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC >T3,N1 I-III PTHWY+RAD
801.41;+73196,;25~WP-start~1
Follow appropriate Stage I-III pathway then radiation
801.41;+73196,;35~WP-start~2
Veteran has elected to FOLLOW the Appropriate STAGE I-III PATHWAY and 
then RADIATION.
801.41;+73196,;100~NATIONAL
801.412;+73197,+73196,;.01~5
801.412;+73197,+73196,;2~VA-ONC BRCA LRM RADIATION FN
801.412;+73198,+73196,;.01~10
801.412;+73198,+73196,;2~VA-ONC RADIATION ONCOLOGY CONSULT
801.44;+73199,+73196,;.01~06/09/2026@08:52:58
801.44;+73199,+73196,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73197^1
73198^2
73199^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR T3 NI GREATER</POINT_01>
<INTERNAL_ENTRY_NUMBER>73195</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2354745190</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73195,;.01~VA-GP ONC BRCA LRM PRIOR T3 NI GREATER
801.41;+73195,;4~dialog group
801.41;+73195,;6~YES
801.41;+73195,;7~2
801.41;+73195,;9~ONE SELECTION ONLY
801.41;+73195,;25~WP-start~1
T3 or more OR N1 or more:
801.41;+73195,;51~SUPPRESS
801.41;+73195,;100~NATIONAL
801.412;+73196,+73195,;.01~10
801.412;+73196,+73195,;2~VA-GP ONC BRCA LRM PRIOR T3N1 FOLLOW PTHWY+RAD
801.412;+73197,+73195,;.01~5
801.412;+73197,+73195,;2~VA-ONC BRCA LRM PRIOR NO BC >T3 CLIN TRIAL
801.412;+73198,+73195,;.01~30
801.412;+73198,+73195,;2~VA-GP ONC BRCA LRM PRIOR NO BC >T3 OFF PTHWY
801.44;+73199,+73195,;.01~06/09/2026@08:52:58
801.44;+73199,+73195,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73196^1
73197^3
73198^4
73199^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR T3 OR N1</POINT_01>
<INTERNAL_ENTRY_NUMBER>73192</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2999819404</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73192,;.01~VA-GP ONC BRCA LRM PRIOR T3 OR N1
801.41;+73192,;4~dialog group
801.41;+73192,;6~YES
801.41;+73192,;7~2
801.41;+73192,;9~NONE OR ONE SELECTION
801.41;+73192,;23~YES
801.41;+73192,;25~WP-start~2
T3 OR N1 Status:\\
++ IF LESS than T3 or N1- Follow appropriate Stage I-III Pathway. ++
801.41;+73192,;51~SUPPRESS
801.41;+73192,;100~NATIONAL
801.412;+73193,+73192,;.01~10
801.412;+73193,+73192,;2~VA-GP ONC BRCA LRM PRIOR T3 NI GREATER
801.44;+73194,+73192,;.01~06/09/2026@08:52:58
801.44;+73194,+73192,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73193^1
73194^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR PROCEED TO MARGINS</POINT_01>
<INTERNAL_ENTRY_NUMBER>78897</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2751743928</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78897,;.01~VA-GP ONC BRCA LRM PRIOR PROCEED TO MARGINS
801.41;+78897,;4~dialog group
801.41;+78897,;6~YES
801.41;+78897,;7~2
801.41;+78897,;25~WP-start~1
++ Proceed to Margin Clearance. ++
801.41;+78897,;35~WP-start~1
After Margin Clearance:
801.41;+78897,;51~SUPPRESS
801.41;+78897,;52~INDENT
801.41;+78897,;100~NATIONAL
801.412;+78898,+78897,;.01~10
801.412;+78898,+78897,;2~VA-GP ONC BRCA LRM PRIOR T3 OR N1
801.44;+78899,+78897,;.01~06/09/2026@08:52:58
801.44;+78899,+78897,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78898^1
78899^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR MAST NEG MARGINS NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73191</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2330385661</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73191,;.01~VA-GP ONC BRCA LRM PRIOR MAST NEG MARGINS NO
801.41;+73191,;4~dialog group
801.41;+73191,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NO NEG MARGIN 
801.41;+73191,;25~WP-start~1
Positive Margins:
801.41;+73191,;100~NATIONAL
801.412;+73192,+73191,;.01~10
801.412;+73192,+73191,;2~VA-GP ONC BRCA LRM PRIOR PROCEED TO MARGINS
801.44;+73193,+73191,;.01~06/09/2026@08:52:58
801.44;+73193,+73191,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73192^1
73193^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR MAST NEG MARGINS YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73190</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3233886931</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73190,;.01~VA-GP ONC BRCA LRM PRIOR MAST NEG MARGINS YES
801.41;+73190,;4~dialog group
801.41;+73190,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC S/P MAST NEG MARGIN
801.41;+73190,;25~WP-start~1
Negative Margins:
801.41;+73190,;100~NATIONAL
801.412;+73191,+73190,;.01~10
801.412;+73191,+73190,;2~VA-GP ONC BRCA LRM PRIOR T3 OR N1
801.44;+73192,+73190,;.01~06/09/2026@08:52:58
801.44;+73192,+73190,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73191^1
73192^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR MAST MARGINS MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73189</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3956460535</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73189,;.01~VA-GP ONC BRCA LRM PRIOR MAST MARGINS MAIN
801.41;+73189,;4~dialog group
801.41;+73189,;6~YES
801.41;+73189,;7~2
801.41;+73189,;9~NONE OR ONE SELECTION
801.41;+73189,;23~YES
801.41;+73189,;25~WP-start~1
Margins AFTER mastectomy and node dissection:\\
801.41;+73189,;100~NATIONAL
801.412;+73190,+73189,;.01~10
801.412;+73190,+73189,;2~VA-GP ONC BRCA LRM PRIOR MAST NEG MARGINS YES
801.412;+73191,+73189,;.01~20
801.412;+73191,+73189,;2~VA-GP ONC BRCA LRM PRIOR MAST NEG MARGINS NO
801.44;+73192,+73189,;.01~06/09/2026@08:52:58
801.44;+73192,+73189,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73190^1
73191^2
73192^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NO BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78847</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1694089324</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78847,;.01~VA-ONC BRCA LRM PRIOR NO BC N0 OFF PATH RSN
801.41;+78847,;4~dialog element
801.41;+78847,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH RSN
801.41;+78847,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78847,;51~SUPPRESS
801.41;+78847,;100~NATIONAL
801.412;+78848,+78847,;.01~5
801.412;+78848,+78847,;2~VA-ONC OFF PATHWAY
801.412;+78848,+78847,;7~YES
801.412;+78848,+78847,;9~YES
801.44;+78849,+78847,;.01~06/09/2026@08:52:58
801.44;+78849,+78847,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78848^1
78849^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NO BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78846</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3354528840</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78846,;.01~VA-ONC BRCA LRM PRIOR NO BC N0 OFF PATH TX
801.41;+78846,;4~dialog element
801.41;+78846,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC N0 OFF PATH TX
801.41;+78846,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78846,;51~SUPPRESS
801.41;+78846,;100~NATIONAL
801.412;+78847,+78846,;.01~5
801.412;+78847,+78846,;2~VA-ONC BLANK
801.412;+78847,+78846,;7~YES
801.412;+78847,+78846,;9~YES
801.44;+78848,+78846,;.01~06/09/2026@08:52:58
801.44;+78848,+78846,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78847^1
78848^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR NO BC N0 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78845</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2045100532</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78845,;.01~VA-GP ONC BRCA LRM PRIOR NO BC N0 OFF PTHWY
801.41;+78845,;4~dialog group
801.41;+78845,;6~YES
801.41;+78845,;7~2
801.41;+78845,;23~YES
801.41;+78845,;25~WP-start~1
Off pathway:
801.41;+78845,;52~INDENT
801.41;+78845,;100~NATIONAL
801.412;+78846,+78845,;.01~10
801.412;+78846,+78845,;2~VA-ONC BRCA LRM PRIOR NO BC N0 OFF PATH TX
801.412;+78847,+78845,;.01~20
801.412;+78847,+78845,;2~VA-ONC BRCA LRM PRIOR NO BC N0 OFF PATH RSN
801.44;+78848,+78845,;.01~06/09/2026@08:52:58
801.44;+78848,+78845,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78846^1
78847^2
78848^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR NO BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78844</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3352652583</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78844,;.01~VA-ONC BRCA LRM PRIOR NO BC N0 CLIN TRIAL
801.41;+78844,;4~dialog element
801.41;+78844,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC N0 CLIN TRIAL
801.41;+78844,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78844,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78844,;100~NATIONAL
801.412;+78845,+78844,;.01~5
801.412;+78845,+78844,;2~VA-ONC CLINICAL TRIAL
801.412;+78845,+78844,;9~YES
801.44;+78846,+78844,;.01~06/09/2026@08:52:58
801.44;+78846,+78844,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78845^1
78846^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM N0 SENT NODE FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73134</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1420411622</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73134,;.01~VA-ONC BRCA LRM N0 SENT NODE FN
801.41;+73134,;3~DISABLE AND DO NOT SEND MESSAGE
801.41;+73134,;4~dialog element
801.41;+73134,;23~YES
801.41;+73134,;25~WP-start~3
++ Sentinel Node Biopsy not routinely recommended if patient age greater 
than 69 and T1 ER+/HER2- tumors. 
   Axillary Dissection includes complete level I/II clearance. ++
801.41;+73134,;51~SUPPRESS
801.41;+73134,;100~NATIONAL
801.44;+73135,+73134,;.01~06/09/2026@08:52:58
801.44;+73135,+73134,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73135^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM N0 MAST W/SENT BX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73168</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2523005483</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73168,;.01~VA-GP ONC BRCA LRM N0 MAST W/SENT BX
801.41;+73168,;4~dialog group
801.41;+73168,;7~2
801.41;+73168,;15~HF.VA-ONC BRCA LRM PRIOR NOT BC N0 MAST+AX
801.41;+73168,;25~WP-start~2
Mastectomy with sentinel node biopsy; then axillary node dissection if 
greater than or equal to 3+ nodes positive
801.41;+73168,;35~WP-start~3
Veteran has elected to pursue MASTECTOMY with SENTINEL NODE BIOPSY, 
followed by AXILLARY DISSECTION if greater than or equal to 3+ nodes 
positive.
801.41;+73168,;100~NATIONAL
801.412;+73169,+73168,;.01~5
801.412;+73169,+73168,;2~VA-ONC BRCA LRM N0 SENT NODE FN
801.44;+73170,+73168,;.01~06/09/2026@08:52:58
801.44;+73170,+73168,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73169^1
73170^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA LRM CONSERVE NO N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73166</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1265356456</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73166,;.01~VA-GP ONC BR CA LRM CONSERVE NO N0
801.41;+73166,;4~dialog group
801.41;+73166,;6~YES
801.41;+73166,;7~2
801.41;+73166,;9~ONE SELECTION ONLY
801.41;+73166,;25~WP-start~1
Nodal Status N0:
801.41;+73166,;52~INDENT
801.41;+73166,;100~NATIONAL
801.412;+73167,+73166,;.01~10
801.412;+73167,+73166,;2~VA-GP ONC BRCA LRM N0 MAST W/SENT BX
801.412;+73168,+73166,;.01~5
801.412;+73168,+73166,;2~VA-ONC BRCA LRM PRIOR NO BC N0 CLIN TRIAL
801.412;+73169,+73166,;.01~20
801.412;+73169,+73166,;2~VA-GP ONC BRCA LRM PRIOR NO BC N0 OFF PTHWY
801.44;+73170,+73166,;.01~06/09/2026@08:52:58
801.44;+73170,+73166,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73167^1
73168^2
73169^3
73170^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA FOLLOW LRM AFTER NEOADJ TX FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108478</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3003887188</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108478,;.01~VA-ONC BRCA FOLLOW LRM AFTER NEOADJ TX FN
801.41;+108478,;4~dialog group
801.41;+108478,;6~YES
801.41;+108478,;7~2
801.41;+108478,;9~NONE OR ONE SELECTION
801.41;+108478,;23~YES
801.41;+108478,;25~WP-start~2
++ If Nodal Status N1- Follow Local/Regional Management After 
Neoadjuvant\\   Treatment pathway. ++
801.41;+108478,;51~SUPPRESS
801.41;+108478,;100~NATIONAL
801.412;+108479,+108478,;.01~15
801.412;+108479,+108478,;2~VA-GP ONC BR CA LRM CONSERVE NO N0
801.412;+108480,+108478,;.01~30
801.412;+108480,+108478,;2~VA-GP ONC BRCA LRM PRIOR MAST MARGINS MAIN
801.44;+108481,+108478,;.01~06/09/2026@08:52:58
801.44;+108481,+108478,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108479^1
108480^2
108481^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA LRM PRIOR CONSERVE NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>70996</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>947175546</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+70996,;.01~VA-GP ONC BR CA LRM PRIOR CONSERVE NO
801.41;+70996,;4~dialog group
801.41;+70996,;7~2
801.41;+70996,;25~WP-start~1
Not a candidate for breast conservation:
801.41;+70996,;52~INDENT
801.41;+70996,;100~NATIONAL
801.412;+70997,+70996,;.01~20
801.412;+70997,+70996,;2~VA-ONC BRCA FOLLOW LRM AFTER NEOADJ TX FN
801.44;+70998,+70996,;.01~06/09/2026@08:52:58
801.44;+70998,+70996,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
70997^1
70998^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC POS MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78833</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>876426508</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78833,;.01~VA-ONC BRCA LRM PRIOR BC POS MARG OFF PATH RSN
801.41;+78833,;4~dialog element
801.41;+78833,;15~HF.VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH RSN
801.41;+78833,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78833,;51~SUPPRESS
801.41;+78833,;100~NATIONAL
801.412;+78834,+78833,;.01~5
801.412;+78834,+78833,;2~VA-ONC OFF PATHWAY
801.412;+78834,+78833,;7~YES
801.412;+78834,+78833,;9~YES
801.44;+78835,+78833,;.01~06/09/2026@08:52:58
801.44;+78835,+78833,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78834^1
78835^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC POS MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78836</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2917580836</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78836,;.01~VA-ONC BRCA LRM PRIOR BC POS MARG OFF PATH TX
801.41;+78836,;4~dialog element
801.41;+78836,;15~HF.VA-ONC BRCA LRM PRIOR BC NO NEG MARG OFF PATH TX
801.41;+78836,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78836,;51~SUPPRESS
801.41;+78836,;100~NATIONAL
801.412;+78837,+78836,;.01~5
801.412;+78837,+78836,;2~VA-ONC BLANK
801.412;+78837,+78836,;7~YES
801.412;+78837,+78836,;9~YES
801.44;+78838,+78836,;.01~06/09/2026@08:52:58
801.44;+78838,+78836,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78837^1
78838^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR BC POS MARG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78842</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2618219561</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78842,;.01~VA-GP ONC BRCA LRM PRIOR BC POS MARG OFF PTHWY
801.41;+78842,;4~dialog group
801.41;+78842,;6~YES
801.41;+78842,;7~2
801.41;+78842,;23~YES
801.41;+78842,;25~WP-start~1
Off pathway:
801.41;+78842,;52~INDENT
801.41;+78842,;100~NATIONAL
801.412;+78843,+78842,;.01~10
801.412;+78843,+78842,;2~VA-ONC BRCA LRM PRIOR BC POS MARG OFF PATH TX
801.412;+78844,+78842,;.01~20
801.412;+78844,+78842,;2~VA-ONC BRCA LRM PRIOR BC POS MARG OFF PATH RSN
801.44;+78845,+78842,;.01~06/09/2026@08:52:58
801.44;+78845,+78842,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78843^1
78844^2
78845^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC POS MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78839</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2188160703</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78839,;.01~VA-ONC BRCA LRM PRIOR BC POS MARG CLIN TRIAL
801.41;+78839,;4~dialog element
801.41;+78839,;15~HF.VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLIN TRIAL
801.41;+78839,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78839,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78839,;100~NATIONAL
801.412;+78840,+78839,;.01~5
801.412;+78840,+78839,;2~VA-ONC CLINICAL TRIAL
801.412;+78840,+78839,;9~YES
801.44;+78841,+78839,;.01~06/09/2026@08:52:58
801.44;+78841,+78839,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78840^1
78841^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM NEG MARGIN CLEARANCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73147</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1935259779</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73147,;.01~VA-ONC BRCA LRM NEG MARGIN CLEARANCE
801.41;+73147,;4~dialog element
801.41;+73147,;15~HF.VA-ONC BRCA LRM PRIOR BC NO NEG MARG CLEARANCE
801.41;+73147,;25~WP-start~1
Margin clearance, then follow appropriate Stage I-III Pathway
801.41;+73147,;35~WP-start~2
Veteran has elected to pursue MARGIN CLEARANCE and then FOLLOW Appropriate
Stage I-III Pathway.
801.41;+73147,;100~NATIONAL
801.44;+73148,+73147,;.01~06/09/2026@08:52:58
801.44;+73148,+73147,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73148^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM NEG MARGINS NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73146</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4169563669</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73146,;.01~VA-GP ONC BRCA LRM NEG MARGINS NO
801.41;+73146,;4~dialog group
801.41;+73146,;6~YES
801.41;+73146,;7~2
801.41;+73146,;9~ONE SELECTION ONLY
801.41;+73146,;25~WP-start~1
Positive Margins:
801.41;+73146,;35~WP-start~1
Positive Margins:
801.41;+73146,;52~INDENT
801.41;+73146,;100~NATIONAL
801.412;+73147,+73146,;.01~10
801.412;+73147,+73146,;2~VA-ONC BRCA LRM NEG MARGIN CLEARANCE
801.412;+73148,+73146,;.01~5
801.412;+73148,+73146,;2~VA-ONC BRCA LRM PRIOR BC POS MARG CLIN TRIAL
801.412;+73149,+73146,;.01~20
801.412;+73149,+73146,;2~VA-GP ONC BRCA LRM PRIOR BC POS MARG OFF PTHWY
801.44;+73150,+73146,;.01~06/09/2026@08:52:58
801.44;+73150,+73146,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73147^1
73148^2
73149^3
73150^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR NEG MARG RAD+PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>82364</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3846841310</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+82364,;.01~VA-GP ONC BRCA LRM PRIOR NEG MARG RAD+PTHWY
801.41;+82364,;4~dialog group
801.41;+82364,;7~2
801.41;+82364,;15~HF.VA-ONC BRCA LRM PRIOR BC NEG MARG I-III PTHWY+RAD
801.41;+82364,;25~WP-start~1
Follow appropriate Stage I-III pathway then radiation
801.41;+82364,;35~WP-start~2
Veteran has elected to FOLLOW the Appropriate STAGE I-III PATHWAY and 
then RADIATION.
801.41;+82364,;100~NATIONAL
801.412;+82365,+82364,;.01~5
801.412;+82365,+82364,;2~VA-ONC BRCA LRM RADIATION FN
801.412;+82366,+82364,;.01~10
801.412;+82366,+82364,;2~VA-ONC RADIATION ONCOLOGY CONSULT
801.44;+82367,+82364,;.01~06/09/2026@08:52:58
801.44;+82367,+82364,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
82365^1
82366^2
82367^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78832</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>40436932</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78832,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH RSN
801.41;+78832,;4~dialog element
801.41;+78832,;15~HF.VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH RSN
801.41;+78832,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78832,;51~SUPPRESS
801.41;+78832,;100~NATIONAL
801.412;+78833,+78832,;.01~5
801.412;+78833,+78832,;2~VA-ONC OFF PATHWAY
801.412;+78833,+78832,;7~YES
801.412;+78833,+78832,;9~YES
801.44;+78834,+78832,;.01~06/09/2026@08:52:58
801.44;+78834,+78832,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78833^1
78834^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78835</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2451553268</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78835,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX
801.41;+78835,;4~dialog element
801.41;+78835,;15~HF.VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX
801.41;+78835,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78835,;51~SUPPRESS
801.41;+78835,;100~NATIONAL
801.412;+78836,+78835,;.01~5
801.412;+78836,+78835,;2~VA-ONC BLANK
801.412;+78836,+78835,;7~YES
801.412;+78836,+78835,;9~YES
801.44;+78837,+78835,;.01~06/09/2026@08:52:58
801.44;+78837,+78835,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78836^1
78837^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR BC NEG MARG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78841</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>33340684</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78841,;.01~VA-GP ONC BRCA LRM PRIOR BC NEG MARG OFF PTHWY
801.41;+78841,;4~dialog group
801.41;+78841,;6~YES
801.41;+78841,;7~2
801.41;+78841,;23~YES
801.41;+78841,;25~WP-start~1
Off pathway:
801.41;+78841,;52~INDENT
801.41;+78841,;100~NATIONAL
801.412;+78842,+78841,;.01~10
801.412;+78842,+78841,;2~VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH TX
801.412;+78843,+78841,;.01~20
801.412;+78843,+78841,;2~VA-ONC BRCA LRM PRIOR BC NEG MARG OFF PATH RSN
801.44;+78844,+78841,;.01~06/09/2026@08:52:58
801.44;+78844,+78841,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78842^1
78843^2
78844^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78838</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1277323880</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78838,;.01~VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
801.41;+78838,;4~dialog element
801.41;+78838,;15~HF.VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
801.41;+78838,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78838,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78838,;100~NATIONAL
801.412;+78839,+78838,;.01~5
801.412;+78839,+78838,;2~VA-ONC CLINICAL TRIAL
801.412;+78839,+78838,;9~YES
801.44;+78840,+78838,;.01~06/09/2026@08:52:58
801.44;+78840,+78838,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78839^1
78840^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR NEG MARGINS YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73142</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2288519540</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73142,;.01~VA-GP ONC BRCA LRM PRIOR NEG MARGINS YES
801.41;+73142,;4~dialog group
801.41;+73142,;6~YES
801.41;+73142,;7~2
801.41;+73142,;9~ONE SELECTION ONLY
801.41;+73142,;25~WP-start~1
Negative Margins:
801.41;+73142,;52~INDENT
801.41;+73142,;100~NATIONAL
801.412;+73143,+73142,;.01~5
801.412;+73143,+73142,;2~VA-ONC BRCA LRM PRIOR BC NEG MARG CLIN TRIAL
801.412;+73144,+73142,;.01~20
801.412;+73144,+73142,;2~VA-GP ONC BRCA LRM PRIOR BC NEG MARG OFF PTHWY
801.412;+73145,+73142,;.01~10
801.412;+73145,+73142,;2~VA-GP ONC BRCA LRM PRIOR NEG MARG RAD+PTHWY
801.44;+73146,+73142,;.01~06/09/2026@08:52:58
801.44;+73146,+73142,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73143^4
73144^5
73145^6
73146^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR POST LUMP MARGINS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73139</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3644644756</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73139,;.01~VA-GP ONC BRCA LRM PRIOR POST LUMP MARGINS
801.41;+73139,;4~dialog group
801.41;+73139,;6~YES
801.41;+73139,;7~2
801.41;+73139,;9~NONE OR ONE SELECTION
801.41;+73139,;23~YES
801.41;+73139,;25~WP-start~1
Margins AFTER lumpectomy and node dissection:\\
801.41;+73139,;100~NATIONAL
801.412;+73140,+73139,;.01~20
801.412;+73140,+73139,;2~VA-GP ONC BRCA LRM PRIOR NEG MARGINS YES
801.412;+73141,+73139,;.01~30
801.412;+73141,+73139,;2~VA-GP ONC BRCA LRM NEG MARGINS NO
801.44;+73142,+73139,;.01~06/09/2026@08:52:58
801.44;+73142,+73139,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73140^2
73141^3
73142^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78831</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1704647241</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78831,;.01~VA-ONC BRCA LRM PRIOR BC N1 OFF PATH RSN
801.41;+78831,;4~dialog element
801.41;+78831,;15~HF.VA-ONC BRCA LRM PRIOR BC N1 OFF PATH RSN
801.41;+78831,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78831,;51~SUPPRESS
801.41;+78831,;100~NATIONAL
801.412;+78832,+78831,;.01~5
801.412;+78832,+78831,;2~VA-ONC OFF PATHWAY
801.412;+78832,+78831,;7~YES
801.412;+78832,+78831,;9~YES
801.44;+78833,+78831,;.01~06/09/2026@08:52:58
801.44;+78833,+78831,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78832^1
78833^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78834</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>77702211</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78834,;.01~VA-ONC BRCA LRM PRIOR BC N1 OFF PATH TX
801.41;+78834,;4~dialog element
801.41;+78834,;15~HF.VA-ONC BRCA LRM PRIOR BC N1 OFF PATH TX
801.41;+78834,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78834,;51~SUPPRESS
801.41;+78834,;100~NATIONAL
801.412;+78835,+78834,;.01~5
801.412;+78835,+78834,;2~VA-ONC BLANK
801.412;+78835,+78834,;7~YES
801.412;+78835,+78834,;9~YES
801.44;+78836,+78834,;.01~06/09/2026@08:52:58
801.44;+78836,+78834,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78835^1
78836^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR BC N1 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78840</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>796453436</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78840,;.01~VA-GP ONC BRCA LRM PRIOR BC N1 OFF PTHWY
801.41;+78840,;4~dialog group
801.41;+78840,;6~YES
801.41;+78840,;7~2
801.41;+78840,;23~YES
801.41;+78840,;25~WP-start~1
Off pathway:
801.41;+78840,;52~INDENT
801.41;+78840,;100~NATIONAL
801.412;+78841,+78840,;.01~10
801.412;+78841,+78840,;2~VA-ONC BRCA LRM PRIOR BC N1 OFF PATH TX
801.412;+78842,+78840,;.01~20
801.412;+78842,+78840,;2~VA-ONC BRCA LRM PRIOR BC N1 OFF PATH RSN
801.44;+78843,+78840,;.01~06/09/2026@08:52:58
801.44;+78843,+78840,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78841^1
78842^2
78843^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78837</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4073227976</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78837,;.01~VA-ONC BRCA LRM PRIOR BC N1 CLIN TRIAL
801.41;+78837,;4~dialog element
801.41;+78837,;15~HF.VA-ONC BRCA LRM PRIOR BC N1 CLIN TRIAL
801.41;+78837,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78837,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78837,;100~NATIONAL
801.412;+78838,+78837,;.01~5
801.412;+78838,+78837,;2~VA-ONC CLINICAL TRIAL
801.412;+78838,+78837,;9~YES
801.44;+78839,+78837,;.01~06/09/2026@08:52:58
801.44;+78839,+78837,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78838^1
78839^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM N1 LUMP+AX FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73137</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>300440021</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73137,;.01~VA-ONC BRCA LRM N1 LUMP+AX FN
801.41;+73137,;3~DISABLE AND DO NOT SEND MESSAGE
801.41;+73137,;4~dialog element
801.41;+73137,;23~YES
801.41;+73137,;25~WP-start~1
++ Axillary Dissection includes complete level I/II clearance. ++
801.41;+73137,;51~SUPPRESS
801.41;+73137,;100~NATIONAL
801.44;+73138,+73137,;.01~06/09/2026@08:52:58
801.44;+73138,+73137,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73138^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA LRM N1 LUMP+AX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73136</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3071922539</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73136,;.01~VA-GP ONC BR CA LRM N1 LUMP+AX
801.41;+73136,;4~dialog group
801.41;+73136,;7~2
801.41;+73136,;15~HF.VA-ONC BRCA LRM PRIOR BC N1 LUMP+AX
801.41;+73136,;25~WP-start~1
Lumpectomy and axillary node dissection
801.41;+73136,;35~WP-start~2
Veteran has elected to pursue treatment with LUMPECTOMY and AXILLARY NODE
DISSECTION.
801.41;+73136,;100~NATIONAL
801.412;+73137,+73136,;.01~5
801.412;+73137,+73136,;2~VA-ONC BRCA LRM N1 LUMP+AX FN
801.44;+73138,+73136,;.01~06/09/2026@08:52:58
801.44;+73138,+73136,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73137^1
73138^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA LRM CONSERVE YES N1</POINT_01>
<INTERNAL_ENTRY_NUMBER>73135</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2576524095</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73135,;.01~VA-GP ONC BR CA LRM CONSERVE YES N1
801.41;+73135,;4~dialog group
801.41;+73135,;6~YES
801.41;+73135,;7~2
801.41;+73135,;9~NONE OR ONE SELECTION
801.41;+73135,;25~WP-start~1
Nodal Status N1:\\
801.41;+73135,;35~WP-start~1
Nodal Status N1:
801.41;+73135,;52~INDENT
801.41;+73135,;100~NATIONAL
801.412;+73136,+73135,;.01~10
801.412;+73136,+73135,;2~VA-GP ONC BR CA LRM N1 LUMP+AX
801.412;+73137,+73135,;.01~5
801.412;+73137,+73135,;2~VA-ONC BRCA LRM PRIOR BC N1 CLIN TRIAL
801.412;+73138,+73135,;.01~20
801.412;+73138,+73135,;2~VA-GP ONC BRCA LRM PRIOR BC N1 OFF PTHWY
801.44;+73139,+73135,;.01~06/09/2026@08:52:58
801.44;+73139,+73135,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73136^1
73137^2
73138^3
73139^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78830</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2455735935</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78830,;.01~VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN
801.41;+78830,;4~dialog element
801.41;+78830,;15~HF.VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN
801.41;+78830,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78830,;51~SUPPRESS
801.41;+78830,;100~NATIONAL
801.412;+78831,+78830,;.01~5
801.412;+78831,+78830,;2~VA-ONC OFF PATHWAY
801.412;+78831,+78830,;7~YES
801.412;+78831,+78830,;9~YES
801.44;+78832,+78830,;.01~06/09/2026@08:52:58
801.44;+78832,+78830,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78831^1
78832^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78829</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4248633487</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78829,;.01~VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
801.41;+78829,;4~dialog element
801.41;+78829,;15~HF.VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
801.41;+78829,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78829,;51~SUPPRESS
801.41;+78829,;100~NATIONAL
801.412;+78830,+78829,;.01~5
801.412;+78830,+78829,;2~VA-ONC BLANK
801.412;+78830,+78829,;7~YES
801.412;+78830,+78829,;9~YES
801.44;+78831,+78829,;.01~06/09/2026@08:52:58
801.44;+78831,+78829,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78830^1
78831^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR BC N0 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78828</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2343836788</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78828,;.01~VA-GP ONC BRCA LRM PRIOR BC N0 OFF PTHWY
801.41;+78828,;4~dialog group
801.41;+78828,;6~YES
801.41;+78828,;7~2
801.41;+78828,;23~YES
801.41;+78828,;25~WP-start~1
Off pathway:
801.41;+78828,;52~INDENT
801.41;+78828,;100~NATIONAL
801.412;+78829,+78828,;.01~10
801.412;+78829,+78828,;2~VA-ONC BRCA LRM PRIOR BC N0 OFF PATH TX
801.412;+78830,+78828,;.01~20
801.412;+78830,+78828,;2~VA-ONC BRCA LRM PRIOR BC N0 OFF PATH RSN
801.44;+78831,+78828,;.01~06/09/2026@08:52:58
801.44;+78831,+78828,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78829^1
78830^2
78831^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78827</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3071685543</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78827,;.01~VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
801.41;+78827,;4~dialog element
801.41;+78827,;15~HF.VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
801.41;+78827,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78827,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78827,;100~NATIONAL
801.412;+78828,+78827,;.01~5
801.412;+78828,+78827,;2~VA-ONC CLINICAL TRIAL
801.412;+78828,+78827,;9~YES
801.44;+78829,+78827,;.01~06/09/2026@08:52:58
801.44;+78829,+78827,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78828^1
78829^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM N0 LUMP+SENT BX</POINT_01>
<INTERNAL_ENTRY_NUMBER>73133</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1133003799</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73133,;.01~VA-GP ONC BRCA LRM N0 LUMP+SENT BX
801.41;+73133,;4~dialog group
801.41;+73133,;7~2
801.41;+73133,;15~HF.VA-ONC BRCA LRM PRIOR BC N0 LUMP+BX+AX
801.41;+73133,;25~WP-start~2
Lumpectomy and sentinel node biopsy,then axillary dissection if greater 
than or equal to 3+ nodes positive
801.41;+73133,;35~WP-start~3
Veteran has elected pursue treatment with LUMPECTOMY and SENTINEL NODE
BIOPSY, followed by AXILLARY DISSECTION if greater than or equal to 3+
nodes positive.
801.41;+73133,;100~NATIONAL
801.412;+73134,+73133,;.01~5
801.412;+73134,+73133,;2~VA-ONC BRCA LRM N0 SENT NODE FN
801.44;+73135,+73133,;.01~06/09/2026@08:52:58
801.44;+73135,+73133,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73134^1
73135^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM CONSERVE YES N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73132</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1311892168</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73132,;.01~VA-GP ONC BRCA LRM CONSERVE YES N0
801.41;+73132,;4~dialog group
801.41;+73132,;6~YES
801.41;+73132,;7~2
801.41;+73132,;9~ONE SELECTION ONLY
801.41;+73132,;25~WP-start~1
Nodal Status N0:
801.41;+73132,;52~INDENT
801.41;+73132,;100~NATIONAL
801.412;+73133,+73132,;.01~20
801.412;+73133,+73132,;2~VA-GP ONC BRCA LRM N0 LUMP+SENT BX
801.412;+73134,+73132,;.01~5
801.412;+73134,+73132,;2~VA-ONC BRCA LRM PRIOR BC N0 CLIN TRIAL
801.412;+73135,+73132,;.01~30
801.412;+73135,+73132,;2~VA-GP ONC BRCA LRM PRIOR BC N0 OFF PTHWY
801.44;+73136,+73132,;.01~06/09/2026@08:52:58
801.44;+73136,+73132,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73133^1
73134^2
73135^3
73136^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR CONSERVE YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>70995</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3932092858</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+70995,;.01~VA-GP ONC BRCA LRM PRIOR CONSERVE YES
801.41;+70995,;4~dialog group
801.41;+70995,;6~YES
801.41;+70995,;7~2
801.41;+70995,;9~ONE SELECTION ONLY
801.41;+70995,;25~WP-start~1
Candidate for breast conservation:
801.41;+70995,;52~INDENT
801.41;+70995,;100~NATIONAL
801.412;+70996,+70995,;.01~10
801.412;+70996,+70995,;2~VA-GP ONC BRCA LRM CONSERVE YES N0
801.412;+70997,+70995,;.01~20
801.412;+70997,+70995,;2~VA-GP ONC BR CA LRM CONSERVE YES N1
801.412;+70998,+70995,;.01~30
801.412;+70998,+70995,;2~VA-GP ONC BRCA LRM PRIOR POST LUMP MARGINS
801.44;+70999,+70995,;.01~06/09/2026@08:52:58
801.44;+70999,+70995,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
70996^1
70997^2
70998^3
70999^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA LRM PRIOR ADJ CONSERVE FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>70994</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2892746040</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+70994,;.01~VA-GP ONC BRCA LRM PRIOR ADJ CONSERVE FN
801.41;+70994,;4~dialog group
801.41;+70994,;6~YES
801.41;+70994,;9~NONE OR ONE SELECTION
801.41;+70994,;23~YES
801.41;+70994,;51~SUPPRESS
801.41;+70994,;100~NATIONAL
801.412;+70995,+70994,;.01~10
801.412;+70995,+70994,;2~VA-GP ONC BRCA LRM PRIOR CONSERVE YES
801.412;+70996,+70994,;.01~20
801.412;+70996,+70994,;2~VA-GP ONC BR CA LRM PRIOR CONSERVE NO
801.44;+70997,+70994,;.01~06/09/2026@08:52:58
801.44;+70997,+70994,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
70995^1
70996^2
70997^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA LRM PRIOR ADJUVANT</POINT_01>
<INTERNAL_ENTRY_NUMBER>70993</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>137175235</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+70993,;.01~VA-GP ONC BREAST CA LRM PRIOR ADJUVANT
801.41;+70993,;4~dialog group
801.41;+70993,;7~2
801.41;+70993,;15~HF.VA-ONC BRCA LRM PRIOR ADJ TX CLINICAL PATHWAY
801.41;+70993,;25~WP-start~1
Local/Regional Management PRIOR to Adjuvant Treatment:
801.41;+70993,;35~WP-start~1
\\Local/Regional Management Prior to Adjuvant Treatment
801.41;+70993,;52~INDENT
801.41;+70993,;100~NATIONAL
801.41;+70993,;101~VHA ONCOLOGY
801.412;+70994,+70993,;.01~10
801.412;+70994,+70993,;2~VA-GP ONC BRCA LRM PRIOR ADJ CONSERVE FN
801.412;+70995,+70993,;.01~5
801.412;+70995,+70993,;2~VA-ONC BRCA LRM PRCA PRIOR ADJ FN
801.44;+70996,+70993,;.01~06/09/2026@08:52:58
801.44;+70996,+70993,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
70994^1
70995^2
70996^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III OPTIONAL ADJ TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78794</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1292221707</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78794,;.01~VA-GP ONC BRCA I-III OPTIONAL ADJ TX
801.41;+78794,;4~dialog group
801.41;+78794,;5~(Optional)
801.41;+78794,;6~YES
801.41;+78794,;7~2
801.41;+78794,;9~NONE OR ONE SELECTION
801.41;+78794,;23~YES
801.41;+78794,;25~WP-start~1
Select the following options if indicated from the Pathways above:
801.41;+78794,;51~SUPPRESS
801.41;+78794,;100~NATIONAL
801.412;+78795,+78794,;.01~10
801.412;+78795,+78794,;2~VA-GP ONC BREAST CA LRM PRIOR ADJUVANT
801.412;+78796,+78794,;.01~20
801.412;+78796,+78794,;2~VA-GP ONC BREAST CA LRM AFTER ADJUVANT
801.412;+78797,+78794,;.01~30
801.412;+78797,+78794,;2~VA-GP ONC BREAST CA ADJ HT ER+/PR+/HER2 ANY
801.412;+78798,+78794,;.01~50
801.412;+78798,+78794,;2~VA-GP ONC BREAST CA ADJ HT ER+/PR+/HER2-
801.44;+78799,+78794,;.01~06/09/2026@08:52:58
801.44;+78799,+78794,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78795^1
78796^2
78797^3
78798^4
78799^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA PERFORM GERMLINE TEST</POINT_01>
<INTERNAL_ENTRY_NUMBER>73333</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>536715678</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73333,;.01~VA-ONC BRCA PERFORM GERMLINE TEST
801.41;+73333,;4~dialog element
801.41;+73333,;23~YES
801.41;+73333,;25~WP-start~1
- Perform germline testing.
801.41;+73333,;51~SUPPRESS
801.41;+73333,;100~NATIONAL
801.44;+73334,+73333,;.01~06/09/2026@08:52:58
801.44;+73334,+73333,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73334^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NO GL NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78536</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3922459500</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78536,;.01~VA-ONC BRCA I-III ER-T2 IT NO GL NEG OFF PATH RSN
801.41;+78536,;4~dialog element
801.41;+78536,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH RSN
801.41;+78536,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78536,;51~SUPPRESS
801.41;+78536,;100~NATIONAL
801.412;+78537,+78536,;.01~5
801.412;+78537,+78536,;2~VA-ONC OFF PATHWAY
801.412;+78537,+78536,;7~YES
801.412;+78537,+78536,;9~YES
801.44;+78538,+78536,;.01~06/09/2026@08:52:58
801.44;+78538,+78536,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78537^1
78538^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NO GL NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78527</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>147453167</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78527,;.01~VA-ONC BRCA I-III ER-T2 IT NO GL NEG OFF PATH TX
801.41;+78527,;4~dialog element
801.41;+78527,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- OFF PATH TX
801.41;+78527,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78527,;51~SUPPRESS
801.41;+78527,;100~NATIONAL
801.412;+78528,+78527,;.01~5
801.412;+78528,+78527,;2~VA-ONC BLANK
801.412;+78528,+78527,;7~YES
801.412;+78528,+78527,;9~YES
801.44;+78529,+78527,;.01~06/09/2026@08:52:58
801.44;+78529,+78527,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78528^1
78529^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IT NO GL NEG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78519</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>123036861</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78519,;.01~VA-GP ONC BRCA I-III ER-T2 IT NO GL NEG OFF PTHWY
801.41;+78519,;4~dialog group
801.41;+78519,;6~YES
801.41;+78519,;7~2
801.41;+78519,;23~YES
801.41;+78519,;25~WP-start~1
Off pathway:
801.41;+78519,;52~INDENT
801.41;+78519,;100~NATIONAL
801.412;+78520,+78519,;.01~10
801.412;+78520,+78519,;2~VA-ONC BRCA I-III ER-T2 IT NO GL NEG OFF PATH TX
801.412;+78521,+78519,;.01~20
801.412;+78521,+78519,;2~VA-ONC BRCA I-III ER-T2 IT NO GL NEG OFF PATH RSN
801.44;+78522,+78519,;.01~06/09/2026@08:52:58
801.44;+78522,+78519,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78520^1
78521^2
78522^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NO GL NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78503</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1399003872</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78503,;.01~VA-ONC BRCA I-III ER-T2 IT NO GL NEG CLIN TRIAL
801.41;+78503,;4~dialog element
801.41;+78503,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CLIN TRIAL
801.41;+78503,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78503,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78503,;100~NATIONAL
801.412;+78504,+78503,;.01~5
801.412;+78504,+78503,;2~VA-ONC CLINICAL TRIAL
801.412;+78504,+78503,;9~YES
801.44;+78505,+78503,;.01~06/09/2026@08:52:58
801.44;+78505,+78503,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78504^1
78505^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IMM NO GL CAPE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74239</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>990800070</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74239,;.01~VA-ONC BRCA I-III ER-T2 IMM NO GL CAPE
801.41;+74239,;4~dialog element
801.41;+74239,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM- CAP
801.41;+74239,;25~WP-start~1
Capecitabine
801.41;+74239,;35~WP-start~1
Veteran has elected to pursue treatment with CAPECITABINE.
801.41;+74239,;100~NATIONAL
801.44;+74240,+74239,;.01~06/09/2026@08:52:58
801.44;+74240,+74239,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74240^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IMTH NO GL NEG</POINT_01>
<INTERNAL_ENTRY_NUMBER>74238</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3960441672</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74238,;.01~VA-GP ONC BRCA I-III ER-T2 IMTH NO GL NEG
801.41;+74238,;4~dialog group
801.41;+74238,;6~YES
801.41;+74238,;7~2
801.41;+74238,;9~ONE SELECTION ONLY
801.41;+74238,;25~WP-start~1
NEGATIVE Germline BRCA1/2 PV:
801.41;+74238,;35~WP-start~1
Negative Germline BRCA1/2 PV:
801.41;+74238,;100~NATIONAL
801.412;+74239,+74238,;.01~10
801.412;+74239,+74238,;2~VA-ONC BRCA I-III ER-T2 IMM NO GL CAPE
801.412;+74240,+74238,;.01~5
801.412;+74240,+74238,;2~VA-ONC BRCA I-III ER-T2 IT NO GL NEG CLIN TRIAL
801.412;+74241,+74238,;.01~20
801.412;+74241,+74238,;2~VA-GP ONC BRCA I-III ER-T2 IT NO GL NEG OFF PTHWY
801.44;+74242,+74238,;.01~06/09/2026@08:52:58
801.44;+74242,+74238,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74239^1
74240^2
74241^3
74242^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NO GL OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78535</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1990174759</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78535,;.01~VA-ONC BRCA I-III ER-T2 IT NO GL OFF PATH RSN
801.41;+78535,;4~dialog element
801.41;+78535,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH RSN
801.41;+78535,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78535,;51~SUPPRESS
801.41;+78535,;100~NATIONAL
801.412;+78536,+78535,;.01~5
801.412;+78536,+78535,;2~VA-ONC OFF PATHWAY
801.412;+78536,+78535,;7~YES
801.412;+78536,+78535,;9~YES
801.44;+78537,+78535,;.01~06/09/2026@08:52:58
801.44;+78537,+78535,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78536^1
78537^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NO GL OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78526</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3525741983</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78526,;.01~VA-ONC BRCA I-III ER-T2 IT NO GL OFF PATH TX
801.41;+78526,;4~dialog element
801.41;+78526,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OFF PATH TX
801.41;+78526,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78526,;51~SUPPRESS
801.41;+78526,;100~NATIONAL
801.412;+78527,+78526,;.01~5
801.412;+78527,+78526,;2~VA-ONC BLANK
801.412;+78527,+78526,;7~YES
801.412;+78527,+78526,;9~YES
801.44;+78528,+78526,;.01~06/09/2026@08:52:58
801.44;+78528,+78526,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78527^1
78528^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IT NO GL POS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78518</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>335249866</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78518,;.01~VA-GP ONC BRCA I-III ER-T2 IT NO GL POS OFF PTHWY
801.41;+78518,;4~dialog group
801.41;+78518,;6~YES
801.41;+78518,;7~2
801.41;+78518,;23~YES
801.41;+78518,;25~WP-start~1
Off pathway:
801.41;+78518,;52~INDENT
801.41;+78518,;100~NATIONAL
801.412;+78519,+78518,;.01~10
801.412;+78519,+78518,;2~VA-ONC BRCA I-III ER-T2 IT NO GL OFF PATH TX
801.412;+78520,+78518,;.01~20
801.412;+78520,+78518,;2~VA-ONC BRCA I-III ER-T2 IT NO GL OFF PATH RSN
801.44;+78521,+78518,;.01~06/09/2026@08:52:58
801.44;+78521,+78518,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78519^1
78520^2
78521^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NO GL POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78501</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1154407701</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78501,;.01~VA-ONC BRCA I-III ER-T2 IT NO GL POS CLIN TRIAL
801.41;+78501,;4~dialog element
801.41;+78501,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ CLIN TRIAL
801.41;+78501,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78501,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78501,;100~NATIONAL
801.412;+78502,+78501,;.01~5
801.412;+78502,+78501,;2~VA-ONC CLINICAL TRIAL
801.412;+78502,+78501,;9~YES
801.44;+78503,+78501,;.01~06/09/2026@08:52:58
801.44;+78503,+78501,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78502^1
78503^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA OLAP FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>74186</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2904929958</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74186,;.01~VA-ONC BRCA OLAP FN
801.41;+74186,;4~dialog element
801.41;+74186,;23~YES
801.41;+74186,;25~WP-start~2
++ Patients should not be on concomitant olaparib and abemaciclib 
therapy. ++
801.41;+74186,;51~SUPPRESS
801.41;+74186,;100~NATIONAL
801.44;+74187,+74186,;.01~06/09/2026@08:52:58
801.44;+74187,+74186,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74187^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IMTH NO GL OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>74237</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4144966942</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74237,;.01~VA-GP ONC BRCA I-III ER-T2 IMTH NO GL OLAP
801.41;+74237,;4~dialog group
801.41;+74237,;7~2
801.41;+74237,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM RESID GERM+ OLAP
801.41;+74237,;25~WP-start~1
Olaparib (1 Year)
801.41;+74237,;35~WP-start~1
Veteran has elected to pursue treatment with OLAPARIB for 1 Year.
801.41;+74237,;100~NATIONAL
801.412;+74238,+74237,;.01~5
801.412;+74238,+74237,;2~VA-ONC BRCA OLAP FN
801.44;+74239,+74237,;.01~06/09/2026@08:52:58
801.44;+74239,+74237,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74238^1
74239^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IMTH NO GL POS</POINT_01>
<INTERNAL_ENTRY_NUMBER>74236</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2504787507</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74236,;.01~VA-GP ONC BRCA I-III ER-T2 IMTH NO GL POS
801.41;+74236,;4~dialog group
801.41;+74236,;6~YES
801.41;+74236,;7~2
801.41;+74236,;9~ONE SELECTION ONLY
801.41;+74236,;25~WP-start~1
POSITIVE Germline BRCA1/2 PV:
801.41;+74236,;35~WP-start~1
Positive Germline BRCA1/2 PV:
801.41;+74236,;100~NATIONAL
801.412;+74237,+74236,;.01~10
801.412;+74237,+74236,;2~VA-GP ONC BRCA I-III ER-T2 IMTH NO GL OLAP
801.412;+74238,+74236,;.01~5
801.412;+74238,+74236,;2~VA-ONC BRCA I-III ER-T2 IT NO GL POS CLIN TRIAL
801.412;+74239,+74236,;.01~20
801.412;+74239,+74236,;2~VA-GP ONC BRCA I-III ER-T2 IT NO GL POS OFF PTHWY
801.44;+74240,+74236,;.01~06/09/2026@08:52:58
801.44;+74240,+74236,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74237^1
74238^2
74239^3
74240^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III ER- T2 IMTH RESIDUAL YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>74235</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3487821023</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74235,;.01~VA-GP ONC BR CA I-III ER- T2 IMTH RESIDUAL YES
801.41;+74235,;4~dialog group
801.41;+74235,;6~YES
801.41;+74235,;7~2
801.41;+74235,;9~ONE SELECTION ONLY
801.41;+74235,;25~WP-start~1
Residual disease:
801.41;+74235,;100~NATIONAL
801.412;+74236,+74235,;.01~10
801.412;+74236,+74235,;2~VA-GP ONC BRCA I-III ER-T2 IMTH NO GL POS
801.412;+74237,+74235,;.01~20
801.412;+74237,+74235,;2~VA-GP ONC BRCA I-III ER-T2 IMTH NO GL NEG
801.44;+74238,+74235,;.01~06/09/2026@08:52:58
801.44;+74238,+74235,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74236^1
74237^2
74238^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NR OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78534</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3194221172</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78534,;.01~VA-ONC BRCA I-III ER-T2 IT NR OFF PATH RSN
801.41;+78534,;4~dialog element
801.41;+78534,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH RSN
801.41;+78534,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78534,;51~SUPPRESS
801.41;+78534,;100~NATIONAL
801.412;+78535,+78534,;.01~5
801.412;+78535,+78534,;2~VA-ONC OFF PATHWAY
801.412;+78535,+78534,;7~YES
801.412;+78535,+78534,;9~YES
801.44;+78536,+78534,;.01~06/09/2026@08:52:58
801.44;+78536,+78534,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78535^1
78536^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NR OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78525</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2801827346</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78525,;.01~VA-ONC BRCA I-III ER-T2 IT NR OFF PATH TX
801.41;+78525,;4~dialog element
801.41;+78525,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID OFF PATH TX
801.41;+78525,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78525,;51~SUPPRESS
801.41;+78525,;100~NATIONAL
801.412;+78526,+78525,;.01~5
801.412;+78526,+78525,;2~VA-ONC BLANK
801.412;+78526,+78525,;7~YES
801.412;+78526,+78525,;9~YES
801.44;+78527,+78525,;.01~06/09/2026@08:52:59
801.44;+78527,+78525,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78526^1
78527^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IT NR OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78514</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>409690005</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78514,;.01~VA-GP ONC BRCA I-III ER-T2 IT NR OFF PTHWY
801.41;+78514,;4~dialog group
801.41;+78514,;6~YES
801.41;+78514,;7~2
801.41;+78514,;23~YES
801.41;+78514,;25~WP-start~1
Off pathway:
801.41;+78514,;52~INDENT
801.41;+78514,;100~NATIONAL
801.412;+78515,+78514,;.01~10
801.412;+78515,+78514,;2~VA-ONC BRCA I-III ER-T2 IT NR OFF PATH TX
801.412;+78516,+78514,;.01~20
801.412;+78516,+78514,;2~VA-ONC BRCA I-III ER-T2 IT NR OFF PATH RSN
801.44;+78517,+78514,;.01~06/09/2026@08:52:59
801.44;+78517,+78514,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78515^1
78516^2
78517^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IT NR CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78499</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3982218684</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78499,;.01~VA-ONC BRCA I-III ER-T2 IT NR CLIN TRIAL
801.41;+78499,;4~dialog element
801.41;+78499,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID CLIN TRIAL
801.41;+78499,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78499,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78499,;100~NATIONAL
801.412;+78500,+78499,;.01~5
801.412;+78500,+78499,;2~VA-ONC CLINICAL TRIAL
801.412;+78500,+78499,;9~YES
801.44;+78501,+78499,;.01~06/09/2026@08:52:59
801.44;+78501,+78499,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78500^1
78501^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T2 IMTH NO RESID SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>74234</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>755523208</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74234,;.01~VA-ONC BR I-III ER- T2 IMTH NO RESID SURV
801.41;+74234,;4~dialog element
801.41;+74234,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM NO RESID SURV
801.41;+74234,;25~WP-start~1
Surveillance
801.41;+74234,;35~WP-start~1
Veteran has elected to pursue SURVEILLANCE.
801.41;+74234,;100~NATIONAL
801.44;+74235,+74234,;.01~06/09/2026@08:52:59
801.44;+74235,+74234,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74235^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IMTH RESIDUAL NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74233</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2251018746</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74233,;.01~VA-GP ONC BRCA I-III ER-T2 IMTH RESIDUAL NO
801.41;+74233,;4~dialog group
801.41;+74233,;6~YES
801.41;+74233,;7~2
801.41;+74233,;9~ONE SELECTION ONLY
801.41;+74233,;25~WP-start~1
No residual disease:
801.41;+74233,;35~WP-start~1
No Residual Disease:
801.41;+74233,;100~NATIONAL
801.412;+74234,+74233,;.01~10
801.412;+74234,+74233,;2~VA-ONC BR I-III ER- T2 IMTH NO RESID SURV
801.412;+74235,+74233,;.01~5
801.412;+74235,+74233,;2~VA-ONC BRCA I-III ER-T2 IT NR CLIN TRIAL
801.412;+74236,+74233,;.01~20
801.412;+74236,+74233,;2~VA-GP ONC BRCA I-III ER-T2 IT NR OFF PTHWY
801.44;+74237,+74233,;.01~06/09/2026@08:52:59
801.44;+74237,+74233,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74234^1
74235^2
74236^3
74237^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER- T2 IMTHPY NO RESID DZ</POINT_01>
<INTERNAL_ENTRY_NUMBER>74231</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1327392091</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74231,;.01~VA-GP ONC BRCA I-III ER- T2 IMTHPY NO RESID DZ
801.41;+74231,;4~dialog group
801.41;+74231,;6~YES
801.41;+74231,;7~2
801.41;+74231,;9~ONE SELECTION ONLY
801.41;+74231,;23~YES
801.41;+74231,;25~WP-start~1
Residual Disease AFTER Neoadjuvant Therapy:
801.41;+74231,;100~NATIONAL
801.412;+74232,+74231,;.01~10
801.412;+74232,+74231,;2~VA-GP ONC BRCA I-III ER-T2 IMTH RESIDUAL NO
801.412;+74233,+74231,;.01~20
801.412;+74233,+74231,;2~VA-GP ONC BR CA I-III ER- T2 IMTH RESIDUAL YES
801.44;+74234,+74231,;.01~06/09/2026@08:52:59
801.44;+74234,+74231,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74232^1
74233^2
74234^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL IT NO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78533</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1860736287</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78533,;.01~VA-ONC BRCA I-III ER-T2 GL IT NO OFF PATH RSN
801.41;+78533,;4~dialog element
801.41;+78533,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH RSN
801.41;+78533,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78533,;51~SUPPRESS
801.41;+78533,;100~NATIONAL
801.412;+78534,+78533,;.01~5
801.412;+78534,+78533,;2~VA-ONC OFF PATHWAY
801.412;+78534,+78533,;7~YES
801.412;+78534,+78533,;9~YES
801.44;+78535,+78533,;.01~06/09/2026@08:52:59
801.44;+78535,+78533,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78534^1
78535^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL IT NO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78524</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>834339521</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78524,;.01~VA-ONC BRCA I-III ER-T2 GL IT NO OFF PATH TX
801.41;+78524,;4~dialog element
801.41;+78524,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND OFF PATH TX
801.41;+78524,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78524,;51~SUPPRESS
801.41;+78524,;100~NATIONAL
801.412;+78525,+78524,;.01~5
801.412;+78525,+78524,;2~VA-ONC BLANK
801.412;+78525,+78524,;7~YES
801.412;+78525,+78524,;9~YES
801.44;+78526,+78524,;.01~06/09/2026@08:52:59
801.44;+78526,+78524,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78525^1
78526^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 GL IT NO OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78513</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1599059890</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78513,;.01~VA-GP ONC BRCA I-III ER-T2 GL IT NO OFF PTHWY
801.41;+78513,;4~dialog group
801.41;+78513,;6~YES
801.41;+78513,;7~2
801.41;+78513,;23~YES
801.41;+78513,;25~WP-start~1
Off pathway:
801.41;+78513,;52~INDENT
801.41;+78513,;100~NATIONAL
801.412;+78514,+78513,;.01~10
801.412;+78514,+78513,;2~VA-ONC BRCA I-III ER-T2 GL IT NO OFF PATH TX
801.412;+78515,+78513,;.01~20
801.412;+78515,+78513,;2~VA-ONC BRCA I-III ER-T2 GL IT NO OFF PATH RSN
801.44;+78516,+78513,;.01~06/09/2026@08:52:59
801.44;+78516,+78513,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78514^1
78515^2
78516^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL IT NO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78497</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1528440973</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78497,;.01~VA-ONC BRCA I-III ER-T2 GL IT NO CLIN TRIAL
801.41;+78497,;4~dialog element
801.41;+78497,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND CLIN TRIAL
801.41;+78497,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78497,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78497,;100~NATIONAL
801.412;+78498,+78497,;.01~5
801.412;+78498,+78497,;2~VA-ONC CLINICAL TRIAL
801.412;+78498,+78497,;9~YES
801.44;+78499,+78497,;.01~06/09/2026@08:52:59
801.44;+78499,+78497,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78498^1
78499^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 IMTH NO ADJ DDAC-T+LRM</POINT_01>
<INTERNAL_ENTRY_NUMBER>74232</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1725071286</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74232,;.01~VA-ONC BRCA I-III ER-T2 IMTH NO ADJ DDAC-T+LRM
801.41;+74232,;4~dialog element
801.41;+74232,;15~HF.VA-ONC BRCA I-III ER- T2N+ NOT IMM CAND ddAC-T+LRM AFTER
801.41;+74232,;25~WP-start~2
ddAC-T; then Follow Local/Regional Management After Neoadjuvant Treatment
Pathway
801.41;+74232,;35~WP-start~2
Veteran has elected to pursue treatment with neoadjuvant ddAC-T then
FOLLOW LOCAL/REGIONAL MANAGEMENT AFTER NEOADJUVANT TREATMENT PATHWAY.
801.41;+74232,;100~NATIONAL
801.44;+74233,+74232,;.01~06/09/2026@08:52:59
801.44;+74233,+74232,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74233^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 IMTHPY NO NEOADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>74230</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>244836217</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74230,;.01~VA-GP ONC BRCA I-III ER-T2 IMTHPY NO NEOADJ THERAPY
801.41;+74230,;4~dialog group
801.41;+74230,;6~YES
801.41;+74230,;7~2
801.41;+74230,;9~ONE SELECTION ONLY
801.41;+74230,;25~WP-start~1
Neoadjuvant Therapy:
801.41;+74230,;52~INDENT
801.41;+74230,;100~NATIONAL
801.412;+74231,+74230,;.01~10
801.412;+74231,+74230,;2~VA-ONC BRCA I-III ER-T2 IMTH NO ADJ DDAC-T+LRM
801.412;+74232,+74230,;.01~5
801.412;+74232,+74230,;2~VA-ONC BRCA I-III ER-T2 GL IT NO CLIN TRIAL
801.412;+74233,+74230,;.01~20
801.412;+74233,+74230,;2~VA-GP ONC BRCA I-III ER-T2 GL IT NO OFF PTHWY
801.44;+74234,+74230,;.01~06/09/2026@08:52:59
801.44;+74234,+74230,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74231^1
74232^2
74233^3
74234^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III ER- T2 IMTHPY NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74194</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>452418276</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74194,;.01~VA-GP ONC BR CA I-III ER- T2 IMTHPY NO
801.41;+74194,;4~dialog group
801.41;+74194,;6~YES
801.41;+74194,;7~2
801.41;+74194,;9~ONE SELECTION ONLY
801.41;+74194,;25~WP-start~1
Not a Candidate for Immunotherapy:
801.41;+74194,;52~INDENT
801.41;+74194,;100~NATIONAL
801.412;+74195,+74194,;.01~20
801.412;+74195,+74194,;2~VA-GP ONC BRCA I-III ER-T2 IMTHPY NO NEOADJ THERAPY
801.412;+74196,+74194,;.01~40
801.412;+74196,+74194,;2~VA-GP ONC BRCA I-III ER- T2 IMTHPY NO RESID DZ
801.44;+74197,+74194,;.01~06/09/2026@08:52:59
801.44;+74197,+74194,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74195^1
74196^2
74197^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL NEG OFF PATH RSN2</POINT_01>
<INTERNAL_ENTRY_NUMBER>78567</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3762391210</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78567,;.01~VA-ONC BRCA I-III ER-T2 GL NEG OFF PATH RSN2
801.41;+78567,;4~dialog element
801.41;+78567,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH RSN
801.41;+78567,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78567,;51~SUPPRESS
801.41;+78567,;100~NATIONAL
801.412;+78568,+78567,;.01~5
801.412;+78568,+78567,;2~VA-ONC OFF PATHWAY
801.412;+78568,+78567,;7~YES
801.412;+78568,+78567,;9~YES
801.44;+78569,+78567,;.01~06/09/2026@08:52:59
801.44;+78569,+78567,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78568^1
78569^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL NEG OFF PATH TX2</POINT_01>
<INTERNAL_ENTRY_NUMBER>78566</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2400713971</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78566,;.01~VA-ONC BRCA I-III ER-T2 GL NEG OFF PATH TX2
801.41;+78566,;4~dialog element
801.41;+78566,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- OFF PATH TX
801.41;+78566,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78566,;51~SUPPRESS
801.41;+78566,;100~NATIONAL
801.412;+78567,+78566,;.01~5
801.412;+78567,+78566,;2~VA-ONC BLANK
801.412;+78567,+78566,;7~YES
801.412;+78567,+78566,;9~YES
801.44;+78568,+78566,;.01~06/09/2026@08:52:59
801.44;+78568,+78566,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78567^1
78568^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 GL NEG OFF PTHWY2</POINT_01>
<INTERNAL_ENTRY_NUMBER>78565</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>502242277</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78565,;.01~VA-GP ONC BRCA I-III ER-T2 GL NEG OFF PTHWY2
801.41;+78565,;4~dialog group
801.41;+78565,;6~YES
801.41;+78565,;7~2
801.41;+78565,;23~YES
801.41;+78565,;25~WP-start~1
Off pathway:
801.41;+78565,;52~INDENT
801.41;+78565,;100~NATIONAL
801.412;+78566,+78565,;.01~10
801.412;+78566,+78565,;2~VA-ONC BRCA I-III ER-T2 GL NEG OFF PATH TX2
801.412;+78567,+78565,;.01~20
801.412;+78567,+78565,;2~VA-ONC BRCA I-III ER-T2 GL NEG OFF PATH RSN2
801.44;+78568,+78565,;.01~06/09/2026@08:52:59
801.44;+78568,+78565,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78566^1
78567^2
78568^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78564</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4096094235</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78564,;.01~VA-ONC BRCA I-III ER-T2 GL NEG CLIN TRIAL
801.41;+78564,;4~dialog element
801.41;+78564,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- CLIN TRIAL
801.41;+78564,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78564,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78564,;100~NATIONAL
801.412;+78565,+78564,;.01~5
801.412;+78565,+78564,;2~VA-ONC CLINICAL TRIAL
801.412;+78565,+78564,;9~YES
801.44;+78566,+78564,;.01~06/09/2026@08:52:59
801.44;+78566,+78564,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78565^1
78566^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T2 BRCA NEG PEMBRO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74229</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>21934627</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74229,;.01~VA-ONC BR I-III ER- T2 BRCA NEG PEMBRO
801.41;+74229,;4~dialog element
801.41;+74229,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB
801.41;+74229,;25~WP-start~1
Pembrolizumab
801.41;+74229,;35~WP-start~1
Veteran has elected to pursue treatment with PEMBROLIZUMAB.
801.41;+74229,;100~NATIONAL
801.44;+74230,+74229,;.01~06/09/2026@08:52:59
801.44;+74230,+74229,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74230^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T2 BRCA NEG PEM+CAPE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74228</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2789506965</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74228,;.01~VA-ONC BR I-III ER- T2 BRCA NEG PEM+CAPE
801.41;+74228,;4~dialog element
801.41;+74228,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM- PEMB+CAP
801.41;+74228,;25~WP-start~1
Pembrolizumab and capecitabine
801.41;+74228,;35~WP-start~2
Veteran has elected to pursue treatment with PEMBROLIZUMAB and
CAPECITABINE Therapy.
801.41;+74228,;100~NATIONAL
801.44;+74229,+74228,;.01~06/09/2026@08:52:59
801.44;+74229,+74228,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74229^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 BRCA NEG PREFER</POINT_01>
<INTERNAL_ENTRY_NUMBER>74227</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2906297002</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74227,;.01~VA-GP ONC BR I-III ER- T2 BRCA NEG PREFER
801.41;+74227,;4~dialog group
801.41;+74227,;6~YES
801.41;+74227,;7~2
801.41;+74227,;9~ONE SELECTION ONLY
801.41;+74227,;25~WP-start~1
Patient preference after shared decision making:
801.41;+74227,;51~SUPPRESS
801.41;+74227,;100~NATIONAL
801.412;+74228,+74227,;.01~10
801.412;+74228,+74227,;2~VA-ONC BR I-III ER- T2 BRCA NEG PEM+CAPE
801.412;+74229,+74227,;.01~20
801.412;+74229,+74227,;2~VA-ONC BR I-III ER- T2 BRCA NEG PEMBRO
801.412;+74230,+74227,;.01~5
801.412;+74230,+74227,;2~VA-ONC BRCA I-III ER-T2 GL NEG CLIN TRIAL
801.412;+74231,+74227,;.01~30
801.412;+74231,+74227,;2~VA-GP ONC BRCA I-III ER-T2 GL NEG OFF PTHWY2
801.44;+74232,+74227,;.01~06/09/2026@08:52:59
801.44;+74232,+74227,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74228^1
74229^2
74230^3
74231^4
74232^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 BRCA NEG</POINT_01>
<INTERNAL_ENTRY_NUMBER>74221</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1474484524</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74221,;.01~VA-GP ONC BR I-III ER- T2 BRCA NEG
801.41;+74221,;4~dialog group
801.41;+74221,;7~2
801.41;+74221,;25~WP-start~1
Germline BRCA1/2 PV NEGATIVE:
801.41;+74221,;35~WP-start~1
Germline BRCA1/2 PV Negative:
801.41;+74221,;100~NATIONAL
801.412;+74222,+74221,;.01~20
801.412;+74222,+74221,;2~VA-GP ONC BR I-III ER- T2 BRCA NEG PREFER
801.44;+74223,+74221,;.01~06/09/2026@08:52:59
801.44;+74223,+74221,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74222^1
74223^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL POS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78531</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2628923134</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78531,;.01~VA-ONC BRCA I-III ER-T2 GL POS OFF PATH RSN
801.41;+78531,;4~dialog element
801.41;+78531,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ OFF PATH RSN
801.41;+78531,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78531,;51~SUPPRESS
801.41;+78531,;100~NATIONAL
801.412;+78532,+78531,;.01~5
801.412;+78532,+78531,;2~VA-ONC OFF PATHWAY
801.412;+78532,+78531,;7~YES
801.412;+78532,+78531,;9~YES
801.44;+78533,+78531,;.01~06/09/2026@08:52:59
801.44;+78533,+78531,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78532^1
78533^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL POS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78522</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1259866358</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78522,;.01~VA-ONC BRCA I-III ER-T2 GL POS OFF PATH TX
801.41;+78522,;4~dialog element
801.41;+78522,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ OFF PATH TX
801.41;+78522,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78522,;51~SUPPRESS
801.41;+78522,;100~NATIONAL
801.412;+78523,+78522,;.01~5
801.412;+78523,+78522,;2~VA-ONC BLANK
801.412;+78523,+78522,;7~YES
801.412;+78523,+78522,;9~YES
801.44;+78524,+78522,;.01~06/09/2026@08:52:59
801.44;+78524,+78522,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78523^1
78524^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 GL POS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78510</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1504074820</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78510,;.01~VA-GP ONC BRCA I-III ER-T2 GL POS OFF PTHWY
801.41;+78510,;4~dialog group
801.41;+78510,;6~YES
801.41;+78510,;7~2
801.41;+78510,;23~YES
801.41;+78510,;25~WP-start~1
Off pathway:
801.41;+78510,;52~INDENT
801.41;+78510,;100~NATIONAL
801.412;+78511,+78510,;.01~10
801.412;+78511,+78510,;2~VA-ONC BRCA I-III ER-T2 GL POS OFF PATH TX
801.412;+78512,+78510,;.01~20
801.412;+78512,+78510,;2~VA-ONC BRCA I-III ER-T2 GL POS OFF PATH RSN
801.44;+78513,+78510,;.01~06/09/2026@08:52:59
801.44;+78513,+78510,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78511^1
78512^2
78513^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 GL POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78495</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3609370524</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78495,;.01~VA-ONC BRCA I-III ER-T2 GL POS CLIN TRIAL
801.41;+78495,;4~dialog element
801.41;+78495,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ CLIN TRIAL
801.41;+78495,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78495,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78495,;100~NATIONAL
801.412;+78496,+78495,;.01~5
801.412;+78496,+78495,;2~VA-ONC CLINICAL TRIAL
801.412;+78496,+78495,;9~YES
801.44;+78497,+78495,;.01~06/09/2026@08:52:59
801.44;+78497,+78495,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78496^1
78497^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T2 BRCA POS PEMBRO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74220</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3245758802</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74220,;.01~VA-ONC BR I-III ER- T2 BRCA POS PEMBRO
801.41;+74220,;4~dialog element
801.41;+74220,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB
801.41;+74220,;25~WP-start~1
Pembrolizumab
801.41;+74220,;35~WP-start~1
Veteran has elected to pursue treatment with PEMBROLIZUMAB.
801.41;+74220,;100~NATIONAL
801.44;+74221,+74220,;.01~06/09/2026@08:52:59
801.44;+74221,+74220,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74221^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 BRCA POS PEM+OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>74216</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>507814492</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74216,;.01~VA-GP ONC BR I-III ER- T2 BRCA POS PEM+OLAP
801.41;+74216,;4~dialog group
801.41;+74216,;7~2
801.41;+74216,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM RESID GERM+ PEMB+OLAP
801.41;+74216,;25~WP-start~1
Pembrolizumab and olaparib (1 year)
801.41;+74216,;35~WP-start~2
Veteran has elected to pursue treatment with PEMBROLIZUMAB and OLAPARIB
Therapy for 1 Year.
801.41;+74216,;100~NATIONAL
801.412;+74217,+74216,;.01~5
801.412;+74217,+74216,;2~VA-ONC BRCA OLAP FN
801.44;+74218,+74216,;.01~06/09/2026@08:52:59
801.44;+74218,+74216,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74217^1
74218^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 GL POS PREFER</POINT_01>
<INTERNAL_ENTRY_NUMBER>74214</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3900524993</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74214,;.01~VA-GP ONC BRCA I-III ER-T2 GL POS PREFER
801.41;+74214,;4~dialog group
801.41;+74214,;6~YES
801.41;+74214,;7~2
801.41;+74214,;9~NONE OR ONE SELECTION
801.41;+74214,;25~WP-start~1
Patient preference after shared decision making:
801.41;+74214,;51~SUPPRESS
801.41;+74214,;100~NATIONAL
801.412;+74215,+74214,;.01~20
801.412;+74215,+74214,;2~VA-GP ONC BR I-III ER- T2 BRCA POS PEM+OLAP
801.412;+74216,+74214,;.01~40
801.412;+74216,+74214,;2~VA-ONC BR I-III ER- T2 BRCA POS PEMBRO
801.412;+74217,+74214,;.01~10
801.412;+74217,+74214,;2~VA-ONC BRCA I-III ER-T2 GL POS CLIN TRIAL
801.412;+74218,+74214,;.01~50
801.412;+74218,+74214,;2~VA-GP ONC BRCA I-III ER-T2 GL POS OFF PTHWY
801.44;+74219,+74214,;.01~06/09/2026@08:52:59
801.44;+74219,+74214,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74215^1
74216^2
74217^3
74218^4
74219^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 BRCA POS</POINT_01>
<INTERNAL_ENTRY_NUMBER>74213</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>244386099</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74213,;.01~VA-GP ONC BR I-III ER- T2 BRCA POS
801.41;+74213,;4~dialog group
801.41;+74213,;7~2
801.41;+74213,;25~WP-start~1
Germline BRCA1/2 PV POSITIVE:
801.41;+74213,;35~WP-start~1
Germline BRCA1/2 PV Positive:
801.41;+74213,;100~NATIONAL
801.412;+74214,+74213,;.01~10
801.412;+74214,+74213,;2~VA-GP ONC BRCA I-III ER-T2 GL POS PREFER
801.44;+74215,+74213,;.01~06/09/2026@08:52:59
801.44;+74215,+74213,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74214^1
74215^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 RESIDUAL YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>74212</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1879336176</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74212,;.01~VA-GP ONC BR I-III ER- T2 RESIDUAL YES
801.41;+74212,;4~dialog group
801.41;+74212,;6~YES
801.41;+74212,;7~2
801.41;+74212,;9~ONE SELECTION ONLY
801.41;+74212,;25~WP-start~1
Residual disease:
801.41;+74212,;52~INDENT
801.41;+74212,;100~NATIONAL
801.412;+74213,+74212,;.01~10
801.412;+74213,+74212,;2~VA-GP ONC BR I-III ER- T2 BRCA POS
801.412;+74214,+74212,;.01~20
801.412;+74214,+74212,;2~VA-GP ONC BR I-III ER- T2 BRCA NEG
801.44;+74215,+74212,;.01~06/09/2026@08:52:59
801.44;+74215,+74212,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74213^1
74214^2
74215^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 NR OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78530</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1984749667</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78530,;.01~VA-ONC BRCA I-III ER-T2 NR OFF PATH RSN
801.41;+78530,;4~dialog element
801.41;+78530,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH RSN
801.41;+78530,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78530,;51~SUPPRESS
801.41;+78530,;100~NATIONAL
801.412;+78531,+78530,;.01~5
801.412;+78531,+78530,;2~VA-ONC OFF PATHWAY
801.412;+78531,+78530,;7~YES
801.412;+78531,+78530,;9~YES
801.44;+78532,+78530,;.01~06/09/2026@08:52:59
801.44;+78532,+78530,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78531^1
78532^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 NR OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78537</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3882789735</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78537,;.01~VA-ONC BRCA I-III ER-T2 NR OFF PATH TX
801.41;+78537,;4~dialog element
801.41;+78537,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM NO RESID OFF PATH TX
801.41;+78537,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78537,;51~SUPPRESS
801.41;+78537,;100~NATIONAL
801.412;+78538,+78537,;.01~5
801.412;+78538,+78537,;2~VA-ONC BLANK
801.412;+78538,+78537,;7~YES
801.412;+78538,+78537,;9~YES
801.44;+78539,+78537,;.01~06/09/2026@08:52:59
801.44;+78539,+78537,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78538^1
78539^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 NR OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78509</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1850396771</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78509,;.01~VA-GP ONC BRCA I-III ER-T2 NR OFF PTHWY
801.41;+78509,;4~dialog group
801.41;+78509,;6~YES
801.41;+78509,;7~2
801.41;+78509,;23~YES
801.41;+78509,;25~WP-start~1
Off pathway:
801.41;+78509,;52~INDENT
801.41;+78509,;100~NATIONAL
801.412;+78510,+78509,;.01~10
801.412;+78510,+78509,;2~VA-ONC BRCA I-III ER-T2 NR OFF PATH TX
801.412;+78511,+78509,;.01~20
801.412;+78511,+78509,;2~VA-ONC BRCA I-III ER-T2 NR OFF PATH RSN
801.44;+78512,+78509,;.01~06/09/2026@08:52:59
801.44;+78512,+78509,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78510^1
78511^2
78512^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 NR CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78494</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1238535043</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78494,;.01~VA-ONC BRCA I-III ER-T2 NR CLIN TRIAL
801.41;+78494,;4~dialog element
801.41;+78494,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM NO RESID CLIN TRIAL
801.41;+78494,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78494,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78494,;100~NATIONAL
801.412;+78495,+78494,;.01~5
801.412;+78495,+78494,;2~VA-ONC CLINICAL TRIAL
801.412;+78495,+78494,;9~YES
801.44;+78496,+78494,;.01~06/09/2026@08:52:59
801.44;+78496,+78494,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78495^1
78496^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T2 RESIDUAL NO ADJ PEMBRO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74211</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4212821263</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74211,;.01~VA-ONC BR I-III ER- T2 RESIDUAL NO ADJ PEMBRO
801.41;+74211,;4~dialog element
801.41;+74211,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM NO RESID ADJ PEMB
801.41;+74211,;25~WP-start~1
Adjuvant pembrolizumab (9 cycles, 27 weeks)
801.41;+74211,;35~WP-start~2
Veteran has elected to pursue treatment with ADJUVANT PEMBROLIZUMAB
Therapy of 9 cycles, for 27 weeks.
801.41;+74211,;100~NATIONAL
801.44;+74212,+74211,;.01~06/09/2026@08:52:59
801.44;+74212,+74211,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74212^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 RESIDUAL NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74210</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2221690469</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74210,;.01~VA-GP ONC BR I-III ER- T2 RESIDUAL NO
801.41;+74210,;4~dialog group
801.41;+74210,;6~YES
801.41;+74210,;7~2
801.41;+74210,;9~ONE SELECTION ONLY
801.41;+74210,;25~WP-start~1
No residual disease:
801.41;+74210,;35~WP-start~1
No Residual Disease:
801.41;+74210,;52~INDENT
801.41;+74210,;100~NATIONAL
801.412;+74211,+74210,;.01~10
801.412;+74211,+74210,;2~VA-ONC BR I-III ER- T2 RESIDUAL NO ADJ PEMBRO
801.412;+74212,+74210,;.01~5
801.412;+74212,+74210,;2~VA-ONC BRCA I-III ER-T2 NR CLIN TRIAL
801.412;+74213,+74210,;.01~20
801.412;+74213,+74210,;2~VA-GP ONC BRCA I-III ER-T2 NR OFF PTHWY
801.44;+74214,+74210,;.01~06/09/2026@08:52:59
801.44;+74214,+74210,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74211^1
74212^2
74213^3
74214^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 RESIDUAL DZ</POINT_01>
<INTERNAL_ENTRY_NUMBER>74209</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2447678879</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74209,;.01~VA-GP ONC BR I-III ER- T2 RESIDUAL DZ
801.41;+74209,;4~dialog group
801.41;+74209,;6~YES
801.41;+74209,;7~2
801.41;+74209,;9~ONE SELECTION ONLY
801.41;+74209,;23~YES
801.41;+74209,;25~WP-start~1
Residual Disease AFTER NeoAdjuvant Therapy:
801.41;+74209,;100~NATIONAL
801.412;+74210,+74209,;.01~20
801.412;+74210,+74209,;2~VA-GP ONC BR I-III ER- T2 RESIDUAL NO
801.412;+74211,+74209,;.01~40
801.412;+74211,+74209,;2~VA-GP ONC BR I-III ER- T2 RESIDUAL YES
801.44;+74212,+74209,;.01~06/09/2026@08:52:59
801.44;+74212,+74209,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74210^1
74211^2
74212^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78529</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3320618642</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78529,;.01~VA-ONC BRCA I-III ER-T2 OFF PATH RSN
801.41;+78529,;4~dialog element
801.41;+78529,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH RSN
801.41;+78529,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78529,;51~SUPPRESS
801.41;+78529,;100~NATIONAL
801.412;+78530,+78529,;.01~5
801.412;+78530,+78529,;2~VA-ONC OFF PATHWAY
801.412;+78530,+78529,;7~YES
801.412;+78530,+78529,;9~YES
801.44;+78531,+78529,;.01~06/09/2026@08:52:59
801.44;+78531,+78529,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78530^1
78531^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78521</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2103514066</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78521,;.01~VA-ONC BRCA I-III ER-T2 OFF PATH TX
801.41;+78521,;4~dialog element
801.41;+78521,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM CAND OFF PATH TX
801.41;+78521,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78521,;51~SUPPRESS
801.41;+78521,;100~NATIONAL
801.412;+78522,+78521,;.01~5
801.412;+78522,+78521,;2~VA-ONC BLANK
801.412;+78522,+78521,;7~YES
801.412;+78522,+78521,;9~YES
801.44;+78523,+78521,;.01~06/09/2026@08:52:59
801.44;+78523,+78521,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78522^1
78523^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78508</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4275526141</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78508,;.01~VA-GP ONC BRCA I-III ER-T2 OFF PTHWY
801.41;+78508,;4~dialog group
801.41;+78508,;6~YES
801.41;+78508,;7~2
801.41;+78508,;23~YES
801.41;+78508,;25~WP-start~1
Off pathway:
801.41;+78508,;52~INDENT
801.41;+78508,;100~NATIONAL
801.412;+78509,+78508,;.01~10
801.412;+78509,+78508,;2~VA-ONC BRCA I-III ER-T2 OFF PATH TX
801.412;+78510,+78508,;.01~20
801.412;+78510,+78508,;2~VA-ONC BRCA I-III ER-T2 OFF PATH RSN
801.44;+78511,+78508,;.01~06/09/2026@08:52:59
801.44;+78511,+78508,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78509^1
78510^2
78511^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T2 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78493</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1482896643</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78493,;.01~VA-ONC BRCA I-III ER-T2 CLIN TRIAL
801.41;+78493,;4~dialog element
801.41;+78493,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM CAND CLIN TRIAL
801.41;+78493,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78493,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78493,;100~NATIONAL
801.412;+78494,+78493,;.01~5
801.412;+78494,+78493,;2~VA-ONC CLINICAL TRIAL
801.412;+78494,+78493,;9~YES
801.44;+78495,+78493,;.01~06/09/2026@08:52:59
801.44;+78495,+78493,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78494^1
78495^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III T2 ADJ THERAPY FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>74208</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2347701998</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74208,;.01~VA-ONC BR I-III T2 ADJ THERAPY FN
801.41;+74208,;4~dialog element
801.41;+74208,;23~YES
801.41;+74208,;25~WP-start~4
++ -Evaluate Cardiovascular Risk Factors, baseline LVEF (with ECHO or 
MUGA) and CMP. 
\\   -Effective Nonhormonal or Barrier Contraceptive Methods should be
used during treatment. ++
801.41;+74208,;51~SUPPRESS
801.41;+74208,;100~NATIONAL
801.44;+74209,+74208,;.01~06/09/2026@08:52:59
801.44;+74209,+74208,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74209^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T2 ADJ THERAPY PEMBRO+</POINT_01>
<INTERNAL_ENTRY_NUMBER>74207</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>454921619</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74207,;.01~VA-GP ONC BR I-III ER- T2 ADJ THERAPY PEMBRO+
801.41;+74207,;4~dialog group
801.41;+74207,;7~2
801.41;+74207,;15~HF.VA-ONC BRCA I-III ER- T2N+ IMM CAND PEMB+CARB/PAC
801.41;+74207,;25~WP-start~4
Pembrolizumab and carboplatin/paclitaxel (4 cycles, 12 weeks); then 
Pembrolizumab and neoadjuvant adriamycin/cyclophosphamide (AC) (4 cycles,
12 weeks); then Follow Local/Regional Management After Neoadjuvant
Treatment Pathway
801.41;+74207,;35~WP-start~4
Veteran has elected to pursue treatment with PEMBROLIZUMAB and
CARBOPLATIN/PACLITAXEL (4 cycles, 12 weeks); then PEMBROLIZUMAB and AC (4
cycles, 12 weeks); then FOLLOW LOCAL/REGIONAL MANAGEMENT AFTER NEOADJUVANT
TREATMENT PATHWAY.
801.41;+74207,;100~NATIONAL
801.412;+74208,+74207,;.01~5
801.412;+74208,+74207,;2~VA-ONC BR I-III T2 ADJ THERAPY FN
801.44;+74209,+74207,;.01~06/09/2026@08:52:59
801.44;+74209,+74207,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74208^1
74209^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T2 NEOADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>74206</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3146422431</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74206,;.01~VA-GP ONC BRCA I-III ER-T2 NEOADJ THERAPY
801.41;+74206,;4~dialog group
801.41;+74206,;6~YES
801.41;+74206,;7~2
801.41;+74206,;9~NONE OR ONE SELECTION
801.41;+74206,;23~YES
801.41;+74206,;25~WP-start~1
Neoadjuvant Therapy:
801.41;+74206,;52~INDENT
801.41;+74206,;100~NATIONAL
801.412;+74207,+74206,;.01~10
801.412;+74207,+74206,;2~VA-GP ONC BR I-III ER- T2 ADJ THERAPY PEMBRO+
801.412;+74208,+74206,;.01~5
801.412;+74208,+74206,;2~VA-ONC BRCA I-III ER-T2 CLIN TRIAL
801.412;+74209,+74206,;.01~20
801.412;+74209,+74206,;2~VA-GP ONC BRCA I-III ER-T2 OFF PTHWY
801.44;+74210,+74206,;.01~06/09/2026@08:52:59
801.44;+74210,+74206,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74207^1
74208^2
74209^3
74210^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III T2 IMTHPY YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>74193</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3646525218</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74193,;.01~VA-GP ONC BRCA I-III T2 IMTHPY YES
801.41;+74193,;4~dialog group
801.41;+74193,;7~2
801.41;+74193,;9~ONE SELECTION ONLY
801.41;+74193,;25~WP-start~1
Candidate for Immunotherapy:
801.41;+74193,;100~NATIONAL
801.412;+74194,+74193,;.01~20
801.412;+74194,+74193,;2~VA-GP ONC BRCA I-III ER-T2 NEOADJ THERAPY
801.412;+74195,+74193,;.01~40
801.412;+74195,+74193,;2~VA-GP ONC BR I-III ER- T2 RESIDUAL DZ
801.44;+74196,+74193,;.01~06/09/2026@08:52:59
801.44;+74196,+74193,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74194^1
74195^2
74196^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III T2 IMMUNOTHRPY CAND</POINT_01>
<INTERNAL_ENTRY_NUMBER>55073</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1791373185</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+55073,;.01~VA-GP ONC BRCA I-III T2 IMMUNOTHRPY CAND
801.41;+55073,;4~dialog group
801.41;+55073,;6~YES
801.41;+55073,;9~ONE SELECTION ONLY
801.41;+55073,;23~YES
801.41;+55073,;25~WP-start~4
++ Candidate for Immunotherapy = patient without active autoimmune 
disease, primary immune deficiency, concurrent\\   immunosuppression 
(including pred. equiv. greater than 10 mg/d), or prior HSCT/solid organ
transplant. ++
801.41;+55073,;51~SUPPRESS
801.41;+55073,;52~INDENT
801.41;+55073,;100~NATIONAL
801.412;+55074,+55073,;.01~10
801.412;+55074,+55073,;2~VA-GP ONC BRCA I-III T2 IMTHPY YES
801.412;+55075,+55073,;.01~20
801.412;+55075,+55073,;2~VA-GP ONC BR CA I-III ER- T2 IMTHPY NO
801.44;+55076,+55073,;.01~06/09/2026@08:52:59
801.44;+55076,+55073,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
55074^1
55075^2
55076^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-/PR-/HER2-T2</POINT_01>
<INTERNAL_ENTRY_NUMBER>74153</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>284854270</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74153,;.01~VA-GP ONC BRCA I-III ER-/PR-/HER2-T2
801.41;+74153,;4~dialog group
801.41;+74153,;6~NO
801.41;+74153,;7~2
801.41;+74153,;25~WP-start~1
T2 or greater or N+:
801.41;+74153,;35~WP-start~1
Stage T2 or greater or N+:
801.41;+74153,;100~NATIONAL
801.412;+74154,+74153,;.01~20
801.412;+74154,+74153,;2~VA-GP ONC BRCA I-III T2 IMMUNOTHRPY CAND
801.44;+74155,+74153,;.01~06/09/2026@08:52:59
801.44;+74155,+74153,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74154^1
74155^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78528</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>527352946</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78528,;.01~VA-ONC BRCA I-III ER-T1 OFF PATH RSN
801.41;+78528,;4~dialog element
801.41;+78528,;15~HF.VA-ONC BRCA I-III ER- T1B OFF PATH RSN
801.41;+78528,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78528,;51~SUPPRESS
801.41;+78528,;100~NATIONAL
801.412;+78529,+78528,;.01~5
801.412;+78529,+78528,;2~VA-ONC OFF PATHWAY
801.412;+78529,+78528,;7~YES
801.412;+78529,+78528,;9~YES
801.44;+78530,+78528,;.01~06/09/2026@08:52:59
801.44;+78530,+78528,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78529^1
78530^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78520</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>244217052</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78520,;.01~VA-ONC BRCA I-III ER-T1 OFF PATH TX
801.41;+78520,;4~dialog element
801.41;+78520,;15~HF.VA-ONC BRCA I-III ER- T1B OFF PATH TX
801.41;+78520,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78520,;51~SUPPRESS
801.41;+78520,;100~NATIONAL
801.412;+78521,+78520,;.01~5
801.412;+78521,+78520,;2~VA-ONC BLANK
801.412;+78521,+78520,;7~YES
801.412;+78521,+78520,;9~YES
801.44;+78522,+78520,;.01~06/09/2026@08:52:59
801.44;+78522,+78520,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78521^1
78522^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78506</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>800689461</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78506,;.01~VA-GP ONC BRCA I-III ER-T1 OFF PTHWY
801.41;+78506,;4~dialog group
801.41;+78506,;6~YES
801.41;+78506,;7~2
801.41;+78506,;23~YES
801.41;+78506,;25~WP-start~1
Off pathway:
801.41;+78506,;52~INDENT
801.41;+78506,;100~NATIONAL
801.412;+78507,+78506,;.01~10
801.412;+78507,+78506,;2~VA-ONC BRCA I-III ER-T1 OFF PATH TX
801.412;+78508,+78506,;.01~20
801.412;+78508,+78506,;2~VA-ONC BRCA I-III ER-T1 OFF PATH RSN
801.44;+78509,+78506,;.01~06/09/2026@08:52:59
801.44;+78509,+78506,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78507^1
78508^2
78509^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T1BC PREFER TC+LRM+SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>86915</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>95056899</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86915,;.01~VA-ONC BR I-III ER- T1BC PREFER TC+LRM+SURV
801.41;+86915,;4~dialog element
801.41;+86915,;15~HF.VA-ONC BRCA I-III ER- T1B TC+LRM PRIOR+SURV
801.41;+86915,;25~WP-start~2
Docetaxel and cyclophosphamide (TC), follow Local/Regional Management
Prior to Adjuvant Treatment Pathway; then Surveillance
801.41;+86915,;35~WP-start~3
Veteran has elected to pursue TREATMENT with DOCETAXEL and 
CYCLOPHOSPHAMIDE (TC), Follow LOCAL/REGIONAL MANAGEMENT PRIOR TO ADJUVANT
TREATMENT PATHWAY, FOLLOWED by SURVEILLANCE.
801.41;+86915,;100~NATIONAL
801.44;+86916,+86915,;.01~06/09/2026@08:52:59
801.44;+86916,+86915,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86916^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B UPSTAGE NO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78697</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1441319207</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78697,;.01~VA-ONC BRCA I-III ER-T1B UPSTAGE NO OFF PATH TX
801.41;+78697,;4~dialog element
801.41;+78697,;15~HF.VA-ONC BRCA I-III ER- T1B NOT UPSTG OFF PATH TX
801.41;+78697,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78697,;51~SUPPRESS
801.41;+78697,;100~NATIONAL
801.412;+78698,+78697,;.01~5
801.412;+78698,+78697,;2~VA-ONC BLANK
801.412;+78698,+78697,;7~YES
801.412;+78698,+78697,;9~YES
801.44;+78699,+78697,;.01~06/09/2026@08:52:59
801.44;+78699,+78697,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78698^1
78699^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B UPSTAGE NO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78698</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>576533329</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78698,;.01~VA-ONC BRCA I-III ER-T1B UPSTAGE NO OFF PATH RSN
801.41;+78698,;4~dialog element
801.41;+78698,;15~HF.VA-ONC BRCA I-III ER- T1B NOT UPSTG OFF PATH RSN
801.41;+78698,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78698,;51~SUPPRESS
801.41;+78698,;100~NATIONAL
801.412;+78699,+78698,;.01~5
801.412;+78699,+78698,;2~VA-ONC OFF PATHWAY
801.412;+78699,+78698,;7~YES
801.412;+78699,+78698,;9~YES
801.44;+78700,+78698,;.01~06/09/2026@08:52:59
801.44;+78700,+78698,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78699^1
78700^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1B UPSTAGE NO OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78696</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2456570229</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78696,;.01~VA-GP ONC BRCA I-III ER-T1B UPSTAGE NO OFF PTHWY
801.41;+78696,;4~dialog group
801.41;+78696,;6~YES
801.41;+78696,;7~2
801.41;+78696,;23~YES
801.41;+78696,;25~WP-start~1
Off pathway:
801.41;+78696,;52~INDENT
801.41;+78696,;100~NATIONAL
801.412;+78697,+78696,;.01~20
801.412;+78697,+78696,;2~VA-ONC BRCA I-III ER-T1B UPSTAGE NO OFF PATH RSN
801.412;+78698,+78696,;.01~10
801.412;+78698,+78696,;2~VA-ONC BRCA I-III ER-T1B UPSTAGE NO OFF PATH TX
801.44;+78699,+78696,;.01~06/09/2026@08:52:59
801.44;+78699,+78696,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78697^2
78698^3
78699^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER-T1B UPSTAGE NO TC</POINT_01>
<INTERNAL_ENTRY_NUMBER>74191</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1661380336</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74191,;.01~VA-ONC BR I-III ER-T1B UPSTAGE NO TC
801.41;+74191,;4~dialog element
801.41;+74191,;15~HF.VA-ONC BRCA I-III ER- T1B NOT UPSTG TC+SURV
801.41;+74191,;25~WP-start~1
Docetaxel and cyclophosphamide (TC); then Surveillance
801.41;+74191,;35~WP-start~2
Veteran has elected to pursue TREATMENT with DOCETAXEL and
CYCLOPHOSPHAMIDE (TC) FOLLOWED by SURVEILLANCE.
801.41;+74191,;100~NATIONAL
801.44;+74192,+74191,;.01~06/09/2026@08:52:59
801.44;+74192,+74191,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74192^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B UPSTAGE NO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78695</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4009568482</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78695,;.01~VA-ONC BRCA I-III ER-T1B UPSTAGE NO CLIN TRIAL
801.41;+78695,;4~dialog element
801.41;+78695,;15~HF.VA-ONC BRCA I-III ER- T1B NOT UPSTG CLIN TRIAL
801.41;+78695,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78695,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78695,;100~NATIONAL
801.412;+78696,+78695,;.01~5
801.412;+78696,+78695,;2~VA-ONC CLINICAL TRIAL
801.412;+78696,+78695,;9~YES
801.44;+78697,+78695,;.01~06/09/2026@08:52:59
801.44;+78697,+78695,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78696^1
78697^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T1BC NOT UPSTAGE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74170</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2306679376</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74170,;.01~VA-GP ONC BR I-III ER- T1BC NOT UPSTAGE
801.41;+74170,;4~dialog group
801.41;+74170,;6~YES
801.41;+74170,;7~2
801.41;+74170,;9~ONE SELECTION ONLY
801.41;+74170,;25~WP-start~1
Not surgically upstage:
801.41;+74170,;100~NATIONAL
801.412;+74171,+74170,;.01~5
801.412;+74171,+74170,;2~VA-ONC BRCA I-III ER-T1B UPSTAGE NO CLIN TRIAL
801.412;+74172,+74170,;.01~10
801.412;+74172,+74170,;2~VA-ONC BR I-III ER-T1B UPSTAGE NO TC
801.412;+74173,+74170,;.01~20
801.412;+74173,+74170,;2~VA-GP ONC BRCA I-III ER-T1B UPSTAGE NO OFF PTHWY
801.44;+74174,+74170,;.01~06/09/2026@08:52:59
801.44;+74174,+74170,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74171^1
74172^2
74173^3
74174^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B GL NO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78690</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2073552304</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78690,;.01~VA-ONC BRCA I-III ER-T1B GL NO OFF PATH RSN
801.41;+78690,;4~dialog element
801.41;+78690,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM OFF PATH RSN
801.41;+78690,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78690,;51~SUPPRESS
801.41;+78690,;100~NATIONAL
801.412;+78691,+78690,;.01~5
801.412;+78691,+78690,;2~VA-ONC OFF PATHWAY
801.412;+78691,+78690,;7~YES
801.412;+78691,+78690,;9~YES
801.44;+78692,+78690,;.01~06/09/2026@08:52:59
801.44;+78692,+78690,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78691^1
78692^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B GL NO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78689</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4159103021</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78689,;.01~VA-ONC BRCA I-III ER-T1B GL NO OFF PATH TX
801.41;+78689,;4~dialog element
801.41;+78689,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM OFF PATH TX
801.41;+78689,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78689,;51~SUPPRESS
801.41;+78689,;100~NATIONAL
801.412;+78690,+78689,;.01~5
801.412;+78690,+78689,;2~VA-ONC BLANK
801.412;+78690,+78689,;7~YES
801.412;+78690,+78689,;9~YES
801.44;+78691,+78689,;.01~06/09/2026@08:52:59
801.44;+78691,+78689,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78690^1
78691^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1B GL NO OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78688</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1366298358</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78688,;.01~VA-GP ONC BRCA I-III ER-T1B GL NO OFF PTHWY
801.41;+78688,;4~dialog group
801.41;+78688,;6~YES
801.41;+78688,;7~2
801.41;+78688,;23~YES
801.41;+78688,;25~WP-start~1
Off pathway:
801.41;+78688,;52~INDENT
801.41;+78688,;100~NATIONAL
801.412;+78689,+78688,;.01~10
801.412;+78689,+78688,;2~VA-ONC BRCA I-III ER-T1B GL NO OFF PATH TX
801.412;+78690,+78688,;.01~20
801.412;+78690,+78688,;2~VA-ONC BRCA I-III ER-T1B GL NO OFF PATH RSN
801.44;+78691,+78688,;.01~06/09/2026@08:52:59
801.44;+78691,+78688,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78689^1
78690^2
78691^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B GL NO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78687</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2735784585</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78687,;.01~VA-ONC BRCA I-III ER-T1B GL NO CLIN TRIAL
801.41;+78687,;4~dialog element
801.41;+78687,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM CLIN TRIAL
801.41;+78687,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78687,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78687,;100~NATIONAL
801.412;+78688,+78687,;.01~5
801.412;+78688,+78687,;2~VA-ONC CLINICAL TRIAL
801.412;+78688,+78687,;9~YES
801.44;+78689,+78687,;.01~06/09/2026@08:52:59
801.44;+78689,+78687,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78688^1
78689^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T1BC BRCA NO SURV</POINT_01>
<INTERNAL_ENTRY_NUMBER>74188</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2379080546</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74188,;.01~VA-ONC BR I-III ER- T1BC BRCA NO SURV
801.41;+74188,;4~dialog element
801.41;+74188,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG NOT GERM SURV
801.41;+74188,;25~WP-start~1
Surveillance
801.41;+74188,;35~WP-start~1
Veteran has elected to pursue SURVEILLANCE.
801.41;+74188,;100~NATIONAL
801.44;+74189,+74188,;.01~06/09/2026@08:52:59
801.44;+74189,+74188,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74189^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T1BC BRCA NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>74187</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>473535898</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74187,;.01~VA-GP ONC BR I-III ER- T1BC BRCA NO
801.41;+74187,;4~dialog group
801.41;+74187,;6~YES
801.41;+74187,;7~2
801.41;+74187,;9~ONE SELECTION ONLY
801.41;+74187,;25~WP-start~1
Not Germline BRCA1/2 PV and T2 or greater or N+:
801.41;+74187,;100~NATIONAL
801.412;+74188,+74187,;.01~10
801.412;+74188,+74187,;2~VA-ONC BR I-III ER- T1BC BRCA NO SURV
801.412;+74189,+74187,;.01~5
801.412;+74189,+74187,;2~VA-ONC BRCA I-III ER-T1B GL NO CLIN TRIAL
801.412;+74190,+74187,;.01~20
801.412;+74190,+74187,;2~VA-GP ONC BRCA I-III ER-T1B GL NO OFF PTHWY
801.44;+74191,+74187,;.01~06/09/2026@08:52:59
801.44;+74191,+74187,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74188^1
74189^2
74190^3
74191^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B GL OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78685</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2225836325</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78685,;.01~VA-ONC BRCA I-III ER-T1B GL OFF PATH RSN
801.41;+78685,;4~dialog element
801.41;+78685,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG GERM OFF PATH RSN
801.41;+78685,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78685,;51~SUPPRESS
801.41;+78685,;100~NATIONAL
801.412;+78686,+78685,;.01~5
801.412;+78686,+78685,;2~VA-ONC OFF PATHWAY
801.412;+78686,+78685,;7~YES
801.412;+78686,+78685,;9~YES
801.44;+78687,+78685,;.01~06/09/2026@08:52:59
801.44;+78687,+78685,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78686^1
78687^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B GL OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78686</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>345007413</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78686,;.01~VA-ONC BRCA I-III ER-T1B GL OFF PATH TX
801.41;+78686,;4~dialog element
801.41;+78686,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG GERM OFF PATH TX
801.41;+78686,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78686,;51~SUPPRESS
801.41;+78686,;100~NATIONAL
801.412;+78687,+78686,;.01~5
801.412;+78687,+78686,;2~VA-ONC BLANK
801.412;+78687,+78686,;7~YES
801.412;+78687,+78686,;9~YES
801.44;+78688,+78686,;.01~06/09/2026@08:52:59
801.44;+78688,+78686,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78687^1
78688^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1B GL OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78683</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>882193545</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78683,;.01~VA-GP ONC BRCA I-III ER-T1B GL OFF PTHWY
801.41;+78683,;4~dialog group
801.41;+78683,;6~YES
801.41;+78683,;7~2
801.41;+78683,;23~YES
801.41;+78683,;25~WP-start~1
Off pathway:
801.41;+78683,;52~INDENT
801.41;+78683,;100~NATIONAL
801.412;+78684,+78683,;.01~10
801.412;+78684,+78683,;2~VA-ONC BRCA I-III ER-T1B GL OFF PATH TX
801.412;+78685,+78683,;.01~20
801.412;+78685,+78683,;2~VA-ONC BRCA I-III ER-T1B GL OFF PATH RSN
801.44;+78686,+78683,;.01~06/09/2026@08:52:59
801.44;+78686,+78683,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78684^1
78685^2
78686^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1B GL CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78682</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3159665126</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78682,;.01~VA-ONC BRCA I-III ER-T1B GL CLIN TRIAL
801.41;+78682,;4~dialog element
801.41;+78682,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG GERM CLIN TRIAL
801.41;+78682,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78682,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78682,;100~NATIONAL
801.412;+78683,+78682,;.01~5
801.412;+78683,+78682,;2~VA-ONC CLINICAL TRIAL
801.412;+78683,+78682,;9~YES
801.44;+78684,+78682,;.01~06/09/2026@08:52:59
801.44;+78684,+78682,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78683^1
78684^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T1BC OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>74185</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4147762125</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74185,;.01~VA-GP ONC BR I-III ER- T1BC OLAP
801.41;+74185,;4~dialog group
801.41;+74185,;7~2
801.41;+74185,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTG GERM OLAP
801.41;+74185,;25~WP-start~1
Olaparib (1 year)
801.41;+74185,;35~WP-start~1
Veteran has elected to pursue treatment with OLAPARIB for 1 Year.
801.41;+74185,;100~NATIONAL
801.412;+74186,+74185,;.01~5
801.412;+74186,+74185,;2~VA-ONC BRCA OLAP FN
801.44;+74187,+74185,;.01~06/09/2026@08:52:59
801.44;+74187,+74185,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74186^1
74187^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T1BC BRCA YES</POINT_01>
<INTERNAL_ENTRY_NUMBER>74184</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2786794354</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74184,;.01~VA-GP ONC BR I-III ER- T1BC BRCA YES
801.41;+74184,;4~dialog group
801.41;+74184,;6~YES
801.41;+74184,;7~2
801.41;+74184,;9~ONE SELECTION ONLY
801.41;+74184,;25~WP-start~1
Germline BRCA1/2 PV and T2 or greater or N+:
801.41;+74184,;100~NATIONAL
801.412;+74185,+74184,;.01~10
801.412;+74185,+74184,;2~VA-GP ONC BR I-III ER- T1BC OLAP
801.412;+74186,+74184,;.01~5
801.412;+74186,+74184,;2~VA-ONC BRCA I-III ER-T1B GL CLIN TRIAL
801.412;+74187,+74184,;.01~20
801.412;+74187,+74184,;2~VA-GP ONC BRCA I-III ER-T1B GL OFF PTHWY
801.44;+74188,+74184,;.01~06/09/2026@08:52:59
801.44;+74188,+74184,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74185^1
74186^2
74187^3
74188^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III T1BC GERMLINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74177</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2239938169</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74177,;.01~VA-GP ONC BR I-III T1BC GERMLINE
801.41;+74177,;4~dialog group
801.41;+74177,;6~YES
801.41;+74177,;7~2
801.41;+74177,;9~NONE OR ONE SELECTION
801.41;+74177,;23~YES
801.41;+74177,;25~WP-start~1
After ddAC-T Therapy:
801.41;+74177,;100~NATIONAL
801.412;+74178,+74177,;.01~10
801.412;+74178,+74177,;2~VA-GP ONC BR I-III ER- T1BC BRCA YES
801.412;+74179,+74177,;.01~20
801.412;+74179,+74177,;2~VA-GP ONC BR I-III ER- T1BC BRCA NO
801.44;+74180,+74177,;.01~06/09/2026@08:52:59
801.44;+74180,+74177,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74178^1
74179^2
74180^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR DDAC-T+CV RISK FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>74176</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2456071536</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74176,;.01~VA-ONC BR DDAC-T+CV RISK FN
801.41;+74176,;4~dialog element
801.41;+74176,;23~YES
801.41;+74176,;25~WP-start~3
++ - ddAC-T followed by weekly paclitaxel (T). 
\\   - Evaluate Cardiovascular Risk Factors, baseline LVEF (with ECHO or 
MUGA) and CMP. ++
801.41;+74176,;51~SUPPRESS
801.41;+74176,;100~NATIONAL
801.44;+74177,+74176,;.01~06/09/2026@08:52:59
801.44;+74177,+74176,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74177^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T1BC UPSTAGE DDAC-T</POINT_01>
<INTERNAL_ENTRY_NUMBER>74171</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1563700585</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74171,;.01~VA-GP ONC BR I-III ER- T1BC UPSTAGE DDAC-T
801.41;+74171,;4~dialog group
801.41;+74171,;7~2
801.41;+74171,;15~HF.VA-ONC BRCA I-III ER- T1B UPSTAGE DDAC-T
801.41;+74171,;25~WP-start~1
Treatment escalation to ddAC-T
801.41;+74171,;35~WP-start~1
Veteran has elected to pursue TREATMENT ESCALATION to ddAC-T.
801.41;+74171,;100~NATIONAL
801.412;+74172,+74171,;.01~5
801.412;+74172,+74171,;2~VA-ONC BR DDAC-T+CV RISK FN
801.44;+74173,+74171,;.01~06/09/2026@08:52:59
801.44;+74173,+74171,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74172^1
74173^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR I-III ER- T1BC UPSTAGE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74167</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2041719149</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74167,;.01~VA-GP ONC BR I-III ER- T1BC UPSTAGE
801.41;+74167,;4~dialog group
801.41;+74167,;6~YES
801.41;+74167,;7~2
801.41;+74167,;9~ONE SELECTION ONLY
801.41;+74167,;25~WP-start~1
Surgically upstage:
801.41;+74167,;100~NATIONAL
801.412;+74168,+74167,;.01~20
801.412;+74168,+74167,;2~VA-GP ONC BR I-III ER- T1BC UPSTAGE DDAC-T
801.412;+74169,+74167,;.01~40
801.412;+74169,+74167,;2~VA-GP ONC BR I-III T1BC GERMLINE
801.44;+74170,+74167,;.01~06/09/2026@08:52:59
801.44;+74170,+74167,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74168^1
74169^2
74170^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER- T1BC SURG UPSTAGE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74165</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3651562681</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74165,;.01~VA-GP ONC BRCA I-III ER- T1BC SURG UPSTAGE
801.41;+74165,;4~dialog group
801.41;+74165,;9~NONE OR ONE SELECTION
801.41;+74165,;23~YES
801.41;+74165,;51~SUPPRESS
801.41;+74165,;100~NATIONAL
801.412;+74166,+74165,;.01~10
801.412;+74166,+74165,;2~VA-GP ONC BR I-III ER- T1BC UPSTAGE
801.412;+74167,+74165,;.01~20
801.412;+74167,+74165,;2~VA-GP ONC BR I-III ER- T1BC NOT UPSTAGE
801.44;+74168,+74165,;.01~06/09/2026@08:52:59
801.44;+74168,+74165,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74166^1
74167^2
74168^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER- T1BC FIRST LINE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74163</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>466381314</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74163,;.01~VA-GP ONC BRCA I-III ER- T1BC FIRST LINE
801.41;+74163,;4~dialog group
801.41;+74163,;6~YES
801.41;+74163,;7~2
801.41;+74163,;9~ONE SELECTION ONLY
801.41;+74163,;15~HF.VA-ONC BRCA I-III ER- T1B FOLLOW LRM PRIOR ADJ PTHWY
801.41;+74163,;25~WP-start~1
Follow Local/Regional Management Prior to Adjuvant Treatment Pathway:
801.41;+74163,;52~INDENT
801.41;+74163,;100~NATIONAL
801.412;+74164,+74163,;.01~20
801.412;+74164,+74163,;2~VA-GP ONC BRCA I-III ER- T1BC SURG UPSTAGE
801.44;+74165,+74163,;.01~06/09/2026@08:52:59
801.44;+74165,+74163,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74164^2
74165^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78491</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1892883322</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78491,;.01~VA-ONC BRCA I-III ER-T1 CLIN TRIAL
801.41;+78491,;4~dialog element
801.41;+78491,;15~HF.VA-ONC BRCA I-III ER- T1B CLIN TRIAL
801.41;+78491,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78491,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78491,;100~NATIONAL
801.412;+78492,+78491,;.01~5
801.412;+78492,+78491,;2~VA-ONC CLINICAL TRIAL
801.412;+78492,+78491,;9~YES
801.44;+78493,+78491,;.01~06/09/2026@08:52:59
801.44;+78493,+78491,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78492^1
78493^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA T1BC PT PREFERENCE</POINT_01>
<INTERNAL_ENTRY_NUMBER>74164</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>506748228</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74164,;.01~VA-GP ONC BRCA T1BC PT PREFERENCE
801.41;+74164,;4~dialog group
801.41;+74164,;6~YES
801.41;+74164,;9~ONE SELECTION ONLY
801.41;+74164,;25~WP-start~1
Patient preference after shared decision making:
801.41;+74164,;51~SUPPRESS
801.41;+74164,;52~INDENT
801.41;+74164,;100~NATIONAL
801.412;+74165,+74164,;.01~10
801.412;+74165,+74164,;2~VA-ONC BRCA I-III ER-T1 CLIN TRIAL
801.412;+74166,+74164,;.01~20
801.412;+74166,+74164,;2~VA-GP ONC BRCA I-III ER- T1BC FIRST LINE
801.412;+74167,+74164,;.01~30
801.412;+74167,+74164,;2~VA-ONC BR I-III ER- T1BC PREFER TC+LRM+SURV
801.412;+74168,+74164,;.01~40
801.412;+74168,+74164,;2~VA-GP ONC BRCA I-III ER-T1 OFF PTHWY
801.44;+74169,+74164,;.01~06/09/2026@08:52:59
801.44;+74169,+74164,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74165^1
74166^2
74167^3
74168^4
74169^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1B MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73978</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3565955593</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73978,;.01~VA-GP ONC BRCA I-III ER-T1B MAIN
801.41;+73978,;4~dialog group
801.41;+73978,;7~2
801.41;+73978,;9~ONE SELECTION ONLY
801.41;+73978,;25~WP-start~1
T1b/c, N0:
801.41;+73978,;35~WP-start~1
Stage T1b/c, N0:
801.41;+73978,;52~INDENT
801.41;+73978,;100~NATIONAL
801.412;+73979,+73978,;.01~20
801.412;+73979,+73978,;2~VA-GP ONC BRCA T1BC PT PREFERENCE
801.44;+73980,+73978,;.01~06/09/2026@08:52:59
801.44;+73980,+73978,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73979^1
73980^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1A OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78694</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3829284620</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78694,;.01~VA-ONC BRCA I-III ER-T1A OFF PATH RSN
801.41;+78694,;4~dialog element
801.41;+78694,;15~HF.VA-ONC BRCA I-III ER- T1A OFF PATH RSN
801.41;+78694,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78694,;51~SUPPRESS
801.41;+78694,;100~NATIONAL
801.412;+78695,+78694,;.01~5
801.412;+78695,+78694,;2~VA-ONC OFF PATHWAY
801.412;+78695,+78694,;7~YES
801.412;+78695,+78694,;9~YES
801.44;+78696,+78694,;.01~06/09/2026@08:52:59
801.44;+78696,+78694,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78695^1
78696^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1A OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78693</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2034052936</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78693,;.01~VA-ONC BRCA I-III ER-T1A OFF PATH TX
801.41;+78693,;4~dialog element
801.41;+78693,;15~HF.VA-ONC BRCA I-III ER- T1A OFF PATH TX
801.41;+78693,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78693,;51~SUPPRESS
801.41;+78693,;100~NATIONAL
801.412;+78694,+78693,;.01~5
801.412;+78694,+78693,;2~VA-ONC BLANK
801.412;+78694,+78693,;7~YES
801.412;+78694,+78693,;9~YES
801.44;+78695,+78693,;.01~06/09/2026@08:52:59
801.44;+78695,+78693,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78694^1
78695^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1A OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78692</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1603993444</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78692,;.01~VA-GP ONC BRCA I-III ER-T1A OFF PTHWY
801.41;+78692,;4~dialog group
801.41;+78692,;6~YES
801.41;+78692,;7~2
801.41;+78692,;23~YES
801.41;+78692,;25~WP-start~1
Off pathway:
801.41;+78692,;52~INDENT
801.41;+78692,;100~NATIONAL
801.412;+78693,+78692,;.01~10
801.412;+78693,+78692,;2~VA-ONC BRCA I-III ER-T1A OFF PATH TX
801.412;+78694,+78692,;.01~20
801.412;+78694,+78692,;2~VA-ONC BRCA I-III ER-T1A OFF PATH RSN
801.44;+78695,+78692,;.01~06/09/2026@08:52:59
801.44;+78695,+78692,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78693^1
78694^2
78695^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR I-III ER- T1A LRM PRIOR PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>74192</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>318284079</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+74192,;.01~VA-ONC BR I-III ER- T1A LRM PRIOR PTHWY
801.41;+74192,;4~dialog element
801.41;+74192,;15~HF.VA-ONC BRCA I-III ER- T1A LRM PRIOR+SURVEILLANCE
801.41;+74192,;25~WP-start~2
Follow Local/Regional Management Prior to Adjuvant Treatment Pathway; then
Surveillance
801.41;+74192,;35~WP-start~2
Veteran has elected to FOLLOW LOCAL/REGIONAL MANAGEMENT PRIOR TO ADJUVANT
TREATMENT PATHWAY Then SURVEILLANCE.
801.41;+74192,;100~NATIONAL
801.44;+74193,+74192,;.01~06/09/2026@08:52:59
801.44;+74193,+74192,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
74193^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER-T1A CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78691</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3022917784</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78691,;.01~VA-ONC BRCA I-III ER-T1A CLIN TRIAL
801.41;+78691,;4~dialog element
801.41;+78691,;15~HF.VA-ONC BRCA I-III ER- T1A CLIN TRIAL
801.41;+78691,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78691,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78691,;100~NATIONAL
801.412;+78692,+78691,;.01~5
801.412;+78692,+78691,;2~VA-ONC CLINICAL TRIAL
801.412;+78692,+78691,;9~YES
801.44;+78693,+78691,;.01~06/09/2026@08:52:59
801.44;+78693,+78691,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78692^1
78693^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-T1A</POINT_01>
<INTERNAL_ENTRY_NUMBER>73977</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3659936466</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73977,;.01~VA-GP ONC BRCA I-III ER-T1A
801.41;+73977,;4~dialog group
801.41;+73977,;6~YES
801.41;+73977,;7~2
801.41;+73977,;9~ONE SELECTION ONLY
801.41;+73977,;25~WP-start~1
T1a, N0:
801.41;+73977,;35~WP-start~1
Stage T1a, N0:
801.41;+73977,;52~INDENT
801.41;+73977,;100~NATIONAL
801.412;+73978,+73977,;.01~5
801.412;+73978,+73977,;2~VA-ONC BRCA I-III ER-T1A CLIN TRIAL
801.412;+73979,+73977,;.01~10
801.412;+73979,+73977,;2~VA-ONC BR I-III ER- T1A LRM PRIOR PTHWY
801.412;+73980,+73977,;.01~20
801.412;+73980,+73977,;2~VA-GP ONC BRCA I-III ER-T1A OFF PTHWY
801.44;+73981,+73977,;.01~06/09/2026@08:52:59
801.44;+73981,+73977,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73978^1
73979^2
73980^3
73981^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER-STAGE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73976</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1299844979</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73976,;.01~VA-GP ONC BRCA I-III ER-STAGE
801.41;+73976,;4~dialog group
801.41;+73976,;5~Stage:
801.41;+73976,;6~YES
801.41;+73976,;9~ONE SELECTION ONLY
801.41;+73976,;23~YES
801.41;+73976,;51~SUPPRESS
801.41;+73976,;100~NATIONAL
801.412;+73977,+73976,;.01~20
801.412;+73977,+73976,;2~VA-GP ONC BRCA I-III ER-T1A
801.412;+73978,+73976,;.01~30
801.412;+73978,+73976,;2~VA-GP ONC BRCA I-III ER-T1B MAIN
801.412;+73979,+73976,;.01~40
801.412;+73979,+73976,;2~VA-GP ONC BRCA I-III ER-/PR-/HER2-T2
801.44;+73980,+73976,;.01~06/09/2026@08:52:59
801.44;+73980,+73976,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73977^1
73978^2
73979^3
73980^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA I-III ER-/PR-/HER2-</POINT_01>
<INTERNAL_ENTRY_NUMBER>73975</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>833400552</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73975,;.01~VA-GP ONC BREAST CA I-III ER-/PR-/HER2-
801.41;+73975,;4~dialog group
801.41;+73975,;6~YES
801.41;+73975,;7~2
801.41;+73975,;15~HF.VA-ONC BRCA STG I-III ER-/PR-/HER2- CLINICAL PATHWAY
801.41;+73975,;25~WP-start~1
ER-/PR-/HER2-(Triple Negative [TNBC]) Clinical Pathway:
801.41;+73975,;35~WP-start~3
VA National Breast Cancer - Stage I-III ER-/PR-/HER2-
\\ (Triple Negative [TNBC]) Clinical Pathway\\
=====================================================
801.41;+73975,;100~NATIONAL
801.412;+73976,+73975,;.01~20
801.412;+73976,+73975,;2~VA-GP ONC BRCA I-III ER-STAGE
801.412;+73977,+73975,;.01~10
801.412;+73977,+73975,;2~VA-ONC BRCA PERFORM GERMLINE TEST
801.44;+73978,+73975,;.01~06/09/2026@08:52:59
801.44;+73978,+73975,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73976^2
73977^3
73978^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 ER/PR+ FOOTNOTE</POINT_01>
<INTERNAL_ENTRY_NUMBER>106236</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4140069515</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+106236,;.01~VA-ONC BRCA I-III ANY N0 ER/PR+ FOOTNOTE
801.41;+106236,;4~dialog element
801.41;+106236,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+106236,;23~YES
801.41;+106236,;25~WP-start~1
- Perform germline testing.
801.41;+106236,;35~WP-start~28
 (a)Evaluate Cardiovascular Risk Factors with baseline LVEF (with ECHO or 
MUGA)\\    and CMP; monitor LVEF every 3 months during therapy.\\
 
 (b)Complete pathological response = absence of residual invasive 
carcinoma\\    in both the breast and lymph nodes.\\
 
 (c)Ado-trastuzumab Emtansine: radiation and hormone therapy can be given 
con-\\    comitantly with trastuzumab, pertuzumab, and ado-trastuzumab 
emtansine.\\
 
 (d)Menopausal defined as patient that is 60 years of age or older; 1 or 
more\\    year amenorrhea (not medically induced); history of Bilaterally 
Salpingo-\\    Oophorectomy (BSO; or confirmed with labs.\\
 
 (e)Ovarian Suppression (OS) includes surgical or medical suppression.\\
 
 (f)Anastrozole: only for post menopausal women or women undergoing 
ovarian\\    suppression; evaluate baseline bone density; promote 
weight-bearing\\    exercise, smoking cessation, reduced alcohol intake, 
and calcium/vitamin D\\    supplementation; if not a candidate for 
anastrozole, tamoxifen is an\\    alternative; if patients do not tolerate
one AI, any AI is a\\    suitable alternative.\\
 
 (g)Tamoxifen: avoid if prior history of DVT or known hypercoagulability; 
if\\    contraindication to tamoxifen in men, prescribe AI with ADT; 
patients\\    should use effective nonhormonal contraception or barrier 
contraceptive\\    during tamoxifen therapy; continue for 2 months after 
last dose.
801.41;+106236,;51~SUPPRESS
801.41;+106236,;100~NATIONAL
801.412;+106237,+106236,;.01~5
801.412;+106237,+106236,;2~PXRM GF VIEW BUTTON
801.412;+106237,+106236,;6~VIEW Footnote
801.44;+106238,+106236,;.01~06/09/2026@08:52:59
801.44;+106238,+106236,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
106237^1
106238^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78471</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2803873606</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78471,;.01~VA-ONC BRCA I-III ANY N+ OFF PATH RSN
801.41;+78471,;4~dialog element
801.41;+78471,;15~HF.VA-ONC BRCA I-III ANY ER N+ OFF PATH RSN
801.41;+78471,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78471,;51~SUPPRESS
801.41;+78471,;100~NATIONAL
801.412;+78472,+78471,;.01~5
801.412;+78472,+78471,;2~VA-ONC OFF PATHWAY
801.412;+78472,+78471,;7~YES
801.412;+78472,+78471,;9~YES
801.44;+78473,+78471,;.01~06/09/2026@08:52:59
801.44;+78473,+78471,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78472^1
78473^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78470</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3281819758</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78470,;.01~VA-ONC BRCA I-III ANY N+ OFF PATH TX
801.41;+78470,;4~dialog element
801.41;+78470,;15~HF.VA-ONC BRCA I-III ANY ER N+ OFF PATH TX
801.41;+78470,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78470,;51~SUPPRESS
801.41;+78470,;100~NATIONAL
801.412;+78471,+78470,;.01~5
801.412;+78471,+78470,;2~VA-ONC BLANK
801.412;+78471,+78470,;7~YES
801.412;+78471,+78470,;9~YES
801.44;+78472,+78470,;.01~06/09/2026@08:52:59
801.44;+78472,+78470,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78471^1
78472^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78468</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4112556174</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78468,;.01~VA-GP ONC BRCA I-III ANY N+ OFF PTHWY
801.41;+78468,;4~dialog group
801.41;+78468,;6~YES
801.41;+78468,;7~2
801.41;+78468,;23~YES
801.41;+78468,;25~WP-start~1
Off pathway:
801.41;+78468,;52~INDENT
801.41;+78468,;100~NATIONAL
801.412;+78469,+78468,;.01~10
801.412;+78469,+78468,;2~VA-ONC BRCA I-III ANY N+ OFF PATH TX
801.412;+78470,+78468,;.01~20
801.412;+78470,+78468,;2~VA-ONC BRCA I-III ANY N+ OFF PATH RSN
801.44;+78471,+78468,;.01~06/09/2026@08:52:59
801.44;+78471,+78468,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78469^1
78470^2
78471^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78467</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3322150403</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78467,;.01~VA-ONC BRCA I-III ANY N+ CLIN TRIAL
801.41;+78467,;4~dialog element
801.41;+78467,;15~HF.VA-ONC BRCA I-III ANY ER N+ CLIN TRIAL
801.41;+78467,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78467,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78467,;100~NATIONAL
801.412;+78468,+78467,;.01~5
801.412;+78468,+78467,;2~VA-ONC CLINICAL TRIAL
801.412;+78468,+78467,;9~YES
801.44;+78469,+78467,;.01~06/09/2026@08:53
801.44;+78469,+78467,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78468^1
78469^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ ER/PR NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78486</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>784931898</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78486,;.01~VA-ONC BRCA I-III ANY N+ ER/PR NEG OFF PATH RSN
801.41;+78486,;4~dialog element
801.41;+78486,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH RSN
801.41;+78486,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78486,;51~SUPPRESS
801.41;+78486,;100~NATIONAL
801.412;+78487,+78486,;.01~5
801.412;+78487,+78486,;2~VA-ONC OFF PATHWAY
801.412;+78487,+78486,;7~YES
801.412;+78487,+78486,;9~YES
801.44;+78488,+78486,;.01~06/09/2026@08:53
801.44;+78488,+78486,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78487^1
78488^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ ER/PR NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78488</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2560815455</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78488,;.01~VA-ONC BRCA I-III ANY N+ ER/PR NEG OFF PATH TX
801.41;+78488,;4~dialog element
801.41;+78488,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR NEG OFF PATH TX
801.41;+78488,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78488,;51~SUPPRESS
801.41;+78488,;100~NATIONAL
801.412;+78489,+78488,;.01~5
801.412;+78489,+78488,;2~VA-ONC BLANK
801.412;+78489,+78488,;7~YES
801.412;+78489,+78488,;9~YES
801.44;+78490,+78488,;.01~06/09/2026@08:53
801.44;+78490,+78488,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78489^1
78490^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ ER/PR NEG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78490</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2892729795</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78490,;.01~VA-GP ONC BRCA I-III ANY N+ ER/PR NEG OFF PTHWY
801.41;+78490,;4~dialog group
801.41;+78490,;6~YES
801.41;+78490,;7~2
801.41;+78490,;23~YES
801.41;+78490,;25~WP-start~1
Off pathway:
801.41;+78490,;52~INDENT
801.41;+78490,;100~NATIONAL
801.412;+78491,+78490,;.01~10
801.412;+78491,+78490,;2~VA-ONC BRCA I-III ANY N+ ER/PR NEG OFF PATH TX
801.412;+78492,+78490,;.01~20
801.412;+78492,+78490,;2~VA-ONC BRCA I-III ANY N+ ER/PR NEG OFF PATH RSN
801.44;+78493,+78490,;.01~06/09/2026@08:53
801.44;+78493,+78490,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78491^1
78492^2
78493^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ ER/PR NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78484</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1580692461</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78484,;.01~VA-ONC BRCA I-III ANY N+ ER/PR NEG CLIN TRIAL
801.41;+78484,;4~dialog element
801.41;+78484,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR NEG CLIN TRIAL
801.41;+78484,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78484,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78484,;100~NATIONAL
801.412;+78485,+78484,;.01~5
801.412;+78485,+78484,;2~VA-ONC CLINICAL TRIAL
801.412;+78485,+78484,;9~YES
801.44;+78486,+78484,;.01~06/09/2026@08:53
801.44;+78486,+78484,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78485^1
78486^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ ER/PR NEG HER2 DT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73679</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>898650990</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73679,;.01~VA-ONC BRCA I-III ANY N+ ER/PR NEG HER2 DT
801.41;+73679,;4~dialog element
801.41;+73679,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR NEG HER2 TX+SURV
801.41;+73679,;25~WP-start~1
Complete HER2 directed therapy; followed by surveillance
801.41;+73679,;35~WP-start~2
Veteran has elected to COMPLETE HER2 DIRECTED Therapy; followed by 
SURVEILLANCE.
801.41;+73679,;100~NATIONAL
801.44;+73680,+73679,;.01~06/09/2026@08:53
801.44;+73680,+73679,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73680^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY ER ER N+ ER/PR NEG</POINT_01>
<INTERNAL_ENTRY_NUMBER>73662</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3997188260</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73662,;.01~VA-GP ONC BRCA I-III ANY ER ER N+ ER/PR NEG
801.41;+73662,;4~dialog group
801.41;+73662,;6~YES
801.41;+73662,;7~2
801.41;+73662,;9~ONE SELECTION ONLY
801.41;+73662,;25~WP-start~1
ER/PR Negative:
801.41;+73662,;100~NATIONAL
801.412;+73663,+73662,;.01~10
801.412;+73663,+73662,;2~VA-ONC BRCA I-III ANY N+ ER/PR NEG HER2 DT
801.412;+73664,+73662,;.01~5
801.412;+73664,+73662,;2~VA-ONC BRCA I-III ANY N+ ER/PR NEG CLIN TRIAL
801.412;+73665,+73662,;.01~20
801.412;+73665,+73662,;2~VA-GP ONC BRCA I-III ANY N+ ER/PR NEG OFF PTHWY
801.44;+73666,+73662,;.01~06/09/2026@08:53
801.44;+73666,+73662,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73663^1
73664^2
73665^3
73666^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78485</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1445314696</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78485,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH RSN
801.41;+78485,;4~dialog element
801.41;+78485,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH RSN
801.41;+78485,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78485,;51~SUPPRESS
801.41;+78485,;100~NATIONAL
801.412;+78486,+78485,;.01~5
801.412;+78486,+78485,;2~VA-ONC OFF PATHWAY
801.412;+78486,+78485,;7~YES
801.412;+78486,+78485,;9~YES
801.44;+78487,+78485,;.01~06/09/2026@08:53
801.44;+78487,+78485,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78486^1
78487^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78487</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>956170128</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78487,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX
801.41;+78487,;4~dialog element
801.41;+78487,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX
801.41;+78487,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78487,;51~SUPPRESS
801.41;+78487,;100~NATIONAL
801.412;+78488,+78487,;.01~5
801.412;+78488,+78487,;2~VA-ONC BLANK
801.412;+78488,+78487,;7~YES
801.412;+78488,+78487,;9~YES
801.44;+78489,+78487,;.01~06/09/2026@08:53
801.44;+78489,+78487,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78488^1
78489^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ ER/PR POS OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78489</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3223147398</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78489,;.01~VA-GP ONC BRCA I-III ANY N+ ER/PR POS OFF PTHWY
801.41;+78489,;4~dialog group
801.41;+78489,;6~YES
801.41;+78489,;7~2
801.41;+78489,;23~YES
801.41;+78489,;25~WP-start~1
Off pathway:
801.41;+78489,;52~INDENT
801.41;+78489,;100~NATIONAL
801.412;+78490,+78489,;.01~10
801.412;+78490,+78489,;2~VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH TX
801.412;+78491,+78489,;.01~20
801.412;+78491,+78489,;2~VA-ONC BRCA I-III ANY ER N+ ER/PR POS OFF PATH RSN
801.44;+78492,+78489,;.01~06/09/2026@08:53
801.44;+78492,+78489,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78490^1
78491^2
78492^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ ER/PR POS CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78483</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>227257847</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78483,;.01~VA-ONC BRCA I-III ANY N+ ER/PR POS CLIN TRIAL
801.41;+78483,;4~dialog element
801.41;+78483,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR POS CLIN TRIAL
801.41;+78483,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78483,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78483,;100~NATIONAL
801.412;+78484,+78483,;.01~5
801.412;+78484,+78483,;2~VA-ONC CLINICAL TRIAL
801.412;+78484,+78483,;9~YES
801.44;+78485,+78483,;.01~06/09/2026@08:53
801.44;+78485,+78483,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78484^1
78485^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N+ ER/PR POS ADJ HT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73661</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4077640556</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73661,;.01~VA-ONC BRCA I-III ANY ER N+ ER/PR POS ADJ HT
801.41;+73661,;4~dialog element
801.41;+73661,;15~HF.VA-ONC BRCA I-III ANY ER N+ ER/PR POS ADJ HT
801.41;+73661,;25~WP-start~1
Adjuvant Hormone Therapy for ER/PR/HER2 Positive
801.41;+73661,;35~WP-start~2
Veteran has elected to pursue ADJUVANT HORMONE THERAPY for ER/PR/HER2 
Positive.
801.41;+73661,;100~NATIONAL
801.44;+73662,+73661,;.01~06/09/2026@08:53
801.44;+73662,+73661,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73662^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ ER/PR POS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73657</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1093236121</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73657,;.01~VA-GP ONC BRCA I-III ANY N+ ER/PR POS
801.41;+73657,;4~dialog group
801.41;+73657,;6~YES
801.41;+73657,;7~2
801.41;+73657,;9~ONE SELECTION ONLY
801.41;+73657,;25~WP-start~1
ER/PR Positive:
801.41;+73657,;100~NATIONAL
801.412;+73658,+73657,;.01~10
801.412;+73658,+73657,;2~VA-ONC BRCA I-III ANY ER N+ ER/PR POS ADJ HT
801.412;+73659,+73657,;.01~5
801.412;+73659,+73657,;2~VA-ONC BRCA I-III ANY N+ ER/PR POS CLIN TRIAL
801.412;+73660,+73657,;.01~20
801.412;+73660,+73657,;2~VA-GP ONC BRCA I-III ANY N+ ER/PR POS OFF PTHWY
801.44;+73661,+73657,;.01~06/09/2026@08:53
801.44;+73661,+73657,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73658^1
73659^4
73660^5
73661^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY ER N+ POST ADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73640</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2645469848</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73640,;.01~VA-GP ONC BRCA I-III ANY ER N+ POST ADJ THERAPY
801.41;+73640,;4~dialog group
801.41;+73640,;6~YES
801.41;+73640,;7~2
801.41;+73640,;9~ONE SELECTION ONLY
801.41;+73640,;23~YES
801.41;+73640,;25~WP-start~1
ER/PR Status AFTER Adjuvant Therapy:
801.41;+73640,;35~WP-start~1
\\ER/PR Status:
801.41;+73640,;52~INDENT
801.41;+73640,;100~NATIONAL
801.412;+73641,+73640,;.01~20
801.412;+73641,+73640,;2~VA-GP ONC BRCA I-III ANY N+ ER/PR POS
801.412;+73642,+73640,;.01~40
801.412;+73642,+73640,;2~VA-GP ONC BRCA I-III ANY ER ER N+ ER/PR NEG
801.44;+73643,+73640,;.01~06/09/2026@08:53
801.44;+73643,+73640,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73641^1
73642^2
73643^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ PR INCOM OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78476</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1179680801</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78476,;.01~VA-ONC BRCA I-III ANY N+ PR INCOM OFF PATH RSN
801.41;+78476,;4~dialog element
801.41;+78476,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH RSN
801.41;+78476,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78476,;51~SUPPRESS
801.41;+78476,;100~NATIONAL
801.412;+78477,+78476,;.01~5
801.412;+78477,+78476,;2~VA-ONC OFF PATHWAY
801.412;+78477,+78476,;7~YES
801.412;+78477,+78476,;9~YES
801.44;+78478,+78476,;.01~06/09/2026@08:53
801.44;+78478,+78476,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78477^1
78478^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ PR INCOM OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78477</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1815544438</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78477,;.01~VA-ONC BRCA I-III ANY N+ PR INCOM OFF PATH TX
801.41;+78477,;4~dialog element
801.41;+78477,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR OFF PATH TX
801.41;+78477,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78477,;51~SUPPRESS
801.41;+78477,;100~NATIONAL
801.412;+78478,+78477,;.01~5
801.412;+78478,+78477,;2~VA-ONC BLANK
801.412;+78478,+78477,;7~YES
801.412;+78478,+78477,;9~YES
801.44;+78479,+78477,;.01~06/09/2026@08:53
801.44;+78479,+78477,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78478^1
78479^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ PR INCOM OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78478</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1586957571</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78478,;.01~VA-GP ONC BRCA I-III ANY N+ PR INCOM OFF PTHWY
801.41;+78478,;4~dialog group
801.41;+78478,;6~YES
801.41;+78478,;7~2
801.41;+78478,;23~YES
801.41;+78478,;25~WP-start~1
Off pathway:
801.41;+78478,;52~INDENT
801.41;+78478,;100~NATIONAL
801.412;+78479,+78478,;.01~10
801.412;+78479,+78478,;2~VA-ONC BRCA I-III ANY N+ PR INCOM OFF PATH TX
801.412;+78480,+78478,;.01~20
801.412;+78480,+78478,;2~VA-ONC BRCA I-III ANY N+ PR INCOM OFF PATH RSN
801.44;+78481,+78478,;.01~06/09/2026@08:53
801.44;+78481,+78478,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78479^1
78480^2
78481^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ PR INCOM CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78479</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>775498542</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78479,;.01~VA-ONC BRCA I-III ANY N+ PR INCOM CLIN TRIAL
801.41;+78479,;4~dialog element
801.41;+78479,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR CLIN TRIAL
801.41;+78479,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78479,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78479,;100~NATIONAL
801.412;+78480,+78479,;.01~5
801.412;+78480,+78479,;2~VA-ONC CLINICAL TRIAL
801.412;+78480,+78479,;9~YES
801.44;+78481,+78479,;.01~06/09/2026@08:53
801.44;+78481,+78479,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78480^1
78481^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N+ ADO-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73638</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>789620588</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73638,;.01~VA-GP ONC BRCA I-III N+ ADO-TRAS
801.41;+73638,;4~dialog group
801.41;+73638,;7~2
801.41;+73638,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP INCOMP PR ADO-TRAS
801.41;+73638,;25~WP-start~1
Ado-trastuzumab Emtansine
801.41;+73638,;35~WP-start~1
Veteran has elected to pursue TREATMENT with ADO-TRASTUZUMAB EMTANSINE.
801.41;+73638,;100~NATIONAL
801.44;+73639,+73638,;.01~06/09/2026@08:53
801.44;+73639,+73638,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73639^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N+ INCOMP RESPONSE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73635</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3090527465</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73635,;.01~VA-GP ONC BRCA I-III N+ INCOMP RESPONSE
801.41;+73635,;4~dialog group
801.41;+73635,;6~YES
801.41;+73635,;7~2
801.41;+73635,;9~ONE SELECTION ONLY
801.41;+73635,;25~WP-start~1
Incomplete:
801.41;+73635,;35~WP-start~1
\\Incomplete pathological response:
801.41;+73635,;52~INDENT
801.41;+73635,;100~NATIONAL
801.412;+73636,+73635,;.01~10
801.412;+73636,+73635,;2~VA-GP ONC BRCA I-III N+ ADO-TRAS
801.412;+73637,+73635,;.01~5
801.412;+73637,+73635,;2~VA-ONC BRCA I-III ANY N+ PR INCOM CLIN TRIAL
801.412;+73638,+73635,;.01~20
801.412;+73638,+73635,;2~VA-GP ONC BRCA I-III ANY N+ PR INCOM OFF PTHWY
801.44;+73639,+73635,;.01~06/09/2026@08:53
801.44;+73639,+73635,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73636^1
73637^2
73638^3
73639^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ PR COM OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78475</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2175867090</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78475,;.01~VA-ONC BRCA I-III ANY N+ PR COM OFF PATH RSN
801.41;+78475,;4~dialog element
801.41;+78475,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH RSN
801.41;+78475,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78475,;51~SUPPRESS
801.41;+78475,;100~NATIONAL
801.412;+78476,+78475,;.01~5
801.412;+78476,+78475,;2~VA-ONC OFF PATHWAY
801.412;+78476,+78475,;7~YES
801.412;+78476,+78475,;9~YES
801.44;+78477,+78475,;.01~06/09/2026@08:53
801.44;+78477,+78475,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78476^1
78477^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ PR COM OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78474</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1187869959</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78474,;.01~VA-ONC BRCA I-III ANY N+ PR COM OFF PATH TX
801.41;+78474,;4~dialog element
801.41;+78474,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR OFF PATH TX
801.41;+78474,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78474,;51~SUPPRESS
801.41;+78474,;100~NATIONAL
801.412;+78475,+78474,;.01~5
801.412;+78475,+78474,;2~VA-ONC BLANK
801.412;+78475,+78474,;7~YES
801.412;+78475,+78474,;9~YES
801.44;+78476,+78474,;.01~06/09/2026@08:53
801.44;+78476,+78474,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78475^1
78476^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ PR COM OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78473</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>454402420</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78473,;.01~VA-GP ONC BRCA I-III ANY N+ PR COM OFF PTHWY
801.41;+78473,;4~dialog group
801.41;+78473,;6~YES
801.41;+78473,;7~2
801.41;+78473,;23~YES
801.41;+78473,;25~WP-start~1
Off pathway:
801.41;+78473,;52~INDENT
801.41;+78473,;100~NATIONAL
801.412;+78474,+78473,;.01~10
801.412;+78474,+78473,;2~VA-ONC BRCA I-III ANY N+ PR COM OFF PATH TX
801.412;+78475,+78473,;.01~20
801.412;+78475,+78473,;2~VA-ONC BRCA I-III ANY N+ PR COM OFF PATH RSN
801.44;+78476,+78473,;.01~06/09/2026@08:53
801.44;+78476,+78473,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78474^1
78475^2
78476^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ PR COM CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78472</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2203679496</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78472,;.01~VA-ONC BRCA I-III ANY N+ PR COM CLIN TRIAL
801.41;+78472,;4~dialog element
801.41;+78472,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR CLIN TRIAL
801.41;+78472,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78472,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78472,;100~NATIONAL
801.412;+78473,+78472,;.01~5
801.412;+78473,+78472,;2~VA-ONC CLINICAL TRIAL
801.412;+78473,+78472,;9~YES
801.44;+78474,+78472,;.01~06/09/2026@08:53
801.44;+78474,+78472,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78473^1
78474^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N+ TRAS+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73636</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4117017586</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73636,;.01~VA-GP ONC BRCA I-III N+ TRAS+PERT
801.41;+73636,;4~dialog group
801.41;+73636,;7~2
801.41;+73636,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP COMP PR TRAS+PERT
801.41;+73636,;25~WP-start~1
Trastuzumab and pertuzumab (1 year)
801.41;+73636,;35~WP-start~2
Veteran has elected to pursue TREATMENT with TRASTUZUMAB and PERTUZUMAB
for 1 Year.
801.41;+73636,;100~NATIONAL
801.44;+73637,+73636,;.01~06/09/2026@08:53
801.44;+73637,+73636,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73637^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N+ COMP RESPONSE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73634</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1350770106</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73634,;.01~VA-GP ONC BRCA I-III N+ COMP RESPONSE
801.41;+73634,;4~dialog group
801.41;+73634,;6~YES
801.41;+73634,;7~2
801.41;+73634,;9~ONE SELECTION ONLY
801.41;+73634,;25~WP-start~1
Complete:
801.41;+73634,;35~WP-start~1
\\Complete pathological response:
801.41;+73634,;52~INDENT
801.41;+73634,;100~NATIONAL
801.412;+73635,+73634,;.01~10
801.412;+73635,+73634,;2~VA-GP ONC BRCA I-III N+ TRAS+PERT
801.412;+73636,+73634,;.01~5
801.412;+73636,+73634,;2~VA-ONC BRCA I-III ANY N+ PR COM CLIN TRIAL
801.412;+73637,+73634,;.01~20
801.412;+73637,+73634,;2~VA-GP ONC BRCA I-III ANY N+ PR COM OFF PTHWY
801.44;+73638,+73634,;.01~06/09/2026@08:53
801.44;+73638,+73634,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73635^1
73636^2
73637^3
73638^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N+ PATH RESPONSE FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73633</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1471057185</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73633,;.01~VA-GP ONC BRCA I-III N+ PATH RESPONSE FN
801.41;+73633,;4~dialog group
801.41;+73633,;6~YES
801.41;+73633,;9~ONE SELECTION ONLY
801.41;+73633,;23~YES
801.41;+73633,;25~WP-start~2
++ Complete Pathological Response = absence of residual\\   invasive
carcinoma in both the breast and lymph nodes. ++
801.41;+73633,;51~SUPPRESS
801.41;+73633,;100~NATIONAL
801.412;+73634,+73633,;.01~10
801.412;+73634,+73633,;2~VA-GP ONC BRCA I-III N+ COMP RESPONSE
801.412;+73635,+73633,;.01~20
801.412;+73635,+73633,;2~VA-GP ONC BRCA I-III N+ INCOMP RESPONSE
801.412;+73636,+73633,;.01~30
801.412;+73636,+73633,;2~VA-GP ONC BRCA I-III ANY ER N+ POST ADJ THERAPY
801.44;+73637,+73633,;.01~06/09/2026@08:53
801.44;+73637,+73633,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73634^1
73635^2
73636^3
73637^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER/PR/HER2+ N+ RESPONSE MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73632</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1295394202</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73632,;.01~VA-GP ONC BRCA I-III ER/PR/HER2+ N+ RESPONSE MAIN
801.41;+73632,;4~dialog group
801.41;+73632,;51~SUPPRESS
801.41;+73632,;100~NATIONAL
801.412;+73633,+73632,;.01~10
801.412;+73633,+73632,;2~VA-GP ONC BRCA I-III N+ PATH RESPONSE FN
801.44;+73634,+73632,;.01~06/09/2026@08:53
801.44;+73634,+73632,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73633^1
73634^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER/PR/HER2+ LRM AFTER ADJ</POINT_01>
<INTERNAL_ENTRY_NUMBER>73631</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>733668240</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73631,;.01~VA-ONC BRCA I-III ER/PR/HER2+ LRM AFTER ADJ
801.41;+73631,;4~dialog element
801.41;+73631,;23~YES
801.41;+73631,;25~WP-start~1
- Follow Local/Regional Management After Neoadjuvant Treatment Pathway.
801.41;+73631,;51~SUPPRESS
801.41;+73631,;100~NATIONAL
801.44;+73632,+73631,;.01~06/09/2026@08:53
801.44;+73632,+73631,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73632^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER/PR/HER2+ TCHP</POINT_01>
<INTERNAL_ENTRY_NUMBER>73612</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4070165924</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73612,;.01~VA-GP ONC BRCA I-III ER/PR/HER2+ TCHP
801.41;+73612,;4~dialog group
801.41;+73612,;7~2
801.41;+73612,;15~HF.VA-ONC BRCA I-III ANY ER N+ TCHP
801.41;+73612,;25~WP-start~1
Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP):
801.41;+73612,;35~WP-start~3
Veteran has elected to pursue treatment with 
Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) then follow
LOCAL/REGIONAL MANAGEMENT AFTER Neoadjuvant Therapy Pathway.
801.41;+73612,;100~NATIONAL
801.412;+73613,+73612,;.01~10
801.412;+73613,+73612,;2~VA-ONC BRCA I-III ER/PR/HER2+ LRM AFTER ADJ
801.412;+73614,+73612,;.01~20
801.412;+73614,+73612,;2~VA-GP ONC BRCA I-III ER/PR/HER2+ N+ RESPONSE MAIN
801.44;+73615,+73612,;.01~06/09/2026@08:53
801.44;+73615,+73612,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73613^1
73614^2
73615^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER/PR/HER2+ STAGE N+</POINT_01>
<INTERNAL_ENTRY_NUMBER>73611</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3365211968</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73611,;.01~VA-GP ONC BRCA I-III ER/PR/HER2+ STAGE N+
801.41;+73611,;4~dialog group
801.41;+73611,;6~YES
801.41;+73611,;7~2
801.41;+73611,;9~ONE SELECTION ONLY
801.41;+73611,;25~WP-start~1
N+:
801.41;+73611,;35~WP-start~1
Clinical Stage N+:
801.41;+73611,;52~INDENT
801.41;+73611,;100~NATIONAL
801.412;+73612,+73611,;.01~10
801.412;+73612,+73611,;2~VA-GP ONC BRCA I-III ER/PR/HER2+ TCHP
801.412;+73613,+73611,;.01~5
801.412;+73613,+73611,;2~VA-ONC BRCA I-III ANY N+ CLIN TRIAL
801.412;+73614,+73611,;.01~20
801.412;+73614,+73611,;2~VA-GP ONC BRCA I-III ANY N+ OFF PTHWY
801.44;+73615,+73611,;.01~06/09/2026@08:53
801.44;+73615,+73611,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73612^1
73613^2
73614^3
73615^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY NO NEOADJ TT-PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>86896</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1116878659</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86896,;.01~VA-GP ONC BRCA I-III ANY NO NEOADJ TT-PERT
801.41;+86896,;4~dialog group
801.41;+86896,;7~2
801.41;+86896,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ TAX+TRAS-PERT
801.41;+86896,;25~WP-start~1
Taxane and trastuzumab-containing regimen WITHOUT pertuzumab
801.41;+86896,;35~WP-start~2
Veteran has elected to pursue TREATMENT with TAXANE and
TRASTUZUMAB-containing regimen WITHOUT PERTUZUMAB.
801.41;+86896,;100~NATIONAL
801.44;+86897,+86896,;.01~06/09/2026@08:53
801.44;+86897,+86896,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86897^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY NO NEOADJ TT+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>86895</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>834098957</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86895,;.01~VA-GP ONC BRCA I-III ANY NO NEOADJ TT+PERT
801.41;+86895,;4~dialog group
801.41;+86895,;7~2
801.41;+86895,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ TAX+TRAS+PERT
801.41;+86895,;25~WP-start~1
Taxane and trastuzumab-containing regimen WITH pertuzumab
801.41;+86895,;35~WP-start~2
Veteran has elected to pursue TREATMENT with TAXANE and
TRASTUZUMAB-containing regimen WITH PERTUZUMAB.
801.41;+86895,;100~NATIONAL
801.44;+86896,+86895,;.01~06/09/2026@08:53
801.44;+86896,+86895,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86896^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY NO ADJ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86891</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2291280264</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86891,;.01~VA-ONC BRCA I-III ANY NO ADJ CLIN TRIAL
801.41;+86891,;4~dialog element
801.41;+86891,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ CLIN TRIAL
801.41;+86891,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86891,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86891,;100~NATIONAL
801.412;+86892,+86891,;.01~5
801.412;+86892,+86891,;2~VA-ONC CLINICAL TRIAL
801.412;+86892,+86891,;9~YES
801.44;+86893,+86891,;.01~06/09/2026@08:53
801.44;+86893,+86891,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86892^1
86893^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY NO ADJ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86894</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3397888958</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86894,;.01~VA-ONC BRCA I-III ANY NO ADJ OFF PATH RSN
801.41;+86894,;4~dialog element
801.41;+86894,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ OFF PATH RSN
801.41;+86894,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86894,;51~SUPPRESS
801.41;+86894,;100~NATIONAL
801.412;+86895,+86894,;.01~5
801.412;+86895,+86894,;2~VA-ONC OFF PATHWAY
801.412;+86895,+86894,;7~YES
801.412;+86895,+86894,;9~YES
801.44;+86896,+86894,;.01~06/09/2026@08:53
801.44;+86896,+86894,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86895^1
86896^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY NO ADJ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86893</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1520070099</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86893,;.01~VA-ONC BRCA I-III ANY NO ADJ OFF PATH TX
801.41;+86893,;4~dialog element
801.41;+86893,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NO NEOADJ OFF PATH TX
801.41;+86893,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86893,;51~SUPPRESS
801.41;+86893,;100~NATIONAL
801.412;+86894,+86893,;.01~5
801.412;+86894,+86893,;2~VA-ONC BLANK
801.412;+86894,+86893,;7~YES
801.412;+86894,+86893,;9~YES
801.44;+86895,+86893,;.01~06/09/2026@08:53
801.44;+86895,+86893,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86894^1
86895^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY NO ADJ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86892</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3742641493</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86892,;.01~VA-GP ONC BRCA I-III ANY NO ADJ OFF PTHWY
801.41;+86892,;4~dialog group
801.41;+86892,;6~YES
801.41;+86892,;7~2
801.41;+86892,;23~YES
801.41;+86892,;25~WP-start~1
Off pathway:
801.41;+86892,;52~INDENT
801.41;+86892,;100~NATIONAL
801.412;+86893,+86892,;.01~10
801.412;+86893,+86892,;2~VA-ONC BRCA I-III ANY NO ADJ OFF PATH TX
801.412;+86894,+86892,;.01~20
801.412;+86894,+86892,;2~VA-ONC BRCA I-III ANY NO ADJ OFF PATH RSN
801.44;+86895,+86892,;.01~06/09/2026@08:53
801.44;+86895,+86892,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86893^1
86894^2
86895^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N0 NEOADJ NO LRM+TAX+TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73699</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3614885702</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73699,;.01~VA-GP ONC BRCA I-III N0 NEOADJ NO LRM+TAX+TRAS
801.41;+73699,;4~dialog group
801.41;+73699,;6~YES
801.41;+73699,;7~2
801.41;+73699,;9~NONE OR ONE SELECTION
801.41;+73699,;23~YES
801.41;+73699,;25~WP-start~1
- Follow Local/Regional Management Prior to Adjuvant Treatment Pathway.
801.41;+73699,;51~SUPPRESS
801.41;+73699,;100~NATIONAL
801.412;+73700,+73699,;.01~30
801.412;+73700,+73699,;2~VA-GP ONC BRCA I-III ANY NO ADJ OFF PTHWY
801.412;+73701,+73699,;.01~5
801.412;+73701,+73699,;2~VA-ONC BRCA I-III ANY NO ADJ CLIN TRIAL
801.412;+73702,+73699,;.01~10
801.412;+73702,+73699,;2~VA-GP ONC BRCA I-III ANY NO NEOADJ TT+PERT
801.412;+73703,+73699,;.01~20
801.412;+73703,+73699,;2~VA-GP ONC BRCA I-III ANY NO NEOADJ TT-PERT
801.44;+73704,+73699,;.01~06/09/2026@08:53
801.44;+73704,+73699,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73700^1
73701^2
73702^3
73703^4
73704^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N0 NEOADJ CAND NO</POINT_01>
<INTERNAL_ENTRY_NUMBER>73698</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>765690986</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73698,;.01~VA-GP ONC BRCA I-III N0 NEOADJ CAND NO
801.41;+73698,;4~dialog group
801.41;+73698,;7~2
801.41;+73698,;25~WP-start~1
Not a candidate for neoadjuvant therapy:
801.41;+73698,;100~NATIONAL
801.412;+73699,+73698,;.01~10
801.412;+73699,+73698,;2~VA-GP ONC BRCA I-III N0 NEOADJ NO LRM+TAX+TRAS
801.44;+73700,+73698,;.01~06/09/2026@08:53
801.44;+73700,+73698,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73699^1
73700^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 INCOMP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78464</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2858412086</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78464,;.01~VA-ONC BRCA I-III ANY N0 INCOMP OFF PATH RSN
801.41;+78464,;4~dialog element
801.41;+78464,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP OFF PATH RSN
801.41;+78464,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78464,;51~SUPPRESS
801.41;+78464,;100~NATIONAL
801.412;+78465,+78464,;.01~5
801.412;+78465,+78464,;2~VA-ONC OFF PATHWAY
801.412;+78465,+78464,;7~YES
801.412;+78465,+78464,;9~YES
801.44;+78466,+78464,;.01~06/09/2026@08:53
801.44;+78466,+78464,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78465^1
78466^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 INCOMP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78465</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2138768294</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78465,;.01~VA-ONC BRCA I-III ANY N0 INCOMP OFF PATH TX
801.41;+78465,;4~dialog element
801.41;+78465,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP OFF PATH TX
801.41;+78465,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78465,;51~SUPPRESS
801.41;+78465,;100~NATIONAL
801.412;+78466,+78465,;.01~5
801.412;+78466,+78465,;2~VA-ONC BLANK
801.412;+78466,+78465,;7~YES
801.412;+78466,+78465,;9~YES
801.44;+78467,+78465,;.01~06/09/2026@08:53
801.44;+78467,+78465,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78466^1
78467^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 INCOMP OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78466</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>494164811</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78466,;.01~VA-GP ONC BRCA I-III ANY N0 INCOMP OFF PTHWY
801.41;+78466,;4~dialog group
801.41;+78466,;6~YES
801.41;+78466,;7~2
801.41;+78466,;23~YES
801.41;+78466,;25~WP-start~1
Off pathway:
801.41;+78466,;52~INDENT
801.41;+78466,;100~NATIONAL
801.412;+78467,+78466,;.01~10
801.412;+78467,+78466,;2~VA-ONC BRCA I-III ANY N0 INCOMP OFF PATH TX
801.412;+78468,+78466,;.01~20
801.412;+78468,+78466,;2~VA-ONC BRCA I-III ANY N0 INCOMP OFF PATH RSN
801.44;+78469,+78466,;.01~06/09/2026@08:53
801.44;+78469,+78466,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78467^1
78468^2
78469^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 INCOMP CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78463</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1627039261</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78463,;.01~VA-ONC BRCA I-III ANY N0 INCOMP CLIN TRIAL
801.41;+78463,;4~dialog element
801.41;+78463,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP CLIN TRIAL
801.41;+78463,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78463,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78463,;100~NATIONAL
801.412;+78464,+78463,;.01~5
801.412;+78464,+78463,;2~VA-ONC CLINICAL TRIAL
801.412;+78464,+78463,;9~YES
801.44;+78465,+78463,;.01~06/09/2026@08:53
801.44;+78465,+78463,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78464^1
78465^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III N0 AFTER IR ADO-TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73740</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>183380681</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73740,;.01~VA-GP ONC BR CA I-III N0 AFTER IR ADO-TRAS
801.41;+73740,;4~dialog group
801.41;+73740,;7~2
801.41;+73740,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B INCOMP ADO-TRAS
801.41;+73740,;25~WP-start~1
Ado-trastuzumab Emtansine 
801.41;+73740,;35~WP-start~1
Veteran has elected to pursue TREATMENT with ADO-TRASTUZUMAB EMTANSINE.
801.41;+73740,;100~NATIONAL
801.44;+73741,+73740,;.01~06/09/2026@08:53
801.44;+73741,+73740,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73741^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III N0 AFTER INCOMP RESP</POINT_01>
<INTERNAL_ENTRY_NUMBER>73739</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>226729020</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73739,;.01~VA-GP ONC BR CA I-III N0 AFTER INCOMP RESP
801.41;+73739,;4~dialog group
801.41;+73739,;6~YES
801.41;+73739,;7~2
801.41;+73739,;9~ONE SELECTION ONLY
801.41;+73739,;25~WP-start~1
Incomplete:
801.41;+73739,;35~WP-start~1
Incomplete pathological response:
801.41;+73739,;52~INDENT
801.41;+73739,;100~NATIONAL
801.412;+73740,+73739,;.01~10
801.412;+73740,+73739,;2~VA-GP ONC BR CA I-III N0 AFTER IR ADO-TRAS
801.412;+73741,+73739,;.01~5
801.412;+73741,+73739,;2~VA-ONC BRCA I-III ANY N0 INCOMP CLIN TRIAL
801.412;+73742,+73739,;.01~20
801.412;+73742,+73739,;2~VA-GP ONC BRCA I-III ANY N0 INCOMP OFF PTHWY
801.44;+73743,+73739,;.01~06/09/2026@08:53
801.44;+73743,+73739,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73740^1
73741^2
73742^3
73743^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 ER/PR POS FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>108499</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3946303981</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+108499,;.01~VA-ONC BRCA I-III ANY N0 ER/PR POS FN
801.41;+108499,;4~dialog element
801.41;+108499,;23~YES
801.41;+108499,;25~WP-start~1
++ If ER/PR Positive - follow ER+ Adjuvant pathway. ++
801.41;+108499,;51~SUPPRESS
801.41;+108499,;100~NATIONAL
801.44;+108500,+108499,;.01~06/09/2026@08:53
801.44;+108500,+108499,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
108500^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86914</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3206650398</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86914,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH RSN
801.41;+86914,;4~dialog element
801.41;+86914,;15~HF.VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH RSN
801.41;+86914,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86914,;51~SUPPRESS
801.41;+86914,;100~NATIONAL
801.412;+86915,+86914,;.01~5
801.412;+86915,+86914,;2~VA-ONC OFF PATHWAY
801.412;+86915,+86914,;7~YES
801.412;+86915,+86914,;9~YES
801.44;+86916,+86914,;.01~06/09/2026@08:53
801.44;+86916,+86914,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86915^1
86916^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86913</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4097617440</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86913,;.01~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX
801.41;+86913,;4~dialog element
801.41;+86913,;15~HF.VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX
801.41;+86913,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86913,;51~SUPPRESS
801.41;+86913,;100~NATIONAL
801.412;+86914,+86913,;.01~5
801.412;+86914,+86913,;2~VA-ONC BLANK
801.412;+86914,+86913,;7~YES
801.412;+86914,+86913,;9~YES
801.44;+86915,+86913,;.01~06/09/2026@08:53
801.44;+86915,+86913,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86914^1
86915^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 ER/PR NEG OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86912</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2066437888</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86912,;.01~VA-GP ONC BRCA I-III ANY N0 ER/PR NEG OFF PTHWY
801.41;+86912,;4~dialog group
801.41;+86912,;6~YES
801.41;+86912,;7~2
801.41;+86912,;23~YES
801.41;+86912,;25~WP-start~1
Off pathway:
801.41;+86912,;52~INDENT
801.41;+86912,;100~NATIONAL
801.412;+86913,+86912,;.01~10
801.412;+86913,+86912,;2~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH TX
801.412;+86914,+86912,;.01~20
801.412;+86914,+86912,;2~VA-ONC BRCA I-III ANY ER N0 ER/PR NEG OFF PATH RSN
801.44;+86915,+86912,;.01~06/09/2026@08:53
801.44;+86915,+86912,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86913^1
86914^2
86915^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR CA I-III N0 ER/PR NEGATIVE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73762</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>84119132</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73762,;.01~VA-ONC BR CA I-III N0 ER/PR NEGATIVE
801.41;+73762,;4~dialog element
801.41;+73762,;15~HF.VA-ONC BRCA I-III ANY ER N0 ER/PR NEG HER2 TX+SURV
801.41;+73762,;25~WP-start~1
Complete HER2 directed therapy; followed by Surveillance
801.41;+73762,;35~WP-start~2
Veteran has elected to COMPLETE HER2 DIRECTED THERAPY; followed by
SURVEILLANCE.
801.41;+73762,;100~NATIONAL
801.44;+73763,+73762,;.01~06/09/2026@08:53
801.44;+73763,+73762,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73763^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 ER/PR NEG CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86911</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2806717237</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86911,;.01~VA-ONC BRCA I-III ANY N0 ER/PR NEG CLIN TRIAL
801.41;+86911,;4~dialog element
801.41;+86911,;15~HF.VA-ONC BRCA I-III ANY ER N0 ER/PR NEG CLIN TRIAL
801.41;+86911,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86911,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86911,;100~NATIONAL
801.412;+86912,+86911,;.01~5
801.412;+86912,+86911,;2~VA-ONC CLINICAL TRIAL
801.412;+86912,+86911,;9~YES
801.44;+86913,+86911,;.01~06/09/2026@08:53
801.44;+86913,+86911,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86912^1
86913^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 ER/PR NEG</POINT_01>
<INTERNAL_ENTRY_NUMBER>86910</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3838145883</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86910,;.01~VA-GP ONC BRCA I-III ANY N0 ER/PR NEG
801.41;+86910,;4~dialog group
801.41;+86910,;6~YES
801.41;+86910,;7~2
801.41;+86910,;9~NONE OR ONE SELECTION
801.41;+86910,;25~WP-start~1
ER/PR Negative:
801.41;+86910,;51~SUPPRESS
801.41;+86910,;100~NATIONAL
801.412;+86911,+86910,;.01~5
801.412;+86911,+86910,;2~VA-ONC BRCA I-III ANY N0 ER/PR NEG CLIN TRIAL
801.412;+86912,+86910,;.01~10
801.412;+86912,+86910,;2~VA-ONC BR CA I-III N0 ER/PR NEGATIVE
801.412;+86913,+86910,;.01~20
801.412;+86913,+86910,;2~VA-GP ONC BRCA I-III ANY N0 ER/PR NEG OFF PTHWY
801.44;+86914,+86910,;.01~06/09/2026@08:53
801.44;+86914,+86910,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86911^4
86912^5
86913^6
86914^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N0 ER/PR STATUS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73749</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>242163633</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73749,;.01~VA-GP ONC BRCA I-III N0 ER/PR STATUS
801.41;+73749,;4~dialog group
801.41;+73749,;6~YES
801.41;+73749,;7~2
801.41;+73749,;23~YES
801.41;+73749,;25~WP-start~1
ER/PR Status AFTER Adjuvant Therapy:
801.41;+73749,;100~NATIONAL
801.412;+73750,+73749,;.01~20
801.412;+73750,+73749,;2~VA-GP ONC BRCA I-III ANY N0 ER/PR NEG
801.412;+73751,+73749,;.01~10
801.412;+73751,+73749,;2~VA-ONC BRCA I-III ANY N0 ER/PR POS FN
801.44;+73752,+73749,;.01~06/09/2026@08:53
801.44;+73752,+73749,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73750^2
73751^3
73752^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ COMP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>80484</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3685060057</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+80484,;.01~VA-ONC BRCA I-III ANY N+ COMP OFF PATH RSN
801.41;+80484,;4~dialog element
801.41;+80484,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ OFF PATH RSN
801.41;+80484,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+80484,;51~SUPPRESS
801.41;+80484,;100~NATIONAL
801.412;+80485,+80484,;.01~5
801.412;+80485,+80484,;2~VA-ONC OFF PATHWAY
801.412;+80485,+80484,;7~YES
801.412;+80485,+80484,;9~YES
801.44;+80486,+80484,;.01~06/09/2026@08:53
801.44;+80486,+80484,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
80485^1
80486^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ COMP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>80483</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>508754631</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+80483,;.01~VA-ONC BRCA I-III ANY N+ COMP OFF PATH TX
801.41;+80483,;4~dialog element
801.41;+80483,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ OFF PATH TX
801.41;+80483,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+80483,;51~SUPPRESS
801.41;+80483,;100~NATIONAL
801.412;+80484,+80483,;.01~5
801.412;+80484,+80483,;2~VA-ONC BLANK
801.412;+80484,+80483,;7~YES
801.412;+80484,+80483,;9~YES
801.44;+80485,+80483,;.01~06/09/2026@08:53
801.44;+80485,+80483,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
80484^1
80485^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N+ COMP OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78457</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>303677276</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78457,;.01~VA-GP ONC BRCA I-III ANY N+ COMP OFF PTHWY
801.41;+78457,;4~dialog group
801.41;+78457,;6~YES
801.41;+78457,;7~2
801.41;+78457,;23~YES
801.41;+78457,;25~WP-start~1
Off pathway:
801.41;+78457,;52~INDENT
801.41;+78457,;100~NATIONAL
801.412;+78458,+78457,;.01~10
801.412;+78458,+78457,;2~VA-ONC BRCA I-III ANY N+ COMP OFF PATH TX
801.412;+78459,+78457,;.01~20
801.412;+78459,+78457,;2~VA-ONC BRCA I-III ANY N+ COMP OFF PATH RSN
801.44;+78460,+78457,;.01~06/09/2026@08:53
801.44;+78460,+78457,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78458^1
78459^2
78460^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N+ COMP CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78456</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>485638013</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78456,;.01~VA-ONC BRCA I-III ANY N+ COMP CLIN TRIAL
801.41;+78456,;4~dialog element
801.41;+78456,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ CLIN TRIAL
801.41;+78456,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78456,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78456,;100~NATIONAL
801.412;+78457,+78456,;.01~5
801.412;+78457,+78456,;2~VA-ONC CLINICAL TRIAL
801.412;+78457,+78456,;9~YES
801.44;+78458,+78456,;.01~06/09/2026@08:53
801.44;+78458,+78456,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78457^1
78458^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N0 CR NODE N+ TRAS+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73748</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3378151421</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73748,;.01~VA-GP ONC BRCA I-III N0 CR NODE N+ TRAS+PERT
801.41;+73748,;4~dialog group
801.41;+73748,;7~2
801.41;+73748,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N+ TRAS+PERT
801.41;+73748,;25~WP-start~1
Trastuzumab and pertuzumab (1 year)
801.41;+73748,;35~WP-start~2
Veteran has elected to pursue TREATMENT with TRASTUZUMAB and PERTUZUMAB
for 1 Year.
801.41;+73748,;100~NATIONAL
801.44;+73749,+73748,;.01~06/09/2026@08:53
801.44;+73749,+73748,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73749^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III N0 AFTER CR NODE N+</POINT_01>
<INTERNAL_ENTRY_NUMBER>73746</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3662343619</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73746,;.01~VA-GP ONC BR CA I-III N0 AFTER CR NODE N+
801.41;+73746,;4~dialog group
801.41;+73746,;6~YES
801.41;+73746,;7~2
801.41;+73746,;9~ONE SELECTION ONLY
801.41;+73746,;25~WP-start~1
Nodal Status N+:
801.41;+73746,;100~NATIONAL
801.412;+73747,+73746,;.01~10
801.412;+73747,+73746,;2~VA-GP ONC BRCA I-III N0 CR NODE N+ TRAS+PERT
801.412;+73748,+73746,;.01~5
801.412;+73748,+73746,;2~VA-ONC BRCA I-III ANY N+ COMP CLIN TRIAL
801.412;+73749,+73746,;.01~20
801.412;+73749,+73746,;2~VA-GP ONC BRCA I-III ANY N+ COMP OFF PTHWY
801.44;+73750,+73746,;.01~06/09/2026@08:53
801.44;+73750,+73746,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73747^1
73748^2
73749^3
73750^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 COMP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78455</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2884717490</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78455,;.01~VA-ONC BRCA I-III ANY N0 COMP OFF PATH RSN
801.41;+78455,;4~dialog element
801.41;+78455,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N0 OFF PATH RSN
801.41;+78455,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78455,;51~SUPPRESS
801.41;+78455,;100~NATIONAL
801.412;+78456,+78455,;.01~5
801.412;+78456,+78455,;2~VA-ONC OFF PATHWAY
801.412;+78456,+78455,;7~YES
801.412;+78456,+78455,;9~YES
801.44;+78457,+78455,;.01~06/09/2026@08:53
801.44;+78457,+78455,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78456^1
78457^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 COMP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78454</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2616888270</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78454,;.01~VA-ONC BRCA I-III ANY N0 COMP OFF PATH TX
801.41;+78454,;4~dialog element
801.41;+78454,;15~HF.VA-ONC BRCA I-III ANY ER N0 > TIB COMP N0 OFF PATH TX
801.41;+78454,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78454,;51~SUPPRESS
801.41;+78454,;100~NATIONAL
801.412;+78455,+78454,;.01~5
801.412;+78455,+78454,;2~VA-ONC BLANK
801.412;+78455,+78454,;7~YES
801.412;+78455,+78454,;9~YES
801.44;+78456,+78454,;.01~06/09/2026@08:53
801.44;+78456,+78454,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78455^1
78456^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 COMP OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78453</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4046749313</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78453,;.01~VA-GP ONC BRCA I-III ANY N0 COMP OFF PTHWY
801.41;+78453,;4~dialog group
801.41;+78453,;6~YES
801.41;+78453,;7~2
801.41;+78453,;23~YES
801.41;+78453,;25~WP-start~1
Off pathway:
801.41;+78453,;52~INDENT
801.41;+78453,;100~NATIONAL
801.412;+78454,+78453,;.01~10
801.412;+78454,+78453,;2~VA-ONC BRCA I-III ANY N0 COMP OFF PATH TX
801.412;+78455,+78453,;.01~20
801.412;+78455,+78453,;2~VA-ONC BRCA I-III ANY N0 COMP OFF PATH RSN
801.44;+78456,+78453,;.01~06/09/2026@08:53
801.44;+78456,+78453,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78454^1
78455^2
78456^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY N0 COMP CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78452</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3586125771</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78452,;.01~VA-ONC BRCA I-III ANY N0 COMP CLIN TRIAL
801.41;+78452,;4~dialog element
801.41;+78452,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N0 CLIN TRIAL
801.41;+78452,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78452,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78452,;100~NATIONAL
801.412;+78453,+78452,;.01~5
801.412;+78453,+78452,;2~VA-ONC CLINICAL TRIAL
801.412;+78453,+78452,;9~YES
801.44;+78454,+78452,;.01~06/09/2026@08:53
801.44;+78454,+78452,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78453^1
78454^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III N0 CR NODE N0 TRAS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73745</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2968543488</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73745,;.01~VA-GP ONC BR CA I-III N0 CR NODE N0 TRAS
801.41;+73745,;4~dialog group
801.41;+73745,;7~2
801.41;+73745,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B COMP N0 TRAS
801.41;+73745,;25~WP-start~1
Trastuzumab (1 year)
801.41;+73745,;35~WP-start~1
Veteran has elected to pursue TREATMENT with TRASTUZUMAB for 1 Year.
801.41;+73745,;100~NATIONAL
801.44;+73746,+73745,;.01~06/09/2026@08:53
801.44;+73746,+73745,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73746^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III N0 AFTER CR NODE N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73742</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2285726676</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73742,;.01~VA-GP ONC BR CA I-III N0 AFTER CR NODE N0
801.41;+73742,;4~dialog group
801.41;+73742,;6~YES
801.41;+73742,;7~2
801.41;+73742,;9~ONE SELECTION ONLY
801.41;+73742,;25~WP-start~1
Nodal Status N0:
801.41;+73742,;100~NATIONAL
801.412;+73743,+73742,;.01~10
801.412;+73743,+73742,;2~VA-GP ONC BR CA I-III N0 CR NODE N0 TRAS
801.412;+73744,+73742,;.01~5
801.412;+73744,+73742,;2~VA-ONC BRCA I-III ANY N0 COMP CLIN TRIAL
801.412;+73745,+73742,;.01~20
801.412;+73745,+73742,;2~VA-GP ONC BRCA I-III ANY N0 COMP OFF PTHWY
801.44;+73746,+73742,;.01~06/09/2026@08:53
801.44;+73746,+73742,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73743^1
73744^2
73745^3
73746^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 AFTER COMP RESP</POINT_01>
<INTERNAL_ENTRY_NUMBER>73738</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>774572976</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73738,;.01~VA-GP ONC BRCA I-III ANY N0 AFTER COMP RESP
801.41;+73738,;4~dialog group
801.41;+73738,;6~YES
801.41;+73738,;7~2
801.41;+73738,;9~NONE OR ONE SELECTION
801.41;+73738,;25~WP-start~1
Complete:
801.41;+73738,;35~WP-start~1
Complete pathological response:
801.41;+73738,;52~INDENT
801.41;+73738,;100~NATIONAL
801.412;+73739,+73738,;.01~10
801.412;+73739,+73738,;2~VA-GP ONC BR CA I-III N0 AFTER CR NODE N0
801.412;+73740,+73738,;.01~20
801.412;+73740,+73738,;2~VA-GP ONC BR CA I-III N0 AFTER CR NODE N+
801.412;+73741,+73738,;.01~30
801.412;+73741,+73738,;2~VA-GP ONC BRCA I-III N0 ER/PR STATUS
801.44;+73742,+73738,;.01~06/09/2026@08:53
801.44;+73742,+73738,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73739^1
73740^2
73741^3
73742^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 AFTER ADJ PR FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73737</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>967179348</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73737,;.01~VA-GP ONC BRCA I-III ANY N0 AFTER ADJ PR FN
801.41;+73737,;4~dialog group
801.41;+73737,;6~YES
801.41;+73737,;7~2
801.41;+73737,;9~ONE SELECTION ONLY
801.41;+73737,;23~YES
801.41;+73737,;25~WP-start~2
++ Complete = absence of residual invasive carcinoma in both the
breast and lymph nodes. ++
801.41;+73737,;51~SUPPRESS
801.41;+73737,;100~NATIONAL
801.412;+73738,+73737,;.01~10
801.412;+73738,+73737,;2~VA-GP ONC BRCA I-III ANY N0 AFTER COMP RESP
801.412;+73739,+73737,;.01~20
801.412;+73739,+73737,;2~VA-GP ONC BR CA I-III N0 AFTER INCOMP RESP
801.44;+73740,+73737,;.01~06/09/2026@08:53
801.44;+73740,+73737,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73738^1
73739^2
73740^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 AFTER ADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73735</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>897106589</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73735,;.01~VA-GP ONC BRCA I-III ANY N0 AFTER ADJ THERAPY
801.41;+73735,;4~dialog group
801.41;+73735,;7~2
801.41;+73735,;23~YES
801.41;+73735,;25~WP-start~1
Pathological Response AFTER Neoadjuvant Therapy:
801.41;+73735,;100~NATIONAL
801.412;+73736,+73735,;.01~10
801.412;+73736,+73735,;2~VA-GP ONC BRCA I-III ANY N0 AFTER ADJ PR FN
801.44;+73737,+73735,;.01~06/09/2026@08:53
801.44;+73737,+73735,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73736^1
73737^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 ADJ TT-PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>86897</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>607208716</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86897,;.01~VA-GP ONC BRCA I-III ANY N0 ADJ TT-PERT
801.41;+86897,;4~dialog group
801.41;+86897,;7~2
801.41;+86897,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ TAX+TRAS W/O PERT
801.41;+86897,;25~WP-start~2
Taxane and trastuzumab-containing regimen WITHOUT pertuzumab; then
Follow Local/Regional Management After Neoadjuvant Treatment Pathway
801.41;+86897,;35~WP-start~3
Veteran has elected to pursue TREATMENT with TAXANE and
TRASTUZUMAB-containing regimen WITHOUT PERTUZUMAB; then FOLLOW
LOCAL/REGIONAL MANAGEMENT AFTER NEOADJUVANT TREATMENT PATHWAY.
801.41;+86897,;100~NATIONAL
801.44;+86898,+86897,;.01~06/09/2026@08:53
801.44;+86898,+86897,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86898^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ADJ OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78450</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2487327973</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78450,;.01~VA-ONC BRCA I-III ANY ADJ OFF PATH RSN
801.41;+78450,;4~dialog element
801.41;+78450,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ OFF PATH RSN
801.41;+78450,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78450,;51~SUPPRESS
801.41;+78450,;100~NATIONAL
801.412;+78451,+78450,;.01~5
801.412;+78451,+78450,;2~VA-ONC OFF PATHWAY
801.412;+78451,+78450,;7~YES
801.412;+78451,+78450,;9~YES
801.44;+78452,+78450,;.01~06/09/2026@08:53
801.44;+78452,+78450,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78451^1
78452^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ADJ OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78449</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3224139269</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78449,;.01~VA-ONC BRCA I-III ANY ADJ OFF PATH TX
801.41;+78449,;4~dialog element
801.41;+78449,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ OFF PATH TX
801.41;+78449,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78449,;51~SUPPRESS
801.41;+78449,;100~NATIONAL
801.412;+78450,+78449,;.01~5
801.412;+78450,+78449,;2~VA-ONC BLANK
801.412;+78450,+78449,;7~YES
801.412;+78450,+78449,;9~YES
801.44;+78451,+78449,;.01~06/09/2026@08:53
801.44;+78451,+78449,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78450^1
78451^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY ADJ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78451</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1169065423</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78451,;.01~VA-GP ONC BRCA I-III ANY ADJ OFF PTHWY
801.41;+78451,;4~dialog group
801.41;+78451,;6~YES
801.41;+78451,;7~2
801.41;+78451,;23~YES
801.41;+78451,;25~WP-start~1
Off pathway:
801.41;+78451,;52~INDENT
801.41;+78451,;100~NATIONAL
801.412;+78452,+78451,;.01~10
801.412;+78452,+78451,;2~VA-ONC BRCA I-III ANY ADJ OFF PATH TX
801.412;+78453,+78451,;.01~20
801.412;+78453,+78451,;2~VA-ONC BRCA I-III ANY ADJ OFF PATH RSN
801.44;+78454,+78451,;.01~06/09/2026@08:53
801.44;+78454,+78451,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78452^1
78453^2
78454^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ANY ADJ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78448</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3562427881</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78448,;.01~VA-ONC BRCA I-III ANY ADJ CLIN TRIAL
801.41;+78448,;4~dialog element
801.41;+78448,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ CLIN TRIA
801.41;+78448,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78448,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78448,;100~NATIONAL
801.412;+78449,+78448,;.01~5
801.412;+78449,+78448,;2~VA-ONC CLINICAL TRIAL
801.412;+78449,+78448,;9~YES
801.44;+78450,+78448,;.01~06/09/2026@08:53
801.44;+78450,+78448,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78449^1
78450^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 ADJ TT+PERT</POINT_01>
<INTERNAL_ENTRY_NUMBER>73733</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2805559073</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73733,;.01~VA-GP ONC BRCA I-III ANY N0 ADJ TT+PERT
801.41;+73733,;4~dialog group
801.41;+73733,;7~2
801.41;+73733,;15~HF.VA-ONC BRCA I-III ANY ER N0 > T1B NEOADJ TAX+TRAS W/PERT
801.41;+73733,;25~WP-start~2
Taxane and trastuzumab-containing regimen WITH pertuzumab; then
Follow Local/Regional Management After Neoadjuvant Treatment Pathway
801.41;+73733,;35~WP-start~3
Veteran has elected to pursue TREATMENT with TAXANE and
TRASTUZUMAB-containing regimen WITH PERTUZUMAB; then FOLLOW LOCAL/REGIONAL
MANAGEMENT AFTER NEOADJUVANT TREATMENT PATHWAY.
801.41;+73733,;100~NATIONAL
801.44;+73734,+73733,;.01~06/09/2026@08:53
801.44;+73734,+73733,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73734^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY N0 NEOADJ FL THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73732</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>694132157</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73732,;.01~VA-GP ONC BRCA I-III ANY N0 NEOADJ FL THERAPY
801.41;+73732,;4~dialog group
801.41;+73732,;6~YES
801.41;+73732,;7~2
801.41;+73732,;9~ONE SELECTION ONLY
801.41;+73732,;23~YES
801.41;+73732,;25~WP-start~1
Neoadjuvant Therapy:
801.41;+73732,;100~NATIONAL
801.412;+73733,+73732,;.01~10
801.412;+73733,+73732,;2~VA-GP ONC BRCA I-III ANY N0 ADJ TT+PERT
801.412;+73734,+73732,;.01~5
801.412;+73734,+73732,;2~VA-ONC BRCA I-III ANY ADJ CLIN TRIAL
801.412;+73735,+73732,;.01~20
801.412;+73735,+73732,;2~VA-GP ONC BRCA I-III ANY ADJ OFF PTHWY
801.412;+73736,+73732,;.01~15
801.412;+73736,+73732,;2~VA-GP ONC BRCA I-III ANY N0 ADJ TT-PERT
801.44;+73737,+73732,;.01~06/09/2026@08:53
801.44;+73737,+73732,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73733^1
73734^2
73735^3
73736^4
73737^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III N0 NEOADJ CAND</POINT_01>
<INTERNAL_ENTRY_NUMBER>73697</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1901242526</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73697,;.01~VA-GP ONC BRCA I-III N0 NEOADJ CAND
801.41;+73697,;4~dialog group
801.41;+73697,;6~YES
801.41;+73697,;7~2
801.41;+73697,;9~ONE SELECTION ONLY
801.41;+73697,;25~WP-start~1
Candidate for neoadjuvant therapy:
801.41;+73697,;100~NATIONAL
801.412;+73698,+73697,;.01~10
801.412;+73698,+73697,;2~VA-GP ONC BRCA I-III ANY N0 NEOADJ FL THERAPY
801.412;+73699,+73697,;.01~20
801.412;+73699,+73697,;2~VA-GP ONC BRCA I-III ANY N0 AFTER ADJ THERAPY
801.44;+73700,+73697,;.01~06/09/2026@08:53
801.44;+73700,+73697,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73698^1
73699^2
73700^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER/PR/HER2+ N0 T1B</POINT_01>
<INTERNAL_ENTRY_NUMBER>73695</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3689237019</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73695,;.01~VA-GP ONC BRCA I-III ER/PR/HER2+ N0 T1B
801.41;+73695,;4~dialog group
801.41;+73695,;9~ONE SELECTION ONLY
801.41;+73695,;25~WP-start~1
Tumor size, T1b or greater:
801.41;+73695,;51~SUPPRESS
801.41;+73695,;52~INDENT
801.41;+73695,;100~NATIONAL
801.412;+73696,+73695,;.01~10
801.412;+73696,+73695,;2~VA-GP ONC BRCA I-III N0 NEOADJ CAND
801.412;+73697,+73695,;.01~20
801.412;+73697,+73695,;2~VA-GP ONC BRCA I-III N0 NEOADJ CAND NO
801.44;+73698,+73695,;.01~06/09/2026@08:53
801.44;+73698,+73695,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73696^1
73697^2
73698^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER/PR/HER2+ N0 &lt;0.5</POINT_01>
<INTERNAL_ENTRY_NUMBER>73693</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2598029588</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73693,;.01~VA-GP ONC BRCA I-III ER/PR/HER2+ N0 <0.5
801.41;+73693,;4~dialog group
801.41;+73693,;6~YES
801.41;+73693,;9~NONE OR ONE SELECTION
801.41;+73693,;23~YES
801.41;+73693,;25~WP-start~3
++ If Tumor Size T1a: Follow Local/Regional Management Prior to Adjuvant
Treatment\\   Pathway; then refer to Medical Oncology for risk reduction
discussion. ++
801.41;+73693,;51~SUPPRESS
801.41;+73693,;52~INDENT
801.41;+73693,;100~NATIONAL
801.412;+73694,+73693,;.01~20
801.412;+73694,+73693,;2~VA-GP ONC BRCA I-III ER/PR/HER2+ N0 T1B
801.44;+73695,+73693,;.01~06/09/2026@08:53
801.44;+73695,+73693,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73694^2
73695^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER/PR/HER2+ STAGE N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73610</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>620907240</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73610,;.01~VA-GP ONC BRCA I-III ER/PR/HER2+ STAGE N0
801.41;+73610,;4~dialog group
801.41;+73610,;7~2
801.41;+73610,;25~WP-start~1
N0:
801.41;+73610,;35~WP-start~1
Clinical Stage N0:
801.41;+73610,;100~NATIONAL
801.412;+73611,+73610,;.01~10
801.412;+73611,+73610,;2~VA-GP ONC BRCA I-III ER/PR/HER2+ N0 <0.5
801.44;+73612,+73610,;.01~06/09/2026@08:53
801.44;+73612,+73610,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73611^1
73612^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY ER/PR/HER+ STAGE</POINT_01>
<INTERNAL_ENTRY_NUMBER>77840</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2347145589</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77840,;.01~VA-GP ONC BRCA I-III ANY ER/PR/HER+ STAGE
801.41;+77840,;4~dialog group
801.41;+77840,;5~Clinical Stage:
801.41;+77840,;6~YES
801.41;+77840,;9~ONE SELECTION ONLY
801.41;+77840,;23~YES
801.41;+77840,;51~SUPPRESS
801.41;+77840,;100~NATIONAL
801.412;+77841,+77840,;.01~20
801.412;+77841,+77840,;2~VA-GP ONC BRCA I-III ER/PR/HER2+ STAGE N0
801.412;+77842,+77840,;.01~40
801.412;+77842,+77840,;2~VA-GP ONC BRCA I-III ER/PR/HER2+ STAGE N+
801.44;+77843,+77840,;.01~06/09/2026@08:53
801.44;+77843,+77840,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77841^1
77842^2
77843^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA I-III ANY ER/PR/HER2+</POINT_01>
<INTERNAL_ENTRY_NUMBER>73606</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1824807939</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73606,;.01~VA-GP ONC BREAST CA I-III ANY ER/PR/HER2+
801.41;+73606,;4~dialog group
801.41;+73606,;7~2
801.41;+73606,;9~NO SELECTION REQUIRED
801.41;+73606,;15~HF.VA-ONC BRCA STG I-III ANY ER OR PR/HER2+ CLINICAL PATHWAY
801.41;+73606,;25~WP-start~1
Any ER or PR/HER2+ Clinical Pathway:
801.41;+73606,;35~WP-start~3
VA National Breast Cancer - Stage I-III Any ER or PR/HER2+\\  Clinical
Pathway\\
==========================================================
801.41;+73606,;100~NATIONAL
801.412;+73607,+73606,;.01~20
801.412;+73607,+73606,;2~VA-GP ONC BRCA I-III ANY ER/PR/HER+ STAGE
801.412;+73608,+73606,;.01~15
801.412;+73608,+73606,;2~VA-ONC BRCA I-III ANY N0 ER/PR+ FOOTNOTE
801.44;+73609,+73606,;.01~06/09/2026@08:53
801.44;+73609,+73606,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73607^5
73608^7
73609^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A FOLLOW LRM PRIOR TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86761</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3538790375</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86761,;.01~VA-ONC BRCA I-III ER+ T1A FOLLOW LRM PRIOR TX
801.41;+86761,;4~dialog element
801.41;+86761,;15~HF.VA-ONC BRCA I-III ER+ T1A LRM PRIOR+MED ONC
801.41;+86761,;25~WP-start~2
Follow Local/Regional Management Prior to Adjuvant Treatment Pathway; then
Refer to Medical Oncology for risk reduction discussion
801.41;+86761,;35~WP-start~3
Veteran has elected to FOLLOW the LOCAL/REGIONAL MANAGEMENT PRIOR to 
ADJUVANT TREATMENT PATHWAY; Then REFERRAL to MEDICAL ONCOLOGY for Risk
Reduction Discussion.
801.41;+86761,;100~NATIONAL
801.44;+86762,+86761,;.01~06/09/2026@08:53
801.44;+86762,+86761,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86762^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86752</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3331621416</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86752,;.01~VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
801.41;+86752,;4~dialog element
801.41;+86752,;15~HF.VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
801.41;+86752,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86752,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86752,;100~NATIONAL
801.412;+86753,+86752,;.01~5
801.412;+86753,+86752,;2~VA-ONC CLINICAL TRIAL
801.412;+86753,+86752,;9~YES
801.44;+86754,+86752,;.01~06/09/2026@08:53
801.44;+86754,+86752,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86753^1
86754^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86755</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3101452018</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86755,;.01~VA-ONC BRCA I-III ER+ T1A OFF PATH RSN
801.41;+86755,;4~dialog element
801.41;+86755,;15~HF.VA-ONC BRCA I-III ER+ T1A OFF PATH TX
801.41;+86755,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86755,;51~SUPPRESS
801.41;+86755,;100~NATIONAL
801.412;+86756,+86755,;.01~5
801.412;+86756,+86755,;2~VA-ONC OFF PATHWAY
801.412;+86756,+86755,;7~YES
801.412;+86756,+86755,;9~YES
801.44;+86757,+86755,;.01~06/09/2026@08:53
801.44;+86757,+86755,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86756^1
86757^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1A OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86754</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3113950940</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86754,;.01~VA-ONC BRCA I-III ER+ T1A OFF PATH TX
801.41;+86754,;4~dialog element
801.41;+86754,;15~HF.VA-ONC BRCA I-III ER+ T1A OFF PATH RSN
801.41;+86754,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86754,;51~SUPPRESS
801.41;+86754,;100~NATIONAL
801.412;+86755,+86754,;.01~5
801.412;+86755,+86754,;2~VA-ONC BLANK
801.412;+86755,+86754,;7~YES
801.412;+86755,+86754,;9~YES
801.44;+86756,+86754,;.01~06/09/2026@08:53
801.44;+86756,+86754,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86755^1
86756^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1A OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86753</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4022016233</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86753,;.01~VA-GP ONC BRCA I-III ER+ T1A OFF PTHWY
801.41;+86753,;4~dialog group
801.41;+86753,;6~YES
801.41;+86753,;7~2
801.41;+86753,;23~YES
801.41;+86753,;25~WP-start~1
Off pathway:
801.41;+86753,;52~INDENT
801.41;+86753,;100~NATIONAL
801.412;+86754,+86753,;.01~10
801.412;+86754,+86753,;2~VA-ONC BRCA I-III ER+ T1A OFF PATH TX
801.412;+86755,+86753,;.01~20
801.412;+86755,+86753,;2~VA-ONC BRCA I-III ER+ T1A OFF PATH RSN
801.44;+86756,+86753,;.01~06/09/2026@08:53
801.44;+86756,+86753,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86754^1
86755^2
86756^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1A SUBMAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86747</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1434117476</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86747,;.01~VA-GP ONC BRCA I-III ER+ T1A SUBMAIN
801.41;+86747,;4~dialog group
801.41;+86747,;6~YES
801.41;+86747,;7~2
801.41;+86747,;9~ONE SELECTION ONLY
801.41;+86747,;25~WP-start~1
T1a, N0:
801.41;+86747,;35~WP-start~1
Stage T1a, N0: 
801.41;+86747,;52~INDENT
801.41;+86747,;100~NATIONAL
801.412;+86748,+86747,;.01~20
801.412;+86748,+86747,;2~VA-GP ONC BRCA I-III ER+ T1A OFF PTHWY
801.412;+86749,+86747,;.01~5
801.412;+86749,+86747,;2~VA-ONC BRCA I-III ER+ T1A CLIN TRIAL
801.412;+86750,+86747,;.01~10
801.412;+86750,+86747,;2~VA-ONC BRCA I-III ER+ T1A FOLLOW LRM PRIOR TX
801.44;+86751,+86747,;.01~06/09/2026@08:53
801.44;+86751,+86747,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86748^1
86749^2
86750^3
86751^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 &lt;3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86873</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3437129698</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86873,;.01~VA-ONC BRCA I-III ER+ T>N2 <3 OFF PATH RSN
801.41;+86873,;4~dialog element
801.41;+86873,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS<3 OFF PATH RSN
801.41;+86873,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86873,;51~SUPPRESS
801.41;+86873,;100~NATIONAL
801.412;+86874,+86873,;.01~5
801.412;+86874,+86873,;2~VA-ONC OFF PATHWAY
801.412;+86874,+86873,;7~YES
801.412;+86874,+86873,;9~YES
801.44;+86875,+86873,;.01~06/09/2026@08:53
801.44;+86875,+86873,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86874^1
86875^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 &lt;3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86872</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3596982714</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86872,;.01~VA-ONC BRCA I-III ER+ T>N2 <3 OFF PATH TX
801.41;+86872,;4~dialog element
801.41;+86872,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS<3 OFF PATH TX
801.41;+86872,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86872,;51~SUPPRESS
801.41;+86872,;100~NATIONAL
801.412;+86873,+86872,;.01~5
801.412;+86873,+86872,;2~VA-ONC BLANK
801.412;+86873,+86872,;7~YES
801.412;+86873,+86872,;9~YES
801.44;+86874,+86872,;.01~06/09/2026@08:53
801.44;+86874,+86872,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86873^1
86874^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 &lt;3 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86874</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1869464882</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86874,;.01~VA-GP ONC BRCA I-III ER+ T>N2 <3 OFF PTHWY
801.41;+86874,;4~dialog group
801.41;+86874,;6~YES
801.41;+86874,;7~2
801.41;+86874,;23~YES
801.41;+86874,;25~WP-start~1
Off pathway:
801.41;+86874,;52~INDENT
801.41;+86874,;100~NATIONAL
801.412;+86875,+86874,;.01~10
801.412;+86875,+86874,;2~VA-ONC BRCA I-III ER+ T>N2 <3 OFF PATH TX
801.412;+86876,+86874,;.01~20
801.412;+86876,+86874,;2~VA-ONC BRCA I-III ER+ T>N2 <3 OFF PATH RSN
801.44;+86877,+86874,;.01~06/09/2026@08:53
801.44;+86877,+86874,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86875^1
86876^2
86877^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 &lt;3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86871</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2214366839</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86871,;.01~VA-ONC BRCA I-III ER+ T>N2 <3 CLIN TRIAL
801.41;+86871,;4~dialog element
801.41;+86871,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS<3 CLIN TRIAL
801.41;+86871,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86871,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86871,;100~NATIONAL
801.412;+86872,+86871,;.01~5
801.412;+86872,+86871,;2~VA-ONC CLINICAL TRIAL
801.412;+86872,+86871,;9~YES
801.44;+86873,+86871,;.01~06/09/2026@08:53:01
801.44;+86873,+86871,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86872^1
86873^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 &lt;3 FOLLOW ADJ PTWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73414</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2247279798</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73414,;.01~VA-ONC BRCA I-III ER+ T>N2 <3 FOLLOW ADJ PTWY
801.41;+73414,;4~dialog element
801.41;+73414,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS<3 ADJ HT PTHWY
801.41;+73414,;25~WP-start~1
Follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any Pathway
801.41;+73414,;35~WP-start~2
Veteran has elected to FOLLOW ADJUVANT HORMONE THERAPY for ER+ or 
PR+/HER2 ANY PATHWAY.
801.41;+73414,;100~NATIONAL
801.44;+73415,+73414,;.01~06/09/2026@08:53:01
801.44;+73415,+73414,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73415^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 CPS+EG &lt;3</POINT_01>
<INTERNAL_ENTRY_NUMBER>73413</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>495379555</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73413,;.01~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG <3
801.41;+73413,;4~dialog group
801.41;+73413,;6~YES
801.41;+73413,;7~2
801.41;+73413,;9~ONE SELECTION ONLY
801.41;+73413,;25~WP-start~1
CPS+EG Score less than 3:
801.41;+73413,;100~NATIONAL
801.412;+73414,+73413,;.01~10
801.412;+73414,+73413,;2~VA-ONC BRCA I-III ER+ T>N2 <3 FOLLOW ADJ PTWY
801.412;+73415,+73413,;.01~5
801.412;+73415,+73413,;2~VA-ONC BRCA I-III ER+ T>N2 <3 CLIN TRIAL
801.412;+73416,+73413,;.01~20
801.412;+73416,+73413,;2~VA-GP ONC BRCA I-III ER+ T>N2 <3 OFF PTHWY
801.44;+73417,+73413,;.01~06/09/2026@08:53:01
801.44;+73417,+73413,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73414^1
73415^2
73416^3
73417^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ CPS+EG &gt;3 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78355</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>665995087</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78355,;.01~VA-ONC BRCA I-III ER+ CPS+EG >3 OFF PATH RSN
801.41;+78355,;4~dialog element
801.41;+78355,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS>3 OFF PATH RSN
801.41;+78355,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78355,;51~SUPPRESS
801.41;+78355,;100~NATIONAL
801.412;+78356,+78355,;.01~5
801.412;+78356,+78355,;2~VA-ONC OFF PATHWAY
801.412;+78356,+78355,;7~YES
801.412;+78356,+78355,;9~YES
801.44;+78357,+78355,;.01~06/09/2026@08:53:01
801.44;+78357,+78355,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78356^1
78357^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ CPS+EG &gt;3 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78336</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3469532809</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78336,;.01~VA-ONC BRCA I-III ER+ CPS+EG >3 OFF PATH TX
801.41;+78336,;4~dialog element
801.41;+78336,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS>3 OFF PATH TX
801.41;+78336,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78336,;51~SUPPRESS
801.41;+78336,;100~NATIONAL
801.412;+78337,+78336,;.01~5
801.412;+78337,+78336,;2~VA-ONC BLANK
801.412;+78337,+78336,;7~YES
801.412;+78337,+78336,;9~YES
801.44;+78338,+78336,;.01~06/09/2026@08:53:01
801.44;+78338,+78336,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78337^1
78338^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ CPS+EG &gt;3 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78362</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>400008428</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78362,;.01~VA-GP ONC BRCA I-III ER+ CPS+EG >3 OFF PTHWY
801.41;+78362,;4~dialog group
801.41;+78362,;6~YES
801.41;+78362,;7~2
801.41;+78362,;23~YES
801.41;+78362,;25~WP-start~1
Off pathway:
801.41;+78362,;52~INDENT
801.41;+78362,;100~NATIONAL
801.412;+78363,+78362,;.01~10
801.412;+78363,+78362,;2~VA-ONC BRCA I-III ER+ CPS+EG >3 OFF PATH TX
801.412;+78364,+78362,;.01~20
801.412;+78364,+78362,;2~VA-ONC BRCA I-III ER+ CPS+EG >3 OFF PATH RSN
801.44;+78365,+78362,;.01~06/09/2026@08:53:01
801.44;+78365,+78362,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78363^1
78364^2
78365^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ CPS+EG &gt;3 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78327</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2923754371</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78327,;.01~VA-ONC BRCA I-III ER+ CPS+EG >3 CLIN TRIAL
801.41;+78327,;4~dialog element
801.41;+78327,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS>3 CLIN TRIAL
801.41;+78327,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78327,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78327,;100~NATIONAL
801.412;+78328,+78327,;.01~5
801.412;+78328,+78327,;2~VA-ONC CLINICAL TRIAL
801.412;+78328,+78327,;9~YES
801.44;+78329,+78327,;.01~06/09/2026@08:53:01
801.44;+78329,+78327,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78328^1
78329^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T&gt;N2 OLAP FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73412</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2615079122</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73412,;.01~VA-ONC BRCA I-III ER+ T>N2 OLAP FN
801.41;+73412,;4~dialog element
801.41;+73412,;23~YES
801.41;+73412,;25~WP-start~2
++ Olaparib patients should not be on concomitant olaparib and abemaciclib
therapy. ++
801.41;+73412,;51~SUPPRESS
801.41;+73412,;100~NATIONAL
801.44;+73413,+73412,;.01~06/09/2026@08:53:01
801.44;+73413,+73412,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73413^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 CPS+EG &gt;3 OLAP</POINT_01>
<INTERNAL_ENTRY_NUMBER>73409</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2837076886</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73409,;.01~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG >3 OLAP
801.41;+73409,;4~dialog group
801.41;+73409,;7~2
801.41;+73409,;15~HF.VA-ONC BRCA I-III ER+ GERMLINE CPS>3 OLAP+ADJ HT
801.41;+73409,;25~WP-start~2
Olaparib (1 year) and follow Adjuvant Hormone Therapy for ER+ or PR+/HER2
Any Pathway 
801.41;+73409,;35~WP-start~2
Veteran has elected to pursue TREATMENT with OLAPARIB FOR 1 YEAR and then 
FOLLOW ADJUVANT HORMONE THERAPY for ER+ or PR+/HER2 ANY PATHWAY.
801.41;+73409,;100~NATIONAL
801.412;+73410,+73409,;.01~10
801.412;+73410,+73409,;2~VA-ONC BRCA I-III ER+ T>N2 OLAP FN
801.44;+73411,+73409,;.01~06/09/2026@08:53:01
801.44;+73411,+73409,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73410^1
73411^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 CPS+EG &gt;3</POINT_01>
<INTERNAL_ENTRY_NUMBER>73408</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3154988454</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73408,;.01~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG >3
801.41;+73408,;4~dialog group
801.41;+73408,;6~YES
801.41;+73408,;7~2
801.41;+73408,;9~ONE SELECTION ONLY
801.41;+73408,;25~WP-start~1
CPS+EG Score 3 or more:
801.41;+73408,;100~NATIONAL
801.412;+73409,+73408,;.01~10
801.412;+73409,+73408,;2~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG >3 OLAP
801.412;+73410,+73408,;.01~5
801.412;+73410,+73408,;2~VA-ONC BRCA I-III ER+ CPS+EG >3 CLIN TRIAL
801.412;+73411,+73408,;.01~15
801.412;+73411,+73408,;2~VA-GP ONC BRCA I-III ER+ CPS+EG >3 OFF PTHWY
801.44;+73412,+73408,;.01~06/09/2026@08:53:01
801.44;+73412,+73408,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73409^1
73410^2
73411^3
73412^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 CPS+EG FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73407</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2625554280</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73407,;.01~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG FN
801.41;+73407,;4~dialog group
801.41;+73407,;6~YES
801.41;+73407,;7~2
801.41;+73407,;9~NONE OR ONE SELECTION
801.41;+73407,;23~YES
801.41;+73407,;25~WP-start~4
++ CPS + EG Score incorporates estrogen receptor (ER) status and tumor 
grade with pretreatment\\   clinical stage (CS) and post-treatment
pathologic stage (PS); Follow Calculation for\\   CPS & EG Staging System
pathway for further information.\\
801.41;+73407,;51~SUPPRESS
801.41;+73407,;100~NATIONAL
801.412;+73408,+73407,;.01~10
801.412;+73408,+73407,;2~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG >3
801.412;+73409,+73407,;.01~20
801.412;+73409,+73407,;2~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG <3
801.44;+73410,+73407,;.01~06/09/2026@08:53:01
801.44;+73410,+73407,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73408^1
73409^2
73410^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 INCOMP CALC</POINT_01>
<INTERNAL_ENTRY_NUMBER>73404</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2669796974</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73404,;.01~VA-GP ONC BRCA I-III ER+ T>N2 INCOMP CALC
801.41;+73404,;4~dialog group
801.41;+73404,;6~YES
801.41;+73404,;9~NONE OR ONE SELECTION
801.41;+73404,;23~YES
801.41;+73404,;25~WP-start~1
Follow Calculation for the CPS & EG Staging System pathway:
801.41;+73404,;51~SUPPRESS
801.41;+73404,;100~NATIONAL
801.412;+73405,+73404,;.01~10
801.412;+73405,+73404,;2~VA-GP ONC BRCA I-III ER+ T>N2 CPS+EG FN
801.44;+73406,+73404,;.01~06/09/2026@08:53:01
801.44;+73406,+73404,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73405^1
73406^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 INCOM GL POS</POINT_01>
<INTERNAL_ENTRY_NUMBER>73403</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4230101514</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73403,;.01~VA-GP ONC BRCA I-III ER+ T>N2 INCOM GL POS
801.41;+73403,;4~dialog group
801.41;+73403,;25~WP-start~1
Germline BRCA 1/2 PV, Positive:
801.41;+73403,;51~SUPPRESS
801.41;+73403,;100~NATIONAL
801.412;+73404,+73403,;.01~10
801.412;+73404,+73403,;2~VA-GP ONC BRCA I-III ER+ T>N2 INCOMP CALC
801.44;+73405,+73403,;.01~06/09/2026@08:53:01
801.44;+73405,+73403,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73404^1
73405^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 INCOMPLETE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73397</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3569067012</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73397,;.01~VA-GP ONC BRCA I-III ER+ T>N2 INCOMPLETE
801.41;+73397,;4~dialog group
801.41;+73397,;6~YES
801.41;+73397,;7~2
801.41;+73397,;9~NONE OR ONE SELECTION
801.41;+73397,;25~WP-start~1
Incomplete Pathological Response:\\
801.41;+73397,;51~SUPPRESS
801.41;+73397,;52~INDENT
801.41;+73397,;100~NATIONAL
801.412;+73398,+73397,;.01~10
801.412;+73398,+73397,;2~VA-GP ONC BRCA I-III ER+ T>N2 INCOM GL POS
801.44;+73399,+73397,;.01~06/09/2026@08:53:01
801.44;+73399,+73397,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73398^1
73399^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 COMPLETE</POINT_01>
<INTERNAL_ENTRY_NUMBER>73381</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>838725937</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73381,;.01~VA-GP ONC BRCA I-III ER+ T>N2 COMPLETE
801.41;+73381,;4~dialog group
801.41;+73381,;6~YES
801.41;+73381,;7~2
801.41;+73381,;23~YES
801.41;+73381,;25~WP-start~3
++ IF COMPLETE pathological response OR INCOMPLETE pathological response
AND Germline BRCA 1/2 PV NEGATIVE:\\   Follow Adjuvant Hormone Therapy for
ER+ or PR+/HER2 Any Pathway. ++
801.41;+73381,;51~SUPPRESS
801.41;+73381,;100~NATIONAL
801.44;+73382,+73381,;.01~06/09/2026@08:53:01
801.44;+73382,+73381,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73382^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 POST NEOADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73380</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1711383891</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73380,;.01~VA-GP ONC BRCA I-III ER+ T>N2 POST NEOADJ THERAPY
801.41;+73380,;4~dialog group
801.41;+73380,;15~HF.VA-ONC BRCA I-III ER+ ANY T > N2
801.41;+73380,;23~YES
801.41;+73380,;25~WP-start~1
Pathological Response AFTER Neoadjuvant Therapy:
801.41;+73380,;100~NATIONAL
801.412;+73381,+73380,;.01~10
801.412;+73381,+73380,;2~VA-GP ONC BRCA I-III ER+ T>N2 COMPLETE
801.412;+73382,+73380,;.01~20
801.412;+73382,+73380,;2~VA-GP ONC BRCA I-III ER+ T>N2 INCOMPLETE
801.44;+73383,+73380,;.01~06/09/2026@08:53:01
801.44;+73383,+73380,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73381^1
73382^2
73383^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ NO ANTH OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78351</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1509209970</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78351,;.01~VA-ONC BRCA I-III ER+ NO ANTH OFF PATH RSN
801.41;+78351,;4~dialog element
801.41;+78351,;15~HF.VA-ONC BRCA I-III ER+ T>N2 NOT ANTH OFF PATH RSN
801.41;+78351,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78351,;51~SUPPRESS
801.41;+78351,;100~NATIONAL
801.412;+78352,+78351,;.01~5
801.412;+78352,+78351,;2~VA-ONC OFF PATHWAY
801.412;+78352,+78351,;7~YES
801.412;+78352,+78351,;9~YES
801.44;+78353,+78351,;.01~06/09/2026@08:53:01
801.44;+78353,+78351,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78352^1
78353^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ NO ANTH OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78347</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2389144585</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78347,;.01~VA-ONC BRCA I-III ER+ NO ANTH OFF PATH TX
801.41;+78347,;4~dialog element
801.41;+78347,;15~HF.VA-ONC BRCA I-III ER+ T>N2 NOT ANTH OFF PATH TX
801.41;+78347,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78347,;51~SUPPRESS
801.41;+78347,;100~NATIONAL
801.412;+78348,+78347,;.01~5
801.412;+78348,+78347,;2~VA-ONC BLANK
801.412;+78348,+78347,;7~YES
801.412;+78348,+78347,;9~YES
801.44;+78349,+78347,;.01~06/09/2026@08:53:01
801.44;+78349,+78347,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78348^1
78349^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ NO ANTH OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78369</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>878907092</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78369,;.01~VA-GP ONC BRCA I-III ER+ NO ANTH OFF PTHWY
801.41;+78369,;4~dialog group
801.41;+78369,;6~YES
801.41;+78369,;7~2
801.41;+78369,;23~YES
801.41;+78369,;25~WP-start~1
Off pathway:
801.41;+78369,;52~INDENT
801.41;+78369,;100~NATIONAL
801.412;+78370,+78369,;.01~10
801.412;+78370,+78369,;2~VA-ONC BRCA I-III ER+ NO ANTH OFF PATH TX
801.412;+78371,+78369,;.01~20
801.412;+78371,+78369,;2~VA-ONC BRCA I-III ER+ NO ANTH OFF PATH RSN
801.44;+78372,+78369,;.01~06/09/2026@08:53:01
801.44;+78372,+78369,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78370^1
78371^2
78372^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ NO ANTH CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78330</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>273388185</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78330,;.01~VA-ONC BRCA I-III ER+ NO ANTH CLIN TRIAL
801.41;+78330,;4~dialog element
801.41;+78330,;15~HF.VA-ONC BRCA I-III ER+ T>N2 NOT ANTH CLIN TRIAL
801.41;+78330,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78330,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78330,;100~NATIONAL
801.412;+78331,+78330,;.01~5
801.412;+78331,+78330,;2~VA-ONC CLINICAL TRIAL
801.412;+78331,+78330,;9~YES
801.44;+78332,+78330,;.01~06/09/2026@08:53:01
801.44;+78332,+78330,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78331^1
78332^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BR CA I-III ER+ T&gt;N2 TC</POINT_01>
<INTERNAL_ENTRY_NUMBER>73364</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>700410166</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73364,;.01~VA-ONC BR CA I-III ER+ T>N2 TC
801.41;+73364,;4~dialog element
801.41;+73364,;15~HF.VA-ONC BRCA I-III ER+ T>N2 NOT ANTH TC+LRM AFTER PTHWY
801.41;+73364,;25~WP-start~2
Docetaxel and cyclophosphamide (TC); then Follow Local/Regional Management
After Neodjuvant Treatment Pathway
801.41;+73364,;35~WP-start~3
Veteran has elected to pursue TREATMENT with DOCETAXEL and
CYCLOPHOSPHAMIDE (TC); then to FOLLOW LOCAL/REGIONAL MANAGEMENT AFTER
NEOADJUVANT TREATMENT PATHWAY.
801.41;+73364,;100~NATIONAL
801.44;+73365,+73364,;.01~06/09/2026@08:53:01
801.44;+73365,+73364,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73365^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III ER+ T&gt;N2 NOT ATC CAND</POINT_01>
<INTERNAL_ENTRY_NUMBER>73363</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3306555385</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73363,;.01~VA-GP ONC BR CA I-III ER+ T>N2 NOT ATC CAND
801.41;+73363,;4~dialog group
801.41;+73363,;6~YES
801.41;+73363,;7~2
801.41;+73363,;9~ONE SELECTION ONLY
801.41;+73363,;25~WP-start~1
Not a Candidate for Anthracycline:
801.41;+73363,;52~INDENT
801.41;+73363,;100~NATIONAL
801.412;+73364,+73363,;.01~10
801.412;+73364,+73363,;2~VA-ONC BR CA I-III ER+ T>N2 TC
801.412;+73365,+73363,;.01~5
801.412;+73365,+73363,;2~VA-ONC BRCA I-III ER+ NO ANTH CLIN TRIAL
801.412;+73366,+73363,;.01~15
801.412;+73366,+73363,;2~VA-GP ONC BRCA I-III ER+ NO ANTH OFF PTHWY
801.44;+73367,+73363,;.01~06/09/2026@08:53:01
801.44;+73367,+73363,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73364^1
73365^2
73366^3
73367^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ ANTH OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78358</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2078031768</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78358,;.01~VA-ONC BRCA I-III ER+ ANTH OFF PATH RSN
801.41;+78358,;4~dialog element
801.41;+78358,;15~HF.VA-ONC BRCA I-III ER+ T>N2 ANTH CAND OFF PATH RSN
801.41;+78358,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78358,;51~SUPPRESS
801.41;+78358,;100~NATIONAL
801.412;+78359,+78358,;.01~5
801.412;+78359,+78358,;2~VA-ONC OFF PATHWAY
801.412;+78359,+78358,;7~YES
801.412;+78359,+78358,;9~YES
801.44;+78360,+78358,;.01~06/09/2026@08:53:01
801.44;+78360,+78358,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78359^1
78360^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ ANTH OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78339</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2251010933</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78339,;.01~VA-ONC BRCA I-III ER+ ANTH OFF PATH TX
801.41;+78339,;4~dialog element
801.41;+78339,;15~HF.VA-ONC BRCA I-III ER+ T>N2 ANTH CAND OFF PATH TX
801.41;+78339,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78339,;51~SUPPRESS
801.41;+78339,;100~NATIONAL
801.412;+78340,+78339,;.01~5
801.412;+78340,+78339,;2~VA-ONC BLANK
801.412;+78340,+78339,;7~YES
801.412;+78340,+78339,;9~YES
801.44;+78341,+78339,;.01~06/09/2026@08:53:01
801.44;+78341,+78339,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78340^1
78341^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ ANTH OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78366</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>368383604</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78366,;.01~VA-GP ONC BRCA I-III ER+ ANTH OFF PTHWY
801.41;+78366,;4~dialog group
801.41;+78366,;6~YES
801.41;+78366,;7~2
801.41;+78366,;23~YES
801.41;+78366,;25~WP-start~1
Off pathway:
801.41;+78366,;52~INDENT
801.41;+78366,;100~NATIONAL
801.412;+78367,+78366,;.01~10
801.412;+78367,+78366,;2~VA-ONC BRCA I-III ER+ ANTH OFF PATH TX
801.412;+78368,+78366,;.01~20
801.412;+78368,+78366,;2~VA-ONC BRCA I-III ER+ ANTH OFF PATH RSN
801.44;+78369,+78366,;.01~06/09/2026@08:53:01
801.44;+78369,+78366,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78367^1
78368^2
78369^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ ANTH CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78329</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3293797332</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78329,;.01~VA-ONC BRCA I-III ER+ ANTH CLIN TRIAL
801.41;+78329,;4~dialog element
801.41;+78329,;15~HF.VA-ONC BRCA I-III ER+ T>N2 ANTH CAND CLIN TRIAL
801.41;+78329,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78329,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78329,;100~NATIONAL
801.412;+78330,+78329,;.01~5
801.412;+78330,+78329,;2~VA-ONC CLINICAL TRIAL
801.412;+78330,+78329,;9~YES
801.44;+78331,+78329,;.01~06/09/2026@08:53:01
801.44;+78331,+78329,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78330^1
78331^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ DDAC-T FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73377</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1611267428</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73377,;.01~VA-ONC BRCA I-III ER+ DDAC-T FN
801.41;+73377,;4~dialog element
801.41;+73377,;23~YES
801.41;+73377,;25~WP-start~2
++ ddAC-T followed by weekly paclitaxel (T). 
   Evaluate Cardiovascular Risk factors with baseline LVEF and CMP. ++
801.41;+73377,;51~SUPPRESS
801.41;+73377,;100~NATIONAL
801.44;+73378,+73377,;.01~06/09/2026@08:53:01
801.44;+73378,+73377,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73378^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T&gt;N2 DDAC-T</POINT_01>
<INTERNAL_ENTRY_NUMBER>73372</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1588790584</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73372,;.01~VA-GP ONC BRCA I-III ER+ T>N2 DDAC-T
801.41;+73372,;4~dialog group
801.41;+73372,;7~2
801.41;+73372,;15~HF.VA-ONC BRCA I-III ER+ T>N2 ANTH CAND ddAC-T+LRM AFT PTHWY
801.41;+73372,;25~WP-start~2
Dose-dense AC-T Doxorubicin and Cyclophosphamide (ddAC-T); then Follow 
Local/Regional Management After Neoadjuvant Treatment Pathway
801.41;+73372,;35~WP-start~3
Veteran has elected to pursue TREATMENT with DOSE-DENSE AC-T DOXORUBICIN 
and CYCLOPHOSPHAMIDE (ddAC-T); then FOLLOW LOCAL/REGIONAL MANAGEMENT AFTER
NEOADJUVANT TREATMENT PATHWAY.
801.41;+73372,;52~INDENT
801.41;+73372,;100~NATIONAL
801.412;+73373,+73372,;.01~10
801.412;+73373,+73372,;2~VA-ONC BRCA I-III ER+ DDAC-T FN
801.44;+73374,+73372,;.01~06/09/2026@08:53:01
801.44;+73374,+73372,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73373^1
73374^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III ANY T&gt;N2 ATC CAND</POINT_01>
<INTERNAL_ENTRY_NUMBER>73358</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>695176285</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73358,;.01~VA-GP ONC BR CA I-III ANY T>N2 ATC CAND
801.41;+73358,;4~dialog group
801.41;+73358,;6~YES
801.41;+73358,;7~2
801.41;+73358,;9~ONE SELECTION ONLY
801.41;+73358,;25~WP-start~1
Candidate for Anthracycline:
801.41;+73358,;52~INDENT
801.41;+73358,;100~NATIONAL
801.412;+73359,+73358,;.01~10
801.412;+73359,+73358,;2~VA-GP ONC BRCA I-III ER+ T>N2 DDAC-T
801.412;+73360,+73358,;.01~5
801.412;+73360,+73358,;2~VA-ONC BRCA I-III ER+ ANTH CLIN TRIAL
801.412;+73361,+73358,;.01~15
801.412;+73361,+73358,;2~VA-GP ONC BRCA I-III ER+ ANTH OFF PTHWY
801.44;+73362,+73358,;.01~06/09/2026@08:53:01
801.44;+73362,+73358,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73359^1
73360^2
73361^3
73362^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ANY T&gt;N2 MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73357</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3331485132</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73357,;.01~VA-GP ONC BRCA I-III ANY T>N2 MAIN
801.41;+73357,;4~dialog group
801.41;+73357,;6~YES
801.41;+73357,;7~2
801.41;+73357,;9~ONE SELECTION ONLY
801.41;+73357,;25~WP-start~1
Any T greater than or equal to N2:
801.41;+73357,;52~INDENT
801.41;+73357,;100~NATIONAL
801.412;+73358,+73357,;.01~10
801.412;+73358,+73357,;2~VA-GP ONC BR CA I-III ANY T>N2 ATC CAND
801.412;+73359,+73357,;.01~20
801.412;+73359,+73357,;2~VA-GP ONC BR CA I-III ER+ T>N2 NOT ATC CAND
801.412;+73360,+73357,;.01~30
801.412;+73360,+73357,;2~VA-GP ONC BRCA I-III ER+ T>N2 POST NEOADJ THERAPY
801.44;+73361,+73357,;.01~06/09/2026@08:53:01
801.44;+73361,+73357,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73358^1
73359^2
73360^3
73361^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ NO CHEMO OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86738</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1554500185</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86738,;.01~VA-ONC BRCA I-III ER+ NO CHEMO OFF PATH RSN
801.41;+86738,;4~dialog element
801.41;+86738,;15~HF.VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH RSN
801.41;+86738,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86738,;51~SUPPRESS
801.41;+86738,;100~NATIONAL
801.412;+86739,+86738,;.01~5
801.412;+86739,+86738,;2~VA-ONC OFF PATHWAY
801.412;+86739,+86738,;7~YES
801.412;+86739,+86738,;9~YES
801.44;+86740,+86738,;.01~06/09/2026@08:53:01
801.44;+86740,+86738,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86739^1
86740^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ NO CHEMO OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86740</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1724782838</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86740,;.01~VA-ONC BRCA I-III ER+ NO CHEMO OFF PATH TX
801.41;+86740,;4~dialog element
801.41;+86740,;15~HF.VA-ONC BRCA I-III ER+ T1B NO CHEMO OFF PATH TX
801.41;+86740,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86740,;51~SUPPRESS
801.41;+86740,;100~NATIONAL
801.412;+86741,+86740,;.01~5
801.412;+86741,+86740,;2~VA-ONC BLANK
801.412;+86741,+86740,;7~YES
801.412;+86741,+86740,;9~YES
801.44;+86742,+86740,;.01~06/09/2026@08:53:01
801.44;+86742,+86740,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86741^1
86742^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ NO CHEMO OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86741</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3779904648</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86741,;.01~VA-GP ONC BRCA I-III ER+ NO CHEMO OFF PTHWY
801.41;+86741,;4~dialog group
801.41;+86741,;6~YES
801.41;+86741,;7~2
801.41;+86741,;23~YES
801.41;+86741,;25~WP-start~1
Off pathway:
801.41;+86741,;52~INDENT
801.41;+86741,;100~NATIONAL
801.412;+86742,+86741,;.01~10
801.412;+86742,+86741,;2~VA-ONC BRCA I-III ER+ NO CHEMO OFF PATH TX
801.412;+86743,+86741,;.01~20
801.412;+86743,+86741,;2~VA-ONC BRCA I-III ER+ NO CHEMO OFF PATH RSN
801.44;+86744,+86741,;.01~06/09/2026@08:53:01
801.44;+86744,+86741,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86742^1
86743^2
86744^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ NO CHEMO CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86736</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>412857998</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86736,;.01~VA-ONC BRCA I-III ER+ NO CHEMO CLIN TRIAL
801.41;+86736,;4~dialog element
801.41;+86736,;15~HF.VA-ONC BRCA I-III ER+ T1B NO CHEMO CLIN TRIAL
801.41;+86736,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86736,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86736,;100~NATIONAL
801.412;+86737,+86736,;.01~5
801.412;+86737,+86736,;2~VA-ONC CLINICAL TRIAL
801.412;+86737,+86736,;9~YES
801.44;+86738,+86736,;.01~06/09/2026@08:53:01
801.44;+86738,+86736,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86737^1
86738^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B NO CHEMO FOLLOW ADJ HT</POINT_01>
<INTERNAL_ENTRY_NUMBER>86735</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3983058744</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86735,;.01~VA-ONC BRCA I-III ER+ T1B NO CHEMO FOLLOW ADJ HT
801.41;+86735,;4~dialog element
801.41;+86735,;15~HF.VA-ONC BRCA I-III ER+ T1B NO CHEMO ADJ HT PATHWAY
801.41;+86735,;25~WP-start~1
Follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any Pathway
801.41;+86735,;35~WP-start~2
Veteran has elected to FOLLOW ADJUVANT HORMONE THERAPY for ER+ or 
PR+/HER2 ANY PATHWAY.
801.41;+86735,;100~NATIONAL
801.44;+86736,+86735,;.01~06/09/2026@08:53:01
801.44;+86736,+86735,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86736^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III T1B NOT CHEMO CAND</POINT_01>
<INTERNAL_ENTRY_NUMBER>73340</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>773254434</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73340,;.01~VA-GP ONC BRCA I-III T1B NOT CHEMO CAND
801.41;+73340,;4~dialog group
801.41;+73340,;6~YES
801.41;+73340,;7~2
801.41;+73340,;9~ONE SELECTION ONLY
801.41;+73340,;25~WP-start~1
Not a Candidate for Chemotherapy:
801.41;+73340,;52~INDENT
801.41;+73340,;100~NATIONAL
801.412;+73341,+73340,;.01~10
801.412;+73341,+73340,;2~VA-ONC BRCA I-III ER+ T1B NO CHEMO FOLLOW ADJ HT
801.412;+73342,+73340,;.01~5
801.412;+73342,+73340,;2~VA-ONC BRCA I-III ER+ NO CHEMO CLIN TRIAL
801.412;+73343,+73340,;.01~20
801.412;+73343,+73340,;2~VA-GP ONC BRCA I-III ER+ NO CHEMO OFF PTHWY
801.44;+73344,+73340,;.01~06/09/2026@08:53:01
801.44;+73344,+73340,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73341^1
73342^2
73343^3
73344^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B POST RS&gt;25 ADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>80465</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1321115852</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+80465,;.01~VA-GP ONC BRCA I-III ER+ T1B POST RS>25 ADJ THERAPY
801.41;+80465,;4~dialog group
801.41;+80465,;6~YES
801.41;+80465,;7~2
801.41;+80465,;15~HF.VA-ONC BRCA I-III ER+ T1B RS > 25
801.41;+80465,;23~YES
801.41;+80465,;25~WP-start~1
Pathological Response AFTER Neoadjuvant Therapy:
801.41;+80465,;100~NATIONAL
801.412;+80466,+80465,;.01~10
801.412;+80466,+80465,;2~VA-GP ONC BRCA I-III ER+ T>N2 COMPLETE
801.412;+80467,+80465,;.01~20
801.412;+80467,+80465,;2~VA-GP ONC BRCA I-III ER+ T>N2 INCOMPLETE
801.44;+80468,+80465,;.01~06/09/2026@08:53:01
801.44;+80468,+80465,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
80466^1
80467^2
80468^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ RS&gt;25 DDAC-T</POINT_01>
<INTERNAL_ENTRY_NUMBER>80426</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3389205281</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+80426,;.01~VA-GP ONC BRCA I-III ER+ RS>25 DDAC-T
801.41;+80426,;4~dialog group
801.41;+80426,;7~2
801.41;+80426,;15~HF.VA-ONC BRCA I-III ER+ RS > 25 ddAC-T+LRM AFTER PTHWY
801.41;+80426,;25~WP-start~2
Dose-dense AC-T Doxorubicin and Cyclophosphamide (ddAC-T); then Follow 
Local/Regional Management After Neoadjuvant Treatment Pathway
801.41;+80426,;35~WP-start~3
Veteran has elected to pursue TREATMENT with DOSE-DENSE AC-T 
DOXORUBICIN and CYCLOPHOSPHAMIDE (ddAC-T); then FOLLOW LOCAL/REGIONAL
MANAGEMENT AFTER NEOADJUVANT TREATMENT PATHWAY.
801.41;+80426,;52~INDENT
801.41;+80426,;100~NATIONAL
801.412;+80427,+80426,;.01~10
801.412;+80427,+80426,;2~VA-ONC BRCA I-III ER+ DDAC-T FN
801.44;+80428,+80426,;.01~06/09/2026@08:53:01
801.44;+80428,+80426,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
80427^1
80428^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS&gt;25 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78356</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4284658172</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78356,;.01~VA-ONC BRCA I-III ER+ RS>25 OFF PATH RSN
801.41;+78356,;4~dialog element
801.41;+78356,;15~HF.VA-ONC BRCA I-III ER+ RS > 25 OFF PATH RSN
801.41;+78356,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78356,;51~SUPPRESS
801.41;+78356,;100~NATIONAL
801.412;+78357,+78356,;.01~5
801.412;+78357,+78356,;2~VA-ONC OFF PATHWAY
801.412;+78357,+78356,;7~YES
801.412;+78357,+78356,;9~YES
801.44;+78358,+78356,;.01~06/09/2026@08:53:01
801.44;+78358,+78356,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78357^1
78358^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS&gt;25 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78337</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3562130312</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78337,;.01~VA-ONC BRCA I-III ER+ RS>25 OFF PATH TX
801.41;+78337,;4~dialog element
801.41;+78337,;15~HF.VA-ONC BRCA I-III ER+ RS > 25 OFF PATH TX
801.41;+78337,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78337,;51~SUPPRESS
801.41;+78337,;100~NATIONAL
801.412;+78338,+78337,;.01~5
801.412;+78338,+78337,;2~VA-ONC BLANK
801.412;+78338,+78337,;7~YES
801.412;+78338,+78337,;9~YES
801.44;+78339,+78337,;.01~06/09/2026@08:53:01
801.44;+78339,+78337,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78338^1
78339^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ RS&gt;25 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78364</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1659641966</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78364,;.01~VA-GP ONC BRCA I-III ER+ RS>25 OFF PTHWY
801.41;+78364,;4~dialog group
801.41;+78364,;6~YES
801.41;+78364,;7~2
801.41;+78364,;23~YES
801.41;+78364,;25~WP-start~1
Off pathway:
801.41;+78364,;52~INDENT
801.41;+78364,;100~NATIONAL
801.412;+78365,+78364,;.01~10
801.412;+78365,+78364,;2~VA-ONC BRCA I-III ER+ RS>25 OFF PATH TX
801.412;+78366,+78364,;.01~20
801.412;+78366,+78364,;2~VA-ONC BRCA I-III ER+ RS>25 OFF PATH RSN
801.44;+78367,+78364,;.01~06/09/2026@08:53:01
801.44;+78367,+78364,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78365^1
78366^2
78367^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS&gt;25 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78328</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>158012786</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78328,;.01~VA-ONC BRCA I-III ER+ RS>25 CLIN TRIAL
801.41;+78328,;4~dialog element
801.41;+78328,;15~HF.VA-ONC BRCA I-III ER+ RS > 25 CLIN TRIAL
801.41;+78328,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78328,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78328,;100~NATIONAL
801.412;+78329,+78328,;.01~5
801.412;+78329,+78328,;2~VA-ONC CLINICAL TRIAL
801.412;+78329,+78328,;9~YES
801.44;+78330,+78328,;.01~06/09/2026@08:53:01
801.44;+78330,+78328,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78329^1
78330^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B RS&gt;25 ADJ TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78390</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>881919195</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78390,;.01~VA-GP ONC BRCA I-III ER+ T1B RS>25 ADJ TX
801.41;+78390,;4~dialog group
801.41;+78390,;6~YES
801.41;+78390,;7~2
801.41;+78390,;9~ONE SELECTION ONLY
801.41;+78390,;23~YES
801.41;+78390,;25~WP-start~1
Neoadjuvant Therapy:
801.41;+78390,;52~INDENT
801.41;+78390,;100~NATIONAL
801.412;+78391,+78390,;.01~5
801.412;+78391,+78390,;2~VA-ONC BRCA I-III ER+ RS>25 CLIN TRIAL
801.412;+78392,+78390,;.01~20
801.412;+78392,+78390,;2~VA-GP ONC BRCA I-III ER+ RS>25 OFF PTHWY
801.412;+78393,+78390,;.01~10
801.412;+78393,+78390,;2~VA-GP ONC BRCA I-III ER+ RS>25 DDAC-T
801.44;+78394,+78390,;.01~06/09/2026@08:53:01
801.44;+78394,+78390,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78391^1
78392^3
78393^4
78394^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B RS&gt;25</POINT_01>
<INTERNAL_ENTRY_NUMBER>73574</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>459815877</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73574,;.01~VA-GP ONC BRCA I-III ER+ T1B RS>25
801.41;+73574,;4~dialog group
801.41;+73574,;6~YES
801.41;+73574,;7~2
801.41;+73574,;9~ONE SELECTION ONLY
801.41;+73574,;25~WP-start~1
More than 25:
801.41;+73574,;100~NATIONAL
801.412;+73575,+73574,;.01~10
801.412;+73575,+73574,;2~VA-GP ONC BRCA I-III ER+ T1B RS>25 ADJ TX
801.412;+73576,+73574,;.01~20
801.412;+73576,+73574,;2~VA-GP ONC BRCA I-III ER+ T1B POST RS>25 ADJ THERAPY
801.44;+73577,+73574,;.01~06/09/2026@08:53:01
801.44;+73577,+73574,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73575^3
73576^4
73577^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B POST OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86882</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4067781408</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86882,;.01~VA-ONC BRCA I-III ER+ T1B POST OFF PATH RSN
801.41;+86882,;4~dialog element
801.41;+86882,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 POST OFF PATH RSN
801.41;+86882,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86882,;51~SUPPRESS
801.41;+86882,;100~NATIONAL
801.412;+86883,+86882,;.01~5
801.412;+86883,+86882,;2~VA-ONC OFF PATHWAY
801.412;+86883,+86882,;7~YES
801.412;+86883,+86882,;9~YES
801.44;+86884,+86882,;.01~06/09/2026@08:53:01
801.44;+86884,+86882,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86883^1
86884^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B POST OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86883</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1551958262</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86883,;.01~VA-ONC BRCA I-III ER+ T1B POST OFF PATH TX
801.41;+86883,;4~dialog element
801.41;+86883,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 POST OFF PATH TX
801.41;+86883,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86883,;51~SUPPRESS
801.41;+86883,;100~NATIONAL
801.412;+86884,+86883,;.01~5
801.412;+86884,+86883,;2~VA-ONC BLANK
801.412;+86884,+86883,;7~YES
801.412;+86884,+86883,;9~YES
801.44;+86885,+86883,;.01~06/09/2026@08:53:01
801.44;+86885,+86883,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86884^1
86885^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B POST OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86884</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3385721300</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86884,;.01~VA-GP ONC BRCA I-III ER+ T1B POST OFF PTHWY
801.41;+86884,;4~dialog group
801.41;+86884,;6~YES
801.41;+86884,;7~2
801.41;+86884,;23~YES
801.41;+86884,;25~WP-start~1
Off pathway:
801.41;+86884,;52~INDENT
801.41;+86884,;100~NATIONAL
801.412;+86885,+86884,;.01~10
801.412;+86885,+86884,;2~VA-ONC BRCA I-III ER+ T1B POST OFF PATH TX
801.412;+86886,+86884,;.01~20
801.412;+86886,+86884,;2~VA-ONC BRCA I-III ER+ T1B POST OFF PATH RSN
801.44;+86887,+86884,;.01~06/09/2026@08:53:01
801.44;+86887,+86884,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86885^1
86886^2
86887^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B POST CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86881</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3932380798</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86881,;.01~VA-ONC BRCA I-III ER+ T1B POST CLIN TRIAL
801.41;+86881,;4~dialog element
801.41;+86881,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 POST CLIN TRIAL
801.41;+86881,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86881,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86881,;100~NATIONAL
801.412;+86882,+86881,;.01~5
801.412;+86882,+86881,;2~VA-ONC CLINICAL TRIAL
801.412;+86882,+86881,;9~YES
801.44;+86883,+86881,;.01~06/09/2026@08:53:01
801.44;+86883,+86881,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86882^1
86883^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B POST ADJ HT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86880</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3643726169</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86880,;.01~VA-ONC BRCA I-III ER+ T1B POST ADJ HT PTHWY
801.41;+86880,;4~dialog element
801.41;+86880,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 POST ADJ HT PTHWY
801.41;+86880,;25~WP-start~1
Follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any Pathway
801.41;+86880,;35~WP-start~2
Veteran has elected to FOLLOW ADJUVANT HORMONE THERAPY for ER+ or 
PR+/HER2 ANY PATHWAY.
801.41;+86880,;100~NATIONAL
801.44;+86881,+86880,;.01~06/09/2026@08:53:01
801.44;+86881,+86880,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86881^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B POST-MENOPAUSE</POINT_01>
<INTERNAL_ENTRY_NUMBER>68591</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3285814563</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+68591,;.01~VA-GP ONC BRCA I-III ER+ T1B POST-MENOPAUSE
801.41;+68591,;4~dialog group
801.41;+68591,;6~YES
801.41;+68591,;7~2
801.41;+68591,;9~ONE SELECTION ONLY
801.41;+68591,;25~WP-start~1
Post-menopause:
801.41;+68591,;100~NATIONAL
801.412;+68592,+68591,;.01~10
801.412;+68592,+68591,;2~VA-ONC BRCA I-III ER+ T1B POST ADJ HT PTHWY
801.412;+68593,+68591,;.01~5
801.412;+68593,+68591,;2~VA-ONC BRCA I-III ER+ T1B POST CLIN TRIAL
801.412;+68594,+68591,;.01~20
801.412;+68594,+68591,;2~VA-GP ONC BRCA I-III ER+ T1B POST OFF PTHWY
801.44;+68595,+68591,;.01~06/09/2026@08:53:01
801.44;+68595,+68591,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
68592^1
68593^2
68594^3
68595^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B POST N+ ADJ THERAPY</POINT_01>
<INTERNAL_ENTRY_NUMBER>80463</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>554764298</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+80463,;.01~VA-GP ONC BRCA I-III ER+ T1B POST N+ ADJ THERAPY
801.41;+80463,;4~dialog group
801.41;+80463,;6~YES
801.41;+80463,;7~2
801.41;+80463,;15~HF.VA-ONC BRCA I-III ER+ RS 16-25 NODE N+
801.41;+80463,;23~YES
801.41;+80463,;25~WP-start~1
Pathological Response AFTER Neoadjuvant Therapy:
801.41;+80463,;100~NATIONAL
801.412;+80464,+80463,;.01~10
801.412;+80464,+80463,;2~VA-GP ONC BRCA I-III ER+ T>N2 COMPLETE
801.412;+80465,+80463,;.01~20
801.412;+80465,+80463,;2~VA-GP ONC BRCA I-III ER+ T>N2 INCOMPLETE
801.44;+80466,+80463,;.01~06/09/2026@08:53:01
801.44;+80466,+80463,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
80464^1
80465^2
80466^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ RS&lt;25 DDAC-T</POINT_01>
<INTERNAL_ENTRY_NUMBER>80427</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2276088212</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+80427,;.01~VA-GP ONC BRCA I-III ER+ RS<25 DDAC-T
801.41;+80427,;4~dialog group
801.41;+80427,;7~2
801.41;+80427,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N+ ddAC-T+LRM AFTER PTHWY
801.41;+80427,;25~WP-start~2
Dose-dense AC-T Doxorubicin and Cyclophosphamide (ddAC-T); then Follow 
Local/Regional Management After Neoadjuvant Treatment Pathway
801.41;+80427,;35~WP-start~3
Veteran has elected to pursue TREATMENT with DOSE-DENSE AC-T DOXORUBICIN 
and CYCLOPHOSPHAMIDE (ddAC-T); then FOLLOW LOCAL/REGIONAL MANAGEMENT AFTER
NEOADJUVANT TREATMENT PATHWAY.
801.41;+80427,;52~INDENT
801.41;+80427,;100~NATIONAL
801.412;+80428,+80427,;.01~10
801.412;+80428,+80427,;2~VA-ONC BRCA I-III ER+ DDAC-T FN
801.44;+80429,+80427,;.01~06/09/2026@08:53:01
801.44;+80429,+80427,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
80428^1
80429^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ N+ COMP OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78461</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1308858206</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78461,;.01~VA-ONC BRCA I-III ER+ N+ COMP OFF PATH RSN
801.41;+78461,;4~dialog element
801.41;+78461,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N+ OFF PATH RSN
801.41;+78461,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78461,;51~SUPPRESS
801.41;+78461,;100~NATIONAL
801.412;+78462,+78461,;.01~5
801.412;+78462,+78461,;2~VA-ONC OFF PATHWAY
801.412;+78462,+78461,;7~YES
801.412;+78462,+78461,;9~YES
801.44;+78463,+78461,;.01~06/09/2026@08:53:01
801.44;+78463,+78461,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78462^1
78463^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ N+ COMP OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78458</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4236149709</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78458,;.01~VA-ONC BRCA I-III ER+ N+ COMP OFF PATH TX
801.41;+78458,;4~dialog element
801.41;+78458,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N+ OFF PATH TX
801.41;+78458,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78458,;51~SUPPRESS
801.41;+78458,;100~NATIONAL
801.412;+78459,+78458,;.01~5
801.412;+78459,+78458,;2~VA-ONC BLANK
801.412;+78459,+78458,;7~YES
801.412;+78459,+78458,;9~YES
801.44;+78460,+78458,;.01~06/09/2026@08:53:01
801.44;+78460,+78458,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78459^1
78460^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ N+ OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78361</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2007695289</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78361,;.01~VA-GP ONC BRCA I-III ER+ N+ OFF PTHWY
801.41;+78361,;4~dialog group
801.41;+78361,;6~YES
801.41;+78361,;7~2
801.41;+78361,;23~YES
801.41;+78361,;25~WP-start~1
Off pathway:
801.41;+78361,;52~INDENT
801.41;+78361,;100~NATIONAL
801.412;+78362,+78361,;.01~10
801.412;+78362,+78361,;2~VA-ONC BRCA I-III ER+ N+ COMP OFF PATH TX
801.412;+78363,+78361,;.01~20
801.412;+78363,+78361,;2~VA-ONC BRCA I-III ER+ N+ COMP OFF PATH RSN
801.44;+78364,+78361,;.01~06/09/2026@08:53:01
801.44;+78364,+78361,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78362^1
78363^2
78364^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ N+ CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78325</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>944618468</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78325,;.01~VA-ONC BRCA I-III ER+ N+ CLIN TRIAL
801.41;+78325,;4~dialog element
801.41;+78325,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N+ CLIN TRIAL
801.41;+78325,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78325,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78325,;100~NATIONAL
801.412;+78326,+78325,;.01~5
801.412;+78326,+78325,;2~VA-ONC CLINICAL TRIAL
801.412;+78326,+78325,;9~YES
801.44;+78327,+78325,;.01~06/09/2026@08:53:01
801.44;+78327,+78325,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78326^1
78327^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B N+ NEOADJ TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78415</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>677830635</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78415,;.01~VA-GP ONC BRCA I-III ER+ T1B N+ NEOADJ TX
801.41;+78415,;4~dialog group
801.41;+78415,;6~YES
801.41;+78415,;7~2
801.41;+78415,;9~ONE SELECTION ONLY
801.41;+78415,;23~YES
801.41;+78415,;25~WP-start~1
Neoadjuvant Therapy:
801.41;+78415,;100~NATIONAL
801.412;+78416,+78415,;.01~10
801.412;+78416,+78415,;2~VA-ONC BRCA I-III ER+ N+ CLIN TRIAL
801.412;+78417,+78415,;.01~30
801.412;+78417,+78415,;2~VA-GP ONC BRCA I-III ER+ N+ OFF PTHWY
801.412;+78418,+78415,;.01~20
801.412;+78418,+78415,;2~VA-GP ONC BRCA I-III ER+ RS<25 DDAC-T
801.44;+78419,+78415,;.01~06/09/2026@08:53:01
801.44;+78419,+78415,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78416^1
78417^3
78418^4
78419^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B PRE NODE N+</POINT_01>
<INTERNAL_ENTRY_NUMBER>73356</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2893332697</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73356,;.01~VA-GP ONC BRCA I-III ER+ T1B PRE NODE N+
801.41;+73356,;4~dialog group
801.41;+73356,;6~YES
801.41;+73356,;7~2
801.41;+73356,;9~ONE SELECTION ONLY
801.41;+73356,;25~WP-start~1
Nodal Status, N+:
801.41;+73356,;100~NATIONAL
801.412;+73357,+73356,;.01~10
801.412;+73357,+73356,;2~VA-GP ONC BRCA I-III ER+ T1B N+ NEOADJ TX
801.412;+73358,+73356,;.01~20
801.412;+73358,+73356,;2~VA-GP ONC BRCA I-III ER+ T1B POST N+ ADJ THERAPY
801.44;+73359,+73356,;.01~06/09/2026@08:53:01
801.44;+73359,+73356,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73357^3
73358^4
73359^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ N0 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78352</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1627083906</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78352,;.01~VA-ONC BRCA I-III ER+ N0 OFF PATH RSN
801.41;+78352,;4~dialog element
801.41;+78352,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N0 OFF PATH RSN
801.41;+78352,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+78352,;51~SUPPRESS
801.41;+78352,;100~NATIONAL
801.412;+78353,+78352,;.01~5
801.412;+78353,+78352,;2~VA-ONC OFF PATHWAY
801.412;+78353,+78352,;7~YES
801.412;+78353,+78352,;9~YES
801.44;+78354,+78352,;.01~06/09/2026@08:53:01
801.44;+78354,+78352,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78353^1
78354^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ N0 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>78331</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>4292641588</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78331,;.01~VA-ONC BRCA I-III ER+ N0 OFF PATH TX
801.41;+78331,;4~dialog element
801.41;+78331,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N0 OFF PATH TX
801.41;+78331,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+78331,;51~SUPPRESS
801.41;+78331,;100~NATIONAL
801.412;+78332,+78331,;.01~5
801.412;+78332,+78331,;2~VA-ONC BLANK
801.412;+78332,+78331,;7~YES
801.412;+78332,+78331,;9~YES
801.44;+78333,+78331,;.01~06/09/2026@08:53:01
801.44;+78333,+78331,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78332^1
78333^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ N0 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>78360</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3792153429</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78360,;.01~VA-GP ONC BRCA I-III ER+ N0 OFF PTHWY
801.41;+78360,;4~dialog group
801.41;+78360,;6~YES
801.41;+78360,;7~2
801.41;+78360,;23~YES
801.41;+78360,;25~WP-start~1
Off pathway:
801.41;+78360,;52~INDENT
801.41;+78360,;100~NATIONAL
801.412;+78361,+78360,;.01~10
801.412;+78361,+78360,;2~VA-ONC BRCA I-III ER+ N0 OFF PATH TX
801.412;+78362,+78360,;.01~20
801.412;+78362,+78360,;2~VA-ONC BRCA I-III ER+ N0 OFF PATH RSN
801.44;+78363,+78360,;.01~06/09/2026@08:53:01
801.44;+78363,+78360,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78361^1
78362^2
78363^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ N0 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>78324</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3326970897</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78324,;.01~VA-ONC BRCA I-III ER+ N0 CLIN TRIAL
801.41;+78324,;4~dialog element
801.41;+78324,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N0 CLIN TRIAL
801.41;+78324,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+78324,;35~WP-start~1
Veteran has elected to pursue:
801.41;+78324,;100~NATIONAL
801.412;+78325,+78324,;.01~5
801.412;+78325,+78324,;2~VA-ONC CLINICAL TRIAL
801.412;+78325,+78324,;9~YES
801.44;+78326,+78324,;.01~06/09/2026@08:53:01
801.44;+78326,+78324,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78325^1
78326^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B N0 PREFER ADJ PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73355</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2350276852</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73355,;.01~VA-ONC BRCA I-III ER+ T1B N0 PREFER ADJ PTHWY
801.41;+73355,;4~dialog element
801.41;+73355,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N0 ADJ HT PATHWAY
801.41;+73355,;25~WP-start~1
Follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any Pathway
801.41;+73355,;35~WP-start~2
Veteran has elected to FOLLOW ADJUVANT HORMONE THERAPY for ER+ or 
PR+/HER2 ANY PATHWAY.
801.41;+73355,;100~NATIONAL
801.44;+73356,+73355,;.01~06/09/2026@08:53:01
801.44;+73356,+73355,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73356^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B N0 PREFER TC</POINT_01>
<INTERNAL_ENTRY_NUMBER>73354</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2941310342</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73354,;.01~VA-ONC BRCA I-III ER+ T1B N0 PREFER TC
801.41;+73354,;4~dialog element
801.41;+73354,;15~HF.VA-ONC BRCA I-III ER+ RS < 25 N0 TC+ADJ HT PTHWY
801.41;+73354,;25~WP-start~2
Docetaxel and cyclophosphamide (TC); then Follow Adjuvant Hormone Therapy 
for ER+ or PR+/HER2 Any Pathway
801.41;+73354,;35~WP-start~3
Veteran has elected to pursue TREATMENT with DOCETAXEL and 
CYCLOPHOSPHAMIDE (TC) and then FOLLOW ADJUVANT HORMONE THERAPY for ER+ or
PR+/HER2 ANY PATHWAY.
801.41;+73354,;100~NATIONAL
801.44;+73355,+73354,;.01~06/09/2026@08:53:01
801.44;+73355,+73354,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73355^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B N0 PREFER</POINT_01>
<INTERNAL_ENTRY_NUMBER>73353</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3134205142</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73353,;.01~VA-GP ONC BRCA I-III ER+ T1B N0 PREFER
801.41;+73353,;4~dialog group
801.41;+73353,;6~YES
801.41;+73353,;7~2
801.41;+73353,;9~ONE SELECTION ONLY
801.41;+73353,;25~WP-start~1
Patient preference after shared decision making:
801.41;+73353,;51~SUPPRESS
801.41;+73353,;100~NATIONAL
801.412;+73354,+73353,;.01~10
801.412;+73354,+73353,;2~VA-ONC BRCA I-III ER+ T1B N0 PREFER TC
801.412;+73355,+73353,;.01~20
801.412;+73355,+73353,;2~VA-ONC BRCA I-III ER+ T1B N0 PREFER ADJ PTHWY
801.412;+73356,+73353,;.01~5
801.412;+73356,+73353,;2~VA-ONC BRCA I-III ER+ N0 CLIN TRIAL
801.412;+73357,+73353,;.01~30
801.412;+73357,+73353,;2~VA-GP ONC BRCA I-III ER+ N0 OFF PTHWY
801.44;+73358,+73353,;.01~06/09/2026@08:53:01
801.44;+73358,+73353,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73354^1
73355^2
73356^3
73357^4
73358^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B PRE NODE N0</POINT_01>
<INTERNAL_ENTRY_NUMBER>73351</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1359398442</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73351,;.01~VA-GP ONC BRCA I-III ER+ T1B PRE NODE N0
801.41;+73351,;4~dialog group
801.41;+73351,;6~YES
801.41;+73351,;25~WP-start~1
Nodal Status, N0:
801.41;+73351,;100~NATIONAL
801.412;+73352,+73351,;.01~20
801.412;+73352,+73351,;2~VA-GP ONC BRCA I-III ER+ T1B N0 PREFER
801.44;+73353,+73351,;.01~06/09/2026@08:53:01
801.44;+73353,+73351,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73352^2
73353^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B PRE-MENOPAUSE</POINT_01>
<INTERNAL_ENTRY_NUMBER>68081</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1321540532</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+68081,;.01~VA-GP ONC BRCA I-III ER+ T1B PRE-MENOPAUSE
801.41;+68081,;4~dialog group
801.41;+68081,;6~YES
801.41;+68081,;7~2
801.41;+68081,;9~ONE SELECTION ONLY
801.41;+68081,;25~WP-start~1
Pre-menopause:
801.41;+68081,;100~NATIONAL
801.412;+68082,+68081,;.01~10
801.412;+68082,+68081,;2~VA-GP ONC BRCA I-III ER+ T1B PRE NODE N0
801.412;+68083,+68081,;.01~20
801.412;+68083,+68081,;2~VA-GP ONC BRCA I-III ER+ T1B PRE NODE N+
801.44;+68084,+68081,;.01~06/09/2026@08:53:01
801.44;+68084,+68081,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
68082^1
68083^2
68084^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B MENOPAUSE STATUS</POINT_01>
<INTERNAL_ENTRY_NUMBER>68079</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1770307397</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+68079,;.01~VA-GP ONC BRCA I-III ER+ T1B MENOPAUSE STATUS
801.41;+68079,;4~dialog group
801.41;+68079,;6~YES
801.41;+68079,;7~2
801.41;+68079,;9~NONE OR ONE SELECTION
801.41;+68079,;23~YES
801.41;+68079,;25~WP-start~4
Menopause Status: \\
++ Menopausal defined as patient that is 60 years of age or older, 1 year
or more amenorrhea\\   (not medically induced), history of Bilateral
Salpingo-Oophorectomy (BSO), or confirmed with labs. ++
801.41;+68079,;51~SUPPRESS
801.41;+68079,;100~NATIONAL
801.412;+68080,+68079,;.01~10
801.412;+68080,+68079,;2~VA-GP ONC BRCA I-III ER+ T1B PRE-MENOPAUSE
801.412;+68081,+68079,;.01~20
801.412;+68081,+68079,;2~VA-GP ONC BRCA I-III ER+ T1B POST-MENOPAUSE
801.44;+68082,+68079,;.01~06/09/2026@08:53:01
801.44;+68082,+68079,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
68080^1
68081^2
68082^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B RS 16-25</POINT_01>
<INTERNAL_ENTRY_NUMBER>67746</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>769799155</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+67746,;.01~VA-GP ONC BRCA I-III ER+ T1B RS 16-25
801.41;+67746,;4~dialog group
801.41;+67746,;6~YES
801.41;+67746,;7~2
801.41;+67746,;9~ONE SELECTION ONLY
801.41;+67746,;25~WP-start~1
16-25:
801.41;+67746,;52~INDENT
801.41;+67746,;100~NATIONAL
801.412;+67747,+67746,;.01~10
801.412;+67747,+67746,;2~VA-GP ONC BRCA I-III ER+ T1B MENOPAUSE STATUS
801.44;+67748,+67746,;.01~06/09/2026@08:53:01
801.44;+67748,+67746,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
67747^1
67748^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B RS &lt;15 OFF PATH RSN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86879</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2367760377</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86879,;.01~VA-ONC BRCA I-III ER+ T1B RS <15 OFF PATH RSN
801.41;+86879,;4~dialog element
801.41;+86879,;15~HF.VA-ONC BRCA I-III ER+ RS <= 15 OFF PATH RSN
801.41;+86879,;25~WP-start~1
{FLD:VA-ONC OFF REASON TXT}
801.41;+86879,;51~SUPPRESS
801.41;+86879,;100~NATIONAL
801.412;+86880,+86879,;.01~5
801.412;+86880,+86879,;2~VA-ONC OFF PATHWAY
801.412;+86880,+86879,;7~YES
801.412;+86880,+86879,;9~YES
801.44;+86881,+86879,;.01~06/09/2026@08:53:01
801.44;+86881,+86879,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86880^1
86881^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B RS &lt;15 OFF PATH TX</POINT_01>
<INTERNAL_ENTRY_NUMBER>86878</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>990562570</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86878,;.01~VA-ONC BRCA I-III ER+ T1B RS <15 OFF PATH TX
801.41;+86878,;4~dialog element
801.41;+86878,;15~HF.VA-ONC BRCA I-III ER+ RS <= 15 OFF PATH TX
801.41;+86878,;25~WP-start~1
Veteran has elected to pursue: {FLD:VA-ONC TREATMENT REASON}
801.41;+86878,;51~SUPPRESS
801.41;+86878,;100~NATIONAL
801.412;+86879,+86878,;.01~5
801.412;+86879,+86878,;2~VA-ONC BLANK
801.412;+86879,+86878,;7~YES
801.412;+86879,+86878,;9~YES
801.44;+86880,+86878,;.01~06/09/2026@08:53:01
801.44;+86880,+86878,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86879^1
86880^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B RS &lt;15 OFF PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>86875</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2783343204</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86875,;.01~VA-GP ONC BRCA I-III ER+ T1B RS <15 OFF PTHWY
801.41;+86875,;4~dialog group
801.41;+86875,;6~YES
801.41;+86875,;7~2
801.41;+86875,;23~YES
801.41;+86875,;25~WP-start~1
Off pathway:
801.41;+86875,;52~INDENT
801.41;+86875,;100~NATIONAL
801.412;+86876,+86875,;.01~10
801.412;+86876,+86875,;2~VA-ONC BRCA I-III ER+ T1B RS <15 OFF PATH TX
801.412;+86877,+86875,;.01~20
801.412;+86877,+86875,;2~VA-ONC BRCA I-III ER+ T1B RS <15 OFF PATH RSN
801.44;+86878,+86875,;.01~06/09/2026@08:53:01
801.44;+86878,+86875,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86876^1
86877^2
86878^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ T1B RS &lt;15 CLIN TRIAL</POINT_01>
<INTERNAL_ENTRY_NUMBER>86877</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>133498064</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86877,;.01~VA-ONC BRCA I-III ER+ T1B RS <15 CLIN TRIAL
801.41;+86877,;4~dialog element
801.41;+86877,;15~HF.VA-ONC BRCA I-III ER+ RS <= 15 CLIN TRIAL
801.41;+86877,;25~WP-start~1
{FLD:VA-ONC CLINICAL TRIAL}
801.41;+86877,;35~WP-start~1
Veteran has elected to pursue:
801.41;+86877,;100~NATIONAL
801.412;+86878,+86877,;.01~5
801.412;+86878,+86877,;2~VA-ONC CLINICAL TRIAL
801.412;+86878,+86877,;9~YES
801.44;+86879,+86877,;.01~06/09/2026@08:53:01
801.44;+86879,+86877,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86878^1
86879^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+ RS&lt;15 ADJ HT PTHWY</POINT_01>
<INTERNAL_ENTRY_NUMBER>67136</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>519629302</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+67136,;.01~VA-ONC BRCA I-III ER+ RS<15 ADJ HT PTHWY
801.41;+67136,;4~dialog element
801.41;+67136,;15~HF.VA-ONC BRCA I-III ER+ RS <= 15 ADJ HT PTHWY
801.41;+67136,;25~WP-start~1
Follow Adjuvant Hormone Therapy for ER+ or PR+/HER2 Any Pathway
801.41;+67136,;35~WP-start~2
Veteran has elected to FOLLOW ADJUVANT HORMONE THERAPY for ER+ or 
PR+/HER2 ANY PATHWAY.
801.41;+67136,;100~NATIONAL
801.44;+67137,+67136,;.01~06/09/2026@08:53:01
801.44;+67137,+67136,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
67137^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BR CA I-III T1B RS &lt;15</POINT_01>
<INTERNAL_ENTRY_NUMBER>67135</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1937588204</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+67135,;.01~VA-GP ONC BR CA I-III T1B RS <15
801.41;+67135,;4~dialog group
801.41;+67135,;6~YES
801.41;+67135,;7~2
801.41;+67135,;9~ONE SELECTION ONLY
801.41;+67135,;25~WP-start~1
15 or less:
801.41;+67135,;100~NATIONAL
801.412;+67136,+67135,;.01~10
801.412;+67136,+67135,;2~VA-ONC BRCA I-III ER+ RS<15 ADJ HT PTHWY
801.412;+67137,+67135,;.01~5
801.412;+67137,+67135,;2~VA-ONC BRCA I-III ER+ T1B RS <15 CLIN TRIAL
801.412;+67138,+67135,;.01~20
801.412;+67138,+67135,;2~VA-GP ONC BRCA I-III ER+ T1B RS <15 OFF PTHWY
801.44;+67139,+67135,;.01~06/09/2026@08:53:01
801.44;+67139,+67135,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
67136^1
67137^2
67138^3
67139^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B RISK SCORE</POINT_01>
<INTERNAL_ENTRY_NUMBER>58080</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>682205684</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+58080,;.01~VA-GP ONC BRCA I-III ER+ T1B RISK SCORE
801.41;+58080,;4~dialog group
801.41;+58080,;6~YES
801.41;+58080,;9~NONE OR ONE SELECTION
801.41;+58080,;25~WP-start~3
***********\\
Risk Score:\\
***********\\
801.41;+58080,;35~WP-start~1
Risk Score:
801.41;+58080,;51~SUPPRESS
801.41;+58080,;100~NATIONAL
801.412;+58081,+58080,;.01~10
801.412;+58081,+58080,;2~VA-GP ONC BR CA I-III T1B RS <15
801.412;+58082,+58080,;.01~20
801.412;+58082,+58080,;2~VA-GP ONC BRCA I-III ER+ T1B RS 16-25
801.412;+58083,+58080,;.01~40
801.412;+58083,+58080,;2~VA-GP ONC BRCA I-III ER+ T1B RS>25
801.44;+58084,+58080,;.01~06/09/2026@08:53:01
801.44;+58084,+58080,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
58081^1
58082^2
58083^3
58084^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B RT PCR ASSAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>73339</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2747963825</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73339,;.01~VA-GP ONC BRCA I-III ER+ T1B RT PCR ASSAY
801.41;+73339,;4~dialog group
801.41;+73339,;6~YES
801.41;+73339,;7~2
801.41;+73339,;23~YES
801.41;+73339,;25~WP-start~8
- Order 21 gene RT-PCR assay.\\
++ Blocks Preferred to Unstained Slides if using unstained slides, 
one must submit 15 5-um-thick sections that\\   are numbered to
indicate their order; choose tissue from the block with the greatest
contiguous area\\   of the highest grade of invasive carcinoma;   
microinvasive carcinomas are not acceptable; biopsy, lumpectomy,\\   and
resection specimens can be used; tissue must have been fixed in
formalin. ++
801.41;+73339,;51~SUPPRESS
801.41;+73339,;100~NATIONAL
801.412;+73340,+73339,;.01~20
801.412;+73340,+73339,;2~VA-GP ONC BRCA I-III ER+ T1B RISK SCORE
801.44;+73341,+73339,;.01~06/09/2026@08:53:01
801.44;+73341,+73339,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73340^1
73341^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B CHEMO CAND</POINT_01>
<INTERNAL_ENTRY_NUMBER>73338</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1216217738</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73338,;.01~VA-GP ONC BRCA I-III ER+ T1B CHEMO CAND
801.41;+73338,;4~dialog group
801.41;+73338,;7~2
801.41;+73338,;25~WP-start~1
Candidate for Chemotherapy:
801.41;+73338,;52~INDENT
801.41;+73338,;100~NATIONAL
801.412;+73339,+73338,;.01~10
801.412;+73339,+73338,;2~VA-GP ONC BRCA I-III ER+ T1B RT PCR ASSAY
801.44;+73340,+73338,;.01~06/09/2026@08:53:01
801.44;+73340,+73338,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73339^1
73340^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ T1B CHEMO MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>78323</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2331605563</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78323,;.01~VA-GP ONC BRCA I-III ER+ T1B CHEMO MAIN
801.41;+78323,;4~dialog group
801.41;+78323,;6~YES
801.41;+78323,;9~NONE OR ONE SELECTION
801.41;+78323,;25~WP-start~2
++ Follow Local/Regional Management Prior to Adjuvant Treatment Pathway. 
++
801.41;+78323,;35~WP-start~2
After following the Local/Regional Management Prior to Adjuvant 
Treatment Pathway:
801.41;+78323,;51~SUPPRESS
801.41;+78323,;52~INDENT
801.41;+78323,;100~NATIONAL
801.412;+78324,+78323,;.01~20
801.412;+78324,+78323,;2~VA-GP ONC BRCA I-III ER+ T1B CHEMO CAND
801.412;+78325,+78323,;.01~40
801.412;+78325,+78323,;2~VA-GP ONC BRCA I-III T1B NOT CHEMO CAND
801.44;+78326,+78323,;.01~06/09/2026@08:53:01
801.44;+78326,+78323,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78324^1
78325^2
78326^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ &gt;T1B SUBMAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>73337</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3537549779</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73337,;.01~VA-GP ONC BRCA I-III ER+ >T1B SUBMAIN
801.41;+73337,;4~dialog group
801.41;+73337,;7~2
801.41;+73337,;25~WP-start~1
T1b or greater, N0, or N1:
801.41;+73337,;35~WP-start~1
Stage T1b or greater, N0, or N1:
801.41;+73337,;52~INDENT
801.41;+73337,;100~NATIONAL
801.412;+73338,+73337,;.01~10
801.412;+73338,+73337,;2~VA-GP ONC BRCA I-III ER+ T1B CHEMO MAIN
801.44;+73339,+73337,;.01~06/09/2026@08:53:01
801.44;+73339,+73337,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73338^4
73339^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ STAGES</POINT_01>
<INTERNAL_ENTRY_NUMBER>73334</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>286645507</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73334,;.01~VA-GP ONC BRCA I-III ER+ STAGES
801.41;+73334,;4~dialog group
801.41;+73334,;5~Stage:
801.41;+73334,;6~YES
801.41;+73334,;9~NONE OR ONE SELECTION
801.41;+73334,;23~YES
801.41;+73334,;51~SUPPRESS
801.41;+73334,;100~NATIONAL
801.412;+73335,+73334,;.01~40
801.412;+73335,+73334,;2~VA-GP ONC BRCA I-III ER+ >T1B SUBMAIN
801.412;+73336,+73334,;.01~60
801.412;+73336,+73334,;2~VA-GP ONC BRCA I-III ANY T>N2 MAIN
801.412;+73337,+73334,;.01~20
801.412;+73337,+73334,;2~VA-GP ONC BRCA I-III ER+ T1A SUBMAIN
801.44;+73338,+73334,;.01~06/09/2026@08:53:01
801.44;+73338,+73334,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73335^2
73336^3
73337^4
73338^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA I-III ER+ MOL TEST MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86743</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2427297986</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86743,;.01~VA-GP ONC BRCA I-III ER+ MOL TEST MAIN
801.41;+86743,;4~dialog group
801.41;+86743,;7~2
801.41;+86743,;9~ONE SELECTION ONLY
801.41;+86743,;23~YES
801.41;+86743,;25~WP-start~1
- Perform germline testing.
801.41;+86743,;51~SUPPRESS
801.41;+86743,;100~NATIONAL
801.412;+86744,+86743,;.01~20
801.412;+86744,+86743,;2~VA-GP ONC BRCA I-III ER+ STAGES
801.44;+86745,+86743,;.01~06/09/2026@08:53:01
801.44;+86745,+86743,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86744^1
86745^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA I-III ER+/PR+/HER2- FN</POINT_01>
<INTERNAL_ENTRY_NUMBER>86690</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>945888467</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+86690,;.01~VA-ONC BRCA I-III ER+/PR+/HER2- FN
801.41;+86690,;4~dialog element
801.41;+86690,;23~YES
801.41;+86690,;25~WP-start~6
++ Invasive Carcinoma to include ductal, lobular, metaplastic, and 
mammary;\\   less aggressive breast carcinoma list includes tubular 
carcinoma, cribriform carcinoma,\\   mucinous (colloid) carcinoma,
mucinous cystadenocarcinoma, adenoid cystic carcinoma,\\   secretory
carcinoma, low-grade mucoepidermoid carcinoma, and tall cell carcinoma
with\\   reversed polarity. ++
801.41;+86690,;51~SUPPRESS
801.41;+86690,;100~NATIONAL
801.44;+86691,+86690,;.01~06/09/2026@08:53:01
801.44;+86691,+86690,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
86691^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BREAST CA I-III ER+/PR+/HER2-</POINT_01>
<INTERNAL_ENTRY_NUMBER>73332</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2513938748</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+73332,;.01~VA-GP ONC BREAST CA I-III ER+/PR+/HER2-
801.41;+73332,;4~dialog group
801.41;+73332,;6~YES
801.41;+73332,;7~2
801.41;+73332,;15~HF.VA-ONC BRCA STG I-III ER+ OR PR+/HER2- CLINICAL PATHWAY
801.41;+73332,;25~WP-start~1
ER+ or PR+/HER2- Clinical Pathway:
801.41;+73332,;35~WP-start~3
VA National Breast Cancer - Stage I-III ER+ or PR+/HER2-\\  Clinical 
Pathway\\
========================================================
801.41;+73332,;100~NATIONAL
801.412;+73333,+73332,;.01~5
801.412;+73333,+73332,;2~VA-ONC BRCA I-III ER+/PR+/HER2- FN
801.412;+73334,+73332,;.01~10
801.412;+73334,+73332,;2~VA-GP ONC BRCA I-III ER+ MOL TEST MAIN
801.44;+73335,+73332,;.01~06/09/2026@08:53:01
801.44;+73335,+73332,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
73333^4
73334^5
73335^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA STAGE I-III PATHWAY OPTIONS</POINT_01>
<INTERNAL_ENTRY_NUMBER>78793</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2175660919</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+78793,;.01~VA-GP ONC BRCA STAGE I-III PATHWAY OPTIONS
801.41;+78793,;4~dialog group
801.41;+78793,;5~(Select One)
801.41;+78793,;6~YES
801.41;+78793,;7~2
801.41;+78793,;9~NONE OR ONE SELECTION
801.41;+78793,;15~HF.VA-ONC BRCA STAGE I-III CLINICAL PATHWAY
801.41;+78793,;23~YES
801.41;+78793,;25~WP-start~1
Stage I-III:
801.41;+78793,;51~SUPPRESS
801.41;+78793,;100~NATIONAL
801.412;+78794,+78793,;.01~10
801.412;+78794,+78793,;2~VA-GP ONC BREAST CA I-III ER+/PR+/HER2-
801.412;+78795,+78793,;.01~20
801.412;+78795,+78793,;2~VA-GP ONC BREAST CA I-III ANY ER/PR/HER2+
801.412;+78796,+78793,;.01~30
801.412;+78796,+78793,;2~VA-GP ONC BREAST CA I-III ER-/PR-/HER2-
801.44;+78797,+78793,;.01~06/09/2026@08:53:01
801.44;+78797,+78793,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
78794^1
78795^2
78796^3
78797^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA STG I-III SUBMAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>88686</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>306258141</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+88686,;.01~VA-GP ONC BRCA STG I-III SUBMAIN
801.41;+88686,;4~dialog group
801.41;+88686,;6~YES
801.41;+88686,;51~SUPPRESS
801.41;+88686,;100~NATIONAL
801.412;+88687,+88686,;.01~80
801.412;+88687,+88686,;2~VA-GP ONC BRCA STAGE I-III PATHWAY OPTIONS
801.412;+88688,+88686,;.01~100
801.412;+88688,+88686,;2~VA-GP ONC BRCA I-III OPTIONAL ADJ TX
801.44;+88689,+88686,;.01~06/09/2026@08:53:01
801.44;+88689,+88686,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
88687^3
88688^4
88689^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC ON PATHWAY INSTRUCTIONS</POINT_01>
<INTERNAL_ENTRY_NUMBER>69212</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1036420653</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+69212,;.01~VA-ONC ON PATHWAY INSTRUCTIONS
801.41;+69212,;4~dialog element
801.41;+69212,;23~YES
801.41;+69212,;25~WP-start~3
++ Selections for each treatment decision are listed with the recommended 
treatment\\   in order of preference and are considered On Pathway, unless
stated Off Pathway. ++
801.41;+69212,;51~SUPPRESS
801.41;+69212,;100~NATIONAL
801.44;+69213,+69212,;.01~06/09/2026@08:53:01
801.44;+69213,+69212,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
69213^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA MALE/FEMALE DEFINITION</POINT_01>
<INTERNAL_ENTRY_NUMBER>87611</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3198920090</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+87611,;.01~VA-ONC BRCA MALE/FEMALE DEFINITION
801.41;+87611,;4~dialog element
801.41;+87611,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+87611,;23~YES
801.41;+87611,;25~WP-start~1
Definition of male and female used in pathways:
801.41;+87611,;35~WP-start~14
For the purposes of this breast cancer clinical pathway,
male is defined as male sex assigned at birth and female
is defined as female sex assigned at birth. For transgender
and gender diverse (TGD) Veterans receiving gender affirming
hormone therapy (GAHT), breast cancer treatment needs to be
personalized based on many individual factors, i.e., any
remaining breast tissue, any hormone supplementation etc.
 
Breast cancer treatment in TGD Veterans undergoing GAHT 
should be undertaken in consultation with a specialist using
an individualized approach. TGD Veterans may use the term
'chest' instead of 'breast', therefore it is important to
verify shared language between patient and provider to avoid
misunderstanding and provide affirming care.
801.41;+87611,;51~SUPPRESS
801.41;+87611,;100~NATIONAL
801.412;+87612,+87611,;.01~5
801.412;+87612,+87611,;2~PXRM GF VIEW BUTTON
801.412;+87612,+87611,;6~VIEW Definition
801.412;+87612,+87611,;8~YES
801.44;+87613,+87611,;.01~06/09/2026@08:53:01
801.44;+87613,+87611,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
87612^1
87613^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-EL ONC DASHED LINE NO SHOW</POINT_01>
<INTERNAL_ENTRY_NUMBER>38513</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>923036641</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+38513,;.01~VA-EL ONC DASHED LINE NO SHOW
801.41;+38513,;4~dialog element
801.41;+38513,;23~YES
801.41;+38513,;25~WP-start~1
========================================================
801.41;+38513,;51~SUPPRESS
801.41;+38513,;100~NATIONAL
801.44;+38514,+38513,;.01~06/09/2026@08:53:01
801.44;+38514,+38513,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
38514^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC PATHWAYS BREAST PREVIOUS DATA IN NOTE</POINT_01>
<INTERNAL_ENTRY_NUMBER>77822</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>608301300</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77822,;.01~VA-ONC PATHWAYS BREAST PREVIOUS DATA IN NOTE
801.41;+77822,;4~dialog element
801.41;+77822,;25~WP-start~2
Click to include previous Oncology Pathway documentation in your
progress note\\
801.41;+77822,;35~WP-start~3
\\Previous Oncology Pathways documented:
  |VA-ONCOLOGY PATHWAYS BREAST|\\
========================================================
801.41;+77822,;100~NATIONAL
801.44;+77823,+77822,;.01~06/09/2026@08:53:02
801.44;+77823,+77822,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77823^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC PATHWAYS BREAST PRIOR DATA OBJECT</POINT_01>
<INTERNAL_ENTRY_NUMBER>77823</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>75322877</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77823,;.01~VA-ONC PATHWAYS BREAST PRIOR DATA OBJECT
801.41;+77823,;4~dialog element
801.41;+77823,;23~YES
801.41;+77823,;25~WP-start~2
=======================================================\\
Oncology Pathways Documented:\\|VA-ONCOLOGY PATHWAYS BREAST|\\
801.41;+77823,;51~SUPPRESS
801.41;+77823,;100~NATIONAL
801.44;+77824,+77823,;.01~06/09/2026@08:53:02
801.44;+77824,+77823,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77824^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BREAST CA PRES CONDITION VIEW BOX</POINT_01>
<INTERNAL_ENTRY_NUMBER>67134</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2854419752</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+67134,;.01~VA-ONC BREAST CA PRES CONDITION VIEW BOX
801.41;+67134,;4~dialog element
801.41;+67134,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+67134,;23~YES
801.41;+67134,;25~WP-start~1
{FLD:VA-ONC PRESUMPTIVE CONDITIONS}
801.41;+67134,;35~WP-start~22
Breast Cancer-Presumptive Conditions:\\
====================================\\
 
VA automatically presumes that certain disabilities were caused by 
military service (presumptive conditions). This is because of the unique
circumstances of a specific Veteran's military service. If a Veteran is
diagnosed with a presumptive condition and meets the service requirements
for the presumption, disability compensation may be awarded.\\
 
Radiation Exposed Veterans-Ionizing Radiation Exposure in\\Specified 
Locations and Time Periods:\\
---------------------------------------------------------\\
   -Breast cancer
 
Gulf War and Post 9/11 Veterans-Burn Pits/Fine Particulate Matter 
\\Exposure in Specified Locations and Time Periods:\\
-----------------------------------------------------------------\\
   -Reproductive cancer of any type
 
 
For more information, please visit U.S. Department of Veterans Affairs - 
Presumptive Disability Benefits (domain.ext)
801.41;+67134,;51~SUPPRESS
801.41;+67134,;100~NATIONAL
801.412;+67135,+67134,;.01~5
801.412;+67135,+67134,;2~PXRM GF VIEW BUTTON
801.412;+67135,+67134,;6~VIEW Breast CA Presumptive Conditions
801.412;+67135,+67134,;8~YES
801.44;+67136,+67134,;.01~06/09/2026@08:53:02
801.44;+67136,+67134,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
67135^1
67136^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BREAST CA SHAREPOINT VIEW ABBREVIATION</POINT_01>
<INTERNAL_ENTRY_NUMBER>67133</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1746989959</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+67133,;.01~VA-ONC BREAST CA SHAREPOINT VIEW ABBREVIATION
801.41;+67133,;4~dialog element
801.41;+67133,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+67133,;23~YES
801.41;+67133,;25~WP-start~1
{FLD:VA-ONC PATHWAYS SHAREPOINT}
801.41;+67133,;35~WP-start~22
Abbreviations:\\   AC = Neoadjuvant Adriamycin/Cyclophosphamide\\   ADH =
Atypical Ductal Hyperplasia\\   ADT = Androgen Deprivation Therapy\\   AI
= Aromatase Inhibitor\\   ALH = Atypical Lobular Hyperplasia\\   BRCA = 
Breast Cancer Gene\\   CGP = Comprehensive Genome Profiling\\   CMP =
Comprehensive Metabolic Panel\\   CPS = Combined Positive Score\\   CPS +
EG Score = based on pre-treatment clinical stage (C) and post-treatment\\
     pathological stage (PS), estrogen-receptor status (E) and grade
(G)\\   ddAC-T = Dose-dense AC-T (doxorubicin and cyclophosphamide)\\   
DCIS = Ductal Carcinoma In Situ\\   ER = Estrogen Receptor\\   ESR1 =
Estrogen Receptor 1\\   FISH = Fluorescence In Situ Hybridization\\   HER2
= Human Epidermal Growth Factor Receptor 2\\   HR = Hormone Receptor\\   
HSCT = Hematopoietic Stem-Cell Transplantation\\   IHC =
Immunohistochemistry\\   LCIS = Lobular Carcinoma In Situ\\   LVEF = Left
Ventricular Ejection Fraction\\   MMR = Mismatch Repair\\   MRM = Modified
Radical Mastectomy\\   MSI = Microsatellite Instability\\   NGS =
Next-Generation Sequencing\\   OFS = Ovarian Function Suppression\\
   PALB2 = Partner and Localizer of BRCA2\\   PD-L1 = Programmed
Death-Ligand 1\\   PR = Progesterone Receptor\\   PV = Pathogenic
Variant\\   OS = Ovarian Suppression\\   TC = Docetaxel and
Cyclophosphamide\\   TMB = Tumor Mutation Burden\\   TCHP =
Docetaxel/Carboplatin/Trastuzumab/Pertuzumab\\   TNBC = Triple Negative
Breast Cancer
801.41;+67133,;51~SUPPRESS
801.41;+67133,;100~NATIONAL
801.412;+67134,+67133,;.01~5
801.412;+67134,+67133,;2~PXRM GF VIEW BUTTON
801.412;+67134,+67133,;6~VIEW Abbreviations
801.44;+67135,+67133,;.01~06/09/2026@08:53:02
801.44;+67135,+67133,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
67134^1
67135^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC PATHWAY GEN INSTRUCT/INTENDED USER</POINT_01>
<INTERNAL_ENTRY_NUMBER>49891</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1563233907</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+49891,;.01~VA-ONC PATHWAY GEN INSTRUCT/INTENDED USER
801.41;+49891,;4~dialog element
801.41;+49891,;15~GF.VIEW PROGRESS NOTE TEXT
801.41;+49891,;23~YES
801.41;+49891,;25~WP-start~6
Intended User: Oncology Practitioners: Physician (Attending, Resident,
Fellow), Nurse Practitioner,\\               Physician Assistant, 
Clinical Pharmacist Practitioner, Pathologist, Clinical Nurse
               Specialist, Surgical Oncologist, and Radiation Oncologist
 
++ For help finding a Clinical Trial, email: {FLD:VA-ONC CT RN NAV} ++
801.41;+49891,;35~WP-start~61
Oncology Clinical Pathways are a decision support tool designed by 
interdisciplinary subject matter experts for all members of a Veteran's
care team to use for the treatment of specific cancers.
 
Clinical Pathways templates facilitate the documentation of medical 
decision-making. 
 
Document using the pathway templates when a treatment decision is made. 
Documentation of historical treatments is not necessary (except for 
molecular testing).
 
Pathway recommended care is stated for each pathway. Indicate use 
of the pathway by checking the check box. Recommended treatment listed 
is considered 'On Pathway', unless otherwise stated.
 
Clinical trial and shared decision making always considered on pathway.
Document the name and number of the clinical trial.\\
    Please contact CancerClinicalTrialsNavigation@domain.ext for\\
     assistance with cancer trial navigation.
 
If off pathway, document the treatment that is being pursued and a reason
why treating off pathway.\\
    Off Pathway Options:\\
      Patient preference/declined: Patient prefers not to receive the 
treatment\\        specified on pathway or declines that treatment after
the provider has\\        discussed the evidence and best clinical
practice.\\
      Toxicity and/or comorbidity: Provider does not recommend on 
pathway\\        treatment due to concerns about anticipated toxicities or
due to medical\\        problems the patient has that impact their
eligibility for the on\\        pathway treatment.\\
      Prior treatment continued: Patient was started on another treatment 
prior\\        to pathways and a change in therapy is not indicated.\\
      Prior treatment precludes: Patient's prior cancer history or 
treatment\\        precludes abiding by the pathway.\\
      Pathway guidance needs update: Pathway or CPRS template has not 
been\\        updated to reflect most recent data.\\
      Patient barriers: Patient related factors other than medical issues 
that\\        potentially make them not eligible for on pathway choice,
such as\\        transportation issues, support barriers, etc.\\
      Treatment unavailable: Specified on pathway treatments are not 
available\\        at specific center due to national shortages, or other
factors.
 
Some templates have detailed instructions that provide specific data 
definitions of each selection.
 
Document that molecular testing has been ordered for complete data 
capture (i.e., molecular testing completed 3 years ago, choose 
'Previously ordered'). 
 
When a choice is followed by a colon (:), there will be more selections 
revealed when clicked.
 
Uncheck a checkbox if you change your mind and do not wish to indicate 
use for a section of the pathway.
 
If you click Finish on the template, any selections you made will
add health factors to the encounter. If you make an incorrect selection
and click Finish, you should remove the incorrect health factor from the 
encounter.
801.41;+49891,;51~SUPPRESS
801.41;+49891,;100~NATIONAL
801.412;+49892,+49891,;.01~5
801.412;+49892,+49891,;2~PXRM GF VIEW BUTTON
801.412;+49892,+49891,;6~VIEW General Instructions
801.412;+49892,+49891,;8~YES
801.44;+49893,+49891,;.01~06/09/2026@08:53:02
801.44;+49893,+49891,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
49892^1
49893^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONC BRCA STAGE I-III PATHWAY VERSION</POINT_01>
<INTERNAL_ENTRY_NUMBER>81442</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2041354810</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+81442,;.01~VA-ONC BRCA STAGE I-III PATHWAY VERSION
801.41;+81442,;4~dialog element
801.41;+81442,;23~YES
801.41;+81442,;25~WP-start~1
VA National Breast Cancer Stage I-III Clinical Pathways v2.1
801.41;+81442,;51~SUPPRESS
801.41;+81442,;100~NATIONAL
801.44;+81443,+81442,;.01~06/09/2026@08:53:02
801.44;+81443,+81442,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
81443^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA STG I-III INTRO</POINT_01>
<INTERNAL_ENTRY_NUMBER>88681</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>279732056</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+88681,;.01~VA-GP ONC BRCA STG I-III INTRO
801.41;+88681,;4~dialog group
801.41;+88681,;6~YES
801.41;+88681,;51~SUPPRESS
801.41;+88681,;100~NATIONAL
801.412;+88682,+88681,;.01~20
801.412;+88682,+88681,;2~VA-ONC BRCA STAGE I-III PATHWAY VERSION
801.412;+88683,+88681,;.01~40
801.412;+88683,+88681,;2~VA-ONC PATHWAY GEN INSTRUCT/INTENDED USER
801.412;+88684,+88681,;.01~60
801.412;+88684,+88681,;2~VA-ONC BREAST CA SHAREPOINT VIEW ABBREVIATION
801.412;+88685,+88681,;.01~80
801.412;+88685,+88681,;2~VA-ONC BREAST CA PRES CONDITION VIEW BOX
801.412;+88686,+88681,;.01~100
801.412;+88686,+88681,;2~VA-ONC PATHWAYS BREAST PRIOR DATA OBJECT
801.412;+88687,+88681,;.01~120
801.412;+88687,+88681,;2~VA-ONC PATHWAYS BREAST PREVIOUS DATA IN NOTE
801.412;+88688,+88681,;.01~140
801.412;+88688,+88681,;2~VA-EL ONC DASHED LINE NO SHOW
801.412;+88689,+88681,;.01~160
801.412;+88689,+88681,;2~VA-ONC BRCA MALE/FEMALE DEFINITION
801.412;+88690,+88681,;.01~180
801.412;+88690,+88681,;2~VA-ONC ON PATHWAY INSTRUCTIONS
801.44;+88691,+88681,;.01~06/09/2026@08:53:02
801.44;+88691,+88681,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
88682^1
88683^2
88684^3
88685^4
88686^5
88687^6
88688^7
88689^8
88690^9
88691^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-GP ONC BRCA STG I-III PATHWAYS MAIN</POINT_01>
<INTERNAL_ENTRY_NUMBER>77820</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1859608883</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+77820,;.01~VA-GP ONC BRCA STG I-III PATHWAYS MAIN
801.41;+77820,;4~dialog group
801.41;+77820,;6~YES
801.41;+77820,;51~SUPPRESS
801.41;+77820,;100~NATIONAL
801.412;+77821,+77820,;.01~20
801.412;+77821,+77820,;2~VA-GP ONC BRCA STG I-III INTRO
801.412;+77822,+77820,;.01~60
801.412;+77822,+77820,;2~VA-GP ONC BRCA STG I-III SUBMAIN
801.412;+77823,+77820,;.01~40
801.412;+77823,+77820,;2~VA-GP ONC BRCA STG I-III WORKUP/GERMLINE
801.44;+77824,+77820,;.01~06/09/2026@08:53:02
801.44;+77824,+77820,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
77821^1
77822^3
77823^4
77824^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DIALOG</FILE_NAME>
<FILE_NUMBER>801.41</FILE_NUMBER>
<POINT_01>VA-ONCOLOGY BRCA STAGE I-III PATHWAY</POINT_01>
<INTERNAL_ENTRY_NUMBER>70952</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1594763778</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.41;+70952,;.01~VA-ONCOLOGY BRCA STAGE I-III PATHWAY
801.41;+70952,;4~reminder dialog
801.41;+70952,;100~NATIONAL
801.41;+70952,;101~VHA ONCOLOGY
801.41;+70952,;112~TRUE
801.412;+70953,+70952,;.01~10
801.412;+70953,+70952,;2~VA-GP ONC BRCA STG I-III PATHWAYS MAIN
801.44;+70954,+70952,;.01~06/09/2026@08:53:02
801.44;+70954,+70952,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
70953^1
70954^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<INDEX>
<NUMBER_OF_COMPONENTS>1301</NUMBER_OF_COMPONENTS>
<COMPONENT>
<M_ROUTINE_START>26</M_ROUTINE_START>
<ROUTINE_CODE_END>325</ROUTINE_CODE_END>
<ROUTINE_CODE_START>31</ROUTINE_CODE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>343</FDA_END>
<FDA_START>338</FDA_START>
<FILE_START>329</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>370</FDA_END>
<FDA_START>356</FDA_START>
<FILE_START>347</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>397</FDA_END>
<FDA_START>383</FDA_START>
<FILE_START>374</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>424</FDA_END>
<FDA_START>410</FDA_START>
<FILE_START>401</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>451</FDA_END>
<FDA_START>437</FDA_START>
<FILE_START>428</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>478</FDA_END>
<FDA_START>464</FDA_START>
<FILE_START>455</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>505</FDA_END>
<FDA_START>491</FDA_START>
<FILE_START>482</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>532</FDA_END>
<FDA_START>518</FDA_START>
<FILE_START>509</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>548</FDA_END>
<FDA_START>545</FDA_START>
<FILE_START>536</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>572</FDA_END>
<FDA_START>561</FDA_START>
<FILE_START>552</FILE_START>
<IEN_ROOT_END>578</IEN_ROOT_END>
<IEN_ROOT_START>577</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>605</FDA_END>
<FDA_START>591</FDA_START>
<FILE_START>582</FILE_START>
<IEN_ROOT_END>613</IEN_ROOT_END>
<IEN_ROOT_START>610</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>639</FDA_END>
<FDA_START>626</FDA_START>
<FILE_START>617</FILE_START>
<IEN_ROOT_END>645</IEN_ROOT_END>
<IEN_ROOT_START>644</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>671</FDA_END>
<FDA_START>658</FDA_START>
<FILE_START>649</FILE_START>
<IEN_ROOT_END>677</IEN_ROOT_END>
<IEN_ROOT_START>676</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>703</FDA_END>
<FDA_START>690</FDA_START>
<FILE_START>681</FILE_START>
<IEN_ROOT_END>709</IEN_ROOT_END>
<IEN_ROOT_START>708</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>736</FDA_END>
<FDA_START>722</FDA_START>
<FILE_START>713</FILE_START>
<IEN_ROOT_END>742</IEN_ROOT_END>
<IEN_ROOT_START>741</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>768</FDA_END>
<FDA_START>755</FDA_START>
<FILE_START>746</FILE_START>
<IEN_ROOT_END>774</IEN_ROOT_END>
<IEN_ROOT_START>773</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>800</FDA_END>
<FDA_START>787</FDA_START>
<FILE_START>778</FILE_START>
<IEN_ROOT_END>806</IEN_ROOT_END>
<IEN_ROOT_START>805</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>832</FDA_END>
<FDA_START>819</FDA_START>
<FILE_START>810</FILE_START>
<IEN_ROOT_END>838</IEN_ROOT_END>
<IEN_ROOT_START>837</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>864</FDA_END>
<FDA_START>851</FDA_START>
<FILE_START>842</FILE_START>
<IEN_ROOT_END>870</IEN_ROOT_END>
<IEN_ROOT_START>869</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>896</FDA_END>
<FDA_START>883</FDA_START>
<FILE_START>874</FILE_START>
<IEN_ROOT_END>902</IEN_ROOT_END>
<IEN_ROOT_START>901</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>928</FDA_END>
<FDA_START>915</FDA_START>
<FILE_START>906</FILE_START>
<IEN_ROOT_END>934</IEN_ROOT_END>
<IEN_ROOT_START>933</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>960</FDA_END>
<FDA_START>947</FDA_START>
<FILE_START>938</FILE_START>
<IEN_ROOT_END>966</IEN_ROOT_END>
<IEN_ROOT_START>965</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>994</FDA_END>
<FDA_START>979</FDA_START>
<FILE_START>970</FILE_START>
<IEN_ROOT_END>1000</IEN_ROOT_END>
<IEN_ROOT_START>999</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1026</FDA_END>
<FDA_START>1013</FDA_START>
<FILE_START>1004</FILE_START>
<IEN_ROOT_END>1032</IEN_ROOT_END>
<IEN_ROOT_START>1031</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1058</FDA_END>
<FDA_START>1045</FDA_START>
<FILE_START>1036</FILE_START>
<IEN_ROOT_END>1064</IEN_ROOT_END>
<IEN_ROOT_START>1063</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1090</FDA_END>
<FDA_START>1077</FDA_START>
<FILE_START>1068</FILE_START>
<IEN_ROOT_END>1096</IEN_ROOT_END>
<IEN_ROOT_START>1095</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1124</FDA_END>
<FDA_START>1109</FDA_START>
<FILE_START>1100</FILE_START>
<IEN_ROOT_END>1130</IEN_ROOT_END>
<IEN_ROOT_START>1129</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1157</FDA_END>
<FDA_START>1143</FDA_START>
<FILE_START>1134</FILE_START>
<IEN_ROOT_END>1164</IEN_ROOT_END>
<IEN_ROOT_START>1162</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1190</FDA_END>
<FDA_START>1177</FDA_START>
<FILE_START>1168</FILE_START>
<IEN_ROOT_END>1196</IEN_ROOT_END>
<IEN_ROOT_START>1195</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1222</FDA_END>
<FDA_START>1209</FDA_START>
<FILE_START>1200</FILE_START>
<IEN_ROOT_END>1228</IEN_ROOT_END>
<IEN_ROOT_START>1227</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1254</FDA_END>
<FDA_START>1241</FDA_START>
<FILE_START>1232</FILE_START>
<IEN_ROOT_END>1260</IEN_ROOT_END>
<IEN_ROOT_START>1259</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1286</FDA_END>
<FDA_START>1273</FDA_START>
<FILE_START>1264</FILE_START>
<IEN_ROOT_END>1292</IEN_ROOT_END>
<IEN_ROOT_START>1291</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1318</FDA_END>
<FDA_START>1305</FDA_START>
<FILE_START>1296</FILE_START>
<IEN_ROOT_END>1324</IEN_ROOT_END>
<IEN_ROOT_START>1323</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1350</FDA_END>
<FDA_START>1337</FDA_START>
<FILE_START>1328</FILE_START>
<IEN_ROOT_END>1356</IEN_ROOT_END>
<IEN_ROOT_START>1355</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1381</FDA_END>
<FDA_START>1369</FDA_START>
<FILE_START>1360</FILE_START>
<IEN_ROOT_END>1387</IEN_ROOT_END>
<IEN_ROOT_START>1386</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1413</FDA_END>
<FDA_START>1400</FDA_START>
<FILE_START>1391</FILE_START>
<IEN_ROOT_END>1419</IEN_ROOT_END>
<IEN_ROOT_START>1418</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1444</FDA_END>
<FDA_START>1432</FDA_START>
<FILE_START>1423</FILE_START>
<IEN_ROOT_END>1451</IEN_ROOT_END>
<IEN_ROOT_START>1449</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1478</FDA_END>
<FDA_START>1464</FDA_START>
<FILE_START>1455</FILE_START>
<IEN_ROOT_END>1485</IEN_ROOT_END>
<IEN_ROOT_START>1483</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1509</FDA_END>
<FDA_START>1498</FDA_START>
<FILE_START>1489</FILE_START>
<IEN_ROOT_END>1514</IEN_ROOT_END>
<IEN_ROOT_START>1514</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1538</FDA_END>
<FDA_START>1527</FDA_START>
<FILE_START>1518</FILE_START>
<IEN_ROOT_END>1543</IEN_ROOT_END>
<IEN_ROOT_START>1543</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1570</FDA_END>
<FDA_START>1556</FDA_START>
<FILE_START>1547</FILE_START>
<IEN_ROOT_END>1577</IEN_ROOT_END>
<IEN_ROOT_START>1575</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1603</FDA_END>
<FDA_START>1590</FDA_START>
<FILE_START>1581</FILE_START>
<IEN_ROOT_END>1609</IEN_ROOT_END>
<IEN_ROOT_START>1608</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1636</FDA_END>
<FDA_START>1622</FDA_START>
<FILE_START>1613</FILE_START>
<IEN_ROOT_END>1643</IEN_ROOT_END>
<IEN_ROOT_START>1641</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1670</FDA_END>
<FDA_START>1656</FDA_START>
<FILE_START>1647</FILE_START>
<IEN_ROOT_END>1677</IEN_ROOT_END>
<IEN_ROOT_START>1675</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1702</FDA_END>
<FDA_START>1690</FDA_START>
<FILE_START>1681</FILE_START>
<IEN_ROOT_END>1708</IEN_ROOT_END>
<IEN_ROOT_START>1707</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1734</FDA_END>
<FDA_START>1721</FDA_START>
<FILE_START>1712</FILE_START>
<IEN_ROOT_END>1740</IEN_ROOT_END>
<IEN_ROOT_START>1739</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1766</FDA_END>
<FDA_START>1753</FDA_START>
<FILE_START>1744</FILE_START>
<IEN_ROOT_END>1772</IEN_ROOT_END>
<IEN_ROOT_START>1771</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1798</FDA_END>
<FDA_START>1785</FDA_START>
<FILE_START>1776</FILE_START>
<IEN_ROOT_END>1804</IEN_ROOT_END>
<IEN_ROOT_START>1803</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1831</FDA_END>
<FDA_START>1817</FDA_START>
<FILE_START>1808</FILE_START>
<IEN_ROOT_END>1837</IEN_ROOT_END>
<IEN_ROOT_START>1836</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1864</FDA_END>
<FDA_START>1850</FDA_START>
<FILE_START>1841</FILE_START>
<IEN_ROOT_END>1870</IEN_ROOT_END>
<IEN_ROOT_START>1869</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1896</FDA_END>
<FDA_START>1883</FDA_START>
<FILE_START>1874</FILE_START>
<IEN_ROOT_END>1902</IEN_ROOT_END>
<IEN_ROOT_START>1901</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1928</FDA_END>
<FDA_START>1915</FDA_START>
<FILE_START>1906</FILE_START>
<IEN_ROOT_END>1934</IEN_ROOT_END>
<IEN_ROOT_START>1933</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1960</FDA_END>
<FDA_START>1947</FDA_START>
<FILE_START>1938</FILE_START>
<IEN_ROOT_END>1966</IEN_ROOT_END>
<IEN_ROOT_START>1965</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>1993</FDA_END>
<FDA_START>1979</FDA_START>
<FILE_START>1970</FILE_START>
<IEN_ROOT_END>1999</IEN_ROOT_END>
<IEN_ROOT_START>1998</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2026</FDA_END>
<FDA_START>2012</FDA_START>
<FILE_START>2003</FILE_START>
<IEN_ROOT_END>2032</IEN_ROOT_END>
<IEN_ROOT_START>2031</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2058</FDA_END>
<FDA_START>2045</FDA_START>
<FILE_START>2036</FILE_START>
<IEN_ROOT_END>2064</IEN_ROOT_END>
<IEN_ROOT_START>2063</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2091</FDA_END>
<FDA_START>2077</FDA_START>
<FILE_START>2068</FILE_START>
<IEN_ROOT_END>2097</IEN_ROOT_END>
<IEN_ROOT_START>2096</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2124</FDA_END>
<FDA_START>2110</FDA_START>
<FILE_START>2101</FILE_START>
<IEN_ROOT_END>2130</IEN_ROOT_END>
<IEN_ROOT_START>2129</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2157</FDA_END>
<FDA_START>2143</FDA_START>
<FILE_START>2134</FILE_START>
<IEN_ROOT_END>2163</IEN_ROOT_END>
<IEN_ROOT_START>2162</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2190</FDA_END>
<FDA_START>2176</FDA_START>
<FILE_START>2167</FILE_START>
<IEN_ROOT_END>2196</IEN_ROOT_END>
<IEN_ROOT_START>2195</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2223</FDA_END>
<FDA_START>2209</FDA_START>
<FILE_START>2200</FILE_START>
<IEN_ROOT_END>2229</IEN_ROOT_END>
<IEN_ROOT_START>2228</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2256</FDA_END>
<FDA_START>2242</FDA_START>
<FILE_START>2233</FILE_START>
<IEN_ROOT_END>2262</IEN_ROOT_END>
<IEN_ROOT_START>2261</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2289</FDA_END>
<FDA_START>2275</FDA_START>
<FILE_START>2266</FILE_START>
<IEN_ROOT_END>2295</IEN_ROOT_END>
<IEN_ROOT_START>2294</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2322</FDA_END>
<FDA_START>2308</FDA_START>
<FILE_START>2299</FILE_START>
<IEN_ROOT_END>2328</IEN_ROOT_END>
<IEN_ROOT_START>2327</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2355</FDA_END>
<FDA_START>2341</FDA_START>
<FILE_START>2332</FILE_START>
<IEN_ROOT_END>2361</IEN_ROOT_END>
<IEN_ROOT_START>2360</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2388</FDA_END>
<FDA_START>2374</FDA_START>
<FILE_START>2365</FILE_START>
<IEN_ROOT_END>2394</IEN_ROOT_END>
<IEN_ROOT_START>2393</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2421</FDA_END>
<FDA_START>2407</FDA_START>
<FILE_START>2398</FILE_START>
<IEN_ROOT_END>2427</IEN_ROOT_END>
<IEN_ROOT_START>2426</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2454</FDA_END>
<FDA_START>2440</FDA_START>
<FILE_START>2431</FILE_START>
<IEN_ROOT_END>2460</IEN_ROOT_END>
<IEN_ROOT_START>2459</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2487</FDA_END>
<FDA_START>2473</FDA_START>
<FILE_START>2464</FILE_START>
<IEN_ROOT_END>2493</IEN_ROOT_END>
<IEN_ROOT_START>2492</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2520</FDA_END>
<FDA_START>2506</FDA_START>
<FILE_START>2497</FILE_START>
<IEN_ROOT_END>2526</IEN_ROOT_END>
<IEN_ROOT_START>2525</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2553</FDA_END>
<FDA_START>2539</FDA_START>
<FILE_START>2530</FILE_START>
<IEN_ROOT_END>2559</IEN_ROOT_END>
<IEN_ROOT_START>2558</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2585</FDA_END>
<FDA_START>2572</FDA_START>
<FILE_START>2563</FILE_START>
<IEN_ROOT_END>2591</IEN_ROOT_END>
<IEN_ROOT_START>2590</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2618</FDA_END>
<FDA_START>2604</FDA_START>
<FILE_START>2595</FILE_START>
<IEN_ROOT_END>2624</IEN_ROOT_END>
<IEN_ROOT_START>2623</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2651</FDA_END>
<FDA_START>2637</FDA_START>
<FILE_START>2628</FILE_START>
<IEN_ROOT_END>2657</IEN_ROOT_END>
<IEN_ROOT_START>2656</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2684</FDA_END>
<FDA_START>2670</FDA_START>
<FILE_START>2661</FILE_START>
<IEN_ROOT_END>2690</IEN_ROOT_END>
<IEN_ROOT_START>2689</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2717</FDA_END>
<FDA_START>2703</FDA_START>
<FILE_START>2694</FILE_START>
<IEN_ROOT_END>2723</IEN_ROOT_END>
<IEN_ROOT_START>2722</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2749</FDA_END>
<FDA_START>2736</FDA_START>
<FILE_START>2727</FILE_START>
<IEN_ROOT_END>2755</IEN_ROOT_END>
<IEN_ROOT_START>2754</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2782</FDA_END>
<FDA_START>2768</FDA_START>
<FILE_START>2759</FILE_START>
<IEN_ROOT_END>2788</IEN_ROOT_END>
<IEN_ROOT_START>2787</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2815</FDA_END>
<FDA_START>2801</FDA_START>
<FILE_START>2792</FILE_START>
<IEN_ROOT_END>2821</IEN_ROOT_END>
<IEN_ROOT_START>2820</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2848</FDA_END>
<FDA_START>2834</FDA_START>
<FILE_START>2825</FILE_START>
<IEN_ROOT_END>2854</IEN_ROOT_END>
<IEN_ROOT_START>2853</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2881</FDA_END>
<FDA_START>2867</FDA_START>
<FILE_START>2858</FILE_START>
<IEN_ROOT_END>2887</IEN_ROOT_END>
<IEN_ROOT_START>2886</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2914</FDA_END>
<FDA_START>2900</FDA_START>
<FILE_START>2891</FILE_START>
<IEN_ROOT_END>2920</IEN_ROOT_END>
<IEN_ROOT_START>2919</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2947</FDA_END>
<FDA_START>2933</FDA_START>
<FILE_START>2924</FILE_START>
<IEN_ROOT_END>2953</IEN_ROOT_END>
<IEN_ROOT_START>2952</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>2979</FDA_END>
<FDA_START>2966</FDA_START>
<FILE_START>2957</FILE_START>
<IEN_ROOT_END>2985</IEN_ROOT_END>
<IEN_ROOT_START>2984</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3012</FDA_END>
<FDA_START>2998</FDA_START>
<FILE_START>2989</FILE_START>
<IEN_ROOT_END>3018</IEN_ROOT_END>
<IEN_ROOT_START>3017</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3045</FDA_END>
<FDA_START>3031</FDA_START>
<FILE_START>3022</FILE_START>
<IEN_ROOT_END>3051</IEN_ROOT_END>
<IEN_ROOT_START>3050</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3078</FDA_END>
<FDA_START>3064</FDA_START>
<FILE_START>3055</FILE_START>
<IEN_ROOT_END>3084</IEN_ROOT_END>
<IEN_ROOT_START>3083</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3111</FDA_END>
<FDA_START>3097</FDA_START>
<FILE_START>3088</FILE_START>
<IEN_ROOT_END>3117</IEN_ROOT_END>
<IEN_ROOT_START>3116</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3144</FDA_END>
<FDA_START>3130</FDA_START>
<FILE_START>3121</FILE_START>
<IEN_ROOT_END>3150</IEN_ROOT_END>
<IEN_ROOT_START>3149</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3177</FDA_END>
<FDA_START>3163</FDA_START>
<FILE_START>3154</FILE_START>
<IEN_ROOT_END>3183</IEN_ROOT_END>
<IEN_ROOT_START>3182</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3209</FDA_END>
<FDA_START>3196</FDA_START>
<FILE_START>3187</FILE_START>
<IEN_ROOT_END>3215</IEN_ROOT_END>
<IEN_ROOT_START>3214</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3241</FDA_END>
<FDA_START>3228</FDA_START>
<FILE_START>3219</FILE_START>
<IEN_ROOT_END>3247</IEN_ROOT_END>
<IEN_ROOT_START>3246</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3273</FDA_END>
<FDA_START>3260</FDA_START>
<FILE_START>3251</FILE_START>
<IEN_ROOT_END>3279</IEN_ROOT_END>
<IEN_ROOT_START>3278</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3306</FDA_END>
<FDA_START>3292</FDA_START>
<FILE_START>3283</FILE_START>
<IEN_ROOT_END>3312</IEN_ROOT_END>
<IEN_ROOT_START>3311</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3339</FDA_END>
<FDA_START>3325</FDA_START>
<FILE_START>3316</FILE_START>
<IEN_ROOT_END>3345</IEN_ROOT_END>
<IEN_ROOT_START>3344</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3371</FDA_END>
<FDA_START>3358</FDA_START>
<FILE_START>3349</FILE_START>
<IEN_ROOT_END>3377</IEN_ROOT_END>
<IEN_ROOT_START>3376</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3403</FDA_END>
<FDA_START>3390</FDA_START>
<FILE_START>3381</FILE_START>
<IEN_ROOT_END>3409</IEN_ROOT_END>
<IEN_ROOT_START>3408</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3435</FDA_END>
<FDA_START>3422</FDA_START>
<FILE_START>3413</FILE_START>
<IEN_ROOT_END>3441</IEN_ROOT_END>
<IEN_ROOT_START>3440</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3467</FDA_END>
<FDA_START>3454</FDA_START>
<FILE_START>3445</FILE_START>
<IEN_ROOT_END>3473</IEN_ROOT_END>
<IEN_ROOT_START>3472</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3499</FDA_END>
<FDA_START>3486</FDA_START>
<FILE_START>3477</FILE_START>
<IEN_ROOT_END>3505</IEN_ROOT_END>
<IEN_ROOT_START>3504</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3531</FDA_END>
<FDA_START>3518</FDA_START>
<FILE_START>3509</FILE_START>
<IEN_ROOT_END>3537</IEN_ROOT_END>
<IEN_ROOT_START>3536</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3563</FDA_END>
<FDA_START>3550</FDA_START>
<FILE_START>3541</FILE_START>
<IEN_ROOT_END>3569</IEN_ROOT_END>
<IEN_ROOT_START>3568</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3596</FDA_END>
<FDA_START>3582</FDA_START>
<FILE_START>3573</FILE_START>
<IEN_ROOT_END>3603</IEN_ROOT_END>
<IEN_ROOT_START>3601</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3630</FDA_END>
<FDA_START>3616</FDA_START>
<FILE_START>3607</FILE_START>
<IEN_ROOT_END>3636</IEN_ROOT_END>
<IEN_ROOT_START>3635</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3663</FDA_END>
<FDA_START>3649</FDA_START>
<FILE_START>3640</FILE_START>
<IEN_ROOT_END>3669</IEN_ROOT_END>
<IEN_ROOT_START>3668</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3695</FDA_END>
<FDA_START>3682</FDA_START>
<FILE_START>3673</FILE_START>
<IEN_ROOT_END>3701</IEN_ROOT_END>
<IEN_ROOT_START>3700</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3727</FDA_END>
<FDA_START>3714</FDA_START>
<FILE_START>3705</FILE_START>
<IEN_ROOT_END>3733</IEN_ROOT_END>
<IEN_ROOT_START>3732</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3759</FDA_END>
<FDA_START>3746</FDA_START>
<FILE_START>3737</FILE_START>
<IEN_ROOT_END>3765</IEN_ROOT_END>
<IEN_ROOT_START>3764</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3792</FDA_END>
<FDA_START>3778</FDA_START>
<FILE_START>3769</FILE_START>
<IEN_ROOT_END>3798</IEN_ROOT_END>
<IEN_ROOT_START>3797</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3825</FDA_END>
<FDA_START>3811</FDA_START>
<FILE_START>3802</FILE_START>
<IEN_ROOT_END>3831</IEN_ROOT_END>
<IEN_ROOT_START>3830</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3858</FDA_END>
<FDA_START>3844</FDA_START>
<FILE_START>3835</FILE_START>
<IEN_ROOT_END>3864</IEN_ROOT_END>
<IEN_ROOT_START>3863</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3890</FDA_END>
<FDA_START>3877</FDA_START>
<FILE_START>3868</FILE_START>
<IEN_ROOT_END>3896</IEN_ROOT_END>
<IEN_ROOT_START>3895</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3922</FDA_END>
<FDA_START>3909</FDA_START>
<FILE_START>3900</FILE_START>
<IEN_ROOT_END>3928</IEN_ROOT_END>
<IEN_ROOT_START>3927</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3954</FDA_END>
<FDA_START>3941</FDA_START>
<FILE_START>3932</FILE_START>
<IEN_ROOT_END>3960</IEN_ROOT_END>
<IEN_ROOT_START>3959</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>3986</FDA_END>
<FDA_START>3973</FDA_START>
<FILE_START>3964</FILE_START>
<IEN_ROOT_END>3992</IEN_ROOT_END>
<IEN_ROOT_START>3991</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4018</FDA_END>
<FDA_START>4005</FDA_START>
<FILE_START>3996</FILE_START>
<IEN_ROOT_END>4024</IEN_ROOT_END>
<IEN_ROOT_START>4023</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4050</FDA_END>
<FDA_START>4037</FDA_START>
<FILE_START>4028</FILE_START>
<IEN_ROOT_END>4056</IEN_ROOT_END>
<IEN_ROOT_START>4055</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4082</FDA_END>
<FDA_START>4069</FDA_START>
<FILE_START>4060</FILE_START>
<IEN_ROOT_END>4088</IEN_ROOT_END>
<IEN_ROOT_START>4087</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4113</FDA_END>
<FDA_START>4101</FDA_START>
<FILE_START>4092</FILE_START>
<IEN_ROOT_END>4118</IEN_ROOT_END>
<IEN_ROOT_START>4118</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4144</FDA_END>
<FDA_START>4131</FDA_START>
<FILE_START>4122</FILE_START>
<IEN_ROOT_END>4150</IEN_ROOT_END>
<IEN_ROOT_START>4149</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4176</FDA_END>
<FDA_START>4163</FDA_START>
<FILE_START>4154</FILE_START>
<IEN_ROOT_END>4182</IEN_ROOT_END>
<IEN_ROOT_START>4181</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4209</FDA_END>
<FDA_START>4195</FDA_START>
<FILE_START>4186</FILE_START>
<IEN_ROOT_END>4215</IEN_ROOT_END>
<IEN_ROOT_START>4214</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4241</FDA_END>
<FDA_START>4228</FDA_START>
<FILE_START>4219</FILE_START>
<IEN_ROOT_END>4247</IEN_ROOT_END>
<IEN_ROOT_START>4246</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4274</FDA_END>
<FDA_START>4260</FDA_START>
<FILE_START>4251</FILE_START>
<IEN_ROOT_END>4280</IEN_ROOT_END>
<IEN_ROOT_START>4279</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4307</FDA_END>
<FDA_START>4293</FDA_START>
<FILE_START>4284</FILE_START>
<IEN_ROOT_END>4313</IEN_ROOT_END>
<IEN_ROOT_START>4312</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4339</FDA_END>
<FDA_START>4326</FDA_START>
<FILE_START>4317</FILE_START>
<IEN_ROOT_END>4346</IEN_ROOT_END>
<IEN_ROOT_START>4344</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4373</FDA_END>
<FDA_START>4359</FDA_START>
<FILE_START>4350</FILE_START>
<IEN_ROOT_END>4379</IEN_ROOT_END>
<IEN_ROOT_START>4378</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4406</FDA_END>
<FDA_START>4392</FDA_START>
<FILE_START>4383</FILE_START>
<IEN_ROOT_END>4412</IEN_ROOT_END>
<IEN_ROOT_START>4411</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4439</FDA_END>
<FDA_START>4425</FDA_START>
<FILE_START>4416</FILE_START>
<IEN_ROOT_END>4445</IEN_ROOT_END>
<IEN_ROOT_START>4444</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4473</FDA_END>
<FDA_START>4458</FDA_START>
<FILE_START>4449</FILE_START>
<IEN_ROOT_END>4480</IEN_ROOT_END>
<IEN_ROOT_START>4478</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4507</FDA_END>
<FDA_START>4493</FDA_START>
<FILE_START>4484</FILE_START>
<IEN_ROOT_END>4513</IEN_ROOT_END>
<IEN_ROOT_START>4512</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4540</FDA_END>
<FDA_START>4526</FDA_START>
<FILE_START>4517</FILE_START>
<IEN_ROOT_END>4546</IEN_ROOT_END>
<IEN_ROOT_START>4545</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4573</FDA_END>
<FDA_START>4559</FDA_START>
<FILE_START>4550</FILE_START>
<IEN_ROOT_END>4579</IEN_ROOT_END>
<IEN_ROOT_START>4578</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4606</FDA_END>
<FDA_START>4592</FDA_START>
<FILE_START>4583</FILE_START>
<IEN_ROOT_END>4612</IEN_ROOT_END>
<IEN_ROOT_START>4611</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4639</FDA_END>
<FDA_START>4625</FDA_START>
<FILE_START>4616</FILE_START>
<IEN_ROOT_END>4645</IEN_ROOT_END>
<IEN_ROOT_START>4644</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4672</FDA_END>
<FDA_START>4658</FDA_START>
<FILE_START>4649</FILE_START>
<IEN_ROOT_END>4678</IEN_ROOT_END>
<IEN_ROOT_START>4677</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4705</FDA_END>
<FDA_START>4691</FDA_START>
<FILE_START>4682</FILE_START>
<IEN_ROOT_END>4711</IEN_ROOT_END>
<IEN_ROOT_START>4710</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4738</FDA_END>
<FDA_START>4724</FDA_START>
<FILE_START>4715</FILE_START>
<IEN_ROOT_END>4744</IEN_ROOT_END>
<IEN_ROOT_START>4743</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4771</FDA_END>
<FDA_START>4757</FDA_START>
<FILE_START>4748</FILE_START>
<IEN_ROOT_END>4777</IEN_ROOT_END>
<IEN_ROOT_START>4776</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4804</FDA_END>
<FDA_START>4790</FDA_START>
<FILE_START>4781</FILE_START>
<IEN_ROOT_END>4810</IEN_ROOT_END>
<IEN_ROOT_START>4809</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4837</FDA_END>
<FDA_START>4823</FDA_START>
<FILE_START>4814</FILE_START>
<IEN_ROOT_END>4843</IEN_ROOT_END>
<IEN_ROOT_START>4842</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4870</FDA_END>
<FDA_START>4856</FDA_START>
<FILE_START>4847</FILE_START>
<IEN_ROOT_END>4876</IEN_ROOT_END>
<IEN_ROOT_START>4875</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4904</FDA_END>
<FDA_START>4889</FDA_START>
<FILE_START>4880</FILE_START>
<IEN_ROOT_END>4911</IEN_ROOT_END>
<IEN_ROOT_START>4909</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4939</FDA_END>
<FDA_START>4924</FDA_START>
<FILE_START>4915</FILE_START>
<IEN_ROOT_END>4946</IEN_ROOT_END>
<IEN_ROOT_START>4944</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>4974</FDA_END>
<FDA_START>4959</FDA_START>
<FILE_START>4950</FILE_START>
<IEN_ROOT_END>4981</IEN_ROOT_END>
<IEN_ROOT_START>4979</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5010</FDA_END>
<FDA_START>4994</FDA_START>
<FILE_START>4985</FILE_START>
<IEN_ROOT_END>5017</IEN_ROOT_END>
<IEN_ROOT_START>5015</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5043</FDA_END>
<FDA_START>5030</FDA_START>
<FILE_START>5021</FILE_START>
<IEN_ROOT_END>5049</IEN_ROOT_END>
<IEN_ROOT_START>5048</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5076</FDA_END>
<FDA_START>5062</FDA_START>
<FILE_START>5053</FILE_START>
<IEN_ROOT_END>5082</IEN_ROOT_END>
<IEN_ROOT_START>5081</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5109</FDA_END>
<FDA_START>5095</FDA_START>
<FILE_START>5086</FILE_START>
<IEN_ROOT_END>5115</IEN_ROOT_END>
<IEN_ROOT_START>5114</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5141</FDA_END>
<FDA_START>5128</FDA_START>
<FILE_START>5119</FILE_START>
<IEN_ROOT_END>5147</IEN_ROOT_END>
<IEN_ROOT_START>5146</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5175</FDA_END>
<FDA_START>5160</FDA_START>
<FILE_START>5151</FILE_START>
<IEN_ROOT_END>5181</IEN_ROOT_END>
<IEN_ROOT_START>5180</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5209</FDA_END>
<FDA_START>5194</FDA_START>
<FILE_START>5185</FILE_START>
<IEN_ROOT_END>5215</IEN_ROOT_END>
<IEN_ROOT_START>5214</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5243</FDA_END>
<FDA_START>5228</FDA_START>
<FILE_START>5219</FILE_START>
<IEN_ROOT_END>5249</IEN_ROOT_END>
<IEN_ROOT_START>5248</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5277</FDA_END>
<FDA_START>5262</FDA_START>
<FILE_START>5253</FILE_START>
<IEN_ROOT_END>5283</IEN_ROOT_END>
<IEN_ROOT_START>5282</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5311</FDA_END>
<FDA_START>5296</FDA_START>
<FILE_START>5287</FILE_START>
<IEN_ROOT_END>5317</IEN_ROOT_END>
<IEN_ROOT_START>5316</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5345</FDA_END>
<FDA_START>5330</FDA_START>
<FILE_START>5321</FILE_START>
<IEN_ROOT_END>5351</IEN_ROOT_END>
<IEN_ROOT_START>5350</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5379</FDA_END>
<FDA_START>5364</FDA_START>
<FILE_START>5355</FILE_START>
<IEN_ROOT_END>5385</IEN_ROOT_END>
<IEN_ROOT_START>5384</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5413</FDA_END>
<FDA_START>5398</FDA_START>
<FILE_START>5389</FILE_START>
<IEN_ROOT_END>5419</IEN_ROOT_END>
<IEN_ROOT_START>5418</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5447</FDA_END>
<FDA_START>5432</FDA_START>
<FILE_START>5423</FILE_START>
<IEN_ROOT_END>5453</IEN_ROOT_END>
<IEN_ROOT_START>5452</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5481</FDA_END>
<FDA_START>5466</FDA_START>
<FILE_START>5457</FILE_START>
<IEN_ROOT_END>5487</IEN_ROOT_END>
<IEN_ROOT_START>5486</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5516</FDA_END>
<FDA_START>5500</FDA_START>
<FILE_START>5491</FILE_START>
<IEN_ROOT_END>5522</IEN_ROOT_END>
<IEN_ROOT_START>5521</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5549</FDA_END>
<FDA_START>5535</FDA_START>
<FILE_START>5526</FILE_START>
<IEN_ROOT_END>5555</IEN_ROOT_END>
<IEN_ROOT_START>5554</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5582</FDA_END>
<FDA_START>5568</FDA_START>
<FILE_START>5559</FILE_START>
<IEN_ROOT_END>5588</IEN_ROOT_END>
<IEN_ROOT_START>5587</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5615</FDA_END>
<FDA_START>5601</FDA_START>
<FILE_START>5592</FILE_START>
<IEN_ROOT_END>5621</IEN_ROOT_END>
<IEN_ROOT_START>5620</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5649</FDA_END>
<FDA_START>5634</FDA_START>
<FILE_START>5625</FILE_START>
<IEN_ROOT_END>5655</IEN_ROOT_END>
<IEN_ROOT_START>5654</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5684</FDA_END>
<FDA_START>5668</FDA_START>
<FILE_START>5659</FILE_START>
<IEN_ROOT_END>5691</IEN_ROOT_END>
<IEN_ROOT_START>5689</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5719</FDA_END>
<FDA_START>5704</FDA_START>
<FILE_START>5695</FILE_START>
<IEN_ROOT_END>5725</IEN_ROOT_END>
<IEN_ROOT_START>5724</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5753</FDA_END>
<FDA_START>5738</FDA_START>
<FILE_START>5729</FILE_START>
<IEN_ROOT_END>5760</IEN_ROOT_END>
<IEN_ROOT_START>5758</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5788</FDA_END>
<FDA_START>5773</FDA_START>
<FILE_START>5764</FILE_START>
<IEN_ROOT_END>5794</IEN_ROOT_END>
<IEN_ROOT_START>5793</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5823</FDA_END>
<FDA_START>5807</FDA_START>
<FILE_START>5798</FILE_START>
<IEN_ROOT_END>5830</IEN_ROOT_END>
<IEN_ROOT_START>5828</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5859</FDA_END>
<FDA_START>5843</FDA_START>
<FILE_START>5834</FILE_START>
<IEN_ROOT_END>5866</IEN_ROOT_END>
<IEN_ROOT_START>5864</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5895</FDA_END>
<FDA_START>5879</FDA_START>
<FILE_START>5870</FILE_START>
<IEN_ROOT_END>5902</IEN_ROOT_END>
<IEN_ROOT_START>5900</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5929</FDA_END>
<FDA_START>5915</FDA_START>
<FILE_START>5906</FILE_START>
<IEN_ROOT_END>5935</IEN_ROOT_END>
<IEN_ROOT_START>5934</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5962</FDA_END>
<FDA_START>5948</FDA_START>
<FILE_START>5939</FILE_START>
<IEN_ROOT_END>5968</IEN_ROOT_END>
<IEN_ROOT_START>5967</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>5995</FDA_END>
<FDA_START>5981</FDA_START>
<FILE_START>5972</FILE_START>
<IEN_ROOT_END>6001</IEN_ROOT_END>
<IEN_ROOT_START>6000</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6029</FDA_END>
<FDA_START>6014</FDA_START>
<FILE_START>6005</FILE_START>
<IEN_ROOT_END>6035</IEN_ROOT_END>
<IEN_ROOT_START>6034</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6062</FDA_END>
<FDA_START>6048</FDA_START>
<FILE_START>6039</FILE_START>
<IEN_ROOT_END>6068</IEN_ROOT_END>
<IEN_ROOT_START>6067</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6095</FDA_END>
<FDA_START>6081</FDA_START>
<FILE_START>6072</FILE_START>
<IEN_ROOT_END>6101</IEN_ROOT_END>
<IEN_ROOT_START>6100</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6128</FDA_END>
<FDA_START>6114</FDA_START>
<FILE_START>6105</FILE_START>
<IEN_ROOT_END>6134</IEN_ROOT_END>
<IEN_ROOT_START>6133</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6162</FDA_END>
<FDA_START>6147</FDA_START>
<FILE_START>6138</FILE_START>
<IEN_ROOT_END>6168</IEN_ROOT_END>
<IEN_ROOT_START>6167</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6194</FDA_END>
<FDA_START>6181</FDA_START>
<FILE_START>6172</FILE_START>
<IEN_ROOT_END>6200</IEN_ROOT_END>
<IEN_ROOT_START>6199</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6227</FDA_END>
<FDA_START>6213</FDA_START>
<FILE_START>6204</FILE_START>
<IEN_ROOT_END>6235</IEN_ROOT_END>
<IEN_ROOT_START>6232</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6262</FDA_END>
<FDA_START>6248</FDA_START>
<FILE_START>6239</FILE_START>
<IEN_ROOT_END>6268</IEN_ROOT_END>
<IEN_ROOT_START>6267</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6295</FDA_END>
<FDA_START>6281</FDA_START>
<FILE_START>6272</FILE_START>
<IEN_ROOT_END>6301</IEN_ROOT_END>
<IEN_ROOT_START>6300</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6328</FDA_END>
<FDA_START>6314</FDA_START>
<FILE_START>6305</FILE_START>
<IEN_ROOT_END>6334</IEN_ROOT_END>
<IEN_ROOT_START>6333</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6364</FDA_END>
<FDA_START>6347</FDA_START>
<FILE_START>6338</FILE_START>
<IEN_ROOT_END>6372</IEN_ROOT_END>
<IEN_ROOT_START>6369</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6399</FDA_END>
<FDA_START>6385</FDA_START>
<FILE_START>6376</FILE_START>
<IEN_ROOT_END>6407</IEN_ROOT_END>
<IEN_ROOT_START>6404</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6434</FDA_END>
<FDA_START>6420</FDA_START>
<FILE_START>6411</FILE_START>
<IEN_ROOT_END>6440</IEN_ROOT_END>
<IEN_ROOT_START>6439</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6467</FDA_END>
<FDA_START>6453</FDA_START>
<FILE_START>6444</FILE_START>
<IEN_ROOT_END>6473</IEN_ROOT_END>
<IEN_ROOT_START>6472</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6499</FDA_END>
<FDA_START>6486</FDA_START>
<FILE_START>6477</FILE_START>
<IEN_ROOT_END>6505</IEN_ROOT_END>
<IEN_ROOT_START>6504</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6531</FDA_END>
<FDA_START>6518</FDA_START>
<FILE_START>6509</FILE_START>
<IEN_ROOT_END>6537</IEN_ROOT_END>
<IEN_ROOT_START>6536</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6563</FDA_END>
<FDA_START>6550</FDA_START>
<FILE_START>6541</FILE_START>
<IEN_ROOT_END>6569</IEN_ROOT_END>
<IEN_ROOT_START>6568</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6596</FDA_END>
<FDA_START>6582</FDA_START>
<FILE_START>6573</FILE_START>
<IEN_ROOT_END>6602</IEN_ROOT_END>
<IEN_ROOT_START>6601</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6628</FDA_END>
<FDA_START>6615</FDA_START>
<FILE_START>6606</FILE_START>
<IEN_ROOT_END>6634</IEN_ROOT_END>
<IEN_ROOT_START>6633</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6661</FDA_END>
<FDA_START>6647</FDA_START>
<FILE_START>6638</FILE_START>
<IEN_ROOT_END>6668</IEN_ROOT_END>
<IEN_ROOT_START>6666</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6695</FDA_END>
<FDA_START>6681</FDA_START>
<FILE_START>6672</FILE_START>
<IEN_ROOT_END>6702</IEN_ROOT_END>
<IEN_ROOT_START>6700</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6731</FDA_END>
<FDA_START>6715</FDA_START>
<FILE_START>6706</FILE_START>
<IEN_ROOT_END>6739</IEN_ROOT_END>
<IEN_ROOT_START>6736</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6767</FDA_END>
<FDA_START>6752</FDA_START>
<FILE_START>6743</FILE_START>
<IEN_ROOT_END>6774</IEN_ROOT_END>
<IEN_ROOT_START>6772</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6803</FDA_END>
<FDA_START>6787</FDA_START>
<FILE_START>6778</FILE_START>
<IEN_ROOT_END>6811</IEN_ROOT_END>
<IEN_ROOT_START>6808</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6841</FDA_END>
<FDA_START>6824</FDA_START>
<FILE_START>6815</FILE_START>
<IEN_ROOT_END>6850</IEN_ROOT_END>
<IEN_ROOT_START>6846</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6877</FDA_END>
<FDA_START>6863</FDA_START>
<FILE_START>6854</FILE_START>
<IEN_ROOT_END>6883</IEN_ROOT_END>
<IEN_ROOT_START>6882</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6911</FDA_END>
<FDA_START>6896</FDA_START>
<FILE_START>6887</FILE_START>
<IEN_ROOT_END>6918</IEN_ROOT_END>
<IEN_ROOT_START>6916</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6946</FDA_END>
<FDA_START>6931</FDA_START>
<FILE_START>6922</FILE_START>
<IEN_ROOT_END>6953</IEN_ROOT_END>
<IEN_ROOT_START>6951</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>6982</FDA_END>
<FDA_START>6966</FDA_START>
<FILE_START>6957</FILE_START>
<IEN_ROOT_END>6990</IEN_ROOT_END>
<IEN_ROOT_START>6987</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7020</FDA_END>
<FDA_START>7003</FDA_START>
<FILE_START>6994</FILE_START>
<IEN_ROOT_END>7029</IEN_ROOT_END>
<IEN_ROOT_START>7025</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7057</FDA_END>
<FDA_START>7042</FDA_START>
<FILE_START>7033</FILE_START>
<IEN_ROOT_END>7064</IEN_ROOT_END>
<IEN_ROOT_START>7062</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7092</FDA_END>
<FDA_START>7077</FDA_START>
<FILE_START>7068</FILE_START>
<IEN_ROOT_END>7099</IEN_ROOT_END>
<IEN_ROOT_START>7097</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7127</FDA_END>
<FDA_START>7112</FDA_START>
<FILE_START>7103</FILE_START>
<IEN_ROOT_END>7134</IEN_ROOT_END>
<IEN_ROOT_START>7132</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7164</FDA_END>
<FDA_START>7147</FDA_START>
<FILE_START>7138</FILE_START>
<IEN_ROOT_END>7172</IEN_ROOT_END>
<IEN_ROOT_START>7169</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7198</FDA_END>
<FDA_START>7185</FDA_START>
<FILE_START>7176</FILE_START>
<IEN_ROOT_END>7204</IEN_ROOT_END>
<IEN_ROOT_START>7203</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7230</FDA_END>
<FDA_START>7217</FDA_START>
<FILE_START>7208</FILE_START>
<IEN_ROOT_END>7236</IEN_ROOT_END>
<IEN_ROOT_START>7235</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7262</FDA_END>
<FDA_START>7249</FDA_START>
<FILE_START>7240</FILE_START>
<IEN_ROOT_END>7268</IEN_ROOT_END>
<IEN_ROOT_START>7267</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7296</FDA_END>
<FDA_START>7281</FDA_START>
<FILE_START>7272</FILE_START>
<IEN_ROOT_END>7303</IEN_ROOT_END>
<IEN_ROOT_START>7301</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7330</FDA_END>
<FDA_START>7316</FDA_START>
<FILE_START>7307</FILE_START>
<IEN_ROOT_END>7337</IEN_ROOT_END>
<IEN_ROOT_START>7335</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7364</FDA_END>
<FDA_START>7350</FDA_START>
<FILE_START>7341</FILE_START>
<IEN_ROOT_END>7371</IEN_ROOT_END>
<IEN_ROOT_START>7369</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7399</FDA_END>
<FDA_START>7384</FDA_START>
<FILE_START>7375</FILE_START>
<IEN_ROOT_END>7407</IEN_ROOT_END>
<IEN_ROOT_START>7404</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7435</FDA_END>
<FDA_START>7420</FDA_START>
<FILE_START>7411</FILE_START>
<IEN_ROOT_END>7442</IEN_ROOT_END>
<IEN_ROOT_START>7440</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7470</FDA_END>
<FDA_START>7455</FDA_START>
<FILE_START>7446</FILE_START>
<IEN_ROOT_END>7477</IEN_ROOT_END>
<IEN_ROOT_START>7475</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7507</FDA_END>
<FDA_START>7490</FDA_START>
<FILE_START>7481</FILE_START>
<IEN_ROOT_END>7515</IEN_ROOT_END>
<IEN_ROOT_START>7512</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7545</FDA_END>
<FDA_START>7528</FDA_START>
<FILE_START>7519</FILE_START>
<IEN_ROOT_END>7554</IEN_ROOT_END>
<IEN_ROOT_START>7550</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7582</FDA_END>
<FDA_START>7567</FDA_START>
<FILE_START>7558</FILE_START>
<IEN_ROOT_END>7589</IEN_ROOT_END>
<IEN_ROOT_START>7587</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7616</FDA_END>
<FDA_START>7602</FDA_START>
<FILE_START>7593</FILE_START>
<IEN_ROOT_END>7622</IEN_ROOT_END>
<IEN_ROOT_START>7621</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7649</FDA_END>
<FDA_START>7635</FDA_START>
<FILE_START>7626</FILE_START>
<IEN_ROOT_END>7655</IEN_ROOT_END>
<IEN_ROOT_START>7654</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7683</FDA_END>
<FDA_START>7668</FDA_START>
<FILE_START>7659</FILE_START>
<IEN_ROOT_END>7690</IEN_ROOT_END>
<IEN_ROOT_START>7688</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7718</FDA_END>
<FDA_START>7703</FDA_START>
<FILE_START>7694</FILE_START>
<IEN_ROOT_END>7725</IEN_ROOT_END>
<IEN_ROOT_START>7723</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7752</FDA_END>
<FDA_START>7738</FDA_START>
<FILE_START>7729</FILE_START>
<IEN_ROOT_END>7758</IEN_ROOT_END>
<IEN_ROOT_START>7757</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7786</FDA_END>
<FDA_START>7771</FDA_START>
<FILE_START>7762</FILE_START>
<IEN_ROOT_END>7793</IEN_ROOT_END>
<IEN_ROOT_START>7791</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7819</FDA_END>
<FDA_START>7806</FDA_START>
<FILE_START>7797</FILE_START>
<IEN_ROOT_END>7825</IEN_ROOT_END>
<IEN_ROOT_START>7824</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7851</FDA_END>
<FDA_START>7838</FDA_START>
<FILE_START>7829</FILE_START>
<IEN_ROOT_END>7857</IEN_ROOT_END>
<IEN_ROOT_START>7856</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7883</FDA_END>
<FDA_START>7870</FDA_START>
<FILE_START>7861</FILE_START>
<IEN_ROOT_END>7889</IEN_ROOT_END>
<IEN_ROOT_START>7888</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7917</FDA_END>
<FDA_START>7902</FDA_START>
<FILE_START>7893</FILE_START>
<IEN_ROOT_END>7923</IEN_ROOT_END>
<IEN_ROOT_START>7922</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7950</FDA_END>
<FDA_START>7936</FDA_START>
<FILE_START>7927</FILE_START>
<IEN_ROOT_END>7956</IEN_ROOT_END>
<IEN_ROOT_START>7955</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>7983</FDA_END>
<FDA_START>7969</FDA_START>
<FILE_START>7960</FILE_START>
<IEN_ROOT_END>7989</IEN_ROOT_END>
<IEN_ROOT_START>7988</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8016</FDA_END>
<FDA_START>8002</FDA_START>
<FILE_START>7993</FILE_START>
<IEN_ROOT_END>8022</IEN_ROOT_END>
<IEN_ROOT_START>8021</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8050</FDA_END>
<FDA_START>8035</FDA_START>
<FILE_START>8026</FILE_START>
<IEN_ROOT_END>8056</IEN_ROOT_END>
<IEN_ROOT_START>8055</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8085</FDA_END>
<FDA_START>8069</FDA_START>
<FILE_START>8060</FILE_START>
<IEN_ROOT_END>8092</IEN_ROOT_END>
<IEN_ROOT_START>8090</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8119</FDA_END>
<FDA_START>8105</FDA_START>
<FILE_START>8096</FILE_START>
<IEN_ROOT_END>8125</IEN_ROOT_END>
<IEN_ROOT_START>8124</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8152</FDA_END>
<FDA_START>8138</FDA_START>
<FILE_START>8129</FILE_START>
<IEN_ROOT_END>8158</IEN_ROOT_END>
<IEN_ROOT_START>8157</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8185</FDA_END>
<FDA_START>8171</FDA_START>
<FILE_START>8162</FILE_START>
<IEN_ROOT_END>8191</IEN_ROOT_END>
<IEN_ROOT_START>8190</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8217</FDA_END>
<FDA_START>8204</FDA_START>
<FILE_START>8195</FILE_START>
<IEN_ROOT_END>8223</IEN_ROOT_END>
<IEN_ROOT_START>8222</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8249</FDA_END>
<FDA_START>8236</FDA_START>
<FILE_START>8227</FILE_START>
<IEN_ROOT_END>8255</IEN_ROOT_END>
<IEN_ROOT_START>8254</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8281</FDA_END>
<FDA_START>8268</FDA_START>
<FILE_START>8259</FILE_START>
<IEN_ROOT_END>8287</IEN_ROOT_END>
<IEN_ROOT_START>8286</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8315</FDA_END>
<FDA_START>8300</FDA_START>
<FILE_START>8291</FILE_START>
<IEN_ROOT_END>8322</IEN_ROOT_END>
<IEN_ROOT_START>8320</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8348</FDA_END>
<FDA_START>8335</FDA_START>
<FILE_START>8326</FILE_START>
<IEN_ROOT_END>8354</IEN_ROOT_END>
<IEN_ROOT_START>8353</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8380</FDA_END>
<FDA_START>8367</FDA_START>
<FILE_START>8358</FILE_START>
<IEN_ROOT_END>8386</IEN_ROOT_END>
<IEN_ROOT_START>8385</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8411</FDA_END>
<FDA_START>8399</FDA_START>
<FILE_START>8390</FILE_START>
<IEN_ROOT_END>8416</IEN_ROOT_END>
<IEN_ROOT_START>8416</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8444</FDA_END>
<FDA_START>8429</FDA_START>
<FILE_START>8420</FILE_START>
<IEN_ROOT_END>8450</IEN_ROOT_END>
<IEN_ROOT_START>8449</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8477</FDA_END>
<FDA_START>8463</FDA_START>
<FILE_START>8454</FILE_START>
<IEN_ROOT_END>8483</IEN_ROOT_END>
<IEN_ROOT_START>8482</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8509</FDA_END>
<FDA_START>8496</FDA_START>
<FILE_START>8487</FILE_START>
<IEN_ROOT_END>8516</IEN_ROOT_END>
<IEN_ROOT_START>8514</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8543</FDA_END>
<FDA_START>8529</FDA_START>
<FILE_START>8520</FILE_START>
<IEN_ROOT_END>8549</IEN_ROOT_END>
<IEN_ROOT_START>8548</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8576</FDA_END>
<FDA_START>8562</FDA_START>
<FILE_START>8553</FILE_START>
<IEN_ROOT_END>8582</IEN_ROOT_END>
<IEN_ROOT_START>8581</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8609</FDA_END>
<FDA_START>8595</FDA_START>
<FILE_START>8586</FILE_START>
<IEN_ROOT_END>8615</IEN_ROOT_END>
<IEN_ROOT_START>8614</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8642</FDA_END>
<FDA_START>8628</FDA_START>
<FILE_START>8619</FILE_START>
<IEN_ROOT_END>8648</IEN_ROOT_END>
<IEN_ROOT_START>8647</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8675</FDA_END>
<FDA_START>8661</FDA_START>
<FILE_START>8652</FILE_START>
<IEN_ROOT_END>8681</IEN_ROOT_END>
<IEN_ROOT_START>8680</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8709</FDA_END>
<FDA_START>8694</FDA_START>
<FILE_START>8685</FILE_START>
<IEN_ROOT_END>8716</IEN_ROOT_END>
<IEN_ROOT_START>8714</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8743</FDA_END>
<FDA_START>8729</FDA_START>
<FILE_START>8720</FILE_START>
<IEN_ROOT_END>8749</IEN_ROOT_END>
<IEN_ROOT_START>8748</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8776</FDA_END>
<FDA_START>8762</FDA_START>
<FILE_START>8753</FILE_START>
<IEN_ROOT_END>8782</IEN_ROOT_END>
<IEN_ROOT_START>8781</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8808</FDA_END>
<FDA_START>8795</FDA_START>
<FILE_START>8786</FILE_START>
<IEN_ROOT_END>8814</IEN_ROOT_END>
<IEN_ROOT_START>8813</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8840</FDA_END>
<FDA_START>8827</FDA_START>
<FILE_START>8818</FILE_START>
<IEN_ROOT_END>8846</IEN_ROOT_END>
<IEN_ROOT_START>8845</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8872</FDA_END>
<FDA_START>8859</FDA_START>
<FILE_START>8850</FILE_START>
<IEN_ROOT_END>8878</IEN_ROOT_END>
<IEN_ROOT_START>8877</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8904</FDA_END>
<FDA_START>8891</FDA_START>
<FILE_START>8882</FILE_START>
<IEN_ROOT_END>8910</IEN_ROOT_END>
<IEN_ROOT_START>8909</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8937</FDA_END>
<FDA_START>8923</FDA_START>
<FILE_START>8914</FILE_START>
<IEN_ROOT_END>8944</IEN_ROOT_END>
<IEN_ROOT_START>8942</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>8970</FDA_END>
<FDA_START>8957</FDA_START>
<FILE_START>8948</FILE_START>
<IEN_ROOT_END>8976</IEN_ROOT_END>
<IEN_ROOT_START>8975</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9002</FDA_END>
<FDA_START>8989</FDA_START>
<FILE_START>8980</FILE_START>
<IEN_ROOT_END>9008</IEN_ROOT_END>
<IEN_ROOT_START>9007</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9037</FDA_END>
<FDA_START>9021</FDA_START>
<FILE_START>9012</FILE_START>
<IEN_ROOT_END>9044</IEN_ROOT_END>
<IEN_ROOT_START>9042</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9071</FDA_END>
<FDA_START>9057</FDA_START>
<FILE_START>9048</FILE_START>
<IEN_ROOT_END>9077</IEN_ROOT_END>
<IEN_ROOT_START>9076</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9104</FDA_END>
<FDA_START>9090</FDA_START>
<FILE_START>9081</FILE_START>
<IEN_ROOT_END>9110</IEN_ROOT_END>
<IEN_ROOT_START>9109</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9137</FDA_END>
<FDA_START>9123</FDA_START>
<FILE_START>9114</FILE_START>
<IEN_ROOT_END>9143</IEN_ROOT_END>
<IEN_ROOT_START>9142</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9170</FDA_END>
<FDA_START>9156</FDA_START>
<FILE_START>9147</FILE_START>
<IEN_ROOT_END>9176</IEN_ROOT_END>
<IEN_ROOT_START>9175</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9203</FDA_END>
<FDA_START>9189</FDA_START>
<FILE_START>9180</FILE_START>
<IEN_ROOT_END>9209</IEN_ROOT_END>
<IEN_ROOT_START>9208</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9237</FDA_END>
<FDA_START>9222</FDA_START>
<FILE_START>9213</FILE_START>
<IEN_ROOT_END>9245</IEN_ROOT_END>
<IEN_ROOT_START>9242</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9274</FDA_END>
<FDA_START>9258</FDA_START>
<FILE_START>9249</FILE_START>
<IEN_ROOT_END>9283</IEN_ROOT_END>
<IEN_ROOT_START>9279</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9310</FDA_END>
<FDA_START>9296</FDA_START>
<FILE_START>9287</FILE_START>
<IEN_ROOT_END>9317</IEN_ROOT_END>
<IEN_ROOT_START>9315</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9344</FDA_END>
<FDA_START>9330</FDA_START>
<FILE_START>9321</FILE_START>
<IEN_ROOT_END>9351</IEN_ROOT_END>
<IEN_ROOT_START>9349</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9378</FDA_END>
<FDA_START>9364</FDA_START>
<FILE_START>9355</FILE_START>
<IEN_ROOT_END>9385</IEN_ROOT_END>
<IEN_ROOT_START>9383</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9412</FDA_END>
<FDA_START>9398</FDA_START>
<FILE_START>9389</FILE_START>
<IEN_ROOT_END>9419</IEN_ROOT_END>
<IEN_ROOT_START>9417</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9446</FDA_END>
<FDA_START>9432</FDA_START>
<FILE_START>9423</FILE_START>
<IEN_ROOT_END>9453</IEN_ROOT_END>
<IEN_ROOT_START>9451</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9480</FDA_END>
<FDA_START>9466</FDA_START>
<FILE_START>9457</FILE_START>
<IEN_ROOT_END>9487</IEN_ROOT_END>
<IEN_ROOT_START>9485</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9515</FDA_END>
<FDA_START>9500</FDA_START>
<FILE_START>9491</FILE_START>
<IEN_ROOT_END>9522</IEN_ROOT_END>
<IEN_ROOT_START>9520</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9549</FDA_END>
<FDA_START>9535</FDA_START>
<FILE_START>9526</FILE_START>
<IEN_ROOT_END>9556</IEN_ROOT_END>
<IEN_ROOT_START>9554</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9583</FDA_END>
<FDA_START>9569</FDA_START>
<FILE_START>9560</FILE_START>
<IEN_ROOT_END>9590</IEN_ROOT_END>
<IEN_ROOT_START>9588</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9617</FDA_END>
<FDA_START>9603</FDA_START>
<FILE_START>9594</FILE_START>
<IEN_ROOT_END>9624</IEN_ROOT_END>
<IEN_ROOT_START>9622</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9653</FDA_END>
<FDA_START>9637</FDA_START>
<FILE_START>9628</FILE_START>
<IEN_ROOT_END>9660</IEN_ROOT_END>
<IEN_ROOT_START>9658</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9686</FDA_END>
<FDA_START>9673</FDA_START>
<FILE_START>9664</FILE_START>
<IEN_ROOT_END>9693</IEN_ROOT_END>
<IEN_ROOT_START>9691</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9719</FDA_END>
<FDA_START>9706</FDA_START>
<FILE_START>9697</FILE_START>
<IEN_ROOT_END>9726</IEN_ROOT_END>
<IEN_ROOT_START>9724</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9752</FDA_END>
<FDA_START>9739</FDA_START>
<FILE_START>9730</FILE_START>
<IEN_ROOT_END>9758</IEN_ROOT_END>
<IEN_ROOT_START>9757</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9785</FDA_END>
<FDA_START>9771</FDA_START>
<FILE_START>9762</FILE_START>
<IEN_ROOT_END>9792</IEN_ROOT_END>
<IEN_ROOT_START>9790</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9819</FDA_END>
<FDA_START>9805</FDA_START>
<FILE_START>9796</FILE_START>
<IEN_ROOT_END>9826</IEN_ROOT_END>
<IEN_ROOT_START>9824</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9853</FDA_END>
<FDA_START>9839</FDA_START>
<FILE_START>9830</FILE_START>
<IEN_ROOT_END>9860</IEN_ROOT_END>
<IEN_ROOT_START>9858</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9889</FDA_END>
<FDA_START>9873</FDA_START>
<FILE_START>9864</FILE_START>
<IEN_ROOT_END>9898</IEN_ROOT_END>
<IEN_ROOT_START>9894</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9925</FDA_END>
<FDA_START>9911</FDA_START>
<FILE_START>9902</FILE_START>
<IEN_ROOT_END>9932</IEN_ROOT_END>
<IEN_ROOT_START>9930</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9959</FDA_END>
<FDA_START>9945</FDA_START>
<FILE_START>9936</FILE_START>
<IEN_ROOT_END>9966</IEN_ROOT_END>
<IEN_ROOT_START>9964</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>9993</FDA_END>
<FDA_START>9979</FDA_START>
<FILE_START>9970</FILE_START>
<IEN_ROOT_END>10000</IEN_ROOT_END>
<IEN_ROOT_START>9998</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10027</FDA_END>
<FDA_START>10013</FDA_START>
<FILE_START>10004</FILE_START>
<IEN_ROOT_END>10034</IEN_ROOT_END>
<IEN_ROOT_START>10032</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10061</FDA_END>
<FDA_START>10047</FDA_START>
<FILE_START>10038</FILE_START>
<IEN_ROOT_END>10068</IEN_ROOT_END>
<IEN_ROOT_START>10066</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10095</FDA_END>
<FDA_START>10081</FDA_START>
<FILE_START>10072</FILE_START>
<IEN_ROOT_END>10102</IEN_ROOT_END>
<IEN_ROOT_START>10100</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10129</FDA_END>
<FDA_START>10115</FDA_START>
<FILE_START>10106</FILE_START>
<IEN_ROOT_END>10136</IEN_ROOT_END>
<IEN_ROOT_START>10134</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10163</FDA_END>
<FDA_START>10149</FDA_START>
<FILE_START>10140</FILE_START>
<IEN_ROOT_END>10170</IEN_ROOT_END>
<IEN_ROOT_START>10168</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10198</FDA_END>
<FDA_START>10183</FDA_START>
<FILE_START>10174</FILE_START>
<IEN_ROOT_END>10205</IEN_ROOT_END>
<IEN_ROOT_START>10203</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10233</FDA_END>
<FDA_START>10218</FDA_START>
<FILE_START>10209</FILE_START>
<IEN_ROOT_END>10241</IEN_ROOT_END>
<IEN_ROOT_START>10238</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10267</FDA_END>
<FDA_START>10254</FDA_START>
<FILE_START>10245</FILE_START>
<IEN_ROOT_END>10274</IEN_ROOT_END>
<IEN_ROOT_START>10272</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10300</FDA_END>
<FDA_START>10287</FDA_START>
<FILE_START>10278</FILE_START>
<IEN_ROOT_END>10307</IEN_ROOT_END>
<IEN_ROOT_START>10305</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10333</FDA_END>
<FDA_START>10320</FDA_START>
<FILE_START>10311</FILE_START>
<IEN_ROOT_END>10340</IEN_ROOT_END>
<IEN_ROOT_START>10338</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10367</FDA_END>
<FDA_START>10353</FDA_START>
<FILE_START>10344</FILE_START>
<IEN_ROOT_END>10374</IEN_ROOT_END>
<IEN_ROOT_START>10372</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10400</FDA_END>
<FDA_START>10387</FDA_START>
<FILE_START>10378</FILE_START>
<IEN_ROOT_END>10407</IEN_ROOT_END>
<IEN_ROOT_START>10405</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10433</FDA_END>
<FDA_START>10420</FDA_START>
<FILE_START>10411</FILE_START>
<IEN_ROOT_END>10439</IEN_ROOT_END>
<IEN_ROOT_START>10438</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10465</FDA_END>
<FDA_START>10452</FDA_START>
<FILE_START>10443</FILE_START>
<IEN_ROOT_END>10472</IEN_ROOT_END>
<IEN_ROOT_START>10470</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10498</FDA_END>
<FDA_START>10485</FDA_START>
<FILE_START>10476</FILE_START>
<IEN_ROOT_END>10504</IEN_ROOT_END>
<IEN_ROOT_START>10503</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10530</FDA_END>
<FDA_START>10517</FDA_START>
<FILE_START>10508</FILE_START>
<IEN_ROOT_END>10536</IEN_ROOT_END>
<IEN_ROOT_START>10535</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10562</FDA_END>
<FDA_START>10549</FDA_START>
<FILE_START>10540</FILE_START>
<IEN_ROOT_END>10568</IEN_ROOT_END>
<IEN_ROOT_START>10567</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10594</FDA_END>
<FDA_START>10581</FDA_START>
<FILE_START>10572</FILE_START>
<IEN_ROOT_END>10600</IEN_ROOT_END>
<IEN_ROOT_START>10599</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10626</FDA_END>
<FDA_START>10613</FDA_START>
<FILE_START>10604</FILE_START>
<IEN_ROOT_END>10632</IEN_ROOT_END>
<IEN_ROOT_START>10631</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10658</FDA_END>
<FDA_START>10645</FDA_START>
<FILE_START>10636</FILE_START>
<IEN_ROOT_END>10664</IEN_ROOT_END>
<IEN_ROOT_START>10663</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10691</FDA_END>
<FDA_START>10677</FDA_START>
<FILE_START>10668</FILE_START>
<IEN_ROOT_END>10697</IEN_ROOT_END>
<IEN_ROOT_START>10696</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10723</FDA_END>
<FDA_START>10710</FDA_START>
<FILE_START>10701</FILE_START>
<IEN_ROOT_END>10729</IEN_ROOT_END>
<IEN_ROOT_START>10728</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10755</FDA_END>
<FDA_START>10742</FDA_START>
<FILE_START>10733</FILE_START>
<IEN_ROOT_END>10761</IEN_ROOT_END>
<IEN_ROOT_START>10760</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10787</FDA_END>
<FDA_START>10774</FDA_START>
<FILE_START>10765</FILE_START>
<IEN_ROOT_END>10793</IEN_ROOT_END>
<IEN_ROOT_START>10792</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10820</FDA_END>
<FDA_START>10806</FDA_START>
<FILE_START>10797</FILE_START>
<IEN_ROOT_END>10826</IEN_ROOT_END>
<IEN_ROOT_START>10825</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10852</FDA_END>
<FDA_START>10839</FDA_START>
<FILE_START>10830</FILE_START>
<IEN_ROOT_END>10858</IEN_ROOT_END>
<IEN_ROOT_START>10857</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10884</FDA_END>
<FDA_START>10871</FDA_START>
<FILE_START>10862</FILE_START>
<IEN_ROOT_END>10890</IEN_ROOT_END>
<IEN_ROOT_START>10889</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10916</FDA_END>
<FDA_START>10903</FDA_START>
<FILE_START>10894</FILE_START>
<IEN_ROOT_END>10922</IEN_ROOT_END>
<IEN_ROOT_START>10921</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10948</FDA_END>
<FDA_START>10935</FDA_START>
<FILE_START>10926</FILE_START>
<IEN_ROOT_END>10954</IEN_ROOT_END>
<IEN_ROOT_START>10953</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>10980</FDA_END>
<FDA_START>10967</FDA_START>
<FILE_START>10958</FILE_START>
<IEN_ROOT_END>10986</IEN_ROOT_END>
<IEN_ROOT_START>10985</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11012</FDA_END>
<FDA_START>10999</FDA_START>
<FILE_START>10990</FILE_START>
<IEN_ROOT_END>11018</IEN_ROOT_END>
<IEN_ROOT_START>11017</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11044</FDA_END>
<FDA_START>11031</FDA_START>
<FILE_START>11022</FILE_START>
<IEN_ROOT_END>11050</IEN_ROOT_END>
<IEN_ROOT_START>11049</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11076</FDA_END>
<FDA_START>11063</FDA_START>
<FILE_START>11054</FILE_START>
<IEN_ROOT_END>11082</IEN_ROOT_END>
<IEN_ROOT_START>11081</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11108</FDA_END>
<FDA_START>11095</FDA_START>
<FILE_START>11086</FILE_START>
<IEN_ROOT_END>11114</IEN_ROOT_END>
<IEN_ROOT_START>11113</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11143</FDA_END>
<FDA_START>11127</FDA_START>
<FILE_START>11118</FILE_START>
<IEN_ROOT_END>11150</IEN_ROOT_END>
<IEN_ROOT_START>11148</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11180</FDA_END>
<FDA_START>11163</FDA_START>
<FILE_START>11154</FILE_START>
<IEN_ROOT_END>11188</IEN_ROOT_END>
<IEN_ROOT_START>11185</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11217</FDA_END>
<FDA_START>11201</FDA_START>
<FILE_START>11192</FILE_START>
<IEN_ROOT_END>11225</IEN_ROOT_END>
<IEN_ROOT_START>11222</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11253</FDA_END>
<FDA_START>11238</FDA_START>
<FILE_START>11229</FILE_START>
<IEN_ROOT_END>11260</IEN_ROOT_END>
<IEN_ROOT_START>11258</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11288</FDA_END>
<FDA_START>11273</FDA_START>
<FILE_START>11264</FILE_START>
<IEN_ROOT_END>11295</IEN_ROOT_END>
<IEN_ROOT_START>11293</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11324</FDA_END>
<FDA_START>11308</FDA_START>
<FILE_START>11299</FILE_START>
<IEN_ROOT_END>11332</IEN_ROOT_END>
<IEN_ROOT_START>11329</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11360</FDA_END>
<FDA_START>11345</FDA_START>
<FILE_START>11336</FILE_START>
<IEN_ROOT_END>11367</IEN_ROOT_END>
<IEN_ROOT_START>11365</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11395</FDA_END>
<FDA_START>11380</FDA_START>
<FILE_START>11371</FILE_START>
<IEN_ROOT_END>11402</IEN_ROOT_END>
<IEN_ROOT_START>11400</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11430</FDA_END>
<FDA_START>11415</FDA_START>
<FILE_START>11406</FILE_START>
<IEN_ROOT_END>11437</IEN_ROOT_END>
<IEN_ROOT_START>11435</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11463</FDA_END>
<FDA_START>11450</FDA_START>
<FILE_START>11441</FILE_START>
<IEN_ROOT_END>11469</IEN_ROOT_END>
<IEN_ROOT_START>11468</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11495</FDA_END>
<FDA_START>11482</FDA_START>
<FILE_START>11473</FILE_START>
<IEN_ROOT_END>11501</IEN_ROOT_END>
<IEN_ROOT_START>11500</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11528</FDA_END>
<FDA_START>11514</FDA_START>
<FILE_START>11505</FILE_START>
<IEN_ROOT_END>11534</IEN_ROOT_END>
<IEN_ROOT_START>11533</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11560</FDA_END>
<FDA_START>11547</FDA_START>
<FILE_START>11538</FILE_START>
<IEN_ROOT_END>11566</IEN_ROOT_END>
<IEN_ROOT_START>11565</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11594</FDA_END>
<FDA_START>11579</FDA_START>
<FILE_START>11570</FILE_START>
<IEN_ROOT_END>11601</IEN_ROOT_END>
<IEN_ROOT_START>11599</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11629</FDA_END>
<FDA_START>11614</FDA_START>
<FILE_START>11605</FILE_START>
<IEN_ROOT_END>11636</IEN_ROOT_END>
<IEN_ROOT_START>11634</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11664</FDA_END>
<FDA_START>11649</FDA_START>
<FILE_START>11640</FILE_START>
<IEN_ROOT_END>11671</IEN_ROOT_END>
<IEN_ROOT_START>11669</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11700</FDA_END>
<FDA_START>11684</FDA_START>
<FILE_START>11675</FILE_START>
<IEN_ROOT_END>11707</IEN_ROOT_END>
<IEN_ROOT_START>11705</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11735</FDA_END>
<FDA_START>11720</FDA_START>
<FILE_START>11711</FILE_START>
<IEN_ROOT_END>11742</IEN_ROOT_END>
<IEN_ROOT_START>11740</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11770</FDA_END>
<FDA_START>11755</FDA_START>
<FILE_START>11746</FILE_START>
<IEN_ROOT_END>11777</IEN_ROOT_END>
<IEN_ROOT_START>11775</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11805</FDA_END>
<FDA_START>11790</FDA_START>
<FILE_START>11781</FILE_START>
<IEN_ROOT_END>11812</IEN_ROOT_END>
<IEN_ROOT_START>11810</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11840</FDA_END>
<FDA_START>11825</FDA_START>
<FILE_START>11816</FILE_START>
<IEN_ROOT_END>11847</IEN_ROOT_END>
<IEN_ROOT_START>11845</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11875</FDA_END>
<FDA_START>11860</FDA_START>
<FILE_START>11851</FILE_START>
<IEN_ROOT_END>11881</IEN_ROOT_END>
<IEN_ROOT_START>11880</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11908</FDA_END>
<FDA_START>11894</FDA_START>
<FILE_START>11885</FILE_START>
<IEN_ROOT_END>11915</IEN_ROOT_END>
<IEN_ROOT_START>11913</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11942</FDA_END>
<FDA_START>11928</FDA_START>
<FILE_START>11919</FILE_START>
<IEN_ROOT_END>11949</IEN_ROOT_END>
<IEN_ROOT_START>11947</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>11978</FDA_END>
<FDA_START>11962</FDA_START>
<FILE_START>11953</FILE_START>
<IEN_ROOT_END>11986</IEN_ROOT_END>
<IEN_ROOT_START>11983</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12015</FDA_END>
<FDA_START>11999</FDA_START>
<FILE_START>11990</FILE_START>
<IEN_ROOT_END>12022</IEN_ROOT_END>
<IEN_ROOT_START>12020</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12049</FDA_END>
<FDA_START>12035</FDA_START>
<FILE_START>12026</FILE_START>
<IEN_ROOT_END>12056</IEN_ROOT_END>
<IEN_ROOT_START>12054</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12083</FDA_END>
<FDA_START>12069</FDA_START>
<FILE_START>12060</FILE_START>
<IEN_ROOT_END>12091</IEN_ROOT_END>
<IEN_ROOT_START>12088</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12118</FDA_END>
<FDA_START>12104</FDA_START>
<FILE_START>12095</FILE_START>
<IEN_ROOT_END>12124</IEN_ROOT_END>
<IEN_ROOT_START>12123</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12150</FDA_END>
<FDA_START>12137</FDA_START>
<FILE_START>12128</FILE_START>
<IEN_ROOT_END>12156</IEN_ROOT_END>
<IEN_ROOT_START>12155</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12182</FDA_END>
<FDA_START>12169</FDA_START>
<FILE_START>12160</FILE_START>
<IEN_ROOT_END>12188</IEN_ROOT_END>
<IEN_ROOT_START>12187</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12214</FDA_END>
<FDA_START>12201</FDA_START>
<FILE_START>12192</FILE_START>
<IEN_ROOT_END>12220</IEN_ROOT_END>
<IEN_ROOT_START>12219</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12246</FDA_END>
<FDA_START>12233</FDA_START>
<FILE_START>12224</FILE_START>
<IEN_ROOT_END>12252</IEN_ROOT_END>
<IEN_ROOT_START>12251</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12278</FDA_END>
<FDA_START>12265</FDA_START>
<FILE_START>12256</FILE_START>
<IEN_ROOT_END>12284</IEN_ROOT_END>
<IEN_ROOT_START>12283</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12310</FDA_END>
<FDA_START>12297</FDA_START>
<FILE_START>12288</FILE_START>
<IEN_ROOT_END>12316</IEN_ROOT_END>
<IEN_ROOT_START>12315</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12343</FDA_END>
<FDA_START>12329</FDA_START>
<FILE_START>12320</FILE_START>
<IEN_ROOT_END>12349</IEN_ROOT_END>
<IEN_ROOT_START>12348</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12376</FDA_END>
<FDA_START>12362</FDA_START>
<FILE_START>12353</FILE_START>
<IEN_ROOT_END>12383</IEN_ROOT_END>
<IEN_ROOT_START>12381</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12410</FDA_END>
<FDA_START>12396</FDA_START>
<FILE_START>12387</FILE_START>
<IEN_ROOT_END>12417</IEN_ROOT_END>
<IEN_ROOT_START>12415</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12445</FDA_END>
<FDA_START>12430</FDA_START>
<FILE_START>12421</FILE_START>
<IEN_ROOT_END>12453</IEN_ROOT_END>
<IEN_ROOT_START>12450</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12481</FDA_END>
<FDA_START>12466</FDA_START>
<FILE_START>12457</FILE_START>
<IEN_ROOT_END>12488</IEN_ROOT_END>
<IEN_ROOT_START>12486</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12515</FDA_END>
<FDA_START>12501</FDA_START>
<FILE_START>12492</FILE_START>
<IEN_ROOT_END>12521</IEN_ROOT_END>
<IEN_ROOT_START>12520</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12547</FDA_END>
<FDA_START>12534</FDA_START>
<FILE_START>12525</FILE_START>
<IEN_ROOT_END>12553</IEN_ROOT_END>
<IEN_ROOT_START>12552</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12579</FDA_END>
<FDA_START>12566</FDA_START>
<FILE_START>12557</FILE_START>
<IEN_ROOT_END>12585</IEN_ROOT_END>
<IEN_ROOT_START>12584</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12611</FDA_END>
<FDA_START>12598</FDA_START>
<FILE_START>12589</FILE_START>
<IEN_ROOT_END>12617</IEN_ROOT_END>
<IEN_ROOT_START>12616</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12644</FDA_END>
<FDA_START>12630</FDA_START>
<FILE_START>12621</FILE_START>
<IEN_ROOT_END>12650</IEN_ROOT_END>
<IEN_ROOT_START>12649</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12676</FDA_END>
<FDA_START>12663</FDA_START>
<FILE_START>12654</FILE_START>
<IEN_ROOT_END>12682</IEN_ROOT_END>
<IEN_ROOT_START>12681</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12708</FDA_END>
<FDA_START>12695</FDA_START>
<FILE_START>12686</FILE_START>
<IEN_ROOT_END>12714</IEN_ROOT_END>
<IEN_ROOT_START>12713</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12740</FDA_END>
<FDA_START>12727</FDA_START>
<FILE_START>12718</FILE_START>
<IEN_ROOT_END>12746</IEN_ROOT_END>
<IEN_ROOT_START>12745</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12773</FDA_END>
<FDA_START>12759</FDA_START>
<FILE_START>12750</FILE_START>
<IEN_ROOT_END>12779</IEN_ROOT_END>
<IEN_ROOT_START>12778</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12805</FDA_END>
<FDA_START>12792</FDA_START>
<FILE_START>12783</FILE_START>
<IEN_ROOT_END>12811</IEN_ROOT_END>
<IEN_ROOT_START>12810</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12837</FDA_END>
<FDA_START>12824</FDA_START>
<FILE_START>12815</FILE_START>
<IEN_ROOT_END>12843</IEN_ROOT_END>
<IEN_ROOT_START>12842</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12869</FDA_END>
<FDA_START>12856</FDA_START>
<FILE_START>12847</FILE_START>
<IEN_ROOT_END>12875</IEN_ROOT_END>
<IEN_ROOT_START>12874</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12902</FDA_END>
<FDA_START>12888</FDA_START>
<FILE_START>12879</FILE_START>
<IEN_ROOT_END>12908</IEN_ROOT_END>
<IEN_ROOT_START>12907</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12935</FDA_END>
<FDA_START>12921</FDA_START>
<FILE_START>12912</FILE_START>
<IEN_ROOT_END>12941</IEN_ROOT_END>
<IEN_ROOT_START>12940</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>12968</FDA_END>
<FDA_START>12954</FDA_START>
<FILE_START>12945</FILE_START>
<IEN_ROOT_END>12974</IEN_ROOT_END>
<IEN_ROOT_START>12973</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13000</FDA_END>
<FDA_START>12987</FDA_START>
<FILE_START>12978</FILE_START>
<IEN_ROOT_END>13006</IEN_ROOT_END>
<IEN_ROOT_START>13005</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13032</FDA_END>
<FDA_START>13019</FDA_START>
<FILE_START>13010</FILE_START>
<IEN_ROOT_END>13038</IEN_ROOT_END>
<IEN_ROOT_START>13037</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13065</FDA_END>
<FDA_START>13051</FDA_START>
<FILE_START>13042</FILE_START>
<IEN_ROOT_END>13072</IEN_ROOT_END>
<IEN_ROOT_START>13070</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13098</FDA_END>
<FDA_START>13085</FDA_START>
<FILE_START>13076</FILE_START>
<IEN_ROOT_END>13104</IEN_ROOT_END>
<IEN_ROOT_START>13103</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13130</FDA_END>
<FDA_START>13117</FDA_START>
<FILE_START>13108</FILE_START>
<IEN_ROOT_END>13136</IEN_ROOT_END>
<IEN_ROOT_START>13135</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13162</FDA_END>
<FDA_START>13149</FDA_START>
<FILE_START>13140</FILE_START>
<IEN_ROOT_END>13168</IEN_ROOT_END>
<IEN_ROOT_START>13167</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13196</FDA_END>
<FDA_START>13181</FDA_START>
<FILE_START>13172</FILE_START>
<IEN_ROOT_END>13203</IEN_ROOT_END>
<IEN_ROOT_START>13201</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13232</FDA_END>
<FDA_START>13216</FDA_START>
<FILE_START>13207</FILE_START>
<IEN_ROOT_END>13239</IEN_ROOT_END>
<IEN_ROOT_START>13237</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13266</FDA_END>
<FDA_START>13252</FDA_START>
<FILE_START>13243</FILE_START>
<IEN_ROOT_END>13272</IEN_ROOT_END>
<IEN_ROOT_START>13271</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13298</FDA_END>
<FDA_START>13285</FDA_START>
<FILE_START>13276</FILE_START>
<IEN_ROOT_END>13304</IEN_ROOT_END>
<IEN_ROOT_START>13303</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13330</FDA_END>
<FDA_START>13317</FDA_START>
<FILE_START>13308</FILE_START>
<IEN_ROOT_END>13336</IEN_ROOT_END>
<IEN_ROOT_START>13335</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13362</FDA_END>
<FDA_START>13349</FDA_START>
<FILE_START>13340</FILE_START>
<IEN_ROOT_END>13368</IEN_ROOT_END>
<IEN_ROOT_START>13367</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13394</FDA_END>
<FDA_START>13381</FDA_START>
<FILE_START>13372</FILE_START>
<IEN_ROOT_END>13400</IEN_ROOT_END>
<IEN_ROOT_START>13399</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13426</FDA_END>
<FDA_START>13413</FDA_START>
<FILE_START>13404</FILE_START>
<IEN_ROOT_END>13432</IEN_ROOT_END>
<IEN_ROOT_START>13431</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13458</FDA_END>
<FDA_START>13445</FDA_START>
<FILE_START>13436</FILE_START>
<IEN_ROOT_END>13464</IEN_ROOT_END>
<IEN_ROOT_START>13463</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13491</FDA_END>
<FDA_START>13477</FDA_START>
<FILE_START>13468</FILE_START>
<IEN_ROOT_END>13497</IEN_ROOT_END>
<IEN_ROOT_START>13496</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13524</FDA_END>
<FDA_START>13510</FDA_START>
<FILE_START>13501</FILE_START>
<IEN_ROOT_END>13530</IEN_ROOT_END>
<IEN_ROOT_START>13529</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13556</FDA_END>
<FDA_START>13543</FDA_START>
<FILE_START>13534</FILE_START>
<IEN_ROOT_END>13562</IEN_ROOT_END>
<IEN_ROOT_START>13561</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13588</FDA_END>
<FDA_START>13575</FDA_START>
<FILE_START>13566</FILE_START>
<IEN_ROOT_END>13594</IEN_ROOT_END>
<IEN_ROOT_START>13593</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13622</FDA_END>
<FDA_START>13607</FDA_START>
<FILE_START>13598</FILE_START>
<IEN_ROOT_END>13630</IEN_ROOT_END>
<IEN_ROOT_START>13627</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13659</FDA_END>
<FDA_START>13643</FDA_START>
<FILE_START>13634</FILE_START>
<IEN_ROOT_END>13668</IEN_ROOT_END>
<IEN_ROOT_START>13664</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13694</FDA_END>
<FDA_START>13681</FDA_START>
<FILE_START>13672</FILE_START>
<IEN_ROOT_END>13700</IEN_ROOT_END>
<IEN_ROOT_START>13699</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13726</FDA_END>
<FDA_START>13713</FDA_START>
<FILE_START>13704</FILE_START>
<IEN_ROOT_END>13732</IEN_ROOT_END>
<IEN_ROOT_START>13731</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13758</FDA_END>
<FDA_START>13745</FDA_START>
<FILE_START>13736</FILE_START>
<IEN_ROOT_END>13765</IEN_ROOT_END>
<IEN_ROOT_START>13763</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13792</FDA_END>
<FDA_START>13778</FDA_START>
<FILE_START>13769</FILE_START>
<IEN_ROOT_END>13799</IEN_ROOT_END>
<IEN_ROOT_START>13797</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13827</FDA_END>
<FDA_START>13812</FDA_START>
<FILE_START>13803</FILE_START>
<IEN_ROOT_END>13835</IEN_ROOT_END>
<IEN_ROOT_START>13832</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13862</FDA_END>
<FDA_START>13848</FDA_START>
<FILE_START>13839</FILE_START>
<IEN_ROOT_END>13869</IEN_ROOT_END>
<IEN_ROOT_START>13867</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13895</FDA_END>
<FDA_START>13882</FDA_START>
<FILE_START>13873</FILE_START>
<IEN_ROOT_END>13902</IEN_ROOT_END>
<IEN_ROOT_START>13900</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13929</FDA_END>
<FDA_START>13915</FDA_START>
<FILE_START>13906</FILE_START>
<IEN_ROOT_END>13937</IEN_ROOT_END>
<IEN_ROOT_START>13934</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13964</FDA_END>
<FDA_START>13950</FDA_START>
<FILE_START>13941</FILE_START>
<IEN_ROOT_END>13971</IEN_ROOT_END>
<IEN_ROOT_START>13969</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>13998</FDA_END>
<FDA_START>13984</FDA_START>
<FILE_START>13975</FILE_START>
<IEN_ROOT_END>14005</IEN_ROOT_END>
<IEN_ROOT_START>14003</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14032</FDA_END>
<FDA_START>14018</FDA_START>
<FILE_START>14009</FILE_START>
<IEN_ROOT_END>14039</IEN_ROOT_END>
<IEN_ROOT_START>14037</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14066</FDA_END>
<FDA_START>14052</FDA_START>
<FILE_START>14043</FILE_START>
<IEN_ROOT_END>14073</IEN_ROOT_END>
<IEN_ROOT_START>14071</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14100</FDA_END>
<FDA_START>14086</FDA_START>
<FILE_START>14077</FILE_START>
<IEN_ROOT_END>14107</IEN_ROOT_END>
<IEN_ROOT_START>14105</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14134</FDA_END>
<FDA_START>14120</FDA_START>
<FILE_START>14111</FILE_START>
<IEN_ROOT_END>14141</IEN_ROOT_END>
<IEN_ROOT_START>14139</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14168</FDA_END>
<FDA_START>14154</FDA_START>
<FILE_START>14145</FILE_START>
<IEN_ROOT_END>14175</IEN_ROOT_END>
<IEN_ROOT_START>14173</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14202</FDA_END>
<FDA_START>14188</FDA_START>
<FILE_START>14179</FILE_START>
<IEN_ROOT_END>14209</IEN_ROOT_END>
<IEN_ROOT_START>14207</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14236</FDA_END>
<FDA_START>14222</FDA_START>
<FILE_START>14213</FILE_START>
<IEN_ROOT_END>14243</IEN_ROOT_END>
<IEN_ROOT_START>14241</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14271</FDA_END>
<FDA_START>14256</FDA_START>
<FILE_START>14247</FILE_START>
<IEN_ROOT_END>14279</IEN_ROOT_END>
<IEN_ROOT_START>14276</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14307</FDA_END>
<FDA_START>14292</FDA_START>
<FILE_START>14283</FILE_START>
<IEN_ROOT_END>14315</IEN_ROOT_END>
<IEN_ROOT_START>14312</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14342</FDA_END>
<FDA_START>14328</FDA_START>
<FILE_START>14319</FILE_START>
<IEN_ROOT_END>14349</IEN_ROOT_END>
<IEN_ROOT_START>14347</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14376</FDA_END>
<FDA_START>14362</FDA_START>
<FILE_START>14353</FILE_START>
<IEN_ROOT_END>14383</IEN_ROOT_END>
<IEN_ROOT_START>14381</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14410</FDA_END>
<FDA_START>14396</FDA_START>
<FILE_START>14387</FILE_START>
<IEN_ROOT_END>14417</IEN_ROOT_END>
<IEN_ROOT_START>14415</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14444</FDA_END>
<FDA_START>14430</FDA_START>
<FILE_START>14421</FILE_START>
<IEN_ROOT_END>14451</IEN_ROOT_END>
<IEN_ROOT_START>14449</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14478</FDA_END>
<FDA_START>14464</FDA_START>
<FILE_START>14455</FILE_START>
<IEN_ROOT_END>14485</IEN_ROOT_END>
<IEN_ROOT_START>14483</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14512</FDA_END>
<FDA_START>14498</FDA_START>
<FILE_START>14489</FILE_START>
<IEN_ROOT_END>14519</IEN_ROOT_END>
<IEN_ROOT_START>14517</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14546</FDA_END>
<FDA_START>14532</FDA_START>
<FILE_START>14523</FILE_START>
<IEN_ROOT_END>14553</IEN_ROOT_END>
<IEN_ROOT_START>14551</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14580</FDA_END>
<FDA_START>14566</FDA_START>
<FILE_START>14557</FILE_START>
<IEN_ROOT_END>14587</IEN_ROOT_END>
<IEN_ROOT_START>14585</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14614</FDA_END>
<FDA_START>14600</FDA_START>
<FILE_START>14591</FILE_START>
<IEN_ROOT_END>14621</IEN_ROOT_END>
<IEN_ROOT_START>14619</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14648</FDA_END>
<FDA_START>14634</FDA_START>
<FILE_START>14625</FILE_START>
<IEN_ROOT_END>14655</IEN_ROOT_END>
<IEN_ROOT_START>14653</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14682</FDA_END>
<FDA_START>14668</FDA_START>
<FILE_START>14659</FILE_START>
<IEN_ROOT_END>14689</IEN_ROOT_END>
<IEN_ROOT_START>14687</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14716</FDA_END>
<FDA_START>14702</FDA_START>
<FILE_START>14693</FILE_START>
<IEN_ROOT_END>14723</IEN_ROOT_END>
<IEN_ROOT_START>14721</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14750</FDA_END>
<FDA_START>14736</FDA_START>
<FILE_START>14727</FILE_START>
<IEN_ROOT_END>14757</IEN_ROOT_END>
<IEN_ROOT_START>14755</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14784</FDA_END>
<FDA_START>14770</FDA_START>
<FILE_START>14761</FILE_START>
<IEN_ROOT_END>14791</IEN_ROOT_END>
<IEN_ROOT_START>14789</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14819</FDA_END>
<FDA_START>14804</FDA_START>
<FILE_START>14795</FILE_START>
<IEN_ROOT_END>14826</IEN_ROOT_END>
<IEN_ROOT_START>14824</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14854</FDA_END>
<FDA_START>14839</FDA_START>
<FILE_START>14830</FILE_START>
<IEN_ROOT_END>14862</IEN_ROOT_END>
<IEN_ROOT_START>14859</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14889</FDA_END>
<FDA_START>14875</FDA_START>
<FILE_START>14866</FILE_START>
<IEN_ROOT_END>14896</IEN_ROOT_END>
<IEN_ROOT_START>14894</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14923</FDA_END>
<FDA_START>14909</FDA_START>
<FILE_START>14900</FILE_START>
<IEN_ROOT_END>14930</IEN_ROOT_END>
<IEN_ROOT_START>14928</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14958</FDA_END>
<FDA_START>14943</FDA_START>
<FILE_START>14934</FILE_START>
<IEN_ROOT_END>14965</IEN_ROOT_END>
<IEN_ROOT_START>14963</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>14992</FDA_END>
<FDA_START>14978</FDA_START>
<FILE_START>14969</FILE_START>
<IEN_ROOT_END>14999</IEN_ROOT_END>
<IEN_ROOT_START>14997</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15026</FDA_END>
<FDA_START>15012</FDA_START>
<FILE_START>15003</FILE_START>
<IEN_ROOT_END>15033</IEN_ROOT_END>
<IEN_ROOT_START>15031</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15060</FDA_END>
<FDA_START>15046</FDA_START>
<FILE_START>15037</FILE_START>
<IEN_ROOT_END>15067</IEN_ROOT_END>
<IEN_ROOT_START>15065</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15094</FDA_END>
<FDA_START>15080</FDA_START>
<FILE_START>15071</FILE_START>
<IEN_ROOT_END>15101</IEN_ROOT_END>
<IEN_ROOT_START>15099</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15128</FDA_END>
<FDA_START>15114</FDA_START>
<FILE_START>15105</FILE_START>
<IEN_ROOT_END>15135</IEN_ROOT_END>
<IEN_ROOT_START>15133</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15162</FDA_END>
<FDA_START>15148</FDA_START>
<FILE_START>15139</FILE_START>
<IEN_ROOT_END>15169</IEN_ROOT_END>
<IEN_ROOT_START>15167</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15196</FDA_END>
<FDA_START>15182</FDA_START>
<FILE_START>15173</FILE_START>
<IEN_ROOT_END>15203</IEN_ROOT_END>
<IEN_ROOT_START>15201</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15232</FDA_END>
<FDA_START>15216</FDA_START>
<FILE_START>15207</FILE_START>
<IEN_ROOT_END>15241</IEN_ROOT_END>
<IEN_ROOT_START>15237</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15270</FDA_END>
<FDA_START>15254</FDA_START>
<FILE_START>15245</FILE_START>
<IEN_ROOT_END>15279</IEN_ROOT_END>
<IEN_ROOT_START>15275</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15306</FDA_END>
<FDA_START>15292</FDA_START>
<FILE_START>15283</FILE_START>
<IEN_ROOT_END>15313</IEN_ROOT_END>
<IEN_ROOT_START>15311</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15341</FDA_END>
<FDA_START>15326</FDA_START>
<FILE_START>15317</FILE_START>
<IEN_ROOT_END>15349</IEN_ROOT_END>
<IEN_ROOT_START>15346</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15377</FDA_END>
<FDA_START>15362</FDA_START>
<FILE_START>15353</FILE_START>
<IEN_ROOT_END>15385</IEN_ROOT_END>
<IEN_ROOT_START>15382</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15414</FDA_END>
<FDA_START>15398</FDA_START>
<FILE_START>15389</FILE_START>
<IEN_ROOT_END>15423</IEN_ROOT_END>
<IEN_ROOT_START>15419</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15449</FDA_END>
<FDA_START>15436</FDA_START>
<FILE_START>15427</FILE_START>
<IEN_ROOT_END>15455</IEN_ROOT_END>
<IEN_ROOT_START>15454</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15482</FDA_END>
<FDA_START>15468</FDA_START>
<FILE_START>15459</FILE_START>
<IEN_ROOT_END>15488</IEN_ROOT_END>
<IEN_ROOT_START>15487</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15516</FDA_END>
<FDA_START>15501</FDA_START>
<FILE_START>15492</FILE_START>
<IEN_ROOT_END>15523</IEN_ROOT_END>
<IEN_ROOT_START>15521</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15549</FDA_END>
<FDA_START>15536</FDA_START>
<FILE_START>15527</FILE_START>
<IEN_ROOT_END>15555</IEN_ROOT_END>
<IEN_ROOT_START>15554</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15581</FDA_END>
<FDA_START>15568</FDA_START>
<FILE_START>15559</FILE_START>
<IEN_ROOT_END>15587</IEN_ROOT_END>
<IEN_ROOT_START>15586</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15615</FDA_END>
<FDA_START>15600</FDA_START>
<FILE_START>15591</FILE_START>
<IEN_ROOT_END>15621</IEN_ROOT_END>
<IEN_ROOT_START>15620</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15647</FDA_END>
<FDA_START>15634</FDA_START>
<FILE_START>15625</FILE_START>
<IEN_ROOT_END>15653</IEN_ROOT_END>
<IEN_ROOT_START>15652</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15679</FDA_END>
<FDA_START>15666</FDA_START>
<FILE_START>15657</FILE_START>
<IEN_ROOT_END>15685</IEN_ROOT_END>
<IEN_ROOT_START>15684</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15711</FDA_END>
<FDA_START>15698</FDA_START>
<FILE_START>15689</FILE_START>
<IEN_ROOT_END>15717</IEN_ROOT_END>
<IEN_ROOT_START>15716</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15744</FDA_END>
<FDA_START>15730</FDA_START>
<FILE_START>15721</FILE_START>
<IEN_ROOT_END>15750</IEN_ROOT_END>
<IEN_ROOT_START>15749</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15776</FDA_END>
<FDA_START>15763</FDA_START>
<FILE_START>15754</FILE_START>
<IEN_ROOT_END>15782</IEN_ROOT_END>
<IEN_ROOT_START>15781</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15808</FDA_END>
<FDA_START>15795</FDA_START>
<FILE_START>15786</FILE_START>
<IEN_ROOT_END>15815</IEN_ROOT_END>
<IEN_ROOT_START>15813</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15842</FDA_END>
<FDA_START>15828</FDA_START>
<FILE_START>15819</FILE_START>
<IEN_ROOT_END>15848</IEN_ROOT_END>
<IEN_ROOT_START>15847</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15875</FDA_END>
<FDA_START>15861</FDA_START>
<FILE_START>15852</FILE_START>
<IEN_ROOT_END>15881</IEN_ROOT_END>
<IEN_ROOT_START>15880</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15907</FDA_END>
<FDA_START>15894</FDA_START>
<FILE_START>15885</FILE_START>
<IEN_ROOT_END>15913</IEN_ROOT_END>
<IEN_ROOT_START>15912</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15940</FDA_END>
<FDA_START>15926</FDA_START>
<FILE_START>15917</FILE_START>
<IEN_ROOT_END>15946</IEN_ROOT_END>
<IEN_ROOT_START>15945</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>15973</FDA_END>
<FDA_START>15959</FDA_START>
<FILE_START>15950</FILE_START>
<IEN_ROOT_END>15979</IEN_ROOT_END>
<IEN_ROOT_START>15978</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16005</FDA_END>
<FDA_START>15992</FDA_START>
<FILE_START>15983</FILE_START>
<IEN_ROOT_END>16011</IEN_ROOT_END>
<IEN_ROOT_START>16010</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16037</FDA_END>
<FDA_START>16024</FDA_START>
<FILE_START>16015</FILE_START>
<IEN_ROOT_END>16043</IEN_ROOT_END>
<IEN_ROOT_START>16042</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16069</FDA_END>
<FDA_START>16056</FDA_START>
<FILE_START>16047</FILE_START>
<IEN_ROOT_END>16075</IEN_ROOT_END>
<IEN_ROOT_START>16074</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16101</FDA_END>
<FDA_START>16088</FDA_START>
<FILE_START>16079</FILE_START>
<IEN_ROOT_END>16107</IEN_ROOT_END>
<IEN_ROOT_START>16106</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16133</FDA_END>
<FDA_START>16120</FDA_START>
<FILE_START>16111</FILE_START>
<IEN_ROOT_END>16139</IEN_ROOT_END>
<IEN_ROOT_START>16138</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16165</FDA_END>
<FDA_START>16152</FDA_START>
<FILE_START>16143</FILE_START>
<IEN_ROOT_END>16171</IEN_ROOT_END>
<IEN_ROOT_START>16170</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16197</FDA_END>
<FDA_START>16184</FDA_START>
<FILE_START>16175</FILE_START>
<IEN_ROOT_END>16203</IEN_ROOT_END>
<IEN_ROOT_START>16202</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16230</FDA_END>
<FDA_START>16216</FDA_START>
<FILE_START>16207</FILE_START>
<IEN_ROOT_END>16237</IEN_ROOT_END>
<IEN_ROOT_START>16235</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16265</FDA_END>
<FDA_START>16250</FDA_START>
<FILE_START>16241</FILE_START>
<IEN_ROOT_END>16273</IEN_ROOT_END>
<IEN_ROOT_START>16270</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16299</FDA_END>
<FDA_START>16286</FDA_START>
<FILE_START>16277</FILE_START>
<IEN_ROOT_END>16305</IEN_ROOT_END>
<IEN_ROOT_START>16304</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16331</FDA_END>
<FDA_START>16318</FDA_START>
<FILE_START>16309</FILE_START>
<IEN_ROOT_END>16337</IEN_ROOT_END>
<IEN_ROOT_START>16336</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16363</FDA_END>
<FDA_START>16350</FDA_START>
<FILE_START>16341</FILE_START>
<IEN_ROOT_END>16369</IEN_ROOT_END>
<IEN_ROOT_START>16368</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16395</FDA_END>
<FDA_START>16382</FDA_START>
<FILE_START>16373</FILE_START>
<IEN_ROOT_END>16401</IEN_ROOT_END>
<IEN_ROOT_START>16400</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16427</FDA_END>
<FDA_START>16414</FDA_START>
<FILE_START>16405</FILE_START>
<IEN_ROOT_END>16433</IEN_ROOT_END>
<IEN_ROOT_START>16432</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16459</FDA_END>
<FDA_START>16446</FDA_START>
<FILE_START>16437</FILE_START>
<IEN_ROOT_END>16465</IEN_ROOT_END>
<IEN_ROOT_START>16464</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16492</FDA_END>
<FDA_START>16478</FDA_START>
<FILE_START>16469</FILE_START>
<IEN_ROOT_END>16499</IEN_ROOT_END>
<IEN_ROOT_START>16497</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16526</FDA_END>
<FDA_START>16512</FDA_START>
<FILE_START>16503</FILE_START>
<IEN_ROOT_END>16533</IEN_ROOT_END>
<IEN_ROOT_START>16531</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16560</FDA_END>
<FDA_START>16546</FDA_START>
<FILE_START>16537</FILE_START>
<IEN_ROOT_END>16567</IEN_ROOT_END>
<IEN_ROOT_START>16565</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16594</FDA_END>
<FDA_START>16580</FDA_START>
<FILE_START>16571</FILE_START>
<IEN_ROOT_END>16601</IEN_ROOT_END>
<IEN_ROOT_START>16599</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16628</FDA_END>
<FDA_START>16614</FDA_START>
<FILE_START>16605</FILE_START>
<IEN_ROOT_END>16635</IEN_ROOT_END>
<IEN_ROOT_START>16633</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16662</FDA_END>
<FDA_START>16648</FDA_START>
<FILE_START>16639</FILE_START>
<IEN_ROOT_END>16669</IEN_ROOT_END>
<IEN_ROOT_START>16667</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16696</FDA_END>
<FDA_START>16682</FDA_START>
<FILE_START>16673</FILE_START>
<IEN_ROOT_END>16703</IEN_ROOT_END>
<IEN_ROOT_START>16701</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16730</FDA_END>
<FDA_START>16716</FDA_START>
<FILE_START>16707</FILE_START>
<IEN_ROOT_END>16737</IEN_ROOT_END>
<IEN_ROOT_START>16735</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16764</FDA_END>
<FDA_START>16750</FDA_START>
<FILE_START>16741</FILE_START>
<IEN_ROOT_END>16771</IEN_ROOT_END>
<IEN_ROOT_START>16769</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16797</FDA_END>
<FDA_START>16784</FDA_START>
<FILE_START>16775</FILE_START>
<IEN_ROOT_END>16803</IEN_ROOT_END>
<IEN_ROOT_START>16802</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16829</FDA_END>
<FDA_START>16816</FDA_START>
<FILE_START>16807</FILE_START>
<IEN_ROOT_END>16835</IEN_ROOT_END>
<IEN_ROOT_START>16834</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16861</FDA_END>
<FDA_START>16848</FDA_START>
<FILE_START>16839</FILE_START>
<IEN_ROOT_END>16867</IEN_ROOT_END>
<IEN_ROOT_START>16866</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16893</FDA_END>
<FDA_START>16880</FDA_START>
<FILE_START>16871</FILE_START>
<IEN_ROOT_END>16899</IEN_ROOT_END>
<IEN_ROOT_START>16898</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16925</FDA_END>
<FDA_START>16912</FDA_START>
<FILE_START>16903</FILE_START>
<IEN_ROOT_END>16931</IEN_ROOT_END>
<IEN_ROOT_START>16930</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16958</FDA_END>
<FDA_START>16944</FDA_START>
<FILE_START>16935</FILE_START>
<IEN_ROOT_END>16964</IEN_ROOT_END>
<IEN_ROOT_START>16963</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>16991</FDA_END>
<FDA_START>16977</FDA_START>
<FILE_START>16968</FILE_START>
<IEN_ROOT_END>16997</IEN_ROOT_END>
<IEN_ROOT_START>16996</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17024</FDA_END>
<FDA_START>17010</FDA_START>
<FILE_START>17001</FILE_START>
<IEN_ROOT_END>17030</IEN_ROOT_END>
<IEN_ROOT_START>17029</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17057</FDA_END>
<FDA_START>17043</FDA_START>
<FILE_START>17034</FILE_START>
<IEN_ROOT_END>17063</IEN_ROOT_END>
<IEN_ROOT_START>17062</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17089</FDA_END>
<FDA_START>17076</FDA_START>
<FILE_START>17067</FILE_START>
<IEN_ROOT_END>17095</IEN_ROOT_END>
<IEN_ROOT_START>17094</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17120</FDA_END>
<FDA_START>17108</FDA_START>
<FILE_START>17099</FILE_START>
<IEN_ROOT_END>17126</IEN_ROOT_END>
<IEN_ROOT_START>17125</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17151</FDA_END>
<FDA_START>17139</FDA_START>
<FILE_START>17130</FILE_START>
<IEN_ROOT_END>17157</IEN_ROOT_END>
<IEN_ROOT_START>17156</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17182</FDA_END>
<FDA_START>17170</FDA_START>
<FILE_START>17161</FILE_START>
<IEN_ROOT_END>17188</IEN_ROOT_END>
<IEN_ROOT_START>17187</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17213</FDA_END>
<FDA_START>17201</FDA_START>
<FILE_START>17192</FILE_START>
<IEN_ROOT_END>17219</IEN_ROOT_END>
<IEN_ROOT_START>17218</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17248</FDA_END>
<FDA_START>17232</FDA_START>
<FILE_START>17223</FILE_START>
<IEN_ROOT_END>17255</IEN_ROOT_END>
<IEN_ROOT_START>17253</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17284</FDA_END>
<FDA_START>17268</FDA_START>
<FILE_START>17259</FILE_START>
<IEN_ROOT_END>17291</IEN_ROOT_END>
<IEN_ROOT_START>17289</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17320</FDA_END>
<FDA_START>17304</FDA_START>
<FILE_START>17295</FILE_START>
<IEN_ROOT_END>17327</IEN_ROOT_END>
<IEN_ROOT_START>17325</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17356</FDA_END>
<FDA_START>17340</FDA_START>
<FILE_START>17331</FILE_START>
<IEN_ROOT_END>17363</IEN_ROOT_END>
<IEN_ROOT_START>17361</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17392</FDA_END>
<FDA_START>17376</FDA_START>
<FILE_START>17367</FILE_START>
<IEN_ROOT_END>17399</IEN_ROOT_END>
<IEN_ROOT_START>17397</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17425</FDA_END>
<FDA_START>17412</FDA_START>
<FILE_START>17403</FILE_START>
<IEN_ROOT_END>17431</IEN_ROOT_END>
<IEN_ROOT_START>17430</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17458</FDA_END>
<FDA_START>17444</FDA_START>
<FILE_START>17435</FILE_START>
<IEN_ROOT_END>17464</IEN_ROOT_END>
<IEN_ROOT_START>17463</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17491</FDA_END>
<FDA_START>17477</FDA_START>
<FILE_START>17468</FILE_START>
<IEN_ROOT_END>17497</IEN_ROOT_END>
<IEN_ROOT_START>17496</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17524</FDA_END>
<FDA_START>17510</FDA_START>
<FILE_START>17501</FILE_START>
<IEN_ROOT_END>17530</IEN_ROOT_END>
<IEN_ROOT_START>17529</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17557</FDA_END>
<FDA_START>17543</FDA_START>
<FILE_START>17534</FILE_START>
<IEN_ROOT_END>17563</IEN_ROOT_END>
<IEN_ROOT_START>17562</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17589</FDA_END>
<FDA_START>17576</FDA_START>
<FILE_START>17567</FILE_START>
<IEN_ROOT_END>17595</IEN_ROOT_END>
<IEN_ROOT_START>17594</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17621</FDA_END>
<FDA_START>17608</FDA_START>
<FILE_START>17599</FILE_START>
<IEN_ROOT_END>17627</IEN_ROOT_END>
<IEN_ROOT_START>17626</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17653</FDA_END>
<FDA_START>17640</FDA_START>
<FILE_START>17631</FILE_START>
<IEN_ROOT_END>17659</IEN_ROOT_END>
<IEN_ROOT_START>17658</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17685</FDA_END>
<FDA_START>17672</FDA_START>
<FILE_START>17663</FILE_START>
<IEN_ROOT_END>17691</IEN_ROOT_END>
<IEN_ROOT_START>17690</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17717</FDA_END>
<FDA_START>17704</FDA_START>
<FILE_START>17695</FILE_START>
<IEN_ROOT_END>17723</IEN_ROOT_END>
<IEN_ROOT_START>17722</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17749</FDA_END>
<FDA_START>17736</FDA_START>
<FILE_START>17727</FILE_START>
<IEN_ROOT_END>17755</IEN_ROOT_END>
<IEN_ROOT_START>17754</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17783</FDA_END>
<FDA_START>17768</FDA_START>
<FILE_START>17759</FILE_START>
<IEN_ROOT_END>17790</IEN_ROOT_END>
<IEN_ROOT_START>17788</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17818</FDA_END>
<FDA_START>17803</FDA_START>
<FILE_START>17794</FILE_START>
<IEN_ROOT_END>17825</IEN_ROOT_END>
<IEN_ROOT_START>17823</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17851</FDA_END>
<FDA_START>17838</FDA_START>
<FILE_START>17829</FILE_START>
<IEN_ROOT_END>17857</IEN_ROOT_END>
<IEN_ROOT_START>17856</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17883</FDA_END>
<FDA_START>17870</FDA_START>
<FILE_START>17861</FILE_START>
<IEN_ROOT_END>17889</IEN_ROOT_END>
<IEN_ROOT_START>17888</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17915</FDA_END>
<FDA_START>17902</FDA_START>
<FILE_START>17893</FILE_START>
<IEN_ROOT_END>17921</IEN_ROOT_END>
<IEN_ROOT_START>17920</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17948</FDA_END>
<FDA_START>17934</FDA_START>
<FILE_START>17925</FILE_START>
<IEN_ROOT_END>17955</IEN_ROOT_END>
<IEN_ROOT_START>17953</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>17982</FDA_END>
<FDA_START>17968</FDA_START>
<FILE_START>17959</FILE_START>
<IEN_ROOT_END>17989</IEN_ROOT_END>
<IEN_ROOT_START>17987</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18015</FDA_END>
<FDA_START>18002</FDA_START>
<FILE_START>17993</FILE_START>
<IEN_ROOT_END>18021</IEN_ROOT_END>
<IEN_ROOT_START>18020</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18047</FDA_END>
<FDA_START>18034</FDA_START>
<FILE_START>18025</FILE_START>
<IEN_ROOT_END>18053</IEN_ROOT_END>
<IEN_ROOT_START>18052</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18081</FDA_END>
<FDA_START>18066</FDA_START>
<FILE_START>18057</FILE_START>
<IEN_ROOT_END>18088</IEN_ROOT_END>
<IEN_ROOT_START>18086</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18116</FDA_END>
<FDA_START>18101</FDA_START>
<FILE_START>18092</FILE_START>
<IEN_ROOT_END>18123</IEN_ROOT_END>
<IEN_ROOT_START>18121</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18149</FDA_END>
<FDA_START>18136</FDA_START>
<FILE_START>18127</FILE_START>
<IEN_ROOT_END>18155</IEN_ROOT_END>
<IEN_ROOT_START>18154</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18181</FDA_END>
<FDA_START>18168</FDA_START>
<FILE_START>18159</FILE_START>
<IEN_ROOT_END>18188</IEN_ROOT_END>
<IEN_ROOT_START>18186</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18215</FDA_END>
<FDA_START>18201</FDA_START>
<FILE_START>18192</FILE_START>
<IEN_ROOT_END>18221</IEN_ROOT_END>
<IEN_ROOT_START>18220</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18249</FDA_END>
<FDA_START>18234</FDA_START>
<FILE_START>18225</FILE_START>
<IEN_ROOT_END>18256</IEN_ROOT_END>
<IEN_ROOT_START>18254</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18284</FDA_END>
<FDA_START>18269</FDA_START>
<FILE_START>18260</FILE_START>
<IEN_ROOT_END>18291</IEN_ROOT_END>
<IEN_ROOT_START>18289</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18318</FDA_END>
<FDA_START>18304</FDA_START>
<FILE_START>18295</FILE_START>
<IEN_ROOT_END>18324</IEN_ROOT_END>
<IEN_ROOT_START>18323</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18352</FDA_END>
<FDA_START>18337</FDA_START>
<FILE_START>18328</FILE_START>
<IEN_ROOT_END>18358</IEN_ROOT_END>
<IEN_ROOT_START>18357</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18385</FDA_END>
<FDA_START>18371</FDA_START>
<FILE_START>18362</FILE_START>
<IEN_ROOT_END>18391</IEN_ROOT_END>
<IEN_ROOT_START>18390</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18418</FDA_END>
<FDA_START>18404</FDA_START>
<FILE_START>18395</FILE_START>
<IEN_ROOT_END>18424</IEN_ROOT_END>
<IEN_ROOT_START>18423</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18451</FDA_END>
<FDA_START>18437</FDA_START>
<FILE_START>18428</FILE_START>
<IEN_ROOT_END>18457</IEN_ROOT_END>
<IEN_ROOT_START>18456</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18486</FDA_END>
<FDA_START>18470</FDA_START>
<FILE_START>18461</FILE_START>
<IEN_ROOT_END>18493</IEN_ROOT_END>
<IEN_ROOT_START>18491</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18520</FDA_END>
<FDA_START>18506</FDA_START>
<FILE_START>18497</FILE_START>
<IEN_ROOT_END>18526</IEN_ROOT_END>
<IEN_ROOT_START>18525</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18555</FDA_END>
<FDA_START>18539</FDA_START>
<FILE_START>18530</FILE_START>
<IEN_ROOT_END>18563</IEN_ROOT_END>
<IEN_ROOT_START>18560</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18592</FDA_END>
<FDA_START>18576</FDA_START>
<FILE_START>18567</FILE_START>
<IEN_ROOT_END>18600</IEN_ROOT_END>
<IEN_ROOT_START>18597</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18630</FDA_END>
<FDA_START>18613</FDA_START>
<FILE_START>18604</FILE_START>
<IEN_ROOT_END>18638</IEN_ROOT_END>
<IEN_ROOT_START>18635</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18667</FDA_END>
<FDA_START>18651</FDA_START>
<FILE_START>18642</FILE_START>
<IEN_ROOT_END>18675</IEN_ROOT_END>
<IEN_ROOT_START>18672</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18703</FDA_END>
<FDA_START>18688</FDA_START>
<FILE_START>18679</FILE_START>
<IEN_ROOT_END>18710</IEN_ROOT_END>
<IEN_ROOT_START>18708</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18738</FDA_END>
<FDA_START>18723</FDA_START>
<FILE_START>18714</FILE_START>
<IEN_ROOT_END>18745</IEN_ROOT_END>
<IEN_ROOT_START>18743</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18775</FDA_END>
<FDA_START>18758</FDA_START>
<FILE_START>18749</FILE_START>
<IEN_ROOT_END>18783</IEN_ROOT_END>
<IEN_ROOT_START>18780</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18812</FDA_END>
<FDA_START>18796</FDA_START>
<FILE_START>18787</FILE_START>
<IEN_ROOT_END>18820</IEN_ROOT_END>
<IEN_ROOT_START>18817</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18848</FDA_END>
<FDA_START>18833</FDA_START>
<FILE_START>18824</FILE_START>
<IEN_ROOT_END>18854</IEN_ROOT_END>
<IEN_ROOT_START>18853</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18882</FDA_END>
<FDA_START>18867</FDA_START>
<FILE_START>18858</FILE_START>
<IEN_ROOT_END>18888</IEN_ROOT_END>
<IEN_ROOT_START>18887</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18916</FDA_END>
<FDA_START>18901</FDA_START>
<FILE_START>18892</FILE_START>
<IEN_ROOT_END>18922</IEN_ROOT_END>
<IEN_ROOT_START>18921</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18950</FDA_END>
<FDA_START>18935</FDA_START>
<FILE_START>18926</FILE_START>
<IEN_ROOT_END>18956</IEN_ROOT_END>
<IEN_ROOT_START>18955</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>18984</FDA_END>
<FDA_START>18969</FDA_START>
<FILE_START>18960</FILE_START>
<IEN_ROOT_END>18990</IEN_ROOT_END>
<IEN_ROOT_START>18989</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19018</FDA_END>
<FDA_START>19003</FDA_START>
<FILE_START>18994</FILE_START>
<IEN_ROOT_END>19024</IEN_ROOT_END>
<IEN_ROOT_START>19023</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19050</FDA_END>
<FDA_START>19037</FDA_START>
<FILE_START>19028</FILE_START>
<IEN_ROOT_END>19056</IEN_ROOT_END>
<IEN_ROOT_START>19055</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19082</FDA_END>
<FDA_START>19069</FDA_START>
<FILE_START>19060</FILE_START>
<IEN_ROOT_END>19088</IEN_ROOT_END>
<IEN_ROOT_START>19087</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19115</FDA_END>
<FDA_START>19101</FDA_START>
<FILE_START>19092</FILE_START>
<IEN_ROOT_END>19121</IEN_ROOT_END>
<IEN_ROOT_START>19120</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19148</FDA_END>
<FDA_START>19134</FDA_START>
<FILE_START>19125</FILE_START>
<IEN_ROOT_END>19155</IEN_ROOT_END>
<IEN_ROOT_START>19153</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19182</FDA_END>
<FDA_START>19168</FDA_START>
<FILE_START>19159</FILE_START>
<IEN_ROOT_END>19188</IEN_ROOT_END>
<IEN_ROOT_START>19187</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19214</FDA_END>
<FDA_START>19201</FDA_START>
<FILE_START>19192</FILE_START>
<IEN_ROOT_END>19220</IEN_ROOT_END>
<IEN_ROOT_START>19219</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19246</FDA_END>
<FDA_START>19233</FDA_START>
<FILE_START>19224</FILE_START>
<IEN_ROOT_END>19252</IEN_ROOT_END>
<IEN_ROOT_START>19251</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19279</FDA_END>
<FDA_START>19265</FDA_START>
<FILE_START>19256</FILE_START>
<IEN_ROOT_END>19285</IEN_ROOT_END>
<IEN_ROOT_START>19284</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19311</FDA_END>
<FDA_START>19298</FDA_START>
<FILE_START>19289</FILE_START>
<IEN_ROOT_END>19317</IEN_ROOT_END>
<IEN_ROOT_START>19316</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19343</FDA_END>
<FDA_START>19330</FDA_START>
<FILE_START>19321</FILE_START>
<IEN_ROOT_END>19350</IEN_ROOT_END>
<IEN_ROOT_START>19348</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19377</FDA_END>
<FDA_START>19363</FDA_START>
<FILE_START>19354</FILE_START>
<IEN_ROOT_END>19384</IEN_ROOT_END>
<IEN_ROOT_START>19382</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19411</FDA_END>
<FDA_START>19397</FDA_START>
<FILE_START>19388</FILE_START>
<IEN_ROOT_END>19418</IEN_ROOT_END>
<IEN_ROOT_START>19416</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19445</FDA_END>
<FDA_START>19431</FDA_START>
<FILE_START>19422</FILE_START>
<IEN_ROOT_END>19452</IEN_ROOT_END>
<IEN_ROOT_START>19450</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19479</FDA_END>
<FDA_START>19465</FDA_START>
<FILE_START>19456</FILE_START>
<IEN_ROOT_END>19486</IEN_ROOT_END>
<IEN_ROOT_START>19484</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19513</FDA_END>
<FDA_START>19499</FDA_START>
<FILE_START>19490</FILE_START>
<IEN_ROOT_END>19520</IEN_ROOT_END>
<IEN_ROOT_START>19518</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19547</FDA_END>
<FDA_START>19533</FDA_START>
<FILE_START>19524</FILE_START>
<IEN_ROOT_END>19554</IEN_ROOT_END>
<IEN_ROOT_START>19552</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19581</FDA_END>
<FDA_START>19567</FDA_START>
<FILE_START>19558</FILE_START>
<IEN_ROOT_END>19588</IEN_ROOT_END>
<IEN_ROOT_START>19586</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19615</FDA_END>
<FDA_START>19601</FDA_START>
<FILE_START>19592</FILE_START>
<IEN_ROOT_END>19622</IEN_ROOT_END>
<IEN_ROOT_START>19620</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19649</FDA_END>
<FDA_START>19635</FDA_START>
<FILE_START>19626</FILE_START>
<IEN_ROOT_END>19656</IEN_ROOT_END>
<IEN_ROOT_START>19654</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19683</FDA_END>
<FDA_START>19669</FDA_START>
<FILE_START>19660</FILE_START>
<IEN_ROOT_END>19690</IEN_ROOT_END>
<IEN_ROOT_START>19688</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19718</FDA_END>
<FDA_START>19703</FDA_START>
<FILE_START>19694</FILE_START>
<IEN_ROOT_END>19726</IEN_ROOT_END>
<IEN_ROOT_START>19723</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19753</FDA_END>
<FDA_START>19739</FDA_START>
<FILE_START>19730</FILE_START>
<IEN_ROOT_END>19760</IEN_ROOT_END>
<IEN_ROOT_START>19758</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19787</FDA_END>
<FDA_START>19773</FDA_START>
<FILE_START>19764</FILE_START>
<IEN_ROOT_END>19794</IEN_ROOT_END>
<IEN_ROOT_START>19792</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19822</FDA_END>
<FDA_START>19807</FDA_START>
<FILE_START>19798</FILE_START>
<IEN_ROOT_END>19830</IEN_ROOT_END>
<IEN_ROOT_START>19827</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19857</FDA_END>
<FDA_START>19843</FDA_START>
<FILE_START>19834</FILE_START>
<IEN_ROOT_END>19864</IEN_ROOT_END>
<IEN_ROOT_START>19862</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19891</FDA_END>
<FDA_START>19877</FDA_START>
<FILE_START>19868</FILE_START>
<IEN_ROOT_END>19898</IEN_ROOT_END>
<IEN_ROOT_START>19896</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19924</FDA_END>
<FDA_START>19911</FDA_START>
<FILE_START>19902</FILE_START>
<IEN_ROOT_END>19931</IEN_ROOT_END>
<IEN_ROOT_START>19929</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19957</FDA_END>
<FDA_START>19944</FDA_START>
<FILE_START>19935</FILE_START>
<IEN_ROOT_END>19964</IEN_ROOT_END>
<IEN_ROOT_START>19962</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>19991</FDA_END>
<FDA_START>19977</FDA_START>
<FILE_START>19968</FILE_START>
<IEN_ROOT_END>19998</IEN_ROOT_END>
<IEN_ROOT_START>19996</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20025</FDA_END>
<FDA_START>20011</FDA_START>
<FILE_START>20002</FILE_START>
<IEN_ROOT_END>20032</IEN_ROOT_END>
<IEN_ROOT_START>20030</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20059</FDA_END>
<FDA_START>20045</FDA_START>
<FILE_START>20036</FILE_START>
<IEN_ROOT_END>20066</IEN_ROOT_END>
<IEN_ROOT_START>20064</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20093</FDA_END>
<FDA_START>20079</FDA_START>
<FILE_START>20070</FILE_START>
<IEN_ROOT_END>20100</IEN_ROOT_END>
<IEN_ROOT_START>20098</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20127</FDA_END>
<FDA_START>20113</FDA_START>
<FILE_START>20104</FILE_START>
<IEN_ROOT_END>20134</IEN_ROOT_END>
<IEN_ROOT_START>20132</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20161</FDA_END>
<FDA_START>20147</FDA_START>
<FILE_START>20138</FILE_START>
<IEN_ROOT_END>20168</IEN_ROOT_END>
<IEN_ROOT_START>20166</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20195</FDA_END>
<FDA_START>20181</FDA_START>
<FILE_START>20172</FILE_START>
<IEN_ROOT_END>20202</IEN_ROOT_END>
<IEN_ROOT_START>20200</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20229</FDA_END>
<FDA_START>20215</FDA_START>
<FILE_START>20206</FILE_START>
<IEN_ROOT_END>20236</IEN_ROOT_END>
<IEN_ROOT_START>20234</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20265</FDA_END>
<FDA_START>20249</FDA_START>
<FILE_START>20240</FILE_START>
<IEN_ROOT_END>20273</IEN_ROOT_END>
<IEN_ROOT_START>20270</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20300</FDA_END>
<FDA_START>20286</FDA_START>
<FILE_START>20277</FILE_START>
<IEN_ROOT_END>20307</IEN_ROOT_END>
<IEN_ROOT_START>20305</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20334</FDA_END>
<FDA_START>20320</FDA_START>
<FILE_START>20311</FILE_START>
<IEN_ROOT_END>20341</IEN_ROOT_END>
<IEN_ROOT_START>20339</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20368</FDA_END>
<FDA_START>20354</FDA_START>
<FILE_START>20345</FILE_START>
<IEN_ROOT_END>20375</IEN_ROOT_END>
<IEN_ROOT_START>20373</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20403</FDA_END>
<FDA_START>20388</FDA_START>
<FILE_START>20379</FILE_START>
<IEN_ROOT_END>20411</IEN_ROOT_END>
<IEN_ROOT_START>20408</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20439</FDA_END>
<FDA_START>20424</FDA_START>
<FILE_START>20415</FILE_START>
<IEN_ROOT_END>20447</IEN_ROOT_END>
<IEN_ROOT_START>20444</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20464</FDA_END>
<FDA_START>20460</FDA_START>
<FILE_START>20451</FILE_START>
<IEN_ROOT_END>20469</IEN_ROOT_END>
<IEN_ROOT_START>20469</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20490</FDA_END>
<FDA_START>20482</FDA_START>
<FILE_START>20473</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20510</FDA_END>
<FDA_START>20503</FDA_START>
<FILE_START>20494</FILE_START>
<IEN_ROOT_END>20516</IEN_ROOT_END>
<IEN_ROOT_START>20515</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20538</FDA_END>
<FDA_START>20529</FDA_START>
<FILE_START>20520</FILE_START>
<IEN_ROOT_END>20544</IEN_ROOT_END>
<IEN_ROOT_START>20543</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20557</FDA_END>
<FDA_START>20557</FDA_START>
<FILE_START>20548</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20592</FDA_END>
<FDA_START>20570</FDA_START>
<FILE_START>20561</FILE_START>
<IEN_ROOT_END>20611</IEN_ROOT_END>
<IEN_ROOT_START>20597</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20641</FDA_END>
<FDA_START>20624</FDA_START>
<FILE_START>20615</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20659</FDA_END>
<FDA_START>20654</FDA_START>
<FILE_START>20645</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20695</FDA_END>
<FDA_START>20672</FDA_START>
<FILE_START>20663</FILE_START>
<IEN_ROOT_END>20708</IEN_ROOT_END>
<IEN_ROOT_START>20700</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20734</FDA_END>
<FDA_START>20721</FDA_START>
<FILE_START>20712</FILE_START>
<IEN_ROOT_END>20740</IEN_ROOT_END>
<IEN_ROOT_START>20739</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20760</FDA_END>
<FDA_START>20753</FDA_START>
<FILE_START>20744</FILE_START>
<IEN_ROOT_END>20765</IEN_ROOT_END>
<IEN_ROOT_START>20765</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20791</FDA_END>
<FDA_START>20778</FDA_START>
<FILE_START>20769</FILE_START>
<IEN_ROOT_END>20797</IEN_ROOT_END>
<IEN_ROOT_START>20796</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20825</FDA_END>
<FDA_START>20810</FDA_START>
<FILE_START>20801</FILE_START>
<IEN_ROOT_END>20832</IEN_ROOT_END>
<IEN_ROOT_START>20830</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20852</FDA_END>
<FDA_START>20845</FDA_START>
<FILE_START>20836</FILE_START>
<IEN_ROOT_END>20857</IEN_ROOT_END>
<IEN_ROOT_START>20857</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20883</FDA_END>
<FDA_START>20870</FDA_START>
<FILE_START>20861</FILE_START>
<IEN_ROOT_END>20889</IEN_ROOT_END>
<IEN_ROOT_START>20888</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20913</FDA_END>
<FDA_START>20902</FDA_START>
<FILE_START>20893</FILE_START>
<IEN_ROOT_END>20918</IEN_ROOT_END>
<IEN_ROOT_START>20918</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20941</FDA_END>
<FDA_START>20931</FDA_START>
<FILE_START>20922</FILE_START>
<IEN_ROOT_END>20946</IEN_ROOT_END>
<IEN_ROOT_START>20946</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>20980</FDA_END>
<FDA_START>20959</FDA_START>
<FILE_START>20950</FILE_START>
<IEN_ROOT_END>20989</IEN_ROOT_END>
<IEN_ROOT_START>20985</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21012</FDA_END>
<FDA_START>21002</FDA_START>
<FILE_START>20993</FILE_START>
<IEN_ROOT_END>21017</IEN_ROOT_END>
<IEN_ROOT_START>21017</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21040</FDA_END>
<FDA_START>21030</FDA_START>
<FILE_START>21021</FILE_START>
<IEN_ROOT_END>21045</IEN_ROOT_END>
<IEN_ROOT_START>21045</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21071</FDA_END>
<FDA_START>21058</FDA_START>
<FILE_START>21049</FILE_START>
<IEN_ROOT_END>21077</IEN_ROOT_END>
<IEN_ROOT_START>21076</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21103</FDA_END>
<FDA_START>21090</FDA_START>
<FILE_START>21081</FILE_START>
<IEN_ROOT_END>21109</IEN_ROOT_END>
<IEN_ROOT_START>21108</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21135</FDA_END>
<FDA_START>21122</FDA_START>
<FILE_START>21113</FILE_START>
<IEN_ROOT_END>21141</IEN_ROOT_END>
<IEN_ROOT_START>21140</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21169</FDA_END>
<FDA_START>21154</FDA_START>
<FILE_START>21145</FILE_START>
<IEN_ROOT_END>21176</IEN_ROOT_END>
<IEN_ROOT_START>21174</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21199</FDA_END>
<FDA_START>21189</FDA_START>
<FILE_START>21180</FILE_START>
<IEN_ROOT_END>21204</IEN_ROOT_END>
<IEN_ROOT_START>21204</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21241</FDA_END>
<FDA_START>21217</FDA_START>
<FILE_START>21208</FILE_START>
<IEN_ROOT_END>21251</IEN_ROOT_END>
<IEN_ROOT_START>21246</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21282</FDA_END>
<FDA_START>21264</FDA_START>
<FILE_START>21255</FILE_START>
<IEN_ROOT_END>21289</IEN_ROOT_END>
<IEN_ROOT_START>21287</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21314</FDA_END>
<FDA_START>21302</FDA_START>
<FILE_START>21293</FILE_START>
<IEN_ROOT_END>21320</IEN_ROOT_END>
<IEN_ROOT_START>21319</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21342</FDA_END>
<FDA_START>21333</FDA_START>
<FILE_START>21324</FILE_START>
<IEN_ROOT_END>21347</IEN_ROOT_END>
<IEN_ROOT_START>21347</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21376</FDA_END>
<FDA_START>21360</FDA_START>
<FILE_START>21351</FILE_START>
<IEN_ROOT_END>21382</IEN_ROOT_END>
<IEN_ROOT_START>21381</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21408</FDA_END>
<FDA_START>21395</FDA_START>
<FILE_START>21386</FILE_START>
<IEN_ROOT_END>21414</IEN_ROOT_END>
<IEN_ROOT_START>21413</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21440</FDA_END>
<FDA_START>21427</FDA_START>
<FILE_START>21418</FILE_START>
<IEN_ROOT_END>21446</IEN_ROOT_END>
<IEN_ROOT_START>21445</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21474</FDA_END>
<FDA_START>21459</FDA_START>
<FILE_START>21450</FILE_START>
<IEN_ROOT_END>21481</IEN_ROOT_END>
<IEN_ROOT_START>21479</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21507</FDA_END>
<FDA_START>21494</FDA_START>
<FILE_START>21485</FILE_START>
<IEN_ROOT_END>21513</IEN_ROOT_END>
<IEN_ROOT_START>21512</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21545</FDA_END>
<FDA_START>21526</FDA_START>
<FILE_START>21517</FILE_START>
<IEN_ROOT_END>21553</IEN_ROOT_END>
<IEN_ROOT_START>21550</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21575</FDA_END>
<FDA_START>21566</FDA_START>
<FILE_START>21557</FILE_START>
<IEN_ROOT_END>21580</IEN_ROOT_END>
<IEN_ROOT_START>21580</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21608</FDA_END>
<FDA_START>21593</FDA_START>
<FILE_START>21584</FILE_START>
<IEN_ROOT_END>21614</IEN_ROOT_END>
<IEN_ROOT_START>21613</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21640</FDA_END>
<FDA_START>21627</FDA_START>
<FILE_START>21618</FILE_START>
<IEN_ROOT_END>21646</IEN_ROOT_END>
<IEN_ROOT_START>21645</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21665</FDA_END>
<FDA_START>21659</FDA_START>
<FILE_START>21650</FILE_START>
<IEN_ROOT_END>21670</IEN_ROOT_END>
<IEN_ROOT_START>21670</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21696</FDA_END>
<FDA_START>21683</FDA_START>
<FILE_START>21674</FILE_START>
<IEN_ROOT_END>21702</IEN_ROOT_END>
<IEN_ROOT_START>21701</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21728</FDA_END>
<FDA_START>21715</FDA_START>
<FILE_START>21706</FILE_START>
<IEN_ROOT_END>21734</IEN_ROOT_END>
<IEN_ROOT_START>21733</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21762</FDA_END>
<FDA_START>21747</FDA_START>
<FILE_START>21738</FILE_START>
<IEN_ROOT_END>21769</IEN_ROOT_END>
<IEN_ROOT_START>21767</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21803</FDA_END>
<FDA_START>21782</FDA_START>
<FILE_START>21773</FILE_START>
<IEN_ROOT_END>21812</IEN_ROOT_END>
<IEN_ROOT_START>21808</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21844</FDA_END>
<FDA_START>21825</FDA_START>
<FILE_START>21816</FILE_START>
<IEN_ROOT_END>21851</IEN_ROOT_END>
<IEN_ROOT_START>21849</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21876</FDA_END>
<FDA_START>21864</FDA_START>
<FILE_START>21855</FILE_START>
<IEN_ROOT_END>21882</IEN_ROOT_END>
<IEN_ROOT_START>21881</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21908</FDA_END>
<FDA_START>21895</FDA_START>
<FILE_START>21886</FILE_START>
<IEN_ROOT_END>21914</IEN_ROOT_END>
<IEN_ROOT_START>21913</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21940</FDA_END>
<FDA_START>21927</FDA_START>
<FILE_START>21918</FILE_START>
<IEN_ROOT_END>21946</IEN_ROOT_END>
<IEN_ROOT_START>21945</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>21974</FDA_END>
<FDA_START>21959</FDA_START>
<FILE_START>21950</FILE_START>
<IEN_ROOT_END>21981</IEN_ROOT_END>
<IEN_ROOT_START>21979</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22005</FDA_END>
<FDA_START>21994</FDA_START>
<FILE_START>21985</FILE_START>
<IEN_ROOT_END>22010</IEN_ROOT_END>
<IEN_ROOT_START>22010</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22036</FDA_END>
<FDA_START>22023</FDA_START>
<FILE_START>22014</FILE_START>
<IEN_ROOT_END>22042</IEN_ROOT_END>
<IEN_ROOT_START>22041</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22075</FDA_END>
<FDA_START>22055</FDA_START>
<FILE_START>22046</FILE_START>
<IEN_ROOT_END>22083</IEN_ROOT_END>
<IEN_ROOT_START>22080</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22105</FDA_END>
<FDA_START>22096</FDA_START>
<FILE_START>22087</FILE_START>
<IEN_ROOT_END>22110</IEN_ROOT_END>
<IEN_ROOT_START>22110</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22131</FDA_END>
<FDA_START>22123</FDA_START>
<FILE_START>22114</FILE_START>
<IEN_ROOT_END>22136</IEN_ROOT_END>
<IEN_ROOT_START>22136</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22187</FDA_END>
<FDA_START>22149</FDA_START>
<FILE_START>22140</FILE_START>
<IEN_ROOT_END>22193</IEN_ROOT_END>
<IEN_ROOT_START>22192</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22230</FDA_END>
<FDA_START>22206</FDA_START>
<FILE_START>22197</FILE_START>
<IEN_ROOT_END>22240</IEN_ROOT_END>
<IEN_ROOT_START>22235</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22266</FDA_END>
<FDA_START>22253</FDA_START>
<FILE_START>22244</FILE_START>
<IEN_ROOT_END>22272</IEN_ROOT_END>
<IEN_ROOT_START>22271</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22300</FDA_END>
<FDA_START>22285</FDA_START>
<FILE_START>22276</FILE_START>
<IEN_ROOT_END>22306</IEN_ROOT_END>
<IEN_ROOT_START>22305</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22330</FDA_END>
<FDA_START>22319</FDA_START>
<FILE_START>22310</FILE_START>
<IEN_ROOT_END>22336</IEN_ROOT_END>
<IEN_ROOT_START>22335</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22359</FDA_END>
<FDA_START>22349</FDA_START>
<FILE_START>22340</FILE_START>
<IEN_ROOT_END>22364</IEN_ROOT_END>
<IEN_ROOT_START>22364</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22387</FDA_END>
<FDA_START>22377</FDA_START>
<FILE_START>22368</FILE_START>
<IEN_ROOT_END>22392</IEN_ROOT_END>
<IEN_ROOT_START>22392</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22416</FDA_END>
<FDA_START>22405</FDA_START>
<FILE_START>22396</FILE_START>
<IEN_ROOT_END>22421</IEN_ROOT_END>
<IEN_ROOT_START>22421</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22456</FDA_END>
<FDA_START>22434</FDA_START>
<FILE_START>22425</FILE_START>
<IEN_ROOT_END>22467</IEN_ROOT_END>
<IEN_ROOT_START>22461</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22494</FDA_END>
<FDA_START>22480</FDA_START>
<FILE_START>22471</FILE_START>
<IEN_ROOT_END>22500</IEN_ROOT_END>
<IEN_ROOT_START>22499</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22564</FDA_END>
<FDA_START>22513</FDA_START>
<FILE_START>22504</FILE_START>
<IEN_ROOT_END>22570</IEN_ROOT_END>
<IEN_ROOT_START>22569</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22594</FDA_END>
<FDA_START>22583</FDA_START>
<FILE_START>22574</FILE_START>
<IEN_ROOT_END>22601</IEN_ROOT_END>
<IEN_ROOT_START>22599</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22627</FDA_END>
<FDA_START>22614</FDA_START>
<FILE_START>22605</FILE_START>
<IEN_ROOT_END>22633</IEN_ROOT_END>
<IEN_ROOT_START>22632</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22659</FDA_END>
<FDA_START>22646</FDA_START>
<FILE_START>22637</FILE_START>
<IEN_ROOT_END>22665</IEN_ROOT_END>
<IEN_ROOT_START>22664</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22693</FDA_END>
<FDA_START>22678</FDA_START>
<FILE_START>22669</FILE_START>
<IEN_ROOT_END>22700</IEN_ROOT_END>
<IEN_ROOT_START>22698</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22726</FDA_END>
<FDA_START>22713</FDA_START>
<FILE_START>22704</FILE_START>
<IEN_ROOT_END>22732</IEN_ROOT_END>
<IEN_ROOT_START>22731</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22756</FDA_END>
<FDA_START>22745</FDA_START>
<FILE_START>22736</FILE_START>
<IEN_ROOT_END>22761</IEN_ROOT_END>
<IEN_ROOT_START>22761</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22785</FDA_END>
<FDA_START>22774</FDA_START>
<FILE_START>22765</FILE_START>
<IEN_ROOT_END>22790</IEN_ROOT_END>
<IEN_ROOT_START>22790</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22822</FDA_END>
<FDA_START>22803</FDA_START>
<FILE_START>22794</FILE_START>
<IEN_ROOT_END>22831</IEN_ROOT_END>
<IEN_ROOT_START>22827</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22853</FDA_END>
<FDA_START>22844</FDA_START>
<FILE_START>22835</FILE_START>
<IEN_ROOT_END>22859</IEN_ROOT_END>
<IEN_ROOT_START>22858</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22885</FDA_END>
<FDA_START>22872</FDA_START>
<FILE_START>22863</FILE_START>
<IEN_ROOT_END>22891</IEN_ROOT_END>
<IEN_ROOT_START>22890</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22917</FDA_END>
<FDA_START>22904</FDA_START>
<FILE_START>22895</FILE_START>
<IEN_ROOT_END>22923</IEN_ROOT_END>
<IEN_ROOT_START>22922</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22951</FDA_END>
<FDA_START>22936</FDA_START>
<FILE_START>22927</FILE_START>
<IEN_ROOT_END>22958</IEN_ROOT_END>
<IEN_ROOT_START>22956</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>22984</FDA_END>
<FDA_START>22971</FDA_START>
<FILE_START>22962</FILE_START>
<IEN_ROOT_END>22990</IEN_ROOT_END>
<IEN_ROOT_START>22989</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23014</FDA_END>
<FDA_START>23003</FDA_START>
<FILE_START>22994</FILE_START>
<IEN_ROOT_END>23019</IEN_ROOT_END>
<IEN_ROOT_START>23019</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23043</FDA_END>
<FDA_START>23032</FDA_START>
<FILE_START>23023</FILE_START>
<IEN_ROOT_END>23048</IEN_ROOT_END>
<IEN_ROOT_START>23048</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23072</FDA_END>
<FDA_START>23061</FDA_START>
<FILE_START>23052</FILE_START>
<IEN_ROOT_END>23077</IEN_ROOT_END>
<IEN_ROOT_START>23077</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23111</FDA_END>
<FDA_START>23090</FDA_START>
<FILE_START>23081</FILE_START>
<IEN_ROOT_END>23121</IEN_ROOT_END>
<IEN_ROOT_START>23116</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23143</FDA_END>
<FDA_START>23134</FDA_START>
<FILE_START>23125</FILE_START>
<IEN_ROOT_END>23149</IEN_ROOT_END>
<IEN_ROOT_START>23148</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23177</FDA_END>
<FDA_START>23162</FDA_START>
<FILE_START>23153</FILE_START>
<IEN_ROOT_END>23184</IEN_ROOT_END>
<IEN_ROOT_START>23182</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23210</FDA_END>
<FDA_START>23197</FDA_START>
<FILE_START>23188</FILE_START>
<IEN_ROOT_END>23216</IEN_ROOT_END>
<IEN_ROOT_START>23215</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23242</FDA_END>
<FDA_START>23229</FDA_START>
<FILE_START>23220</FILE_START>
<IEN_ROOT_END>23248</IEN_ROOT_END>
<IEN_ROOT_START>23247</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23276</FDA_END>
<FDA_START>23261</FDA_START>
<FILE_START>23252</FILE_START>
<IEN_ROOT_END>23283</IEN_ROOT_END>
<IEN_ROOT_START>23281</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23309</FDA_END>
<FDA_START>23296</FDA_START>
<FILE_START>23287</FILE_START>
<IEN_ROOT_END>23315</IEN_ROOT_END>
<IEN_ROOT_START>23314</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23339</FDA_END>
<FDA_START>23328</FDA_START>
<FILE_START>23319</FILE_START>
<IEN_ROOT_END>23344</IEN_ROOT_END>
<IEN_ROOT_START>23344</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23368</FDA_END>
<FDA_START>23357</FDA_START>
<FILE_START>23348</FILE_START>
<IEN_ROOT_END>23373</IEN_ROOT_END>
<IEN_ROOT_START>23373</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23408</FDA_END>
<FDA_START>23386</FDA_START>
<FILE_START>23377</FILE_START>
<IEN_ROOT_END>23417</IEN_ROOT_END>
<IEN_ROOT_START>23413</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23443</FDA_END>
<FDA_START>23430</FDA_START>
<FILE_START>23421</FILE_START>
<IEN_ROOT_END>23449</IEN_ROOT_END>
<IEN_ROOT_START>23448</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23475</FDA_END>
<FDA_START>23462</FDA_START>
<FILE_START>23453</FILE_START>
<IEN_ROOT_END>23481</IEN_ROOT_END>
<IEN_ROOT_START>23480</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23509</FDA_END>
<FDA_START>23494</FDA_START>
<FILE_START>23485</FILE_START>
<IEN_ROOT_END>23516</IEN_ROOT_END>
<IEN_ROOT_START>23514</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23542</FDA_END>
<FDA_START>23529</FDA_START>
<FILE_START>23520</FILE_START>
<IEN_ROOT_END>23548</IEN_ROOT_END>
<IEN_ROOT_START>23547</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23571</FDA_END>
<FDA_START>23561</FDA_START>
<FILE_START>23552</FILE_START>
<IEN_ROOT_END>23576</IEN_ROOT_END>
<IEN_ROOT_START>23576</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23599</FDA_END>
<FDA_START>23589</FDA_START>
<FILE_START>23580</FILE_START>
<IEN_ROOT_END>23604</IEN_ROOT_END>
<IEN_ROOT_START>23604</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23636</FDA_END>
<FDA_START>23617</FDA_START>
<FILE_START>23608</FILE_START>
<IEN_ROOT_END>23645</IEN_ROOT_END>
<IEN_ROOT_START>23641</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23671</FDA_END>
<FDA_START>23658</FDA_START>
<FILE_START>23649</FILE_START>
<IEN_ROOT_END>23677</IEN_ROOT_END>
<IEN_ROOT_START>23676</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23703</FDA_END>
<FDA_START>23690</FDA_START>
<FILE_START>23681</FILE_START>
<IEN_ROOT_END>23709</IEN_ROOT_END>
<IEN_ROOT_START>23708</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23737</FDA_END>
<FDA_START>23722</FDA_START>
<FILE_START>23713</FILE_START>
<IEN_ROOT_END>23744</IEN_ROOT_END>
<IEN_ROOT_START>23742</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23770</FDA_END>
<FDA_START>23757</FDA_START>
<FILE_START>23748</FILE_START>
<IEN_ROOT_END>23776</IEN_ROOT_END>
<IEN_ROOT_START>23775</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23800</FDA_END>
<FDA_START>23789</FDA_START>
<FILE_START>23780</FILE_START>
<IEN_ROOT_END>23805</IEN_ROOT_END>
<IEN_ROOT_START>23805</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23829</FDA_END>
<FDA_START>23818</FDA_START>
<FILE_START>23809</FILE_START>
<IEN_ROOT_END>23834</IEN_ROOT_END>
<IEN_ROOT_START>23834</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23866</FDA_END>
<FDA_START>23847</FDA_START>
<FILE_START>23838</FILE_START>
<IEN_ROOT_END>23875</IEN_ROOT_END>
<IEN_ROOT_START>23871</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23901</FDA_END>
<FDA_START>23888</FDA_START>
<FILE_START>23879</FILE_START>
<IEN_ROOT_END>23909</IEN_ROOT_END>
<IEN_ROOT_START>23906</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23935</FDA_END>
<FDA_START>23922</FDA_START>
<FILE_START>23913</FILE_START>
<IEN_ROOT_END>23941</IEN_ROOT_END>
<IEN_ROOT_START>23940</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>23967</FDA_END>
<FDA_START>23954</FDA_START>
<FILE_START>23945</FILE_START>
<IEN_ROOT_END>23973</IEN_ROOT_END>
<IEN_ROOT_START>23972</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24001</FDA_END>
<FDA_START>23986</FDA_START>
<FILE_START>23977</FILE_START>
<IEN_ROOT_END>24008</IEN_ROOT_END>
<IEN_ROOT_START>24006</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24034</FDA_END>
<FDA_START>24021</FDA_START>
<FILE_START>24012</FILE_START>
<IEN_ROOT_END>24040</IEN_ROOT_END>
<IEN_ROOT_START>24039</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24064</FDA_END>
<FDA_START>24053</FDA_START>
<FILE_START>24044</FILE_START>
<IEN_ROOT_END>24069</IEN_ROOT_END>
<IEN_ROOT_START>24069</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24093</FDA_END>
<FDA_START>24082</FDA_START>
<FILE_START>24073</FILE_START>
<IEN_ROOT_END>24098</IEN_ROOT_END>
<IEN_ROOT_START>24098</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24133</FDA_END>
<FDA_START>24111</FDA_START>
<FILE_START>24102</FILE_START>
<IEN_ROOT_END>24142</IEN_ROOT_END>
<IEN_ROOT_START>24138</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24168</FDA_END>
<FDA_START>24155</FDA_START>
<FILE_START>24146</FILE_START>
<IEN_ROOT_END>24174</IEN_ROOT_END>
<IEN_ROOT_START>24173</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24200</FDA_END>
<FDA_START>24187</FDA_START>
<FILE_START>24178</FILE_START>
<IEN_ROOT_END>24206</IEN_ROOT_END>
<IEN_ROOT_START>24205</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24234</FDA_END>
<FDA_START>24219</FDA_START>
<FILE_START>24210</FILE_START>
<IEN_ROOT_END>24241</IEN_ROOT_END>
<IEN_ROOT_START>24239</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24267</FDA_END>
<FDA_START>24254</FDA_START>
<FILE_START>24245</FILE_START>
<IEN_ROOT_END>24273</IEN_ROOT_END>
<IEN_ROOT_START>24272</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24297</FDA_END>
<FDA_START>24286</FDA_START>
<FILE_START>24277</FILE_START>
<IEN_ROOT_END>24302</IEN_ROOT_END>
<IEN_ROOT_START>24302</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24326</FDA_END>
<FDA_START>24315</FDA_START>
<FILE_START>24306</FILE_START>
<IEN_ROOT_END>24331</IEN_ROOT_END>
<IEN_ROOT_START>24331</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24355</FDA_END>
<FDA_START>24344</FDA_START>
<FILE_START>24335</FILE_START>
<IEN_ROOT_END>24360</IEN_ROOT_END>
<IEN_ROOT_START>24360</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24384</FDA_END>
<FDA_START>24373</FDA_START>
<FILE_START>24364</FILE_START>
<IEN_ROOT_END>24389</IEN_ROOT_END>
<IEN_ROOT_START>24389</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24425</FDA_END>
<FDA_START>24402</FDA_START>
<FILE_START>24393</FILE_START>
<IEN_ROOT_END>24436</IEN_ROOT_END>
<IEN_ROOT_START>24430</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24462</FDA_END>
<FDA_START>24449</FDA_START>
<FILE_START>24440</FILE_START>
<IEN_ROOT_END>24468</IEN_ROOT_END>
<IEN_ROOT_START>24467</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24494</FDA_END>
<FDA_START>24481</FDA_START>
<FILE_START>24472</FILE_START>
<IEN_ROOT_END>24500</IEN_ROOT_END>
<IEN_ROOT_START>24499</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24528</FDA_END>
<FDA_START>24513</FDA_START>
<FILE_START>24504</FILE_START>
<IEN_ROOT_END>24535</IEN_ROOT_END>
<IEN_ROOT_START>24533</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24561</FDA_END>
<FDA_START>24548</FDA_START>
<FILE_START>24539</FILE_START>
<IEN_ROOT_END>24567</IEN_ROOT_END>
<IEN_ROOT_START>24566</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24591</FDA_END>
<FDA_START>24580</FDA_START>
<FILE_START>24571</FILE_START>
<IEN_ROOT_END>24596</IEN_ROOT_END>
<IEN_ROOT_START>24596</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24620</FDA_END>
<FDA_START>24609</FDA_START>
<FILE_START>24600</FILE_START>
<IEN_ROOT_END>24625</IEN_ROOT_END>
<IEN_ROOT_START>24625</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24649</FDA_END>
<FDA_START>24638</FDA_START>
<FILE_START>24629</FILE_START>
<IEN_ROOT_END>24654</IEN_ROOT_END>
<IEN_ROOT_START>24654</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24678</FDA_END>
<FDA_START>24667</FDA_START>
<FILE_START>24658</FILE_START>
<IEN_ROOT_END>24683</IEN_ROOT_END>
<IEN_ROOT_START>24683</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24719</FDA_END>
<FDA_START>24696</FDA_START>
<FILE_START>24687</FILE_START>
<IEN_ROOT_END>24730</IEN_ROOT_END>
<IEN_ROOT_START>24724</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24756</FDA_END>
<FDA_START>24743</FDA_START>
<FILE_START>24734</FILE_START>
<IEN_ROOT_END>24764</IEN_ROOT_END>
<IEN_ROOT_START>24761</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24792</FDA_END>
<FDA_START>24777</FDA_START>
<FILE_START>24768</FILE_START>
<IEN_ROOT_END>24799</IEN_ROOT_END>
<IEN_ROOT_START>24797</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24825</FDA_END>
<FDA_START>24812</FDA_START>
<FILE_START>24803</FILE_START>
<IEN_ROOT_END>24831</IEN_ROOT_END>
<IEN_ROOT_START>24830</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24857</FDA_END>
<FDA_START>24844</FDA_START>
<FILE_START>24835</FILE_START>
<IEN_ROOT_END>24863</IEN_ROOT_END>
<IEN_ROOT_START>24862</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24891</FDA_END>
<FDA_START>24876</FDA_START>
<FILE_START>24867</FILE_START>
<IEN_ROOT_END>24898</IEN_ROOT_END>
<IEN_ROOT_START>24896</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24924</FDA_END>
<FDA_START>24911</FDA_START>
<FILE_START>24902</FILE_START>
<IEN_ROOT_END>24930</IEN_ROOT_END>
<IEN_ROOT_START>24929</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24954</FDA_END>
<FDA_START>24943</FDA_START>
<FILE_START>24934</FILE_START>
<IEN_ROOT_END>24959</IEN_ROOT_END>
<IEN_ROOT_START>24959</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>24983</FDA_END>
<FDA_START>24972</FDA_START>
<FILE_START>24963</FILE_START>
<IEN_ROOT_END>24988</IEN_ROOT_END>
<IEN_ROOT_START>24988</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25020</FDA_END>
<FDA_START>25001</FDA_START>
<FILE_START>24992</FILE_START>
<IEN_ROOT_END>25029</IEN_ROOT_END>
<IEN_ROOT_START>25025</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25055</FDA_END>
<FDA_START>25042</FDA_START>
<FILE_START>25033</FILE_START>
<IEN_ROOT_END>25061</IEN_ROOT_END>
<IEN_ROOT_START>25060</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25087</FDA_END>
<FDA_START>25074</FDA_START>
<FILE_START>25065</FILE_START>
<IEN_ROOT_END>25093</IEN_ROOT_END>
<IEN_ROOT_START>25092</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25121</FDA_END>
<FDA_START>25106</FDA_START>
<FILE_START>25097</FILE_START>
<IEN_ROOT_END>25128</IEN_ROOT_END>
<IEN_ROOT_START>25126</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25154</FDA_END>
<FDA_START>25141</FDA_START>
<FILE_START>25132</FILE_START>
<IEN_ROOT_END>25160</IEN_ROOT_END>
<IEN_ROOT_START>25159</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25183</FDA_END>
<FDA_START>25173</FDA_START>
<FILE_START>25164</FILE_START>
<IEN_ROOT_END>25188</IEN_ROOT_END>
<IEN_ROOT_START>25188</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25211</FDA_END>
<FDA_START>25201</FDA_START>
<FILE_START>25192</FILE_START>
<IEN_ROOT_END>25216</IEN_ROOT_END>
<IEN_ROOT_START>25216</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25248</FDA_END>
<FDA_START>25229</FDA_START>
<FILE_START>25220</FILE_START>
<IEN_ROOT_END>25257</IEN_ROOT_END>
<IEN_ROOT_START>25253</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25283</FDA_END>
<FDA_START>25270</FDA_START>
<FILE_START>25261</FILE_START>
<IEN_ROOT_END>25289</IEN_ROOT_END>
<IEN_ROOT_START>25288</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25315</FDA_END>
<FDA_START>25302</FDA_START>
<FILE_START>25293</FILE_START>
<IEN_ROOT_END>25321</IEN_ROOT_END>
<IEN_ROOT_START>25320</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25349</FDA_END>
<FDA_START>25334</FDA_START>
<FILE_START>25325</FILE_START>
<IEN_ROOT_END>25356</IEN_ROOT_END>
<IEN_ROOT_START>25354</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25382</FDA_END>
<FDA_START>25369</FDA_START>
<FILE_START>25360</FILE_START>
<IEN_ROOT_END>25388</IEN_ROOT_END>
<IEN_ROOT_START>25387</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25412</FDA_END>
<FDA_START>25401</FDA_START>
<FILE_START>25392</FILE_START>
<IEN_ROOT_END>25417</IEN_ROOT_END>
<IEN_ROOT_START>25417</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25441</FDA_END>
<FDA_START>25430</FDA_START>
<FILE_START>25421</FILE_START>
<IEN_ROOT_END>25446</IEN_ROOT_END>
<IEN_ROOT_START>25446</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25478</FDA_END>
<FDA_START>25459</FDA_START>
<FILE_START>25450</FILE_START>
<IEN_ROOT_END>25487</IEN_ROOT_END>
<IEN_ROOT_START>25483</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25513</FDA_END>
<FDA_START>25500</FDA_START>
<FILE_START>25491</FILE_START>
<IEN_ROOT_END>25521</IEN_ROOT_END>
<IEN_ROOT_START>25518</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25547</FDA_END>
<FDA_START>25534</FDA_START>
<FILE_START>25525</FILE_START>
<IEN_ROOT_END>25553</IEN_ROOT_END>
<IEN_ROOT_START>25552</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25579</FDA_END>
<FDA_START>25566</FDA_START>
<FILE_START>25557</FILE_START>
<IEN_ROOT_END>25585</IEN_ROOT_END>
<IEN_ROOT_START>25584</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25613</FDA_END>
<FDA_START>25598</FDA_START>
<FILE_START>25589</FILE_START>
<IEN_ROOT_END>25620</IEN_ROOT_END>
<IEN_ROOT_START>25618</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25646</FDA_END>
<FDA_START>25633</FDA_START>
<FILE_START>25624</FILE_START>
<IEN_ROOT_END>25652</IEN_ROOT_END>
<IEN_ROOT_START>25651</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25676</FDA_END>
<FDA_START>25665</FDA_START>
<FILE_START>25656</FILE_START>
<IEN_ROOT_END>25681</IEN_ROOT_END>
<IEN_ROOT_START>25681</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25705</FDA_END>
<FDA_START>25694</FDA_START>
<FILE_START>25685</FILE_START>
<IEN_ROOT_END>25710</IEN_ROOT_END>
<IEN_ROOT_START>25710</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25734</FDA_END>
<FDA_START>25723</FDA_START>
<FILE_START>25714</FILE_START>
<IEN_ROOT_END>25739</IEN_ROOT_END>
<IEN_ROOT_START>25739</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25773</FDA_END>
<FDA_START>25752</FDA_START>
<FILE_START>25743</FILE_START>
<IEN_ROOT_END>25783</IEN_ROOT_END>
<IEN_ROOT_START>25778</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25809</FDA_END>
<FDA_START>25796</FDA_START>
<FILE_START>25787</FILE_START>
<IEN_ROOT_END>25815</IEN_ROOT_END>
<IEN_ROOT_START>25814</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25841</FDA_END>
<FDA_START>25828</FDA_START>
<FILE_START>25819</FILE_START>
<IEN_ROOT_END>25847</IEN_ROOT_END>
<IEN_ROOT_START>25846</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25873</FDA_END>
<FDA_START>25860</FDA_START>
<FILE_START>25851</FILE_START>
<IEN_ROOT_END>25879</IEN_ROOT_END>
<IEN_ROOT_START>25878</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25907</FDA_END>
<FDA_START>25892</FDA_START>
<FILE_START>25883</FILE_START>
<IEN_ROOT_END>25914</IEN_ROOT_END>
<IEN_ROOT_START>25912</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25938</FDA_END>
<FDA_START>25927</FDA_START>
<FILE_START>25918</FILE_START>
<IEN_ROOT_END>25943</IEN_ROOT_END>
<IEN_ROOT_START>25943</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25967</FDA_END>
<FDA_START>25956</FDA_START>
<FILE_START>25947</FILE_START>
<IEN_ROOT_END>25972</IEN_ROOT_END>
<IEN_ROOT_START>25972</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>25996</FDA_END>
<FDA_START>25985</FDA_START>
<FILE_START>25976</FILE_START>
<IEN_ROOT_END>26001</IEN_ROOT_END>
<IEN_ROOT_START>26001</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26025</FDA_END>
<FDA_START>26014</FDA_START>
<FILE_START>26005</FILE_START>
<IEN_ROOT_END>26030</IEN_ROOT_END>
<IEN_ROOT_START>26030</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26066</FDA_END>
<FDA_START>26043</FDA_START>
<FILE_START>26034</FILE_START>
<IEN_ROOT_END>26077</IEN_ROOT_END>
<IEN_ROOT_START>26071</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26103</FDA_END>
<FDA_START>26090</FDA_START>
<FILE_START>26081</FILE_START>
<IEN_ROOT_END>26109</IEN_ROOT_END>
<IEN_ROOT_START>26108</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26135</FDA_END>
<FDA_START>26122</FDA_START>
<FILE_START>26113</FILE_START>
<IEN_ROOT_END>26141</IEN_ROOT_END>
<IEN_ROOT_START>26140</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26167</FDA_END>
<FDA_START>26154</FDA_START>
<FILE_START>26145</FILE_START>
<IEN_ROOT_END>26173</IEN_ROOT_END>
<IEN_ROOT_START>26172</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26201</FDA_END>
<FDA_START>26186</FDA_START>
<FILE_START>26177</FILE_START>
<IEN_ROOT_END>26208</IEN_ROOT_END>
<IEN_ROOT_START>26206</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26232</FDA_END>
<FDA_START>26221</FDA_START>
<FILE_START>26212</FILE_START>
<IEN_ROOT_END>26237</IEN_ROOT_END>
<IEN_ROOT_START>26237</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26261</FDA_END>
<FDA_START>26250</FDA_START>
<FILE_START>26241</FILE_START>
<IEN_ROOT_END>26266</IEN_ROOT_END>
<IEN_ROOT_START>26266</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26290</FDA_END>
<FDA_START>26279</FDA_START>
<FILE_START>26270</FILE_START>
<IEN_ROOT_END>26295</IEN_ROOT_END>
<IEN_ROOT_START>26295</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26319</FDA_END>
<FDA_START>26308</FDA_START>
<FILE_START>26299</FILE_START>
<IEN_ROOT_END>26324</IEN_ROOT_END>
<IEN_ROOT_START>26324</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26360</FDA_END>
<FDA_START>26337</FDA_START>
<FILE_START>26328</FILE_START>
<IEN_ROOT_END>26371</IEN_ROOT_END>
<IEN_ROOT_START>26365</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26397</FDA_END>
<FDA_START>26384</FDA_START>
<FILE_START>26375</FILE_START>
<IEN_ROOT_END>26405</IEN_ROOT_END>
<IEN_ROOT_START>26402</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26433</FDA_END>
<FDA_START>26418</FDA_START>
<FILE_START>26409</FILE_START>
<IEN_ROOT_END>26440</IEN_ROOT_END>
<IEN_ROOT_START>26438</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26468</FDA_END>
<FDA_START>26453</FDA_START>
<FILE_START>26444</FILE_START>
<IEN_ROOT_END>26476</IEN_ROOT_END>
<IEN_ROOT_START>26473</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26536</FDA_END>
<FDA_START>26489</FDA_START>
<FILE_START>26480</FILE_START>
<IEN_ROOT_END>26542</IEN_ROOT_END>
<IEN_ROOT_START>26541</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26571</FDA_END>
<FDA_START>26555</FDA_START>
<FILE_START>26546</FILE_START>
<IEN_ROOT_END>26578</IEN_ROOT_END>
<IEN_ROOT_START>26576</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26604</FDA_END>
<FDA_START>26591</FDA_START>
<FILE_START>26582</FILE_START>
<IEN_ROOT_END>26610</IEN_ROOT_END>
<IEN_ROOT_START>26609</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26636</FDA_END>
<FDA_START>26623</FDA_START>
<FILE_START>26614</FILE_START>
<IEN_ROOT_END>26642</IEN_ROOT_END>
<IEN_ROOT_START>26641</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26670</FDA_END>
<FDA_START>26655</FDA_START>
<FILE_START>26646</FILE_START>
<IEN_ROOT_END>26677</IEN_ROOT_END>
<IEN_ROOT_START>26675</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26703</FDA_END>
<FDA_START>26690</FDA_START>
<FILE_START>26681</FILE_START>
<IEN_ROOT_END>26709</IEN_ROOT_END>
<IEN_ROOT_START>26708</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26735</FDA_END>
<FDA_START>26722</FDA_START>
<FILE_START>26713</FILE_START>
<IEN_ROOT_END>26740</IEN_ROOT_END>
<IEN_ROOT_START>26740</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26766</FDA_END>
<FDA_START>26753</FDA_START>
<FILE_START>26744</FILE_START>
<IEN_ROOT_END>26772</IEN_ROOT_END>
<IEN_ROOT_START>26771</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26802</FDA_END>
<FDA_START>26785</FDA_START>
<FILE_START>26776</FILE_START>
<IEN_ROOT_END>26810</IEN_ROOT_END>
<IEN_ROOT_START>26807</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26836</FDA_END>
<FDA_START>26823</FDA_START>
<FILE_START>26814</FILE_START>
<IEN_ROOT_END>26842</IEN_ROOT_END>
<IEN_ROOT_START>26841</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26868</FDA_END>
<FDA_START>26855</FDA_START>
<FILE_START>26846</FILE_START>
<IEN_ROOT_END>26874</IEN_ROOT_END>
<IEN_ROOT_START>26873</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26902</FDA_END>
<FDA_START>26887</FDA_START>
<FILE_START>26878</FILE_START>
<IEN_ROOT_END>26909</IEN_ROOT_END>
<IEN_ROOT_START>26907</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26935</FDA_END>
<FDA_START>26922</FDA_START>
<FILE_START>26913</FILE_START>
<IEN_ROOT_END>26941</IEN_ROOT_END>
<IEN_ROOT_START>26940</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>26966</FDA_END>
<FDA_START>26954</FDA_START>
<FILE_START>26945</FILE_START>
<IEN_ROOT_END>26971</IEN_ROOT_END>
<IEN_ROOT_START>26971</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27000</FDA_END>
<FDA_START>26984</FDA_START>
<FILE_START>26975</FILE_START>
<IEN_ROOT_END>27008</IEN_ROOT_END>
<IEN_ROOT_START>27005</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27034</FDA_END>
<FDA_START>27021</FDA_START>
<FILE_START>27012</FILE_START>
<IEN_ROOT_END>27040</IEN_ROOT_END>
<IEN_ROOT_START>27039</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27066</FDA_END>
<FDA_START>27053</FDA_START>
<FILE_START>27044</FILE_START>
<IEN_ROOT_END>27072</IEN_ROOT_END>
<IEN_ROOT_START>27071</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27100</FDA_END>
<FDA_START>27085</FDA_START>
<FILE_START>27076</FILE_START>
<IEN_ROOT_END>27107</IEN_ROOT_END>
<IEN_ROOT_START>27105</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27133</FDA_END>
<FDA_START>27120</FDA_START>
<FILE_START>27111</FILE_START>
<IEN_ROOT_END>27139</IEN_ROOT_END>
<IEN_ROOT_START>27138</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27163</FDA_END>
<FDA_START>27152</FDA_START>
<FILE_START>27143</FILE_START>
<IEN_ROOT_END>27168</IEN_ROOT_END>
<IEN_ROOT_START>27168</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27197</FDA_END>
<FDA_START>27181</FDA_START>
<FILE_START>27172</FILE_START>
<IEN_ROOT_END>27205</IEN_ROOT_END>
<IEN_ROOT_START>27202</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27230</FDA_END>
<FDA_START>27218</FDA_START>
<FILE_START>27209</FILE_START>
<IEN_ROOT_END>27237</IEN_ROOT_END>
<IEN_ROOT_START>27235</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27279</FDA_END>
<FDA_START>27250</FDA_START>
<FILE_START>27241</FILE_START>
<IEN_ROOT_END>27285</IEN_ROOT_END>
<IEN_ROOT_START>27284</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27318</FDA_END>
<FDA_START>27298</FDA_START>
<FILE_START>27289</FILE_START>
<IEN_ROOT_END>27325</IEN_ROOT_END>
<IEN_ROOT_START>27323</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27348</FDA_END>
<FDA_START>27338</FDA_START>
<FILE_START>27329</FILE_START>
<IEN_ROOT_END>27354</IEN_ROOT_END>
<IEN_ROOT_START>27353</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27383</FDA_END>
<FDA_START>27367</FDA_START>
<FILE_START>27358</FILE_START>
<IEN_ROOT_END>27390</IEN_ROOT_END>
<IEN_ROOT_START>27388</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27414</FDA_END>
<FDA_START>27403</FDA_START>
<FILE_START>27394</FILE_START>
<IEN_ROOT_END>27420</IEN_ROOT_END>
<IEN_ROOT_START>27419</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27446</FDA_END>
<FDA_START>27433</FDA_START>
<FILE_START>27424</FILE_START>
<IEN_ROOT_END>27452</IEN_ROOT_END>
<IEN_ROOT_START>27451</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27478</FDA_END>
<FDA_START>27465</FDA_START>
<FILE_START>27456</FILE_START>
<IEN_ROOT_END>27484</IEN_ROOT_END>
<IEN_ROOT_START>27483</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27512</FDA_END>
<FDA_START>27497</FDA_START>
<FILE_START>27488</FILE_START>
<IEN_ROOT_END>27519</IEN_ROOT_END>
<IEN_ROOT_START>27517</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27545</FDA_END>
<FDA_START>27532</FDA_START>
<FILE_START>27523</FILE_START>
<IEN_ROOT_END>27551</IEN_ROOT_END>
<IEN_ROOT_START>27550</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27577</FDA_END>
<FDA_START>27564</FDA_START>
<FILE_START>27555</FILE_START>
<IEN_ROOT_END>27582</IEN_ROOT_END>
<IEN_ROOT_START>27582</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27609</FDA_END>
<FDA_START>27595</FDA_START>
<FILE_START>27586</FILE_START>
<IEN_ROOT_END>27615</IEN_ROOT_END>
<IEN_ROOT_START>27614</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27644</FDA_END>
<FDA_START>27628</FDA_START>
<FILE_START>27619</FILE_START>
<IEN_ROOT_END>27652</IEN_ROOT_END>
<IEN_ROOT_START>27649</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27678</FDA_END>
<FDA_START>27665</FDA_START>
<FILE_START>27656</FILE_START>
<IEN_ROOT_END>27684</IEN_ROOT_END>
<IEN_ROOT_START>27683</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27710</FDA_END>
<FDA_START>27697</FDA_START>
<FILE_START>27688</FILE_START>
<IEN_ROOT_END>27716</IEN_ROOT_END>
<IEN_ROOT_START>27715</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27744</FDA_END>
<FDA_START>27729</FDA_START>
<FILE_START>27720</FILE_START>
<IEN_ROOT_END>27751</IEN_ROOT_END>
<IEN_ROOT_START>27749</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27777</FDA_END>
<FDA_START>27764</FDA_START>
<FILE_START>27755</FILE_START>
<IEN_ROOT_END>27783</IEN_ROOT_END>
<IEN_ROOT_START>27782</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27811</FDA_END>
<FDA_START>27796</FDA_START>
<FILE_START>27787</FILE_START>
<IEN_ROOT_END>27817</IEN_ROOT_END>
<IEN_ROOT_START>27816</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27846</FDA_END>
<FDA_START>27830</FDA_START>
<FILE_START>27821</FILE_START>
<IEN_ROOT_END>27854</IEN_ROOT_END>
<IEN_ROOT_START>27851</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27880</FDA_END>
<FDA_START>27867</FDA_START>
<FILE_START>27858</FILE_START>
<IEN_ROOT_END>27886</IEN_ROOT_END>
<IEN_ROOT_START>27885</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27912</FDA_END>
<FDA_START>27899</FDA_START>
<FILE_START>27890</FILE_START>
<IEN_ROOT_END>27918</IEN_ROOT_END>
<IEN_ROOT_START>27917</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27946</FDA_END>
<FDA_START>27931</FDA_START>
<FILE_START>27922</FILE_START>
<IEN_ROOT_END>27953</IEN_ROOT_END>
<IEN_ROOT_START>27951</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>27979</FDA_END>
<FDA_START>27966</FDA_START>
<FILE_START>27957</FILE_START>
<IEN_ROOT_END>27985</IEN_ROOT_END>
<IEN_ROOT_START>27984</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28012</FDA_END>
<FDA_START>27998</FDA_START>
<FILE_START>27989</FILE_START>
<IEN_ROOT_END>28018</IEN_ROOT_END>
<IEN_ROOT_START>28017</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28047</FDA_END>
<FDA_START>28031</FDA_START>
<FILE_START>28022</FILE_START>
<IEN_ROOT_END>28055</IEN_ROOT_END>
<IEN_ROOT_START>28052</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28081</FDA_END>
<FDA_START>28068</FDA_START>
<FILE_START>28059</FILE_START>
<IEN_ROOT_END>28088</IEN_ROOT_END>
<IEN_ROOT_START>28086</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28116</FDA_END>
<FDA_START>28101</FDA_START>
<FILE_START>28092</FILE_START>
<IEN_ROOT_END>28123</IEN_ROOT_END>
<IEN_ROOT_START>28121</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28149</FDA_END>
<FDA_START>28136</FDA_START>
<FILE_START>28127</FILE_START>
<IEN_ROOT_END>28155</IEN_ROOT_END>
<IEN_ROOT_START>28154</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28181</FDA_END>
<FDA_START>28168</FDA_START>
<FILE_START>28159</FILE_START>
<IEN_ROOT_END>28187</IEN_ROOT_END>
<IEN_ROOT_START>28186</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28215</FDA_END>
<FDA_START>28200</FDA_START>
<FILE_START>28191</FILE_START>
<IEN_ROOT_END>28222</IEN_ROOT_END>
<IEN_ROOT_START>28220</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28248</FDA_END>
<FDA_START>28235</FDA_START>
<FILE_START>28226</FILE_START>
<IEN_ROOT_END>28254</IEN_ROOT_END>
<IEN_ROOT_START>28253</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28277</FDA_END>
<FDA_START>28267</FDA_START>
<FILE_START>28258</FILE_START>
<IEN_ROOT_END>28282</IEN_ROOT_END>
<IEN_ROOT_START>28282</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28307</FDA_END>
<FDA_START>28295</FDA_START>
<FILE_START>28286</FILE_START>
<IEN_ROOT_END>28312</IEN_ROOT_END>
<IEN_ROOT_START>28312</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28337</FDA_END>
<FDA_START>28325</FDA_START>
<FILE_START>28316</FILE_START>
<IEN_ROOT_END>28342</IEN_ROOT_END>
<IEN_ROOT_START>28342</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28373</FDA_END>
<FDA_START>28355</FDA_START>
<FILE_START>28346</FILE_START>
<IEN_ROOT_END>28381</IEN_ROOT_END>
<IEN_ROOT_START>28378</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28407</FDA_END>
<FDA_START>28394</FDA_START>
<FILE_START>28385</FILE_START>
<IEN_ROOT_END>28413</IEN_ROOT_END>
<IEN_ROOT_START>28412</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28442</FDA_END>
<FDA_START>28426</FDA_START>
<FILE_START>28417</FILE_START>
<IEN_ROOT_END>28450</IEN_ROOT_END>
<IEN_ROOT_START>28447</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28476</FDA_END>
<FDA_START>28463</FDA_START>
<FILE_START>28454</FILE_START>
<IEN_ROOT_END>28482</IEN_ROOT_END>
<IEN_ROOT_START>28481</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28508</FDA_END>
<FDA_START>28495</FDA_START>
<FILE_START>28486</FILE_START>
<IEN_ROOT_END>28514</IEN_ROOT_END>
<IEN_ROOT_START>28513</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28542</FDA_END>
<FDA_START>28527</FDA_START>
<FILE_START>28518</FILE_START>
<IEN_ROOT_END>28549</IEN_ROOT_END>
<IEN_ROOT_START>28547</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28575</FDA_END>
<FDA_START>28562</FDA_START>
<FILE_START>28553</FILE_START>
<IEN_ROOT_END>28581</IEN_ROOT_END>
<IEN_ROOT_START>28580</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28606</FDA_END>
<FDA_START>28594</FDA_START>
<FILE_START>28585</FILE_START>
<IEN_ROOT_END>28611</IEN_ROOT_END>
<IEN_ROOT_START>28611</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28640</FDA_END>
<FDA_START>28624</FDA_START>
<FILE_START>28615</FILE_START>
<IEN_ROOT_END>28648</IEN_ROOT_END>
<IEN_ROOT_START>28645</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28674</FDA_END>
<FDA_START>28661</FDA_START>
<FILE_START>28652</FILE_START>
<IEN_ROOT_END>28680</IEN_ROOT_END>
<IEN_ROOT_START>28679</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28706</FDA_END>
<FDA_START>28693</FDA_START>
<FILE_START>28684</FILE_START>
<IEN_ROOT_END>28712</IEN_ROOT_END>
<IEN_ROOT_START>28711</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28740</FDA_END>
<FDA_START>28725</FDA_START>
<FILE_START>28716</FILE_START>
<IEN_ROOT_END>28747</IEN_ROOT_END>
<IEN_ROOT_START>28745</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28773</FDA_END>
<FDA_START>28760</FDA_START>
<FILE_START>28751</FILE_START>
<IEN_ROOT_END>28779</IEN_ROOT_END>
<IEN_ROOT_START>28778</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28802</FDA_END>
<FDA_START>28792</FDA_START>
<FILE_START>28783</FILE_START>
<IEN_ROOT_END>28807</IEN_ROOT_END>
<IEN_ROOT_START>28807</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28832</FDA_END>
<FDA_START>28820</FDA_START>
<FILE_START>28811</FILE_START>
<IEN_ROOT_END>28837</IEN_ROOT_END>
<IEN_ROOT_START>28837</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28862</FDA_END>
<FDA_START>28850</FDA_START>
<FILE_START>28841</FILE_START>
<IEN_ROOT_END>28867</IEN_ROOT_END>
<IEN_ROOT_START>28867</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28899</FDA_END>
<FDA_START>28880</FDA_START>
<FILE_START>28871</FILE_START>
<IEN_ROOT_END>28907</IEN_ROOT_END>
<IEN_ROOT_START>28904</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28933</FDA_END>
<FDA_START>28920</FDA_START>
<FILE_START>28911</FILE_START>
<IEN_ROOT_END>28939</IEN_ROOT_END>
<IEN_ROOT_START>28938</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>28968</FDA_END>
<FDA_START>28952</FDA_START>
<FILE_START>28943</FILE_START>
<IEN_ROOT_END>28976</IEN_ROOT_END>
<IEN_ROOT_START>28973</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29003</FDA_END>
<FDA_START>28989</FDA_START>
<FILE_START>28980</FILE_START>
<IEN_ROOT_END>29010</IEN_ROOT_END>
<IEN_ROOT_START>29008</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29037</FDA_END>
<FDA_START>29023</FDA_START>
<FILE_START>29014</FILE_START>
<IEN_ROOT_END>29044</IEN_ROOT_END>
<IEN_ROOT_START>29042</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29070</FDA_END>
<FDA_START>29057</FDA_START>
<FILE_START>29048</FILE_START>
<IEN_ROOT_END>29076</IEN_ROOT_END>
<IEN_ROOT_START>29075</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29102</FDA_END>
<FDA_START>29089</FDA_START>
<FILE_START>29080</FILE_START>
<IEN_ROOT_END>29108</IEN_ROOT_END>
<IEN_ROOT_START>29107</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29136</FDA_END>
<FDA_START>29121</FDA_START>
<FILE_START>29112</FILE_START>
<IEN_ROOT_END>29143</IEN_ROOT_END>
<IEN_ROOT_START>29141</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29169</FDA_END>
<FDA_START>29156</FDA_START>
<FILE_START>29147</FILE_START>
<IEN_ROOT_END>29175</IEN_ROOT_END>
<IEN_ROOT_START>29174</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29201</FDA_END>
<FDA_START>29188</FDA_START>
<FILE_START>29179</FILE_START>
<IEN_ROOT_END>29206</IEN_ROOT_END>
<IEN_ROOT_START>29206</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29234</FDA_END>
<FDA_START>29219</FDA_START>
<FILE_START>29210</FILE_START>
<IEN_ROOT_END>29242</IEN_ROOT_END>
<IEN_ROOT_START>29239</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29268</FDA_END>
<FDA_START>29255</FDA_START>
<FILE_START>29246</FILE_START>
<IEN_ROOT_END>29274</IEN_ROOT_END>
<IEN_ROOT_START>29273</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29300</FDA_END>
<FDA_START>29287</FDA_START>
<FILE_START>29278</FILE_START>
<IEN_ROOT_END>29306</IEN_ROOT_END>
<IEN_ROOT_START>29305</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29334</FDA_END>
<FDA_START>29319</FDA_START>
<FILE_START>29310</FILE_START>
<IEN_ROOT_END>29341</IEN_ROOT_END>
<IEN_ROOT_START>29339</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29367</FDA_END>
<FDA_START>29354</FDA_START>
<FILE_START>29345</FILE_START>
<IEN_ROOT_END>29373</IEN_ROOT_END>
<IEN_ROOT_START>29372</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29400</FDA_END>
<FDA_START>29386</FDA_START>
<FILE_START>29377</FILE_START>
<IEN_ROOT_END>29405</IEN_ROOT_END>
<IEN_ROOT_START>29405</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29434</FDA_END>
<FDA_START>29418</FDA_START>
<FILE_START>29409</FILE_START>
<IEN_ROOT_END>29442</IEN_ROOT_END>
<IEN_ROOT_START>29439</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29468</FDA_END>
<FDA_START>29455</FDA_START>
<FILE_START>29446</FILE_START>
<IEN_ROOT_END>29474</IEN_ROOT_END>
<IEN_ROOT_START>29473</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29500</FDA_END>
<FDA_START>29487</FDA_START>
<FILE_START>29478</FILE_START>
<IEN_ROOT_END>29506</IEN_ROOT_END>
<IEN_ROOT_START>29505</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29534</FDA_END>
<FDA_START>29519</FDA_START>
<FILE_START>29510</FILE_START>
<IEN_ROOT_END>29541</IEN_ROOT_END>
<IEN_ROOT_START>29539</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29567</FDA_END>
<FDA_START>29554</FDA_START>
<FILE_START>29545</FILE_START>
<IEN_ROOT_END>29573</IEN_ROOT_END>
<IEN_ROOT_START>29572</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29599</FDA_END>
<FDA_START>29586</FDA_START>
<FILE_START>29577</FILE_START>
<IEN_ROOT_END>29604</IEN_ROOT_END>
<IEN_ROOT_START>29604</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29633</FDA_END>
<FDA_START>29617</FDA_START>
<FILE_START>29608</FILE_START>
<IEN_ROOT_END>29641</IEN_ROOT_END>
<IEN_ROOT_START>29638</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29667</FDA_END>
<FDA_START>29654</FDA_START>
<FILE_START>29645</FILE_START>
<IEN_ROOT_END>29674</IEN_ROOT_END>
<IEN_ROOT_START>29672</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29701</FDA_END>
<FDA_START>29687</FDA_START>
<FILE_START>29678</FILE_START>
<IEN_ROOT_END>29708</IEN_ROOT_END>
<IEN_ROOT_START>29706</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29733</FDA_END>
<FDA_START>29721</FDA_START>
<FILE_START>29712</FILE_START>
<IEN_ROOT_END>29740</IEN_ROOT_END>
<IEN_ROOT_START>29738</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29773</FDA_END>
<FDA_START>29753</FDA_START>
<FILE_START>29744</FILE_START>
<IEN_ROOT_END>29780</IEN_ROOT_END>
<IEN_ROOT_START>29778</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29804</FDA_END>
<FDA_START>29793</FDA_START>
<FILE_START>29784</FILE_START>
<IEN_ROOT_END>29810</IEN_ROOT_END>
<IEN_ROOT_START>29809</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29839</FDA_END>
<FDA_START>29823</FDA_START>
<FILE_START>29814</FILE_START>
<IEN_ROOT_END>29846</IEN_ROOT_END>
<IEN_ROOT_START>29844</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29870</FDA_END>
<FDA_START>29859</FDA_START>
<FILE_START>29850</FILE_START>
<IEN_ROOT_END>29876</IEN_ROOT_END>
<IEN_ROOT_START>29875</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29906</FDA_END>
<FDA_START>29889</FDA_START>
<FILE_START>29880</FILE_START>
<IEN_ROOT_END>29913</IEN_ROOT_END>
<IEN_ROOT_START>29911</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29940</FDA_END>
<FDA_START>29926</FDA_START>
<FILE_START>29917</FILE_START>
<IEN_ROOT_END>29946</IEN_ROOT_END>
<IEN_ROOT_START>29945</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>29972</FDA_END>
<FDA_START>29959</FDA_START>
<FILE_START>29950</FILE_START>
<IEN_ROOT_END>29978</IEN_ROOT_END>
<IEN_ROOT_START>29977</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30004</FDA_END>
<FDA_START>29991</FDA_START>
<FILE_START>29982</FILE_START>
<IEN_ROOT_END>30010</IEN_ROOT_END>
<IEN_ROOT_START>30009</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30036</FDA_END>
<FDA_START>30023</FDA_START>
<FILE_START>30014</FILE_START>
<IEN_ROOT_END>30042</IEN_ROOT_END>
<IEN_ROOT_START>30041</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30070</FDA_END>
<FDA_START>30055</FDA_START>
<FILE_START>30046</FILE_START>
<IEN_ROOT_END>30077</IEN_ROOT_END>
<IEN_ROOT_START>30075</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30103</FDA_END>
<FDA_START>30090</FDA_START>
<FILE_START>30081</FILE_START>
<IEN_ROOT_END>30109</IEN_ROOT_END>
<IEN_ROOT_START>30108</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30139</FDA_END>
<FDA_START>30122</FDA_START>
<FILE_START>30113</FILE_START>
<IEN_ROOT_END>30147</IEN_ROOT_END>
<IEN_ROOT_START>30144</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30171</FDA_END>
<FDA_START>30160</FDA_START>
<FILE_START>30151</FILE_START>
<IEN_ROOT_END>30177</IEN_ROOT_END>
<IEN_ROOT_START>30176</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30205</FDA_END>
<FDA_START>30190</FDA_START>
<FILE_START>30181</FILE_START>
<IEN_ROOT_END>30211</IEN_ROOT_END>
<IEN_ROOT_START>30210</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30234</FDA_END>
<FDA_START>30224</FDA_START>
<FILE_START>30215</FILE_START>
<IEN_ROOT_END>30240</IEN_ROOT_END>
<IEN_ROOT_START>30239</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30266</FDA_END>
<FDA_START>30253</FDA_START>
<FILE_START>30244</FILE_START>
<IEN_ROOT_END>30272</IEN_ROOT_END>
<IEN_ROOT_START>30271</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30300</FDA_END>
<FDA_START>30285</FDA_START>
<FILE_START>30276</FILE_START>
<IEN_ROOT_END>30307</IEN_ROOT_END>
<IEN_ROOT_START>30305</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30333</FDA_END>
<FDA_START>30320</FDA_START>
<FILE_START>30311</FILE_START>
<IEN_ROOT_END>30339</IEN_ROOT_END>
<IEN_ROOT_START>30338</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30365</FDA_END>
<FDA_START>30352</FDA_START>
<FILE_START>30343</FILE_START>
<IEN_ROOT_END>30371</IEN_ROOT_END>
<IEN_ROOT_START>30370</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30399</FDA_END>
<FDA_START>30384</FDA_START>
<FILE_START>30375</FILE_START>
<IEN_ROOT_END>30406</IEN_ROOT_END>
<IEN_ROOT_START>30404</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30432</FDA_END>
<FDA_START>30419</FDA_START>
<FILE_START>30410</FILE_START>
<IEN_ROOT_END>30438</IEN_ROOT_END>
<IEN_ROOT_START>30437</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30462</FDA_END>
<FDA_START>30451</FDA_START>
<FILE_START>30442</FILE_START>
<IEN_ROOT_END>30467</IEN_ROOT_END>
<IEN_ROOT_START>30467</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30496</FDA_END>
<FDA_START>30480</FDA_START>
<FILE_START>30471</FILE_START>
<IEN_ROOT_END>30504</IEN_ROOT_END>
<IEN_ROOT_START>30501</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30530</FDA_END>
<FDA_START>30517</FDA_START>
<FILE_START>30508</FILE_START>
<IEN_ROOT_END>30536</IEN_ROOT_END>
<IEN_ROOT_START>30535</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30562</FDA_END>
<FDA_START>30549</FDA_START>
<FILE_START>30540</FILE_START>
<IEN_ROOT_END>30568</IEN_ROOT_END>
<IEN_ROOT_START>30567</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30596</FDA_END>
<FDA_START>30581</FDA_START>
<FILE_START>30572</FILE_START>
<IEN_ROOT_END>30603</IEN_ROOT_END>
<IEN_ROOT_START>30601</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30629</FDA_END>
<FDA_START>30616</FDA_START>
<FILE_START>30607</FILE_START>
<IEN_ROOT_END>30635</IEN_ROOT_END>
<IEN_ROOT_START>30634</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30661</FDA_END>
<FDA_START>30648</FDA_START>
<FILE_START>30639</FILE_START>
<IEN_ROOT_END>30667</IEN_ROOT_END>
<IEN_ROOT_START>30666</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30693</FDA_END>
<FDA_START>30680</FDA_START>
<FILE_START>30671</FILE_START>
<IEN_ROOT_END>30699</IEN_ROOT_END>
<IEN_ROOT_START>30698</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30727</FDA_END>
<FDA_START>30712</FDA_START>
<FILE_START>30703</FILE_START>
<IEN_ROOT_END>30734</IEN_ROOT_END>
<IEN_ROOT_START>30732</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30760</FDA_END>
<FDA_START>30747</FDA_START>
<FILE_START>30738</FILE_START>
<IEN_ROOT_END>30766</IEN_ROOT_END>
<IEN_ROOT_START>30765</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30789</FDA_END>
<FDA_START>30779</FDA_START>
<FILE_START>30770</FILE_START>
<IEN_ROOT_END>30794</IEN_ROOT_END>
<IEN_ROOT_START>30794</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30824</FDA_END>
<FDA_START>30807</FDA_START>
<FILE_START>30798</FILE_START>
<IEN_ROOT_END>30832</IEN_ROOT_END>
<IEN_ROOT_START>30829</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30861</FDA_END>
<FDA_START>30845</FDA_START>
<FILE_START>30836</FILE_START>
<IEN_ROOT_END>30867</IEN_ROOT_END>
<IEN_ROOT_START>30866</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30897</FDA_END>
<FDA_START>30880</FDA_START>
<FILE_START>30871</FILE_START>
<IEN_ROOT_END>30905</IEN_ROOT_END>
<IEN_ROOT_START>30902</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30935</FDA_END>
<FDA_START>30918</FDA_START>
<FILE_START>30909</FILE_START>
<IEN_ROOT_END>30943</IEN_ROOT_END>
<IEN_ROOT_START>30940</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>30969</FDA_END>
<FDA_START>30956</FDA_START>
<FILE_START>30947</FILE_START>
<IEN_ROOT_END>30975</IEN_ROOT_END>
<IEN_ROOT_START>30974</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31001</FDA_END>
<FDA_START>30988</FDA_START>
<FILE_START>30979</FILE_START>
<IEN_ROOT_END>31007</IEN_ROOT_END>
<IEN_ROOT_START>31006</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31035</FDA_END>
<FDA_START>31020</FDA_START>
<FILE_START>31011</FILE_START>
<IEN_ROOT_END>31042</IEN_ROOT_END>
<IEN_ROOT_START>31040</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31068</FDA_END>
<FDA_START>31055</FDA_START>
<FILE_START>31046</FILE_START>
<IEN_ROOT_END>31074</IEN_ROOT_END>
<IEN_ROOT_START>31073</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31101</FDA_END>
<FDA_START>31087</FDA_START>
<FILE_START>31078</FILE_START>
<IEN_ROOT_END>31107</IEN_ROOT_END>
<IEN_ROOT_START>31106</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31138</FDA_END>
<FDA_START>31120</FDA_START>
<FILE_START>31111</FILE_START>
<IEN_ROOT_END>31146</IEN_ROOT_END>
<IEN_ROOT_START>31143</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31172</FDA_END>
<FDA_START>31159</FDA_START>
<FILE_START>31150</FILE_START>
<IEN_ROOT_END>31178</IEN_ROOT_END>
<IEN_ROOT_START>31177</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31204</FDA_END>
<FDA_START>31191</FDA_START>
<FILE_START>31182</FILE_START>
<IEN_ROOT_END>31210</IEN_ROOT_END>
<IEN_ROOT_START>31209</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31238</FDA_END>
<FDA_START>31223</FDA_START>
<FILE_START>31214</FILE_START>
<IEN_ROOT_END>31245</IEN_ROOT_END>
<IEN_ROOT_START>31243</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31271</FDA_END>
<FDA_START>31258</FDA_START>
<FILE_START>31249</FILE_START>
<IEN_ROOT_END>31277</IEN_ROOT_END>
<IEN_ROOT_START>31276</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31302</FDA_END>
<FDA_START>31290</FDA_START>
<FILE_START>31281</FILE_START>
<IEN_ROOT_END>31307</IEN_ROOT_END>
<IEN_ROOT_START>31307</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31336</FDA_END>
<FDA_START>31320</FDA_START>
<FILE_START>31311</FILE_START>
<IEN_ROOT_END>31344</IEN_ROOT_END>
<IEN_ROOT_START>31341</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31372</FDA_END>
<FDA_START>31357</FDA_START>
<FILE_START>31348</FILE_START>
<IEN_ROOT_END>31379</IEN_ROOT_END>
<IEN_ROOT_START>31377</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31405</FDA_END>
<FDA_START>31392</FDA_START>
<FILE_START>31383</FILE_START>
<IEN_ROOT_END>31411</IEN_ROOT_END>
<IEN_ROOT_START>31410</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31437</FDA_END>
<FDA_START>31424</FDA_START>
<FILE_START>31415</FILE_START>
<IEN_ROOT_END>31443</IEN_ROOT_END>
<IEN_ROOT_START>31442</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31471</FDA_END>
<FDA_START>31456</FDA_START>
<FILE_START>31447</FILE_START>
<IEN_ROOT_END>31478</IEN_ROOT_END>
<IEN_ROOT_START>31476</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31504</FDA_END>
<FDA_START>31491</FDA_START>
<FILE_START>31482</FILE_START>
<IEN_ROOT_END>31510</IEN_ROOT_END>
<IEN_ROOT_START>31509</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31533</FDA_END>
<FDA_START>31523</FDA_START>
<FILE_START>31514</FILE_START>
<IEN_ROOT_END>31538</IEN_ROOT_END>
<IEN_ROOT_START>31538</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31567</FDA_END>
<FDA_START>31551</FDA_START>
<FILE_START>31542</FILE_START>
<IEN_ROOT_END>31575</IEN_ROOT_END>
<IEN_ROOT_START>31572</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31601</FDA_END>
<FDA_START>31588</FDA_START>
<FILE_START>31579</FILE_START>
<IEN_ROOT_END>31607</IEN_ROOT_END>
<IEN_ROOT_START>31606</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31633</FDA_END>
<FDA_START>31620</FDA_START>
<FILE_START>31611</FILE_START>
<IEN_ROOT_END>31639</IEN_ROOT_END>
<IEN_ROOT_START>31638</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31667</FDA_END>
<FDA_START>31652</FDA_START>
<FILE_START>31643</FILE_START>
<IEN_ROOT_END>31674</IEN_ROOT_END>
<IEN_ROOT_START>31672</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31700</FDA_END>
<FDA_START>31687</FDA_START>
<FILE_START>31678</FILE_START>
<IEN_ROOT_END>31706</IEN_ROOT_END>
<IEN_ROOT_START>31705</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31732</FDA_END>
<FDA_START>31719</FDA_START>
<FILE_START>31710</FILE_START>
<IEN_ROOT_END>31738</IEN_ROOT_END>
<IEN_ROOT_START>31737</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31764</FDA_END>
<FDA_START>31751</FDA_START>
<FILE_START>31742</FILE_START>
<IEN_ROOT_END>31770</IEN_ROOT_END>
<IEN_ROOT_START>31769</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31798</FDA_END>
<FDA_START>31783</FDA_START>
<FILE_START>31774</FILE_START>
<IEN_ROOT_END>31805</IEN_ROOT_END>
<IEN_ROOT_START>31803</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31831</FDA_END>
<FDA_START>31818</FDA_START>
<FILE_START>31809</FILE_START>
<IEN_ROOT_END>31837</IEN_ROOT_END>
<IEN_ROOT_START>31836</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31859</FDA_END>
<FDA_START>31850</FDA_START>
<FILE_START>31841</FILE_START>
<IEN_ROOT_END>31864</IEN_ROOT_END>
<IEN_ROOT_START>31864</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31894</FDA_END>
<FDA_START>31877</FDA_START>
<FILE_START>31868</FILE_START>
<IEN_ROOT_END>31902</IEN_ROOT_END>
<IEN_ROOT_START>31899</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31931</FDA_END>
<FDA_START>31915</FDA_START>
<FILE_START>31906</FILE_START>
<IEN_ROOT_END>31937</IEN_ROOT_END>
<IEN_ROOT_START>31936</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>31966</FDA_END>
<FDA_START>31950</FDA_START>
<FILE_START>31941</FILE_START>
<IEN_ROOT_END>31974</IEN_ROOT_END>
<IEN_ROOT_START>31971</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32004</FDA_END>
<FDA_START>31987</FDA_START>
<FILE_START>31978</FILE_START>
<IEN_ROOT_END>32012</IEN_ROOT_END>
<IEN_ROOT_START>32009</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32050</FDA_END>
<FDA_START>32025</FDA_START>
<FILE_START>32016</FILE_START>
<IEN_ROOT_END>32057</IEN_ROOT_END>
<IEN_ROOT_START>32055</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32084</FDA_END>
<FDA_START>32070</FDA_START>
<FILE_START>32061</FILE_START>
<IEN_ROOT_END>32090</IEN_ROOT_END>
<IEN_ROOT_START>32089</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32144</FDA_END>
<FDA_START>32103</FDA_START>
<FILE_START>32094</FILE_START>
<IEN_ROOT_END>32150</IEN_ROOT_END>
<IEN_ROOT_START>32149</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32176</FDA_END>
<FDA_START>32163</FDA_START>
<FILE_START>32154</FILE_START>
<IEN_ROOT_END>32182</IEN_ROOT_END>
<IEN_ROOT_START>32181</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32208</FDA_END>
<FDA_START>32195</FDA_START>
<FILE_START>32186</FILE_START>
<IEN_ROOT_END>32214</IEN_ROOT_END>
<IEN_ROOT_START>32213</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32242</FDA_END>
<FDA_START>32227</FDA_START>
<FILE_START>32218</FILE_START>
<IEN_ROOT_END>32249</IEN_ROOT_END>
<IEN_ROOT_START>32247</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32275</FDA_END>
<FDA_START>32262</FDA_START>
<FILE_START>32253</FILE_START>
<IEN_ROOT_END>32281</IEN_ROOT_END>
<IEN_ROOT_START>32280</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32309</FDA_END>
<FDA_START>32294</FDA_START>
<FILE_START>32285</FILE_START>
<IEN_ROOT_END>32314</IEN_ROOT_END>
<IEN_ROOT_START>32314</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32343</FDA_END>
<FDA_START>32327</FDA_START>
<FILE_START>32318</FILE_START>
<IEN_ROOT_END>32350</IEN_ROOT_END>
<IEN_ROOT_START>32348</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32380</FDA_END>
<FDA_START>32363</FDA_START>
<FILE_START>32354</FILE_START>
<IEN_ROOT_END>32388</IEN_ROOT_END>
<IEN_ROOT_START>32385</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32416</FDA_END>
<FDA_START>32401</FDA_START>
<FILE_START>32392</FILE_START>
<IEN_ROOT_END>32422</IEN_ROOT_END>
<IEN_ROOT_START>32421</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32450</FDA_END>
<FDA_START>32435</FDA_START>
<FILE_START>32426</FILE_START>
<IEN_ROOT_END>32456</IEN_ROOT_END>
<IEN_ROOT_START>32455</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32479</FDA_END>
<FDA_START>32469</FDA_START>
<FILE_START>32460</FILE_START>
<IEN_ROOT_END>32485</IEN_ROOT_END>
<IEN_ROOT_START>32484</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32508</FDA_END>
<FDA_START>32498</FDA_START>
<FILE_START>32489</FILE_START>
<IEN_ROOT_END>32514</IEN_ROOT_END>
<IEN_ROOT_START>32513</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32542</FDA_END>
<FDA_START>32527</FDA_START>
<FILE_START>32518</FILE_START>
<IEN_ROOT_END>32549</IEN_ROOT_END>
<IEN_ROOT_START>32547</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32575</FDA_END>
<FDA_START>32562</FDA_START>
<FILE_START>32553</FILE_START>
<IEN_ROOT_END>32581</IEN_ROOT_END>
<IEN_ROOT_START>32580</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32607</FDA_END>
<FDA_START>32594</FDA_START>
<FILE_START>32585</FILE_START>
<IEN_ROOT_END>32613</IEN_ROOT_END>
<IEN_ROOT_START>32612</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32641</FDA_END>
<FDA_START>32626</FDA_START>
<FILE_START>32617</FILE_START>
<IEN_ROOT_END>32648</IEN_ROOT_END>
<IEN_ROOT_START>32646</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32674</FDA_END>
<FDA_START>32661</FDA_START>
<FILE_START>32652</FILE_START>
<IEN_ROOT_END>32680</IEN_ROOT_END>
<IEN_ROOT_START>32679</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32705</FDA_END>
<FDA_START>32693</FDA_START>
<FILE_START>32684</FILE_START>
<IEN_ROOT_END>32710</IEN_ROOT_END>
<IEN_ROOT_START>32710</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32739</FDA_END>
<FDA_START>32723</FDA_START>
<FILE_START>32714</FILE_START>
<IEN_ROOT_END>32745</IEN_ROOT_END>
<IEN_ROOT_START>32744</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32775</FDA_END>
<FDA_START>32758</FDA_START>
<FILE_START>32749</FILE_START>
<IEN_ROOT_END>32783</IEN_ROOT_END>
<IEN_ROOT_START>32780</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32813</FDA_END>
<FDA_START>32796</FDA_START>
<FILE_START>32787</FILE_START>
<IEN_ROOT_END>32820</IEN_ROOT_END>
<IEN_ROOT_START>32818</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32844</FDA_END>
<FDA_START>32833</FDA_START>
<FILE_START>32824</FILE_START>
<IEN_ROOT_END>32850</IEN_ROOT_END>
<IEN_ROOT_START>32849</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32876</FDA_END>
<FDA_START>32863</FDA_START>
<FILE_START>32854</FILE_START>
<IEN_ROOT_END>32882</IEN_ROOT_END>
<IEN_ROOT_START>32881</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32908</FDA_END>
<FDA_START>32895</FDA_START>
<FILE_START>32886</FILE_START>
<IEN_ROOT_END>32914</IEN_ROOT_END>
<IEN_ROOT_START>32913</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32942</FDA_END>
<FDA_START>32927</FDA_START>
<FILE_START>32918</FILE_START>
<IEN_ROOT_END>32949</IEN_ROOT_END>
<IEN_ROOT_START>32947</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>32975</FDA_END>
<FDA_START>32962</FDA_START>
<FILE_START>32953</FILE_START>
<IEN_ROOT_END>32981</IEN_ROOT_END>
<IEN_ROOT_START>32980</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33005</FDA_END>
<FDA_START>32994</FDA_START>
<FILE_START>32985</FILE_START>
<IEN_ROOT_END>33010</IEN_ROOT_END>
<IEN_ROOT_START>33010</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33042</FDA_END>
<FDA_START>33023</FDA_START>
<FILE_START>33014</FILE_START>
<IEN_ROOT_END>33050</IEN_ROOT_END>
<IEN_ROOT_START>33047</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33079</FDA_END>
<FDA_START>33063</FDA_START>
<FILE_START>33054</FILE_START>
<IEN_ROOT_END>33086</IEN_ROOT_END>
<IEN_ROOT_START>33084</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33112</FDA_END>
<FDA_START>33099</FDA_START>
<FILE_START>33090</FILE_START>
<IEN_ROOT_END>33118</IEN_ROOT_END>
<IEN_ROOT_START>33117</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33144</FDA_END>
<FDA_START>33131</FDA_START>
<FILE_START>33122</FILE_START>
<IEN_ROOT_END>33150</IEN_ROOT_END>
<IEN_ROOT_START>33149</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33178</FDA_END>
<FDA_START>33163</FDA_START>
<FILE_START>33154</FILE_START>
<IEN_ROOT_END>33185</IEN_ROOT_END>
<IEN_ROOT_START>33183</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33211</FDA_END>
<FDA_START>33198</FDA_START>
<FILE_START>33189</FILE_START>
<IEN_ROOT_END>33217</IEN_ROOT_END>
<IEN_ROOT_START>33216</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33247</FDA_END>
<FDA_START>33230</FDA_START>
<FILE_START>33221</FILE_START>
<IEN_ROOT_END>33255</IEN_ROOT_END>
<IEN_ROOT_START>33252</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33283</FDA_END>
<FDA_START>33268</FDA_START>
<FILE_START>33259</FILE_START>
<IEN_ROOT_END>33290</IEN_ROOT_END>
<IEN_ROOT_START>33288</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33316</FDA_END>
<FDA_START>33303</FDA_START>
<FILE_START>33294</FILE_START>
<IEN_ROOT_END>33322</IEN_ROOT_END>
<IEN_ROOT_START>33321</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33348</FDA_END>
<FDA_START>33335</FDA_START>
<FILE_START>33326</FILE_START>
<IEN_ROOT_END>33354</IEN_ROOT_END>
<IEN_ROOT_START>33353</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33382</FDA_END>
<FDA_START>33367</FDA_START>
<FILE_START>33358</FILE_START>
<IEN_ROOT_END>33389</IEN_ROOT_END>
<IEN_ROOT_START>33387</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33415</FDA_END>
<FDA_START>33402</FDA_START>
<FILE_START>33393</FILE_START>
<IEN_ROOT_END>33421</IEN_ROOT_END>
<IEN_ROOT_START>33420</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33444</FDA_END>
<FDA_START>33434</FDA_START>
<FILE_START>33425</FILE_START>
<IEN_ROOT_END>33449</IEN_ROOT_END>
<IEN_ROOT_START>33449</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33476</FDA_END>
<FDA_START>33462</FDA_START>
<FILE_START>33453</FILE_START>
<IEN_ROOT_END>33482</IEN_ROOT_END>
<IEN_ROOT_START>33481</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33514</FDA_END>
<FDA_START>33495</FDA_START>
<FILE_START>33486</FILE_START>
<IEN_ROOT_END>33522</IEN_ROOT_END>
<IEN_ROOT_START>33519</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33548</FDA_END>
<FDA_START>33535</FDA_START>
<FILE_START>33526</FILE_START>
<IEN_ROOT_END>33554</IEN_ROOT_END>
<IEN_ROOT_START>33553</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33580</FDA_END>
<FDA_START>33567</FDA_START>
<FILE_START>33558</FILE_START>
<IEN_ROOT_END>33586</IEN_ROOT_END>
<IEN_ROOT_START>33585</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33614</FDA_END>
<FDA_START>33599</FDA_START>
<FILE_START>33590</FILE_START>
<IEN_ROOT_END>33621</IEN_ROOT_END>
<IEN_ROOT_START>33619</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33647</FDA_END>
<FDA_START>33634</FDA_START>
<FILE_START>33625</FILE_START>
<IEN_ROOT_END>33653</IEN_ROOT_END>
<IEN_ROOT_START>33652</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33682</FDA_END>
<FDA_START>33666</FDA_START>
<FILE_START>33657</FILE_START>
<IEN_ROOT_END>33688</IEN_ROOT_END>
<IEN_ROOT_START>33687</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33718</FDA_END>
<FDA_START>33701</FDA_START>
<FILE_START>33692</FILE_START>
<IEN_ROOT_END>33726</IEN_ROOT_END>
<IEN_ROOT_START>33723</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33756</FDA_END>
<FDA_START>33739</FDA_START>
<FILE_START>33730</FILE_START>
<IEN_ROOT_END>33764</IEN_ROOT_END>
<IEN_ROOT_START>33761</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33790</FDA_END>
<FDA_START>33777</FDA_START>
<FILE_START>33768</FILE_START>
<IEN_ROOT_END>33797</IEN_ROOT_END>
<IEN_ROOT_START>33795</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33827</FDA_END>
<FDA_START>33810</FDA_START>
<FILE_START>33801</FILE_START>
<IEN_ROOT_END>33834</IEN_ROOT_END>
<IEN_ROOT_START>33832</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33868</FDA_END>
<FDA_START>33847</FDA_START>
<FILE_START>33838</FILE_START>
<IEN_ROOT_END>33877</IEN_ROOT_END>
<IEN_ROOT_START>33873</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33899</FDA_END>
<FDA_START>33890</FDA_START>
<FILE_START>33881</FILE_START>
<IEN_ROOT_END>33904</IEN_ROOT_END>
<IEN_ROOT_START>33904</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33930</FDA_END>
<FDA_START>33917</FDA_START>
<FILE_START>33908</FILE_START>
<IEN_ROOT_END>33936</IEN_ROOT_END>
<IEN_ROOT_START>33935</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33962</FDA_END>
<FDA_START>33949</FDA_START>
<FILE_START>33940</FILE_START>
<IEN_ROOT_END>33968</IEN_ROOT_END>
<IEN_ROOT_START>33967</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>33996</FDA_END>
<FDA_START>33981</FDA_START>
<FILE_START>33972</FILE_START>
<IEN_ROOT_END>34003</IEN_ROOT_END>
<IEN_ROOT_START>34001</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34029</FDA_END>
<FDA_START>34016</FDA_START>
<FILE_START>34007</FILE_START>
<IEN_ROOT_END>34035</IEN_ROOT_END>
<IEN_ROOT_START>34034</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34058</FDA_END>
<FDA_START>34048</FDA_START>
<FILE_START>34039</FILE_START>
<IEN_ROOT_END>34063</IEN_ROOT_END>
<IEN_ROOT_START>34063</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34094</FDA_END>
<FDA_START>34076</FDA_START>
<FILE_START>34067</FILE_START>
<IEN_ROOT_END>34102</IEN_ROOT_END>
<IEN_ROOT_START>34099</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34128</FDA_END>
<FDA_START>34115</FDA_START>
<FILE_START>34106</FILE_START>
<IEN_ROOT_END>34134</IEN_ROOT_END>
<IEN_ROOT_START>34133</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34160</FDA_END>
<FDA_START>34147</FDA_START>
<FILE_START>34138</FILE_START>
<IEN_ROOT_END>34166</IEN_ROOT_END>
<IEN_ROOT_START>34165</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34194</FDA_END>
<FDA_START>34179</FDA_START>
<FILE_START>34170</FILE_START>
<IEN_ROOT_END>34201</IEN_ROOT_END>
<IEN_ROOT_START>34199</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34227</FDA_END>
<FDA_START>34214</FDA_START>
<FILE_START>34205</FILE_START>
<IEN_ROOT_END>34233</IEN_ROOT_END>
<IEN_ROOT_START>34232</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34256</FDA_END>
<FDA_START>34246</FDA_START>
<FILE_START>34237</FILE_START>
<IEN_ROOT_END>34261</IEN_ROOT_END>
<IEN_ROOT_START>34261</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34287</FDA_END>
<FDA_START>34274</FDA_START>
<FILE_START>34265</FILE_START>
<IEN_ROOT_END>34293</IEN_ROOT_END>
<IEN_ROOT_START>34292</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34324</FDA_END>
<FDA_START>34306</FDA_START>
<FILE_START>34297</FILE_START>
<IEN_ROOT_END>34332</IEN_ROOT_END>
<IEN_ROOT_START>34329</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34359</FDA_END>
<FDA_START>34345</FDA_START>
<FILE_START>34336</FILE_START>
<IEN_ROOT_END>34366</IEN_ROOT_END>
<IEN_ROOT_START>34364</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34392</FDA_END>
<FDA_START>34379</FDA_START>
<FILE_START>34370</FILE_START>
<IEN_ROOT_END>34398</IEN_ROOT_END>
<IEN_ROOT_START>34397</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34424</FDA_END>
<FDA_START>34411</FDA_START>
<FILE_START>34402</FILE_START>
<IEN_ROOT_END>34430</IEN_ROOT_END>
<IEN_ROOT_START>34429</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34458</FDA_END>
<FDA_START>34443</FDA_START>
<FILE_START>34434</FILE_START>
<IEN_ROOT_END>34465</IEN_ROOT_END>
<IEN_ROOT_START>34463</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34491</FDA_END>
<FDA_START>34478</FDA_START>
<FILE_START>34469</FILE_START>
<IEN_ROOT_END>34497</IEN_ROOT_END>
<IEN_ROOT_START>34496</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34520</FDA_END>
<FDA_START>34510</FDA_START>
<FILE_START>34501</FILE_START>
<IEN_ROOT_END>34525</IEN_ROOT_END>
<IEN_ROOT_START>34525</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34556</FDA_END>
<FDA_START>34538</FDA_START>
<FILE_START>34529</FILE_START>
<IEN_ROOT_END>34564</IEN_ROOT_END>
<IEN_ROOT_START>34561</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34592</FDA_END>
<FDA_START>34577</FDA_START>
<FILE_START>34568</FILE_START>
<IEN_ROOT_END>34599</IEN_ROOT_END>
<IEN_ROOT_START>34597</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34625</FDA_END>
<FDA_START>34612</FDA_START>
<FILE_START>34603</FILE_START>
<IEN_ROOT_END>34631</IEN_ROOT_END>
<IEN_ROOT_START>34630</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34657</FDA_END>
<FDA_START>34644</FDA_START>
<FILE_START>34635</FILE_START>
<IEN_ROOT_END>34663</IEN_ROOT_END>
<IEN_ROOT_START>34662</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34691</FDA_END>
<FDA_START>34676</FDA_START>
<FILE_START>34667</FILE_START>
<IEN_ROOT_END>34698</IEN_ROOT_END>
<IEN_ROOT_START>34696</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34724</FDA_END>
<FDA_START>34711</FDA_START>
<FILE_START>34702</FILE_START>
<IEN_ROOT_END>34730</IEN_ROOT_END>
<IEN_ROOT_START>34729</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34755</FDA_END>
<FDA_START>34743</FDA_START>
<FILE_START>34734</FILE_START>
<IEN_ROOT_END>34760</IEN_ROOT_END>
<IEN_ROOT_START>34760</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34790</FDA_END>
<FDA_START>34773</FDA_START>
<FILE_START>34764</FILE_START>
<IEN_ROOT_END>34798</IEN_ROOT_END>
<IEN_ROOT_START>34795</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34826</FDA_END>
<FDA_START>34811</FDA_START>
<FILE_START>34802</FILE_START>
<IEN_ROOT_END>34833</IEN_ROOT_END>
<IEN_ROOT_START>34831</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34859</FDA_END>
<FDA_START>34846</FDA_START>
<FILE_START>34837</FILE_START>
<IEN_ROOT_END>34865</IEN_ROOT_END>
<IEN_ROOT_START>34864</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34891</FDA_END>
<FDA_START>34878</FDA_START>
<FILE_START>34869</FILE_START>
<IEN_ROOT_END>34897</IEN_ROOT_END>
<IEN_ROOT_START>34896</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34925</FDA_END>
<FDA_START>34910</FDA_START>
<FILE_START>34901</FILE_START>
<IEN_ROOT_END>34932</IEN_ROOT_END>
<IEN_ROOT_START>34930</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34958</FDA_END>
<FDA_START>34945</FDA_START>
<FILE_START>34936</FILE_START>
<IEN_ROOT_END>34964</IEN_ROOT_END>
<IEN_ROOT_START>34963</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>34987</FDA_END>
<FDA_START>34977</FDA_START>
<FILE_START>34968</FILE_START>
<IEN_ROOT_END>34992</IEN_ROOT_END>
<IEN_ROOT_START>34992</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35016</FDA_END>
<FDA_START>35005</FDA_START>
<FILE_START>34996</FILE_START>
<IEN_ROOT_END>35021</IEN_ROOT_END>
<IEN_ROOT_START>35021</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35053</FDA_END>
<FDA_START>35034</FDA_START>
<FILE_START>35025</FILE_START>
<IEN_ROOT_END>35062</IEN_ROOT_END>
<IEN_ROOT_START>35058</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35087</FDA_END>
<FDA_START>35075</FDA_START>
<FILE_START>35066</FILE_START>
<IEN_ROOT_END>35093</IEN_ROOT_END>
<IEN_ROOT_START>35092</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35119</FDA_END>
<FDA_START>35106</FDA_START>
<FILE_START>35097</FILE_START>
<IEN_ROOT_END>35125</IEN_ROOT_END>
<IEN_ROOT_START>35124</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35151</FDA_END>
<FDA_START>35138</FDA_START>
<FILE_START>35129</FILE_START>
<IEN_ROOT_END>35157</IEN_ROOT_END>
<IEN_ROOT_START>35156</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35185</FDA_END>
<FDA_START>35170</FDA_START>
<FILE_START>35161</FILE_START>
<IEN_ROOT_END>35192</IEN_ROOT_END>
<IEN_ROOT_START>35190</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35218</FDA_END>
<FDA_START>35205</FDA_START>
<FILE_START>35196</FILE_START>
<IEN_ROOT_END>35224</IEN_ROOT_END>
<IEN_ROOT_START>35223</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35247</FDA_END>
<FDA_START>35237</FDA_START>
<FILE_START>35228</FILE_START>
<IEN_ROOT_END>35252</IEN_ROOT_END>
<IEN_ROOT_START>35252</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35279</FDA_END>
<FDA_START>35265</FDA_START>
<FILE_START>35256</FILE_START>
<IEN_ROOT_END>35285</IEN_ROOT_END>
<IEN_ROOT_START>35284</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35317</FDA_END>
<FDA_START>35298</FDA_START>
<FILE_START>35289</FILE_START>
<IEN_ROOT_END>35326</IEN_ROOT_END>
<IEN_ROOT_START>35322</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35351</FDA_END>
<FDA_START>35339</FDA_START>
<FILE_START>35330</FILE_START>
<IEN_ROOT_END>35357</IEN_ROOT_END>
<IEN_ROOT_START>35356</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35385</FDA_END>
<FDA_START>35370</FDA_START>
<FILE_START>35361</FILE_START>
<IEN_ROOT_END>35392</IEN_ROOT_END>
<IEN_ROOT_START>35390</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35418</FDA_END>
<FDA_START>35405</FDA_START>
<FILE_START>35396</FILE_START>
<IEN_ROOT_END>35424</IEN_ROOT_END>
<IEN_ROOT_START>35423</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35450</FDA_END>
<FDA_START>35437</FDA_START>
<FILE_START>35428</FILE_START>
<IEN_ROOT_END>35456</IEN_ROOT_END>
<IEN_ROOT_START>35455</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35484</FDA_END>
<FDA_START>35469</FDA_START>
<FILE_START>35460</FILE_START>
<IEN_ROOT_END>35491</IEN_ROOT_END>
<IEN_ROOT_START>35489</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35517</FDA_END>
<FDA_START>35504</FDA_START>
<FILE_START>35495</FILE_START>
<IEN_ROOT_END>35523</IEN_ROOT_END>
<IEN_ROOT_START>35522</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35547</FDA_END>
<FDA_START>35536</FDA_START>
<FILE_START>35527</FILE_START>
<IEN_ROOT_END>35552</IEN_ROOT_END>
<IEN_ROOT_START>35552</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35584</FDA_END>
<FDA_START>35565</FDA_START>
<FILE_START>35556</FILE_START>
<IEN_ROOT_END>35592</IEN_ROOT_END>
<IEN_ROOT_START>35589</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35620</FDA_END>
<FDA_START>35605</FDA_START>
<FILE_START>35596</FILE_START>
<IEN_ROOT_END>35627</IEN_ROOT_END>
<IEN_ROOT_START>35625</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35653</FDA_END>
<FDA_START>35640</FDA_START>
<FILE_START>35631</FILE_START>
<IEN_ROOT_END>35659</IEN_ROOT_END>
<IEN_ROOT_START>35658</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35685</FDA_END>
<FDA_START>35672</FDA_START>
<FILE_START>35663</FILE_START>
<IEN_ROOT_END>35691</IEN_ROOT_END>
<IEN_ROOT_START>35690</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35719</FDA_END>
<FDA_START>35704</FDA_START>
<FILE_START>35695</FILE_START>
<IEN_ROOT_END>35726</IEN_ROOT_END>
<IEN_ROOT_START>35724</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35752</FDA_END>
<FDA_START>35739</FDA_START>
<FILE_START>35730</FILE_START>
<IEN_ROOT_END>35758</IEN_ROOT_END>
<IEN_ROOT_START>35757</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35783</FDA_END>
<FDA_START>35771</FDA_START>
<FILE_START>35762</FILE_START>
<IEN_ROOT_END>35788</IEN_ROOT_END>
<IEN_ROOT_START>35788</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35820</FDA_END>
<FDA_START>35801</FDA_START>
<FILE_START>35792</FILE_START>
<IEN_ROOT_END>35826</IEN_ROOT_END>
<IEN_ROOT_START>35825</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35857</FDA_END>
<FDA_START>35839</FDA_START>
<FILE_START>35830</FILE_START>
<IEN_ROOT_END>35865</IEN_ROOT_END>
<IEN_ROOT_START>35862</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35891</FDA_END>
<FDA_START>35878</FDA_START>
<FILE_START>35869</FILE_START>
<IEN_ROOT_END>35898</IEN_ROOT_END>
<IEN_ROOT_START>35896</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35930</FDA_END>
<FDA_START>35911</FDA_START>
<FILE_START>35902</FILE_START>
<IEN_ROOT_END>35937</IEN_ROOT_END>
<IEN_ROOT_START>35935</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35963</FDA_END>
<FDA_START>35950</FDA_START>
<FILE_START>35941</FILE_START>
<IEN_ROOT_END>35969</IEN_ROOT_END>
<IEN_ROOT_START>35968</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>35995</FDA_END>
<FDA_START>35982</FDA_START>
<FILE_START>35973</FILE_START>
<IEN_ROOT_END>36001</IEN_ROOT_END>
<IEN_ROOT_START>36000</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36027</FDA_END>
<FDA_START>36014</FDA_START>
<FILE_START>36005</FILE_START>
<IEN_ROOT_END>36033</IEN_ROOT_END>
<IEN_ROOT_START>36032</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36061</FDA_END>
<FDA_START>36046</FDA_START>
<FILE_START>36037</FILE_START>
<IEN_ROOT_END>36068</IEN_ROOT_END>
<IEN_ROOT_START>36066</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36094</FDA_END>
<FDA_START>36081</FDA_START>
<FILE_START>36072</FILE_START>
<IEN_ROOT_END>36099</IEN_ROOT_END>
<IEN_ROOT_START>36099</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36125</FDA_END>
<FDA_START>36112</FDA_START>
<FILE_START>36103</FILE_START>
<IEN_ROOT_END>36131</IEN_ROOT_END>
<IEN_ROOT_START>36130</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36157</FDA_END>
<FDA_START>36144</FDA_START>
<FILE_START>36135</FILE_START>
<IEN_ROOT_END>36163</IEN_ROOT_END>
<IEN_ROOT_START>36162</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36191</FDA_END>
<FDA_START>36176</FDA_START>
<FILE_START>36167</FILE_START>
<IEN_ROOT_END>36198</IEN_ROOT_END>
<IEN_ROOT_START>36196</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36222</FDA_END>
<FDA_START>36211</FDA_START>
<FILE_START>36202</FILE_START>
<IEN_ROOT_END>36227</IEN_ROOT_END>
<IEN_ROOT_START>36227</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36253</FDA_END>
<FDA_START>36240</FDA_START>
<FILE_START>36231</FILE_START>
<IEN_ROOT_END>36259</IEN_ROOT_END>
<IEN_ROOT_START>36258</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36288</FDA_END>
<FDA_START>36272</FDA_START>
<FILE_START>36263</FILE_START>
<IEN_ROOT_END>36296</IEN_ROOT_END>
<IEN_ROOT_START>36293</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36322</FDA_END>
<FDA_START>36309</FDA_START>
<FILE_START>36300</FILE_START>
<IEN_ROOT_END>36328</IEN_ROOT_END>
<IEN_ROOT_START>36327</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36354</FDA_END>
<FDA_START>36341</FDA_START>
<FILE_START>36332</FILE_START>
<IEN_ROOT_END>36360</IEN_ROOT_END>
<IEN_ROOT_START>36359</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36388</FDA_END>
<FDA_START>36373</FDA_START>
<FILE_START>36364</FILE_START>
<IEN_ROOT_END>36395</IEN_ROOT_END>
<IEN_ROOT_START>36393</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36421</FDA_END>
<FDA_START>36408</FDA_START>
<FILE_START>36399</FILE_START>
<IEN_ROOT_END>36427</IEN_ROOT_END>
<IEN_ROOT_START>36426</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36450</FDA_END>
<FDA_START>36440</FDA_START>
<FILE_START>36431</FILE_START>
<IEN_ROOT_END>36455</IEN_ROOT_END>
<IEN_ROOT_START>36455</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36484</FDA_END>
<FDA_START>36468</FDA_START>
<FILE_START>36459</FILE_START>
<IEN_ROOT_END>36492</IEN_ROOT_END>
<IEN_ROOT_START>36489</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36518</FDA_END>
<FDA_START>36505</FDA_START>
<FILE_START>36496</FILE_START>
<IEN_ROOT_END>36524</IEN_ROOT_END>
<IEN_ROOT_START>36523</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36550</FDA_END>
<FDA_START>36537</FDA_START>
<FILE_START>36528</FILE_START>
<IEN_ROOT_END>36556</IEN_ROOT_END>
<IEN_ROOT_START>36555</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36584</FDA_END>
<FDA_START>36569</FDA_START>
<FILE_START>36560</FILE_START>
<IEN_ROOT_END>36591</IEN_ROOT_END>
<IEN_ROOT_START>36589</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36617</FDA_END>
<FDA_START>36604</FDA_START>
<FILE_START>36595</FILE_START>
<IEN_ROOT_END>36623</IEN_ROOT_END>
<IEN_ROOT_START>36622</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36649</FDA_END>
<FDA_START>36636</FDA_START>
<FILE_START>36627</FILE_START>
<IEN_ROOT_END>36655</IEN_ROOT_END>
<IEN_ROOT_START>36654</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36684</FDA_END>
<FDA_START>36668</FDA_START>
<FILE_START>36659</FILE_START>
<IEN_ROOT_END>36692</IEN_ROOT_END>
<IEN_ROOT_START>36689</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36720</FDA_END>
<FDA_START>36705</FDA_START>
<FILE_START>36696</FILE_START>
<IEN_ROOT_END>36727</IEN_ROOT_END>
<IEN_ROOT_START>36725</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36751</FDA_END>
<FDA_START>36740</FDA_START>
<FILE_START>36731</FILE_START>
<IEN_ROOT_END>36756</IEN_ROOT_END>
<IEN_ROOT_START>36756</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36782</FDA_END>
<FDA_START>36769</FDA_START>
<FILE_START>36760</FILE_START>
<IEN_ROOT_END>36788</IEN_ROOT_END>
<IEN_ROOT_START>36787</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36815</FDA_END>
<FDA_START>36801</FDA_START>
<FILE_START>36792</FILE_START>
<IEN_ROOT_END>36822</IEN_ROOT_END>
<IEN_ROOT_START>36820</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36847</FDA_END>
<FDA_START>36835</FDA_START>
<FILE_START>36826</FILE_START>
<IEN_ROOT_END>36854</IEN_ROOT_END>
<IEN_ROOT_START>36852</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36881</FDA_END>
<FDA_START>36867</FDA_START>
<FILE_START>36858</FILE_START>
<IEN_ROOT_END>36887</IEN_ROOT_END>
<IEN_ROOT_START>36886</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36913</FDA_END>
<FDA_START>36900</FDA_START>
<FILE_START>36891</FILE_START>
<IEN_ROOT_END>36919</IEN_ROOT_END>
<IEN_ROOT_START>36918</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36951</FDA_END>
<FDA_START>36932</FDA_START>
<FILE_START>36923</FILE_START>
<IEN_ROOT_END>36960</IEN_ROOT_END>
<IEN_ROOT_START>36956</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>36987</FDA_END>
<FDA_START>36973</FDA_START>
<FILE_START>36964</FILE_START>
<IEN_ROOT_END>36993</IEN_ROOT_END>
<IEN_ROOT_START>36992</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37019</FDA_END>
<FDA_START>37006</FDA_START>
<FILE_START>36997</FILE_START>
<IEN_ROOT_END>37025</IEN_ROOT_END>
<IEN_ROOT_START>37024</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37051</FDA_END>
<FDA_START>37038</FDA_START>
<FILE_START>37029</FILE_START>
<IEN_ROOT_END>37057</IEN_ROOT_END>
<IEN_ROOT_START>37056</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37085</FDA_END>
<FDA_START>37070</FDA_START>
<FILE_START>37061</FILE_START>
<IEN_ROOT_END>37092</IEN_ROOT_END>
<IEN_ROOT_START>37090</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37117</FDA_END>
<FDA_START>37105</FDA_START>
<FILE_START>37096</FILE_START>
<IEN_ROOT_END>37122</IEN_ROOT_END>
<IEN_ROOT_START>37122</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37148</FDA_END>
<FDA_START>37135</FDA_START>
<FILE_START>37126</FILE_START>
<IEN_ROOT_END>37154</IEN_ROOT_END>
<IEN_ROOT_START>37153</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37186</FDA_END>
<FDA_START>37167</FDA_START>
<FILE_START>37158</FILE_START>
<IEN_ROOT_END>37194</IEN_ROOT_END>
<IEN_ROOT_START>37191</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37223</FDA_END>
<FDA_START>37207</FDA_START>
<FILE_START>37198</FILE_START>
<IEN_ROOT_END>37231</IEN_ROOT_END>
<IEN_ROOT_START>37228</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37262</FDA_END>
<FDA_START>37244</FDA_START>
<FILE_START>37235</FILE_START>
<IEN_ROOT_END>37269</IEN_ROOT_END>
<IEN_ROOT_START>37267</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37324</FDA_END>
<FDA_START>37282</FDA_START>
<FILE_START>37273</FILE_START>
<IEN_ROOT_END>37330</IEN_ROOT_END>
<IEN_ROOT_START>37329</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37356</FDA_END>
<FDA_START>37343</FDA_START>
<FILE_START>37334</FILE_START>
<IEN_ROOT_END>37362</IEN_ROOT_END>
<IEN_ROOT_START>37361</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37388</FDA_END>
<FDA_START>37375</FDA_START>
<FILE_START>37366</FILE_START>
<IEN_ROOT_END>37394</IEN_ROOT_END>
<IEN_ROOT_START>37393</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37422</FDA_END>
<FDA_START>37407</FDA_START>
<FILE_START>37398</FILE_START>
<IEN_ROOT_END>37429</IEN_ROOT_END>
<IEN_ROOT_START>37427</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37455</FDA_END>
<FDA_START>37442</FDA_START>
<FILE_START>37433</FILE_START>
<IEN_ROOT_END>37461</IEN_ROOT_END>
<IEN_ROOT_START>37460</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37487</FDA_END>
<FDA_START>37474</FDA_START>
<FILE_START>37465</FILE_START>
<IEN_ROOT_END>37493</IEN_ROOT_END>
<IEN_ROOT_START>37492</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37519</FDA_END>
<FDA_START>37506</FDA_START>
<FILE_START>37497</FILE_START>
<IEN_ROOT_END>37525</IEN_ROOT_END>
<IEN_ROOT_START>37524</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37553</FDA_END>
<FDA_START>37538</FDA_START>
<FILE_START>37529</FILE_START>
<IEN_ROOT_END>37560</IEN_ROOT_END>
<IEN_ROOT_START>37558</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37586</FDA_END>
<FDA_START>37573</FDA_START>
<FILE_START>37564</FILE_START>
<IEN_ROOT_END>37592</IEN_ROOT_END>
<IEN_ROOT_START>37591</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37616</FDA_END>
<FDA_START>37605</FDA_START>
<FILE_START>37596</FILE_START>
<IEN_ROOT_END>37621</IEN_ROOT_END>
<IEN_ROOT_START>37621</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37650</FDA_END>
<FDA_START>37634</FDA_START>
<FILE_START>37625</FILE_START>
<IEN_ROOT_END>37658</IEN_ROOT_END>
<IEN_ROOT_START>37655</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37684</FDA_END>
<FDA_START>37671</FDA_START>
<FILE_START>37662</FILE_START>
<IEN_ROOT_END>37690</IEN_ROOT_END>
<IEN_ROOT_START>37689</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37716</FDA_END>
<FDA_START>37703</FDA_START>
<FILE_START>37694</FILE_START>
<IEN_ROOT_END>37722</IEN_ROOT_END>
<IEN_ROOT_START>37721</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37750</FDA_END>
<FDA_START>37735</FDA_START>
<FILE_START>37726</FILE_START>
<IEN_ROOT_END>37757</IEN_ROOT_END>
<IEN_ROOT_START>37755</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37783</FDA_END>
<FDA_START>37770</FDA_START>
<FILE_START>37761</FILE_START>
<IEN_ROOT_END>37789</IEN_ROOT_END>
<IEN_ROOT_START>37788</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37813</FDA_END>
<FDA_START>37802</FDA_START>
<FILE_START>37793</FILE_START>
<IEN_ROOT_END>37818</IEN_ROOT_END>
<IEN_ROOT_START>37818</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37847</FDA_END>
<FDA_START>37831</FDA_START>
<FILE_START>37822</FILE_START>
<IEN_ROOT_END>37855</IEN_ROOT_END>
<IEN_ROOT_START>37852</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37886</FDA_END>
<FDA_START>37868</FDA_START>
<FILE_START>37859</FILE_START>
<IEN_ROOT_END>37893</IEN_ROOT_END>
<IEN_ROOT_START>37891</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37919</FDA_END>
<FDA_START>37906</FDA_START>
<FILE_START>37897</FILE_START>
<IEN_ROOT_END>37925</IEN_ROOT_END>
<IEN_ROOT_START>37924</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37951</FDA_END>
<FDA_START>37938</FDA_START>
<FILE_START>37929</FILE_START>
<IEN_ROOT_END>37957</IEN_ROOT_END>
<IEN_ROOT_START>37956</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>37985</FDA_END>
<FDA_START>37970</FDA_START>
<FILE_START>37961</FILE_START>
<IEN_ROOT_END>37992</IEN_ROOT_END>
<IEN_ROOT_START>37990</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38018</FDA_END>
<FDA_START>38005</FDA_START>
<FILE_START>37996</FILE_START>
<IEN_ROOT_END>38024</IEN_ROOT_END>
<IEN_ROOT_START>38023</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38048</FDA_END>
<FDA_START>38037</FDA_START>
<FILE_START>38028</FILE_START>
<IEN_ROOT_END>38053</IEN_ROOT_END>
<IEN_ROOT_START>38053</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38085</FDA_END>
<FDA_START>38066</FDA_START>
<FILE_START>38057</FILE_START>
<IEN_ROOT_END>38093</IEN_ROOT_END>
<IEN_ROOT_START>38090</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38119</FDA_END>
<FDA_START>38106</FDA_START>
<FILE_START>38097</FILE_START>
<IEN_ROOT_END>38125</IEN_ROOT_END>
<IEN_ROOT_START>38124</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38151</FDA_END>
<FDA_START>38138</FDA_START>
<FILE_START>38129</FILE_START>
<IEN_ROOT_END>38157</IEN_ROOT_END>
<IEN_ROOT_START>38156</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38185</FDA_END>
<FDA_START>38170</FDA_START>
<FILE_START>38161</FILE_START>
<IEN_ROOT_END>38192</IEN_ROOT_END>
<IEN_ROOT_START>38190</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38218</FDA_END>
<FDA_START>38205</FDA_START>
<FILE_START>38196</FILE_START>
<IEN_ROOT_END>38224</IEN_ROOT_END>
<IEN_ROOT_START>38223</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38249</FDA_END>
<FDA_START>38237</FDA_START>
<FILE_START>38228</FILE_START>
<IEN_ROOT_END>38254</IEN_ROOT_END>
<IEN_ROOT_START>38254</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38286</FDA_END>
<FDA_START>38267</FDA_START>
<FILE_START>38258</FILE_START>
<IEN_ROOT_END>38294</IEN_ROOT_END>
<IEN_ROOT_START>38291</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38325</FDA_END>
<FDA_START>38307</FDA_START>
<FILE_START>38298</FILE_START>
<IEN_ROOT_END>38333</IEN_ROOT_END>
<IEN_ROOT_START>38330</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38354</FDA_END>
<FDA_START>38346</FDA_START>
<FILE_START>38337</FILE_START>
<IEN_ROOT_END>38360</IEN_ROOT_END>
<IEN_ROOT_START>38359</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38382</FDA_END>
<FDA_START>38373</FDA_START>
<FILE_START>38364</FILE_START>
<IEN_ROOT_END>38387</IEN_ROOT_END>
<IEN_ROOT_START>38387</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38417</FDA_END>
<FDA_START>38400</FDA_START>
<FILE_START>38391</FILE_START>
<IEN_ROOT_END>38424</IEN_ROOT_END>
<IEN_ROOT_START>38422</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38456</FDA_END>
<FDA_START>38437</FDA_START>
<FILE_START>38428</FILE_START>
<IEN_ROOT_END>38464</IEN_ROOT_END>
<IEN_ROOT_START>38461</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38489</FDA_END>
<FDA_START>38477</FDA_START>
<FILE_START>38468</FILE_START>
<IEN_ROOT_END>38494</IEN_ROOT_END>
<IEN_ROOT_START>38494</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38519</FDA_END>
<FDA_START>38507</FDA_START>
<FILE_START>38498</FILE_START>
<IEN_ROOT_END>38524</IEN_ROOT_END>
<IEN_ROOT_START>38524</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38550</FDA_END>
<FDA_START>38537</FDA_START>
<FILE_START>38528</FILE_START>
<IEN_ROOT_END>38556</IEN_ROOT_END>
<IEN_ROOT_START>38555</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38582</FDA_END>
<FDA_START>38569</FDA_START>
<FILE_START>38560</FILE_START>
<IEN_ROOT_END>38588</IEN_ROOT_END>
<IEN_ROOT_START>38587</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38614</FDA_END>
<FDA_START>38601</FDA_START>
<FILE_START>38592</FILE_START>
<IEN_ROOT_END>38620</IEN_ROOT_END>
<IEN_ROOT_START>38619</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38648</FDA_END>
<FDA_START>38633</FDA_START>
<FILE_START>38624</FILE_START>
<IEN_ROOT_END>38655</IEN_ROOT_END>
<IEN_ROOT_START>38653</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38688</FDA_END>
<FDA_START>38668</FDA_START>
<FILE_START>38659</FILE_START>
<IEN_ROOT_END>38697</IEN_ROOT_END>
<IEN_ROOT_START>38693</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38720</FDA_END>
<FDA_START>38710</FDA_START>
<FILE_START>38701</FILE_START>
<IEN_ROOT_END>38726</IEN_ROOT_END>
<IEN_ROOT_START>38725</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38752</FDA_END>
<FDA_START>38739</FDA_START>
<FILE_START>38730</FILE_START>
<IEN_ROOT_END>38758</IEN_ROOT_END>
<IEN_ROOT_START>38757</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38784</FDA_END>
<FDA_START>38771</FDA_START>
<FILE_START>38762</FILE_START>
<IEN_ROOT_END>38790</IEN_ROOT_END>
<IEN_ROOT_START>38789</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38818</FDA_END>
<FDA_START>38803</FDA_START>
<FILE_START>38794</FILE_START>
<IEN_ROOT_END>38825</IEN_ROOT_END>
<IEN_ROOT_START>38823</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38851</FDA_END>
<FDA_START>38838</FDA_START>
<FILE_START>38829</FILE_START>
<IEN_ROOT_END>38857</IEN_ROOT_END>
<IEN_ROOT_START>38856</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38881</FDA_END>
<FDA_START>38870</FDA_START>
<FILE_START>38861</FILE_START>
<IEN_ROOT_END>38886</IEN_ROOT_END>
<IEN_ROOT_START>38886</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38918</FDA_END>
<FDA_START>38899</FDA_START>
<FILE_START>38890</FILE_START>
<IEN_ROOT_END>38926</IEN_ROOT_END>
<IEN_ROOT_START>38923</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38948</FDA_END>
<FDA_START>38939</FDA_START>
<FILE_START>38930</FILE_START>
<IEN_ROOT_END>38953</IEN_ROOT_END>
<IEN_ROOT_START>38953</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>38979</FDA_END>
<FDA_START>38966</FDA_START>
<FILE_START>38957</FILE_START>
<IEN_ROOT_END>38985</IEN_ROOT_END>
<IEN_ROOT_START>38984</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39011</FDA_END>
<FDA_START>38998</FDA_START>
<FILE_START>38989</FILE_START>
<IEN_ROOT_END>39017</IEN_ROOT_END>
<IEN_ROOT_START>39016</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39045</FDA_END>
<FDA_START>39030</FDA_START>
<FILE_START>39021</FILE_START>
<IEN_ROOT_END>39052</IEN_ROOT_END>
<IEN_ROOT_START>39050</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39076</FDA_END>
<FDA_START>39065</FDA_START>
<FILE_START>39056</FILE_START>
<IEN_ROOT_END>39081</IEN_ROOT_END>
<IEN_ROOT_START>39081</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39107</FDA_END>
<FDA_START>39094</FDA_START>
<FILE_START>39085</FILE_START>
<IEN_ROOT_END>39113</IEN_ROOT_END>
<IEN_ROOT_START>39112</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39143</FDA_END>
<FDA_START>39126</FDA_START>
<FILE_START>39117</FILE_START>
<IEN_ROOT_END>39151</IEN_ROOT_END>
<IEN_ROOT_START>39148</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39178</FDA_END>
<FDA_START>39164</FDA_START>
<FILE_START>39155</FILE_START>
<IEN_ROOT_END>39185</IEN_ROOT_END>
<IEN_ROOT_START>39183</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39211</FDA_END>
<FDA_START>39198</FDA_START>
<FILE_START>39189</FILE_START>
<IEN_ROOT_END>39217</IEN_ROOT_END>
<IEN_ROOT_START>39216</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39243</FDA_END>
<FDA_START>39230</FDA_START>
<FILE_START>39221</FILE_START>
<IEN_ROOT_END>39249</IEN_ROOT_END>
<IEN_ROOT_START>39248</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39277</FDA_END>
<FDA_START>39262</FDA_START>
<FILE_START>39253</FILE_START>
<IEN_ROOT_END>39284</IEN_ROOT_END>
<IEN_ROOT_START>39282</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39310</FDA_END>
<FDA_START>39297</FDA_START>
<FILE_START>39288</FILE_START>
<IEN_ROOT_END>39316</IEN_ROOT_END>
<IEN_ROOT_START>39315</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39341</FDA_END>
<FDA_START>39329</FDA_START>
<FILE_START>39320</FILE_START>
<IEN_ROOT_END>39346</IEN_ROOT_END>
<IEN_ROOT_START>39346</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39375</FDA_END>
<FDA_START>39359</FDA_START>
<FILE_START>39350</FILE_START>
<IEN_ROOT_END>39383</IEN_ROOT_END>
<IEN_ROOT_START>39380</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39409</FDA_END>
<FDA_START>39396</FDA_START>
<FILE_START>39387</FILE_START>
<IEN_ROOT_END>39415</IEN_ROOT_END>
<IEN_ROOT_START>39414</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39441</FDA_END>
<FDA_START>39428</FDA_START>
<FILE_START>39419</FILE_START>
<IEN_ROOT_END>39447</IEN_ROOT_END>
<IEN_ROOT_START>39446</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39475</FDA_END>
<FDA_START>39460</FDA_START>
<FILE_START>39451</FILE_START>
<IEN_ROOT_END>39482</IEN_ROOT_END>
<IEN_ROOT_START>39480</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39508</FDA_END>
<FDA_START>39495</FDA_START>
<FILE_START>39486</FILE_START>
<IEN_ROOT_END>39514</IEN_ROOT_END>
<IEN_ROOT_START>39513</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39538</FDA_END>
<FDA_START>39527</FDA_START>
<FILE_START>39518</FILE_START>
<IEN_ROOT_END>39543</IEN_ROOT_END>
<IEN_ROOT_START>39543</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39572</FDA_END>
<FDA_START>39556</FDA_START>
<FILE_START>39547</FILE_START>
<IEN_ROOT_END>39580</IEN_ROOT_END>
<IEN_ROOT_START>39577</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39612</FDA_END>
<FDA_START>39593</FDA_START>
<FILE_START>39584</FILE_START>
<IEN_ROOT_END>39620</IEN_ROOT_END>
<IEN_ROOT_START>39617</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39650</FDA_END>
<FDA_START>39633</FDA_START>
<FILE_START>39624</FILE_START>
<IEN_ROOT_END>39657</IEN_ROOT_END>
<IEN_ROOT_START>39655</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39681</FDA_END>
<FDA_START>39670</FDA_START>
<FILE_START>39661</FILE_START>
<IEN_ROOT_END>39687</IEN_ROOT_END>
<IEN_ROOT_START>39686</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39714</FDA_END>
<FDA_START>39700</FDA_START>
<FILE_START>39691</FILE_START>
<IEN_ROOT_END>39719</IEN_ROOT_END>
<IEN_ROOT_START>39719</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39745</FDA_END>
<FDA_START>39732</FDA_START>
<FILE_START>39723</FILE_START>
<IEN_ROOT_END>39751</IEN_ROOT_END>
<IEN_ROOT_START>39750</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39777</FDA_END>
<FDA_START>39764</FDA_START>
<FILE_START>39755</FILE_START>
<IEN_ROOT_END>39783</IEN_ROOT_END>
<IEN_ROOT_START>39782</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39811</FDA_END>
<FDA_START>39796</FDA_START>
<FILE_START>39787</FILE_START>
<IEN_ROOT_END>39818</IEN_ROOT_END>
<IEN_ROOT_START>39816</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39844</FDA_END>
<FDA_START>39831</FDA_START>
<FILE_START>39822</FILE_START>
<IEN_ROOT_END>39850</IEN_ROOT_END>
<IEN_ROOT_START>39849</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39877</FDA_END>
<FDA_START>39863</FDA_START>
<FILE_START>39854</FILE_START>
<IEN_ROOT_END>39882</IEN_ROOT_END>
<IEN_ROOT_START>39882</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39914</FDA_END>
<FDA_START>39895</FDA_START>
<FILE_START>39886</FILE_START>
<IEN_ROOT_END>39923</IEN_ROOT_END>
<IEN_ROOT_START>39919</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39950</FDA_END>
<FDA_START>39936</FDA_START>
<FILE_START>39927</FILE_START>
<IEN_ROOT_END>39957</IEN_ROOT_END>
<IEN_ROOT_START>39955</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>39984</FDA_END>
<FDA_START>39970</FDA_START>
<FILE_START>39961</FILE_START>
<IEN_ROOT_END>39991</IEN_ROOT_END>
<IEN_ROOT_START>39989</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40020</FDA_END>
<FDA_START>40004</FDA_START>
<FILE_START>39995</FILE_START>
<IEN_ROOT_END>40026</IEN_ROOT_END>
<IEN_ROOT_START>40025</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40051</FDA_END>
<FDA_START>40039</FDA_START>
<FILE_START>40030</FILE_START>
<IEN_ROOT_END>40057</IEN_ROOT_END>
<IEN_ROOT_START>40056</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40084</FDA_END>
<FDA_START>40070</FDA_START>
<FILE_START>40061</FILE_START>
<IEN_ROOT_END>40091</IEN_ROOT_END>
<IEN_ROOT_START>40089</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40122</FDA_END>
<FDA_START>40104</FDA_START>
<FILE_START>40095</FILE_START>
<IEN_ROOT_END>40129</IEN_ROOT_END>
<IEN_ROOT_START>40127</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40155</FDA_END>
<FDA_START>40142</FDA_START>
<FILE_START>40133</FILE_START>
<IEN_ROOT_END>40160</IEN_ROOT_END>
<IEN_ROOT_START>40160</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40186</FDA_END>
<FDA_START>40173</FDA_START>
<FILE_START>40164</FILE_START>
<IEN_ROOT_END>40192</IEN_ROOT_END>
<IEN_ROOT_START>40191</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40218</FDA_END>
<FDA_START>40205</FDA_START>
<FILE_START>40196</FILE_START>
<IEN_ROOT_END>40224</IEN_ROOT_END>
<IEN_ROOT_START>40223</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40250</FDA_END>
<FDA_START>40237</FDA_START>
<FILE_START>40228</FILE_START>
<IEN_ROOT_END>40256</IEN_ROOT_END>
<IEN_ROOT_START>40255</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40284</FDA_END>
<FDA_START>40269</FDA_START>
<FILE_START>40260</FILE_START>
<IEN_ROOT_END>40291</IEN_ROOT_END>
<IEN_ROOT_START>40289</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40323</FDA_END>
<FDA_START>40304</FDA_START>
<FILE_START>40295</FILE_START>
<IEN_ROOT_END>40331</IEN_ROOT_END>
<IEN_ROOT_START>40328</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40357</FDA_END>
<FDA_START>40344</FDA_START>
<FILE_START>40335</FILE_START>
<IEN_ROOT_END>40363</IEN_ROOT_END>
<IEN_ROOT_START>40362</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40389</FDA_END>
<FDA_START>40376</FDA_START>
<FILE_START>40367</FILE_START>
<IEN_ROOT_END>40395</IEN_ROOT_END>
<IEN_ROOT_START>40394</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40423</FDA_END>
<FDA_START>40408</FDA_START>
<FILE_START>40399</FILE_START>
<IEN_ROOT_END>40430</IEN_ROOT_END>
<IEN_ROOT_START>40428</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40456</FDA_END>
<FDA_START>40443</FDA_START>
<FILE_START>40434</FILE_START>
<IEN_ROOT_END>40462</IEN_ROOT_END>
<IEN_ROOT_START>40461</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40486</FDA_END>
<FDA_START>40475</FDA_START>
<FILE_START>40466</FILE_START>
<IEN_ROOT_END>40491</IEN_ROOT_END>
<IEN_ROOT_START>40491</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40520</FDA_END>
<FDA_START>40504</FDA_START>
<FILE_START>40495</FILE_START>
<IEN_ROOT_END>40528</IEN_ROOT_END>
<IEN_ROOT_START>40525</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40554</FDA_END>
<FDA_START>40541</FDA_START>
<FILE_START>40532</FILE_START>
<IEN_ROOT_END>40560</IEN_ROOT_END>
<IEN_ROOT_START>40559</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40586</FDA_END>
<FDA_START>40573</FDA_START>
<FILE_START>40564</FILE_START>
<IEN_ROOT_END>40592</IEN_ROOT_END>
<IEN_ROOT_START>40591</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40620</FDA_END>
<FDA_START>40605</FDA_START>
<FILE_START>40596</FILE_START>
<IEN_ROOT_END>40627</IEN_ROOT_END>
<IEN_ROOT_START>40625</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40653</FDA_END>
<FDA_START>40640</FDA_START>
<FILE_START>40631</FILE_START>
<IEN_ROOT_END>40659</IEN_ROOT_END>
<IEN_ROOT_START>40658</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40682</FDA_END>
<FDA_START>40672</FDA_START>
<FILE_START>40663</FILE_START>
<IEN_ROOT_END>40687</IEN_ROOT_END>
<IEN_ROOT_START>40687</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40715</FDA_END>
<FDA_START>40700</FDA_START>
<FILE_START>40691</FILE_START>
<IEN_ROOT_END>40721</IEN_ROOT_END>
<IEN_ROOT_START>40720</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40750</FDA_END>
<FDA_START>40734</FDA_START>
<FILE_START>40725</FILE_START>
<IEN_ROOT_END>40758</IEN_ROOT_END>
<IEN_ROOT_START>40755</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40790</FDA_END>
<FDA_START>40771</FDA_START>
<FILE_START>40762</FILE_START>
<IEN_ROOT_END>40797</IEN_ROOT_END>
<IEN_ROOT_START>40795</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40823</FDA_END>
<FDA_START>40810</FDA_START>
<FILE_START>40801</FILE_START>
<IEN_ROOT_END>40829</IEN_ROOT_END>
<IEN_ROOT_START>40828</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40852</FDA_END>
<FDA_START>40842</FDA_START>
<FILE_START>40833</FILE_START>
<IEN_ROOT_END>40858</IEN_ROOT_END>
<IEN_ROOT_START>40857</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40885</FDA_END>
<FDA_START>40871</FDA_START>
<FILE_START>40862</FILE_START>
<IEN_ROOT_END>40891</IEN_ROOT_END>
<IEN_ROOT_START>40890</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40917</FDA_END>
<FDA_START>40904</FDA_START>
<FILE_START>40895</FILE_START>
<IEN_ROOT_END>40922</IEN_ROOT_END>
<IEN_ROOT_START>40922</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40948</FDA_END>
<FDA_START>40935</FDA_START>
<FILE_START>40926</FILE_START>
<IEN_ROOT_END>40955</IEN_ROOT_END>
<IEN_ROOT_START>40953</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>40981</FDA_END>
<FDA_START>40968</FDA_START>
<FILE_START>40959</FILE_START>
<IEN_ROOT_END>40987</IEN_ROOT_END>
<IEN_ROOT_START>40986</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41013</FDA_END>
<FDA_START>41000</FDA_START>
<FILE_START>40991</FILE_START>
<IEN_ROOT_END>41019</IEN_ROOT_END>
<IEN_ROOT_START>41018</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41047</FDA_END>
<FDA_START>41032</FDA_START>
<FILE_START>41023</FILE_START>
<IEN_ROOT_END>41054</IEN_ROOT_END>
<IEN_ROOT_START>41052</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41080</FDA_END>
<FDA_START>41067</FDA_START>
<FILE_START>41058</FILE_START>
<IEN_ROOT_END>41086</IEN_ROOT_END>
<IEN_ROOT_START>41085</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41112</FDA_END>
<FDA_START>41099</FDA_START>
<FILE_START>41090</FILE_START>
<IEN_ROOT_END>41117</IEN_ROOT_END>
<IEN_ROOT_START>41117</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41147</FDA_END>
<FDA_START>41130</FDA_START>
<FILE_START>41121</FILE_START>
<IEN_ROOT_END>41155</IEN_ROOT_END>
<IEN_ROOT_START>41152</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41181</FDA_END>
<FDA_START>41168</FDA_START>
<FILE_START>41159</FILE_START>
<IEN_ROOT_END>41187</IEN_ROOT_END>
<IEN_ROOT_START>41186</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41213</FDA_END>
<FDA_START>41200</FDA_START>
<FILE_START>41191</FILE_START>
<IEN_ROOT_END>41219</IEN_ROOT_END>
<IEN_ROOT_START>41218</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41247</FDA_END>
<FDA_START>41232</FDA_START>
<FILE_START>41223</FILE_START>
<IEN_ROOT_END>41254</IEN_ROOT_END>
<IEN_ROOT_START>41252</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41280</FDA_END>
<FDA_START>41267</FDA_START>
<FILE_START>41258</FILE_START>
<IEN_ROOT_END>41286</IEN_ROOT_END>
<IEN_ROOT_START>41285</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41309</FDA_END>
<FDA_START>41299</FDA_START>
<FILE_START>41290</FILE_START>
<IEN_ROOT_END>41314</IEN_ROOT_END>
<IEN_ROOT_START>41314</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41344</FDA_END>
<FDA_START>41327</FDA_START>
<FILE_START>41318</FILE_START>
<IEN_ROOT_END>41350</IEN_ROOT_END>
<IEN_ROOT_START>41349</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41380</FDA_END>
<FDA_START>41363</FDA_START>
<FILE_START>41354</FILE_START>
<IEN_ROOT_END>41388</IEN_ROOT_END>
<IEN_ROOT_START>41385</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41418</FDA_END>
<FDA_START>41401</FDA_START>
<FILE_START>41392</FILE_START>
<IEN_ROOT_END>41426</IEN_ROOT_END>
<IEN_ROOT_START>41423</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41452</FDA_END>
<FDA_START>41439</FDA_START>
<FILE_START>41430</FILE_START>
<IEN_ROOT_END>41458</IEN_ROOT_END>
<IEN_ROOT_START>41457</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41484</FDA_END>
<FDA_START>41471</FDA_START>
<FILE_START>41462</FILE_START>
<IEN_ROOT_END>41490</IEN_ROOT_END>
<IEN_ROOT_START>41489</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41518</FDA_END>
<FDA_START>41503</FDA_START>
<FILE_START>41494</FILE_START>
<IEN_ROOT_END>41525</IEN_ROOT_END>
<IEN_ROOT_START>41523</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41551</FDA_END>
<FDA_START>41538</FDA_START>
<FILE_START>41529</FILE_START>
<IEN_ROOT_END>41557</IEN_ROOT_END>
<IEN_ROOT_START>41556</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41581</FDA_END>
<FDA_START>41570</FDA_START>
<FILE_START>41561</FILE_START>
<IEN_ROOT_END>41586</IEN_ROOT_END>
<IEN_ROOT_START>41586</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41616</FDA_END>
<FDA_START>41599</FDA_START>
<FILE_START>41590</FILE_START>
<IEN_ROOT_END>41624</IEN_ROOT_END>
<IEN_ROOT_START>41621</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41652</FDA_END>
<FDA_START>41637</FDA_START>
<FILE_START>41628</FILE_START>
<IEN_ROOT_END>41659</IEN_ROOT_END>
<IEN_ROOT_START>41657</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41689</FDA_END>
<FDA_START>41672</FDA_START>
<FILE_START>41663</FILE_START>
<IEN_ROOT_END>41695</IEN_ROOT_END>
<IEN_ROOT_START>41694</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41721</FDA_END>
<FDA_START>41708</FDA_START>
<FILE_START>41699</FILE_START>
<IEN_ROOT_END>41727</IEN_ROOT_END>
<IEN_ROOT_START>41726</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41753</FDA_END>
<FDA_START>41740</FDA_START>
<FILE_START>41731</FILE_START>
<IEN_ROOT_END>41759</IEN_ROOT_END>
<IEN_ROOT_START>41758</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41787</FDA_END>
<FDA_START>41772</FDA_START>
<FILE_START>41763</FILE_START>
<IEN_ROOT_END>41794</IEN_ROOT_END>
<IEN_ROOT_START>41792</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41820</FDA_END>
<FDA_START>41807</FDA_START>
<FILE_START>41798</FILE_START>
<IEN_ROOT_END>41826</IEN_ROOT_END>
<IEN_ROOT_START>41825</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41857</FDA_END>
<FDA_START>41839</FDA_START>
<FILE_START>41830</FILE_START>
<IEN_ROOT_END>41865</IEN_ROOT_END>
<IEN_ROOT_START>41862</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41892</FDA_END>
<FDA_START>41878</FDA_START>
<FILE_START>41869</FILE_START>
<IEN_ROOT_END>41899</IEN_ROOT_END>
<IEN_ROOT_START>41897</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41925</FDA_END>
<FDA_START>41912</FDA_START>
<FILE_START>41903</FILE_START>
<IEN_ROOT_END>41931</IEN_ROOT_END>
<IEN_ROOT_START>41930</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41957</FDA_END>
<FDA_START>41944</FDA_START>
<FILE_START>41935</FILE_START>
<IEN_ROOT_END>41963</IEN_ROOT_END>
<IEN_ROOT_START>41962</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>41991</FDA_END>
<FDA_START>41976</FDA_START>
<FILE_START>41967</FILE_START>
<IEN_ROOT_END>41998</IEN_ROOT_END>
<IEN_ROOT_START>41996</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42024</FDA_END>
<FDA_START>42011</FDA_START>
<FILE_START>42002</FILE_START>
<IEN_ROOT_END>42030</IEN_ROOT_END>
<IEN_ROOT_START>42029</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42054</FDA_END>
<FDA_START>42043</FDA_START>
<FILE_START>42034</FILE_START>
<IEN_ROOT_END>42059</IEN_ROOT_END>
<IEN_ROOT_START>42059</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42088</FDA_END>
<FDA_START>42072</FDA_START>
<FILE_START>42063</FILE_START>
<IEN_ROOT_END>42096</IEN_ROOT_END>
<IEN_ROOT_START>42093</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42124</FDA_END>
<FDA_START>42109</FDA_START>
<FILE_START>42100</FILE_START>
<IEN_ROOT_END>42131</IEN_ROOT_END>
<IEN_ROOT_START>42129</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42161</FDA_END>
<FDA_START>42144</FDA_START>
<FILE_START>42135</FILE_START>
<IEN_ROOT_END>42167</IEN_ROOT_END>
<IEN_ROOT_START>42166</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42193</FDA_END>
<FDA_START>42180</FDA_START>
<FILE_START>42171</FILE_START>
<IEN_ROOT_END>42199</IEN_ROOT_END>
<IEN_ROOT_START>42198</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42225</FDA_END>
<FDA_START>42212</FDA_START>
<FILE_START>42203</FILE_START>
<IEN_ROOT_END>42231</IEN_ROOT_END>
<IEN_ROOT_START>42230</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42259</FDA_END>
<FDA_START>42244</FDA_START>
<FILE_START>42235</FILE_START>
<IEN_ROOT_END>42266</IEN_ROOT_END>
<IEN_ROOT_START>42264</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42292</FDA_END>
<FDA_START>42279</FDA_START>
<FILE_START>42270</FILE_START>
<IEN_ROOT_END>42298</IEN_ROOT_END>
<IEN_ROOT_START>42297</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42328</FDA_END>
<FDA_START>42311</FDA_START>
<FILE_START>42302</FILE_START>
<IEN_ROOT_END>42336</IEN_ROOT_END>
<IEN_ROOT_START>42333</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42363</FDA_END>
<FDA_START>42349</FDA_START>
<FILE_START>42340</FILE_START>
<IEN_ROOT_END>42370</IEN_ROOT_END>
<IEN_ROOT_START>42368</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42396</FDA_END>
<FDA_START>42383</FDA_START>
<FILE_START>42374</FILE_START>
<IEN_ROOT_END>42402</IEN_ROOT_END>
<IEN_ROOT_START>42401</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42428</FDA_END>
<FDA_START>42415</FDA_START>
<FILE_START>42406</FILE_START>
<IEN_ROOT_END>42434</IEN_ROOT_END>
<IEN_ROOT_START>42433</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42462</FDA_END>
<FDA_START>42447</FDA_START>
<FILE_START>42438</FILE_START>
<IEN_ROOT_END>42469</IEN_ROOT_END>
<IEN_ROOT_START>42467</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42495</FDA_END>
<FDA_START>42482</FDA_START>
<FILE_START>42473</FILE_START>
<IEN_ROOT_END>42501</IEN_ROOT_END>
<IEN_ROOT_START>42500</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42525</FDA_END>
<FDA_START>42514</FDA_START>
<FILE_START>42505</FILE_START>
<IEN_ROOT_END>42530</IEN_ROOT_END>
<IEN_ROOT_START>42530</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42556</FDA_END>
<FDA_START>42543</FDA_START>
<FILE_START>42534</FILE_START>
<IEN_ROOT_END>42561</IEN_ROOT_END>
<IEN_ROOT_START>42561</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42593</FDA_END>
<FDA_START>42574</FDA_START>
<FILE_START>42565</FILE_START>
<IEN_ROOT_END>42602</IEN_ROOT_END>
<IEN_ROOT_START>42598</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42625</FDA_END>
<FDA_START>42615</FDA_START>
<FILE_START>42606</FILE_START>
<IEN_ROOT_END>42631</IEN_ROOT_END>
<IEN_ROOT_START>42630</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42658</FDA_END>
<FDA_START>42644</FDA_START>
<FILE_START>42635</FILE_START>
<IEN_ROOT_END>42665</IEN_ROOT_END>
<IEN_ROOT_START>42663</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42697</FDA_END>
<FDA_START>42678</FDA_START>
<FILE_START>42669</FILE_START>
<IEN_ROOT_END>42704</IEN_ROOT_END>
<IEN_ROOT_START>42702</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42730</FDA_END>
<FDA_START>42717</FDA_START>
<FILE_START>42708</FILE_START>
<IEN_ROOT_END>42736</IEN_ROOT_END>
<IEN_ROOT_START>42735</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42762</FDA_END>
<FDA_START>42749</FDA_START>
<FILE_START>42740</FILE_START>
<IEN_ROOT_END>42768</IEN_ROOT_END>
<IEN_ROOT_START>42767</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42794</FDA_END>
<FDA_START>42781</FDA_START>
<FILE_START>42772</FILE_START>
<IEN_ROOT_END>42800</IEN_ROOT_END>
<IEN_ROOT_START>42799</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42828</FDA_END>
<FDA_START>42813</FDA_START>
<FILE_START>42804</FILE_START>
<IEN_ROOT_END>42835</IEN_ROOT_END>
<IEN_ROOT_START>42833</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42861</FDA_END>
<FDA_START>42848</FDA_START>
<FILE_START>42839</FILE_START>
<IEN_ROOT_END>42867</IEN_ROOT_END>
<IEN_ROOT_START>42866</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42891</FDA_END>
<FDA_START>42880</FDA_START>
<FILE_START>42871</FILE_START>
<IEN_ROOT_END>42896</IEN_ROOT_END>
<IEN_ROOT_START>42896</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42925</FDA_END>
<FDA_START>42909</FDA_START>
<FILE_START>42900</FILE_START>
<IEN_ROOT_END>42933</IEN_ROOT_END>
<IEN_ROOT_START>42930</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>42966</FDA_END>
<FDA_START>42946</FDA_START>
<FILE_START>42937</FILE_START>
<IEN_ROOT_END>42974</IEN_ROOT_END>
<IEN_ROOT_START>42971</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43007</FDA_END>
<FDA_START>42987</FDA_START>
<FILE_START>42978</FILE_START>
<IEN_ROOT_END>43013</IEN_ROOT_END>
<IEN_ROOT_START>43012</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43037</FDA_END>
<FDA_START>43026</FDA_START>
<FILE_START>43017</FILE_START>
<IEN_ROOT_END>43043</IEN_ROOT_END>
<IEN_ROOT_START>43042</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43075</FDA_END>
<FDA_START>43056</FDA_START>
<FILE_START>43047</FILE_START>
<IEN_ROOT_END>43082</IEN_ROOT_END>
<IEN_ROOT_START>43080</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43108</FDA_END>
<FDA_START>43095</FDA_START>
<FILE_START>43086</FILE_START>
<IEN_ROOT_END>43114</IEN_ROOT_END>
<IEN_ROOT_START>43113</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43143</FDA_END>
<FDA_START>43127</FDA_START>
<FILE_START>43118</FILE_START>
<IEN_ROOT_END>43151</IEN_ROOT_END>
<IEN_ROOT_START>43148</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43177</FDA_END>
<FDA_START>43164</FDA_START>
<FILE_START>43155</FILE_START>
<IEN_ROOT_END>43183</IEN_ROOT_END>
<IEN_ROOT_START>43182</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43210</FDA_END>
<FDA_START>43196</FDA_START>
<FILE_START>43187</FILE_START>
<IEN_ROOT_END>43215</IEN_ROOT_END>
<IEN_ROOT_START>43215</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43246</FDA_END>
<FDA_START>43228</FDA_START>
<FILE_START>43219</FILE_START>
<IEN_ROOT_END>43253</IEN_ROOT_END>
<IEN_ROOT_START>43251</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43286</FDA_END>
<FDA_START>43266</FDA_START>
<FILE_START>43257</FILE_START>
<IEN_ROOT_END>43294</IEN_ROOT_END>
<IEN_ROOT_START>43291</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43318</FDA_END>
<FDA_START>43307</FDA_START>
<FILE_START>43298</FILE_START>
<IEN_ROOT_END>43325</IEN_ROOT_END>
<IEN_ROOT_START>43323</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43349</FDA_END>
<FDA_START>43338</FDA_START>
<FILE_START>43329</FILE_START>
<IEN_ROOT_END>43354</IEN_ROOT_END>
<IEN_ROOT_START>43354</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43396</FDA_END>
<FDA_START>43367</FDA_START>
<FILE_START>43358</FILE_START>
<IEN_ROOT_END>43402</IEN_ROOT_END>
<IEN_ROOT_START>43401</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43424</FDA_END>
<FDA_START>43415</FDA_START>
<FILE_START>43406</FILE_START>
<IEN_ROOT_END>43429</IEN_ROOT_END>
<IEN_ROOT_START>43429</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43454</FDA_END>
<FDA_START>43442</FDA_START>
<FILE_START>43433</FILE_START>
<IEN_ROOT_END>43459</IEN_ROOT_END>
<IEN_ROOT_START>43459</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43482</FDA_END>
<FDA_START>43472</FDA_START>
<FILE_START>43463</FILE_START>
<IEN_ROOT_END>43487</IEN_ROOT_END>
<IEN_ROOT_START>43487</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43537</FDA_END>
<FDA_START>43500</FDA_START>
<FILE_START>43491</FILE_START>
<IEN_ROOT_END>43543</IEN_ROOT_END>
<IEN_ROOT_START>43542</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43592</FDA_END>
<FDA_START>43556</FDA_START>
<FILE_START>43547</FILE_START>
<IEN_ROOT_END>43598</IEN_ROOT_END>
<IEN_ROOT_START>43597</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43692</FDA_END>
<FDA_START>43611</FDA_START>
<FILE_START>43602</FILE_START>
<IEN_ROOT_END>43698</IEN_ROOT_END>
<IEN_ROOT_START>43697</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43720</FDA_END>
<FDA_START>43711</FDA_START>
<FILE_START>43702</FILE_START>
<IEN_ROOT_END>43725</IEN_ROOT_END>
<IEN_ROOT_START>43725</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43763</FDA_END>
<FDA_START>43738</FDA_START>
<FILE_START>43729</FILE_START>
<IEN_ROOT_END>43777</IEN_ROOT_END>
<IEN_ROOT_START>43768</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43803</FDA_END>
<FDA_START>43790</FDA_START>
<FILE_START>43781</FILE_START>
<IEN_ROOT_END>43811</IEN_ROOT_END>
<IEN_ROOT_START>43808</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>43833</FDA_END>
<FDA_START>43824</FDA_START>
<FILE_START>43815</FILE_START>
<IEN_ROOT_END>43839</IEN_ROOT_END>
<IEN_ROOT_START>43838</IEN_ROOT_START>
</COMPONENT>
</INDEX>
</REMINDER_EXCHANGE_FILE_ENTRY>
